<SEC-DOCUMENT>0001638833-22-000122.txt : 20220802
<SEC-HEADER>0001638833-22-000122.hdr.sgml : 20220802
<ACCEPTANCE-DATETIME>20220802164446
ACCESSION NUMBER:		0001638833-22-000122
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		68
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220802
DATE AS OF CHANGE:		20220802

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Surgery Partners, Inc.
		CENTRAL INDEX KEY:			0001638833
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				473620923
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37576
		FILM NUMBER:		221129400

	BUSINESS ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
		BUSINESS PHONE:		615-234-5900

	MAIL ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sgry-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:bf0c9919-675a-4090-9889-2da6d013d12b,g:8071f056-30bb-4692-9c60-1fa924dc9a77,d:7c5babcb2c6b48dbb62fc1c06bdcd830--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:sgry="http://www.surgerypartners.com/20220630" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgry-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80L2ZyYWc6MjFmM2ViNGIwM2M5NDFkMDg3NDVhYTI0NWE0MTVmOTIvdGFibGU6ODg4NzkxNGZmODJlNDNjNzkwMmY2OTU4MTAwNTFmZTkvdGFibGVyYW5nZTo4ODg3OTE0ZmY4MmU0M2M3OTAyZjY5NTgxMDA1MWZlOV80LTEtMS0xLTQ3NTc1_411be701-095a-43c7-85f1-b8a5aa0109d4">0001638833</ix:nonNumeric><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80L2ZyYWc6MjFmM2ViNGIwM2M5NDFkMDg3NDVhYTI0NWE0MTVmOTIvdGFibGU6ODg4NzkxNGZmODJlNDNjNzkwMmY2OTU4MTAwNTFmZTkvdGFibGVyYW5nZTo4ODg3OTE0ZmY4MmU0M2M3OTAyZjY5NTgxMDA1MWZlOV81LTEtMS0xLTQ3NTc1_7d5ff8d3-1a42-4402-a976-ccda2d0ae06a">12/31</ix:nonNumeric><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80L2ZyYWc6MjFmM2ViNGIwM2M5NDFkMDg3NDVhYTI0NWE0MTVmOTIvdGFibGU6ODg4NzkxNGZmODJlNDNjNzkwMmY2OTU4MTAwNTFmZTkvdGFibGVyYW5nZTo4ODg3OTE0ZmY4MmU0M2M3OTAyZjY5NTgxMDA1MWZlOV85LTEtMS0xLTQ3NTc1_136d182c-844b-45e0-8953-0e42cfc62816">2022</ix:nonNumeric><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80L2ZyYWc6MjFmM2ViNGIwM2M5NDFkMDg3NDVhYTI0NWE0MTVmOTIvdGFibGU6ODg4NzkxNGZmODJlNDNjNzkwMmY2OTU4MTAwNTFmZTkvdGFibGVyYW5nZTo4ODg3OTE0ZmY4MmU0M2M3OTAyZjY5NTgxMDA1MWZlOV8xMC0xLTEtMS00NzU3NQ_6d185400-9471-40f3-90c7-3821be85b064">Q2</ix:nonNumeric><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80L2ZyYWc6MjFmM2ViNGIwM2M5NDFkMDg3NDVhYTI0NWE0MTVmOTIvdGFibGU6ODg4NzkxNGZmODJlNDNjNzkwMmY2OTU4MTAwNTFmZTkvdGFibGVyYW5nZTo4ODg3OTE0ZmY4MmU0M2M3OTAyZjY5NTgxMDA1MWZlOV8xMS0xLTEtMS00NzU3NQ_2f120ab3-2858-4f34-b90d-80d78cc52483">false</ix:nonNumeric><ix:nonNumeric contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_0490c164-1bcc-4f55-85d3-15e9331ed7ed">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_4a2e4f93-28b9-4c5f-bc07-6358d546de18">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_00060c4f-1b87-4bb0-b65b-4b1328751e7d">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_f34bfa11-29e3-4790-b94f-70125ea4d07f">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_82470289-02c8-4ee9-bb12-c86df2a2d59b">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_d09186d5-2c70-43f5-ba46-c5f5d380a2bb">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_2188135b-10a8-4d73-88ea-7b90cf795fbd">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_eb2749f0-b898-4460-8f9b-f8a8c6f0701f">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sgry-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08eaf5cf61dd49bda81b3a7c558d3bc4_I20220726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i05b7208bc5d946119ab875dbf0311579_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65b4d531cb9b48cd894460f4e16463be_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i874b93f4f80843419c99212b693021ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a8ee0761a1d4c8c9f56f071d5e4f410_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5321f94b5324566bedb956ae6c2fb92_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie15ac736956f49c883e02995bab6b9aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ce39eddcaef4480b057800dbc9fc415_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44e20b461fac4de38f9910707892a5b3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i727c848f12464ac9868395007955636a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddbc40dd884d4204a58cb11045457ae7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70c54c1f4edd4426a5c3c25dbe35d19a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic945102fb54c4d69855b08862add35a9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70a9d633a0ba4f6b8deb6abf6e42e588_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bbcf15e953044c9bb4256698275b17c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a2a308f404d4462a20f521a6049c6e7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9f9d0d0f7404a6fb2b9f70e9127679b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cc82a550101490d9ba4c262f7e759a9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa9e74d27950455e8f7ebd062dccc167_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7600816d839d42ceb914df213ec157f6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9b0391f35644b1d9d20974a5c75b7a8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20255b89339547c0a3a555a0aa07dc59_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2627c134a054c6c8194c8cf5b5c40e3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i520879363a004c03b48b9aa26d49ec3b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86d62a7c424e47d19d145f6ebf771221_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64a8818a24674f2faae8cfbfd2edb750_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0cb6e6c59764f929e1812a53232bc2f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75ea718f255443ed9371e7d4a9085825_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4482a6ba65743ca8c0b52945eadf553_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i293881ff9efc4258a9030c4efeddff54_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95848062d06c4c1a9b5d0bb79f725a76_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd8e1125342f40899ab99713e4cf2a1d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d8a3b98e81649a1bd4caa715cb0da2e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eb703a1f5b144eebc1858b52f17e2f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id814edaeefa14859bd8a994f03809e5f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdb0efe93e7640ae8d172d601a4692d6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb268f2da5f547d8a14d3c95c0580e06_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83f9cc0cf2f746de84d60298eb4a0c6f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d1e6d43a40d46928b3eb06e51ef68eb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e600af0037644c58476a1a9eda6a026_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ceadb6d58d648b589f0df8a7a6b998a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ad66b78a6b64609ac23769c262610e5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92460d1af80c4ff7b3a654fd318e31a3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffdcc560f54a4d43ada125b516d24346_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafdeb370ccbb4184863d2f97c17b9079_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f3cf04cf3c64d81915962e56cdaae10_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic07b7144afd5431eb46020ecbc41d2b5_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7a924e0937d48aa9ee3d55bea4ef7c2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39bd68b89c0941a289562ee539763064_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i350bb6d8c988458096fa290f02419cc7_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic14c278f188a4ea6be8e3287cf313398_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d50b5caa3534d6f84e75102afd14fdb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dae7f18f2f34d56b658f35f31fdd441_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa2a718bde80444eb214d2eaf59e0b6c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cdb2c56dc4745448c8e6a876c8890db_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4909f7c61db49b69aa8ecd11570d198_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="facility"><xbrli:measure>sgry:facility</xbrli:measure></xbrli:unit><xbrli:context id="i8635a31bb616432d8bb3e7a8d312f3a5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:FacilitiesAmbulatorySurgeryCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9538a3fb78354d13ae2d5c04403980a5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:FacilitiesSurgicalHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>sgry:state</xbrli:measure></xbrli:unit><xbrli:context id="i69a8b63234044edb8f0a6afda70cdd7f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ibf657c1e4474414d9ed07e96c58ad59d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i552bb5d715f746d0af0896cb8236e297_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86904f5d11ef43b59e207be1a0a75042_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibff8350d312b4ee2964eceaea94a35b0_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c0d2eeb74d34cfc9128ab781a805818_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idab948c415d74a1e874e667af7cefd2c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife3f7aa0dc10478fa288248a9670fa92_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34e9e7220c934670b27ad119a843e336_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i840850c9edd84feea92967f120b69408_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b11393d1e4444258098013cd223901e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6ce9b604fc54f51a04400f3ffd18e4c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ccf871acc2e48a18834c00109df962f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab3bce97216f4963af800c138848af24_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib016f83f44d74921b4f5ce6b9ab4976f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a2aaf930d1c431f8bcf8bc5136ad3b0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d812678eaf54267847b2530339322ec_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic47817178a934289aa981ee5da388b9d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic37df66186ae4e5fb918bd1d2efca702_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf41c461015444fe83e5e4ac21755f08_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44cb302421034882ae2b0562737c1761_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if244251d5c944d3c8d006f96aa5ebbeb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b170b8d71c411192b47b3305a64616_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c2399a17532427a98c0603b2322f33f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26fcec9c0227498db8204ef1cbf8fc8f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0822a8d0912456b81a264a53b470d89_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0f939d7f48e447e90a63291660e7944_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cc712172b944863ad8e1ec9d1f576b5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9a48f2904b44c188eea35ede6799f83_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia80790d713364217852ad6b20c5b9b80_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63e081ac08c44dc5a177a46e62b24af8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b40d040385048f4892471ac83e1a711_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b2cd8126cda47679574168e7959c24f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61b7b590da346e2947662ec3b207f85_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bc26bedce494bfea61792a1ff92ace3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcc3a089528340bbba1aff28988c6812_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d7024453b0a4f5c8ce5d266c8c9e818_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27735b9da4154030bf4e696fb6bc2a59_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97572a73c7164e119219a51fbc609a03_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1dd63f253344cbf9b6a3ea5aca75cc1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eba6e7221624a33acd805897dd778ed_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2da709eec92472d8e6b2eb875df017d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3084cb440f6440539f725074cc141064_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3379039f97441b69503564797be213b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee70145afa7b4a67822ee29af8d0ac67_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad2ccb4850c7418299a1f3d759ad4c1c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90f42610982f4a29bc29dac6a196477b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff79ffa556644f829d223ebc6d3e3e4e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0de9d3bf0e784880a751f9e1dc386914_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18be6ab1a0c548c2b344fd6ed2142372_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc8dfce5bc944bfd937fcf89a20c4c8a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebe60e2bb5c545f98959f8d0f9d2db95_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddd55bfbcc5443ce8c95abb22f917ef7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf891198937c45b68701f2071a3a79c1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3c06ae7e4574d1087fab3bfb50d7437_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1be2d60556148108356e7e3d0c609e6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b0201ec336d4d759ab22d8b3f999534_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if99bdea32bbb4844a79014c52607f56e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic90c5193afd6420fb1c2f4aa57b405e7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18b50bcfbdfb4bb791ecefea65280045_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbbf27a71e2f456398a50c2893221fad_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07a9608cfa094c6684c2b726c01884cb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02fc46716fa94295ba0d78ef52b9bc23_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8831be04004f4e43925db4244ecc0d5c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b3dc06c3b0940c6864cf95b82437b22_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4014a2b0728429f99f1aff4ee095837_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48593468d901450b9f2b3750f730873f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab78f5af1da94146958f7005f99d54ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17b9522ee1a5410c9e521102b0938024_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee1640a7d9ed442fb5430f01e5f729e5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife931bd0ec79459bb3908847c1c58b78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc9575728f644eaa83de881b7d5e9813_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i240776d65f63482e82bae1bb71ef09b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id97f2fe451ad49ebab6e84dfc7448640_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iada7c3ad8c6043cf83baea26ca96c7f5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e7433e734c44d0fbaf0eb6487f2a2fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0455e535db8f4f838179eed4ab11e337_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb5f2b0b8b3a4fb38bed91efd6ed8703_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="physician_practice"><xbrli:measure>sgry:physician_practice</xbrli:measure></xbrli:unit><xbrli:context id="i0c7f757289414463a07207dec757e8d0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfd8f7a8f4154e65a697ab7d0057cc7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia73c117591c64b64acb148493f0ec6d8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a3bff3446ca40c28509f17868f1adc1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesExistingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea5f3abaa0984b2eaa7055cba2542341_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefa24cf2b7dc4ebc86ae0a7a096deb4d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdc566837054408da2d934e520986ebb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3963d4281e5468c8e5368c83dc0b938_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="non-controlling_interest"><xbrli:measure>sgry:non-controlling_interest</xbrli:measure></xbrli:unit><xbrli:context id="i765634ba75024131a79a3d390bb13989_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">sgry:DisposalGroupOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c9ba13353b4c19b6ed54c8402d44cf_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">sgry:DisposalGroupTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib185c098b450421d89d993a6a054fd2c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">sgry:DisposalGroupTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="business_entity"><xbrli:measure>sgry:business_entity</xbrli:measure></xbrli:unit><xbrli:context id="i2b6f41648efd461697a23bab27bf16e5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">sgry:DisposalGroupTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2194c6aaf1a4eec8b2eab9c9b7c3c3a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1aeee4881fa47c580bb5e99e88641ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17cc9fb2945a48038ba149c83e32f783_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49d20d5258ec48e59311e50fe392c175_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea1883c76fa04d069ea8e3cf7e28a781_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sgry:NotesPayableAndSecuredLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63c44749e22b461ca1d58d166427ced2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sgry:NotesPayableAndSecuredLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a5a30a093dc41659d3f312026cb301c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86130d880fcf401e909db4519bccc94f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34519792c7c644368bc1218b81d5eb35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3520bf24329a4e13a3d203c231caa136_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d641fec5a614286a665a368239cb7fe_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="interest_rate_swap"><xbrli:measure>sgry:interest_rate_swap</xbrli:measure></xbrli:unit><xbrli:context id="i624ef5b3954c440ca2df8007f64bb190_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9405d2dfa6a44be3b5a5fddf7e37ce73_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibec9eb2e922848e193c29ccb4d324b59_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if84173ed23fc455c8dc5af7694d68f70_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreePayFixedInterestRateSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i652bb49f02444b3a89f17f2300107e97_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreePayFixedInterestRateSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fccee9038b24758ba351eba3d11e91a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreeReceiveFixedInterestRateSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e675653b29b4a30a95a33a4eafccfa8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bac16b3932b4d9f8c149cbe0186184c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea63fb7682374f5fbce4eaf0268880b3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92b3a62c12c645209db966edaf59e976_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0910d6248ac74aa9bcf915cfa2b93d37_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf9ff04a00914131a0f5c3d690dd4103_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica6bbd0b30fa447bbaa6e2d70abf379e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5e9e67aafa642f1b536a59d612f21b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87459cd7cbda4d60b240d0999c63bd43_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i963697d6f96e442d98f5756ec73485b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfd2fc8ece9341b3adef2ac0e05a7557_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35884d0598254ccb991a911d3502b131_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied5ab0dab33041f989a6b88eb2b43ce3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id545da56246a458a9f507b5e10d6b9cb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee2b1492ec349a2b51e75e9df9f3bb0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i113be4a99c604b2da5b072d5e5d8fa21_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i533833368b6c47bf89ba7a880f670cd8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic848ed09b98c48b0a8a7f23e355be28f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib229dcc9506d4c8398a0910a44f53196_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa055d97ac3b4c02add1ba0a6cc7c820_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ccb9be430ab41d58f216a21128552cf_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fd5b2180b57439b962339cd3bf1d9c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ff529d76c974a7a8aea1a917b35b64b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91cee683d0cb47b8a7410f692915b4ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic454598ff0b04e2b96bfa6db8aed8d32_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccbe30e44be742e4a2c505011293909f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3112ecc656048f9963864a981edf6e8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1c2b5dd09894633b50efcebda46b25c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87e28fb347c94eb9abfe022c9393fe3f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id40745034fee45fba37203084540e1fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida372175cdc044c591964aa8bc62bf11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1657924a29746e68c995f79d41d18f2_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia390bedd4c604d87b921bb743e5001af_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1d2ff8d35f9424eac0c1076c4c642a4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99fa76822a7c4953b5d77c75c594a220_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f2dff4c01ce4f1c8dc3f58ea1d2f195_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabfd2c1c39ee49308512e86fea44e1e4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aa994d75ecc45929183b091586f7b83_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3daec31ecd414074ac61cd4c7433ff05_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf3f8870fede40489dc7020e3bc79d19_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib66f2867150d4f6d9cbba76ffaa3892d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0309fa024ab34d959fd9963466f2ccc3_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36b6a3ca602748ce951abd5c3ecb073a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63a22d68b90b48909dc3d1b1b5b8a20e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i020ea1b80b0942b19fcb6613eff5fd71_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58659716e1cf471dafca42309eeb5309_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd945ed3ab5f4ffda421c746ebe77bab_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34857924f21749c1b51e0cd2f31b0597_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2612faa6b1474823bc2ad95518bc8aa3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i590c785262294ff4b5426d751376a0aa_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7846148240d4ef5af33eeefb926fa03_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe0c66f9f387475f844569ed2d3b3205_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba332caf963a4b5a996c1691527ca638_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c7f8902d58045f499cdd85fdd43307b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:UnusualRiskOrUncertaintyByNatureAxis">sgry:MateriallyMoreRestrictiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i892c4c41e2e949ed919cd99526bbb6dd_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:UnusualRiskOrUncertaintyByNatureAxis">sgry:NotMateriallyMoreRestrictiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>sgry:segment</xbrli:measure></xbrli:unit><xbrli:context id="i33740e780fe041819c21399ef852290a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87b86506be1b428c860321716b7a66d8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i403f917fe58449dd84f395f95d5d45f5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62d2cc75b7bf4e3991b46bd2fe6ab2bf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i410d8e1eee01450cb5b6cfd107a06e90_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3118082a6eee4654817ff68f7ff8cd11_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9e54a8543c64c13be3bc0583a316c0b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cc71adeac1b48e983f02714d00ddc72_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95419c314ef74baa801a963119c98dc5_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd1554a1349741dba5cff54478d06171_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2293dc828b4c49858d186288dc517883_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ea00fc2deb741eeaefccb889320e7bf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23bc251b6a3e49908aa27d058a4353bb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05385bb60fbf427ead13dc4825931c47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73110b114b4e4de8888b67e05068b98f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15e47b2c1f284ef6921de8dbbd99e9a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e234b442be44c11a6adaee5cffc93f3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i981cc515616546ff8ac377ab4fc32af5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib78433cb866f4b209cb42b742ebd6d86_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">sgry:SurgicalFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="property"><xbrli:measure>sgry:property</xbrli:measure></xbrli:unit><xbrli:context id="i1b0e6fb212964ed98b69386800807bd2_I20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">sgry:InDevelopmentDeNovoSurgicalFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if47fc0612aa043b48a03337684354a15_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItMi0xLTEtNDc1NzU_b3757ed0-08fd-40b2-951f-5f73ee2a0304 id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtNi0xLTEtNDkxMTI_3d1fd00d-04c8-4fa9-adf0-0c1747f8024a id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtOC0xLTEtNDkxMjQ_eda99b14-a47d-4f19-bc1f-4fd63729cccd id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtMi0xLTEtNDc1NzU_b5f28d77-5d51-485c-afe8-76e4c5789bb4 id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtOC0xLTEtNDkxMTI_048b778b-e609-4871-8f57-fe0c400a9097 id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtNC0xLTEtNDc1NzU_e87db349-2d4b-4e41-9b9a-5ae3e02c4c6b id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtNi0xLTEtNDkxMjQ_d21dc0c1-7abf-4dee-97b9-4bd96e607bae id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItNC0xLTEtNDc1NzU_f904edcd-d3d3-46d3-8485-a04317ab494b" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington,&#160;D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form&#160;<ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQz_8cd891c1-1fea-4010-8802-8fab377bcaa2">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:9pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQw_c2454d9a-be58-4eec-80e7-588a5c78de7b">&#9746;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yOTg_c5f49270-0ed7-469b-baaa-19a44f4c7f75">June&#160;30, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzUw_d6877614-6a76-4990-b6e5-cd41cb51ac70">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number:&#160; <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQ0_fbfe78ef-662c-45a3-b774-ce63e8a3248d">001-37576</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQx_6309ef20-8593-488c-801e-552353236a9e">Surgery Partners, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.583%"><tr><td style="width:1.0%"></td><td style="width:47.064%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.065%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6MjA2MjJmZWRlYWViNGIwNzg2N2VhZDM1N2U0NDFjYTYvdGFibGVyYW5nZToyMDYyMmZlZGVhZWI0YjA3ODY3ZWFkMzU3ZTQ0MWNhNl8wLTAtMS0xLTQ3NTc1_8187d0ad-006a-4130-bfaf-5c76b5188a44">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6MjA2MjJmZWRlYWViNGIwNzg2N2VhZDM1N2U0NDFjYTYvdGFibGVyYW5nZToyMDYyMmZlZGVhZWI0YjA3ODY3ZWFkMzU3ZTQ0MWNhNl8wLTItMS0xLTQ3NTc1_596f5b26-741d-4c4e-bd34-6d3de6a24de2">47-3620923</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzM3_8780c5c9-bb0e-4c23-9a32-1e3f8af66ca0">310 Seven Springs Way, Suite&#160;500</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzM4_b51fbd3a-341d-48cc-a953-36abb530f977">Brentwood</ix:nonNumeric>, <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQ1_968e4d8f-501c-423a-bb3b-237f5e41e0c9">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQy_48564234-bdfb-4cee-be33-d6dc996b695b">37027</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of principal executive offices and zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzU0_987808e0-f065-47e3-b744-fe888bd48c64">615</ix:nonNumeric>) <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQ2_ae09b67d-f4d1-4b22-b151-65c8411727b7">234-5900</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:33.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.167%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTJiNjQ1OGQ4MzY5NGNiNWI4MzhmOTk3OTg5MTRhOWYvdGFibGVyYW5nZTplMmI2NDU4ZDgzNjk0Y2I1YjgzOGY5OTc5ODkxNGE5Zl8xLTAtMS0xLTQ3NTc1_5fc7b657-51f2-4cd6-98b2-a500112e6652">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTJiNjQ1OGQ4MzY5NGNiNWI4MzhmOTk3OTg5MTRhOWYvdGFibGVyYW5nZTplMmI2NDU4ZDgzNjk0Y2I1YjgzOGY5OTc5ODkxNGE5Zl8xLTItMS0xLTQ3NTc1_4d2c3e9f-7db0-4949-bdf0-2c7790455e17">SGRY</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTJiNjQ1OGQ4MzY5NGNiNWI4MzhmOTk3OTg5MTRhOWYvdGFibGVyYW5nZTplMmI2NDU4ZDgzNjk0Y2I1YjgzOGY5OTc5ODkxNGE5Zl8xLTQtMS0xLTQ3NTc1_2c121149-135c-499c-9b85-445c5a7565ef">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;<ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQ4_bab9ed02-464f-4973-bb20-0208f5e44ac1">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160; <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzM5_64d79b4f-b9d9-415d-b173-4339699a0e60">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.250%"><tr><td style="width:1.0%"></td><td style="width:46.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTZmMThhODNjNzBjNGM0ZWFkNTk5NzRjNzNmMzRjMGUvdGFibGVyYW5nZTplNmYxOGE4M2M3MGM0YzRlYWQ1OTk3NGM3M2YzNGMwZV8wLTAtMS0xLTQ3NTc1L3RleHRyZWdpb246NzA0MDdhNGJlNDU0NGViMWEyMjYzYTI4N2Q2YzdhMjJfNA_db12ede4-acf4-4180-99ed-c9d564bf3373">Large accelerated filer</ix:nonNumeric>&#160;&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer&#160;&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer&#160;&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company&#160;<ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTZmMThhODNjNzBjNGM0ZWFkNTk5NzRjNzNmMzRjMGUvdGFibGVyYW5nZTplNmYxOGE4M2M3MGM0YzRlYWQ1OTk3NGM3M2YzNGMwZV8xLTItMS0xLTQ3NTc1L3RleHRyZWdpb246OWQ1OGY4ODQyYTliNGUwMWE1YjE2YThkNjc1ZTQyNzBfMzA_d2fb74d3-76e0-4a2e-8d11-32298558fe53">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company&#160;<ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTZmMThhODNjNzBjNGM0ZWFkNTk5NzRjNzNmMzRjMGUvdGFibGVyYW5nZTplNmYxOGE4M2M3MGM0YzRlYWQ1OTk3NGM3M2YzNGMwZV8yLTItMS0xLTQ3NTc1L3RleHRyZWdpb246MTRlMzVlNTMyYjExNDQ0YWE1ZWFkYmEzZGI5MTljNGVfMjg_0be9b5ed-9bdd-4d69-8434-e48c0a858165">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQ3_af7a22ee-4e16-45f2-a190-651ea39ace87">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">As of July&#160;26, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i08eaf5cf61dd49bda81b3a7c558d3bc4_I20220726" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMjgx_983ca64e-7cf2-4928-a094-20333a0a0a26">89,935,287</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">shares of the registrant&#8217;s common stock outstanding.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_7"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:11.567%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_10">PART I - FINANCIAL INFORMATION</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_10">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_10">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_13">Condensed Consolidated Balance Sheets (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_16">Condensed Consolidated Statements of Operations (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_19">Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_22">Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_25">Condensed Consolidated Statements of Cash Flows (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_28">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_28">6</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_61">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_61">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_61">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_88">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_88">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_88">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_91">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_91">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_91">29</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_94">PART II - OTHER INFORMATION</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_97">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_97">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_97">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_100">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_100">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_100">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_103">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_103">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_103">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_106">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_106">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_106">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_109">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_109">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_109">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_112">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_112">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_112">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_115">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_115">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_115">31</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_118">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_118">32</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div></div><div style="margin-bottom:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div style="margin-bottom:4pt;text-align:center"><span><br/></span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_13"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Dollars in millions, except per share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNC0yLTEtMS00NzU3NQ_ae9fd8ce-90e2-44d7-8040-4fa0ad4b2d7f">227.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNC00LTEtMS00NzU3NQ_82d20f5e-385e-4f79-b8b1-33961ea720ca">389.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNS0yLTEtMS00NzU3NQ_83da3eca-e77d-4058-bcea-61864260d76f">412.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNS00LTEtMS00NzU3NQ_00f87bac-25a7-4e41-8c67-3e1c9a372081">430.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNi0yLTEtMS00NzU3NQ_f2c52bc4-7b28-4a69-b016-370c84627cdf">64.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNi00LTEtMS00NzU3NQ_4b784208-a21a-432b-8aba-c27634f1e669">61.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNy0yLTEtMS00NzU3NQ_03fc0bb4-27e4-4889-ac4b-0c6c8333be6c">37.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNy00LTEtMS00NzU3NQ_d6ae9529-b8aa-4026-b61e-d6939131a111">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfOC0yLTEtMS00NzU3NQ_030f1ce8-ab37-4a69-8809-267d57d03936">47.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfOC00LTEtMS00NzU3NQ_7b79ac71-c8bd-497b-8799-4079135d29e2">39.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfOS0yLTEtMS00NzU3NQ_d23bb55f-dde4-4537-b493-92f72737e204">788.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfOS00LTEtMS00NzU3NQ_dce8d557-6e30-4fd9-8863-4e87f727c890">946.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation of $<ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTAtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3MDAzMmIzYWM1ZWI0NDg2OTYzNjA2OTk3MmU4OTgxOV82Mw_de110c94-549e-4916-8404-970cc1974552">320.7</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTAtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3MDAzMmIzYWM1ZWI0NDg2OTYzNjA2OTk3MmU4OTgxOV83MA_df7244ca-09d9-4b50-93f1-e4eaee73b68f">272.3</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTAtMi0xLTEtNDc1NzU_0131daf5-d7d0-4936-bd8e-49583c520f45">789.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTAtNC0xLTEtNDc1NzU_0c2178f6-01b9-4428-a306-750796f8316f">629.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and other intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTEtMi0xLTEtNDc1NzU_318ceab7-947d-40d3-a0ac-1c82892090ab">4,035.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTEtNC0xLTEtNDc1NzU_18241a97-e05f-4ae6-b2e2-7cf4521fba0c">3,955.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in and advances to affiliates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTItMi0xLTEtNDc1NzU_69d6db26-0212-47a6-bc81-b4412a02d161">159.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTItNC0xLTEtNDc1NzU_1f67efde-2316-48dc-9c00-2a342099463c">88.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTMtMi0xLTEtNDc1NzU_48d8b4dc-c204-4792-98c3-a739f2a2ec4b">277.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTMtNC0xLTEtNDc1NzU_ea277c3d-9b38-4ffd-ab1a-9ffba860d1da">324.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTQtMi0xLTEtNDc1NzU_4a3b57e8-c07b-4fd2-8611-231be5561f35">110.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTQtNC0xLTEtNDc1NzU_c7136af2-133d-4311-b2c0-c08d4f7f4245">114.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTUtMi0xLTEtNDc1NzU_4ba6822a-2933-442e-89df-12d5c7d47d07">130.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTUtNC0xLTEtNDc1NzU_362cc921-cfdb-4cea-b64d-8b5f25221cab">59.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTYtMi0xLTEtNDc1NzU_c613a232-bdd5-431d-8a1b-d006a1f067e8">6,291.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTYtNC0xLTEtNDc1NzU_34b64aa1-6d16-454e-a855-f9e85a18a420">6,117.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjAtMi0xLTEtNDc1NzU_26a493c4-6c28-49b6-9b02-369e12eb6bc6">126.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjAtNC0xLTEtNDc1NzU_bfa447aa-6970-4ce6-974c-f5ec112d966a">124.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued payroll and benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjEtMi0xLTEtNDc1NzU_d8d4b542-019a-47ac-9cca-f702e01590b5">83.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjEtNC0xLTEtNDc1NzU_8b5adf84-d3d6-468a-b96b-d578a10892f2">77.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare accelerated payments and deferred governmental grants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjItMi0xLTEtNDc1NzU_f68aa1c0-0262-43df-9ab0-3cb91abf549b">21.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjItNC0xLTEtNDc1NzU_6b6b8fd4-9e7d-4141-b0d9-11c67c88662c">64.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjMtMi0xLTEtNDc1NzU_ff111e1b-b39b-48f0-b8fd-594d7df68423">221.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjMtNC0xLTEtNDc1NzU_45ddffb2-b9df-4932-812d-6e59566c1171">210.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjQtMi0xLTEtNDc1NzU_a7f4d84f-a697-4777-8587-04a9d849a5bc">68.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjQtNC0xLTEtNDc1NzU_0087fdaa-e60a-436c-9ae9-fbfa7d1313d6">60.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjUtMi0xLTEtNDc1NzU_87a25351-ec34-4570-bc37-cf87f7cc0d23">521.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjUtNC0xLTEtNDc1NzU_332127af-1337-45b1-8f12-20b52389b56a">536.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjYtMi0xLTEtNDc1NzU_f3c5b649-3330-4b1b-87ae-eb7cb9f4785d">3,019.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjYtNC0xLTEtNDc1NzU_b7b1e88f-527d-4680-9c97-89eb675f2d1a">2,878.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjctMi0xLTEtNDc1NzU_e0e85778-a5ab-452d-9231-336322008220">271.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjctNC0xLTEtNDc1NzU_a7eb6876-4d69-486e-bfcf-3bd8a985da62">315.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjgtMi0xLTEtNDc1NzU_6f28e8d3-d1cb-41f1-b5bb-b778376b0d79">96.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjgtNC0xLTEtNDc1NzU_2e223b44-9c3c-40bf-8636-7d3bf106b427">87.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-controlling interests&#8212;redeemable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzAtMi0xLTEtNDc1NzU_56417a0a-79d2-4c54-97d0-0c43613f2d87">341.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzAtNC0xLTEtNDc1NzU_5f04cf50-0e4f-4c21-9e4b-eb8e19c0c5f3">330.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF8yMQ_192fafe0-27af-4009-ae39-4b74daefbb45"><ix:nonFraction unitRef="usdPerShare" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF8yMQ_e38d8e49-4ae3-4082-946d-d93d16ef2fda">0.01</ix:nonFraction></ix:nonFraction> par value; shares authorized - <ix:nonFraction unitRef="shares" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF81NQ_09043aab-c10d-4ad3-ba7d-4dc3d33792e8"><ix:nonFraction unitRef="shares" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF81NQ_3539b676-0206-4dcc-b683-2a06362f5c35">20,310,000</ix:nonFraction></ix:nonFraction>; shares issued or outstanding - <ix:nonFraction unitRef="shares" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF85MA_04101c1d-7192-41b3-8226-e0886b73f319"><ix:nonFraction unitRef="shares" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF85MA_2816bb7a-0bba-4601-8a76-4f08349978fc"><ix:nonFraction unitRef="shares" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF85MA_7155058c-d479-44e7-9d0b-04844683cf54"><ix:nonFraction unitRef="shares" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF85MA_9915f4c4-408c-4bd0-a718-90a922defc2f">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMi0xLTEtNDc1NzU_7e0fb213-3255-4289-b88f-b3c5ca68bcba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtNC0xLTEtNDc1NzU_43fb70dc-0265-4a6f-8e86-460bae179c14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM18xOA_20c24342-9276-423f-8922-e2a7de16cb2b"><ix:nonFraction unitRef="usdPerShare" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM18xOA_c23f3dd3-f2c0-4d8d-9ca9-4b151474ed16">0.01</ix:nonFraction></ix:nonFraction> par value; shares authorized - <ix:nonFraction unitRef="shares" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM181Mg_096f4fc0-e7f4-4a2d-a5b0-c82e0e822292"><ix:nonFraction unitRef="shares" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM181Mg_f1ba5fab-e6fe-49db-9ee7-d8b15530429f">300,000,000</ix:nonFraction></ix:nonFraction>; shares issued and outstanding - <ix:nonFraction unitRef="shares" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM184OA_8150f5b8-dfaf-431b-b09d-b951db5dfbe4"><ix:nonFraction unitRef="shares" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM184OA_ebe3b284-7003-4773-97f5-f8fa2465f7f8">89,935,287</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM185NQ_b8d888c8-094f-4990-aa22-d185845035f5"><ix:nonFraction unitRef="shares" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM185NQ_c3b506bf-c184-480e-bb36-73360da90760">89,332,557</ix:nonFraction></ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMi0xLTEtNDc1NzU_eb5c7251-b7a8-4903-b162-85c792bf046b">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtNC0xLTEtNDc1NzU_cbf507b9-6df6-4180-b0b2-73f62d568e7d">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzUtMi0xLTEtNDc1NzU_7689b7dd-792e-4aca-9218-febbdcaf8083">1,618.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzUtNC0xLTEtNDc1NzU_31d1438d-1802-4ae5-a242-220def5c3a66">1,622.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzYtMi0xLTEtNDc1NzU_6c5d30f1-5e7e-4295-b3c8-b831bd178940">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzYtNC0xLTEtNDc1NzU_dbb5ac67-c496-441c-b96c-ea6fe03e767f">31.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzctMi0xLTEtNDc1NzU_e87b63ef-2b92-4756-ab23-c2ed658cb223">508.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzctNC0xLTEtNDc1NzU_fa418730-32a8-4c29-bfc5-2e0426a20c72">502.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Surgery Partners, Inc. stockholders' equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzgtMi0xLTEtNDc1NzU_6422c03a-ff06-4358-8201-06aafc9652b0">1,155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzgtNC0xLTEtNDc1NzU_c4c6305d-2ab4-4b3d-b772-56229c6e513b">1,089.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-controlling interests&#8212;non-redeemable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzktMi0xLTEtNDc1NzU_668ad73c-db37-4a00-ada8-8c3086140346">885.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzktNC0xLTEtNDc1NzU_5c4dcffe-ffd2-4e56-8ba6-07f43a4a1959">880.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNDAtMi0xLTEtNDc1NzU_03aa9809-51b1-4e26-9fdc-e0415c4a1620">2,040.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNDAtNC0xLTEtNDc1NzU_5da6c312-e01d-4468-9e42-61f3957e52c6">1,969.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNDEtMi0xLTEtNDc1NzU_dea239c6-21b4-4dc9-83b2-27f068c067da">6,291.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNDEtNC0xLTEtNDc1NzU_e3724944-ae30-47cd-8bd4-b8913c4e1f35">6,117.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_16"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited, dollars in millions, except per share amounts, shares in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.975%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMy0yLTEtMS00NzU3NQ_36ffc073-befa-4bc0-be79-1400f7d1977f">615.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMy00LTEtMS00NzU3NQ_a162fb08-8e05-4bde-9556-184ab87ed50c">543.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMy02LTEtMS00ODg3NQ_c7aa05ab-9535-42e4-a99f-e15cd4612617">1,211.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMy04LTEtMS00ODg4MQ_9acb4a42-b97a-4f71-a6a1-58839997b26d">1,055.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:LaborAndRelatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNS0yLTEtMS00NzU3NQ_c047af7f-7913-4ae6-aa6e-367023b55aa8">181.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:LaborAndRelatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNS00LTEtMS00NzU3NQ_b3871825-81e9-4669-a7b3-fe8dafbf93b7">155.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:LaborAndRelatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNS02LTEtMS00ODg4Nw_e246de21-d188-4e43-bb31-3a6c9d4e91d7">360.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:LaborAndRelatedExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNS04LTEtMS00ODg5Mw_c3d62f02-08f3-4123-86fb-79a866d97447">307.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:SuppliesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNi0yLTEtMS00NzU3NQ_9965df8a-7069-4881-9687-8722380e7e21">173.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:SuppliesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNi00LTEtMS00NzU3NQ_9991abcb-977c-4ec6-94cc-bd1c400ac3a7">157.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:SuppliesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNi02LTEtMS00ODg4Nw_3ac85c93-5942-4f37-82bb-3924c6dab0fc">345.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:SuppliesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNi04LTEtMS00ODg5Mw_b096fd3a-f3e6-45bc-b97a-a1a23ca2ee91">304.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional and medical fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:ProfessionalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNy0yLTEtMS00NzU3NQ_101730ed-d771-4591-a937-95059230faa9">66.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:ProfessionalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNy00LTEtMS00NzU3NQ_6a579b17-c0ae-4c9b-819a-6a4543161382">57.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ProfessionalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNy02LTEtMS00ODg5OQ_1ec3e0d3-22e0-46e9-b420-87267d9ba1d0">130.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ProfessionalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNy04LTEtMS00ODkwNQ_2ede2de6-3e5d-4eb1-8efc-fb5647f24319">112.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="sgry:OperatingAndFinanceLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOC0yLTEtMS00NzU3NQ_0622eff5-3243-4686-bd2b-7dbb935ee8ec">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="sgry:OperatingAndFinanceLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOC00LTEtMS00NzU3NQ_1bfbbb02-4b3f-455b-938e-c842868c35b1">22.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:OperatingAndFinanceLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOC02LTEtMS00ODg5OQ_4d949ec7-9014-4971-a6a8-3ad9c012e7ed">40.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:OperatingAndFinanceLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOC04LTEtMS00ODkwNQ_5f9bf827-268d-41c9-aae6-12d61f8ae09a">45.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOS0yLTEtMS00NzU3NQ_f0a1951d-aa6e-4e6e-85e8-755db65a9cbf">38.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOS00LTEtMS00NzU3NQ_c3e9903a-6967-4906-b1ad-844590728457">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOS02LTEtMS00ODg5OQ_2f8d3bfd-99da-4dff-8317-1bb89e015e51">75.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:OtherCostAndExpenseOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOS04LTEtMS00ODkwNQ_bee0c081-8dbe-4e97-8ce7-1c7e73985dc1">63.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTAtMi0xLTEtNDc1NzU_0f76b1ea-848c-434b-b91b-1e24be923bb2">480.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTAtNC0xLTEtNDc1NzU_0da63860-1b49-4edf-9856-5f9466cb7df9">425.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTAtNi0xLTEtNDg5MTE_e5fc877c-3e9b-4c28-8b3b-0b00ef8f352a">952.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:OperatingCostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTAtOC0xLTEtNDg5MTc_d832a01f-0aa1-498d-87f3-f676fb33dff0">833.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTEtMi0xLTEtNDc1NzU_cbd63f0f-96b1-45c9-8906-b1d3f8557d86">26.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTEtNC0xLTEtNDc1NzU_e25d2d50-431d-47a6-8c52-a9db1ea204e4">24.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTEtNi0xLTEtNDg5MjM_c7639a83-5912-4b85-9ba8-5b85f59ca9ae">55.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTEtOC0xLTEtNDg5MzU_e73a19ea-78c4-4226-ab88-b2765a3a6ada">51.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTItMi0xLTEtNDc1NzU_77059c8c-d8a9-4d53-833f-830f832e370f">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTItNC0xLTEtNDc1NzU_00c73ad5-6396-4554-aff9-4d260f85f08b">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTItNi0xLTEtNDg5MjM_0c320aa2-58d0-49e0-bde9-5ca3807de763">55.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTItOC0xLTEtNDg5MzU_4ddc79da-4a1e-4943-b9ee-14cb1bcf7380">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTMtMi0xLTEtNDc1NzU_fdd1c9d2-0ca9-4096-8904-96aa4b5b2285">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTMtNC0xLTEtNDc1NzU_932cbbae-bdb9-4e17-88d9-ee4f49a2da39">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTMtNi0xLTEtNDg5Mjk_4e226d81-cb1d-434f-96cc-17cdbbd73f34">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTMtOC0xLTEtNDg5NDE_30e102ba-096f-4e55-af85-c28b6dbfac2d">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="sgry:GrantRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTQtMi0xLTEtNDc1NzU_ea8296ab-fff5-4e28-877a-cc85c471b5eb">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="sgry:GrantRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTQtNC0xLTEtNDc1NzU_ce69786e-1f58-4b2a-a007-5472540419a2">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:GrantRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTQtNi0xLTEtNDg5Mjk_8ea8632d-7ca9-43df-a56a-9037ef51ccc3">1.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:GrantRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTQtOC0xLTEtNDg5NDE_70695da7-3b29-49d4-a9ce-c5735be9aac0">20.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTUtMi0xLTEtNDc1NzU_1a41e639-7a01-4e00-963a-5ad61e463e6b">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTUtNC0xLTEtNDc1NzU_b9fa0b91-b3a4-49cc-8b9d-74fa246f364c">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTUtNi0xLTEtNDg5NDc_72d6429c-083c-49fa-908d-070b6f39e034">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTUtOC0xLTEtNDg5NTM_17adca24-65e0-4817-a8fb-575d743934aa">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated affiliates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTYtMi0xLTEtNDc1NzU_202e97f3-bcb5-4688-96da-95118aa280c3">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTYtNC0xLTEtNDc1NzU_9daf215b-003e-40a7-a36c-2317903d8cb3">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTYtNi0xLTEtNDg5NTk_2718bf31-720f-4f36-8a9a-11a19fa96dff">5.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTYtOC0xLTEtNDg5NjU_52bc8eb1-01d0-42c8-8fe7-edac71e098a8">5.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTctMi0xLTEtNDc1NzU_8f4fac89-4f3e-459e-9a40-eef6542a6ed0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTctNC0xLTEtNDc1NzU_509bf41d-7f0f-4a20-8029-5ef2fa521d27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTctNi0xLTEtNDg5NzE_98c0296f-61e3-43fa-bc52-7159bc25f265">32.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTctOC0xLTEtNDg5Nzc_dae1927c-40a8-463e-8665-dbbd5adfafbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktMi0xLTEtNTY1MjQ_2e0a9a2d-5a48-4328-97f1-574d353f4628">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktNC0xLTEtNTY1MjQ_2ed6f009-4367-4d02-8b5c-d72f8890e078">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktNi0xLTEtNTY1MjQ_74c2f3fd-7d15-496d-ab71-ba55b140df61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktOC0xLTEtNTY1MjQ_4effe248-7ddb-4fd6-a041-18bd312221fe">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTgtMi0xLTEtNDc1NzU_c6ee1b06-7d7f-4d87-9c4c-c7b200f7a5af">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTgtNC0xLTEtNDc1NzU_95c2fbe3-fe2b-4aa9-b87f-513ebe29cfe0">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTgtNi0xLTEtNDg5ODc_f991091c-b97e-40b1-8b1b-eafbbae8e070">5.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:OtherNonrecurringIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTgtOC0xLTEtNDg5OTM_16673ae4-84a4-4396-9da2-b20564fc04af">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktMi0xLTEtNDc1NzU_4210b52b-f75a-4398-b6d0-d9290668c4b6">538.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktNC0xLTEtNDc1NzU_0688724c-0845-4ae0-a52c-8c52dbaca598">483.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjAtNi0xLTEtNDkwMjY_c6609cb9-ad09-4c5b-b598-6454f03c7f79">1,034.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjAtOC0xLTEtNDkwMzI_a944bf86-28b6-4730-8603-35597edd799c">931.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjAtMi0xLTEtNDc1NzU_717f077d-1921-4659-87c7-c10651cc20a1">76.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjAtNC0xLTEtNDc1NzU_2bc85921-9697-436d-8925-a07486f890d4">59.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjEtNi0xLTEtNDkwMzg_560740b9-6062-425a-a1a1-e44cb801a22e">176.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjEtOC0xLTEtNDkwNDQ_72ed73b8-1346-45ff-a9eb-0c3a7c6e40eb">123.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjEtMi0xLTEtNDc1NzU_268f04a7-0101-4383-8514-4cd1add57cfd">56.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjEtNC0xLTEtNDc1NzU_12b8cd5a-eef4-4ec1-a4d4-e56afd94a864">53.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjItNi0xLTEtNDkwNTA_9fe969ae-7f9e-4d78-aab8-369c97076e06">113.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjItOC0xLTEtNDkwNDQ_494f77db-9586-4602-9b5c-475fa595ee40">106.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjItMi0xLTEtNDc1NzU_eb518ee5-5cf9-4eda-ba20-c5f9dcfbdffb">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjItNC0xLTEtNDc1NzU_e1a29b0e-8fc0-4b91-a3fc-a3835b70d2c5">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjMtNi0xLTEtNDkwNzA_191fba7e-f82f-463a-99f1-bb5d025bd720">63.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjMtOC0xLTEtNDkwNzY_a2420d25-e2eb-4d13-a49a-ce42f96dc806">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjMtMi0xLTEtNDc1NzU_53e579cd-bd32-491c-bc77-0ef33d72c61d">4.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjMtNC0xLTEtNDc1NzU_46767bcb-abb9-4d87-8723-81310177ae7d">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjQtNi0xLTEtNDkwNzA_de176373-e1f4-4039-add3-5acc8975e127">5.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjQtOC0xLTEtNDkwNzY_244b2029-fc4a-41eb-92e4-df5c2ff46591">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjQtMi0xLTEtNDc1NzU_0d70ecf1-6e85-48d4-b069-d9855d4c249f">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjQtNC0xLTEtNDc1NzU_24fc75e7-4937-4736-8abb-60b38f3c7bdc">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjUtNi0xLTEtNDkwODI_a36ccc60-685c-4eee-bc5a-844558ccab57">58.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjUtOC0xLTEtNDkwODg_47921fa8-74aa-4c92-8263-746c3f1a270f">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjUtMi0xLTEtNDc1NzU_32baac21-9e9f-4922-addd-c8783bf1f88e">33.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjUtNC0xLTEtNDc1NzU_3c031672-2a57-4918-a6d8-6ea52ff5e188">35.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjYtNi0xLTEtNDkwODI_f7fc4768-b3d8-4ac3-bd0b-fa333b89cbec">64.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjYtOC0xLTEtNDkwODg_1caa5ecc-6d9e-442e-9e9f-94ac12aa11a9">67.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjYtMi0xLTEtNDc1NzU_9ea82799-d83e-48a9-86b0-77b28091e9b7">18.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjYtNC0xLTEtNDc1NzU_18f87ff7-b16a-4d20-83c5-74a690327976">26.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjctNi0xLTEtNDkwOTQ_646e7645-1df1-4737-b7f4-78963bd30a23">6.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjctOC0xLTEtNDkxMDA_e5b493b8-d4aa-4f60-9e30-b2a1b322a926">47.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Amounts attributable to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjctMi0xLTEtNDc1NzU_6964aceb-3eb3-45a7-abb0-f13c05e2c52c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjctNC0xLTEtNDc1NzU_cbc40d80-a459-4c4e-bfc7-48094f641918">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjgtNi0xLTEtNDkwOTQ_7812fb5b-eccf-428c-b1f1-df98fa6b487d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjgtOC0xLTEtNDkxMDA_e803d8f5-606f-49c9-b2f1-7f5a133f269c">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjgtMi0xLTEtNDc1NzU_240af1f4-b4ef-4503-98ae-768bfe22c777">18.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjgtNC0xLTEtNDc1NzU_b69a1566-5e1a-4c84-9453-f3e5a68e7387">26.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjktNi0xLTEtNDkwOTQ_f4936076-303a-4771-957e-78a216628721">6.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjktOC0xLTEtNDkxMDA_a3fae1a0-ab4a-4d38-8746-c93876e37b32">58.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzEtMi0xLTEtNDc1NzU_3ba5df49-f9be-4164-844a-3354dde2ed12">0.21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzEtNC0xLTEtNDc1NzU_677d11e6-97ab-4f0b-ac7e-71316d449561">0.39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItNi0xLTEtNDkxMDY_9b215e4b-9d6f-4929-bf09-9af6817aa69a">0.07</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItOC0xLTEtNDkxMDY_331546c0-9650-455a-a910-e292d1fc7b31">0.94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItMi0xLTEtNDc1NzU_b3757ed0-08fd-40b2-951f-5f73ee2a0304">0.21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItNC0xLTEtNDc1NzU_f904edcd-d3d3-46d3-8485-a04317ab494b">0.39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtNi0xLTEtNDkxMTI_3d1fd00d-04c8-4fa9-adf0-0c1747f8024a">0.07</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtOC0xLTEtNDkxMTI_048b778b-e609-4871-8f57-fe0c400a9097">0.94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzQtMi0xLTEtNDc1NzU_466d934c-31eb-4a7d-b2d2-a37f034cfccc">88,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzQtNC0xLTEtNDc1NzU_d244d6ff-e1ff-4989-a71f-ab9e6824bf97">69,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtNi0xLTEtNDkxMTg_44d9df24-efe3-4000-8ef9-82153e60d058">88,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtOC0xLTEtNDkxMTg_df225ac6-d24c-47fa-8226-e45a767d7153">62,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtMi0xLTEtNDc1NzU_b5f28d77-5d51-485c-afe8-76e4c5789bb4">88,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtNC0xLTEtNDc1NzU_e87db349-2d4b-4e41-9b9a-5ae3e02c4c6b">69,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtNi0xLTEtNDkxMjQ_d21dc0c1-7abf-4dee-97b9-4bd96e607bae">88,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtOC0xLTEtNDkxMjQ_eda99b14-a47d-4f19-bc1f-4fd63729cccd">62,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff" footnoteRole="http://www.xbrl.org/2003/role/footnote">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.</ix:footnote></span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited, dollars in millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfMy0yLTEtMS00NzU3NQ_0d70ecf1-6e85-48d4-b069-d9855d4c249f">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfMy00LTEtMS00NzU3NQ_24fc75e7-4937-4736-8abb-60b38f3c7bdc">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfMy02LTEtMS00OTE1Ng_a36ccc60-685c-4eee-bc5a-844558ccab57">58.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfMy04LTEtMS00OTE1OA_47921fa8-74aa-4c92-8263-746c3f1a270f">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNS0yLTEtMS00NzU3NQ_1ace30ce-b144-489a-b79d-8fd6ac4c3b1a">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNS00LTEtMS00NzU3NQ_027e4c75-16db-42af-8021-73ebc076aa40">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNS02LTEtMS00OTE3OQ_963cf77d-934f-49d7-ba32-24af999f7816">75.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNS04LTEtMS01MTY5NA_d987bd64-4435-4449-b757-824a626c2543">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNi0yLTEtMS00NzU3NQ_3da02112-4d41-4bbf-9151-0907ee93e4ee">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNi00LTEtMS00NzU3NQ_2f91bf5d-b92f-46dd-bf47-d3ca9560b658">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNi02LTEtMS01MTY5NA_f3c5382f-6136-4931-bc73-d7aa1b0a40e2">133.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNi04LTEtMS01MTY5NA_d9bf69db-e488-4151-a387-58a753a67ef6">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNy0yLTEtMS00NzU3NQ_88eced1c-d093-41ca-a288-5c53e8e61ac7">33.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNy00LTEtMS00NzU3NQ_8a2100b0-ad6a-4230-8976-d885d1125a5e">35.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNy02LTEtMS00OTE2OQ_fe868aa3-431c-4793-8238-707f5137bbd7">64.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNy04LTEtMS00OTE3NQ_0d6ef8fc-16c7-4f5e-886d-7e1b9f297cbb">67.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to Surgery Partners, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfOC0yLTEtMS00NzU3NQ_83434c26-4f49-4ce4-9965-7f849ff8b940">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfOC00LTEtMS00NzU3NQ_03ebe1ec-9a36-4619-becf-ae6f98ab20ba">26.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfOC02LTEtMS01MTY5NA_ceda42a5-6492-40bb-8da1-f0011b82e122">69.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfOC04LTEtMS01MTY5NA_97cd92fd-c5b2-44ef-b2b7-7951c360229b">41.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited, dollars in millions, shares in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.797%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional <br/>Paid-in Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive (Loss) Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Controlling Interests&#8212;  <br/>Non-Redeemable</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65b4d531cb9b48cd894460f4e16463be_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy0xLTEtMS00NzU3NQ_d37385fc-be74-401c-b4c8-1cc85fa3d2ed">50,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b4d531cb9b48cd894460f4e16463be_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy0zLTEtMS00NzU3NQ_79a3de81-646f-4bad-9a74-c301c89190ba">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i874b93f4f80843419c99212b693021ac_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy01LTEtMS00NzU3NQ_7fb587be-9993-4ed0-95af-571b53879870">607.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a8ee0761a1d4c8c9f56f071d5e4f410_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy03LTEtMS00NzU3NQ_4ef777dd-6b55-4e77-afe5-dfcef38908d8">61.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5321f94b5324566bedb956ae6c2fb92_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy05LTEtMS00NzU3NQ_e4a40ee0-9927-4592-ae73-cee883ed04de">431.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15ac736956f49c883e02995bab6b9aa_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy0xMS0xLTEtNDc1NzU_dafdce8a-c42c-45d2-877e-586fd31d4082">766.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ce39eddcaef4480b057800dbc9fc415_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy0xMy0xLTEtNDc1NzU_727d2f5c-4fcf-43f7-b320-671917f54077">882.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44e20b461fac4de38f9910707892a5b3_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNC05LTEtMS00NzU3NQ_e0df32dc-6efa-4b4a-b201-dc9b0b61d99f">21.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i727c848f12464ac9868395007955636a_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNC0xMS0xLTEtNDc1NzU_6cd7634f-03ee-4ecc-92a0-e30170595fd9">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNC0xMy0xLTEtNDc1NzU_8a4cc880-001b-4e6a-9edb-42b17cb1d825">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iddbc40dd884d4204a58cb11045457ae7_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNS0xLTEtMS00NzU3NQ_fed3f3a6-91b7-464f-ae65-9bcbdee03996">812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70c54c1f4edd4426a5c3c25dbe35d19a_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNS01LTEtMS00NzU3NQ_60e6677b-9e27-400b-a67e-d7c46f769615">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNS0xMy0xLTEtNDc1NzU_d0eea48d-784e-4c5a-9277-2e6d19815b1b">2.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70c54c1f4edd4426a5c3c25dbe35d19a_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNi01LTEtMS00NzU3NQ_a8de31f9-a0cf-43c1-a9f4-72bb706c4bed">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNi0xMy0xLTEtNDc1NzU_1ad34217-14d1-4a96-915f-aff2b1045088">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iddbc40dd884d4204a58cb11045457ae7_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNy0xLTEtMS00NzU3NQ_b33ab131-8c7a-49f9-a3e8-8a522e1eee02">8,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddbc40dd884d4204a58cb11045457ae7_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNy0zLTEtMS00NzU3NQ_f980fea9-b812-4014-8da4-dd8ee7762545">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c54c1f4edd4426a5c3c25dbe35d19a_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNy01LTEtMS00NzU3NQ_3f6d8c5e-e886-4b0e-809d-cda8f26a9f5d">248.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNy0xMy0xLTEtNDc1NzU_697274d5-7b01-47f8-b16a-69aa7012d244">248.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic945102fb54c4d69855b08862add35a9_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfOC03LTEtMS00NzU3NQ_cc28db61-ee82-4187-9e9f-bb90a2bd7ada">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfOC0xMy0xLTEtNDc1NzU_c3742412-44d0-4c88-ad97-765c4bcd1e09">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and disposal of shares of non-controlling interests, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c54c1f4edd4426a5c3c25dbe35d19a_D20210101-20210331" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfOS01LTEtMS00NzU3NQ_c08cd2d2-ae91-42d4-96bc-acf98c3fde5b">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i727c848f12464ac9868395007955636a_D20210101-20210331" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfOS0xMS0xLTEtNDc1NzU_8f5b4879-b3d4-4501-9257-691803f41b5c">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfOS0xMy0xLTEtNDc1NzU_6c49cc8d-1bc9-4dcd-92cf-11591b922e00">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to non-controlling interests&#8212;non-redeemable holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i727c848f12464ac9868395007955636a_D20210101-20210331" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTAtMTEtMS0xLTQ3NTc1_fd324582-b15e-4114-92e6-b15f517c840a">20.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTAtMTMtMS0xLTQ3NTc1_1c24ce57-a79d-4b89-b923-b3f9efbce79f">20.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70a9d633a0ba4f6b8deb6abf6e42e588_I20210331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtMS0xLTEtNDc1NzU_89f72166-3517-4d2c-acdd-f0a9c5a33e1f">59,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a9d633a0ba4f6b8deb6abf6e42e588_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtMy0xLTEtNDc1NzU_75a97df0-e442-4ca1-937c-7f7fa690db73">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbcf15e953044c9bb4256698275b17c_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtNS0xLTEtNDc1NzU_658ff105-e3e7-472d-951c-f22df1869433">843.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2a308f404d4462a20f521a6049c6e7_I20210331" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtNy0xLTEtNDc1NzU_fe5e90a1-8ba8-4ba1-bf75-aa5419c67d8e">54.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9f9d0d0f7404a6fb2b9f70e9127679b_I20210331" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtOS0xLTEtNDc1NzU_9618cf1e-9866-471f-85b1-833833cc3425">452.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cc82a550101490d9ba4c262f7e759a9_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtMTEtMS0xLTQ3NTc1_5d556cf5-270c-4ed4-91d9-b32380bc8f7b">768.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9e74d27950455e8f7ebd062dccc167_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtMTMtMS0xLTQ3NTc1_fade6bea-9d79-4753-ab39-ea8dc37ed86a">1,105.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7600816d839d42ceb914df213ec157f6_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTItOS0xLTEtNDgwOTE_8c8b30c0-cf49-4185-a2e9-441ca0ef7aa8">26.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9b0391f35644b1d9d20974a5c75b7a8_D20210401-20210630" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTItMTEtMS0xLTQ4MDk3_f60c5db0-aaee-427e-9dfe-c5f754523c31">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTItMTMtMS0xLTUxNjk4_ac7730dd-0072-4577-ab61-bba0163d243a">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i20255b89339547c0a3a555a0aa07dc59_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTMtMS0xLTEtNDgwNjI_03539aca-d336-48b0-8b68-959728b5a1c5">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2627c134a054c6c8194c8cf5b5c40e3_D20210401-20210630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTMtNS0xLTEtNDgwNzk_ea60e474-81aa-4385-bd9a-48167ef66652">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTMtMTMtMS0xLTUxNjk4_eb7d3995-10b3-4216-80c5-f1d806e131f6">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred share conversion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i20255b89339547c0a3a555a0aa07dc59_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTQtMS0xLTEtNDgwNjI_9aadcd69-4a5d-467b-848b-0a99c8911203">22,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20255b89339547c0a3a555a0aa07dc59_D20210401-20210630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTQtMy0xLTEtNDgwNjg_d310c367-b563-4554-a2d5-5459af7c3e26">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2627c134a054c6c8194c8cf5b5c40e3_D20210401-20210630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTQtNS0xLTEtNDgwNzk_e530b8d5-614b-4e3b-9c95-8a9280f4f006">439.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTQtMTMtMS0xLTUxNjk4_6347635c-e061-460f-95d0-7257c5751165">439.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i520879363a004c03b48b9aa26d49ec3b_D20210401-20210630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTUtNy0xLTEtNDgwODU_d7cdedde-29b8-47b5-b63e-32006f293ca5">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTUtMTMtMS0xLTUxNjk4_b1179653-b065-4fd6-8e15-6e1d0e94b0af">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and disposal of shares of non-controlling interests, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2627c134a054c6c8194c8cf5b5c40e3_D20210401-20210630" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTYtNS0xLTEtNDgwNzk_baf2f335-73b9-4fec-9bc5-ca45d17c2773">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9b0391f35644b1d9d20974a5c75b7a8_D20210401-20210630" decimals="-5" sign="-" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTYtMTEtMS0xLTQ4MDk3_b351def2-c57d-4c50-b78e-0edacb8b751d">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTYtMTMtMS0xLTUxNjk4_1550697b-a1e2-46d0-a6e4-020821c292be">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to non-controlling interests&#8212;non-redeemable holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9b0391f35644b1d9d20974a5c75b7a8_D20210401-20210630" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTctMTEtMS0xLTQ4MDk3_cf2a3c96-0660-4991-8693-47f239c812ac">22.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTctMTMtMS0xLTUxNjk4_9fa9d39b-2205-4312-ba6b-a32dc2dd7a26">22.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86d62a7c424e47d19d145f6ebf771221_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtMS0xLTEtNTE2OTg_516058c1-1104-4290-8e5c-db3c31111da4">82,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86d62a7c424e47d19d145f6ebf771221_I20210630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtMy0xLTEtNTE2OTg_f08c7980-5c09-4d0a-99f2-615c5509dcb1">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64a8818a24674f2faae8cfbfd2edb750_I20210630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtNS0xLTEtNTE2OTg_4b0cb101-c320-4446-9af5-f9aa183a491a">1,298.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0cb6e6c59764f929e1812a53232bc2f_I20210630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtNy0xLTEtNTE2OTg_b846feb1-506b-4753-a718-dc38435dd3e7">54.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75ea718f255443ed9371e7d4a9085825_I20210630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtOS0xLTEtNTE2OTg_e5e66489-a903-4e82-9b20-53bbcea902c6">479.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4482a6ba65743ca8c0b52945eadf553_I20210630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtMTEtMS0xLTUxNjk4_88b7d6ff-8547-4c0c-bb7a-470ac04f99b7">762.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i293881ff9efc4258a9030c4efeddff54_I20210630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtMTMtMS0xLTUxNjk4_7780ca5b-bda5-4534-8996-f184f194b27e">1,527.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95848062d06c4c1a9b5d0bb79f725a76_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC0xLTEtMS00NzU3NQ_93da62b1-a8f4-4447-9555-7d3371fcfcff">89,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95848062d06c4c1a9b5d0bb79f725a76_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC0zLTEtMS00NzU3NQ_42aecc90-b720-443e-8cef-8adf25c875aa">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd8e1125342f40899ab99713e4cf2a1d_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC01LTEtMS00NzU3NQ_ff040f17-7f9c-4c19-b24e-045fbb30a90d">1,622.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d8a3b98e81649a1bd4caa715cb0da2e_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC03LTEtMS00NzU3NQ_b2e8516e-30eb-4515-82e3-65628f334b6c">31.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9eb703a1f5b144eebc1858b52f17e2f6_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC05LTEtMS00NzU3NQ_f5db689f-27d3-4de2-b700-bcbe54c20c7e">502.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id814edaeefa14859bd8a994f03809e5f_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC0xMS0xLTEtNDc1NzU_a44f848a-0d2c-44db-8996-54d99c19e67c">880.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC0xMy0xLTEtNDc1NzU_011bbabb-622c-4951-9242-875ac5d123b2">1,969.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb0efe93e7640ae8d172d601a4692d6_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMS05LTEtMS00NzU3NQ_94e9f07f-8dca-413a-8e7f-9bad9fa9b15c">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb268f2da5f547d8a14d3c95c0580e06_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMS0xMS0xLTEtNDc1NzU_355cadc9-78ac-4799-83f6-966ea407ec28">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMS0xMy0xLTEtNDc1NzU_354666f3-18ad-4c9c-a26a-a79b49cfb166">32.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i83f9cc0cf2f746de84d60298eb4a0c6f_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMi0xLTEtMS00NzU3NQ_2731e1c7-1bcf-4b02-be0b-654388a9dd2b">572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d1e6d43a40d46928b3eb06e51ef68eb_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMi01LTEtMS00NzU3NQ_520836d9-522f-4a52-99cd-385654deefc5">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMi0xMy0xLTEtNDc1NzU_b0f4ee21-9254-422c-b5de-95aace630176">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e600af0037644c58476a1a9eda6a026_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMy03LTEtMS00NzU3NQ_ac99b333-3937-4cd0-be3d-ebdbf20f1d6d">56.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMy0xMy0xLTEtNDc1NzU_467cdd39-3b18-4f4a-9163-5995810b4f26">56.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and disposal of shares of non-controlling interests, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d1e6d43a40d46928b3eb06e51ef68eb_D20220101-20220331" decimals="-5" sign="-" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNC01LTEtMS00NzU3NQ_2bb91e63-d905-471a-85e6-e988216d35a6">4.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb268f2da5f547d8a14d3c95c0580e06_D20220101-20220331" decimals="-5" sign="-" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNC0xMS0xLTEtNDc1NzU_345cd0c9-b4ff-4f84-9aa2-40690a4eee29">24.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331" decimals="-5" sign="-" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNC0xMy0xLTEtNDc1NzU_11d860c1-cd7c-4faf-836a-e04a0f00b815">29.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to non-controlling interests&#8212;non-redeemable holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb268f2da5f547d8a14d3c95c0580e06_D20220101-20220331" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNS0xMS0xLTEtNDc1NzU_3ca9ef05-c796-42b1-874a-4bf5a5e49ef7">24.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNS0xMy0xLTEtNDc1NzU_c47ec79c-2f55-4810-b5fc-a887044f07f6">24.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ceadb6d58d648b589f0df8a7a6b998a_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi0xLTEtMS00NzU3NQ_0365b913-32a9-4d99-8786-0b6cfc87298a">89,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ceadb6d58d648b589f0df8a7a6b998a_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi0zLTEtMS00NzU3NQ_b34d891d-0102-42e4-b747-96564be9ef0c">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad66b78a6b64609ac23769c262610e5_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi01LTEtMS00NzU3NQ_27c5f4f7-24cb-4f8b-bcb2-fa9a21356a79">1,625.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92460d1af80c4ff7b3a654fd318e31a3_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi03LTEtMS00NzU3NQ_f852de51-1aa9-4ebb-9f6e-de77fe763de2">25.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffdcc560f54a4d43ada125b516d24346_I20220331" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi05LTEtMS00NzU3NQ_0f54b68b-dea9-467e-8e06-cdc48c72f4c9">490.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdeb370ccbb4184863d2f97c17b9079_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi0xMS0xLTEtNDc1NzU_a7b2badd-f61f-4cf4-b9bd-c0e26fdc58c0">851.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f3cf04cf3c64d81915962e56cdaae10_I20220331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi0xMy0xLTEtNDc1NzU_f8c777cc-c4f8-4655-af40-5b9580c8e35d">2,012.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic07b7144afd5431eb46020ecbc41d2b5_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNy05LTEtMS00ODE2Nw_5db96a8e-12ce-4ec6-b6c7-d65a90508050">18.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a924e0937d48aa9ee3d55bea4ef7c2_D20220401-20220630" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNy0xMS0xLTEtNDgxNzM_89b77fc5-e6f6-4a48-af39-90fd90797238">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNy0xMy0xLTEtNTE3MDk_1729e945-3f59-4c21-aa11-0c8f3a0dcb23">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39bd68b89c0941a289562ee539763064_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfOC0xLTEtMS00ODE0Mw_659be96b-1cfc-4c7a-a408-5bb3c85416a9">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350bb6d8c988458096fa290f02419cc7_D20220401-20220630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfOC01LTEtMS00ODE1NQ_287feefb-84e0-4391-a361-96bc0bf90afd">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfOC0xMy0xLTEtNTE3MDk_583157ec-4d53-4d34-8a6f-83d3148a6e19">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic14c278f188a4ea6be8e3287cf313398_D20220401-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfOS03LTEtMS00ODE2MQ_62b5c62e-75d2-49f3-9071-a8c6beb43d8f">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfOS0xMy0xLTEtNTE3MDk_8a50ac78-660b-455f-afb3-681933cccec6">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition and disposal of shares of non-controlling interests, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i350bb6d8c988458096fa290f02419cc7_D20220401-20220630" decimals="-5" sign="-" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTAtNS0xLTEtNDgxNTU_3554ed5f-461c-4236-bb51-e207170a8a03">10.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a924e0937d48aa9ee3d55bea4ef7c2_D20220401-20220630" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTAtMTEtMS0xLTQ4MTcz_d855029b-583a-451d-935d-c19f4b14d7e6">38.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTAtMTMtMS0xLTUxNzA5_5a8b2f0d-7010-4ed9-aedd-0bdf2e1b515a">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to non-controlling interests&#8212;non-redeemable holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7a924e0937d48aa9ee3d55bea4ef7c2_D20220401-20220630" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTEtMTEtMS0xLTQ4MTcz_44a0d9a5-0664-4a11-948f-ab5a5c3d9c56">27.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTEtMTMtMS0xLTUxNzA5_a8c7b703-cbcc-4752-972f-de2c20345353">27.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d50b5caa3534d6f84e75102afd14fdb_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItMS0xLTEtNTE3MDk_1d763c1e-049b-4c0e-8ea7-2204b0dd6fc5">89,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d50b5caa3534d6f84e75102afd14fdb_I20220630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItMy0xLTEtNTE3MDk_0ebf4849-27ff-4bcf-9cec-7628082f0995">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dae7f18f2f34d56b658f35f31fdd441_I20220630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItNS0xLTEtNTE3MDk_3be9ba50-6b09-43d8-ae9a-736b026e0fd8">1,618.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2a718bde80444eb214d2eaf59e0b6c_I20220630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItNy0xLTEtNTE3MDk_b02d329e-389f-4638-92b9-490df723a5df">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cdb2c56dc4745448c8e6a876c8890db_I20220630" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItOS0xLTEtNTE3MDk_f6fb0a0d-201b-40fc-8deb-7315492c3c79">508.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4909f7c61db49b69aa8ecd11570d198_I20220630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItMTEtMS0xLTUxNzA5_7e6755e2-7333-41ce-80ef-c2c0a560fbbf">885.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItMTMtMS0xLTUxNzA5_168a854e-4b8f-4c03-afe5-8705de7b9e3e">2,040.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited, dollars in millions)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:73.266%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.973%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMy0yLTEtMS00NzU3NQ_a36ccc60-685c-4eee-bc5a-844558ccab57">58.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMy00LTEtMS00NzU3NQ_47921fa8-74aa-4c92-8263-746c3f1a270f">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNS0yLTEtMS00NzU3NQ_26e5220c-5171-4670-ac7b-c9af1fd71099">55.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNS00LTEtMS00NzU3NQ_3e74342b-ba59-4300-9d9b-b82d5458c111">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="sgry:NoncashInterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNi0yLTEtMS00NzU3NQ_948b03de-6181-42b4-a982-02c310984f96">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="sgry:NoncashInterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNi00LTEtMS00NzU3NQ_5ade9f20-0bd9-404f-8cce-b9b99626776f">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNy0yLTEtMS00NzU3NQ_42adf000-a90d-4718-b569-f9d824d4abb1">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNy00LTEtMS00NzU3NQ_edf5093a-e7f3-4069-9160-cb90f1cda8e0">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOC0yLTEtMS00NzU3NQ_f87055fb-f48b-4e02-8542-1806d27bf216">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOC00LTEtMS00NzU3NQ_31548b3e-b334-482c-bb86-7e6ef022a3a4">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOS0yLTEtMS00OTIyMg_16d21293-46f6-48ee-a9c4-4e101a4605fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOS00LTEtMS00OTIyMg_b44dd9fd-c5dc-43c3-aec7-97db74eef147">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOS0yLTEtMS00NzU3NQ_7489fb44-4cfa-4c53-8593-6bf2372f187d">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOS00LTEtMS00NzU3NQ_368895b2-afab-4e63-8d13-2f4f62be5ca0">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated affiliates, net of distributions received</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTAtMi0xLTEtNDc1NzU_5c5ef3a9-ce04-4179-956f-d151b91616a8">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTAtNC0xLTEtNDc1NzU_1d1f9d3d-0515-48f5-9e93-9389044556bb">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTEtMi0xLTEtNDc1NzU_f22d21c9-ecf6-4886-812a-f560de84c278">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTEtNC0xLTEtNDc1NzU_7785a3a3-ec00-41fd-9f38-bf738e797d8a">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTMtMi0xLTEtNDc1NzU_039789e4-b875-47dd-9bf9-c01fc541c5df">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTMtNC0xLTEtNDc1NzU_c3638435-ba46-4d32-84be-8eb12c90fc36">3.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare accelerated payments and deferred governmental grants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTQtMi0xLTEtNDc1NzU_2fa4eef3-65e7-41f9-8eea-51d27b99fa74">40.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTQtNC0xLTEtNDc1NzU_7d2d339e-22e3-40e6-b34b-c822bbc3bd1d">28.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOJ settlement payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:IncreaseDecreaseInSettlementPayments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTYtMi0xLTEtNDkyMjg_2d765b2d-f411-4da5-ba4c-ee0e16e20bbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:IncreaseDecreaseInSettlementPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTYtNC0xLTEtNDkyMjg_fc04a61e-1570-48ba-a30f-8677b7d87f1d">32.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTUtMi0xLTEtNDc1NzU_ebafd9c6-1f45-49c4-93e6-5bbb5c9d0e59">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTUtNC0xLTEtNDc1NzU_d3757094-f936-4bc4-b686-1a9dac17e099">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTYtMi0xLTEtNDc1NzU_c65c684d-2a7c-4321-8745-f36324936897">121.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTYtNC0xLTEtNDc1NzU_6158e6c2-9530-4627-a8b2-9d8cf8198804">52.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTktMi0xLTEtNDc1NzU_507773bd-42ec-424c-a655-1e35f71064a0">40.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTktNC0xLTEtNDc1NzU_ed3925b1-2965-4951-857b-22af7df8d757">28.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for acquisitions, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjAtMi0xLTEtNDc1NzU_a98334d8-91d6-4fc5-9d53-0fee26465934">74.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjAtNC0xLTEtNDc1NzU_0163526a-98e1-4276-bae2-a201c92297b7">15.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from disposals of facilities and other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjEtMi0xLTEtNDc1NzU_e0e1a4ba-e7a0-44a8-a33f-587087b8b900">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjEtNC0xLTEtNDc1NzU_8e68f4fb-279f-4e71-ae09-6db944e12ef1">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjQtMi0xLTEtNTQwNzE_ea101c15-c4de-4cbc-b882-8d3c3d980e79">65.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjQtNC0xLTEtNTQwNzE_a9e466e7-a3b6-4fe5-92de-c2b5665c84d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjItMi0xLTEtNDc1NzU_3063d692-581d-400f-8f73-544202de0f5d">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjItNC0xLTEtNDc1NzU_8d266e10-4cc4-48ae-891c-56cd99b4d821">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjMtMi0xLTEtNDc1NzU_44437c65-ae2f-41c8-ab1d-0f6df0fb4bc1">11.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjMtNC0xLTEtNDc1NzU_b20a3e3f-c078-4745-8bfd-06b562cfcbaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjQtMi0xLTEtNDc1NzU_ad5e33b7-9552-4a1b-b822-3245aa0af781">181.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjQtNC0xLTEtNDc1NzU_7b98ee1c-04c3-4cad-bfe9-9b03eeff382c">40.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal payments on long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjctMi0xLTEtNDc1NzU_81ebcdf7-5144-4c10-94ff-6f158a373c17">33.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjctNC0xLTEtNDc1NzU_d766bc58-8948-4792-a041-83b3dba16113">309.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Borrowings of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjgtMi0xLTEtNDc1NzU_c0bf6231-819d-4e48-ae0a-f703f4b3c629">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjgtNC0xLTEtNDc1NzU_cf92fc42-0373-4625-8a27-769aa5c94c95">283.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjktMi0xLTEtNDc1NzU_43dc86e0-74b5-4480-9c55-66ec11f8e75b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjktNC0xLTEtNDc1NzU_69682002-0f83-467b-a7a3-b03d6af83a22">8.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of premium on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:DebtInstrumentPrepaymentPenaltyAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzItMi0xLTEtNDkyNDQ_5cc8ed32-d636-42df-81de-1fc8c54e8489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:DebtInstrumentPrepaymentPenaltyAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzItNC0xLTEtNDkyMzc_90b155f5-d863-4bcc-8b2c-5b95739999ad">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from equity offering</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzAtMi0xLTEtNDc1NzU_3fae6217-b28b-4457-9feb-1887b243c6b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzAtNC0xLTEtNDc1NzU_f5eca210-6772-4aef-b938-4e0272fbca78">260.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of equity offering costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzEtMi0xLTEtNDc1NzU_5ab2ee7d-3cbc-4e6e-9262-163e80aac1a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzEtNC0xLTEtNDc1NzU_8f117843-1d47-45d8-8204-a9c53d7ec5f9">12.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of preferred dividends</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzItMi0xLTEtNDc1NzU_9b9dc6b8-f60f-4db2-a7a7-9451b36a6c4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzItNC0xLTEtNDc1NzU_a7dfd65c-f337-4d85-80da-6ebaa9dc9b7f">5.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to non-controlling interest holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzMtMi0xLTEtNDc1NzU_f45c08cc-423f-4814-859a-019caf08418e">75.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzMtNC0xLTEtNDc1NzU_c4eb1ce9-6eb2-4d83-b761-18a9ccf53f42">63.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Payments) receipts related to ownership transactions with non-controlling interest holders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzQtMi0xLTEtNDc1NzU_0f13a7de-9c9f-4a66-b874-cda05e88c95b">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ProceedsFromMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzQtNC0xLTEtNDc1NzU_7b2ed1d7-d083-470d-b96a-3a9e188cd578">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzUtMi0xLTEtNDc1NzU_24f36b6a-9d0f-4752-a218-2ca351e7238a">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzUtNC0xLTEtNDc1NzU_680a70ec-baa2-43da-aeb8-ae97a34110bf">10.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzYtMi0xLTEtNDc1NzU_47bd124f-21ff-4977-a589-49aea47f97fe">103.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzYtNC0xLTEtNDc1NzU_0bfe8efc-d64c-4efd-a0d8-13698fbe5584">134.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzctMi0xLTEtNDc1NzU_21daeaaa-1ebf-49b6-b0be-c0b0422b177f">162.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzctNC0xLTEtNDc1NzU_a0ed6ad4-2f68-4a3a-98f0-f8531c2d7e87">146.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzgtMi0xLTEtNDc1NzU_55873795-0add-42d2-9985-9b38c7389ec4">389.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ce39eddcaef4480b057800dbc9fc415_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzgtNC0xLTEtNDc1NzU_6a642306-6f8e-401f-87c0-2b6d7a79fa62">318.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzktMi0xLTEtNDc1NzU_0f30a8a2-f5a5-4a4d-bbb6-607146df53c5">227.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i293881ff9efc4258a9030c4efeddff54_I20210630" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzktNC0xLTEtNDc1NzU_9747e862-5773-47d5-a578-3acee56c1060">464.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to unaudited condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_31"></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1.  <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzMzk_4f82f117-b436-4f2d-a0ec-8f0feb2e3a5e" continuedAt="i724d3c9ced744959907b8617e0445d24" escape="true">Organization and Summary of Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i724d3c9ced744959907b8617e0445d24" continuedAt="ifdf09682d93b4790b07752bb20c40cfb"><div style="margin-bottom:6pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of multi-specialty physician practices, urgent care facilities and anesthesia services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the Company owned or operated a portfolio of <ix:nonFraction unitRef="facility" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="sgry:NumberOfSurgicalFacilitiesOwned" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTAyMQ_83de3048-171b-45d9-9131-f896b560e234">133</ix:nonFraction> surgical facilities, comprised of <ix:nonFraction unitRef="facility" contextRef="i8635a31bb616432d8bb3e7a8d312f3a5_I20220630" decimals="INF" name="sgry:NumberOfSurgicalFacilitiesOwned" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTA1OA_7a8c3ced-dfc5-4f67-b638-9c65f93e838c">115</ix:nonFraction> ASCs and <ix:nonFraction unitRef="facility" contextRef="i9538a3fb78354d13ae2d5c04403980a5_I20220630" decimals="INF" name="sgry:NumberOfSurgicalFacilitiesOwned" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTA3MA_bd531742-86b8-453f-aba8-6457e7e6a1c5">18</ix:nonFraction> surgical hospitals in <ix:nonFraction unitRef="state" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTA5NQ_a72b7eb9-2e64-449e-8ceb-bdb579d8c3a8">32</ix:nonFraction> states. The Company owns these facilities in partnership with physicians and, in some cases, health care systems in the markets and communities it serves.&#160;The Company owned a majority interest in <ix:nonFraction unitRef="facility" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="sgry:NumberOfSurgicalFacilitiesOwnedMajorityInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTI5NA_4568d25f-6432-446c-bb93-ec3981ffc166">85</ix:nonFraction> of the surgical facilities and consolidated <ix:nonFraction unitRef="facility" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="sgry:NumberOfSurgicalFacilitiesOwnedConsolidated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTM0MQ_526945af-4ed7-425a-aad4-a287cedaaf9e">109</ix:nonFraction> of the facilities for financial reporting purposes.</span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUyNzY_1cab20ce-25b7-4a54-a0ef-a6547bae8335" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the "2021 Annual Report on Form 10-K").</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzNjM_424399cc-c7b7-48a5-9d73-589eb5b36fbb" escape="true">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzMDQ_26745659-80c3-428c-b704-a8450a3ee309" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUyNzM_e792e529-25e8-42e7-bc90-510a7865ac8b" continuedAt="i8014eda4528748a9b1a581e4ea36af75" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide health care services. The Company recognizes revenues in the period in which its obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to receive. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid and private insurance organizations, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ifdf09682d93b4790b07752bb20c40cfb" continuedAt="i54cf6d8165814a22822e2bdbab2306ab"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUyNzQ_7fb53cb0-e9dc-4b32-b7fd-82780ad5bd93" continuedAt="i502a944210cf4f6982a6d1bffc8519d0" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of revenues by service type as a percentage of total revenues follows:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Surgical facilities revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69a8b63234044edb8f0a6afda70cdd7f_D20220401-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfMy0yLTEtMS00NzU3NQ_a6829922-e08d-4753-b6b6-8dec3c8ac8da">95.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf657c1e4474414d9ed07e96c58ad59d_D20210401-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfMy00LTEtMS00NzU3NQ_c7b81cdb-11d0-4b55-aed1-5b388355bd1a">95.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i552bb5d715f746d0af0896cb8236e297_D20220101-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfMy02LTEtMS00OTI1OQ_f944aecd-784a-4488-9274-669a9879b90d">95.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86904f5d11ef43b59e207be1a0a75042_D20210101-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfMy04LTEtMS00OTI2NQ_e5d68771-96bc-4603-b448-c274290546ea">95.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Ancillary services revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibff8350d312b4ee2964eceaea94a35b0_D20220401-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNC0yLTEtMS00NzU3NQ_92b51d85-ccbd-4dc9-8f74-d5808bc3bf53">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c0d2eeb74d34cfc9128ab781a805818_D20210401-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNC00LTEtMS00NzU3NQ_e7a26b10-339e-41a8-b631-421f1b4da671">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idab948c415d74a1e874e667af7cefd2c_D20220101-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNC02LTEtMS00OTI1OQ_09142088-aeda-459d-ab6d-a0bbc7daeead">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife3f7aa0dc10478fa288248a9670fa92_D20210101-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNC04LTEtMS00OTI2NQ_e55fb768-6118-4aee-8596-173df1aa2add">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i34e9e7220c934670b27ad119a843e336_D20220401-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNS0yLTEtMS00NzU3NQ_e13e23b5-038f-4882-8940-026a88ea6c52">98.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i840850c9edd84feea92967f120b69408_D20210401-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNS00LTEtMS00NzU3NQ_b4704f5a-ef51-4cce-b646-02ef877d7d52">98.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b11393d1e4444258098013cd223901e_D20220101-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNS02LTEtMS01MTcyNg_d700e7f3-7d97-4c67-a994-bcf613e98607">98.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia6ce9b604fc54f51a04400f3ffd18e4c_D20210101-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNS04LTEtMS01MTcyNg_7be84d4a-d86b-4adf-9be0-71e8554edc14">98.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8ccf871acc2e48a18834c00109df962f_D20220401-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNi0yLTEtMS00NzU3NQ_d410f030-e1d5-4ab5-b6c8-561a293204a4">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab3bce97216f4963af800c138848af24_D20210401-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNi00LTEtMS00NzU3NQ_c250e1fb-0d4a-4e40-8aa1-8527cf189052">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib016f83f44d74921b4f5ce6b9ab4976f_D20220101-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNi02LTEtMS00OTI3Mw_a8c7869b-5459-451a-867d-5f73ea02fac9">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a2aaf930d1c431f8bcf8bc5136ad3b0_D20210101-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNi04LTEtMS00OTI3OQ_6b087508-c6c6-44f9-92c5-a1dc21ceb980">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0d812678eaf54267847b2530339322ec_D20220401-20220630" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNy0yLTEtMS00NzU3NQ_3d0a7fea-32ac-4900-a6b2-f63f3269ac0a">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic47817178a934289aa981ee5da388b9d_D20210401-20210630" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNy00LTEtMS00NzU3NQ_8b5a834a-3387-4a2a-84e1-217730b714fa">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic37df66186ae4e5fb918bd1d2efca702_D20220101-20220630" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNy02LTEtMS01MTcyNg_613ff6ec-2836-4405-ac05-61bf860cecd0">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icf41c461015444fe83e5e4ac21755f08_D20210101-20210630" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNy04LTEtMS01MTcyNg_d832ffb7-5f69-4eae-a572-df3ee00afe52">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:continuation id="i8014eda4528748a9b1a581e4ea36af75"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Patient service revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This revenue is related to charging facility fees in exchange for providing patient care. The fee charged for health care procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other service revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Other service revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period, which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.</span></div></ix:continuation><ix:continuation id="i502a944210cf4f6982a6d1bffc8519d0" continuedAt="ifc3b33b0f5b74ddfba961dbee0480e3b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.887%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44cb302421034882ae2b0562737c1761_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNC0yLTEtMS00NzU3NQ_ce388313-dc8e-4dd2-a663-472cadbfb6e7">309.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if244251d5c944d3c8d006f96aa5ebbeb_D20220401-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNC00LTEtMS00NzU3NQ_5faa8153-47ce-45f0-811c-f9267db1101a">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b170b8d71c411192b47b3305a64616_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNC02LTEtMS00NzU3NQ_e668f05d-07eb-4a59-af2d-908c0d8347ee">273.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c2399a17532427a98c0603b2322f33f_D20210401-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNC04LTEtMS00NzU3NQ_632d686d-8a45-4793-9ea1-9781895f3384">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26fcec9c0227498db8204ef1cbf8fc8f_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNS0yLTEtMS00NzU3NQ_fb3b8974-a497-447f-bd74-6f868d56a69c">258.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0822a8d0912456b81a264a53b470d89_D20220401-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNS00LTEtMS00NzU3NQ_f432db86-1b84-402f-9c34-0b66d357c574">42.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0f939d7f48e447e90a63291660e7944_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNS02LTEtMS00NzU3NQ_2bd8a477-215d-4e43-b0e9-4e659e27e795">226.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5cc712172b944863ad8e1ec9d1f576b5_D20210401-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNS04LTEtMS00NzU3NQ_7f09cb5f-dfc9-4891-9164-35c8d393acd6">42.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9a48f2904b44c188eea35ede6799f83_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNi0yLTEtMS00NzU3NQ_d10d0d9a-3f9e-409e-9948-c874a565d00b">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia80790d713364217852ad6b20c5b9b80_D20220401-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNi00LTEtMS00NzU3NQ_e72fb33e-9716-4c55-8422-fda225e7c944">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e081ac08c44dc5a177a46e62b24af8_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNi02LTEtMS00NzU3NQ_55265791-7af1-4fd4-8500-fc3c6fc6b707">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b40d040385048f4892471ac83e1a711_D20210401-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNi04LTEtMS00NzU3NQ_5246c99a-eceb-466e-9b8c-fdafa8e5af41">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2cd8126cda47679574168e7959c24f_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNy0yLTEtMS00NzU3NQ_57e1984a-47b4-4588-85c7-338e0341b047">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id61b7b590da346e2947662ec3b207f85_D20220401-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNy00LTEtMS00NzU3NQ_beb1e67f-8c20-4738-8054-2982511df304">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bc26bedce494bfea61792a1ff92ace3_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNy02LTEtMS00NzU3NQ_cf82fd35-c298-4c56-99f4-f16cbb40845d">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idcc3a089528340bbba1aff28988c6812_D20210401-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNy04LTEtMS00NzU3NQ_60b9d1cb-800e-46cc-b445-07060a1b16ba">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d7024453b0a4f5c8ce5d266c8c9e818_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOC0yLTEtMS00NzU3NQ_656a4745-490e-4b18-9889-7cde13407855">607.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27735b9da4154030bf4e696fb6bc2a59_D20220401-20220630" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOC00LTEtMS00NzU3NQ_d276ab2b-2685-4e2d-908e-ba69f9b14630">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97572a73c7164e119219a51fbc609a03_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOC02LTEtMS00NzU3NQ_51ef9e0e-f737-470b-8cff-44a2085643af">535.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id1dd63f253344cbf9b6a3ea5aca75cc1_D20210401-20210630" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOC04LTEtMS00NzU3NQ_0512af97-59a4-4121-b6b4-c397a921f964">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eba6e7221624a33acd805897dd778ed_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOS0yLTEtMS00NzU3NQ_83f9e4a4-9301-4c64-98fa-79d114fbbf57">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2da709eec92472d8e6b2eb875df017d_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOS02LTEtMS00NzU3NQ_e2bcf8b2-aa44-4b6e-bcfc-6a72d9b36180">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfMTAtMi0xLTEtNDc1NzU_65398768-1388-4efc-a030-97e030952d0f">615.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfMTAtNi0xLTEtNDc1NzU_a6587222-f1fe-4685-bf00-54962dc17ff4">543.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i54cf6d8165814a22822e2bdbab2306ab" continuedAt="i9681ab7e1f404525a2edf9f3b1f80960"><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"><ix:continuation id="ifc3b33b0f5b74ddfba961dbee0480e3b" continuedAt="i0883d1708fb04593afd86292ab7cbc1a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.887%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3084cb440f6440539f725074cc141064_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNC0yLTEtMS00OTMxMg_d922627b-8524-43e9-96fc-046e4154e170">608.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if3379039f97441b69503564797be213b_D20220101-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNC00LTEtMS00OTMzMA_faef13cb-634b-492a-8cbe-91b5921af4b8">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee70145afa7b4a67822ee29af8d0ac67_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNC02LTEtMS00OTMwMA_ef14165c-3c1d-471c-955b-af1658810e28">519.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad2ccb4850c7418299a1f3d759ad4c1c_D20210101-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNC04LTEtMS00OTMyNA_98a831f5-fc83-401b-9370-fb7b5e3379d4">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90f42610982f4a29bc29dac6a196477b_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNS0yLTEtMS00OTMxMg_d6414a52-0007-4540-b433-21daa54530c3">507.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iff79ffa556644f829d223ebc6d3e3e4e_D20220101-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNS00LTEtMS00OTMzMA_0262b503-b230-492d-a1b8-d10000911740">42.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0de9d3bf0e784880a751f9e1dc386914_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNS02LTEtMS00OTMwMA_be9585db-9c74-4531-a71c-ccc5e6a4d433">452.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i18be6ab1a0c548c2b344fd6ed2142372_D20210101-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNS04LTEtMS00OTMyNA_339c88a8-fdad-46a3-aa20-630fdcef63ff">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8dfce5bc944bfd937fcf89a20c4c8a_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNi0yLTEtMS00OTMxMg_d37cfb07-b2da-43b6-a19e-d28b3f9ff964">33.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebe60e2bb5c545f98959f8d0f9d2db95_D20220101-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNi00LTEtMS00OTMzMA_b177d87c-15b7-4346-a1d7-1598ce34be68">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd55bfbcc5443ce8c95abb22f917ef7_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNi02LTEtMS00OTMwMA_17f2adc5-21e0-4039-9ae6-53819bdb0627">31.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf891198937c45b68701f2071a3a79c1_D20210101-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNi04LTEtMS00OTMyNA_64702548-c23c-4de0-a93b-3fc3f7114beb">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c06ae7e4574d1087fab3bfb50d7437_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNy0yLTEtMS00OTMxMg_a278e00c-ebdd-4ad5-9f93-9a973b0b8373">46.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1be2d60556148108356e7e3d0c609e6_D20220101-20220630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNy00LTEtMS00OTMzMA_0f7771f4-7947-48fb-930c-2e6cd482de8f">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b0201ec336d4d759ab22d8b3f999534_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNy02LTEtMS00OTMwMA_c064e3d2-b45b-40fd-92a7-886009ddb981">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if99bdea32bbb4844a79014c52607f56e_D20210101-20210630" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNy04LTEtMS00OTMyNA_c007f970-f08f-4f42-92f2-310230c0e35a">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic90c5193afd6420fb1c2f4aa57b405e7_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOC0yLTEtMS01MTcyOA_5700e0ed-8038-4644-b1af-03f88500b422">1,195.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i18b50bcfbdfb4bb791ecefea65280045_D20220101-20220630" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOC00LTEtMS00OTMzNg_e3fef7bb-01bd-46b7-9f1b-c24557dc874c">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbbf27a71e2f456398a50c2893221fad_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOC02LTEtMS01MTcyOA_e8ae32eb-876d-407f-9998-b8c08c360f16">1,041.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i07a9608cfa094c6684c2b726c01884cb_D20210101-20210630" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOC04LTEtMS01MTcyOA_006e5ba2-6353-4a27-915c-56584b688067">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02fc46716fa94295ba0d78ef52b9bc23_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOS0yLTEtMS00OTMxOA_780afaf8-a5cd-40e6-b645-18844f6135ee">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8831be04004f4e43925db4244ecc0d5c_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOS02LTEtMS00OTMwNg_dbab727f-f969-422f-bd2b-fef322f91386">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfMTAtMi0xLTEtNTE3Mjg_546174a9-d284-497f-a46d-70e1f7264285">1,211.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfMTAtNi0xLTEtNTE3Mjg_a503e215-4eb3-4e23-b157-d545494168a4">1,055.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:continuation id="i0883d1708fb04593afd86292ab7cbc1a" continuedAt="i0e2b7d060e3845f6b6ba320a64f8e470">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"><ix:continuation id="i0e2b7d060e3845f6b6ba320a64f8e470">Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types.</ix:continuation> </span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzNjI_30f9bad1-346f-4b35-8291-c64802f9abe4" continuedAt="id1c889e2029143b49070f30cf3597413" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable from third-party payors are recorded net of estimated implicit price concessions, which are estimated based on the historical trend of the Company's surgical hospitals&#8217; cash collections and contractual write-offs, and for the Company's surgical facilities in general, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), private insurance organizations, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#8217;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="id1c889e2029143b49070f30cf3597413">The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. Collection efforts include direct contact with third-party payors or patients, written correspondence and the use of legal or collection agency assistance, as required.</ix:continuation> </span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTY0OTI2NzUwNTM5MA_d19ed411-7cec-4090-bded-39127e9b8795" escape="true"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in health care regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i9681ab7e1f404525a2edf9f3b1f80960" continuedAt="ifc9c2ced9bef4282848dbd24bda11e02"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's effective tax rate was <ix:nonFraction unitRef="number" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4Njk0Mg_fdd5419e-d8dd-4d46-b03d-b22fa4b2b15e">8.8</ix:nonFraction>% for the six months ended June&#160;30, 2022 compared to (<ix:nonFraction unitRef="number" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4Njk4OA_87386d38-48ca-4406-a4c5-df62ee6baaf1">14.6</ix:nonFraction>)% for the six months ended June&#160;30, 2021. For the six months ended June&#160;30, 2022, the effective tax rate differed from the federal corporate tax rate of 21% primarily due to earnings attributable to non-controlling interests, an increase in the Company&#8217;s valuation allowance attributable to interest expense limitations, and discrete tax benefits of (a) $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4NzI5MQ_6dc8039c-df0b-4c28-8822-636c63dea46b">4.6</ix:nonFraction>&#160;million related to the vesting of restricted stock awards, (b) $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4NzM1MA_a5a5cf3c-aff7-481d-a769-d29d081e054c">1.8</ix:nonFraction>&#160;million attributable to non-recurring earnings&#8217; impact on the Company&#8217;s valuation allowance, and (c) $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4NzQ0Nw_9e44de2c-6c98-4c4d-800f-7c3584406351">1.0</ix:nonFraction>&#160;million related to entity divestitures. For the six months ended June&#160;30, 2021, the effective tax rate differed from 21% due to tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4NzU3OA_0813f5f1-8881-4f99-9337-ac74f8948044">4.1</ix:nonFraction>&#160;million related to the vesting of restricted stock awards, as well as a $<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4NzY0Ng_256d5790-795e-4af2-b3b2-e4fddec50964">3.0</ix:nonFraction>&#160;million tax benefit related to entity divestitures. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzMzU_44d777cf-9d91-430c-80eb-8bfa78b48647" continuedAt="ie351d7523f224ef0b05fa101b60a6981" escape="true">Goodwill</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ie351d7523f224ef0b05fa101b60a6981">Goodwill represents the excess of the fair value of the consideration provided in an acquisition plus the fair value of any non-controlling interests over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.</ix:continuation> A summary of the Company's acquisitions and disposals for the six months ended June 30, 2022 is included in Note 2. "Acquisitions and Disposals."</span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUyOTU_4abc226e-9a3a-45f2-b2dd-672739518b17" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to goodwill for the six months ended June&#160;30, 2022 is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjg2OWRkNmVkYjY1NTRlM2NhMGU2YWZjZGFhODc1ZDMxL3RhYmxlcmFuZ2U6ODY5ZGQ2ZWRiNjU1NGUzY2EwZTZhZmNkYWE4NzVkMzFfMC0yLTEtMS00NzU3NQ_fef9cfa8-f8bb-4e0a-bf07-d04e9741373b">3,911.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, including post acquisition adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjg2OWRkNmVkYjY1NTRlM2NhMGU2YWZjZGFhODc1ZDMxL3RhYmxlcmFuZ2U6ODY5ZGQ2ZWRiNjU1NGUzY2EwZTZhZmNkYWE4NzVkMzFfMS0yLTEtMS00NzU3NQ_eca397b3-8be1-46d0-a5b2-1711f61f0535">110.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposals and deconsolidations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjg2OWRkNmVkYjY1NTRlM2NhMGU2YWZjZGFhODc1ZDMxL3RhYmxlcmFuZ2U6ODY5ZGQ2ZWRiNjU1NGUzY2EwZTZhZmNkYWE4NzVkMzFfMi0yLTEtMS00NzU3NQ_9b0c327c-9de3-4247-bab0-b65e1e03d95f">29.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjg2OWRkNmVkYjY1NTRlM2NhMGU2YWZjZGFhODc1ZDMxL3RhYmxlcmFuZ2U6ODY5ZGQ2ZWRiNjU1NGUzY2EwZTZhZmNkYWE4NzVkMzFfMy0yLTEtMS00NzU3NQ_c116e3c3-bc99-4f40-980c-6bd96f404e0a">3,993.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A detailed evaluation of potential impairment indicators was performed as of June&#160;30, 2022, which specifically considered the ongoing impact of the COVID-19 pandemic, recent increases in interest rates, inflation risk and market volatility. On the basis of available evidence as of June&#160;30, 2022, no indicators of impairment were identified. Future estimates of fair value could be adversely affected if the actual outcome of one or more of the Company's assumptions changes materially in the future, including a material decline in the Company&#8217;s stock price and the fair value of its long-term debt, lower than expected surgical case volumes, higher market interest rates or increased operating costs. Such changes impacting the calculation of fair value could result in a material impairment charge in the future.</span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzNDU_6b6cc28d-c663-4ed8-bbd5-6d627757e047" continuedAt="i648c0115e0b645f0bb621a248b613f0c" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records all derivatives on the balance sheet at fair value and any financing elements treated as debt instruments are recorded at amortized cost. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="sgry:RedeemableNoncontrollingInterestPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzMzc_d1e59f0a-9b54-42c1-94bd-bf891cfa82ff" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-Controlling Interests&#8212;Redeemable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ifc9c2ced9bef4282848dbd24bda11e02" continuedAt="icc3ca142551d4e7a9734d5230ef9e385"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzMjc_2abd0b40-e664-4c19-bbf6-ae612a28fd10" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to non-controlling interests&#8212;redeemable is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.443%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfMy0yLTEtMS00NzU3NQ_2f029b17-bf15-4f8b-a6f7-450305529356">330.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ce39eddcaef4480b057800dbc9fc415_I20201231" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfMy00LTEtMS00NzU3NQ_b74537e1-4c22-4ae6-9c69-5a1a3cb07cbf">306.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests&#8212;redeemable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNC0yLTEtMS00NzU3NQ_350a6c14-cc40-416c-b8fb-4e8b14307423">21.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNC00LTEtMS00NzU3NQ_a648a579-26d8-46a5-931d-4721d149e29c">24.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of shares of non-controlling interests, net&#8212;redeemable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNS0yLTEtMS00NzU3NQ_f3358fc3-cc86-4561-b4cf-cb37fdc606ac">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNS00LTEtMS00NzU3NQ_73bc72d4-301f-4c16-8584-b9dce6f259de">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to non-controlling interest&#8212;redeemable holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNi0yLTEtMS00NzU3NQ_4a54efd4-e7c0-419e-8ba7-4f3e1809b31a">22.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNi00LTEtMS00NzU3NQ_6cebef27-3a7b-44d7-b3f1-8fa12c0929b5">20.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNy0yLTEtMS00NzU3NQ_343e9342-7994-4d43-ba42-218a89ce4bff">341.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i293881ff9efc4258a9030c4efeddff54_I20210630" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNy00LTEtMS00NzU3NQ_9da11924-bd94-4877-a7fc-0912950780eb">312.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Medicare Accelerated Payments and Deferred Governmental Grants</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has received grant funds distributed under the Coronavirus Aid, Relief and Economic Security Act (the &#8220;CARES Act&#8221;) and other governmental assistance programs, including approximately $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-6" name="sgry:ProceedsFromGovernmentAssistance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3MjkyOQ_260fbade-d36c-48ab-a41f-3d9a4e282b2a">1</ix:nonFraction>&#160;million during the six months ended June&#160;30, 2022. Grant funds received during the three months ended June 30, 2022 were minimal. During the three and six months ended June 30, 2021, the Company received grant funds of approximately $<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-6" name="sgry:ProceedsFromGovernmentAssistance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5MDY2Mw_01fb032f-404b-4dd0-9fa1-0ed0b6a57f69">1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-6" name="sgry:ProceedsFromGovernmentAssistance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5MTgyNQ_04d840b8-78c3-44d6-9070-1e1691dc8080">8</ix:nonFraction>&#160;million, respectively. The recognition of amounts received is conditioned upon attestation with terms and conditions that funds will be used for COVID-19 related healthcare expenses or lost revenues. Amounts received, but not recognized as a reduction to operating expenses, are reflected as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets. Any unrecognized amounts may be recognized as a reduction in operating expenses in subsequent periods if the underlying conditions for recognition are met. The Company estimates $<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="sgry:GrantRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3Mzk2Mg_6aae4cf3-0997-445d-bf74-d7a12f12f17c">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:GrantRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3Mzk3MA_041ba430-2434-4ef9-9c83-0e1d3688e35f">1.3</ix:nonFraction> million of grant funds received qualified for recognition as a reduction in operating expenses for the three and six months ended June&#160;30, 2022, respectively. During the three and six months ended June 30, 2021, $<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="sgry:GrantRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5NzUwMQ_7f1bc2d4-acc3-4ad4-8c99-d3beda7c8f86">4.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:GrantRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5NzUyMQ_ba209041-9036-4724-99ca-df33c22e45c2">20.0</ix:nonFraction> million, respectively, was recognized as a reduction in operating expenses. As of both June&#160;30, 2022 and December&#160;31, 2021, approximately $<ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-6" name="sgry:UnrecognizedGrantFundsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5Nzc4MQ_627eae93-b3d7-42be-88cb-1759dc928052"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-6" name="sgry:UnrecognizedGrantFundsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5Nzc4MQ_788b2180-edd4-4afd-9d3a-503482e7f7f6">4</ix:nonFraction></ix:nonFraction>&#160;million of unrecognized grant funds received was reflected within the condensed consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company received accelerated payments under the Medicare Accelerated and Advance Payment Program. The payments received were deferred and included in the condensed consolidated balance sheets. During the three and six months ended June&#160;30, 2022, approximately $<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-6" name="sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3NTQwNg_118a1f74-e2e5-4b7f-a6f3-9f658340b84d">25</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-6" name="sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3NTQxNA_22b32e39-c933-4be5-a3ff-01a7aa926f88">43</ix:nonFraction>&#160;million, respectively, has been repaid in accordance with the terms of the program. These repayments are included as a component of the change in Medicare accelerated payments and deferred government grants in the condensed consolidated statements of cash flows. As of June&#160;30, 2022 and December&#160;31, 2021, the remaining deferred accelerated payments was approximately $<ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-6" name="sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3NjEwOQ_c3f113b1-b9b5-471a-b3c0-12e59104f734">17</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-6" name="sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3NjExNw_81421577-e96a-4b08-b692-53d9bcf8bee8">60</ix:nonFraction>&#160;million, respectively, which was included as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets. The Company does not expect to receive additional Medicare accelerated payments.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s accounting policies for relief received under the CARES Act and other governmental assistance programs, including the recognition of grant funds, is unchanged from the policies described in Note 1 to the Company&#8217;s consolidated financial statements included in the 2021 Annual Report on Form 10-K. </span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTY0OTI2NzUwNTM5MQ_b61d6a50-9de6-4a86-a73d-917ef1a77c59" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on inputs classified into the following hierarchy:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These may include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, depending on the nature of the item being valued.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="icc3ca142551d4e7a9734d5230ef9e385"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTY0OTI2NzUwNTM5Mw_1d827fb9-7ead-4fbc-9e79-b6e8a92803da" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.191%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.787%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.788%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b3dc06c3b0940c6864cf95b82437b22_I20220630" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfMy0yLTEtMS01NDc0MA_d2e39e13-87c9-44a9-8533-44b6a3d9af97">1,523.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4014a2b0728429f99f1aff4ee095837_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfMy00LTEtMS01NDc0MA_5cb2a54c-0cc4-4eca-886b-498b88959f19">1,530.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48593468d901450b9f2b3750f730873f_I20220630" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfMy02LTEtMS01NDc0MA_0e3bcfd0-5623-4ffd-8ac5-2dfb787294f5">1,439.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab78f5af1da94146958f7005f99d54ed_I20211231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfMy04LTEtMS01NDc0MA_9773e165-fd9a-4f23-b102-6f0fd24438b5">1,530.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17b9522ee1a5410c9e521102b0938024_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNC0wLTEtMS01NDc0MC90ZXh0cmVnaW9uOjFjNzc4YWM2YjIzZTRhMDA5MGFkMjU4ZTRlNjRlYzc1XzQ_00899d8b-08cd-48fd-822d-639c4066095a">6.750</ix:nonFraction>% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee1640a7d9ed442fb5430f01e5f729e5_I20220630" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNC0yLTEtMS01NDc0MA_e6567e55-7db5-4d79-a1a5-9fa0a9936fcc">370.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife931bd0ec79459bb3908847c1c58b78_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNC00LTEtMS01NDc0MA_64c658a3-fc31-4a84-82e8-e2f1024ff803">370.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc9575728f644eaa83de881b7d5e9813_I20220630" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNC02LTEtMS01NDc0MA_40cd6edc-fc86-47c6-ad9f-3f15a035329a">339.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240776d65f63482e82bae1bb71ef09b4_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNC04LTEtMS01NDc0MA_baf18240-01da-440d-84f5-ce57d1afd7ac">371.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id97f2fe451ad49ebab6e84dfc7448640_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNS0wLTEtMS01NDc0MC90ZXh0cmVnaW9uOmY2Y2E2MzNmNDE2OTRlYTQ5NjFlY2VhODc4MmJlZDY1XzQ_5fb3dcf9-54e6-47ca-82cb-8f72caf48f0f">10.000</ix:nonFraction>% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iada7c3ad8c6043cf83baea26ca96c7f5_I20220630" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNS0yLTEtMS01NDc0MA_9c872d89-00de-4026-b6f8-72635a7fca83">545.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7433e734c44d0fbaf0eb6487f2a2fd_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNS00LTEtMS01NDc0MA_36c327e4-15d9-49b6-9939-c72a24324076">545.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0455e535db8f4f838179eed4ab11e337_I20220630" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNS02LTEtMS01NDc0MA_6bbb7a7e-e294-4206-aa7f-a94a987933fc">531.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb5f2b0b8b3a4fb38bed91efd6ed8703_I20211231" decimals="-5" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNS04LTEtMS01NDc0MA_879b6d86-0368-43ed-b537-352c5443c419">577.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values in the table above were based on Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values based on Level 3 inputs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTY0OTI2NzUwNTM5Mg_0a4bcb65-992c-48d8-a7e6-430485b8af47" continuedAt="i28a59cebca4c4c90ac36c57bfc8d6b2c" escape="true">Variable Interest Entities</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><ix:continuation id="i28a59cebca4c4c90ac36c57bfc8d6b2c" continuedAt="ibe27cd15589b452ba2de668ba047c116"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ibe27cd15589b452ba2de668ba047c116">". The Company has the power to direct the activities that most significantly impact a VIE's economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur.</ix:continuation> As of June&#160;30, 2022, the Company's consolidated VIEs include <ix:nonFraction unitRef="facility" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="sgry:VariableInterestEntityNumberOfFacilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTEwNg_dbfe2277-34e9-47e7-9c39-26044e5f91ac">six</ix:nonFraction> surgical facilities and <ix:nonFraction unitRef="physician_practice" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="INF" name="sgry:VariableInterestEntityNumberOfFacilities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTEzNA_fa71543c-c20f-437b-819c-4c4ef81283a0">five</ix:nonFraction> physician practices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of June&#160;30, 2022 and December&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="i0c7f757289414463a07207dec757e8d0_I20220630" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTMzOQ_bcfd1843-272d-4272-b7ef-10e62ddbcbd3">69.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idfd8f7a8f4154e65a697ab7d0057cc7e_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTM0Nw_38f77019-8f1a-4ef5-a23d-7cc85517fd82">48.1</ix:nonFraction> million, respectively, and the total liabilities of the consolidated VIEs were $<ix:nonFraction unitRef="usd" contextRef="i0c7f757289414463a07207dec757e8d0_I20220630" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTQyMg_d7fd5d4d-bcca-490f-820a-b2d0df949a92">44.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idfd8f7a8f4154e65a697ab7d0057cc7e_I20211231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTQzMA_39407bc4-b0d0-46f0-a1d4-228fdc8057ab">20.1</ix:nonFraction> million, respectively.</span></div></ix:continuation><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_34"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMzY3Nw_002ab508-b1c2-4ffd-bc3b-d2d19b9761b2" continuedAt="ifb3e08dac42d48c992e4141bf662674c" escape="true">Acquisitions and Disposals</ix:nonNumeric></span></div><ix:continuation id="ifb3e08dac42d48c992e4141bf662674c" continuedAt="i81c17a26ef484f4f956bcde3d7c9e0c2"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company acquired a controlling interest in <ix:nonFraction unitRef="facility" contextRef="ia73c117591c64b64acb148493f0ec6d8_D20220101-20220630" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMTY0OTI2NzQ0NzQ0MQ_7e403ea7-14f9-4918-8752-b3f3a788cf51">four</ix:nonFraction> surgical facilities, <ix:nonFraction unitRef="facility" contextRef="i6a3bff3446ca40c28509f17868f1adc1_D20220101-20220630" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMTY0OTI2NzQ0NzQ1MA_b37f414a-2a55-4fa2-8881-619356709bec">two</ix:nonFraction> of which were merged into existing surgical facilities, for aggregate cash consideration of $<ix:nonFraction unitRef="usd" contextRef="ia73c117591c64b64acb148493f0ec6d8_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMjMz_7726217b-a5b2-42d1-ad2d-acbaa342058f">74.9</ix:nonFraction>&#160;million, net of cash acquired, and non-cash consideration of $<ix:nonFraction unitRef="usd" contextRef="ia73c117591c64b64acb148493f0ec6d8_D20220101-20220630" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMjg5_ea96b702-e229-4528-8864-d095468237e9">2.6</ix:nonFraction>&#160;million, which consisted of a non-controlling interest in one of the Company's existing surgical facilities. In connection with the acquisitions the Company preliminarily recognized non-controlling interests of $<ix:nonFraction unitRef="usd" contextRef="iea5f3abaa0984b2eaa7055cba2542341_I20220630" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0Nzc3NQ_edb78ba9-a5ee-4c32-9b53-2acdec0b6160">41.5</ix:nonFraction>&#160;million and goodwill of $<ix:nonFraction unitRef="usd" contextRef="iea5f3abaa0984b2eaa7055cba2542341_I20220630" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0Nzc4NA_d4b4f342-f238-4ae7-ae6c-e3f2a5df8c49">114.4</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, the Company acquired a controlling interest in a surgical facility in a new market and two surgical facilities in existing markets that were merged into existing facilities for aggregate cash consideration of $<ix:nonFraction unitRef="usd" contextRef="iefa24cf2b7dc4ebc86ae0a7a096deb4d_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0NDE5OQ_6538b334-4f88-4204-accc-a522df750375">15.2</ix:nonFraction>&#160;million, net of cash acquired. In connection with the acquisitions the Company preliminarily recognized non-controlling interests of $<ix:nonFraction unitRef="usd" contextRef="ifdc566837054408da2d934e520986ebb_I20210630" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0NzkyMA_2548773c-fc2f-4ddb-b636-2df28876718c">7.5</ix:nonFraction>&#160;million and goodwill of $<ix:nonFraction unitRef="usd" contextRef="ifdc566837054408da2d934e520986ebb_I20210630" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0NzkyOA_50a6a99f-ea1d-4856-ad33-e2bdc8b3ecca">20.0</ix:nonFraction>&#160;million. During the six months ended June&#160;30, 2022, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, the Company acquired non-controlling interests in <ix:nonFraction unitRef="non-controlling_interest" contextRef="ie3963d4281e5468c8e5368c83dc0b938_D20220101-20220630" decimals="INF" name="sgry:NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0MjcwMQ_ca096f0f-f5f0-4757-a1e8-315cc3e0f2dd">five</ix:nonFraction> surgical facilities and <ix:nonFraction unitRef="non-controlling_interest" contextRef="ie3963d4281e5468c8e5368c83dc0b938_D20220101-20220630" decimals="INF" name="sgry:NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0MjcyNg_121e2dc3-e858-4358-bc46-4bfeb95b6953">four</ix:nonFraction> in-development de novo surgical facilities for an aggregate cash purchase price of $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0Mjc5Mw_1b3275f2-c7fd-45ef-aa28-a8a2e283592c">65.8</ix:nonFraction>&#160;million. The non-controlling interests were accounted for as equity method investments and recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Disposals and Deconsolidations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company sold its interests in a surgical facility, which was previously accounted for as an equity method investment, for net cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i765634ba75024131a79a3d390bb13989_D20220101-20220630" decimals="-5" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMTc2OQ_70619b3e-c7e1-46f8-9251-0950a44ea84a">11.5</ix:nonFraction>&#160;million. The Company recognized a pre-tax loss on the sale of $<ix:nonFraction unitRef="usd" contextRef="i765634ba75024131a79a3d390bb13989_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMTgwNg_77b532be-6fee-47ec-b0de-c29cee45f225">0.4</ix:nonFraction>&#160;million included in loss on disposals and deconsolidations, net in the condensed consolidated statements of operations for the six months ended June&#160;30, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company contributed its interests in <ix:nonFraction unitRef="facility" contextRef="i97c9ba13353b4c19b6ed54c8402d44cf_D20220101-20220630" decimals="INF" name="sgry:DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMjAzNQ_8df450ac-75fd-4c66-8bdd-fa31eaa0e6cd">two</ix:nonFraction> surgical facilities as non-cash consideration for non-controlling interests in <ix:nonFraction unitRef="business_entity" contextRef="ib185c098b450421d89d993a6a054fd2c_D20210101-20210630" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMjExNw_6b78311e-ddaf-4952-b52c-b21a54b25226">two</ix:nonFraction> new separate entities. As a result of these transactions, the Company lost control of the previously controlled surgical facilities but retains a non-controlling interest in each, resulting in the deconsolidation of the previously consolidated entities. The remaining non-controlling interests were accounted for as equity method investments, and initially measured and recorded at fair value as of the dates of the transactions. The fair value measurement utilizes Level 3 inputs, which includes unobservable data, to measure the fair value of the retained non-controlling interests. The fair value determination was based on a combination of multiple valuation methods, which included discounted cash flow and market value approach, which incorporates estimates of future earnings and market valuation multiples for certain guideline companies. The preliminary fair value of the investments of $<ix:nonFraction unitRef="usd" contextRef="i2b6f41648efd461697a23bab27bf16e5_I20220630" decimals="-5" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMzAxNg_0bec397a-f6be-45f7-b3f7-87df9281a26e">9.8</ix:nonFraction>&#160;million was recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets. Further, based on the preliminary valuation, the transactions resulted in a pretax net loss on deconsolidations of $<ix:nonFraction unitRef="usd" contextRef="i97c9ba13353b4c19b6ed54c8402d44cf_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMzI2Ng_070fc474-503b-4828-bb6e-5cc97fed50e5">5.6</ix:nonFraction>&#160;million, which is included in loss on disposals and deconsolidations, net, in the accompanying condensed consolidated statement of operations for the six months ended June&#160;30, </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i81c17a26ef484f4f956bcde3d7c9e0c2">2022. The net loss was determined based on the difference between the fair value of the Company's retained interests in the entities and the carrying values of both the tangible and intangible assets of the entities immediately prior to the transactions.</ix:continuation></span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_37"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNjgx_2a7fc825-9af1-4729-86af-fa9962b54db5" continuedAt="i9ea4ec975ea248008cda3b7358c850a5" escape="true">Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="i9ea4ec975ea248008cda3b7358c850a5" continuedAt="i04407c2f240744f0a107bc4c02b3daff"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNjg0_06c7f279-e473-4e5a-b342-8088d4da3d20" continuedAt="ib33e472c19704165a81627b344b59ddf" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2194c6aaf1a4eec8b2eab9c9b7c3c3a_I20220630" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMi0yLTEtMS00NzU3NQ_1179d1ad-0d0e-49de-9979-139019ac5d14">1,523.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1aeee4881fa47c580bb5e99e88641ce_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMi00LTEtMS00NzU3NQ_158994a2-102e-4f56-add6-d8fb0d5122bf">1,530.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i17b9522ee1a5410c9e521102b0938024_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMy0wLTEtMS00NzU3NS90ZXh0cmVnaW9uOjg3MDU1M2IxZWI0YzQyYmI5YzA5MDA2OTVmM2FmNTA0XzQ_00899d8b-08cd-48fd-822d-639c4066095a">6.750</ix:nonFraction>% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17b9522ee1a5410c9e521102b0938024_I20220630" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMy0yLTEtMS00NzU3NQ_8b34ec4f-96c3-48a1-a5a3-bbba33766d4d">370.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17cc9fb2945a48038ba149c83e32f783_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMy00LTEtMS00NzU3NQ_6025d9ae-aa43-4020-899f-2d3d5680ae8d">370.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id97f2fe451ad49ebab6e84dfc7448640_I20220630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNC0wLTEtMS00NzU3NS90ZXh0cmVnaW9uOmQxMTczMzMwZmEzZTQ1MGViZGI2YjQ2MzdhMzVhMDMwXzQ_5fb3dcf9-54e6-47ca-82cb-8f72caf48f0f">10.000</ix:nonFraction>% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97f2fe451ad49ebab6e84dfc7448640_I20220630" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNC0yLTEtMS00NzU3NQ_7ce996a2-a8d3-46c9-a6bc-316e06159285">545.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d20d5258ec48e59311e50fe392c175_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNC00LTEtMS00NzU3NQ_a0e7711b-8730-4de0-ab49-b5ad90c26ee5">545.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and other secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea1883c76fa04d069ea8e3cf7e28a781_I20220630" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNS0yLTEtMS00NzU3NQ_4258d282-ad7f-421c-85a0-7088db9ab559">160.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c44749e22b461ca1d58d166427ced2_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNS00LTEtMS00NzU3NQ_10adca60-b3ab-43cf-ac03-3440da3d00ff">145.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNi0yLTEtMS00NzU3NQ_8dfeefe1-f77e-4dbe-a1f4-a8a4279d3af0">504.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNi00LTEtMS00NzU3NQ_d1dfc08c-6d3f-41e1-970c-30aa65a87825">364.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs and discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNy0yLTEtMS00NzU3NQ_d3b1c4b0-ff08-4562-be7f-1fbd234d34c8">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNy00LTEtMS00NzU3NQ_96affc0f-45c7-41c0-a638-1277fb43310b">16.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfOC0yLTEtMS00NzU3NQ_ad1ffe03-af66-4619-a6bf-12a86cb14d8a">3,087.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfOC00LTEtMS00NzU3NQ_4a9f53b4-8534-426d-b428-f548eb9c1ac4">2,938.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfOS0yLTEtMS00NzU3NQ_a7f4d84f-a697-4777-8587-04a9d849a5bc">68.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfOS00LTEtMS00NzU3NQ_0087fdaa-e60a-436c-9ae9-fbfa7d1313d6">60.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMTAtMi0xLTEtNDc1NzU_7b43634e-e453-4abd-aa53-8bf80841c8e0">3,019.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMTAtNC0xLTEtNDc1NzU_649b9ab8-ee32-484a-a7dc-6e871517a28e">2,878.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:4pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><ix:continuation id="ib33e472c19704165a81627b344b59ddf" continuedAt="i1db843a4a7244770bd7eccf5c3f701d5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes unamortized fair value discount of $<ix:nonFraction unitRef="usd" contextRef="if2194c6aaf1a4eec8b2eab9c9b7c3c3a_I20220630" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfMTIy_93dfcdfe-f9fe-4e93-a6fe-f3108a009143">2.7</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="ia1aeee4881fa47c580bb5e99e88641ce_I20211231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfMTI5_c69a6535-083a-48f5-8431-b16d79dec704">3.0</ix:nonFraction>&#160;million as of June&#160;30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:continuation id="i1db843a4a7244770bd7eccf5c3f701d5">December&#160;31, 2021, respectively.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The increase in finance lease obligations is a result of the modification of certain existing facility real estate leases that were previously classified as operating leases. See Note 4. "Leases" for further discussion.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i04407c2f240744f0a107bc4c02b3daff">As of June&#160;30, 2022, the Company's availability on its revolving credit facility (the "Revolver") was $<ix:nonFraction unitRef="usd" contextRef="i1a5a30a093dc41659d3f312026cb301c_I20220630" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNTEz_cd34665a-5c54-4ff3-aae7-a18e849b0572">203.0</ix:nonFraction> million (including outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i86130d880fcf401e909db4519bccc94f_I20220630" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNTYw_eeb083e2-6e0b-4f9a-b29d-902861f8656c">7.0</ix:nonFraction> million). There were <ix:nonFraction unitRef="usd" contextRef="i34519792c7c644368bc1218b81d5eb35_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNTc2_17c48399-f892-4f54-8fb5-ab08e1018bc9"><ix:nonFraction unitRef="usd" contextRef="i3520bf24329a4e13a3d203c231caa136_I20220630" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNTc2_2addccbe-dcb9-45cd-a635-1e269ef37b74">no</ix:nonFraction></ix:nonFraction> outstanding borrowings under the Revolver as of both June&#160;30, 2022 and December&#160;31, 2021</ix:continuation>.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_40"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfMTE1MQ_335078b2-f348-4789-af04-1e9c69e408b4" continuedAt="i5a19b31ba1d148f9882fbce02ed5afa1" escape="true"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfMTE1MQ_f2a6c562-0502-4281-a465-548c4a044a72" continuedAt="i8bed82416f0f42a59ddf53133e18b11e" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i5a19b31ba1d148f9882fbce02ed5afa1" continuedAt="i26205b4f9a9e454b957a0975df46305f"><ix:continuation id="i8bed82416f0f42a59ddf53133e18b11e" continuedAt="i0db323b45f3c456bbeb12c2a520c1965"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. </span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="sgry:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfMTE0OA_f38a8c10-8590-420c-a330-52cc22047b36" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the consolidated balance sheets (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.941%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.634%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification in Consolidated Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMy00LTEtMS00NzU3NQ_ad822242-d017-49d3-9010-dd2b65d6add6">277.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMy02LTEtMS00NzU3NQ_467f8508-7e44-407c-9d6b-2d856efa7280">324.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_0490c164-1bcc-4f55-85d3-15e9331ed7ed"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_4a2e4f93-28b9-4c5f-bc07-6358d546de18">Property and equipment, net of accumulated depreciation</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC00LTEtMS00NzU3NQ_9d64b13b-6af9-4693-8d15-4d71476ce510">460.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC02LTEtMS00NzU3NQ_9d118167-42f5-45fb-be7a-7741ffe2643b">329.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="sgry:LeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNS00LTEtMS00NzU3NQ_910f1002-84a5-4abd-8e8c-d5a2a9dff2c3">738.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="sgry:LeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNS02LTEtMS00NzU3NQ_197b8394-4adc-4a20-9ebf-4fd11350bbf9">653.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_00060c4f-1b87-4bb0-b65b-4b1328751e7d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_f34bfa11-29e3-4790-b94f-70125ea4d07f">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS00LTEtMS00NzU3NQ_a4c06b6b-5e4e-482c-ac06-a760bad79df5">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS02LTEtMS00NzU3NQ_d5f8993c-ef50-44a3-a58a-e6088d1e93ff">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTAtNC0xLTEtNDc1NzU_cb06fec6-f27a-45a9-9ac1-554f9dd8310a">271.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTAtNi0xLTEtNDc1NzU_027e122a-4434-42fb-a002-869de8efc13d">315.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTEtNC0xLTEtNDc1NzU_493cc604-0448-4806-bcb6-dd5fd6d5ea67">307.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTEtNi0xLTEtNDc1NzU_31d98d20-e559-4a9d-8149-818a151690f5">355.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_82470289-02c8-4ee9-bb12-c86df2a2d59b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_d09186d5-2c70-43f5-ba46-c5f5d380a2bb">Current maturities of long-term debt</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtNC0xLTEtNDc1NzU_e9ea9474-edf7-419e-ac2e-1e433e749233">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtNi0xLTEtNDc1NzU_524e841a-2dfb-4b64-b766-f6c559b27ae1">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_2188135b-10a8-4d73-88ea-7b90cf795fbd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_eb2749f0-b898-4460-8f9b-f8a8c6f0701f">Long-term debt, less current maturities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtNC0xLTEtNDc1NzU_c4eefb60-ed4c-46e0-8546-e5e8572b9e9c">481.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtNi0xLTEtNDc1NzU_d486c94f-cae7-4170-bfc9-0a8fb1105477">345.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTUtNC0xLTEtNDc1NzU_a7525f84-ab02-4c65-9a1a-ca51589af4ce">504.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTUtNi0xLTEtNDc1NzU_db5cd3c8-7262-48d6-9399-69247e6ca853">364.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="sgry:LeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTYtNC0xLTEtNDc1NzU_dac3846b-6648-4d4d-a229-295a6cd2f0eb">811.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="sgry:LeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTYtNi0xLTEtNDc1NzU_8382d472-39a5-4955-86da-286539c7739e">720.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company extended certain existing facility real estate leases, resulting in the reclassification of the leases from operating to finance. The modifications resulted in an increase to finance lease liabilities and assets of $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:IncreaseDecreaseInFinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfNzUw_55fa5719-5f41-41df-a7f7-ea82482af575">146.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:IncreaseDecreaseInFinanceLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfNzU3_0ec49909-c27b-4822-9138-90d41b2999e2">145.0</ix:nonFraction>&#160;million, respectively, including the reclassification of existing operating lease liabilities and assets of $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfODYw_248cef59-48a5-42b3-86e2-7db9fd7303fa">60.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="sgry:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfODY3_784aea4e-4f31-4b86-9eb2-b2918ccd4cce">59.3</ix:nonFraction>&#160;million, respectively. </span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfMTE1NQ_e3d3c1ab-d789-45c5-809b-c96b0127c44b" continuedAt="i3d3bcb4a22af462ba5e9cf93e4e19b28" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfMi0yLTEtMS00NzU3NQ_d612f97e-9064-4557-b936-1f4da19c5706">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfMi00LTEtMS00NzU3NQ_f8554af4-42d7-41cc-b003-71b96120b367">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNC0yLTEtMS00NzU3NQ_961c04f6-8d9d-487e-affc-383be2a58865">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNC00LTEtMS00NzU3NQ_ea772cac-0684-49cc-9ffe-886473d2b6ad">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNS0yLTEtMS00NzU3NQ_f0f91b46-db66-4e60-bbe1-8ae6c47c89d5">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNS00LTEtMS00NzU3NQ_31ab3c76-7d1f-4b0e-976f-e431bac46efa">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNi0yLTEtMS00NzU3NQ_514270a3-cc0b-405c-adc9-1a6f45e65910">38.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNi00LTEtMS00NzU3NQ_c5b5ab6b-e87c-4de5-8c81-4936cf6a5d6a">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:VariableAndShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNy0yLTEtMS00NzU3NQ_3e6654dd-37d0-49c8-ad6d-b1a262776265">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:VariableAndShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNy00LTEtMS00NzU3NQ_d4da9f8f-6148-462f-8f4c-c15c063b55bc">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfOC0yLTEtMS00NzU3NQ_e604c493-46f7-4cf7-ba22-ac82cc0ade6d">79.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfOC00LTEtMS00NzU3NQ_7f93e33a-ee12-4890-a0f1-85e8c9eb53c5">73.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i26205b4f9a9e454b957a0975df46305f"><ix:continuation id="i0db323b45f3c456bbeb12c2a520c1965"><ix:continuation id="i3d3bcb4a22af462ba5e9cf93e4e19b28"><div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information (dollars in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfMy0xLTEtMS00NzU3NQ_836b8759-1974-44e8-8f44-e5fd8f85f960">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfMy0zLTEtMS00NzU3NQ_b1f86644-7cb4-4216-8445-559b32fb9806">36.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfNC0xLTEtMS00NzU3NQ_09807605-d068-4947-a1fe-4c28143f6e40">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfNC0zLTEtMS00NzU3NQ_0b6d76dd-ae31-45a7-bf4f-9140723869f0">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfNS0xLTEtMS00NzU3NQ_86ddb2e8-f2e9-42d9-a457-9c914de63436">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfNS0zLTEtMS00NzU3NQ_b88d41a9-118b-416a-82bb-22b92f7c6456">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfOC0xLTEtMS00NzU3NQ_f9527a87-a551-45e2-ab25-1e68380fee9d">31.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfOC0zLTEtMS00NzU3NQ_ff6f9990-861d-4e20-9362-5fc412c68e6c">31.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfOS0xLTEtMS00NzU3NQ_3f92c09a-9f8e-4f4f-9b17-ffc10e4e426e">91.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfOS0zLTEtMS00NzU3NQ_7415ffe0-8a33-4731-ac82-6e26c7f45397">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_43"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNDkwOQ_4b98b53c-e928-44b0-8431-b796d2665050" continuedAt="i8d8cdb19a1354b6093baebca915f01e4" escape="true">Derivatives and Hedging Activities</ix:nonNumeric></span></div><ix:continuation id="i8d8cdb19a1354b6093baebca915f01e4" continuedAt="i0bf22e2e77bd4cd5a4bef881d7853cac"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and interest rate caps as part of its interest rate risk management strategy. During 2022 and 2021, such derivatives have been used to hedge the variable cash flows associated with existing variable-rate debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i648c0115e0b645f0bb621a248b613f0c">For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income ("OCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#8217;s accounting policy election. Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt.</ix:continuation> Over the next 12 months, the Company estimates that an additional $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTEyNg_a9d6f8cc-c8fb-47b1-847a-53134e878daa">7.2</ix:nonFraction> million will be reclassified as a decrease to interest expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the Company had <ix:nonFraction unitRef="interest_rate_swap" contextRef="i0d641fec5a614286a665a368239cb7fe_I20220630" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTIxMg_bf7f35c0-3976-4102-b8f3-b07cdf16b0f9">nine</ix:nonFraction> interest rate swaps with a total net hedged notional amount of $<ix:nonFraction unitRef="usd" contextRef="i624ef5b3954c440ca2df8007f64bb190_I20220630" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTI3OA_8fc9c0bd-9035-44da-ab43-34be73c24fb5">1.2</ix:nonFraction>&#160;billion and <ix:nonFraction unitRef="interest_rate_swap" contextRef="i9405d2dfa6a44be3b5a5fddf7e37ce73_I20220630" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTI4NQ_8cf7f7d8-ce66-426c-ac24-26b39d7a8dcc">two</ix:nonFraction> interest rate caps with a total hedged notional amount of $<ix:nonFraction unitRef="usd" contextRef="ibec9eb2e922848e193c29ccb4d324b59_I20220630" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTM0Ng_bb7b1d43-c3ba-48b9-9779-23f1a0cf635a">325.9</ix:nonFraction>&#160;million. Of the <ix:nonFraction unitRef="interest_rate_swap" contextRef="i0d641fec5a614286a665a368239cb7fe_I20220630" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTM1Nw_2ff88dd4-3145-4ee8-b55d-b559cc650a6b">nine</ix:nonFraction> interest rate swaps, three are pay-fixed, receive 1-Month LIBOR (subject to a minimum of <ix:nonFraction unitRef="number" contextRef="if84173ed23fc455c8dc5af7694d68f70_I20220630" decimals="INF" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTQ0Ng_644ba327-8412-4113-a66f-965e768b1017">0.75</ix:nonFraction>%) interest rate swaps designated in cash flow hedging relationships with a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="i624ef5b3954c440ca2df8007f64bb190_I20220630" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTU0OA_a0914b44-4c0e-485d-bb18-56cb778f6c1c">1.2</ix:nonFraction>&#160;billion and a termination date of March 31, 2025. The remaining six interest rate swaps are undesignated and consist of three pay-fixed, receive 1-Month LIBOR (subject to a minimum of <ix:nonFraction unitRef="number" contextRef="i652bb49f02444b3a89f17f2300107e97_I20220630" decimals="INF" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTcxMQ_ac4d3620-ce9e-43a5-b6da-e7705dd2ec98">1.00</ix:nonFraction>%) interest rate swaps and three pay 1-Month LIBOR (subject to a minimum of <ix:nonFraction unitRef="number" contextRef="i0fccee9038b24758ba351eba3d11e91a_I20220630" decimals="INF" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTc4NQ_939a99c3-8a9f-4669-98b7-7dbcbd90bba2">1.00</ix:nonFraction>%), receive-fixed interest rate swaps with a termination date of November 30, 2023. The pay-floating, receive-fixed swaps are designed to economically offset the undesignated pay-fixed, receive-floating swaps. The interest rate caps each have a termination date of March&#160;31, 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The pay-fixed, receive floating interest rate swaps did not meet the requirements to be considered derivatives in their entirety as a result of the financing component. Accordingly, the swaps are considered hybrid instruments, consisting of a financing element treated as a debt instrument and an embedded at-market derivative that was designated as a cash flow hedge. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Within the Company&#8217;s condensed consolidated balance sheets, the financing elements treated as debt instruments described above are carried at amortized cost and the embedded at-market derivatives and the undesignated swaps are recorded at fair value. The cash flows related to the portion treated as debt are classified as financing activities in the condensed consolidated statements of cash flows while the portion treated as an at-market derivative are classified as operating activities. Cash settlements related to the undesignated swaps will offset and are classified as operating activities in the condensed consolidated cash flows. Within the Company&#8217;s condensed consolidated balance sheets, the interest rate caps are recorded at fair value. The cash flows related to the interest rate caps are classified as operating activities in the condensed consolidated statements of cash flows.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i0bf22e2e77bd4cd5a4bef881d7853cac" continuedAt="i5d5cafe8f6bb472b8ed46f41480a9fec"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNDkxMQ_b0109d50-de31-4783-bd27-c16383f9df1a" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The key terms of interest rate swaps and interest rate caps outstanding are presented below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.352%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.144%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.144%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.743%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e675653b29b4a30a95a33a4eafccfa8_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMi00LTEtMS00NzU3NQ_4e9bd4ae-15e9-4c1e-a4ad-71b7f2b3d0c5">435.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bac16b3932b4d9f8c149cbe0186184c_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMi04LTEtMS00NzU3NQ_1c1152f0-d2fd-4913-becf-4cecbd51862d">435.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea63fb7682374f5fbce4eaf0268880b3_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMy00LTEtMS00NzU3NQ_e940219b-7080-4642-9ddf-23e28157eaed">330.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b3a62c12c645209db966edaf59e976_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMy04LTEtMS00NzU3NQ_48d208ff-ae09-40a3-b3d7-80528529195f">330.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0910d6248ac74aa9bcf915cfa2b93d37_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNC00LTEtMS00NzU3NQ_86078262-b572-49d6-8623-c5aa7802394b">435.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf9ff04a00914131a0f5c3d690dd4103_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNC04LTEtMS00NzU3NQ_6d3487d3-c94a-49aa-90bd-0510e0033324">435.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica6bbd0b30fa447bbaa6e2d70abf379e_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNS00LTEtMS00NzU3NQ_c9185407-e3ab-4f94-bab8-6744ae3673c3">163.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e9e67aafa642f1b536a59d612f21b5_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNS04LTEtMS00NzU3NQ_caf25322-9f8b-46db-b8cc-94ad36f23a17">166.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87459cd7cbda4d60b240d0999c63bd43_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNi00LTEtMS00NzU3NQ_421b189b-6aa1-49cb-955a-7b79526b3db7">162.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i963697d6f96e442d98f5756ec73485b5_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNi04LTEtMS00NzU3NQ_44296949-88ce-452f-bb56-d97f2d1b353e">166.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfd2fc8ece9341b3adef2ac0e05a7557_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNy00LTEtMS00NzU3NQ_c9dda88b-aa3b-4d21-a71a-6aefdeb9f6cc">165.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35884d0598254ccb991a911d3502b131_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNy04LTEtMS00NzU3NQ_61cf3e05-47e6-4ba3-a63e-4ca79d692c8c">165.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied5ab0dab33041f989a6b88eb2b43ce3_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfOC00LTEtMS00NzU3NQ_a54b29d9-5c4d-4af3-b1ab-7f378e8c84c3">120.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id545da56246a458a9f507b5e10d6b9cb_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfOC04LTEtMS00NzU3NQ_14602742-f834-4c9a-bc91-e437b365f790">120.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee2b1492ec349a2b51e75e9df9f3bb0_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfOS00LTEtMS00NzU3NQ_9339dccf-c789-45ed-8fa0-4a4f3edd483d">150.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i113be4a99c604b2da5b072d5e5d8fa21_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfOS04LTEtMS00NzU3NQ_fd4028fc-667c-404c-b97c-8d15146d51b1">150.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i533833368b6c47bf89ba7a880f670cd8_I20220630" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTAtNC0xLTEtNDc1NzU_ea70d54d-9b29-4e72-ae9c-dd963edc0a56">165.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic848ed09b98c48b0a8a7f23e355be28f_I20211231" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTAtOC0xLTEtNDc1NzU_201bf56a-683c-4446-80ed-ef656c16b356">165.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib229dcc9506d4c8398a0910a44f53196_I20220630" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTEtNC0xLTEtNDc1NzU_17342a67-aacb-4a65-8ec8-65c55258bfd2">120.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa055d97ac3b4c02add1ba0a6cc7c820_I20211231" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTEtOC0xLTEtNDc1NzU_125f36fb-0fd1-4be8-bc6e-dc903a87242e">120.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ccb9be430ab41d58f216a21128552cf_I20220630" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTItNC0xLTEtNDc1NzU_bd6a750e-6a4e-482b-a8df-b23c28ed8983">150.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fd5b2180b57439b962339cd3bf1d9c0_I20211231" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTItOC0xLTEtNDc1NzU_e55f64a2-ac55-4f50-b44d-deb6071d1e16">150.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTMtNC0xLTEtNDc1NzU_83df8c68-6006-4ffd-a1fc-83b5a567499e">1,525.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTMtOC0xLTEtNDc1NzU_feea789b-25a4-45d7-8c41-cb61e05c90bb">1,533.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our interest rate swap agreements, excluding the portion treated as debt, are recognized at fair value in the condensed consolidated balance sheets and are valued using pricing models that rely on market observable inputs such as yield curve data, which are classified as Level 2 inputs within the fair value hierarchy. The fair value of the interest rate caps are determined using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the caps. The variable interest rates used in the calculation of projected receipts on the caps are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. The interest rate caps are classified using Level 2 inputs within the fair value hierarchy.</span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNDkxMg_aee92b04-1351-4606-82ae-3eb78e9aa393" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the fair values of our derivatives and their location on the condensed consolidated balance sheets (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.989%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ff529d76c974a7a8aea1a917b35b64b_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMy00LTEtMS00NzU3NQ_24954b6b-e505-470c-a39a-e3bb43e0e997">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91cee683d0cb47b8a7410f692915b4ab_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMy04LTEtMS00NzU3NQ_8a1ead4b-161a-4608-adb4-ce94cd646310">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic454598ff0b04e2b96bfa6db8aed8d32_I20220630" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfNC02LTEtMS00NzU3NQ_001f7ff5-cce9-44be-b658-a5b3621842b7">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccbe30e44be742e4a2c505011293909f_I20211231" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfNC0xMC0xLTEtNDc1NzU_ed19f64a-ddc4-4d56-a012-78fe220a6b9a">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate caps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3112ecc656048f9963864a981edf6e8_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfNy00LTEtMS00NzU3NQ_f597e208-ddfd-4c3d-88b5-7fd3c1d01107">13.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c2b5dd09894633b50efcebda46b25c_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfNy04LTEtMS00NzU3NQ_0c84f7c1-4071-4fe1-856b-fe81868d07c8">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e28fb347c94eb9abfe022c9393fe3f_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfOC00LTEtMS00NzU3NQ_5798531f-a15c-4172-9405-f40b9dd069a9">62.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40745034fee45fba37203084540e1fc_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfOC04LTEtMS00NzU3NQ_9b108102-66c0-493b-9a31-aea47814a66f">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d641fec5a614286a665a368239cb7fe_I20220630" decimals="-5" name="sgry:DerivativeLiabilityNotionalAmountFinancingComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfOS02LTEtMS00NzU3NQ_bbf159cd-514e-49e2-a96f-fcd953d3f502">38.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida372175cdc044c591964aa8bc62bf11_I20211231" decimals="-5" name="sgry:DerivativeLiabilityNotionalAmountFinancingComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfOS0xMC0xLTEtNDc1NzU_799b73f4-3413-4686-bc6e-1988f9c00716">45.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMTAtNC0xLTEtNDc1NzU_21f6f7ff-b296-4f3c-9188-a3d19ab9ac5c">78.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMTAtNi0xLTEtNDc1NzU_e68bd371-023e-4aa9-9f4f-9260480333cd">41.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMTAtOC0xLTEtNDc1NzU_4edcd8cc-1fa9-4a7d-83cb-b8f4034ff84e">23.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMTAtMTAtMS0xLTQ3NTc1_b3b12f87-0940-40a5-b2cb-e7bb60825048">58.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.02pt">The balance as of June&#160;30, 2022 and December&#160;31, 2021 is related to the financing component of the pay-fixed, receive floating interest rate swaps.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNDkxMw_b20d5db6-9130-4772-9fd0-3b6257f27233" continuedAt="i124a1d5b14444a5ca91b8389610613aa" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the pre-tax effect of the interest rate swaps and caps on the Company's accumulated OCI and condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.275%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain) loss recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1657924a29746e68c995f79d41d18f2_D20220401-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfMy0zLTEtMS00NzU3NQ_b2c5d5a8-8775-442d-a1ee-24b895c659aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia390bedd4c604d87b921bb743e5001af_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfMy01LTEtMS00NzU3NQ_899550cb-55ed-45a3-bfa8-050597fa2de2">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d2ff8d35f9424eac0c1076c4c642a4_D20220101-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfMy03LTEtMS00OTM2Mw_72711e75-cc21-4960-9d29-9321a454a0a7">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99fa76822a7c4953b5d77c75c594a220_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfMy05LTEtMS00OTM2Mw_3766d279-af7a-4ad6-9316-fa944649aa5a">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2dff4c01ce4f1c8dc3f58ea1d2f195_D20220401-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNi0zLTEtMS00NzU3NQ_07f4eb39-8c67-4af6-a902-09935a73bcd2">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabfd2c1c39ee49308512e86fea44e1e4_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNi01LTEtMS00NzU3NQ_9a8430bd-910e-46d4-aa76-159836aedb92">5.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5aa994d75ecc45929183b091586f7b83_D20220101-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNi03LTEtMS00OTM3MA_be4e0c9c-4921-48a1-a0f8-6809a9a67dad">63.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3daec31ecd414074ac61cd4c7433ff05_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNi05LTEtMS00OTM3MA_882598ac-cc4e-4e60-9f7b-87839082c7c8">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss reclassified from accumulated OCI into income (effective portion) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3f8870fede40489dc7020e3bc79d19_D20220401-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNy0zLTEtMS00NzU3NQ_75d6908e-be98-425d-870c-902b24dae28c">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib66f2867150d4f6d9cbba76ffaa3892d_D20210401-20210630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNy01LTEtMS00NzU3NQ_85d61e08-8d45-4c55-aa64-5c31c0277849">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0309fa024ab34d959fd9963466f2ccc3_D20220101-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNy03LTEtMS00OTM3Ng_578d0e09-21b0-410d-b07c-aa8599f4103c">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b6a3ca602748ce951abd5c3ecb073a_D20210101-20210630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNy05LTEtMS00OTM3Ng_884f7361-5d43-4176-893a-c67b54cc5041">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><ix:continuation id="i5d5cafe8f6bb472b8ed46f41480a9fec"><ix:continuation id="i124a1d5b14444a5ca91b8389610613aa"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNDgyMQ_d3765c41-aa85-48e2-90ef-acf779270cfe">5.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNTQ5NzU1ODE4ODA2_51f24acb-08fd-417a-8d53-a99c60125b23">3.2</ix:nonFraction> million for the three months ended June&#160;30, 2022 and 2021, respectively. Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNTQ5NzU1ODE5MDY3_1bb5571a-16ba-44b5-8d2e-5ea3acfe66e2">10.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNTQ5NzU1ODE5MDcx_8a61ff05-789a-49f2-a43a-7ad3f889413a">3.2</ix:nonFraction> million for the six months ended June&#160;30, 2022 and 2021, respectively.</span></ix:continuation></ix:continuation></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_46"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RleHRyZWdpb246YTkzMDQwYzc4ZDQwNDhkMDhkMzVjNzYzZDQ1YWVhYjlfMTI5MQ_5e0b8b13-43d0-4be0-920b-59b95526d628" continuedAt="i4cec3631a33a4f519a3c6e0c2c568372" escape="true">Earnings Per Share</ix:nonNumeric></span></div><ix:continuation id="i4cec3631a33a4f519a3c6e0c2c568372"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted earnings per share are calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.</span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RleHRyZWdpb246YTkzMDQwYzc4ZDQwNDhkMDhkMzVjNzYzZDQ1YWVhYjlfMTI4OA_1ee13820-bed2-4c5c-8c1b-466d39ac1700" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands): </span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMy0xLTEtMS00NzU3NQ_9ea82799-d83e-48a9-86b0-77b28091e9b7">18.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMy0zLTEtMS00NzU3NQ_18f87ff7-b16a-4d20-83c5-74a690327976">26.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMy01LTEtMS00OTQ2Ng_646e7645-1df1-4737-b7f4-78963bd30a23">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMy03LTEtMS00OTQ2OA_e5b493b8-d4aa-4f60-9e30-b2a1b322a926">47.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: amounts allocated to participating securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNC0xLTEtMS00NzU3NQ_19b03f33-9a3e-4662-9493-851c86b6275e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNC0zLTEtMS00NzU3NQ_f6027f64-02ec-4b94-b1d5-fd928043110b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNC01LTEtMS00OTQ3MA_c7e153c9-ac2f-485e-8f3f-4c1dcc2ad668">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNC03LTEtMS00OTQ3MA_03c73afc-80a4-446c-855f-22efc10bb635">10.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNS0xLTEtMS00NzU3NQ_dc46afe8-59d0-4d8b-abc3-1b3e1e09921a">18.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNS0zLTEtMS00NzU3NQ_ed44b16c-961e-426d-88dc-a5b1bf81dc11">26.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNS01LTEtMS01MTczNw_5d2382ea-9d00-44c0-a364-a202665ff488">6.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNS03LTEtMS01MTczNw_0c929359-1124-44c1-8292-b8c65ed06446">58.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding- basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOC0xLTEtMS00NzU3NQ_7006dcc6-d746-4afb-836f-825cc0074099">88,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOC0zLTEtMS00NzU3NQ_5210479c-ebc8-460e-ab3d-8e73badf45cc">69,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOC01LTEtMS00OTQ3OQ_91bfc1f2-63bc-4f0a-9857-1325b7978fd1">88,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOC03LTEtMS00OTQ3OQ_2be5af9a-09bc-4bd9-86c2-67bd21a09e56">62,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding- diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOS0xLTEtMS00NzU3NQ_6fa8e59d-067d-4f1a-8a3e-44ccb24bae22">88,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOS0zLTEtMS00NzU3NQ_9188b746-7511-4a6e-83f4-d2ad76d21a40">69,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOS01LTEtMS00OTQ5Mw_3d53d51f-b98c-4857-b5d8-4a02d9344f76">88,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOS03LTEtMS00OTQ5Mw_b68bb13b-2f72-4575-a8cd-8f774d4d26b1">62,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTItMS0xLTEtNDc1NzU_4acb88b2-0234-46ed-80b0-23278799b001">0.21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTItMy0xLTEtNDc1NzU_d1bfbe4b-efb7-466e-b40e-5bf6f8bef257">0.39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTItNS0xLTEtNDk1NDI_77981cef-2e63-417d-bfdc-741b1f25724f">0.07</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTItNy0xLTEtNDk1NDI_6ae84e80-d9b7-49b6-b459-f31d3f8ea4e2">0.94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTMtMS0xLTEtNDc1NzU_20c37dcb-16cf-4cd3-81d4-b787c48fd9b3">0.21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTMtMy0xLTEtNDc1NzU_f6027967-7a44-4bca-b236-23ca39f1e501">0.39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTMtNS0xLTEtNDk1NTc_3f034659-b327-4d87-ae7a-dac3fbff533b">0.07</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTMtNy0xLTEtNDk1NjM_effbfac6-e310-4c59-9acb-dfb22a6c610d">0.94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i63a22d68b90b48909dc3d1b1b5b8a20e_D20220401-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTYtMS0xLTEtNDc1NzU_a4812940-92dd-45cc-be97-b46d11c37270">1,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i020ea1b80b0942b19fcb6613eff5fd71_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTYtMy0xLTEtNDc1NzU_41cbfd37-75a7-4f1b-be59-0783641e3982">2,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58659716e1cf471dafca42309eeb5309_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTYtNS0xLTEtNDk1Njk_9a7e049b-67dc-4b1d-8a41-a6dd6c0e1972">1,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd945ed3ab5f4ffda421c746ebe77bab_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTYtNy0xLTEtNDk1Njk_24a575cd-b66b-4c42-a962-6512c1d7d58c">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34857924f21749c1b51e0cd2f31b0597_D20220401-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTctMS0xLTEtNDc1NzU_3822b379-dd36-42b6-ac48-5eba85a25666">628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2612faa6b1474823bc2ad95518bc8aa3_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTctMy0xLTEtNDc1NzU_4ee5c161-4561-4664-ad69-0156ef32d432">1,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i590c785262294ff4b5426d751376a0aa_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTctNS0xLTEtNDk1NzU_eeaa7c9a-bc6d-4299-a659-c5b7934b7a01">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7846148240d4ef5af33eeefb926fa03_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTctNy0xLTEtNDk1NzU_c8be3cda-83b7-4885-9e00-8d5c4bdb8951">1,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes dividends accrued for the Series A Preferred Stock for the six months ended June 30, 2021. The Series A Preferred Stock did  not participate in undistributed losses and was converted to common stock during the second quarter of 2021. There were <ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RleHRyZWdpb246YTkzMDQwYzc4ZDQwNDhkMDhkMzVjNzYzZDQ1YWVhYjlfMTA2Mg_3165975f-4fa5-4fa5-87a3-82469e937080"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RleHRyZWdpb246YTkzMDQwYzc4ZDQwNDhkMDhkMzVjNzYzZDQ1YWVhYjlfMTA2Mg_323deb2e-de00-473a-85da-b05aac93f76f"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RleHRyZWdpb246YTkzMDQwYzc4ZDQwNDhkMDhkMzVjNzYzZDQ1YWVhYjlfMTA2Mg_4e7875d6-c7dd-4c87-bb6f-2500d40f65dc">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> participating securities for the three and six months ended June 30, 2022 and the three months ended June 30, 2021.</span></div><div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.</span></div></ix:nonNumeric></ix:continuation><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_49"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RleHRyZWdpb246ZDE0ZmRlZmViN2EyNGYwMmE0ODE5MmNhZmE1NmY3OGNfMTEw_605b159e-1380-4297-9557-5c0685b817fa" continuedAt="idc4be7176c4c4e7f86398a0b69e23886" escape="true">Other Current Liabilities</ix:nonNumeric></span></div><ix:continuation id="idc4be7176c4c4e7f86398a0b69e23886"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RleHRyZWdpb246ZDE0ZmRlZmViN2EyNGYwMmE0ODE5MmNhZmE1NmY3OGNfMTA1_57261f1b-27b5-48c4-971e-e52a74fd9fb3" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of other current liabilities is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfMi0yLTEtMS00NzU3NQ_fda4c622-400d-447a-b809-fc33a8a9f284">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfMi00LTEtMS00NzU3NQ_b33076df-5eab-406d-acda-933313934591">40.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfMy0yLTEtMS00NzU3NQ_7a9350cb-81ba-45c0-9111-d2701c081d71">28.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfMy00LTEtMS00NzU3NQ_b7360234-d2c5-4918-83a9-7f2101fc359e">29.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due to patients and payors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="srt:PayablesToCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNC0yLTEtMS00NzU3NQ_80edbd2d-f181-41ea-a5be-d14dd541a30b">32.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="srt:PayablesToCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNC00LTEtMS00NzU3NQ_86b9ff02-d676-4dd1-a5b6-35f619a89659">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost report liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="sgry:CostReportLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNS0yLTEtMS00NzU3NQ_03cedbb5-aee0-4a3c-bee4-f7c2a73b544f">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="sgry:CostReportLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNS00LTEtMS00NzU3NQ_22b805d5-b148-46e5-aae8-cca7426ab304">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax receivable agreement liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="sgry:TaxReceivableAgreementLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNi0yLTEtMS00NzU3NQ_7fe71624-0511-48cb-bc6f-5fcf48986cfc">20.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="sgry:TaxReceivableAgreementLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNi00LTEtMS00NzU3NQ_03d97f29-e361-4caa-be26-e33af3165e6e">19.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNy0yLTEtMS00NzU3NQ_b52d7e9e-ebb5-4f5e-9194-9d4c8e6e4162">82.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNy00LTEtMS00NzU3NQ_e68a3c59-07e2-45dd-80c7-e7938cfb468c">68.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfOC0yLTEtMS00NzU3NQ_3d0f07a9-e353-46f8-b657-cc363beaa5cf">221.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfOC00LTEtMS00NzU3NQ_40ff9162-8cd7-4bd4-b41c-987342dc07c3">210.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_52"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">8.  <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODU4Mg_72f8b5c8-7a93-4dcb-be00-8457a1f483dc" continuedAt="i6a546520dfa34df0beedce3b088439bf" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i6a546520dfa34df0beedce3b088439bf" continuedAt="ib403078175384ce183dff4e796729539"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Professional, General and Workers' Compensation Liability Risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains professional, general and workers' compensation liability insurance in excess of self-insured retentions through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity. Total professional, general and workers' compensation claim liabilities as of June&#160;30, 2022 and December&#160;31, 2021 were $<ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfMTAwNg_891820dd-9b95-471b-b295-62d204ca4ffe">18.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfMTAxMw_72f42ab9-be74-4332-85ad-7eb866065e1e">19.8</ix:nonFraction> million, respectively. Expected insurance recoveries of $<ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:EstimatedInsuranceRecoveries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfMTA2NA_54303898-0d81-422e-86f4-93f981d79402"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:EstimatedInsuranceRecoveries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfMTA2NA_835229b9-8e96-4baf-8708-9d0e5caf063e">8.7</ix:nonFraction></ix:nonFraction> million as of both June&#160;30, 2022 and December&#160;31, 2021 are included as a component of other current assets and other long-term assets in the condensed consolidated balance sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory sanctions including fines, penalties, and exclusion from the Medicare, Medicaid and other federal health care programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Stockholder Litigation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December 4, 2017, a purported Company stockholder filed an action in the Delaware Court of Chancery (the "Delaware Action"). That action is captioned Witmer v. H.I.G. Capital, L.L.C., et al., C.A. No. 2017-0862. The plaintiff in the Delaware Action asserted claims against (i) certain current and former members of the Company&#8217;s Board of Directors (together, the "Directors"); (ii) H.I.G. Capital, LLC and certain of its affiliates (collectively, "H.I.G."); and (iii) Bain Capital Private Equity, L.P. and certain of its affiliates (collectively, "Bain Capital" and, together with the Directors and H.I.G., the "Defendants"). The parties to the Delaware Action negotiated a final stipulation of settlement (the &#8220;Settlement Stipulation&#8221;), which governs the terms of the settlement of the Delaware Action, and which they filed with the Court of Chancery on November 22, 2021. On February 11, 2022, the Court of Chancery approved the settlement of the Delaware Action as memorialized in the Settlement Stipulation. That decision became final and non-appealable on March 14, 2022. The case is now closed. Pursuant to the settlement, the Company received $<ix:nonFraction unitRef="usd" contextRef="ibe0c66f9f387475f844569ed2d3b3205_D20220301-20220331" decimals="-5" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfMzQ1Nw_68d83e3f-da08-44cd-842a-2ecd0df55fe9">32.8</ix:nonFraction>&#160;million in March 2022, which was included in litigation settlement in the condensed consolidated statements of operations for the six months ended June&#160;30, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Acquired Facilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with health care laws and regulations, such as billing and reimbursement laws and regulations, the Stark Law, the Anti-Kickback Statute, the FCA, and similar fraud and abuse laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other health care providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ib403078175384ce183dff4e796729539" continuedAt="i245c2c2da2414014a8ca3f0e96586d6a"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Potential Physician Investor Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Tax Receivable Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the "TRA"), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus <ix:nonFraction unitRef="number" contextRef="iba332caf963a4b5a996c1691527ca638_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzA2Mg_3e3aae33-132e-49f2-b2f8-22b8666a7f62">three</ix:nonFraction> percent. The amounts payable under the TRA are related to the Company&#8217;s projected realized tax savings over the next <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="sgry:CollaborativeTaxAgreementProjectedTaxSavingsTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzE4Mg_13ca625a-d293-493e-8149-b1c4ce9f7909">five years</ix:nonNumeric> and are not dependent on the Company&#8217;s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA, such payments will be deferred and will accrue interest at a rate of the LIBOR plus <ix:nonFraction unitRef="number" contextRef="i5c7f8902d58045f499cdd85fdd43307b_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzU0MQ_11d08f7a-08bb-4255-8ee4-23fc916f7f5d">500</ix:nonFraction> basis points until paid. If the terms of credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus <ix:nonFraction unitRef="number" contextRef="i892c4c41e2e949ed919cd99526bbb6dd_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzg2Nw_83a5e03f-7458-43ad-834f-da268b628a5b">300</ix:nonFraction> basis points until paid.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i245c2c2da2414014a8ca3f0e96586d6a">Assuming the Company's tax rate is <ix:nonFraction unitRef="number" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzkzMA_129d53c9-e1cc-4c26-80a3-e8a90dc6aa2b">24</ix:nonFraction>%, calculated as the maximum corporate federal tax rate plus <ix:nonFraction unitRef="number" contextRef="iba332caf963a4b5a996c1691527ca638_D20220101-20220630" decimals="2" name="sgry:CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzk5Mg_83101175-e4f6-40fc-bf45-938151ca7d60">three</ix:nonFraction> percent, throughout the remaining term of the TRA, the Company estimates the total remaining amounts payable under the TRA was approximately $<ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:TaxesPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODEzNg_9d19ab05-d386-4b9c-8ef3-3a3bb5d0f29f"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:TaxesPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODEzNg_ee3c9965-8dcc-4620-acfc-21e95d9573e8">22.0</ix:nonFraction></ix:nonFraction> million as of both June&#160;30, 2022 and December&#160;31, 2021. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company&#8217;s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $<ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODQzNA_0f99eddc-c5e5-4016-b598-d460f3d20395">20.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODQ0MQ_ae96f083-1747-483f-94e7-d7f37799b943">19.7</ix:nonFraction> million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. The current portion of the liability was $<ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODI0NjMzNzIxNzk4Mg_c15b821f-47b1-43ae-b4ea-f7bdfc6eb967">20.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODI0NjMzNzIxNzk4OQ_f7760710-09a5-41f3-8713-554ccae8db21">19.7</ix:nonFraction> million as of June&#160;30, 2022 and December&#160;31, 2021, respectively, and is included as a component of other current liabilities in the condensed consolidated balance sheets. The long-term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets.</ix:continuation> </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_55"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9.  <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfMTE0Nw_54936d36-aaa3-4810-a8af-032fe7ba5d29" continuedAt="if25a1d38d1494a129625ce023ceba8d9" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="if25a1d38d1494a129625ce023ceba8d9" continuedAt="ie8ded5a2735541f49abbb56f20eac713"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company currently operates in&#160;<ix:nonFraction unitRef="segment" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNjE_3dcf1a2a-6c2b-4bcc-ac96-ebe41669f6b9">two</ix:nonFraction>&#160;major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities and the operation of ancillary services. The Surgical Facility Services segment consists of the operation of ASCs, surgical hospitals and anesthesia services. The Ancillary Services segment consists of multi-specialty physician practices. The "All other" line item primarily consists of the Company's corporate general and administrative functions.</span></div><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfMTEzMg_65f89926-51c3-4cb5-a0d4-a4c22672df28" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables present financial information for each reportable segment (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33740e780fe041819c21399ef852290a_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMy0yLTEtMS00NzU3NQ_13411bc8-d801-4846-a097-f91ea2b659ba">597.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b86506be1b428c860321716b7a66d8_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMy00LTEtMS00NzU3NQ_fad32a0c-1f4c-4569-8e34-3354045a2d31">525.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i403f917fe58449dd84f395f95d5d45f5_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMy02LTEtMS00OTYxMg_99c0f40f-1d12-4973-a9fa-4f1eae019595">1,176.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62d2cc75b7bf4e3991b46bd2fe6ab2bf_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMy04LTEtMS00OTYxMg_4466eac5-5b97-4f95-95cf-d4d4c2a677ca">1,021.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410d8e1eee01450cb5b6cfd107a06e90_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNC0yLTEtMS00NzU3NQ_a0cbbe21-9d74-48a7-b679-c760843df3d2">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3118082a6eee4654817ff68f7ff8cd11_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNC00LTEtMS00NzU3NQ_240abf8a-fdab-42c8-80f4-9610003bf716">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e54a8543c64c13be3bc0583a316c0b_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNC02LTEtMS00OTYxMg_489c6e70-9dfb-4aba-ac22-41ae9f057855">34.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc71adeac1b48e983f02714d00ddc72_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNC04LTEtMS00OTYxMg_eb025101-8f57-4a5c-a07e-ebba60f6784d">34.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNS0yLTEtMS00NzU3NQ_1bf6d495-5d54-4664-8602-7b9089230d49">615.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNS00LTEtMS00NzU3NQ_75a7dcc1-6879-448b-8168-d9ecbe7a7637">543.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNS02LTEtMS01MTM0NA_ca83e3ca-2dbe-40aa-abef-d712527ec2fd">1,211.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNS04LTEtMS01MTM0NA_3e5454cd-8685-42b3-b9e9-d1804fc3ab2e">1,055.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33740e780fe041819c21399ef852290a_D20220401-20220630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOC0yLTEtMS00NzU3NQ_6051e6de-22fc-45c9-8a81-66adf0c8ac54">108.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b86506be1b428c860321716b7a66d8_D20210401-20210630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOC00LTEtMS00NzU3NQ_96bde9d0-d4c2-4dfa-bb2b-678ee2608898">95.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i403f917fe58449dd84f395f95d5d45f5_D20220101-20220630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOC02LTEtMS00OTYyMg_a7a66fa2-63a7-46af-b1c5-e2432545198e">209.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62d2cc75b7bf4e3991b46bd2fe6ab2bf_D20210101-20210630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOC04LTEtMS00OTYyMg_b6ef6082-f225-4228-9695-c06ac00a1781">190.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410d8e1eee01450cb5b6cfd107a06e90_D20220401-20220630" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOS0yLTEtMS00NzU3NQ_64f4313a-0898-4288-8788-c1ca12ddbc00">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3118082a6eee4654817ff68f7ff8cd11_D20210401-20210630" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOS00LTEtMS00NzU3NQ_73720d3a-f22b-46c9-99ef-68f73a2ac6cd">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e54a8543c64c13be3bc0583a316c0b_D20220101-20220630" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOS02LTEtMS00OTYyMg_3648533c-ff11-488b-8dc6-7f06ab844857">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4cc71adeac1b48e983f02714d00ddc72_D20210101-20210630" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOS04LTEtMS00OTYyMg_48b858ef-2748-4ee7-9957-ecc0acb2c17a">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95419c314ef74baa801a963119c98dc5_D20220401-20220630" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTAtMi0xLTEtNDc1NzU_52d22716-b1c8-4ffc-a468-a442d88d3f8b">21.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd1554a1349741dba5cff54478d06171_D20210401-20210630" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTAtNC0xLTEtNDc1NzU_928f91b0-8d3b-4070-b710-39a35ab292f8">19.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2293dc828b4c49858d186288dc517883_D20220101-20220630" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTAtNi0xLTEtNDk2MjI_3957e87c-9888-4843-9adb-1c00f49bc0f4">45.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ea00fc2deb741eeaefccb889320e7bf_D20210101-20210630" decimals="-5" sign="-" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTAtOC0xLTEtNDk2MjI_b14f591d-f629-471c-b560-3d5bcdb60d3f">40.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTEtMi0xLTEtNDc1NzU_ea6135f7-b656-4642-aa14-a2b593439129">86.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTEtNC0xLTEtNDc1NzU_6b43ede6-ad5f-4ab5-b58c-c751f136ac9d">75.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTEtNi0xLTEtNTE3NDc_3635bc1f-13f5-40b9-a349-9a0e6963e20e">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTEtOC0xLTEtNTE3NDc_4983e579-a652-4571-931c-26f03b24479c">148.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTQtMi0xLTEtNDc1NzU_b05bdb24-4aa9-49d0-bc74-9644888f6654">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTQtNC0xLTEtNDc1NzU_8ac1615e-f4f9-468b-9f83-6407833b1fa8">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTQtNi0xLTEtNDk2Mjg_a33f476a-4f74-4b4d-aeae-9da541f76103">63.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTQtOC0xLTEtNDk2Mjg_bcd41dae-acb6-4b16-9e0b-ad990791cddc">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTYtMi0xLTEtNDc1NzU_0d507d66-6117-4ad5-b16d-473b853e32b5">33.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTYtNC0xLTEtNDc1NzU_7dceef9f-acf3-40ca-b5ce-0cb2e0919b04">35.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTYtNi0xLTEtNDk2MzQ_83ec9c69-17a5-4ceb-9c69-cab3007c2b16">64.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTYtOC0xLTEtNDk2MzQ_7fdf70b1-b607-49ec-8e59-14269f7309c6">67.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTctMi0xLTEtNDc1NzU_f75e3299-6fa3-44d3-9e27-cbf16b34d2cd">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTctNC0xLTEtNDc1NzU_befa1e3f-ffae-4cf8-b3d6-5e0d75ea2782">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTctNi0xLTEtNDk2MzQ_5e327f7a-7261-43e7-aabd-53b876c55cad">55.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTctOC0xLTEtNDk2MzQ_92491e4b-56e5-4dad-a204-36ce998fd03c">50.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTgtMi0xLTEtNDc1NzU_70e055bb-a479-4d2f-86d0-f1dd212e77cc">56.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTgtNC0xLTEtNDc1NzU_9d9acc4a-666d-42d0-9494-5c626119ab79">53.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTgtNi0xLTEtNDk2MzQ_4440a585-8817-4ee8-a931-bfdde4bd52cb">113.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTgtOC0xLTEtNDk2MzQ_f1760f64-e4d0-4d3a-a90f-75b452aa3ea0">106.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTktMi0xLTEtNDc1NzU_2f6aed2c-1cef-44e7-a802-b9a16f109a8d">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTktNC0xLTEtNDc1NzU_05aece36-9245-476b-b0c8-2158e74c09d3">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTktNi0xLTEtNDk2MzQ_e318632e-4019-42dc-b46c-76ae8f2841f6">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTktOC0xLTEtNDk2MzQ_bc4167d4-7ca9-4a9e-b810-c628b5e5a651">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction, integration and acquisition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjAtMi0xLTEtNDc1NzU_a78384f4-84b0-42a3-a956-3e278aea7a53">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjAtNC0xLTEtNDc1NzU_240ee087-e33e-44f9-8bf4-4c695dfa0e25">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjAtNi0xLTEtNDk2NDA_7245500b-0392-4ea5-a73b-155adccbae84">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjAtOC0xLTEtNDk2NDA_29c9df19-de08-4c1e-bb02-d88273f578a6">20.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjEtMi0xLTEtNDc1NzU_a0201bba-38ff-4418-9410-77d87d5ef1c4">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjEtNC0xLTEtNDc1NzU_3af69366-56f3-431d-9f5d-9bd1bfe1b525">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjEtNi0xLTEtNDk2NDY_46295914-9d6a-4861-88bf-ffd519bc95f4">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="sgry:GainLossOnDispositionOfAssetsAndDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjEtOC0xLTEtNDk2NDY_2ead19e0-0d0c-4430-ab01-6b2571d63220">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on litigation settlement and other litigation costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" sign="-" name="sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItMi0xLTEtNTUxMTc_de177f8a-6ddc-4ff6-84dd-fe3cdfc3bb0b">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItNC0xLTEtNTUxMTc_b13a772d-d302-4833-9c15-ab7ea2fadd00">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItNi0xLTEtNTUxMTc_8e9ba0a9-0b3a-4fee-8075-52144bbe6871">29.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItOC0xLTEtNTUxMTc_2990205a-7149-4e1c-9753-9513d5006a45">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItMi0xLTEtNDk2NTY_8bb6eee8-e830-46d1-9af5-92690aee93d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItNC0xLTEtNDk2NTY_6cde9d05-6437-4c2f-b1f1-21fc1730e0b6">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItNi0xLTEtNDk2NTY_4ef6ed58-63ab-4f98-8ce0-4b7220a9c475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItOC0xLTEtNDk2NTY_a7e0cde3-bf89-47e8-bfbf-d7d7b14dc078">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjMtMi0xLTEtNDc1NzU_1d0f1159-6f30-42e6-9598-bb7bc41c022b">86.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjMtNC0xLTEtNDc1NzU_d51512b1-c471-49f0-94bf-30a24ae8a181">75.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjQtNi0xLTEtNTE3NDc_20c9bca2-6c33-4519-8327-e1fb12ee64d5">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjQtOC0xLTEtNTE3NDc_d7ca1bd6-6850-4180-a698-cdecd91b740b">148.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes transaction and integration costs of $<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNjg5_8c2cd4dd-2d29-44e9-82f6-cb96a8d678a9">8.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNjk2_c42b1966-6682-4f85-a273-8827d8c397f3">9.2</ix:nonFraction> million for the three months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfODM0_b8158109-cedb-4377-b64a-5e1e40199c0e">2.2</ix:nonFraction> million for the three months ended June&#160;30, 2021. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes transaction and integration costs of $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE1MzY4_8a0d6667-1e17-4f7e-8495-19794755d607">15.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE1Mzcy_d16984fe-ff69-4788-9947-3b55a19a538c">14.5</ix:nonFraction> million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE1Mzk0_92076463-e89a-49ed-b762-1cc9af425444">6.3</ix:nonFraction> million for the six months ended June&#160;30, 2021. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes other litigation costs of $<ix:nonFraction unitRef="usd" contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630" decimals="-5" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfOTIz_fd8791bf-2d75-4a77-8e62-f86958305370">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630" decimals="-5" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfOTMw_564143ce-5529-46c0-83fa-dc9c690b4f51">0.8</ix:nonFraction> million for the three months ended June&#160;30, 2022 and 2021, respectively. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes other litigation costs of $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE2MTM3_b68f5cab-5fa2-4dbb-acee-c00650a9ef76">3.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE2MTQx_c9d97fc2-f7cc-44b0-a61a-1534ef9eb2e6">1.8</ix:nonFraction> million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount also includes gain on litigation settlement of $<ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE2MTQ5_55f50bbc-92a7-4ed7-9159-ff4b0579a2d1">32.8</ix:nonFraction> million for the six months ended June&#160;30, 2022.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfMTE0Ng_1c8f1f95-b792-4d40-8f0b-2de417f64302" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23bc251b6a3e49908aa27d058a4353bb_I20220630" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfMi0yLTEtMS00NzU3NQ_0b1cc874-42c5-42df-b349-34d918e9582b">5,691.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05385bb60fbf427ead13dc4825931c47_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfMi00LTEtMS00NzU3NQ_501ef99b-da8a-4b2f-af6e-dda85bcc11c3">5,552.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73110b114b4e4de8888b67e05068b98f_I20220630" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfMy0yLTEtMS00NzU3NQ_aaef5505-4126-4b95-99b6-477b3a7ff800">44.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e47b2c1f284ef6921de8dbbd99e9a8_I20211231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfMy00LTEtMS00NzU3NQ_b8222728-f585-4aee-bbd6-bcb36eeee77c">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e234b442be44c11a6adaee5cffc93f3_I20220630" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfNC0yLTEtMS00NzU3NQ_975a3429-0f70-4c2f-9e01-936f208f9c1c">555.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i981cc515616546ff8ac377ab4fc32af5_I20211231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfNC00LTEtMS00NzU3NQ_87d3b96e-2b18-4681-8d76-f6acaa2d8ac2">517.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfNS0yLTEtMS00NzU3NQ_248a4965-a0de-4d0b-81d2-acc8307b6025">6,291.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfNS00LTEtMS00NzU3NQ_886ab263-0fe0-4174-a3f3-99c08b3c461d">6,117.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SURGERY PARTNERS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><ix:continuation id="ie8ded5a2735541f49abbb56f20eac713"><ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfMTEyOQ_fd62d89b-b386-4b71-9b1c-3ab0e644c9dd" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash purchases of property and equipment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i403f917fe58449dd84f395f95d5d45f5_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfMy0yLTEtMS00NzU3NQ_258bb3d7-11c6-4895-9c83-1c4ea43767cc">36.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62d2cc75b7bf4e3991b46bd2fe6ab2bf_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfMy00LTEtMS00NzU3NQ_1b71a43e-515e-4287-b382-7285742c740a">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e54a8543c64c13be3bc0583a316c0b_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNC0yLTEtMS00NzU3NQ_77565932-f5ea-4962-9979-6732903b0fa4">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc71adeac1b48e983f02714d00ddc72_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNC00LTEtMS00NzU3NQ_3ba21654-c535-4594-99c2-d16694a8bddb">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2293dc828b4c49858d186288dc517883_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNS0yLTEtMS00NzU3NQ_ea31a26a-63b3-4c2a-8405-179c71033dda">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ea00fc2deb741eeaefccb889320e7bf_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNS00LTEtMS00NzU3NQ_1b88ad9c-15ef-4d27-81b6-cf6628578629">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNi0yLTEtMS00NzU3NQ_60fed64b-54b7-4a81-b82f-626e03f1b7fa">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNi00LTEtMS00NzU3NQ_939e5b50-ab9d-4bcc-bfac-d7481676d61a">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_58"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.  <ix:nonNumeric contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81OC9mcmFnOjQyMzk3MTFiYWFkNjQ4OGE4OTQ0ZGZlYzVmYjc4MGU4L3RleHRyZWdpb246NDIzOTcxMWJhYWQ2NDg4YTg5NDRkZmVjNWZiNzgwZThfMjg0_da274322-c3c4-4372-ba5b-2752c8d6ab83" continuedAt="ie9ce3edbe1d14813bf980704f51be692" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ie9ce3edbe1d14813bf980704f51be692">In July 2022, the Company acquired non-controlling interests in <ix:nonFraction unitRef="property" contextRef="ib78433cb866f4b209cb42b742ebd6d86_I20220731" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81OC9mcmFnOjQyMzk3MTFiYWFkNjQ4OGE4OTQ0ZGZlYzVmYjc4MGU4L3RleHRyZWdpb246NDIzOTcxMWJhYWQ2NDg4YTg5NDRkZmVjNWZiNzgwZThfMTY0OTI2NzQ0MjU3MQ_7b66ab63-82e6-4488-8675-84efeee63d0f">two</ix:nonFraction> surgical facilities and <ix:nonFraction unitRef="property" contextRef="i1b0e6fb212964ed98b69386800807bd2_I20220731" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81OC9mcmFnOjQyMzk3MTFiYWFkNjQ4OGE4OTQ0ZGZlYzVmYjc4MGU4L3RleHRyZWdpb246NDIzOTcxMWJhYWQ2NDg4YTg5NDRkZmVjNWZiNzgwZThfMTY0OTI2NzQ0MjU3OQ_ffca4545-b35f-4510-8ece-f72ada488637">three</ix:nonFraction> in-development de novo surgical facilities for a combined purchase price of $<ix:nonFraction unitRef="usd" contextRef="if47fc0612aa043b48a03337684354a15_D20220701-20220731" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81OC9mcmFnOjQyMzk3MTFiYWFkNjQ4OGE4OTQ0ZGZlYzVmYjc4MGU4L3RleHRyZWdpb246NDIzOTcxMWJhYWQ2NDg4YTg5NDRkZmVjNWZiNzgwZThfMTY0OTI2NzQ0MjU1Mg_46dbcb07-5ac8-4aea-9b9d-5661ee8d20e5">29.3</ix:nonFraction>&#160;million. The non-controlling interests will be accounted for as equity method investments.</ix:continuation></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_61"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this report and our 2021 Annual Report on Form 10-K. Unless the context otherwise indicates, the terms "Surgery Partners," "we," "us," "our" or the "Company," as used herein, refer to Surgery Partners, Inc. and its subsidiaries. Unless the context implies otherwise, the term &#8220;affiliates&#8221; means direct and indirect subsidiaries of Surgery Partners, Inc. and partnerships and joint ventures in which such subsidiaries are partners. The terms &#8220;facilities&#8221; or &#8220;hospitals&#8221; refer to entities owned and operated by affiliates of Surgery Partners, Inc. and the term &#8220;employees&#8221; refers to employees of affiliates of Surgery Partners, Inc.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_64"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">This report contains forward-looking statements, which are based on our current expectations, estimates and assumptions about future events. All statements other than statements of current or historical fact contained in this report are forward-looking statements. These statements include, but are not limited to, statements regarding our future financial position, business strategy, budgets, effective tax rate, projected costs and plans and objectives of management for future operations. The words "projections," "believe," "continue," "drive," "estimate," "expect," "intend," "may," "plan," "will," "could," "would" and similar expressions are generally intended to identify forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results to differ from the expectations expressed in the statements. Many of these factors are beyond our ability to control or predict. These factors include, without limitation, the effects of the ongoing COVID-19 pandemic in the United States and the regions in which we operate; the impact to the state and local economies of restrictive orders, vaccine and other mandates and the pandemic generally; our ability to respond nimbly to challenging economic conditions, including recent inflationary pressures; the unpredictability of our case volume in the current environment; our ability to preserve or raise sufficient funds to continue operations throughout this period of uncertainty; the impact of our cost-cutting measures on our future performance; our ability to cause distributions from our subsidiaries; the responsiveness of our payors, including Medicaid and Medicare, to the challenging operating conditions, including their willingness and ability to continue paying in a timely manner and to advance payments in a timely manner, if at all; the impact of COVID-19 related stimulus programs, including the CARES Act, and uncertainty in how these programs may be administered, monitored and modified in the future; our ability to execute on our operational and strategic initiatives; the timing and impact of our portfolio optimization efforts; our ability to continue to improve same-facility volume and revenue growth on the timeline anticipated, if at all; our ability to successfully integrate acquisitions; the anticipated impact and timing of our ongoing efficiency efforts; the impact of adverse weather conditions and other events outside of our control; and the risks and uncertainties set forth under the heading "Risk Factors" in our 2021 Annual Report on Form 10-K and discussed from time to time in our reports filed with the SEC.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Considering these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this report may not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements. When you consider these forward-looking statements, you should keep in mind these risk factors and other cautionary statements in this report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These forward-looking statements speak only as of the date made. Other than as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events or otherwise.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_67"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Executive Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total revenues for the second quarter of 2022 increased 13.3% to&#160;$615.4 million&#160;from&#160;$543.3 million&#160;for the second quarter of 2021. Days adjusted same-facility revenues for the second quarter of 2022 increased 6.9% from the same period last year, with a 4.9% increase in revenue per case and a 1.9% increase in same-facility cases. For the second quarter of 2022, the Company&#8217;s net loss attributable to common stockholders and Adjusted EBITDA was&#160;$18.4 million and $86.1 million, respectively.&#160;For the second quarter of 2021, the Company&#8217;s net loss attributable to common stockholders and Adjusted EBITDA was&#160;$26.9 million and $75.9 million, respectively. A reconciliation of non-GAAP financial measures appears below under "Certain Non-GAAP Measures." </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We&#160;had cash and cash equivalents of&#160;$227.4 million&#160;and $203.0 million of borrowing capacity under our revolving credit facility at June&#160;30, 2022. Operating cash inflows were $42.1 million in the second quarter of 2022, an increase of $39.8 million compared to the prior year period. Net operating cash flows, including operating cash flows less distributions to non-controlling interests, were an inflow of&#160;$3.1 million for the second quarter of 2022, compared to an outflow of $29.8 million for the second quarter of 2021. The increase in operating cash flows and net operating cash flows compared to the same period in 2021 is primarily due to a DOJ settlement payment made in the 2021 period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The public health and economic effects of the COVID-19 pandemic have significantly affected our facilities, employees, patients, communities, business operations and financial performance, as well as the U.S. economy and financial markets. The impact of the COVID-19 pandemic on our surgical facilities varies based on the market in which the facility operates, the type of surgical facility and the procedures typically performed. We cannot provide any certainty regarding the length and severity of the impact of the COVID-19 pandemic, which is difficult to predict and is dependent on factors beyond our control.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Taking into account the pandemic and other factors, the United States economy has recently experienced general inflationary pressures, significant disruptions to global supply networks, and an extremely competitive labor market. We have incurred, and may </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">continue to incur, certain increased expenses arising from the pandemic and these economic conditions, including additional labor, supply chain, capital and other expenditures. While we have implemented cost containment and other measures to try to counteract these developments, we may be unable to fully offset these increases in our costs and otherwise effectively respond to supply disruptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is monitoring legislative actions at federal and state levels, including the impact of the CARES Act and other governmental assistance that might be available.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_73"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our revenues consist of patient service revenues and other service revenues. Patient service revenues consist of revenue from our surgical facility services and ancillary services segments. Specifically, patient service revenues include fees for surgical or diagnostic procedures performed at surgical facilities that we consolidate for financial reporting purposes, as well as for patient visits to our physician practices, anesthesia services, pharmacy services and diagnostic screens ordered by our physicians. Other service revenues include management and administrative service fees derived from our non-consolidated facilities that we account for under the equity method, management of surgical facilities and physician practices in which we do not own an interest and management services we provide to physician practices for which we are not required to provide capital or additional assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes our revenues by service type as a percentage of total revenues for the periods indicated: </span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical facilities revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary services revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other service revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Payor Mix</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth by type of payor the percentage of our patient service revenues generated at the surgical facilities which we consolidate for financial reporting purposes in the periods indicated: </span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance payors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government payors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay payors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other payors </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:1pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Surgical Case Mix</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We primarily operate multi-specialty surgical facilities where physicians perform a variety of procedures in various specialties. We believe this diversification helps to protect us from adverse pricing and utilization trends in any individual procedure type and results in greater consistency in our case volume. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth the percentage of cases in each specialty performed at the surgical facilities which we consolidate for financial reporting purposes for the periods indicated:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Orthopedic and pain management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ophthalmology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gastrointestinal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General surgery</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_76"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Critical Accounting Policies </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of significant accounting policies is disclosed in our 2021 Annual Report on Form 10-K under the caption &#8220;Critical Accounting Policies&#8221; in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section. There have been no material changes in the nature of our critical accounting policies or the application of those policies since December 31, 2021.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_79"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended June&#160;30, 2022 Compared to Three Months Ended June&#160;30, 2021 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes certain results from the statements of operations for the three months ended June&#160;30, 2022 and 2021 (dollars in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">543.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated affiliates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">483.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:  Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Overview.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2022, our revenues increased 13.3% to $615.4 million compared to $543.3 million for the three months ended June&#160;30, 2021. Net loss attributable to Surgery Partners, Inc. was $18.4 million for the 2022 period, compared to a net loss of $26.9 million for the 2021 period. The increase in revenues was primarily attributable to a favorable shift in surgical case mix and acquisitions completed since the prior year period.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues for the three months ended June&#160;30, 2022 compared to the three months ended June&#160;30, 2021 were as follows (dollars in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">543.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patient service revenues increased 13.3% to $607.3 million for the 2022 period compared to $535.9 million for the 2021 period, primarily driven by a 4.9% increase in same-facility revenue per case, a 1.9% increase in days adjusted same-facility case volumes and acquisitions completed since the prior year period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenues increased to $480.8 million for the 2022 period compared to $425.0 million for the 2021 period, primarily driven by acquisitions completed since the prior year period. As a percentage of revenues, cost of revenues were 78.1% for the 2022 period compared to 78.2% for the 2021 period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  As a percentage of revenues, general and administrative expenses decreased to 4.2% for the 2022 period compared to 4.5% for the 2021 period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and Amortization.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a percentage of revenues, depreciation and amortization expenses were 4.5% for the 2022 period compared to 4.6% for the 2021 period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Transaction and Integration Costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  We incurred $8.2 million of transaction and integration costs for the three months ended June&#160;30, 2022 compared to $9.2 million for the three months ended June&#160;30, 2021. The costs for both periods primarily relate to ongoing development initiatives and the integration of acquisitions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Grant Funds.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Based on guidance from HHS and other authorities, the Company updated its estimate of the amount of grant funds received that qualified for recognition, resulting in the recognition of $0.1&#160;million during the three months ended June&#160;30, 2022. Grant funds recognized in the three months ended June&#160;30, 2021 were $4.9&#160;million. For further discussion, see Note 1 to our condensed consolidated financial statements included elsewhere in this report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Loss on Debt Extinguishment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We incurred a loss on debt extinguishment of $9.6&#160;million for the 2021 period related to an amendment to our credit agreement, which refinanced all of the then existing term loans during the three months ended June 30, 2021. There was no comparable loss during the 2022 period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense, Net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  As a percentage of revenues, interest expense, net decreased to 9.2% for the 2022 period compared to 9.8% for the 2021 period. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Income Tax (Expense) Benefit.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160; The income tax expense was $4.3 million for the three months ended June&#160;30, 2022 compared to a benefit of $2.7 million for the three months ended June&#160;30, 2021. The effective tax rate was 21.9% for the three months ended June&#160;30, 2022 compared to (44.3)% for the three months ended June&#160;30, 2021. For the three months ended June&#160;30, 2022, the effective tax rate differed from 21% primarily due to earnings attributable to non-controlling interests and an increase in the Company&#8217;s valuation allowance attributable to interest expense limitations. For the three months ended June&#160;30, 2021, the effective tax rate differed from 21% primarily due to tax benefits of $3.0&#160;million related to entity divestitures. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net Income Attributable to Non-Controlling Interests. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> As a percentage of revenues, net income attributable to non-controlling interests was 5.5% for the 2022 period and 6.6% for the 2021 period.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Six Months Ended June&#160;30, 2022 Compared to Six Months Ended June&#160;30, 2021 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes certain results from the statements of operations for the six months ended June&#160;30, 2022 and 2021 (dollars in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,055.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">952.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">833.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Grant funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated affiliates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,034.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">931.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(106.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:  Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Overview.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, our revenues increased 14.8% to $1,211.6 million compared to $1,055.7 million for the six months ended June&#160;30, 2021. Net loss attributable to Surgery Partners, Inc. was $6.2 million for the 2022 period, compared to a net loss of $47.9 million for the 2021 period. The increase in revenues was primarily attributable to increases in surgical case volumes, a favorable shift in surgical case mix and acquisitions completed since the prior-year period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues for the six months ended June&#160;30, 2022 compared to the six months ended June&#160;30, 2021 were as follows (dollars in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.411%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,055.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patient service revenues increased 14.7% to $1,195.0 million for the 2022 period compared to $1,041.6 million for the 2021 period, primarily driven by a 4.0% increase in days adjusted same-facility case volume, a 3.2% increase in same-facility revenue per case and acquisitions completed since the prior year period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenues were $952.2 million for the 2022 period compared to $833.9 million for the 2021 period, primarily driven by acquisitions completed since the prior year period. As a percentage of revenues, cost of revenues decreased to 78.6% for the 2022 period compared to 79.0% for the 2021 period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  As a percentage of revenues, general and administrative expenses decreased to 4.6% for the 2022 period compared to 4.9% for the 2021 period. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and Amortization.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a percentage of revenues, depreciation and amortization expenses decreased to 4.6% for the 2022 period compared to 4.8% for the 2021 period. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Transaction and Integration Costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  We incurred $15.3 million of transaction and integration costs for the six months ended June&#160;30, 2022 compared to $14.5 million for the six months ended June&#160;30, 2021. The increase primarily relates to costs for ongoing development initiatives and the integration of acquisitions we completed in 2022 and 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Grant Funds.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Based on guidance from HHS and other authorities, the Company updated its estimate of the amount of grant funds received that qualified for recognition, resulting in the recognition of $1.3 million during the six months ended June&#160;30, 2022. Grant funds recognized in the six months ended June&#160;30, 2021 were $20.0 million. For further discussion, see Note 1 to our condensed consolidated financial statements included elsewhere in this report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation Settlement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Gain on litigation settlement was $32.8 million for the six months ended June&#160;30, 2022, related to the resolution of the stockholder litigation matter, as discussed in Note 8. "Commitments and Contingencies" to our condensed consolidated financial statements included elsewhere in this report. There was no comparable activity for the 2021 period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Loss on Debt Extinguishment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We incurred a loss on debt extinguishment of $9.6&#160;million for the 2021 period related to an amendment to our credit agreement, which refinanced all of the then existing term loans during the six months ended June 30, 2021. There was no comparable loss during the 2022 period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense, Net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  As a percentage of revenues, interest expense, net decreased to 9.3% for the 2022 period compared to 10.1% for the 2021 period. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Income Tax (Expense) Benefit.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160; The income tax expense was $5.6 million for the six months ended June&#160;30, 2022 compared to a benefit of $2.5 million for the six months ended June&#160;30, 2021. The effective tax rate was 8.8% for the six months ended June&#160;30, 2022 compared to (14.6)% for the six months ended June&#160;30, 2021. For the six months ended June&#160;30, 2022, the effective tax rate differed from 21% primarily due to earnings attributable to non-controlling interests, an increase in the Company&#8217;s valuation allowance attributable to interest expense limitations, and discrete tax benefits of (a) $4.6&#160;million related to the vesting of restricted stock awards, (b) $1.8&#160;million attributable to non-recurring earnings&#8217; impact on the Company&#8217;s valuation allowance, and (c) $1.0&#160;million related to entity divestitures. For the six months ended June&#160;30, 2021, the effective tax rate differed from 21% due to tax benefits of $4.1&#160;million related to the vesting of restricted stock awards, as well as a $3.0&#160;million tax benefit related to entity divestitures. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net Income Attributable to Non-Controlling Interests. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> As a percentage of revenues, net income attributable to non-controlling interests was 5.3% for the 2022 period and 6.4% for the 2021 period.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_82"></div><div style="margin-bottom:6pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The primary source of our operating cash flow is the collection of accounts receivable from federal and state agencies (under the Medicare and Medicaid programs), private insurance companies and individuals. During the six months ended June&#160;30, 2022, our cash flow provided by operating activities was $121.9 million compared to $52.5 million in the six months ended June&#160;30, 2021. The increase is primarily due to the receipt of stockholder litigation proceeds of $32.8&#160;million in the 2022 period and a DOJ settlement payment of $32.2&#160;million made during the 2021 period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in investing activities during the six months ended June&#160;30, 2022, was $181.4 million compared to $40.7 million for the six months ended June 30, 2021. The increase in cash used is primarily due to an increase of $12.6 million related to purchases of property and equipment, an increase of $59.7 million for acquisitions (net of cash acquired), an increase of $65.8 million for purchases of equity method investments, a decrease of $2.5 million in cash proceeds from divestitures and an increase in other investing activities of $11.6 million. The increases in cash used in investing activities were partially offset by an increase of $11.5 million related to the sale of equity method investments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in financing activities during the six months ended June&#160;30, 2022 was $103.0 million compared to cash provided by financing activities of $134.8 million for the six months ended June 30, 2021. The decrease is primarily due to $248.2 million of proceeds received from an equity offering, net of related costs in the 2021 period, with no comparable activity in the 2022 period, an increase of $11.8 million for distributions to non-controlling interest holders and an increase of $7.4 million of net payments related to ownership transactions with consolidated affiliates. The increases in cash used in financing activities were partially offset by a decrease of $5.4 million in repayments of long-term debt, net of borrowings, a decrease of $11.1 million related to payments of deferred financing costs and a prepayment premium related to the modification of the term loan in the 2021 period, a decrease of $5.1 million for preferred dividends and a decrease in other financing activities of $8.0 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net working capital was approximately $266.7&#160;million at June 30, 2022 compared to $409.3&#160;million at December 31, 2021. The decrease is due to a decrease in cash, primarily as a result of payments for acquisitions, a decrease in accounts receivable and an increase in accrued payroll and benefits, offset by a decrease in deferred Medicare accelerated payments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to cash flows from operations and available cash, other sources of capital include amounts available on our Revolver as well as anticipated continued access to the capital markets. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Material Cash Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the cash requirements related to our long-term debt, operating lease obligations and the tax receivable agreement, pursuant to the CARES Act, repayment of certain advanced payments and other deferrals received as part of relief during 2020 will continue during 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We received approximately $120&#160;million of accelerated payments during the year ended December 31, 2020. Through June&#160;30, 2022, approximately $103&#160;million has been repaid including approximately $25&#160;million and  $43&#160;million during the three and six months ended June&#160;30, 2022, respectively. In addition to the continued repayment of the advanced payments received under the CARES Act, we anticipate additional cash outflows during 2022 for the repayment of the remaining payroll taxes deferred in 2020 pursuant to the CARES Act.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no material changes outside of the ordinary course of business to our upcoming cash obligations during the six months ended June 30, 2022 from those disclosed under &#8220;Material Cash Requirements&#8221; in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in our 2021 Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Broad economic factors resulting from the ongoing COVID-19 pandemic could negatively affect our payor mix, increase the relative proportion of lower margin services we provide and reduce patient volumes, as well as diminish our ability to collect outstanding receivables. Additionally, while we have received grants and accelerated payments under the CARES Act and other government assistance programs and may receive additional amounts in the future, there is no assurance regarding the extent to which anticipated negative impacts arising from the COVID-19 pandemic will be offset by amounts and benefits received under the CARES Act or future legislation. Business closings and layoffs in the areas in which we operate may lead to increases in the uninsured and underinsured populations and adversely affect demand for our services, as well as the ability of payors to pay for services as rendered. Any increase in the amount or deterioration in the collectability of patient accounts receivable will adversely affect our cash flows and results of operations, requiring an increased level of working capital. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If general economic conditions, including recent increases in interest rates, inflation risk and market volatility continue to deteriorate or remain uncertain for an extended period of time, our ability to access capital could be harmed, which could negatively affect our liquidity and ability to repay our outstanding debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Based on our current level of operations, we believe cash flows from operations, available cash, available capacity on our Revolver and continued anticipated access to capital markets, will be adequate to meet our short-term (i.e., 12 months) and long-term (beyond 12 months) liquidity needs.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_85"></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certain Non-GAAP Measures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted EBITDA and Adjusted EBITDA excluding grant funds are not measurements of financial performance under GAAP and should not be considered in isolation or as a substitute for net income, operating income or any other measure calculated in accordance with GAAP. The items excluded from these non-GAAP metrics are significant components in understanding and evaluating our financial performance. We believe such adjustments are appropriate, as the magnitude and frequency of such items can vary significantly and are not related to the assessment of normal operating performance. Our calculation of Adjusted EBITDA and Adjusted EBITDA excluding grant funds may not be comparable to similarly titled measures reported by other companies. We use Adjusted EBITDA and Adjusted EBITDA excluding grant funds as measures of financial performance. Adjusted EBITDA and Adjusted EBITDA excluding grant funds are key measures used by our management to assess operating performance, make business decisions and allocate resources.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table reconciles Adjusted EBITDA and Adjusted EBITDA excluding grant funds to income before income taxes, the most directly comparable GAAP financial measure (in millions and unaudited):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.953%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Statements of Operations Data:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Plus (minus):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction, integration and acquisition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on litigation settlement and other litigation costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Impact of grant funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA excluding grant funds</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes transaction and integration costs of $8.2 million and $9.2 million for the three months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.2 million for the three months ended June&#160;30, 2021. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes transaction and integration costs of $15.3 million and $14.5 million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million for the six months ended June&#160;30, 2021.</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes other litigation costs of $1.7 million and $0.8 million for the three months ended June&#160;30, 2022 and 2021, respectively. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes other litigation costs of $3.7 million and $1.8 million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount also includes gain on litigation settlement of $32.8 million for the six months ended June&#160;30, 2022.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Represents the impact of grant funds recognized, net of amounts attributable to non-controlling interests.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use Credit Agreement EBITDA as a measure of liquidity and to determine our compliance under certain covenants pursuant to our credit facilities. Credit Agreement EBITDA is determined on a trailing twelve-month basis. We have included it because we believe that it provides investors with additional information about our ability to incur and service debt and make capital expenditures. Credit Agreement EBITDA is not a measurement of liquidity under GAAP and should not be considered in isolation or as a substitute for any other measure calculated in accordance with GAAP. The items excluded from Credit Agreement EBITDA are significant components in understanding and evaluating our liquidity. Our calculation of Credit Agreement EBITDA may not be comparable to similarly titled measures reported by other companies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When we use the term &#8220;Credit Agreement EBITDA,&#8221; we are referring to Adjusted EBITDA, as defined above, further adjusted for acquisitions and synergies. These adjustments do not relate to our historical financial performance and instead relate to estimates compiled by our management and calculated in conformance with the definition of &#8220;Consolidated EBITDA&#8221; used in the credit agreements governing our credit facilities. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table reconciles Credit Agreement EBITDA to cash flows from operating activities, the most directly comparable GAAP financial measure (in millions and unaudited):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.852%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Twelve Months Ended June 30, 2022</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Plus (minus):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated affiliates, net of distributions received</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of acquisitions and divestitures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(138.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction, integration and acquisition costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation settlement and other litigation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hurricane-related impacts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions and synergies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Credit Agreement EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">438.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Reflects the impact of insurance proceeds received net of operating losses incurred in the six months ended December 31, 2021, at a surgical facility that was closed following Hurricane Ida.</span></div><div style="margin-bottom:9pt;margin-top:1pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Represents impact of acquisitions as if each acquisition had occurred on July 1, 2021. Further this includes revenue and cost synergies from other business initiatives and de novo facilities and an adjustment for the effects of adopting the new lease accounting standard, as defined in the credit agreement governing the Senior Secured Credit Facilities.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_88"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 3.  Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to market risk primarily from exposure to changes in interest rates based on our financing, investing and cash management activities.&#160;We utilize a balanced mix of maturities along with both fixed rate and variable rate debt to manage our exposures to changes in interest rates.&#160;Additionally, we periodically enter into interest rate swap and cap agreements to manage our exposure to interest rate fluctuations. Our interest rate swap and cap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts of the interest rate swap and cap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the interest rate swap and cap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis. These derivatives have been recognized in the financial statements at their respective fair values. Changes in the fair value of these derivatives, which are designated as cash flow hedges, are included in other comprehensive income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our variable rate debt instruments are primarily indexed to the prime rate or LIBOR.&#160;Without derivatives, interest rate changes would result in gains or losses in the market value of our fixed rate debt portfolio due to differences in market interest rates and the rates at the inception of the debt agreements. Based on our indebtedness and the effectiveness of our interest rate swap and cap agreements at June&#160;30, 2022, we do not expect changes in interest rates to have a material effect on our net earnings or cash flows in 2022.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_91"></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4.  Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An evaluation was performed under the supervision and with the participation of our management, including the chief executive officer and the chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended) as of June&#160;30, 2022. Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the quarter ended June&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_97"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 1.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.  Please refer to the disclosure in Note 8. "Commitments and Contingencies - Stockholder Litigation" to our condensed consolidated financial statements included elsewhere in this report, which is incorporated into this item by reference.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other Litigation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  In addition, we are, from time to time, subject to claims and suits, or threats of claims or suits, relating to our business, including claims for damages for personal injuries, breach of management contracts and employment related claims. In certain of these actions, plaintiffs request payment for damages, including punitive damages, which may not be covered by insurance or may otherwise have a material adverse effect on our business or results of operations.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_100"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 1A.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Risk Factors</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no material changes with respect to the risk factors discussed in our 2021 Annual Report on Form 10-K.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_103"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 2.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company did not repurchase any shares of common stock during the six months ended June&#160;30, 2022. At June&#160;30, 2022, the Company continued to have authority to repurchase up to $46.0&#160;million of shares of common stock under its Board-authorized share repurchase program.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_106"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 3.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Defaults Upon Senior Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_109"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Mine Safety Disclosures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_112"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 5.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Other Information</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_115"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 6.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Exhibits</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.855%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.840%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.905%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022q2exhibit311.htm">Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022q2exhibit312.htm">Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2022q2exhibit321.htm">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Instance Document - the instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The cover page from the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2022, formatted in Inline XBRL (included in Exhibit 101).</span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i7c5babcb2c6b48dbb62fc1c06bdcd830_118"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c5babcb2c6b48dbb62fc1c06bdcd830_7">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:180pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:304.50pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SURGERY PARTNERS,&#160;INC.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">/s/  David T. Doherty</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">David T. Doherty</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</span></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date: August&#160;2, 2022 </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>a2022q2exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id3b7fdb2b27141ffb0f15d12832e3e8b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="padding-left:18pt;text-align:right;text-indent:-18pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, J. Eric Evans, certify that&#58; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1. &#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of Surgery Partners, Inc.&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5. &#160;&#160;&#160;&#160;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:304.50pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;  J. Eric Evans</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Eric Evans</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58;  August&#160;2, 2022 </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>a2022q2exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iee087bd5694842f2a978c3c51d747407_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:right;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="padding-left:18pt;text-align:right;text-indent:-18pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, David T. Doherty, certify that&#58; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1. &#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of Surgery Partners, Inc.&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5. &#160;&#160;&#160;&#160;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:20.25pt"><font><br></font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:304.50pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;  David T. Doherty</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">David T. Doherty</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58;  August&#160;2, 2022</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>a2022q2exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia82d53f62e67416baf422d379b06a002_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the quarterly report of Surgery Partners, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned certifies, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:304.50pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;  J. Eric Evans</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Eric Evans</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58;  August&#160;2, 2022 </font></div><div style="padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:304.50pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:32pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;  David T. Doherty</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">David T. Doherty</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58;  August&#160;2, 2022 </font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>sgry-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bf0c9919-675a-4090-9889-2da6d013d12b,g:8071f056-30bb-4692-9c60-1fa924dc9a77-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sgry="http://www.surgerypartners.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.surgerypartners.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.surgerypartners.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPolicies" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies">
        <link:definition>2101101 - Disclosure - Organization and Summary of Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesPolicies" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Organization and Summary of Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesTables" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Organization and Summary of Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesOrganizationDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails">
        <link:definition>2404401 - Disclosure - Organization and Summary of Accounting Policies - Organization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails">
        <link:definition>2405402 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails">
        <link:definition>2406403 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails">
        <link:definition>2407404 - Disclosure - Organization and Summary of Accounting Policies - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails">
        <link:definition>2408405 - Disclosure - Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails">
        <link:definition>2409406 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails">
        <link:definition>2410407 - Disclosure - Organization and Summary of Accounting Policies - Medicare Accelerated Payments and Deferred Governmental Grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails">
        <link:definition>2411408 - Disclosure - Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails" roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails">
        <link:definition>2412409 - Disclosure - Organization and Summary of Accounting Policies - Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDisposals" roleURI="http://www.surgerypartners.com/role/AcquisitionsandDisposals">
        <link:definition>2113102 - Disclosure - Acquisitions and Disposals</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDisposalsAcquisitionsDetails" roleURI="http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails">
        <link:definition>2414410 - Disclosure - Acquisitions and Disposals - Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDisposalsOtherAcquisitionsDetails" roleURI="http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails">
        <link:definition>2415411 - Disclosure - Acquisitions and Disposals - Other Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails" roleURI="http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails">
        <link:definition>2416412 - Disclosure - Acquisitions and Disposals - Disposals and Deconsolidations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.surgerypartners.com/role/LongTermDebt">
        <link:definition>2117103 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.surgerypartners.com/role/LongTermDebtTables">
        <link:definition>2318302 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtSummaryDetails" roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails">
        <link:definition>2419413 - Disclosure - Long-Term Debt - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtSummaryDetails_1" roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1">
        <link:definition>2419413 - Disclosure - Long-Term Debt - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails">
        <link:definition>2420414 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.surgerypartners.com/role/Leases">
        <link:definition>2121104 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.surgerypartners.com/role/LeasesTables">
        <link:definition>2322303 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails" roleURI="http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails">
        <link:definition>2423415 - Disclosure - Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.surgerypartners.com/role/LeasesNarrativeDetails">
        <link:definition>2424416 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseExpenseandCashFlowInformationDetails" roleURI="http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails">
        <link:definition>2425417 - Disclosure - Leases - Lease Expense and Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivities" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivities">
        <link:definition>2126105 - Disclosure - Derivatives and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesTables" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables">
        <link:definition>2327304 - Disclosure - Derivatives and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesNarrativeDetails" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails">
        <link:definition>2428418 - Disclosure - Derivatives and Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails">
        <link:definition>2429419 - Disclosure - Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails">
        <link:definition>2430420 - Disclosure - Derivatives and Hedging Activities - Derivatives Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails" roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails">
        <link:definition>2431421 - Disclosure - Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.surgerypartners.com/role/EarningsPerShare">
        <link:definition>2132106 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.surgerypartners.com/role/EarningsPerShareTables">
        <link:definition>2333305 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareSummaryDetails" roleURI="http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails">
        <link:definition>2434422 - Disclosure - Earnings Per Share - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilities" roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilities">
        <link:definition>2135107 - Disclosure - Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesTables" roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables">
        <link:definition>2336306 - Disclosure - Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherCurrentLiabilitiesSummaryDetails" roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails">
        <link:definition>2437423 - Disclosure - Other Current Liabilities - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.surgerypartners.com/role/CommitmentsandContingencies">
        <link:definition>2138108 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2439424 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.surgerypartners.com/role/SegmentReporting">
        <link:definition>2140109 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.surgerypartners.com/role/SegmentReportingTables">
        <link:definition>2341307 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails" roleURI="http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails">
        <link:definition>2442425 - Disclosure - Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails" roleURI="http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails">
        <link:definition>2443426 - Disclosure - Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.surgerypartners.com/role/SubsequentEvents">
        <link:definition>2144110 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.surgerypartners.com/role/SubsequentEventsDetails">
        <link:definition>2445427 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" abstract="false" name="RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_ThreeReceiveFixedInterestRateSwapsMember" abstract="true" name="ThreeReceiveFixedInterestRateSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_InterestRateCapTwoMember" abstract="true" name="InterestRateCapTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_FinanceLeaseCost1Abstract" abstract="true" name="FinanceLeaseCost1Abstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sgry_GrantRevenue" abstract="false" name="GrantRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_SurgicalFacilitiesMember" abstract="true" name="SurgicalFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_ReceiveFixedSwapThreeMember" abstract="true" name="ReceiveFixedSwapThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_OtherPatientServiceRevenueSourcesMember" abstract="true" name="OtherPatientServiceRevenueSourcesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_TaxReceivableAgreementLiabilityCurrent" abstract="false" name="TaxReceivableAgreementLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" abstract="false" name="NumberOfSurgicalFacilitiesOwnedMajorityInterest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_SeniorUnsecuredNotesDue2025Member" abstract="true" name="SeniorUnsecuredNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" abstract="false" name="CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sgry_ReceiveFixedSwapTwoMember" abstract="true" name="ReceiveFixedSwapTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" abstract="false" name="GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" abstract="false" name="IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" abstract="false" name="DeferredIncomeTaxLiabilitiesNetOfDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" abstract="false" name="BusinessCombinationIntegrationRelatedCostsAndMergerCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_CostReportLiabilitiesCurrent" abstract="false" name="CostReportLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_AncillaryServicesMember" abstract="true" name="AncillaryServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_SurgicalFacilityMember" abstract="true" name="SurgicalFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" abstract="false" name="CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" abstract="false" name="NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_FacilitiesSurgicalHospitalsMember" abstract="true" name="FacilitiesSurgicalHospitalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sgry_NumberOfSurgicalFacilitiesOwned" abstract="false" name="NumberOfSurgicalFacilitiesOwned" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_A2017SeniorSecuredCreditFacilityMember" abstract="true" name="A2017SeniorSecuredCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" abstract="false" name="NumberOfSurgicalFacilitiesOwnedConsolidated" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_SurgicalFacilitiesExistingMarketsMember" abstract="true" name="SurgicalFacilitiesExistingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_VariableAndShortTermLeaseCost" abstract="false" name="VariableAndShortTermLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_RedeemableNoncontrollingInterestRollForward" abstract="true" name="RedeemableNoncontrollingInterestRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets" abstract="false" name="IncreaseDecreaseInFinanceLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_PayFixedSwapFiveMember" abstract="true" name="PayFixedSwapFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_DisposalGroupOneMember" abstract="true" name="DisposalGroupOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" abstract="false" name="MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" abstract="false" name="EarningsBeforeInterestTaxesDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_PrivateInsuranceMember" abstract="true" name="PrivateInsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" abstract="false" name="RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_OtherServicesMember" abstract="true" name="OtherServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sgry_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_PayFixedSwapFourMember" abstract="true" name="PayFixedSwapFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" abstract="false" name="GainLossOnDispositionOfAssetsAndDeconsolidation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired" abstract="false" name="NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_UnrecognizedGrantFundsReceived" abstract="false" name="UnrecognizedGrantFundsReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" abstract="false" name="CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_ProceedsFromGovernmentAssistance" abstract="false" name="ProceedsFromGovernmentAssistance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_DisposalGroupTwoMember" abstract="true" name="DisposalGroupTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_RedeemableNoncontrollingInterestPolicyTextBlock" abstract="false" name="RedeemableNoncontrollingInterestPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sgry_SelfPayRevenueMember" abstract="true" name="SelfPayRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_ThreePayFixedInterestRateSwapsMember" abstract="true" name="ThreePayFixedInterestRateSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_PayFixedSwapSixMember" abstract="true" name="PayFixedSwapSixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_PayFixedSwapOneMember" abstract="true" name="PayFixedSwapOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_InDevelopmentDeNovoSurgicalFacilityMember" abstract="true" name="InDevelopmentDeNovoSurgicalFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration" abstract="false" name="DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_LeaseRightOfUseAsset" abstract="false" name="LeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_ReceiveFixedSwapOneMember" abstract="true" name="ReceiveFixedSwapOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_MateriallyMoreRestrictiveMember" abstract="true" name="MateriallyMoreRestrictiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_InterestRateCapOneMember" abstract="true" name="InterestRateCapOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_FacilitiesAmbulatorySurgeryCentersMember" abstract="true" name="FacilitiesAmbulatorySurgeryCentersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_PayFixedSwapTwoMember" abstract="true" name="PayFixedSwapTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_IncreaseDecreaseInFinanceLeaseLiability" abstract="false" name="IncreaseDecreaseInFinanceLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" abstract="false" name="DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_NoncashInterestIncomeExpenseNet" abstract="false" name="NoncashInterestIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" abstract="false" name="CollaborativeTaxAgreementProjectedTaxSavingsTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgry_DebtInstrumentPrepaymentPenaltyAmount" abstract="false" name="DebtInstrumentPrepaymentPenaltyAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_VariableInterestEntityNumberOfFacilities" abstract="false" name="VariableInterestEntityNumberOfFacilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_SeniorUnsecuredNotesDue2027Member" abstract="true" name="SeniorUnsecuredNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired" abstract="false" name="NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" abstract="false" name="GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_OperatingAndFinanceLeaseExpense" abstract="false" name="OperatingAndFinanceLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_DerivativeLiabilityNotionalAmountFinancingComponent" abstract="false" name="DerivativeLiabilityNotionalAmountFinancingComponent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_SurgicalFacilityServicesMember" abstract="true" name="SurgicalFacilityServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_A2017TermLoanMaturing2024Member" abstract="true" name="A2017TermLoanMaturing2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_IncreaseDecreaseInSettlementPayments" abstract="false" name="IncreaseDecreaseInSettlementPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgry_PayFixedSwapThreeMember" abstract="true" name="PayFixedSwapThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_NotMateriallyMoreRestrictiveMember" abstract="true" name="NotMateriallyMoreRestrictiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_HealthcareOrganizationPatientServiceMember" abstract="true" name="HealthcareOrganizationPatientServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgry_NotesPayableAndSecuredLoansMember" abstract="true" name="NotesPayableAndSecuredLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>sgry-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bf0c9919-675a-4090-9889-2da6d013d12b,g:8071f056-30bb-4692-9c60-1fa924dc9a77-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sgry-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ab21b38a-7dc0-4ede-acfd-e5bf7c82aaee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_df3b9b54-2dcb-4ae5-96e7-3bf77afca648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ab21b38a-7dc0-4ede-acfd-e5bf7c82aaee" xlink:to="loc_us-gaap_PreferredStockValue_df3b9b54-2dcb-4ae5-96e7-3bf77afca648" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_c0146401-a32f-41de-bd36-7aa78378fcb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ab21b38a-7dc0-4ede-acfd-e5bf7c82aaee" xlink:to="loc_us-gaap_CommonStockValueOutstanding_c0146401-a32f-41de-bd36-7aa78378fcb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_69cf30d5-b1f5-48e1-874f-320caddf8fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ab21b38a-7dc0-4ede-acfd-e5bf7c82aaee" xlink:to="loc_us-gaap_AdditionalPaidInCapital_69cf30d5-b1f5-48e1-874f-320caddf8fb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_09070ceb-4a9e-4494-a850-41dc372d6773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ab21b38a-7dc0-4ede-acfd-e5bf7c82aaee" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_09070ceb-4a9e-4494-a850-41dc372d6773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9bb09359-59d4-414a-a60a-8e1ad6a3d8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ab21b38a-7dc0-4ede-acfd-e5bf7c82aaee" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9bb09359-59d4-414a-a60a-8e1ad6a3d8c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cab064ec-0ec5-44cf-adbf-a4e9d279ff6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_83d8aedf-e814-4d55-a786-6e780cade866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cab064ec-0ec5-44cf-adbf-a4e9d279ff6a" xlink:to="loc_us-gaap_LiabilitiesCurrent_83d8aedf-e814-4d55-a786-6e780cade866" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e2f130b0-af59-446e-b587-6a24fd43c9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cab064ec-0ec5-44cf-adbf-a4e9d279ff6a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e2f130b0-af59-446e-b587-6a24fd43c9f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_09293aa6-8dd6-4388-99a2-d3b73d0bcfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cab064ec-0ec5-44cf-adbf-a4e9d279ff6a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_09293aa6-8dd6-4388-99a2-d3b73d0bcfc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fe933dd1-b7b6-4998-abd1-a0c2423944ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cab064ec-0ec5-44cf-adbf-a4e9d279ff6a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fe933dd1-b7b6-4998-abd1-a0c2423944ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e3a8a6f7-07d1-4da3-857f-13e404332015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cab064ec-0ec5-44cf-adbf-a4e9d279ff6a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e3a8a6f7-07d1-4da3-857f-13e404332015" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e8a80108-5b26-467b-b160-60bd176e76dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cab064ec-0ec5-44cf-adbf-a4e9d279ff6a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e8a80108-5b26-467b-b160-60bd176e76dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_47465c11-a96a-4bde-be7e-4834d16dfc7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d1c7b1e5-b72b-43b5-a61a-518035642969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_47465c11-a96a-4bde-be7e-4834d16dfc7e" xlink:to="loc_us-gaap_AssetsCurrent_d1c7b1e5-b72b-43b5-a61a-518035642969" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_87d29f64-707f-459f-9cad-8262720a5449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_47465c11-a96a-4bde-be7e-4834d16dfc7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_87d29f64-707f-459f-9cad-8262720a5449" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_58293252-5288-4c77-85ea-32aa138df629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_47465c11-a96a-4bde-be7e-4834d16dfc7e" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_58293252-5288-4c77-85ea-32aa138df629" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_cb731964-0c8d-4ad5-9d51-c054d5b5280d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_47465c11-a96a-4bde-be7e-4834d16dfc7e" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_cb731964-0c8d-4ad5-9d51-c054d5b5280d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a6ce7f13-e0a1-489d-a446-a2ad8acf821f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_47465c11-a96a-4bde-be7e-4834d16dfc7e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a6ce7f13-e0a1-489d-a446-a2ad8acf821f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_8ffa6906-3e86-4c62-89b1-f339fba82670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_47465c11-a96a-4bde-be7e-4834d16dfc7e" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_8ffa6906-3e86-4c62-89b1-f339fba82670" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_32b7c3e6-fc5e-418f-95e0-896d5c9ec810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_47465c11-a96a-4bde-be7e-4834d16dfc7e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_32b7c3e6-fc5e-418f-95e0-896d5c9ec810" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_984c5ef1-8c59-4038-8e8f-7be7c82a4dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_1279d650-746b-48ee-9b10-a8ae76a56b97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_984c5ef1-8c59-4038-8e8f-7be7c82a4dd0" xlink:to="loc_us-gaap_AccountsPayableCurrent_1279d650-746b-48ee-9b10-a8ae76a56b97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b9c7ba1d-42e2-4a4c-8466-6e9443a2392d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_984c5ef1-8c59-4038-8e8f-7be7c82a4dd0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b9c7ba1d-42e2-4a4c-8466-6e9443a2392d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_322e4da7-2be3-4f52-ae74-e3679e95adfd" xlink:href="sgry-20220630.xsd#sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_984c5ef1-8c59-4038-8e8f-7be7c82a4dd0" xlink:to="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_322e4da7-2be3-4f52-ae74-e3679e95adfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_dd40e9e7-917a-4dc7-bed3-9f26e61963c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_984c5ef1-8c59-4038-8e8f-7be7c82a4dd0" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_dd40e9e7-917a-4dc7-bed3-9f26e61963c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_b14363d3-8054-4cd7-993d-e6232d11498a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_984c5ef1-8c59-4038-8e8f-7be7c82a4dd0" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_b14363d3-8054-4cd7-993d-e6232d11498a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3e8609e8-97ad-41cd-8f15-2b097d1da42d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b3c26aab-9701-4614-abfb-6d466114c54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3e8609e8-97ad-41cd-8f15-2b097d1da42d" xlink:to="loc_us-gaap_StockholdersEquity_b3c26aab-9701-4614-abfb-6d466114c54f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d38bbe5a-214c-42ff-a1ce-0a777e6f316c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3e8609e8-97ad-41cd-8f15-2b097d1da42d" xlink:to="loc_us-gaap_MinorityInterest_d38bbe5a-214c-42ff-a1ce-0a777e6f316c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_96f9e379-d120-4987-93cb-56f4a0ee6c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5c4686eb-d8d2-495b-b8c4-bf3d54cba02f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_96f9e379-d120-4987-93cb-56f4a0ee6c0c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5c4686eb-d8d2-495b-b8c4-bf3d54cba02f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a4170a23-fec0-40b8-848f-d5693d933ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_96f9e379-d120-4987-93cb-56f4a0ee6c0c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a4170a23-fec0-40b8-848f-d5693d933ce3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5daef9dd-c622-4b4e-b56f-aaf955ff981e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_96f9e379-d120-4987-93cb-56f4a0ee6c0c" xlink:to="loc_us-gaap_InventoryNet_5daef9dd-c622-4b4e-b56f-aaf955ff981e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_94bb923a-12df-4c67-9e55-d83267a723ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_96f9e379-d120-4987-93cb-56f4a0ee6c0c" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_94bb923a-12df-4c67-9e55-d83267a723ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_bfa0ab17-71a3-44c9-82de-85530587ba07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_96f9e379-d120-4987-93cb-56f4a0ee6c0c" xlink:to="loc_us-gaap_OtherAssetsCurrent_bfa0ab17-71a3-44c9-82de-85530587ba07" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="sgry-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_c008afe3-8821-4baa-abe0-0806cfccb4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_5742c782-1460-4f1b-b005-09a81873b4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_c008afe3-8821-4baa-abe0-0806cfccb4a9" xlink:to="loc_us-gaap_LaborAndRelatedExpense_5742c782-1460-4f1b-b005-09a81873b4e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuppliesExpense_64a89895-9406-412e-9c1f-3d08522bf43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuppliesExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_c008afe3-8821-4baa-abe0-0806cfccb4a9" xlink:to="loc_us-gaap_SuppliesExpense_64a89895-9406-412e-9c1f-3d08522bf43b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_7a509dc6-f232-42a5-9208-a79afbd7749b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_c008afe3-8821-4baa-abe0-0806cfccb4a9" xlink:to="loc_us-gaap_ProfessionalFees_7a509dc6-f232-42a5-9208-a79afbd7749b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OperatingAndFinanceLeaseExpense_34b85e4a-620b-4703-ba5f-1fde0d7b1ea0" xlink:href="sgry-20220630.xsd#sgry_OperatingAndFinanceLeaseExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_c008afe3-8821-4baa-abe0-0806cfccb4a9" xlink:to="loc_sgry_OperatingAndFinanceLeaseExpense_34b85e4a-620b-4703-ba5f-1fde0d7b1ea0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_3c5fd4d8-3f67-470f-aad7-63504fe11432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_c008afe3-8821-4baa-abe0-0806cfccb4a9" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_3c5fd4d8-3f67-470f-aad7-63504fe11432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_33bdedd2-b23c-469c-a9ea-f17385ad4ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0051ac76-0b25-46ed-b787-57cf67e449e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_33bdedd2-b23c-469c-a9ea-f17385ad4ed6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_0051ac76-0b25-46ed-b787-57cf67e449e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ba902bba-90a4-44d1-b361-d54f34ad5d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_33bdedd2-b23c-469c-a9ea-f17385ad4ed6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ba902bba-90a4-44d1-b361-d54f34ad5d50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cd8babba-8daf-46d0-9914-187057ef7248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_556e6aa9-5aec-4c37-a677-04f72d1da385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_cd8babba-8daf-46d0-9914-187057ef7248" xlink:to="loc_us-gaap_ProfitLoss_556e6aa9-5aec-4c37-a677-04f72d1da385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6b851a00-a7d2-473b-9369-eb0e8c80243e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_cd8babba-8daf-46d0-9914-187057ef7248" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6b851a00-a7d2-473b-9369-eb0e8c80243e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_32013be2-e619-420e-bcd1-483d48384f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_d51870bd-5493-4a6d-be63-f080e10fed04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_32013be2-e619-420e-bcd1-483d48384f31" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_d51870bd-5493-4a6d-be63-f080e10fed04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_8d9f426f-88d3-4245-a835-a4bf8bc53d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_32013be2-e619-420e-bcd1-483d48384f31" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_8d9f426f-88d3-4245-a835-a4bf8bc53d07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a81b6402-97af-4659-9c4f-60a8873ffa6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_32013be2-e619-420e-bcd1-483d48384f31" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a81b6402-97af-4659-9c4f-60a8873ffa6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_b01d1492-953b-441c-818f-6f73fa664f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_32013be2-e619-420e-bcd1-483d48384f31" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_b01d1492-953b-441c-818f-6f73fa664f83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GrantRevenue_28459342-b221-4a94-aa46-84708b709388" xlink:href="sgry-20220630.xsd#sgry_GrantRevenue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_32013be2-e619-420e-bcd1-483d48384f31" xlink:to="loc_sgry_GrantRevenue_28459342-b221-4a94-aa46-84708b709388" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_f88c4082-b123-448b-af2f-71d294f7429e" xlink:href="sgry-20220630.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_32013be2-e619-420e-bcd1-483d48384f31" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_f88c4082-b123-448b-af2f-71d294f7429e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b5f38f54-f7de-40b1-9cf7-38e365a7f634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_32013be2-e619-420e-bcd1-483d48384f31" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b5f38f54-f7de-40b1-9cf7-38e365a7f634" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_f4d5ddaf-6547-46db-88d9-9d977de6d537" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_32013be2-e619-420e-bcd1-483d48384f31" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_f4d5ddaf-6547-46db-88d9-9d977de6d537" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_caf33dac-54df-4b14-875f-52d34da56d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_32013be2-e619-420e-bcd1-483d48384f31" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_caf33dac-54df-4b14-875f-52d34da56d8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_99b87608-911f-4ac0-b7c7-150d37869e78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_32013be2-e619-420e-bcd1-483d48384f31" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_99b87608-911f-4ac0-b7c7-150d37869e78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_8e147d7a-1781-4601-b449-d6f1593bda90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0b3b24a1-fdc2-4c71-94fd-7127b6b97d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_8e147d7a-1781-4601-b449-d6f1593bda90" xlink:to="loc_us-gaap_NetIncomeLoss_0b3b24a1-fdc2-4c71-94fd-7127b6b97d7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_0bd01fe6-45e3-402c-a413-28906fc52ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_8e147d7a-1781-4601-b449-d6f1593bda90" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_0bd01fe6-45e3-402c-a413-28906fc52ae8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6532895b-ea21-4583-9af4-ab7de608badf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_9164d292-e718-4539-a36c-531ca23d628a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6532895b-ea21-4583-9af4-ab7de608badf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_9164d292-e718-4539-a36c-531ca23d628a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c1407a89-945d-4a8f-9abb-c58fb43973e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6532895b-ea21-4583-9af4-ab7de608badf" xlink:to="loc_us-gaap_OperatingExpenses_c1407a89-945d-4a8f-9abb-c58fb43973e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_832afe68-7a03-4649-a727-b2fe4d804a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a1050276-7281-4773-b8a1-56b57c42c526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_832afe68-7a03-4649-a727-b2fe4d804a13" xlink:to="loc_us-gaap_OperatingIncomeLoss_a1050276-7281-4773-b8a1-56b57c42c526" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_79a1e8c6-df33-44c9-9201-f92d74076bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_832afe68-7a03-4649-a727-b2fe4d804a13" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_79a1e8c6-df33-44c9-9201-f92d74076bd4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="sgry-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_99a1ed12-0951-4540-9e1d-99dfbf5b22b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5e6ba89f-ec93-4db9-a163-5b09ce4be3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_99a1ed12-0951-4540-9e1d-99dfbf5b22b3" xlink:to="loc_us-gaap_ProfitLoss_5e6ba89f-ec93-4db9-a163-5b09ce4be3c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b273e47e-1bf8-4c9e-8429-66a6170433df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_99a1ed12-0951-4540-9e1d-99dfbf5b22b3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b273e47e-1bf8-4c9e-8429-66a6170433df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ce4f383-5e71-4e82-a4c3-d32c9eddd709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b2b59053-4d47-4040-bbd3-f0a8a822a214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ce4f383-5e71-4e82-a4c3-d32c9eddd709" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b2b59053-4d47-4040-bbd3-f0a8a822a214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_72bc47da-ae92-4a5c-8c88-4aa9bd3feef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ce4f383-5e71-4e82-a4c3-d32c9eddd709" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_72bc47da-ae92-4a5c-8c88-4aa9bd3feef5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sgry-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8b3f3aa7-b61c-4e6c-8b9c-ccd09135bb92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_us-gaap_ProfitLoss_8b3f3aa7-b61c-4e6c-8b9c-ccd09135bb92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_966e5c11-ea32-4681-a930-91fc2bc67b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_966e5c11-ea32-4681-a930-91fc2bc67b07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NoncashInterestIncomeExpenseNet_efff59ae-5fb8-43b4-ac61-c5b98e2fb704" xlink:href="sgry-20220630.xsd#sgry_NoncashInterestIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_sgry_NoncashInterestIncomeExpenseNet_efff59ae-5fb8-43b4-ac61-c5b98e2fb704" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3b847f65-4620-44ba-a558-6dc9b13cb855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_us-gaap_ShareBasedCompensation_3b847f65-4620-44ba-a558-6dc9b13cb855" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_2dfe2e5f-69ff-4a3b-8a90-41f09d206261" xlink:href="sgry-20220630.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_2dfe2e5f-69ff-4a3b-8a90-41f09d206261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a946f45a-79ac-4df3-b0c9-1ba06297a064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a946f45a-79ac-4df3-b0c9-1ba06297a064" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_07ef7cfa-b867-4593-880b-a61c89c113d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_07ef7cfa-b867-4593-880b-a61c89c113d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_ce9fb509-5bff-47b0-b097-d3bba6485f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_us-gaap_OperatingLeaseExpense_ce9fb509-5bff-47b0-b097-d3bba6485f91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ef094c26-c235-43ec-8a66-c5ccaddc49a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ef094c26-c235-43ec-8a66-c5ccaddc49a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_234adc13-261d-4ff1-a452-62bfa6b663ed" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_234adc13-261d-4ff1-a452-62bfa6b663ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_871dec6a-90ab-466b-8a7f-647591a399f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_871dec6a-90ab-466b-8a7f-647591a399f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_584adfe1-385a-49d2-b86c-8ab6eec7e832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_584adfe1-385a-49d2-b86c-8ab6eec7e832" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInSettlementPayments_e1767693-5547-42cd-b8fa-08b37a39c825" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInSettlementPayments"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a7cede8-a53c-4359-9180-f478f3d525bb" xlink:to="loc_sgry_IncreaseDecreaseInSettlementPayments_e1767693-5547-42cd-b8fa-08b37a39c825" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_6c995be8-2199-46fa-85d4-5b0630a279ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_6c995be8-2199-46fa-85d4-5b0630a279ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_cc3700cb-6eec-4778-9cad-506e6c8e7505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_cc3700cb-6eec-4778-9cad-506e6c8e7505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_babd3b53-5094-4261-a080-29c2c47fedea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_babd3b53-5094-4261-a080-29c2c47fedea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dbe9c3fc-1ed7-4ab7-b562-25399db12c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dbe9c3fc-1ed7-4ab7-b562-25399db12c04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2f10e3a0-5881-439b-8794-7c6d5aac7b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2f10e3a0-5881-439b-8794-7c6d5aac7b08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_6caaf8ab-1b5f-443a-a59d-0c4ded10d879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_6caaf8ab-1b5f-443a-a59d-0c4ded10d879" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_8a8f0a7e-fa49-4ded-b590-9d9464301a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:to="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_8a8f0a7e-fa49-4ded-b590-9d9464301a4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4f277841-fb2c-40db-97c7-7f25806b5219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4f277841-fb2c-40db-97c7-7f25806b5219" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_1c67cf9f-b0e1-40f5-90d6-4307f7c6a77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_1c67cf9f-b0e1-40f5-90d6-4307f7c6a77c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_b311f5cc-bf10-4114-a271-a82887425c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_b311f5cc-bf10-4114-a271-a82887425c8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentPrepaymentPenaltyAmount_8ee25be1-9d39-45e6-a631-d1b0ee7e8aba" xlink:href="sgry-20220630.xsd#sgry_DebtInstrumentPrepaymentPenaltyAmount"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4f44f64-ee1b-41b6-b113-2780606626b0" xlink:to="loc_sgry_DebtInstrumentPrepaymentPenaltyAmount_8ee25be1-9d39-45e6-a631-d1b0ee7e8aba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_77ab8a0d-89b0-4a2a-8638-b79fd59a3232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_11a57ad8-da5f-41c5-9361-593ebf350f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_77ab8a0d-89b0-4a2a-8638-b79fd59a3232" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_11a57ad8-da5f-41c5-9361-593ebf350f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bc430130-2b32-4d86-b175-72c012a6bbaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_77ab8a0d-89b0-4a2a-8638-b79fd59a3232" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bc430130-2b32-4d86-b175-72c012a6bbaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_e5b8ac6a-feaa-42c1-9f12-7ee8e0a21e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_77ab8a0d-89b0-4a2a-8638-b79fd59a3232" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_e5b8ac6a-feaa-42c1-9f12-7ee8e0a21e5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_41d3119e-27e6-4d3e-8ca6-27e5554202f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_77ab8a0d-89b0-4a2a-8638-b79fd59a3232" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_41d3119e-27e6-4d3e-8ca6-27e5554202f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_71260b13-851c-4824-8f6c-c1efb5b0b4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_77ab8a0d-89b0-4a2a-8638-b79fd59a3232" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_71260b13-851c-4824-8f6c-c1efb5b0b4af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_8a96e333-3ae9-484e-81ae-5a735b668865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_77ab8a0d-89b0-4a2a-8638-b79fd59a3232" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_8a96e333-3ae9-484e-81ae-5a735b668865" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_86467e22-d626-4332-813e-1896bb5c8c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dacd96a5-8d89-49a0-aca9-ce8fd329651c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_86467e22-d626-4332-813e-1896bb5c8c4f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dacd96a5-8d89-49a0-aca9-ce8fd329651c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5036ee1f-0f06-4d93-823e-52181acae641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_86467e22-d626-4332-813e-1896bb5c8c4f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5036ee1f-0f06-4d93-823e-52181acae641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7659c218-5878-40dd-b6bc-8f5135be61e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_86467e22-d626-4332-813e-1896bb5c8c4f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7659c218-5878-40dd-b6bc-8f5135be61e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#LongTermDebtSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_4eac2350-6f6b-47ac-9024-c26f10cdd5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_49efab6a-a155-478c-a9fa-51367502edb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_4eac2350-6f6b-47ac-9024-c26f10cdd5f8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_49efab6a-a155-478c-a9fa-51367502edb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_58cad94f-88e2-4348-9113-ca8e17316959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_4eac2350-6f6b-47ac-9024-c26f10cdd5f8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_58cad94f-88e2-4348-9113-ca8e17316959" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1" xlink:type="simple" xlink:href="sgry-20220630.xsd#LongTermDebtSummaryDetails_1"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_b333a6e8-7d4e-45d3-949f-9f963dcfd1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_452155db-897c-4355-b053-a99b35b9aa5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_b333a6e8-7d4e-45d3-949f-9f963dcfd1a0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_452155db-897c-4355-b053-a99b35b9aa5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b0bda6d5-f4f6-4c54-b255-705282c22da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_b333a6e8-7d4e-45d3-949f-9f963dcfd1a0" xlink:to="loc_us-gaap_FinanceLeaseLiability_b0bda6d5-f4f6-4c54-b255-705282c22da5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e9229930-1e8b-47ea-af3a-b0d3a96f2724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_b333a6e8-7d4e-45d3-949f-9f963dcfd1a0" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e9229930-1e8b-47ea-af3a-b0d3a96f2724" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sgry_LeaseLiability_b0c81405-da1f-4b81-a8f6-592fed19b419" xlink:href="sgry-20220630.xsd#sgry_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4032b3fc-167b-478c-8c09-fdb680501dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgry_LeaseLiability_b0c81405-da1f-4b81-a8f6-592fed19b419" xlink:to="loc_us-gaap_FinanceLeaseLiability_4032b3fc-167b-478c-8c09-fdb680501dfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ed988f6b-5503-4a35-b1ba-be69b775201e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgry_LeaseLiability_b0c81405-da1f-4b81-a8f6-592fed19b419" xlink:to="loc_us-gaap_OperatingLeaseLiability_ed988f6b-5503-4a35-b1ba-be69b775201e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_LeaseRightOfUseAsset_71717e9c-8c3a-499c-989d-c50ef16af39b" xlink:href="sgry-20220630.xsd#sgry_LeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_cd7f881d-b4a1-49ee-9b05-651431975341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgry_LeaseRightOfUseAsset_71717e9c-8c3a-499c-989d-c50ef16af39b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_cd7f881d-b4a1-49ee-9b05-651431975341" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_ef7664b1-c9c0-4e59-b7b3-a049042d3442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgry_LeaseRightOfUseAsset_71717e9c-8c3a-499c-989d-c50ef16af39b" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_ef7664b1-c9c0-4e59-b7b3-a049042d3442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a0450b14-c636-43b2-afaa-15ea27bd6a43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_72c135d9-e6ae-4506-b6a8-30f627421e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a0450b14-c636-43b2-afaa-15ea27bd6a43" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_72c135d9-e6ae-4506-b6a8-30f627421e14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3a2d40d5-c0c9-4c29-ac9f-41e6034d20df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a0450b14-c636-43b2-afaa-15ea27bd6a43" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3a2d40d5-c0c9-4c29-ac9f-41e6034d20df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_07c6dd11-a50f-4a9e-9908-4b39f0db84be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_0bf2d41b-3d09-4324-899e-945ec4bc0c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_07c6dd11-a50f-4a9e-9908-4b39f0db84be" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_0bf2d41b-3d09-4324-899e-945ec4bc0c0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_73ea0c2f-0334-4336-982d-5abb5e886cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_07c6dd11-a50f-4a9e-9908-4b39f0db84be" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_73ea0c2f-0334-4336-982d-5abb5e886cde" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#LeasesLeaseExpenseandCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost_81e18c54-7991-4b5d-8237-d7ac2d2e1137" xlink:href="sgry-20220630.xsd#sgry_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_ba0d7e3e-6f02-4638-9f2e-b303c4da06d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgry_FinanceLeaseCost_81e18c54-7991-4b5d-8237-d7ac2d2e1137" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_ba0d7e3e-6f02-4638-9f2e-b303c4da06d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_a32351e0-cc08-438e-addd-5d7afade40b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgry_FinanceLeaseCost_81e18c54-7991-4b5d-8237-d7ac2d2e1137" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_a32351e0-cc08-438e-addd-5d7afade40b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_39725ac0-34b6-41a5-a667-826e23e036b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_f23fbf99-f7a1-419e-acfb-db35b1deb10f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_39725ac0-34b6-41a5-a667-826e23e036b9" xlink:to="loc_us-gaap_OperatingLeaseCost_f23fbf99-f7a1-419e-acfb-db35b1deb10f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost_0970a39e-e957-4290-b229-8ae3b0a92996" xlink:href="sgry-20220630.xsd#sgry_FinanceLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_39725ac0-34b6-41a5-a667-826e23e036b9" xlink:to="loc_sgry_FinanceLeaseCost_0970a39e-e957-4290-b229-8ae3b0a92996" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableAndShortTermLeaseCost_73fc6144-810b-4689-9a32-c0370ece550e" xlink:href="sgry-20220630.xsd#sgry_VariableAndShortTermLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_39725ac0-34b6-41a5-a667-826e23e036b9" xlink:to="loc_sgry_VariableAndShortTermLeaseCost_73fc6144-810b-4689-9a32-c0370ece550e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OtherCurrentLiabilitiesSummaryDetails"/>
  <link:calculationLink xlink:role="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_881f1b70-1ed4-4b71-a505-13eaf3904395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f1141add-132e-40fd-924e-24dcdad5a42e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_881f1b70-1ed4-4b71-a505-13eaf3904395" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f1141add-132e-40fd-924e-24dcdad5a42e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_b16b20d6-5d37-47ee-8ac5-e6b9d532a3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_881f1b70-1ed4-4b71-a505-13eaf3904395" xlink:to="loc_us-gaap_InterestPayableCurrent_b16b20d6-5d37-47ee-8ac5-e6b9d532a3f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TaxReceivableAgreementLiabilityCurrent_cbe820db-16a0-4f3f-91c1-859745e76e3f" xlink:href="sgry-20220630.xsd#sgry_TaxReceivableAgreementLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_881f1b70-1ed4-4b71-a505-13eaf3904395" xlink:to="loc_sgry_TaxReceivableAgreementLiabilityCurrent_cbe820db-16a0-4f3f-91c1-859745e76e3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PayablesToCustomers_adffd2b0-b344-4d80-8f50-3876381ea695" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_PayablesToCustomers"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_881f1b70-1ed4-4b71-a505-13eaf3904395" xlink:to="loc_srt_PayablesToCustomers_adffd2b0-b344-4d80-8f50-3876381ea695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CostReportLiabilitiesCurrent_f24e42a1-6786-4d06-8997-58e755d6850e" xlink:href="sgry-20220630.xsd#sgry_CostReportLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_881f1b70-1ed4-4b71-a505-13eaf3904395" xlink:to="loc_sgry_CostReportLiabilitiesCurrent_f24e42a1-6786-4d06-8997-58e755d6850e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_be0cf238-b31d-4cda-a5d8-2cecc47c9edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_881f1b70-1ed4-4b71-a505-13eaf3904395" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_be0cf238-b31d-4cda-a5d8-2cecc47c9edf" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>sgry-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bf0c9919-675a-4090-9889-2da6d013d12b,g:8071f056-30bb-4692-9c60-1fa924dc9a77-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sgry-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i14729de81b3e445c93ecaa53f9349d72_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1d7be473-efaf-4e08-85df-54b7a7cb5b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d7be473-efaf-4e08-85df-54b7a7cb5b1c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5f22d306-af79-42ac-9a59-69859df09572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5f22d306-af79-42ac-9a59-69859df09572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_09cff53c-3f16-42d8-8627-fe5bd38fea1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_09cff53c-3f16-42d8-8627-fe5bd38fea1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_271ab156-aca0-4669-a221-21693084b619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_271ab156-aca0-4669-a221-21693084b619" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ad1fe98f-7488-41ef-9e79-206264dd9800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ad1fe98f-7488-41ef-9e79-206264dd9800" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0e607e0a-6c4e-40f4-afe9-1fb29fc2b24e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0e607e0a-6c4e-40f4-afe9-1fb29fc2b24e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_c483c729-40aa-4c9f-ac0e-1a26b741a198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_c483c729-40aa-4c9f-ac0e-1a26b741a198" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_34b80661-233c-41ac-867e-ad55ac3fcce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_34b80661-233c-41ac-867e-ad55ac3fcce1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fed6532a-21c6-4bb8-bf08-912da355948a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fed6532a-21c6-4bb8-bf08-912da355948a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3b60bbd1-e60e-40c3-b14b-721c83e3dba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3b60bbd1-e60e-40c3-b14b-721c83e3dba6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2e5ef320-fb45-45d6-a7d2-7a7b4489d79c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2e5ef320-fb45-45d6-a7d2-7a7b4489d79c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_00c080d6-5950-4a01-a05a-d3fc5f0f883a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_00c080d6-5950-4a01-a05a-d3fc5f0f883a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_bb1cd298-2ec5-457e-9dfc-f80fe12b3a3a" xlink:href="sgry-20220630.xsd#sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_bb1cd298-2ec5-457e-9dfc-f80fe12b3a3a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_a1990b6a-9f61-4c61-8204-c5aa614c3636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_a1990b6a-9f61-4c61-8204-c5aa614c3636" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5d28abaf-a9c6-41ff-8007-593e13bbad23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_939ff3f5-c0c7-46f3-bab6-202eb9471a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c0cd0809-fcb6-407e-af0f-cd3474dd0f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1d7be473-efaf-4e08-85df-54b7a7cb5b1c" xlink:to="loc_us-gaap_StatementTable_c0cd0809-fcb6-407e-af0f-cd3474dd0f83" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dab59b8e-fc72-4ddb-9ce0-6f0956ebfa19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c0cd0809-fcb6-407e-af0f-cd3474dd0f83" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dab59b8e-fc72-4ddb-9ce0-6f0956ebfa19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dab59b8e-fc72-4ddb-9ce0-6f0956ebfa19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dab59b8e-fc72-4ddb-9ce0-6f0956ebfa19" xlink:to="loc_us-gaap_EquityComponentDomain_dab59b8e-fc72-4ddb-9ce0-6f0956ebfa19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dab59b8e-fc72-4ddb-9ce0-6f0956ebfa19" xlink:to="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1d54c5ae-1c78-48c6-a320-16df19563c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:to="loc_us-gaap_CommonStockMember_1d54c5ae-1c78-48c6-a320-16df19563c8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_795ff030-5960-4af7-adb6-49177d71786c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_795ff030-5960-4af7-adb6-49177d71786c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4e2a53b7-affd-41ae-8a64-2cde32512a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4e2a53b7-affd-41ae-8a64-2cde32512a0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_874e910a-6f63-49b8-83d2-1bb4437d89c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:to="loc_us-gaap_RetainedEarningsMember_874e910a-6f63-49b8-83d2-1bb4437d89c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_3aea65ef-40b0-4e8d-8e31-5fe798780c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:to="loc_us-gaap_NoncontrollingInterestMember_3aea65ef-40b0-4e8d-8e31-5fe798780c6a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesOrganizationDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails" xlink:type="extended" id="i4fadd07b7517481f80b7bf11721745f5_OrganizationandSummaryofAccountingPoliciesOrganizationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwned_c3c53209-7bf6-47c1-95e5-babc99507098" xlink:href="sgry-20220630.xsd#sgry_NumberOfSurgicalFacilitiesOwned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwned_c3c53209-7bf6-47c1-95e5-babc99507098" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_4f62ca3d-cee6-4e59-b9f1-7532a7e932c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_4f62ca3d-cee6-4e59-b9f1-7532a7e932c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_6348039f-1912-4c24-a166-ee905b294d7f" xlink:href="sgry-20220630.xsd#sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_6348039f-1912-4c24-a166-ee905b294d7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_2fdc6faa-a17e-4850-a071-8bdee378cc6f" xlink:href="sgry-20220630.xsd#sgry_NumberOfSurgicalFacilitiesOwnedConsolidated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_2fdc6faa-a17e-4850-a071-8bdee378cc6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable_7a1a701d-8e62-4681-8165-5bad572daa80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsTable_7a1a701d-8e62-4681-8165-5bad572daa80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d006c4dc-e46d-48eb-8c6e-ec95a91ab234" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_7a1a701d-8e62-4681-8165-5bad572daa80" xlink:to="loc_srt_ProductOrServiceAxis_d006c4dc-e46d-48eb-8c6e-ec95a91ab234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d006c4dc-e46d-48eb-8c6e-ec95a91ab234_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d006c4dc-e46d-48eb-8c6e-ec95a91ab234" xlink:to="loc_srt_ProductsAndServicesDomain_d006c4dc-e46d-48eb-8c6e-ec95a91ab234_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_71e6cf82-63d3-4e48-8814-149cba3a9b22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d006c4dc-e46d-48eb-8c6e-ec95a91ab234" xlink:to="loc_srt_ProductsAndServicesDomain_71e6cf82-63d3-4e48-8814-149cba3a9b22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember_af5db90f-f4ea-4eaf-9777-0f24f813c318" xlink:href="sgry-20220630.xsd#sgry_FacilitiesAmbulatorySurgeryCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_71e6cf82-63d3-4e48-8814-149cba3a9b22" xlink:to="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember_af5db90f-f4ea-4eaf-9777-0f24f813c318" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesSurgicalHospitalsMember_3788c3a3-d5f1-46c4-a5e6-a005fc77a1fe" xlink:href="sgry-20220630.xsd#sgry_FacilitiesSurgicalHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_71e6cf82-63d3-4e48-8814-149cba3a9b22" xlink:to="loc_sgry_FacilitiesSurgicalHospitalsMember_3788c3a3-d5f1-46c4-a5e6-a005fc77a1fe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails" xlink:type="extended" id="ia57e48ecfdac4ba9bdf3f691c4df16d4_OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ab5da6d9-a6a3-4878-b006-f4f2172683c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0fdd96e0-da2d-4edc-a556-e63689bce8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ab5da6d9-a6a3-4878-b006-f4f2172683c4" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0fdd96e0-da2d-4edc-a556-e63689bce8ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_fba3bba8-5d47-427d-be55-7fc4de2e7562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ab5da6d9-a6a3-4878-b006-f4f2172683c4" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_fba3bba8-5d47-427d-be55-7fc4de2e7562" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_642649b2-6f5c-44cc-9890-9f9c4ffc85ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_fba3bba8-5d47-427d-be55-7fc4de2e7562" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_642649b2-6f5c-44cc-9890-9f9c4ffc85ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_642649b2-6f5c-44cc-9890-9f9c4ffc85ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_642649b2-6f5c-44cc-9890-9f9c4ffc85ad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_642649b2-6f5c-44cc-9890-9f9c4ffc85ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a920e700-e1c8-4e42-a15e-bb86542c1e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_642649b2-6f5c-44cc-9890-9f9c4ffc85ad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a920e700-e1c8-4e42-a15e-bb86542c1e9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_48ff841d-716e-405a-99eb-90cc5fa4cac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a920e700-e1c8-4e42-a15e-bb86542c1e9a" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_48ff841d-716e-405a-99eb-90cc5fa4cac7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3e85e01c-4bb1-4dd8-a8ef-a336bb57a784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_fba3bba8-5d47-427d-be55-7fc4de2e7562" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3e85e01c-4bb1-4dd8-a8ef-a336bb57a784" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3e85e01c-4bb1-4dd8-a8ef-a336bb57a784_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3e85e01c-4bb1-4dd8-a8ef-a336bb57a784" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3e85e01c-4bb1-4dd8-a8ef-a336bb57a784_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0844d5-4ef8-49a0-a4d4-db718e326a34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3e85e01c-4bb1-4dd8-a8ef-a336bb57a784" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0844d5-4ef8-49a0-a4d4-db718e326a34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_5746753a-32f1-449a-a1e7-b295c1af819d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0844d5-4ef8-49a0-a4d4-db718e326a34" xlink:to="loc_us-gaap_SalesRevenueNetMember_5746753a-32f1-449a-a1e7-b295c1af819d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_00378d8b-6a70-4cb9-9aee-e08724db50a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_fba3bba8-5d47-427d-be55-7fc4de2e7562" xlink:to="loc_srt_ProductOrServiceAxis_00378d8b-6a70-4cb9-9aee-e08724db50a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_00378d8b-6a70-4cb9-9aee-e08724db50a7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_00378d8b-6a70-4cb9-9aee-e08724db50a7" xlink:to="loc_srt_ProductsAndServicesDomain_00378d8b-6a70-4cb9-9aee-e08724db50a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6f62583f-ab15-466e-bae9-39e6b9f89a04" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_00378d8b-6a70-4cb9-9aee-e08724db50a7" xlink:to="loc_srt_ProductsAndServicesDomain_6f62583f-ab15-466e-bae9-39e6b9f89a04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_HealthcareOrganizationPatientServiceMember_309d9f1a-bd87-4a66-b611-25f548cc130f" xlink:href="sgry-20220630.xsd#sgry_HealthcareOrganizationPatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6f62583f-ab15-466e-bae9-39e6b9f89a04" xlink:to="loc_sgry_HealthcareOrganizationPatientServiceMember_309d9f1a-bd87-4a66-b611-25f548cc130f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_f7fab0ed-f4e6-4000-959e-56406e60c247" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_309d9f1a-bd87-4a66-b611-25f548cc130f" xlink:to="loc_sgry_SurgicalFacilityServicesMember_f7fab0ed-f4e6-4000-959e-56406e60c247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_0280a719-2e22-4ec7-9ae4-a74c430cb77c" xlink:href="sgry-20220630.xsd#sgry_AncillaryServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_309d9f1a-bd87-4a66-b611-25f548cc130f" xlink:to="loc_sgry_AncillaryServicesMember_0280a719-2e22-4ec7-9ae4-a74c430cb77c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherServicesMember_8e5b8d4d-386b-4427-b9e8-a126b67e59f4" xlink:href="sgry-20220630.xsd#sgry_OtherServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6f62583f-ab15-466e-bae9-39e6b9f89a04" xlink:to="loc_sgry_OtherServicesMember_8e5b8d4d-386b-4427-b9e8-a126b67e59f4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails" xlink:type="extended" id="i9cc356a1c2ad4660b3ba8f8cfae7a84d_OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c8b0f3bd-8fad-411c-b1a1-a1e86dc2353b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_6338ba49-07b9-4464-a118-1738480fb6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8b0f3bd-8fad-411c-b1a1-a1e86dc2353b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_6338ba49-07b9-4464-a118-1738480fb6e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_786429f3-1a02-4bdf-ba31-0018e875a633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8b0f3bd-8fad-411c-b1a1-a1e86dc2353b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_786429f3-1a02-4bdf-ba31-0018e875a633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_639f40f9-e67b-4c88-9c79-259dcca71ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8b0f3bd-8fad-411c-b1a1-a1e86dc2353b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_639f40f9-e67b-4c88-9c79-259dcca71ffb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_50d4093e-5294-48e9-a3ad-7f123fc51296" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_639f40f9-e67b-4c88-9c79-259dcca71ffb" xlink:to="loc_srt_ProductOrServiceAxis_50d4093e-5294-48e9-a3ad-7f123fc51296" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_50d4093e-5294-48e9-a3ad-7f123fc51296_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_50d4093e-5294-48e9-a3ad-7f123fc51296" xlink:to="loc_srt_ProductsAndServicesDomain_50d4093e-5294-48e9-a3ad-7f123fc51296_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5e62cd43-7097-4549-a56a-28dcf94a52db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_50d4093e-5294-48e9-a3ad-7f123fc51296" xlink:to="loc_srt_ProductsAndServicesDomain_5e62cd43-7097-4549-a56a-28dcf94a52db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:href="sgry-20220630.xsd#sgry_HealthcareOrganizationPatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5e62cd43-7097-4549-a56a-28dcf94a52db" xlink:to="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PrivateInsuranceMember_18415261-4312-4485-a1db-010ad82c8c5d" xlink:href="sgry-20220630.xsd#sgry_PrivateInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:to="loc_sgry_PrivateInsuranceMember_18415261-4312-4485-a1db-010ad82c8c5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractMember_96a13745-3364-4050-b1e0-c499be1059e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:to="loc_us-gaap_GovernmentContractMember_96a13745-3364-4050-b1e0-c499be1059e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SelfPayRevenueMember_146c4be4-6e58-4fc3-8843-34cf43ee360f" xlink:href="sgry-20220630.xsd#sgry_SelfPayRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:to="loc_sgry_SelfPayRevenueMember_146c4be4-6e58-4fc3-8843-34cf43ee360f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherPatientServiceRevenueSourcesMember_729c1170-9cd2-4e79-9bde-881a5b7ede83" xlink:href="sgry-20220630.xsd#sgry_OtherPatientServiceRevenueSourcesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:to="loc_sgry_OtherPatientServiceRevenueSourcesMember_729c1170-9cd2-4e79-9bde-881a5b7ede83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherServicesMember_12ef86b3-2981-463d-99b0-9ab4dcac5146" xlink:href="sgry-20220630.xsd#sgry_OtherServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5e62cd43-7097-4549-a56a-28dcf94a52db" xlink:to="loc_sgry_OtherServicesMember_12ef86b3-2981-463d-99b0-9ab4dcac5146" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ee47c843-9422-4512-9cc4-5523661d5f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_639f40f9-e67b-4c88-9c79-259dcca71ffb" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ee47c843-9422-4512-9cc4-5523661d5f34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ee47c843-9422-4512-9cc4-5523661d5f34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ee47c843-9422-4512-9cc4-5523661d5f34" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ee47c843-9422-4512-9cc4-5523661d5f34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f890fe47-d118-4ec6-bd8a-ea8fac3d652b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ee47c843-9422-4512-9cc4-5523661d5f34" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f890fe47-d118-4ec6-bd8a-ea8fac3d652b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_497accc2-1354-42cd-9219-1fa40321b5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f890fe47-d118-4ec6-bd8a-ea8fac3d652b" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_497accc2-1354-42cd-9219-1fa40321b5d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d077ebdb-2c68-4c12-9e95-d0ad499a0e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_639f40f9-e67b-4c88-9c79-259dcca71ffb" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d077ebdb-2c68-4c12-9e95-d0ad499a0e13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d077ebdb-2c68-4c12-9e95-d0ad499a0e13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d077ebdb-2c68-4c12-9e95-d0ad499a0e13" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d077ebdb-2c68-4c12-9e95-d0ad499a0e13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9007dd83-966c-4da6-9c58-83d0bcdb36f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d077ebdb-2c68-4c12-9e95-d0ad499a0e13" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9007dd83-966c-4da6-9c58-83d0bcdb36f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_8d33aa33-3f75-4f13-a05b-6c5159681832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9007dd83-966c-4da6-9c58-83d0bcdb36f6" xlink:to="loc_us-gaap_SalesRevenueNetMember_8d33aa33-3f75-4f13-a05b-6c5159681832" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails" xlink:type="extended" id="i3ead17e46f79480b94726d0006a2ed44_OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1da354e3-4e05-4d15-8b9c-70e4341d8a81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d71f22b7-241c-439d-9f30-01a6844320ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1da354e3-4e05-4d15-8b9c-70e4341d8a81" xlink:to="loc_us-gaap_LongTermDebt_d71f22b7-241c-439d-9f30-01a6844320ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8d87d7c4-c931-46f5-8fe9-112228d568bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1da354e3-4e05-4d15-8b9c-70e4341d8a81" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8d87d7c4-c931-46f5-8fe9-112228d568bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1da354e3-4e05-4d15-8b9c-70e4341d8a81" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_043fa411-2e0a-4631-b518-34e67c264cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_043fa411-2e0a-4631-b518-34e67c264cf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_043fa411-2e0a-4631-b518-34e67c264cf5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_043fa411-2e0a-4631-b518-34e67c264cf5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_043fa411-2e0a-4631-b518-34e67c264cf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c109e500-b087-4de0-8ea5-5cf095a724bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_043fa411-2e0a-4631-b518-34e67c264cf5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c109e500-b087-4de0-8ea5-5cf095a724bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_3d37583f-f28c-4c23-9f60-9679e5b3749d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c109e500-b087-4de0-8ea5-5cf095a724bc" xlink:to="loc_us-gaap_SecuredDebtMember_3d37583f-f28c-4c23-9f60-9679e5b3749d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d195fb87-71a8-4e2e-b315-a3cc01677acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c109e500-b087-4de0-8ea5-5cf095a724bc" xlink:to="loc_us-gaap_SeniorNotesMember_d195fb87-71a8-4e2e-b315-a3cc01677acc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_129eaac4-08fd-482e-a8f4-92a19a257c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:to="loc_us-gaap_DebtInstrumentAxis_129eaac4-08fd-482e-a8f4-92a19a257c84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_129eaac4-08fd-482e-a8f4-92a19a257c84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_129eaac4-08fd-482e-a8f4-92a19a257c84" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_129eaac4-08fd-482e-a8f4-92a19a257c84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b1ec48de-92cf-4a9b-a948-2ab7fb3d6801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_129eaac4-08fd-482e-a8f4-92a19a257c84" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b1ec48de-92cf-4a9b-a948-2ab7fb3d6801" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017TermLoanMaturing2024Member_00275203-9ad7-4849-8f8e-1b103e3d958a" xlink:href="sgry-20220630.xsd#sgry_A2017TermLoanMaturing2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ec48de-92cf-4a9b-a948-2ab7fb3d6801" xlink:to="loc_sgry_A2017TermLoanMaturing2024Member_00275203-9ad7-4849-8f8e-1b103e3d958a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member_2ed32e78-7125-40e7-8b35-f6e38d1c95e1" xlink:href="sgry-20220630.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ec48de-92cf-4a9b-a948-2ab7fb3d6801" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2025Member_2ed32e78-7125-40e7-8b35-f6e38d1c95e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2027Member_7a3cc211-7b63-445c-9dc7-e2cea403a04f" xlink:href="sgry-20220630.xsd#sgry_SeniorUnsecuredNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ec48de-92cf-4a9b-a948-2ab7fb3d6801" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2027Member_7a3cc211-7b63-445c-9dc7-e2cea403a04f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_7008a28a-7d25-46cc-9706-870fab7c0884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_7008a28a-7d25-46cc-9706-870fab7c0884" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7008a28a-7d25-46cc-9706-870fab7c0884_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_7008a28a-7d25-46cc-9706-870fab7c0884" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7008a28a-7d25-46cc-9706-870fab7c0884_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5eab982f-c569-4f76-af10-01f7395a22ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_7008a28a-7d25-46cc-9706-870fab7c0884" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5eab982f-c569-4f76-af10-01f7395a22ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_26ba1b47-26e3-4bd4-a081-6a224dba991e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5eab982f-c569-4f76-af10-01f7395a22ab" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_26ba1b47-26e3-4bd4-a081-6a224dba991e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a3893808-4008-4946-ac10-8011ecb17cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_26ba1b47-26e3-4bd4-a081-6a224dba991e" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a3893808-4008-4946-ac10-8011ecb17cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c95af4d8-4d8b-499d-bea0-7233e4e307c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_26ba1b47-26e3-4bd4-a081-6a224dba991e" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c95af4d8-4d8b-499d-bea0-7233e4e307c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a3ce63d-3a59-49c8-ade6-142807c5043b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a3ce63d-3a59-49c8-ade6-142807c5043b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a3ce63d-3a59-49c8-ade6-142807c5043b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a3ce63d-3a59-49c8-ade6-142807c5043b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4a3ce63d-3a59-49c8-ade6-142807c5043b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1605a9bb-a48f-4955-b8ea-65f0a28359e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a3ce63d-3a59-49c8-ade6-142807c5043b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1605a9bb-a48f-4955-b8ea-65f0a28359e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ae5051ea-de46-49d7-b335-b112eb34cf99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1605a9bb-a48f-4955-b8ea-65f0a28359e1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ae5051ea-de46-49d7-b335-b112eb34cf99" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="extended" id="i10023fca3e5c4cdaa0f09d5e36c34af2_OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_90f3f8da-d4fd-40c4-9735-d005868dec11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableInterestEntityNumberOfFacilities_1dc7a46c-06ef-4eee-b751-9e149bddaf76" xlink:href="sgry-20220630.xsd#sgry_VariableInterestEntityNumberOfFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_90f3f8da-d4fd-40c4-9735-d005868dec11" xlink:to="loc_sgry_VariableInterestEntityNumberOfFacilities_1dc7a46c-06ef-4eee-b751-9e149bddaf76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_153a54b6-0721-4523-91d2-897776826a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_90f3f8da-d4fd-40c4-9735-d005868dec11" xlink:to="loc_us-gaap_Assets_153a54b6-0721-4523-91d2-897776826a39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2297227b-63c8-45c8-a30e-08d310cb045d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_90f3f8da-d4fd-40c4-9735-d005868dec11" xlink:to="loc_us-gaap_Liabilities_2297227b-63c8-45c8-a30e-08d310cb045d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9f10526d-5a26-4173-94c0-946f68a4c045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_90f3f8da-d4fd-40c4-9735-d005868dec11" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9f10526d-5a26-4173-94c0-946f68a4c045" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5caad319-5217-4379-91e4-8febb915aa3f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9f10526d-5a26-4173-94c0-946f68a4c045" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5caad319-5217-4379-91e4-8febb915aa3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5caad319-5217-4379-91e4-8febb915aa3f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5caad319-5217-4379-91e4-8febb915aa3f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5caad319-5217-4379-91e4-8febb915aa3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_53aafd9c-ccaa-4e7b-8edc-79b6711c4df3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5caad319-5217-4379-91e4-8febb915aa3f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_53aafd9c-ccaa-4e7b-8edc-79b6711c4df3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_7e9346f4-6903-48d9-b3fc-4ebee6886426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_53aafd9c-ccaa-4e7b-8edc-79b6711c4df3" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_7e9346f4-6903-48d9-b3fc-4ebee6886426" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#AcquisitionsandDisposalsAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails" xlink:type="extended" id="i48dc858f7c624cd9b531d40ec422a443_AcquisitionsandDisposalsAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_34d85efd-47be-4b4f-872f-b1036101b234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_34d85efd-47be-4b4f-872f-b1036101b234" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f623a2df-7184-4517-b427-7503f8347f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f623a2df-7184-4517-b427-7503f8347f8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_88557461-92e8-46ba-ad79-b89ba0e40d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_88557461-92e8-46ba-ad79-b89ba0e40d50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_8c003544-eed5-46e0-9dfd-ff20e11c8019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_8c003544-eed5-46e0-9dfd-ff20e11c8019" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_19d2e3e6-b295-465c-ae3c-2bf24c445b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:to="loc_us-gaap_Goodwill_19d2e3e6-b295-465c-ae3c-2bf24c445b75" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b4ec394c-4d6a-4b80-ad20-036c4750b6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b4ec394c-4d6a-4b80-ad20-036c4750b6b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6413b4e9-ff2b-4ecf-9772-8524b6c0cc05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b4ec394c-4d6a-4b80-ad20-036c4750b6b5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6413b4e9-ff2b-4ecf-9772-8524b6c0cc05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6413b4e9-ff2b-4ecf-9772-8524b6c0cc05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6413b4e9-ff2b-4ecf-9772-8524b6c0cc05" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6413b4e9-ff2b-4ecf-9772-8524b6c0cc05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9abd9c73-55a9-4613-a421-7ba051629b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6413b4e9-ff2b-4ecf-9772-8524b6c0cc05" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9abd9c73-55a9-4613-a421-7ba051629b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesMember_6dbc34dc-3146-4fb2-ab68-da8e6c8c696f" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9abd9c73-55a9-4613-a421-7ba051629b02" xlink:to="loc_sgry_SurgicalFacilitiesMember_6dbc34dc-3146-4fb2-ab68-da8e6c8c696f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesExistingMarketsMember_25b22ed8-18e1-4184-b05c-eb3657e7a99f" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilitiesExistingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgry_SurgicalFacilitiesMember_6dbc34dc-3146-4fb2-ab68-da8e6c8c696f" xlink:to="loc_sgry_SurgicalFacilitiesExistingMarketsMember_25b22ed8-18e1-4184-b05c-eb3657e7a99f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#AcquisitionsandDisposalsOtherAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails" xlink:type="extended" id="i21097b5a48e74eeabd1a2ca2f0651893_AcquisitionsandDisposalsOtherAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8ecbd48d-96f2-4426-af9e-cd9c1512b785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired_cfc2c4b7-691a-49e1-b41f-6ad4eebed6c2" xlink:href="sgry-20220630.xsd#sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8ecbd48d-96f2-4426-af9e-cd9c1512b785" xlink:to="loc_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired_cfc2c4b7-691a-49e1-b41f-6ad4eebed6c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired_c2cc5379-1a30-4ac8-aa5b-cbeb4c1d214b" xlink:href="sgry-20220630.xsd#sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8ecbd48d-96f2-4426-af9e-cd9c1512b785" xlink:to="loc_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired_c2cc5379-1a30-4ac8-aa5b-cbeb4c1d214b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_f5a98a29-99aa-4375-9b00-69b60374781d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8ecbd48d-96f2-4426-af9e-cd9c1512b785" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_f5a98a29-99aa-4375-9b00-69b60374781d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8b8e632e-15b2-430e-b716-1947251cdea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8ecbd48d-96f2-4426-af9e-cd9c1512b785" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8b8e632e-15b2-430e-b716-1947251cdea0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_126a31a3-ba4b-4db3-832a-17f9b3d746ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8b8e632e-15b2-430e-b716-1947251cdea0" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_126a31a3-ba4b-4db3-832a-17f9b3d746ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_126a31a3-ba4b-4db3-832a-17f9b3d746ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_126a31a3-ba4b-4db3-832a-17f9b3d746ce" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_126a31a3-ba4b-4db3-832a-17f9b3d746ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_46c1d128-4bb6-41af-a687-ce53fd2af133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_126a31a3-ba4b-4db3-832a-17f9b3d746ce" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_46c1d128-4bb6-41af-a687-ce53fd2af133" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember_70829703-6916-40c7-9cf5-ad539578cfd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_46c1d128-4bb6-41af-a687-ce53fd2af133" xlink:to="loc_us-gaap_EquityMethodInvestmentsMember_70829703-6916-40c7-9cf5-ad539578cfd1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails" xlink:type="extended" id="ib507d28854444c13bf4802d10de8a1b6_AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_6082b790-650d-4194-824e-459640ad7979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_6082b790-650d-4194-824e-459640ad7979" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_8ed01ea8-442e-4798-b219-f370d4febf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_8ed01ea8-442e-4798-b219-f370d4febf1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration_80608609-245b-49a8-9139-e69eb3286574" xlink:href="sgry-20220630.xsd#sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:to="loc_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration_80608609-245b-49a8-9139-e69eb3286574" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_e35c9173-e618-42f6-9187-b3cf09d67179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_e35c9173-e618-42f6-9187-b3cf09d67179" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_24bbe046-f77e-4e87-bbf1-47655a2267d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_24bbe046-f77e-4e87-bbf1-47655a2267d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6030127d-bebf-4bc0-94c6-80bf634d5726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6030127d-bebf-4bc0-94c6-80bf634d5726" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_df55f4bd-2fd2-4e79-8859-5e365c3131b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6030127d-bebf-4bc0-94c6-80bf634d5726" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_df55f4bd-2fd2-4e79-8859-5e365c3131b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_df55f4bd-2fd2-4e79-8859-5e365c3131b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_df55f4bd-2fd2-4e79-8859-5e365c3131b9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_df55f4bd-2fd2-4e79-8859-5e365c3131b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_73a7a309-fc44-435c-9ddd-c56c2e6a1417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_df55f4bd-2fd2-4e79-8859-5e365c3131b9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_73a7a309-fc44-435c-9ddd-c56c2e6a1417" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DisposalGroupOneMember_803e889a-7ac1-4453-bb52-59a953e8e2a0" xlink:href="sgry-20220630.xsd#sgry_DisposalGroupOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_73a7a309-fc44-435c-9ddd-c56c2e6a1417" xlink:to="loc_sgry_DisposalGroupOneMember_803e889a-7ac1-4453-bb52-59a953e8e2a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DisposalGroupTwoMember_224c638d-4eff-484c-95e9-a665c1beca91" xlink:href="sgry-20220630.xsd#sgry_DisposalGroupTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_73a7a309-fc44-435c-9ddd-c56c2e6a1417" xlink:to="loc_sgry_DisposalGroupTwoMember_224c638d-4eff-484c-95e9-a665c1beca91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_f78254c2-1cd9-4451-b253-39f7e185f618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6030127d-bebf-4bc0-94c6-80bf634d5726" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_f78254c2-1cd9-4451-b253-39f7e185f618" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_f78254c2-1cd9-4451-b253-39f7e185f618_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f78254c2-1cd9-4451-b253-39f7e185f618" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_f78254c2-1cd9-4451-b253-39f7e185f618_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3e5010f1-c2e9-4102-acba-dcc6854c6a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f78254c2-1cd9-4451-b253-39f7e185f618" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3e5010f1-c2e9-4102-acba-dcc6854c6a70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_d5374c23-1e9a-46c8-9a27-4fa1fe30f5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3e5010f1-c2e9-4102-acba-dcc6854c6a70" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_d5374c23-1e9a-46c8-9a27-4fa1fe30f5e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f83fd5cd-568d-4148-a525-58e356a9c401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6030127d-bebf-4bc0-94c6-80bf634d5726" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f83fd5cd-568d-4148-a525-58e356a9c401" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f83fd5cd-568d-4148-a525-58e356a9c401_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f83fd5cd-568d-4148-a525-58e356a9c401" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f83fd5cd-568d-4148-a525-58e356a9c401_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97943e10-8fbd-4077-bd02-f98e5eff2964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f83fd5cd-568d-4148-a525-58e356a9c401" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97943e10-8fbd-4077-bd02-f98e5eff2964" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_fa064c32-5c53-4b3d-b254-e188ef9960df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97943e10-8fbd-4077-bd02-f98e5eff2964" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_fa064c32-5c53-4b3d-b254-e188ef9960df" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#LongTermDebtSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="extended" id="i55a6b33f6cf8491ab76b21b56c3bd12c_LongTermDebtSummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a61fe4d9-301a-4cca-879b-e424cb89b2a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a61fe4d9-301a-4cca-879b-e424cb89b2a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_ac87cb2e-36d1-4c97-b630-5d767d964578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_FinanceLeaseLiability_ac87cb2e-36d1-4c97-b630-5d767d964578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c34b67f5-25c2-4188-8c99-ce285a651f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c34b67f5-25c2-4188-8c99-ce285a651f06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_c27304f0-a4cf-425a-af9d-e488a76cd9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_c27304f0-a4cf-425a-af9d-e488a76cd9a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d8059adc-9e2c-4b78-a14e-d5043438af5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d8059adc-9e2c-4b78-a14e-d5043438af5f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_172e570e-aa3d-44da-a175-3dd521472932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_172e570e-aa3d-44da-a175-3dd521472932" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cdfa63c5-08ef-4240-870b-7ddbed3cc096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cdfa63c5-08ef-4240-870b-7ddbed3cc096" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_8c3aad51-5c03-4b77-8db5-2640eb9bac90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_8c3aad51-5c03-4b77-8db5-2640eb9bac90" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_28a99ac9-ec0a-4b91-8b4c-1fbe5e83b199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_DebtInstrumentTable_28a99ac9-ec0a-4b91-8b4c-1fbe5e83b199" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9f018cf6-69d6-4caa-95cb-f27c7445702a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_28a99ac9-ec0a-4b91-8b4c-1fbe5e83b199" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9f018cf6-69d6-4caa-95cb-f27c7445702a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9f018cf6-69d6-4caa-95cb-f27c7445702a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9f018cf6-69d6-4caa-95cb-f27c7445702a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9f018cf6-69d6-4caa-95cb-f27c7445702a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c2706ffe-4635-4535-b049-d36f7e0e4033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9f018cf6-69d6-4caa-95cb-f27c7445702a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c2706ffe-4635-4535-b049-d36f7e0e4033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4d5882e4-a599-4dd7-8c79-57e102489cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2706ffe-4635-4535-b049-d36f7e0e4033" xlink:to="loc_us-gaap_SecuredDebtMember_4d5882e4-a599-4dd7-8c79-57e102489cf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1fff0faa-084c-481d-9516-2dd084c366b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2706ffe-4635-4535-b049-d36f7e0e4033" xlink:to="loc_us-gaap_SeniorNotesMember_1fff0faa-084c-481d-9516-2dd084c366b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotesPayableAndSecuredLoansMember_c4e3447f-c2ea-4b22-8b27-c7c264d1e1c0" xlink:href="sgry-20220630.xsd#sgry_NotesPayableAndSecuredLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2706ffe-4635-4535-b049-d36f7e0e4033" xlink:to="loc_sgry_NotesPayableAndSecuredLoansMember_c4e3447f-c2ea-4b22-8b27-c7c264d1e1c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_129c263a-346b-45c2-a5a2-c659e46e2baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_28a99ac9-ec0a-4b91-8b4c-1fbe5e83b199" xlink:to="loc_us-gaap_DebtInstrumentAxis_129c263a-346b-45c2-a5a2-c659e46e2baa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_129c263a-346b-45c2-a5a2-c659e46e2baa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_129c263a-346b-45c2-a5a2-c659e46e2baa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_129c263a-346b-45c2-a5a2-c659e46e2baa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b013c558-0c51-45c8-9e18-b80eef094563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_129c263a-346b-45c2-a5a2-c659e46e2baa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b013c558-0c51-45c8-9e18-b80eef094563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017TermLoanMaturing2024Member_45ed4213-0b44-4eb3-abf8-f36bb6cdfa85" xlink:href="sgry-20220630.xsd#sgry_A2017TermLoanMaturing2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b013c558-0c51-45c8-9e18-b80eef094563" xlink:to="loc_sgry_A2017TermLoanMaturing2024Member_45ed4213-0b44-4eb3-abf8-f36bb6cdfa85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member_5ec7f5b0-442f-4b7e-830a-971f4de131c6" xlink:href="sgry-20220630.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b013c558-0c51-45c8-9e18-b80eef094563" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2025Member_5ec7f5b0-442f-4b7e-830a-971f4de131c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2027Member_588196b2-1189-4913-bd93-fdeffd1994c9" xlink:href="sgry-20220630.xsd#sgry_SeniorUnsecuredNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b013c558-0c51-45c8-9e18-b80eef094563" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2027Member_588196b2-1189-4913-bd93-fdeffd1994c9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="i14fe665effaa4afea8170bf392b0953b_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e30cb7c3-f03e-49ec-b6f2-6c58056c67e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_247cd034-84b3-4e81-ad61-03b658cd4aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e30cb7c3-f03e-49ec-b6f2-6c58056c67e3" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_247cd034-84b3-4e81-ad61-03b658cd4aae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_7d6e9507-c7cd-461d-98ba-192d63b4f4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e30cb7c3-f03e-49ec-b6f2-6c58056c67e3" xlink:to="loc_us-gaap_LineOfCredit_7d6e9507-c7cd-461d-98ba-192d63b4f4b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d47d26ce-df63-406f-86ca-6822d9827b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e30cb7c3-f03e-49ec-b6f2-6c58056c67e3" xlink:to="loc_us-gaap_DebtInstrumentTable_d47d26ce-df63-406f-86ca-6822d9827b2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c8b248d1-00d0-4e46-9423-b1d990f22934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d47d26ce-df63-406f-86ca-6822d9827b2b" xlink:to="loc_us-gaap_CreditFacilityAxis_c8b248d1-00d0-4e46-9423-b1d990f22934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c8b248d1-00d0-4e46-9423-b1d990f22934_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c8b248d1-00d0-4e46-9423-b1d990f22934" xlink:to="loc_us-gaap_CreditFacilityDomain_c8b248d1-00d0-4e46-9423-b1d990f22934_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8e90c8f8-6d2e-46e8-82b7-a3f56fd92cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c8b248d1-00d0-4e46-9423-b1d990f22934" xlink:to="loc_us-gaap_CreditFacilityDomain_8e90c8f8-6d2e-46e8-82b7-a3f56fd92cc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7a416432-505a-4227-88b8-b027a79a7858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_8e90c8f8-6d2e-46e8-82b7-a3f56fd92cc6" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7a416432-505a-4227-88b8-b027a79a7858" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_53a3da95-980e-4450-8f1a-d031235734c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_8e90c8f8-6d2e-46e8-82b7-a3f56fd92cc6" xlink:to="loc_us-gaap_LetterOfCreditMember_53a3da95-980e-4450-8f1a-d031235734c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_03fb5122-f691-43d0-ad90-5bbe921a2c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d47d26ce-df63-406f-86ca-6822d9827b2b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_03fb5122-f691-43d0-ad90-5bbe921a2c5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_03fb5122-f691-43d0-ad90-5bbe921a2c5f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03fb5122-f691-43d0-ad90-5bbe921a2c5f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_03fb5122-f691-43d0-ad90-5bbe921a2c5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d4aa49d7-1fad-41ad-b3b6-c8ef65d54d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03fb5122-f691-43d0-ad90-5bbe921a2c5f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d4aa49d7-1fad-41ad-b3b6-c8ef65d54d74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_aba872ae-3bd7-493d-90ab-30030acef78b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d4aa49d7-1fad-41ad-b3b6-c8ef65d54d74" xlink:to="loc_us-gaap_SecuredDebtMember_aba872ae-3bd7-493d-90ab-30030acef78b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b26229b0-825c-4edb-8e1d-996456ed2ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d47d26ce-df63-406f-86ca-6822d9827b2b" xlink:to="loc_us-gaap_DebtInstrumentAxis_b26229b0-825c-4edb-8e1d-996456ed2ba4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b26229b0-825c-4edb-8e1d-996456ed2ba4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b26229b0-825c-4edb-8e1d-996456ed2ba4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b26229b0-825c-4edb-8e1d-996456ed2ba4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d904ee56-e7aa-4303-8165-85465b26aae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b26229b0-825c-4edb-8e1d-996456ed2ba4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d904ee56-e7aa-4303-8165-85465b26aae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017SeniorSecuredCreditFacilityMember_b5f9bd7c-ef16-4c64-8b1b-2c722d251344" xlink:href="sgry-20220630.xsd#sgry_A2017SeniorSecuredCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d904ee56-e7aa-4303-8165-85465b26aae5" xlink:to="loc_sgry_A2017SeniorSecuredCreditFacilityMember_b5f9bd7c-ef16-4c64-8b1b-2c722d251344" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#DerivativesandHedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails" xlink:type="extended" id="i4ad2a8ad81334cbba1a1731f619b8f71_DerivativesandHedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a0f45993-1e6d-4f91-849a-438274fc9c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a0f45993-1e6d-4f91-849a-438274fc9c35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_56078ae7-a4d3-474f-b433-62a83fc015c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_56078ae7-a4d3-474f-b433-62a83fc015c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9cdedf2d-dad3-472a-a6a9-727d82d809db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9cdedf2d-dad3-472a-a6a9-727d82d809db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_5bd2b5fb-1b7c-45dd-9148-41fafa4aa69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_5bd2b5fb-1b7c-45dd-9148-41fafa4aa69b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_71cfc553-0e80-4bd7-b0dc-16f48eea924d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_71cfc553-0e80-4bd7-b0dc-16f48eea924d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_71cfc553-0e80-4bd7-b0dc-16f48eea924d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_71cfc553-0e80-4bd7-b0dc-16f48eea924d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_71cfc553-0e80-4bd7-b0dc-16f48eea924d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_71cfc553-0e80-4bd7-b0dc-16f48eea924d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ecd6eb7c-3617-4398-a69a-0874eacc7e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:to="loc_us-gaap_InterestRateSwapMember_ecd6eb7c-3617-4398-a69a-0874eacc7e99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c5ac2ad4-3c59-4280-907d-61f19271d2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:to="loc_us-gaap_InterestRateCapMember_c5ac2ad4-3c59-4280-907d-61f19271d2b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreePayFixedInterestRateSwapsMember_1e8db266-5fb1-49d8-8f5b-9646915388b9" xlink:href="sgry-20220630.xsd#sgry_ThreePayFixedInterestRateSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:to="loc_sgry_ThreePayFixedInterestRateSwapsMember_1e8db266-5fb1-49d8-8f5b-9646915388b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember_de02a757-205f-4484-bd3a-e19ee8ebcd42" xlink:href="sgry-20220630.xsd#sgry_ThreeReceiveFixedInterestRateSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:to="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember_de02a757-205f-4484-bd3a-e19ee8ebcd42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_28a6edf7-80fe-4188-86c2-68ebf1c56367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:to="loc_us-gaap_HedgingDesignationAxis_28a6edf7-80fe-4188-86c2-68ebf1c56367" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_28a6edf7-80fe-4188-86c2-68ebf1c56367_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_28a6edf7-80fe-4188-86c2-68ebf1c56367" xlink:to="loc_us-gaap_HedgingDesignationDomain_28a6edf7-80fe-4188-86c2-68ebf1c56367_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0449048a-d952-47ea-a65d-3f7f33a61995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_28a6edf7-80fe-4188-86c2-68ebf1c56367" xlink:to="loc_us-gaap_HedgingDesignationDomain_0449048a-d952-47ea-a65d-3f7f33a61995" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a6092f33-b957-46b4-8812-04cdb08ce86b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0449048a-d952-47ea-a65d-3f7f33a61995" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a6092f33-b957-46b4-8812-04cdb08ce86b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_dd8676e4-8fa9-43b0-afa2-b20b3783b090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0449048a-d952-47ea-a65d-3f7f33a61995" xlink:to="loc_us-gaap_NondesignatedMember_dd8676e4-8fa9-43b0-afa2-b20b3783b090" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f62117c6-82f6-4f9a-b83a-f94cf25ec3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:to="loc_us-gaap_VariableRateAxis_f62117c6-82f6-4f9a-b83a-f94cf25ec3b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f62117c6-82f6-4f9a-b83a-f94cf25ec3b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f62117c6-82f6-4f9a-b83a-f94cf25ec3b5" xlink:to="loc_us-gaap_VariableRateDomain_f62117c6-82f6-4f9a-b83a-f94cf25ec3b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2e587e5f-1046-4e7d-8e96-35c6573e2be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f62117c6-82f6-4f9a-b83a-f94cf25ec3b5" xlink:to="loc_us-gaap_VariableRateDomain_2e587e5f-1046-4e7d-8e96-35c6573e2be0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9ef525c3-f1b0-405c-b7ab-c42630943c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_2e587e5f-1046-4e7d-8e96-35c6573e2be0" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9ef525c3-f1b0-405c-b7ab-c42630943c60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_55ac22db-9537-4b9e-b1e4-8ceaa2534663" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:to="loc_srt_RangeAxis_55ac22db-9537-4b9e-b1e4-8ceaa2534663" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55ac22db-9537-4b9e-b1e4-8ceaa2534663_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_55ac22db-9537-4b9e-b1e4-8ceaa2534663" xlink:to="loc_srt_RangeMember_55ac22db-9537-4b9e-b1e4-8ceaa2534663_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_94144845-1fb5-44b3-ac8c-df7df87cbe05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_55ac22db-9537-4b9e-b1e4-8ceaa2534663" xlink:to="loc_srt_RangeMember_94144845-1fb5-44b3-ac8c-df7df87cbe05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fb2a5264-4815-4a92-9e08-791083bf694c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_94144845-1fb5-44b3-ac8c-df7df87cbe05" xlink:to="loc_srt_MinimumMember_fb2a5264-4815-4a92-9e08-791083bf694c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails" xlink:type="extended" id="if788e32df4ab42e7ac8b958b5fbc3518_DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a47bce7b-e07f-4041-8ef4-622576a611c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_f560ef4f-d86c-4825-ab6e-b41aff607be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a47bce7b-e07f-4041-8ef4-622576a611c5" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_f560ef4f-d86c-4825-ab6e-b41aff607be1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_16f115d5-d1a8-473f-ab99-4c2212e467e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a47bce7b-e07f-4041-8ef4-622576a611c5" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_16f115d5-d1a8-473f-ab99-4c2212e467e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_63edbc4d-7eb5-478d-9ebb-21b834896b76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a47bce7b-e07f-4041-8ef4-622576a611c5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_63edbc4d-7eb5-478d-9ebb-21b834896b76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3308c8c3-fcaf-4a20-8ce0-b8c6ef2bc0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a47bce7b-e07f-4041-8ef4-622576a611c5" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3308c8c3-fcaf-4a20-8ce0-b8c6ef2bc0c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0d05850-dd44-4e12-9163-b0efae9ad42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3308c8c3-fcaf-4a20-8ce0-b8c6ef2bc0c8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0d05850-dd44-4e12-9163-b0efae9ad42f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f0d05850-dd44-4e12-9163-b0efae9ad42f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0d05850-dd44-4e12-9163-b0efae9ad42f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f0d05850-dd44-4e12-9163-b0efae9ad42f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0d05850-dd44-4e12-9163-b0efae9ad42f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapOneMember_13fd82d7-51b4-45d9-a913-997381db3d5d" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapOneMember_13fd82d7-51b4-45d9-a913-997381db3d5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapTwoMember_0913c2ac-f020-49df-a37e-ac2db8777661" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapTwoMember_0913c2ac-f020-49df-a37e-ac2db8777661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapThreeMember_7d7151eb-c953-4f51-85be-06ac16cddf4e" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapThreeMember_7d7151eb-c953-4f51-85be-06ac16cddf4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapOneMember_7af1fd84-2a70-444d-aae7-f7003298723b" xlink:href="sgry-20220630.xsd#sgry_InterestRateCapOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_InterestRateCapOneMember_7af1fd84-2a70-444d-aae7-f7003298723b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapTwoMember_731c9023-fc37-463b-852c-a4a7cf62eaf5" xlink:href="sgry-20220630.xsd#sgry_InterestRateCapTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_InterestRateCapTwoMember_731c9023-fc37-463b-852c-a4a7cf62eaf5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFourMember_b8d3ceb3-1daf-49bd-9df4-0ab8d9220c9a" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapFourMember_b8d3ceb3-1daf-49bd-9df4-0ab8d9220c9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFiveMember_698dfea5-93db-45da-911f-84602c77015f" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapFiveMember_698dfea5-93db-45da-911f-84602c77015f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapSixMember_2775b5de-7e4c-4c98-9db3-eca57dca8428" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapSixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapSixMember_2775b5de-7e4c-4c98-9db3-eca57dca8428" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapOneMember_cfe743dd-8d0c-4296-90c9-c2b87cf68448" xlink:href="sgry-20220630.xsd#sgry_ReceiveFixedSwapOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_ReceiveFixedSwapOneMember_cfe743dd-8d0c-4296-90c9-c2b87cf68448" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapTwoMember_7b7f0ed7-2051-4278-b651-058384837d17" xlink:href="sgry-20220630.xsd#sgry_ReceiveFixedSwapTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_ReceiveFixedSwapTwoMember_7b7f0ed7-2051-4278-b651-058384837d17" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapThreeMember_1b220fcb-775b-4191-9e4b-98df21249224" xlink:href="sgry-20220630.xsd#sgry_ReceiveFixedSwapThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_ReceiveFixedSwapThreeMember_1b220fcb-775b-4191-9e4b-98df21249224" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails" xlink:type="extended" id="if7414b5cc4cf4b00bd588c1e909c63f7_DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0dc59bcf-633e-4547-b4c0-1a494a38828f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_3ee00429-c959-45a7-a5bb-6732f04cbf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0dc59bcf-633e-4547-b4c0-1a494a38828f" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_3ee00429-c959-45a7-a5bb-6732f04cbf2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_b061f8eb-d7c2-4925-9685-b0ace3148aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0dc59bcf-633e-4547-b4c0-1a494a38828f" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_b061f8eb-d7c2-4925-9685-b0ace3148aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_914bde5b-5ad7-4195-972c-95fb2e8da55b" xlink:href="sgry-20220630.xsd#sgry_DerivativeLiabilityNotionalAmountFinancingComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0dc59bcf-633e-4547-b4c0-1a494a38828f" xlink:to="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_914bde5b-5ad7-4195-972c-95fb2e8da55b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d5770736-784e-4d6f-9f03-8a515f720896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0dc59bcf-633e-4547-b4c0-1a494a38828f" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d5770736-784e-4d6f-9f03-8a515f720896" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_31007059-0047-4b60-844a-761bcc237d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d5770736-784e-4d6f-9f03-8a515f720896" xlink:to="loc_us-gaap_HedgingDesignationAxis_31007059-0047-4b60-844a-761bcc237d6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_31007059-0047-4b60-844a-761bcc237d6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_31007059-0047-4b60-844a-761bcc237d6e" xlink:to="loc_us-gaap_HedgingDesignationDomain_31007059-0047-4b60-844a-761bcc237d6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_10d9aa60-c958-40f8-8e1e-5dc9a4ad3e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_31007059-0047-4b60-844a-761bcc237d6e" xlink:to="loc_us-gaap_HedgingDesignationDomain_10d9aa60-c958-40f8-8e1e-5dc9a4ad3e99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e332a524-d4fb-406f-9e23-f7e5375652c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_10d9aa60-c958-40f8-8e1e-5dc9a4ad3e99" xlink:to="loc_us-gaap_NondesignatedMember_e332a524-d4fb-406f-9e23-f7e5375652c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7677019c-b65c-4de3-8d1c-77c2716aab5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_10d9aa60-c958-40f8-8e1e-5dc9a4ad3e99" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7677019c-b65c-4de3-8d1c-77c2716aab5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ad0a2ee8-98b4-462c-9f9a-390cb6473ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d5770736-784e-4d6f-9f03-8a515f720896" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ad0a2ee8-98b4-462c-9f9a-390cb6473ba0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ad0a2ee8-98b4-462c-9f9a-390cb6473ba0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ad0a2ee8-98b4-462c-9f9a-390cb6473ba0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ad0a2ee8-98b4-462c-9f9a-390cb6473ba0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_be29d973-aa1e-4e0b-b20c-6364b1bf2e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ad0a2ee8-98b4-462c-9f9a-390cb6473ba0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_be29d973-aa1e-4e0b-b20c-6364b1bf2e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_5e815fcb-9cfe-4b1b-8ce5-b52c51c001f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_be29d973-aa1e-4e0b-b20c-6364b1bf2e63" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_5e815fcb-9cfe-4b1b-8ce5-b52c51c001f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_5ca923c1-5495-4d17-b81b-39ff181e92fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_be29d973-aa1e-4e0b-b20c-6364b1bf2e63" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_5ca923c1-5495-4d17-b81b-39ff181e92fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e646e6-86b0-4201-9666-5820b64f4463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d5770736-784e-4d6f-9f03-8a515f720896" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e646e6-86b0-4201-9666-5820b64f4463" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f0e646e6-86b0-4201-9666-5820b64f4463_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e646e6-86b0-4201-9666-5820b64f4463" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f0e646e6-86b0-4201-9666-5820b64f4463_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e26d905d-d4bc-45b4-a824-ad7d975937e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e646e6-86b0-4201-9666-5820b64f4463" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e26d905d-d4bc-45b4-a824-ad7d975937e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d47c191f-30d9-43d2-992b-6217940e51a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e26d905d-d4bc-45b4-a824-ad7d975937e1" xlink:to="loc_us-gaap_InterestRateSwapMember_d47c191f-30d9-43d2-992b-6217940e51a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_afa8be96-5afe-4638-809c-c0923d48c85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e26d905d-d4bc-45b4-a824-ad7d975937e1" xlink:to="loc_us-gaap_InterestRateCapMember_afa8be96-5afe-4638-809c-c0923d48c85b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails" xlink:type="extended" id="i1ef3a8551f814aaea2cc505db6efc16e_DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_8b9d3c54-a40e-4bc7-be04-6827c16beb91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3d102e8f-1f47-4453-baed-3dad22cfaeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_8b9d3c54-a40e-4bc7-be04-6827c16beb91" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3d102e8f-1f47-4453-baed-3dad22cfaeb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_da74095c-5dfb-4044-ab74-6a85b7c39f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_8b9d3c54-a40e-4bc7-be04-6827c16beb91" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_da74095c-5dfb-4044-ab74-6a85b7c39f61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_daa9df6e-d24c-4177-9d14-633975689556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_8b9d3c54-a40e-4bc7-be04-6827c16beb91" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_daa9df6e-d24c-4177-9d14-633975689556" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_9705c163-9d50-4a31-bb6f-f8646967857e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_8b9d3c54-a40e-4bc7-be04-6827c16beb91" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_9705c163-9d50-4a31-bb6f-f8646967857e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7e39db68-bef3-42dc-8b07-29a04cec2a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_9705c163-9d50-4a31-bb6f-f8646967857e" xlink:to="loc_us-gaap_HedgingDesignationAxis_7e39db68-bef3-42dc-8b07-29a04cec2a0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7e39db68-bef3-42dc-8b07-29a04cec2a0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e39db68-bef3-42dc-8b07-29a04cec2a0f" xlink:to="loc_us-gaap_HedgingDesignationDomain_7e39db68-bef3-42dc-8b07-29a04cec2a0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c1b0da24-bb20-425b-a3b3-35a063d3ff96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e39db68-bef3-42dc-8b07-29a04cec2a0f" xlink:to="loc_us-gaap_HedgingDesignationDomain_c1b0da24-bb20-425b-a3b3-35a063d3ff96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_712f06c8-7863-4d40-a2e5-c985e470ce72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c1b0da24-bb20-425b-a3b3-35a063d3ff96" xlink:to="loc_us-gaap_NondesignatedMember_712f06c8-7863-4d40-a2e5-c985e470ce72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_03d6a1e6-8d67-417f-bc0a-bacf8bd5d7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c1b0da24-bb20-425b-a3b3-35a063d3ff96" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_03d6a1e6-8d67-417f-bc0a-bacf8bd5d7ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a7ee09f1-df95-401e-b8ce-811e9d656e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_9705c163-9d50-4a31-bb6f-f8646967857e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a7ee09f1-df95-401e-b8ce-811e9d656e62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a7ee09f1-df95-401e-b8ce-811e9d656e62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a7ee09f1-df95-401e-b8ce-811e9d656e62" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a7ee09f1-df95-401e-b8ce-811e9d656e62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2ffb9406-bbc0-4dc4-bc37-455a0c3eb54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a7ee09f1-df95-401e-b8ce-811e9d656e62" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2ffb9406-bbc0-4dc4-bc37-455a0c3eb54f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_2993c255-081c-4ec6-977b-c3f2be6cf450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2ffb9406-bbc0-4dc4-bc37-455a0c3eb54f" xlink:to="loc_us-gaap_OtherIncomeMember_2993c255-081c-4ec6-977b-c3f2be6cf450" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_2687fded-a21b-489d-93bb-6c69de52cb20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2ffb9406-bbc0-4dc4-bc37-455a0c3eb54f" xlink:to="loc_us-gaap_InterestExpenseMember_2687fded-a21b-489d-93bb-6c69de52cb20" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#EarningsPerShareSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails" xlink:type="extended" id="i375a0d61213b4ac7a940547d1fd42b74_EarningsPerShareSummaryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_5e8b9030-81be-4969-9c63-42a3f15591e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:to="loc_us-gaap_NetIncomeLossAbstract_5e8b9030-81be-4969-9c63-42a3f15591e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4018fd1-1ca6-43f4-9376-eb50fcab88b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAbstract_5e8b9030-81be-4969-9c63-42a3f15591e7" xlink:to="loc_us-gaap_NetIncomeLoss_e4018fd1-1ca6-43f4-9376-eb50fcab88b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_15039c42-cef0-4e4a-a89e-6b011f0cb8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAbstract_5e8b9030-81be-4969-9c63-42a3f15591e7" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_15039c42-cef0-4e4a-a89e-6b011f0cb8d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c77bb98b-4785-4fb7-9acf-fed7383f724f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAbstract_5e8b9030-81be-4969-9c63-42a3f15591e7" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c77bb98b-4785-4fb7-9acf-fed7383f724f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cbbe7a36-ddf4-465c-af81-8af48720fc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cbbe7a36-ddf4-465c-af81-8af48720fc98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_df807833-447c-47a3-9102-870597e179c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cbbe7a36-ddf4-465c-af81-8af48720fc98" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_df807833-447c-47a3-9102-870597e179c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16113bd3-6b68-4489-b90f-96a339f3fd08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cbbe7a36-ddf4-465c-af81-8af48720fc98" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16113bd3-6b68-4489-b90f-96a339f3fd08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_d91d0167-a57d-41c7-aa23-a332ebd091e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_d91d0167-a57d-41c7-aa23-a332ebd091e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_02a78140-8d63-47ce-9124-ca0e7ee2e260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_d91d0167-a57d-41c7-aa23-a332ebd091e3" xlink:to="loc_us-gaap_EarningsPerShareBasic_02a78140-8d63-47ce-9124-ca0e7ee2e260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_596f2ab8-0f77-4dd4-8636-e70fd3c5530e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_d91d0167-a57d-41c7-aa23-a332ebd091e3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_596f2ab8-0f77-4dd4-8636-e70fd3c5530e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_55d2e47e-a41f-4e70-b3b6-2663ee1fce68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_55d2e47e-a41f-4e70-b3b6-2663ee1fce68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_be7fb48d-bc45-4649-bd81-7ae14548428d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_be7fb48d-bc45-4649-bd81-7ae14548428d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_961f73cd-134f-419f-a05b-974c5a7ca4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_be7fb48d-bc45-4649-bd81-7ae14548428d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_961f73cd-134f-419f-a05b-974c5a7ca4fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_961f73cd-134f-419f-a05b-974c5a7ca4fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_961f73cd-134f-419f-a05b-974c5a7ca4fd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_961f73cd-134f-419f-a05b-974c5a7ca4fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_86013e8a-48ca-4f10-950e-bf86c97373da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_961f73cd-134f-419f-a05b-974c5a7ca4fd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_86013e8a-48ca-4f10-950e-bf86c97373da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1a56cc87-d285-4c42-8aad-ee462fb0da27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_86013e8a-48ca-4f10-950e-bf86c97373da" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1a56cc87-d285-4c42-8aad-ee462fb0da27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_195a8385-533f-470f-9b92-b2bdf7f748ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_86013e8a-48ca-4f10-950e-bf86c97373da" xlink:to="loc_us-gaap_RestrictedStockMember_195a8385-533f-470f-9b92-b2bdf7f748ee" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i3f4de804eac24321ac06a93e8a6a65b0_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_161a0857-aa2a-49a1-a6e1-50b382533a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_SelfInsuranceReserve_161a0857-aa2a-49a1-a6e1-50b382533a03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimatedInsuranceRecoveries_9966ee64-fc2a-4353-8f13-416fc64eb1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimatedInsuranceRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_EstimatedInsuranceRecoveries_9966ee64-fc2a-4353-8f13-416fc64eb1fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_2bce2b17-ed86-4130-9da7-c68ba270e5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_2bce2b17-ed86-4130-9da7-c68ba270e5a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0a73db9a-6f3e-4902-96b4-7c5a62987816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0a73db9a-6f3e-4902-96b4-7c5a62987816" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_a50ba708-7c4d-4d4e-9e73-35fc7dc9de56" xlink:href="sgry-20220630.xsd#sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_a50ba708-7c4d-4d4e-9e73-35fc7dc9de56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_25c553ae-5c4c-4f7d-874d-266845718247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_25c553ae-5c4c-4f7d-874d-266845718247" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_a71ea49b-78e4-4ee8-8809-673bd680df3b" xlink:href="sgry-20220630.xsd#sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_a71ea49b-78e4-4ee8-8809-673bd680df3b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_ed3a10c5-cd6e-4d65-87c7-55df770af271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_ed3a10c5-cd6e-4d65-87c7-55df770af271" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_7e0b16a1-4fb6-47f8-af08-60078bf16ee4" xlink:href="sgry-20220630.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_7e0b16a1-4fb6-47f8-af08-60078bf16ee4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_5ed6e740-2c98-443d-9799-05230c346edc" xlink:href="sgry-20220630.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_5ed6e740-2c98-443d-9799-05230c346edc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b7b57b88-06ce-4d6a-a1eb-76e02b48e8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b7b57b88-06ce-4d6a-a1eb-76e02b48e8c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a1fa22c1-1d95-49c8-a3a1-80c337cdf8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b7b57b88-06ce-4d6a-a1eb-76e02b48e8c3" xlink:to="loc_us-gaap_VariableRateAxis_a1fa22c1-1d95-49c8-a3a1-80c337cdf8a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a1fa22c1-1d95-49c8-a3a1-80c337cdf8a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_a1fa22c1-1d95-49c8-a3a1-80c337cdf8a9" xlink:to="loc_us-gaap_VariableRateDomain_a1fa22c1-1d95-49c8-a3a1-80c337cdf8a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_30868e33-d40a-40ce-86f4-f118fba46814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_a1fa22c1-1d95-49c8-a3a1-80c337cdf8a9" xlink:to="loc_us-gaap_VariableRateDomain_30868e33-d40a-40ce-86f4-f118fba46814" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_a360549d-f0bf-428d-862f-48dbf2f3ee34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_30868e33-d40a-40ce-86f4-f118fba46814" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_a360549d-f0bf-428d-862f-48dbf2f3ee34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9458b1fe-eace-4210-9112-c7e87207d3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_30868e33-d40a-40ce-86f4-f118fba46814" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9458b1fe-eace-4210-9112-c7e87207d3b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_4d2d44e7-b108-40ce-96a1-6b67e84806b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b7b57b88-06ce-4d6a-a1eb-76e02b48e8c3" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_4d2d44e7-b108-40ce-96a1-6b67e84806b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_4d2d44e7-b108-40ce-96a1-6b67e84806b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_4d2d44e7-b108-40ce-96a1-6b67e84806b6" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_4d2d44e7-b108-40ce-96a1-6b67e84806b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_3d483e8a-3a4b-4e07-939e-e1204cc514c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_4d2d44e7-b108-40ce-96a1-6b67e84806b6" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_3d483e8a-3a4b-4e07-939e-e1204cc514c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MateriallyMoreRestrictiveMember_1ad1f459-4915-4ea5-a16e-000fac014367" xlink:href="sgry-20220630.xsd#sgry_MateriallyMoreRestrictiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_3d483e8a-3a4b-4e07-939e-e1204cc514c3" xlink:to="loc_sgry_MateriallyMoreRestrictiveMember_1ad1f459-4915-4ea5-a16e-000fac014367" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotMateriallyMoreRestrictiveMember_0ca2ee35-2b2e-4eb2-a486-37e0274656aa" xlink:href="sgry-20220630.xsd#sgry_NotMateriallyMoreRestrictiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_3d483e8a-3a4b-4e07-939e-e1204cc514c3" xlink:to="loc_sgry_NotMateriallyMoreRestrictiveMember_0ca2ee35-2b2e-4eb2-a486-37e0274656aa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails" xlink:type="extended" id="ie110d2461a4448c6a6efdb157a387dbf_SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_a4c83073-aabc-4a81-a157-6cb19cbefcdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7de7f941-5bdd-48c8-a136-1c2abee53923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a4c83073-aabc-4a81-a157-6cb19cbefcdc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7de7f941-5bdd-48c8-a136-1c2abee53923" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_455d098c-eefa-4f5d-8b04-f3d6956571bc" xlink:href="sgry-20220630.xsd#sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a4c83073-aabc-4a81-a157-6cb19cbefcdc" xlink:to="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_455d098c-eefa-4f5d-8b04-f3d6956571bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a4c83073-aabc-4a81-a157-6cb19cbefcdc" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2297bda5-7f3a-4703-a721-432aee8c9a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2297bda5-7f3a-4703-a721-432aee8c9a76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9be22a77-dc42-4f8e-951a-399254f0cbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9be22a77-dc42-4f8e-951a-399254f0cbeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_984cea7f-4e39-40db-b530-5eb338ae442f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_984cea7f-4e39-40db-b530-5eb338ae442f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_f48b48b5-37f3-4cca-839e-c6021a4fe069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_f48b48b5-37f3-4cca-839e-c6021a4fe069" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_74e76639-f3e8-482c-93af-7e6f7892641a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_ShareBasedCompensation_74e76639-f3e8-482c-93af-7e6f7892641a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_04828c83-54be-41b2-bb60-4b45d1770bd9" xlink:href="sgry-20220630.xsd#sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_04828c83-54be-41b2-bb60-4b45d1770bd9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_5c0e6627-e077-4c56-b83c-51bd33f1b035" xlink:href="sgry-20220630.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_5c0e6627-e077-4c56-b83c-51bd33f1b035" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_1249e5cc-7f56-4da9-91b9-14c85dece32b" xlink:href="sgry-20220630.xsd#sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_1249e5cc-7f56-4da9-91b9-14c85dece32b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1344bc59-f20b-4eeb-b88d-f70646bc1eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1344bc59-f20b-4eeb-b88d-f70646bc1eef" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_e5719958-5f80-4f29-acb4-a05e716a6f45" xlink:href="sgry-20220630.xsd#sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_06a01de2-323b-4da8-b55a-d33fbef82e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_06a01de2-323b-4da8-b55a-d33fbef82e57" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_38a82085-be84-432a-9fb5-dcf5a0ac0534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_38a82085-be84-432a-9fb5-dcf5a0ac0534" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_c2a4a6df-5923-40d2-a0b2-29f310a3e02f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_LitigationSettlementExpense_c2a4a6df-5923-40d2-a0b2-29f310a3e02f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_c67a49d5-66d7-482a-9893-5e36f16fd191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_c67a49d5-66d7-482a-9893-5e36f16fd191" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fef48871-f52f-4ec4-aad7-2a6dd918865e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a4c83073-aabc-4a81-a157-6cb19cbefcdc" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fef48871-f52f-4ec4-aad7-2a6dd918865e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b79df458-8e08-49a5-836b-1adb6a84037e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fef48871-f52f-4ec4-aad7-2a6dd918865e" xlink:to="loc_srt_ConsolidationItemsAxis_b79df458-8e08-49a5-836b-1adb6a84037e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b79df458-8e08-49a5-836b-1adb6a84037e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b79df458-8e08-49a5-836b-1adb6a84037e" xlink:to="loc_srt_ConsolidationItemsDomain_b79df458-8e08-49a5-836b-1adb6a84037e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9d0a60cd-b093-4863-8c8b-2c4ff921b6a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b79df458-8e08-49a5-836b-1adb6a84037e" xlink:to="loc_srt_ConsolidationItemsDomain_9d0a60cd-b093-4863-8c8b-2c4ff921b6a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9a3f8b13-b5ed-4b9c-ba7f-a4a966670f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9d0a60cd-b093-4863-8c8b-2c4ff921b6a1" xlink:to="loc_us-gaap_OperatingSegmentsMember_9a3f8b13-b5ed-4b9c-ba7f-a4a966670f52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7898b6a7-ccf2-42bc-b30d-65334b91f990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9d0a60cd-b093-4863-8c8b-2c4ff921b6a1" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7898b6a7-ccf2-42bc-b30d-65334b91f990" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_617816df-59be-468c-acb2-c5d7e02506c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fef48871-f52f-4ec4-aad7-2a6dd918865e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_617816df-59be-468c-acb2-c5d7e02506c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_617816df-59be-468c-acb2-c5d7e02506c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_617816df-59be-468c-acb2-c5d7e02506c4" xlink:to="loc_us-gaap_SegmentDomain_617816df-59be-468c-acb2-c5d7e02506c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4b374d9e-902d-4e71-a2b6-d236ba655f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_617816df-59be-468c-acb2-c5d7e02506c4" xlink:to="loc_us-gaap_SegmentDomain_4b374d9e-902d-4e71-a2b6-d236ba655f79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_f7337b9f-dad0-4ea8-9752-c960d56ca317" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4b374d9e-902d-4e71-a2b6-d236ba655f79" xlink:to="loc_sgry_SurgicalFacilityServicesMember_f7337b9f-dad0-4ea8-9752-c960d56ca317" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_d40174c5-7d9b-4d33-b49d-830f43b493d7" xlink:href="sgry-20220630.xsd#sgry_AncillaryServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4b374d9e-902d-4e71-a2b6-d236ba655f79" xlink:to="loc_sgry_AncillaryServicesMember_d40174c5-7d9b-4d33-b49d-830f43b493d7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails" xlink:type="extended" id="i15bb902b1d0b488d9789373771b9711e_SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f23896ed-7960-40da-b258-80c38a153b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8c2a5f28-efed-423d-959e-ba2fe580eac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f23896ed-7960-40da-b258-80c38a153b5f" xlink:to="loc_us-gaap_Assets_8c2a5f28-efed-423d-959e-ba2fe580eac7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_95b18d54-4c3e-49a0-a439-10d7d58bab77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f23896ed-7960-40da-b258-80c38a153b5f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_95b18d54-4c3e-49a0-a439-10d7d58bab77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5bd28f39-1e5a-4988-ac75-f63824af970b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f23896ed-7960-40da-b258-80c38a153b5f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5bd28f39-1e5a-4988-ac75-f63824af970b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2bbdc752-90ad-4ed1-b962-e75815d472fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5bd28f39-1e5a-4988-ac75-f63824af970b" xlink:to="loc_srt_ConsolidationItemsAxis_2bbdc752-90ad-4ed1-b962-e75815d472fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2bbdc752-90ad-4ed1-b962-e75815d472fb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_2bbdc752-90ad-4ed1-b962-e75815d472fb" xlink:to="loc_srt_ConsolidationItemsDomain_2bbdc752-90ad-4ed1-b962-e75815d472fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_859e822f-0295-4fe6-b804-02b3c9c2c52b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_2bbdc752-90ad-4ed1-b962-e75815d472fb" xlink:to="loc_srt_ConsolidationItemsDomain_859e822f-0295-4fe6-b804-02b3c9c2c52b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_616bcc06-4b03-4d3a-acc1-4bff60ea8392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_859e822f-0295-4fe6-b804-02b3c9c2c52b" xlink:to="loc_us-gaap_OperatingSegmentsMember_616bcc06-4b03-4d3a-acc1-4bff60ea8392" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_600a0c70-90a2-4765-87ce-707bb095288a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_859e822f-0295-4fe6-b804-02b3c9c2c52b" xlink:to="loc_us-gaap_CorporateNonSegmentMember_600a0c70-90a2-4765-87ce-707bb095288a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1b7ef44f-9ee5-4929-b1f0-94a8f175c144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5bd28f39-1e5a-4988-ac75-f63824af970b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1b7ef44f-9ee5-4929-b1f0-94a8f175c144" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1b7ef44f-9ee5-4929-b1f0-94a8f175c144_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1b7ef44f-9ee5-4929-b1f0-94a8f175c144" xlink:to="loc_us-gaap_SegmentDomain_1b7ef44f-9ee5-4929-b1f0-94a8f175c144_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_63919232-2993-425a-ac3f-79d439816585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1b7ef44f-9ee5-4929-b1f0-94a8f175c144" xlink:to="loc_us-gaap_SegmentDomain_63919232-2993-425a-ac3f-79d439816585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_bf123fe4-633f-461e-98f6-ec7cd6feb3bc" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_63919232-2993-425a-ac3f-79d439816585" xlink:to="loc_sgry_SurgicalFacilityServicesMember_bf123fe4-633f-461e-98f6-ec7cd6feb3bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_f083f23b-5cd8-43a3-b341-29f10871c9fd" xlink:href="sgry-20220630.xsd#sgry_AncillaryServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_63919232-2993-425a-ac3f-79d439816585" xlink:to="loc_sgry_AncillaryServicesMember_f083f23b-5cd8-43a3-b341-29f10871c9fd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.surgerypartners.com/role/SubsequentEventsDetails" xlink:type="extended" id="ie590d9ea5840439bbd82f24849692924_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_0c3ad200-c83f-42fb-aa0b-0f1b71152fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_fccc5c5f-771d-4397-9b8b-1eca0d1e79ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0c3ad200-c83f-42fb-aa0b-0f1b71152fc9" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_fccc5c5f-771d-4397-9b8b-1eca0d1e79ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_77f7ef46-5880-46c0-a9d5-3a26a11b8716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0c3ad200-c83f-42fb-aa0b-0f1b71152fc9" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_77f7ef46-5880-46c0-a9d5-3a26a11b8716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_ee9213f9-c3c2-4946-a736-a2f9f3b3ec58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_0c3ad200-c83f-42fb-aa0b-0f1b71152fc9" xlink:to="loc_us-gaap_SubsequentEventTable_ee9213f9-c3c2-4946-a736-a2f9f3b3ec58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4772e1ae-39d1-40c3-ae54-83f6ec4b59a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_ee9213f9-c3c2-4946-a736-a2f9f3b3ec58" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4772e1ae-39d1-40c3-ae54-83f6ec4b59a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4772e1ae-39d1-40c3-ae54-83f6ec4b59a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4772e1ae-39d1-40c3-ae54-83f6ec4b59a8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4772e1ae-39d1-40c3-ae54-83f6ec4b59a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_43625078-a3f0-4833-a165-74a2bdd50704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4772e1ae-39d1-40c3-ae54-83f6ec4b59a8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_43625078-a3f0-4833-a165-74a2bdd50704" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b29868ce-ed87-41a2-9f1b-e6c514ef7233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_43625078-a3f0-4833-a165-74a2bdd50704" xlink:to="loc_us-gaap_SubsequentEventMember_b29868ce-ed87-41a2-9f1b-e6c514ef7233" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_b756f30e-b279-42a2-a5c4-defd86495463" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_ee9213f9-c3c2-4946-a736-a2f9f3b3ec58" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_b756f30e-b279-42a2-a5c4-defd86495463" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_b756f30e-b279-42a2-a5c4-defd86495463_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_b756f30e-b279-42a2-a5c4-defd86495463" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_b756f30e-b279-42a2-a5c4-defd86495463_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3000049c-7c2d-4812-b0a9-11ca4fc9549d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_b756f30e-b279-42a2-a5c4-defd86495463" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3000049c-7c2d-4812-b0a9-11ca4fc9549d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityMember_24d07d94-af71-44c1-82e2-19b2568b912b" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3000049c-7c2d-4812-b0a9-11ca4fc9549d" xlink:to="loc_sgry_SurgicalFacilityMember_24d07d94-af71-44c1-82e2-19b2568b912b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InDevelopmentDeNovoSurgicalFacilityMember_dcba96e6-c564-4a62-a341-932a8124f1c8" xlink:href="sgry-20220630.xsd#sgry_InDevelopmentDeNovoSurgicalFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3000049c-7c2d-4812-b0a9-11ca4fc9549d" xlink:to="loc_sgry_InDevelopmentDeNovoSurgicalFacilityMember_dcba96e6-c564-4a62-a341-932a8124f1c8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>sgry-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bf0c9919-675a-4090-9889-2da6d013d12b,g:8071f056-30bb-4692-9c60-1fa924dc9a77-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e9c7595a-f9ba-484d-a349-f8f1ebe9d009_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e4a8456-9f8b-429f-b986-7cd775844fe5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_aa465f6a-1548-402a-87ca-4dabe2f8025d_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_57fc2bad-165b-485a-b371-038733f27330_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_69ff004c-8b0f-4012-9f79-d39ddfe8a57b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_9a132462-1346-477b-a67a-f4447f188a36_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_79474320-a522-4dd3-bb37-3b0a05e38d5b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a4b2f8d5-bdbc-4aa6-922a-93bb9a4723ef_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_6e37505e-e013-42e2-954d-f8206b1bd374_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_1d5170c0-581a-49b9-b650-afa2a0775ecd_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0beda184-faf5-4847-8344-1847e0b1f2ce_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_6719a655-5a9a-4850-aedd-cfb62c58ea63_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_ac9b94dc-f973-4c76-af9d-0db9fcbda1e7_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_15e27e79-ba62-4e8b-84bf-fc265e54fb68_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_ced6e05c-1499-4673-905e-e665feaea824_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_4e1a8f7c-6777-4e33-94a6-d8ae43c07e13_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_fa7d20c9-779b-41b9-ae61-69373bed8f39_terseLabel_en-US" xlink:label="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted EBITDA</link:label>
    <link:label id="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_label_en-US" xlink:label="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Interest Taxes Depreciation And Amortization</link:label>
    <link:label id="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Interest Taxes Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:href="sgry-20220630.xsd#sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:to="lab_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_6745833a-fc5d-41bb-b123-10513c9e61b4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SuppliesExpense_7b685f0c-79c4-475c-a6ca-8a42988613d0_terseLabel_en-US" xlink:label="lab_us-gaap_SuppliesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies</link:label>
    <link:label id="lab_us-gaap_SuppliesExpense_label_en-US" xlink:label="lab_us-gaap_SuppliesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuppliesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuppliesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SuppliesExpense" xlink:to="lab_us-gaap_SuppliesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_9bad6c9c-126a-4ff6-9cc0-5d3e3c277ac7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_f89bbf77-1152-4541-970d-5c2e076b1239_terseLabel_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of liability, net of discount</link:label>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_label_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net Of Discount</link:label>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_documentation_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net Of Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:href="sgry-20220630.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:to="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DebtInstrumentPrepaymentPenaltyAmount_4a207d4b-f87e-4929-9114-41bd9e89aca6_negatedTerseLabel_en-US" xlink:label="lab_sgry_DebtInstrumentPrepaymentPenaltyAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of premium on debt extinguishment</link:label>
    <link:label id="lab_sgry_DebtInstrumentPrepaymentPenaltyAmount_label_en-US" xlink:label="lab_sgry_DebtInstrumentPrepaymentPenaltyAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty Amount</link:label>
    <link:label id="lab_sgry_DebtInstrumentPrepaymentPenaltyAmount_documentation_en-US" xlink:label="lab_sgry_DebtInstrumentPrepaymentPenaltyAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Prepayment Penalty Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentPrepaymentPenaltyAmount" xlink:href="sgry-20220630.xsd#sgry_DebtInstrumentPrepaymentPenaltyAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DebtInstrumentPrepaymentPenaltyAmount" xlink:to="lab_sgry_DebtInstrumentPrepaymentPenaltyAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_c100eb18-9e3b-4b98-a7d9-93ff2bbffed3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2fa399a7-9c22-48a2-a914-f904dc97b7e5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, basis spread on variable rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a0dfdac0-6588-4806-af99-17bc5fa6196e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_e233ef60-198e-46fc-a5e0-bdfa31b32743_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_8b81e8e0-8c6b-412e-920a-a7f3f6880bbf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d09afd85-05bd-4380-8548-73b6f3fbc300_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred share conversion</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_LeaseLiability_d379f67f-7df3-4c78-b702-d794529ce7ce_totalLabel_en-US" xlink:label="lab_sgry_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_sgry_LeaseLiability_label_en-US" xlink:label="lab_sgry_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_sgry_LeaseLiability_documentation_en-US" xlink:label="lab_sgry_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_LeaseLiability" xlink:href="sgry-20220630.xsd#sgry_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_LeaseLiability" xlink:to="lab_sgry_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_712afc98-ae72-4f1d-97a8-1326352c10d7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net of accumulated depreciation of $320.7 and $272.3, respectively</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyNatureDomain_acbb9743-de7b-43eb-a397-29baee7c0f9a_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyNatureDomain_label_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:to="lab_us-gaap_UnusualRiskOrUncertaintyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_97476da9-fffc-4fd5-aa97-69e151ead93e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Surgery Partners, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_df8f715c-b5ba-48e5-844f-0bd1a3aea09b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Surgery Partners, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests_08c9432e-39f6-4050-b415-f6e49dadf397_terseLabel_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of shares of non-controlling interests, net&#8212;redeemable</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests_label_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Increase (Decrease) From Redemptions Or Purchase Of Interests</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests_documentation_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Increase (Decrease) from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:href="sgry-20220630.xsd#sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:to="lab_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_a9b67339-b5b3-47c4-9bdd-3d4125f080e9_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term tax receivable agreement liability</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_aa554892-6f05-4fbb-98c1-1584011ed595_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_885eb88b-2e3e-40a5-be53-47b374e47cbd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_fc241ea4-8e1a-4649-a200-b9121f4cafdd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_7fc47af2-4f83-45b0-ba44-1d88a3b3191f_terseLabel_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Funds Rate</link:label>
    <link:label id="lab_us-gaap_FederalFundsEffectiveSwapRateMember_label_en-US" xlink:label="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fed Funds Effective Rate Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:to="lab_us-gaap_FederalFundsEffectiveSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapSixMember_216ad656-ca5b-411a-947b-2af4b617aab6_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapSixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapSixMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapSixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Six [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapSixMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapSixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Six Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapSixMember" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapSixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapSixMember" xlink:to="lab_sgry_PayFixedSwapSixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_c299da6c-94a5-4b89-8fbc-09241bc2a727_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_81371a21-5e77-4336-bcbb-900f2f1fafc7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_0020427d-e1cd-46c5-979e-6a740d31e6e2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_f1c3445d-06bb-462e-986f-0edb8685589d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_1702e762-9697-43c9-8ac9-9746566ce477_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_f4034b61-dadd-479f-a52f-6eedb260d0fc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_b8862815-d485-49dc-8355-04348cc79061_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_be959eb6-a1fe-4c3f-8ca5-b80c006bcd9d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits attributable to non-recurring earnings' impact on the valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PrivateInsuranceMember_a49b487e-5fad-4d35-81d0-c531afc0ead2_terseLabel_en-US" xlink:label="lab_sgry_PrivateInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private insurance</link:label>
    <link:label id="lab_sgry_PrivateInsuranceMember_label_en-US" xlink:label="lab_sgry_PrivateInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Insurance [Member]</link:label>
    <link:label id="lab_sgry_PrivateInsuranceMember_documentation_en-US" xlink:label="lab_sgry_PrivateInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Insurance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PrivateInsuranceMember" xlink:href="sgry-20220630.xsd#sgry_PrivateInsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PrivateInsuranceMember" xlink:to="lab_sgry_PrivateInsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NotesPayableAndSecuredLoansMember_9c7dae2a-5fcb-4741-a104-7d790eac2ce7_terseLabel_en-US" xlink:label="lab_sgry_NotesPayableAndSecuredLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable and other secured loans</link:label>
    <link:label id="lab_sgry_NotesPayableAndSecuredLoansMember_label_en-US" xlink:label="lab_sgry_NotesPayableAndSecuredLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable and Secured Loans [Member]</link:label>
    <link:label id="lab_sgry_NotesPayableAndSecuredLoansMember_documentation_en-US" xlink:label="lab_sgry_NotesPayableAndSecuredLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable and Secured Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotesPayableAndSecuredLoansMember" xlink:href="sgry-20220630.xsd#sgry_NotesPayableAndSecuredLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NotesPayableAndSecuredLoansMember" xlink:to="lab_sgry_NotesPayableAndSecuredLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_ff4cfb89-698e-4529-a30b-f0e9ce0bdaf1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_3d658cfc-6377-492f-800a-8843ed2504c4_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of interest rate swaps</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_051c1c2a-0e10-475f-9a28-f22f4950ff64_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of leased assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DisposalGroupTwoMember_baec177c-e77f-49fd-83f3-17f8825d164c_terseLabel_en-US" xlink:label="lab_sgry_DisposalGroupTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Two</link:label>
    <link:label id="lab_sgry_DisposalGroupTwoMember_label_en-US" xlink:label="lab_sgry_DisposalGroupTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Two [Member]</link:label>
    <link:label id="lab_sgry_DisposalGroupTwoMember_documentation_en-US" xlink:label="lab_sgry_DisposalGroupTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DisposalGroupTwoMember" xlink:href="sgry-20220630.xsd#sgry_DisposalGroupTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DisposalGroupTwoMember" xlink:to="lab_sgry_DisposalGroupTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_b515ec06-c890-4415-886a-2ab498bb0017_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_853d6f0f-f0d6-4a06-9ad3-c80038d8ab8b_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_eb72c08e-d8e0-4da5-8a5d-8d9be9a70371_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_ac6ea971-4803-4f9b-86e0-b353aec9d266_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_7a929688-9712-4fe4-bfdf-71847917be77_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_72c94454-3fbc-42dd-95b6-affc2bddce60_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_293505ba-1a39-4c59-9147-3059455d9a3d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of line of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_7751e6fb-90b2-417b-95f1-fb36a3bf6858_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 89,935,287 and 89,332,557, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_dcff87b6-87da-4f19-b3dc-cf28e9c6af09_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_bd4ed756-6c0e-4bc9-b227-8435d7429b1a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_d9d5487d-bebb-4e49-841b-f7218b91f4f3_terseLabel_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of surgical facilities owned, majority interest</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_label_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Surgical Facilities Owned, Majority Interest</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_documentation_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Surgical Facilities Owned, Majority Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:href="sgry-20220630.xsd#sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:to="lab_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_63d919e7-23e9-4a34-93a4-621f2f524e34_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_11780041-0215-4ad3-8893-936adb276800_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Summary of Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f104210-fbc2-4459-b5f6-8070145ae2a2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_1018c81f-a6ff-40d0-b97b-3c0c4d87767d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_131a42e6-ef16-4b7d-b0ab-c2a9ebcd1d0b_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d141d13b-1d42-464d-9812-0d338e06e690_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_becda62d-4d78-44ac-9b00-3c5cc1c7ec3e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits related to the sale of partnership interests</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation_5310fa04-a577-4c55-a17d-820bfbaf4d4c_negatedTerseLabel_en-US" xlink:label="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals and deconsolidations</link:label>
    <link:label id="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation_label_en-US" xlink:label="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit and Deconsolidation</link:label>
    <link:label id="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation_documentation_en-US" xlink:label="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit and Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:href="sgry-20220630.xsd#sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:to="lab_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_GrantRevenue_03ef205b-d5cd-4921-9ea9-eab93cbe50cb_negatedTerseLabel_en-US" xlink:label="lab_sgry_GrantRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant funds</link:label>
    <link:label id="lab_sgry_GrantRevenue_label_en-US" xlink:label="lab_sgry_GrantRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Revenue</link:label>
    <link:label id="lab_sgry_GrantRevenue_documentation_en-US" xlink:label="lab_sgry_GrantRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GrantRevenue" xlink:href="sgry-20220630.xsd#sgry_GrantRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_GrantRevenue" xlink:to="lab_sgry_GrantRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_cc43f9bb-6692-4aa9-a00a-11783a581663_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_16380f78-74ac-44f4-b524-cb6390afdfd6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposals of facilities and other assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_cbbfc2c1-d28b-454d-9f91-c241ea78a883_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss recognized in income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_644b1e0f-472c-4355-bac8-3cbef6f3f35e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0f872050-7022-4e9f-8810-6dc05f662529_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ad060d1a-8326-4fb9-b946-f25be9c19ed8_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_24c343a3-1ea7-4859-8c44-41b2fc46ac22_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_0fbcb845-f3cf-4e56-a1ad-c00f0824f90c_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ReceiveFixedSwapThreeMember_458b9821-c19a-4185-a2dd-40a0f516b1a8_terseLabel_en-US" xlink:label="lab_sgry_ReceiveFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed swap</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapThreeMember_label_en-US" xlink:label="lab_sgry_ReceiveFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap Three [Member]</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapThreeMember_documentation_en-US" xlink:label="lab_sgry_ReceiveFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap Three Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapThreeMember" xlink:href="sgry-20220630.xsd#sgry_ReceiveFixedSwapThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ReceiveFixedSwapThreeMember" xlink:to="lab_sgry_ReceiveFixedSwapThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_445bc55c-ffd0-4d43-9155-a5dbea69f42e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_b6b889eb-06e3-4ecb-90a2-ef9f754225b1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1c184bca-a9bb-4a78-8b32-bbb350126d6f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_aef1610c-e682-43b9-90de-598010631f91_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_89d72a23-89ab-4e20-8c2e-feb3446bd6b4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_cb7101b7-aaf6-4f77-97cd-908453df4881_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_ec452ea1-8263-4f30-a3b7-41b0cfcc7117_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_49a6833f-26a1-4408-913d-e433926ff8f8_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty, Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_label_en-US" xlink:label="lab_us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual Risk or Uncertainty, Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:to="lab_us-gaap_UnusualRiskOrUncertaintyByNatureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_95c17c73-91a1-4890-989f-e7587e4f1d06_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_1e0e4d0e-78d7-400c-82a7-851bf4ff3e3e_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_02da19df-aca8-4e04-bd31-445818351cf4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_A2017SeniorSecuredCreditFacilityMember_ecdc1dd8-5d7a-4aa4-9240-81ebc20ef1f4_terseLabel_en-US" xlink:label="lab_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Revolver</link:label>
    <link:label id="lab_sgry_A2017SeniorSecuredCreditFacilityMember_label_en-US" xlink:label="lab_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Senior Secured Credit Facility [Member]</link:label>
    <link:label id="lab_sgry_A2017SeniorSecuredCreditFacilityMember_documentation_en-US" xlink:label="lab_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Senior Secured Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:href="sgry-20220630.xsd#sgry_A2017SeniorSecuredCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:to="lab_sgry_A2017SeniorSecuredCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_fbe3959a-77fb-4ac7-97e9-420a5e9374f8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_4d868a99-f53f-449a-984d-2bf12a76e1da_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in OCI (effective portion)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_430608bc-553a-4529-8a33-69c3e2afbc0e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_651736fb-4fa9-4592-9290-3936357ceaaa_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_95643901-dd76-4c4e-bad6-5814a1942643_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_FacilitiesSurgicalHospitalsMember_302cadff-4120-4abe-b0a0-f8ceca50c4cd_terseLabel_en-US" xlink:label="lab_sgry_FacilitiesSurgicalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Surgical Hospitals</link:label>
    <link:label id="lab_sgry_FacilitiesSurgicalHospitalsMember_label_en-US" xlink:label="lab_sgry_FacilitiesSurgicalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Surgical Hospitals [Member]</link:label>
    <link:label id="lab_sgry_FacilitiesSurgicalHospitalsMember_documentation_en-US" xlink:label="lab_sgry_FacilitiesSurgicalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Surgical Hospitals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesSurgicalHospitalsMember" xlink:href="sgry-20220630.xsd#sgry_FacilitiesSurgicalHospitalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_FacilitiesSurgicalHospitalsMember" xlink:to="lab_sgry_FacilitiesSurgicalHospitalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e5a875e1-3ee9-4d3d-8eec-826fd045361b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_094ca241-1a3b-488b-92c8-4e323309b942_terseLabel_en-US" xlink:label="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction, integration and acquisition costs</link:label>
    <link:label id="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_label_en-US" xlink:label="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs, And Merger Costs</link:label>
    <link:label id="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_documentation_en-US" xlink:label="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs, And Merger Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:href="sgry-20220630.xsd#sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:to="lab_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_TaxReceivableAgreementLiabilityCurrent_74942108-ec33-49fb-b499-8a7e183183c4_terseLabel_en-US" xlink:label="lab_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax receivable agreement liability</link:label>
    <link:label id="lab_sgry_TaxReceivableAgreementLiabilityCurrent_label_en-US" xlink:label="lab_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement Liability, Current</link:label>
    <link:label id="lab_sgry_TaxReceivableAgreementLiabilityCurrent_documentation_en-US" xlink:label="lab_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Receivable Agreement Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:href="sgry-20220630.xsd#sgry_TaxReceivableAgreementLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:to="lab_sgry_TaxReceivableAgreementLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_9cec7ae1-651e-49e7-8937-6170329ac95c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_0ef2dc21-39db-4ee4-b5a3-522b7b448533_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_7d89ed96-fecc-45f7-abcc-1e808c373e92_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_4a51457b-6a41-4bea-8cee-b843370f7df3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_c04290cb-d940-4cb0-b6ce-8cf6bdbbe2b2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_62bc9e6e-a68a-4ae3-9e62-454ab2054f6f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems_97afee6d-c3b6-4ff9-b603-3e9781b1015b_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems_label_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="lab_us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9fd31607-de8f-47a9-97d7-4b4ad41fda36_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_c67abae2-cf16-4dc4-9efa-1decf4bb789a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapFiveMember_dd7a11b5-3ac0-4e18-abbd-e8912b467479_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapFiveMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Five [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapFiveMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Five Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFiveMember" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapFiveMember" xlink:to="lab_sgry_PayFixedSwapFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2929fb08-a0a4-4af7-829b-6393b3ffa2d5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2027Member_767f0352-b2da-4389-81b6-14a0efc289ae_terseLabel_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">10.000% senior unsecured notes due 2027</link:label>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2027Member_label_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due 2027 [Member]</link:label>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2027Member_documentation_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2027Member" xlink:href="sgry-20220630.xsd#sgry_SeniorUnsecuredNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SeniorUnsecuredNotesDue2027Member" xlink:to="lab_sgry_SeniorUnsecuredNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1f99adfd-56b1-425f-8ab7-7223f65833be_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_f67cc8b7-9258-4f34-856c-11d8da90273d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_e69e1f54-f502-4fe8-b863-4399c54d2dbb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of preferred dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Preferred Stock and Preference Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:to="lab_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_eccce8b1-9b60-44f3-828c-f4ec8a87cb25_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_FinanceLeaseCost1Abstract_59778212-93db-4dd4-8dcb-6fc4cfdbe40a_terseLabel_en-US" xlink:label="lab_sgry_FinanceLeaseCost1Abstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease costs:</link:label>
    <link:label id="lab_sgry_FinanceLeaseCost1Abstract_label_en-US" xlink:label="lab_sgry_FinanceLeaseCost1Abstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost1 [Abstract]</link:label>
    <link:label id="lab_sgry_FinanceLeaseCost1Abstract_documentation_en-US" xlink:label="lab_sgry_FinanceLeaseCost1Abstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost1 [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost1Abstract" xlink:href="sgry-20220630.xsd#sgry_FinanceLeaseCost1Abstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_FinanceLeaseCost1Abstract" xlink:to="lab_sgry_FinanceLeaseCost1Abstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_387507c2-13ef-45a9-86db-7fbdf55d166d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_2e2d340b-91a2-4d46-af0e-8d38e8848534_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_eb6243aa-cf45-404f-abf5-c7a6222b7cb4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_PayablesToCustomers_fcf82b51-e740-4fb6-abf9-8db94446414e_terseLabel_en-US" xlink:label="lab_srt_PayablesToCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due to patients and payors</link:label>
    <link:label id="lab_srt_PayablesToCustomers_label_en-US" xlink:label="lab_srt_PayablesToCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Broker-Dealer, Payable to Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PayablesToCustomers" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_PayablesToCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_PayablesToCustomers" xlink:to="lab_srt_PayablesToCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_0db748ce-27c9-429c-9d19-d1fbc4474a7a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0665038f-f45f-4288-939d-051b819293d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_14fd3fff-1099-41b0-a075-49eb7335ad62_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_3f0d2260-ce6b-49b8-85c4-c4b32cbe2136_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of accumulated OCI related</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_db856332-3790-4538-96dd-38e952e16661_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_e6812f9a-4242-4d85-a59e-718297fc0748_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_ce08a18d-fd38-4bc6-9db2-b0452f8b716c_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_IncreaseDecreaseInSettlementPayments_50e23459-2c57-416d-90c9-c7e5689213a6_negatedTerseLabel_en-US" xlink:label="lab_sgry_IncreaseDecreaseInSettlementPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DOJ settlement payments</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInSettlementPayments_label_en-US" xlink:label="lab_sgry_IncreaseDecreaseInSettlementPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Settlement Payments</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInSettlementPayments_documentation_en-US" xlink:label="lab_sgry_IncreaseDecreaseInSettlementPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Settlement Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInSettlementPayments" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInSettlementPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_IncreaseDecreaseInSettlementPayments" xlink:to="lab_sgry_IncreaseDecreaseInSettlementPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_318ab348-e9f2-4279-b899-3b81293a88cc_negatedTerseLabel_en-US" xlink:label="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on litigation settlement and other litigation costs</link:label>
    <link:label id="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_label_en-US" xlink:label="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement And Other Litigation Costs</link:label>
    <link:label id="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_documentation_en-US" xlink:label="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement And Other Litigation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:href="sgry-20220630.xsd#sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:to="lab_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_5daf017a-194f-464d-9ef8-14f63b5b0e91_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_c4dd7e53-807c-4df8-9ed4-ee537bee76e5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_05577fb1-e201-4d66-9d17-3ee4d724caf8_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6f1b406b-1f41-447a-8247-b045b14f522c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8aecc49e-8dc0-4fb5-ade5-67364fff7e91_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity offering (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_cdb90ba7-48c4-43da-8593-1a89816906fa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_4d10bea2-2daf-4f52-98f2-796db3140f28_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_d5badd9d-dddc-4fbf-8248-600ea71c11c7_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions</link:label>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_label_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6f013bff-0288-4904-9be9-ca3e6ecb54be_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_fed149a6-38d8-4136-871c-ba814aa65fd6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonrecurringIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonrecurring (Income) Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonrecurringIncomeExpense" xlink:to="lab_us-gaap_OtherNonrecurringIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_820ad658-426d-4e46-baae-5b8225d5f2f6_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_eb50da35-b75f-4036-95cc-43bf44935564_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c48df73e-b88f-4d34-9574-6020852da48a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ce407d99-78e1-4ff2-a2ee-8f0fbdc047eb_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aa0bd112-e21b-4124-9407-76bcc6841004_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_8e6e053f-d605-48ea-b59f-46b36f9e9363_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_8fb07c34-b92a-44e4-a48e-104f3e486877_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsTable_6e45addb-3191-42a3-a18b-064925fb613b_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_SummaryOfInvestmentHoldingsTable_label_en-US" xlink:label="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Investment Holdings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:to="lab_us-gaap_SummaryOfInvestmentHoldingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_28638e59-0708-43b5-a965-d0f8bf2a04e7_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_859a88d5-d009-447a-aad4-32371d28233f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests&#8212;non-redeemable</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_74a9c7b0-4dce-4ceb-8230-c7fe0d9bcdec_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7b7bd406-58a4-4f34-bd05-cfaa1038d1b4_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_60874536-a8be-4ba3-a05c-ee81ff37e04d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_0496f938-21c5-4d8e-aae8-91e04a2690e0_negatedTerseLabel_en-US" xlink:label="lab_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in operating lease assets</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease, Right-Of-Use Assets</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease, Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:to="lab_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SurgicalFacilitiesMember_8c2e9e1d-5b4a-4d24-b649-bb9fc077bf24_terseLabel_en-US" xlink:label="lab_sgry_SurgicalFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities</link:label>
    <link:label id="lab_sgry_SurgicalFacilitiesMember_label_en-US" xlink:label="lab_sgry_SurgicalFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities [Member]</link:label>
    <link:label id="lab_sgry_SurgicalFacilitiesMember_documentation_en-US" xlink:label="lab_sgry_SurgicalFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesMember" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SurgicalFacilitiesMember" xlink:to="lab_sgry_SurgicalFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_60d432a9-aa43-4543-9867-1fa973bdf383_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e526d933-1e02-4d54-bc32-7c7ec8237998_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_56fc86e2-ac9b-497a-ae83-f568e23b8e48_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to non-controlling interest holders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0b123550-43c5-45a9-85dd-1b2a526be578_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_60bcbd64-b243-49b7-ada6-542bab5b7b1c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_0419ff86-3ee0-4a0b-bf47-56418903f223_negatedLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amounts attributable to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_3a963375-b0e4-4c8d-adf7-0ad365af10c0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payable</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_36cd195b-f456-484d-be21-f793db6f0b2b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SurgicalFacilityMember_679aa0bc-0595-46b5-8420-6fbc758b6212_terseLabel_en-US" xlink:label="lab_sgry_SurgicalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facility</link:label>
    <link:label id="lab_sgry_SurgicalFacilityMember_label_en-US" xlink:label="lab_sgry_SurgicalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facility [Member]</link:label>
    <link:label id="lab_sgry_SurgicalFacilityMember_documentation_en-US" xlink:label="lab_sgry_SurgicalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityMember" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SurgicalFacilityMember" xlink:to="lab_sgry_SurgicalFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_e92a5dc6-40ab-417b-ae2c-ac3804d9256d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_23e77374-6b04-4457-bb43-a0d45dfb861d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_43807496-b8d8-4c64-99b0-1bcd8ad4d124_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_6cba4b84-9ecb-4f31-b4df-ef7ae6bda6ef_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_f682db97-8ba7-4a28-b54c-2bbab4d9fe59_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_abc94b24-058e-4693-ae38-b5ae340a5fec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_020ad093-eed0-49dd-9c0c-27919403a1d8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_ab417206-9e8e-4e03-b041-ab266270c0f2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Disposals</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_9a538641-1ae0-488c-b99b-53b4096937e9_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_791beb1f-44c9-4973-a20b-413b5337940b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_3886209b-7d30-436a-956f-e4ce494464b8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_f4e633de-8ae6-4c66-b56c-2fa3a4b2f436_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue by service type as a proportion of total revenues (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_807b9964-ca67-4c62-b0c7-c100edc39cfa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative activity</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_82bf0010-ecac-4a6f-b345-a568546183f3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ReceiveFixedSwapTwoMember_a6b60638-c552-420d-91c1-0d8fa1b76560_terseLabel_en-US" xlink:label="lab_sgry_ReceiveFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed swap</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapTwoMember_label_en-US" xlink:label="lab_sgry_ReceiveFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap Two [Member]</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapTwoMember_documentation_en-US" xlink:label="lab_sgry_ReceiveFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap Two Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapTwoMember" xlink:href="sgry-20220630.xsd#sgry_ReceiveFixedSwapTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ReceiveFixedSwapTwoMember" xlink:to="lab_sgry_ReceiveFixedSwapTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_b9e80c7d-5493-497e-a655-33e8b6b4d91a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_UnrecognizedGrantFundsReceived_bbcb5933-f342-40a7-8098-a0f25a3bdbd1_terseLabel_en-US" xlink:label="lab_sgry_UnrecognizedGrantFundsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized grant funds received</link:label>
    <link:label id="lab_sgry_UnrecognizedGrantFundsReceived_label_en-US" xlink:label="lab_sgry_UnrecognizedGrantFundsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Grant Funds Received</link:label>
    <link:label id="lab_sgry_UnrecognizedGrantFundsReceived_documentation_en-US" xlink:label="lab_sgry_UnrecognizedGrantFundsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Grant Funds Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_UnrecognizedGrantFundsReceived" xlink:href="sgry-20220630.xsd#sgry_UnrecognizedGrantFundsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_UnrecognizedGrantFundsReceived" xlink:to="lab_sgry_UnrecognizedGrantFundsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_544b822b-79c9-4533-8873-4adabb9fd47a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Rollforward of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_88cf0185-f8a4-4890-95fb-31f05873a61d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d5d274af-8eb1-4a8f-9328-5078a36a85d4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_7831c93a-2f4b-40d4-95d0-0e8a47f0ec4c_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_510f8352-0b53-4602-9552-e5c2cd8b46ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Payments) receipts related to ownership transactions with non-controlling interest holders</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_InDevelopmentDeNovoSurgicalFacilityMember_088abe52-1d85-4e20-9ce9-e229c066d78b_terseLabel_en-US" xlink:label="lab_sgry_InDevelopmentDeNovoSurgicalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Development De Novo Surgical Facility</link:label>
    <link:label id="lab_sgry_InDevelopmentDeNovoSurgicalFacilityMember_label_en-US" xlink:label="lab_sgry_InDevelopmentDeNovoSurgicalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Development De Novo Surgical Facility [Member]</link:label>
    <link:label id="lab_sgry_InDevelopmentDeNovoSurgicalFacilityMember_documentation_en-US" xlink:label="lab_sgry_InDevelopmentDeNovoSurgicalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Development De Novo Surgical Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InDevelopmentDeNovoSurgicalFacilityMember" xlink:href="sgry-20220630.xsd#sgry_InDevelopmentDeNovoSurgicalFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_InDevelopmentDeNovoSurgicalFacilityMember" xlink:to="lab_sgry_InDevelopmentDeNovoSurgicalFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_e56bba4c-9120-4ea4-a02e-40859acd9d8d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_7d2c5694-5fc4-49ea-8a4b-8b8be4f7bbe3_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Surgery Partners, Inc. stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ed5dd9b9-f1fb-456d-8d64-f8c68128f26d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_74ade778-43e6-47a8-8853-0868a54d78f5_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_f9847174-dd1b-45d2-86df-ee7eb0540f5e_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for finance lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_cf6447dd-10e3-4dfc-96ab-5707961802bb_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_02b9ae9a-1d4a-4bc5-80ca-8aabc64f4662_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e4b07ecc-b0c1-4276-ae20-76cc8a417520_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_da10a7aa-6800-40fb-bb75-7fbd0f084a9b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_a55957d9-ff6f-476f-bc95-ed0431d736a7_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b972a2e1-f719-43d5-9fba-86725574f86e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_61bc4ca1-c253-4f02-9076-93c12aa0f3cc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_92e8cfef-4728-431f-8e54-041daa608d1f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_bbcce0e0-1194-4291-a414-863f52f0ea70_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_44c6a6c9-5da3-4231-9703-1303b93c2769_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_57a240e4-a97f-4b07-adc1-7385c6e96323_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3abd20ae-e68a-44c0-9ce1-68ed75f7a4fa_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_45a70240-6018-4230-b48d-08de561500ff_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Expense and Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_9df0751d-1e9e-4494-b39f-48c6954fbd44_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d0d4c41a-8bab-4a5a-ab76-be38def1dd26_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_f179ebf4-1f7c-45a7-aba5-6870cb385ae3_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_8e870e41-2b7a-4081-a163-82b42fe2abbd_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_1b0802f5-24f4-4391-806f-14f8058ade1e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_24ad3d02-4ebc-4943-b627-6b14c0fb348d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities:</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_5f39b228-65dd-4c1a-865a-0f5c0b3c864e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7eeda3d5-0e85-4d52-8e7c-d043d32351cb_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_OperatingAndFinanceLeaseExpense_02b552d2-38c6-4796-910a-799f3cbc3a56_terseLabel_en-US" xlink:label="lab_sgry_OperatingAndFinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease expense</link:label>
    <link:label id="lab_sgry_OperatingAndFinanceLeaseExpense_label_en-US" xlink:label="lab_sgry_OperatingAndFinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Expense</link:label>
    <link:label id="lab_sgry_OperatingAndFinanceLeaseExpense_documentation_en-US" xlink:label="lab_sgry_OperatingAndFinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OperatingAndFinanceLeaseExpense" xlink:href="sgry-20220630.xsd#sgry_OperatingAndFinanceLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_OperatingAndFinanceLeaseExpense" xlink:to="lab_sgry_OperatingAndFinanceLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_6fef3eb0-2a7d-4379-8f89-ecb9919dc76a_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c789211f-acce-4d02-bd46-40ebaf89c34c_negatedTerseLabel_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to non-controlling interest&#8212;redeemable holders</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="sgry-20220630.xsd#sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_b20c13f9-850a-4c8a-95ff-5b292eb95e82_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6e9b9023-e389-477f-936b-4e59b42a4967_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_8b4f0ead-d9ba-476e-b296-7393b54b0d6c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_38c27bd4-b7ae-4751-96ab-4cb4ddb1ebd2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_9d33a224-d5e6-4ed9-9f86-5c4b4ec32e84_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Payments) receipts related to ownership transactions with non-controlling interest holders</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_9ef13006-8cf3-4e4a-a7f4-f800b87a3bd7_negatedLabel_en-US" xlink:label="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposals and deconsolidations, net</link:label>
    <link:label id="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_871798ca-ca1e-4b5d-b91e-81d3ab5cc511_negatedTerseLabel_en-US" xlink:label="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposals and deconsolidations, net</link:label>
    <link:label id="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_label_en-US" xlink:label="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposition Of Assets And Deconsolidation</link:label>
    <link:label id="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_documentation_en-US" xlink:label="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Disposition of Assets And Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:href="sgry-20220630.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:to="lab_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_VariableInterestEntityNumberOfFacilities_e2be5d63-40ac-45b1-a08b-abd1053a49f6_terseLabel_en-US" xlink:label="lab_sgry_VariableInterestEntityNumberOfFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of facilities included in VIE</link:label>
    <link:label id="lab_sgry_VariableInterestEntityNumberOfFacilities_label_en-US" xlink:label="lab_sgry_VariableInterestEntityNumberOfFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Number Of Facilities</link:label>
    <link:label id="lab_sgry_VariableInterestEntityNumberOfFacilities_documentation_en-US" xlink:label="lab_sgry_VariableInterestEntityNumberOfFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Number of Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableInterestEntityNumberOfFacilities" xlink:href="sgry-20220630.xsd#sgry_VariableInterestEntityNumberOfFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_VariableInterestEntityNumberOfFacilities" xlink:to="lab_sgry_VariableInterestEntityNumberOfFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_a5de3a4a-9b6d-4f27-b858-8f6b0def9e42_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_14998037-f41c-4e1a-8444-9f690a8cf5ff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ffb2d6bc-29e6-48f9-af8a-685c3405f0e7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_512443c2-1160-48a2-86e2-1c509e79f74e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_OtherServicesMember_cc0e60b6-c243-46d8-9c14-a87f64e6bf57_verboseLabel_en-US" xlink:label="lab_sgry_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other service revenues</link:label>
    <link:label id="lab_sgry_OtherServicesMember_label_en-US" xlink:label="lab_sgry_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Services [Member]</link:label>
    <link:label id="lab_sgry_OtherServicesMember_documentation_en-US" xlink:label="lab_sgry_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherServicesMember" xlink:href="sgry-20220630.xsd#sgry_OtherServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_OtherServicesMember" xlink:to="lab_sgry_OtherServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_55fd3f05-d31b-4367-8fe8-d6699b379755_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_4acb23c0-3931-446c-bea6-457495082150_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash outflows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_AssetsAndLiabilitiesLesseeTableTextBlock_c7340bf1-a924-4ac5-9c5d-ea3206ba36fd_terseLabel_en-US" xlink:label="lab_sgry_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Right-of-use Assets and Liabilities Related to Leases</link:label>
    <link:label id="lab_sgry_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_sgry_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_sgry_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_sgry_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="sgry-20220630.xsd#sgry_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_sgry_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentContractMember_1c69c85f-17b9-4503-8493-e25af1e514b7_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government</link:label>
    <link:label id="lab_us-gaap_GovernmentContractMember_label_en-US" xlink:label="lab_us-gaap_GovernmentContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentContractMember" xlink:to="lab_us-gaap_GovernmentContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_231c7426-5eae-4e01-b736-28eeb2788cf8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of unconsolidated affiliates, net of distributions received</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestRollForward_a9b265a1-f3f7-4a14-af3d-5890285f2b9f_terseLabel_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interests - Redeemable [Roll Forward]</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestRollForward_label_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Roll Forward]</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestRollForward_documentation_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestRollForward" xlink:href="sgry-20220630.xsd#sgry_RedeemableNoncontrollingInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward" xlink:to="lab_sgry_RedeemableNoncontrollingInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ThreePayFixedInterestRateSwapsMember_e4ffc730-d49d-48b9-ac89-13e0bbb48141_terseLabel_en-US" xlink:label="lab_sgry_ThreePayFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Pay-fixed Interest Rate Swaps</link:label>
    <link:label id="lab_sgry_ThreePayFixedInterestRateSwapsMember_label_en-US" xlink:label="lab_sgry_ThreePayFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Pay-fixed Interest Rate Swaps [Member]</link:label>
    <link:label id="lab_sgry_ThreePayFixedInterestRateSwapsMember_documentation_en-US" xlink:label="lab_sgry_ThreePayFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Pay-fixed Interest Rate Swaps Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreePayFixedInterestRateSwapsMember" xlink:href="sgry-20220630.xsd#sgry_ThreePayFixedInterestRateSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ThreePayFixedInterestRateSwapsMember" xlink:to="lab_sgry_ThreePayFixedInterestRateSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_44fa8594-903c-4954-a9b0-e010e2e023f8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of investments</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:to="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ReceiveFixedSwapOneMember_1eb6e558-3dc5-40ab-9abf-cf3e64b7e359_terseLabel_en-US" xlink:label="lab_sgry_ReceiveFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed swap</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapOneMember_label_en-US" xlink:label="lab_sgry_ReceiveFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap One [Member]</link:label>
    <link:label id="lab_sgry_ReceiveFixedSwapOneMember_documentation_en-US" xlink:label="lab_sgry_ReceiveFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receive-fixed Swap One Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapOneMember" xlink:href="sgry-20220630.xsd#sgry_ReceiveFixedSwapOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ReceiveFixedSwapOneMember" xlink:to="lab_sgry_ReceiveFixedSwapOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_5869f958-46a5-4e84-9ee8-3b549ae3d2cf_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_a705ae40-cb75-4285-bdc4-7f942a62d9ce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments_dae1f9e8-332e-466f-9906-4607fc141b5b_terseLabel_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of grants received</link:label>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments_label_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Repayments</link:label>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments_documentation_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Repayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:href="sgry-20220630.xsd#sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:to="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_94d6ec38-80b6-408e-9428-e0e75f4b5d09_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_d240dca7-1b6d-4100-abc7-ddc6be30e8f2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c2bfe104-fe32-4f38-a84e-9ddf7fe7f1e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_7b89d44c-403a-4841-b715-3457692d0b3b_terseLabel_en-US" xlink:label="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare accelerated payments and deferred governmental grants</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_label_en-US" xlink:label="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Medicare Accelerated Payments And Deferred Governmental Grants</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_documentation_en-US" xlink:label="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Medicare Accelerated Payments And Deferred Governmental Grants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:to="lab_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_69c8d994-1901-4cd9-841b-ab035ba97747_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_335861a9-940e-4d7a-915a-3ab76d170ebf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_582be505-856e-4f95-8fa5-4305998615d3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2b91ce06-c74f-4495-84d0-145b48bb5148_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2bdfd7ca-ab5a-46f8-a423-7faddfb215be_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_20a41d3f-0655-40c5-8c43-cad30a23233f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expenses</link:label>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_label_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostAndExpenseOperating" xlink:to="lab_us-gaap_OtherCostAndExpenseOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_5b87f19e-ff1e-44e3-ab48-f3314a0eb0d1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized fair value discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_26599072-d78f-432f-8620-a4eb5e44fd8a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4ae6dd44-0024-45b7-968b-ef2a0404c242_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b533dce3-707c-4786-89df-830f7ff99872_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d128f4ef-cd7d-42ac-8736-e1ba0d0d951d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_3865ef38-5314-462c-b5b7-76c62500783e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and advances to affiliates</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_dce26d32-7437-4fdc-ba1c-7b1595f93d84_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_e317381e-476f-4114-87eb-58ff4109dd91_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_5aef1aff-a855-4a34-93b1-8315bd05001f_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bc0d080b-3e7f-4d71-b25b-e89ac821408a_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_6781ca6e-e07a-45cb-9ecc-8504b55bc86f_terseLabel_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of surgical facilities owned, consolidated</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_label_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Surgical Facilities Owned, Consolidated</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_documentation_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Surgical Facilities Owned, Consolidated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:href="sgry-20220630.xsd#sgry_NumberOfSurgicalFacilitiesOwnedConsolidated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:to="lab_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_90c29ae5-f461-4092-86fe-b920bec00d3f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (expense) benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_2ba9ab47-0669-4d51-9b68-cb489d51ab7b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_860910ac-f064-42b7-b120-8af0ef07c496_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_70d3b8f7-5220-4fa6-a77f-14c1baf16472_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_3ede758b-d43e-47b1-bb04-5ea8a00363bd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_bde70baa-4e30-4239-9634-1ced3c3c0eab_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_8b90e555-b863-4664-8258-868fdb81f3ce_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NotMateriallyMoreRestrictiveMember_ba9e7f31-c3f2-4023-8183-e1ad4826dc1d_terseLabel_en-US" xlink:label="lab_sgry_NotMateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Materially More Restrictive</link:label>
    <link:label id="lab_sgry_NotMateriallyMoreRestrictiveMember_label_en-US" xlink:label="lab_sgry_NotMateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Materially More Restrictive [Member]</link:label>
    <link:label id="lab_sgry_NotMateriallyMoreRestrictiveMember_documentation_en-US" xlink:label="lab_sgry_NotMateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Materially More Restrictive [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotMateriallyMoreRestrictiveMember" xlink:href="sgry-20220630.xsd#sgry_NotMateriallyMoreRestrictiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NotMateriallyMoreRestrictiveMember" xlink:to="lab_sgry_NotMateriallyMoreRestrictiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_125cf308-7557-4a7e-bbe4-cd43b9071758_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of equity investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_714c9184-7bef-4a0a-a733-6d74f390120f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_344477ff-b344-429d-94d2-003eecfd0be1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding- diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsLineItems_91ddc545-ceab-4445-b008-d8fc2af2961e_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations [Line Items]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsLineItems_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems" xlink:to="lab_us-gaap_GuaranteeObligationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DisposalGroupOneMember_a32e3f81-13b6-44bd-a026-d864ec83b094_terseLabel_en-US" xlink:label="lab_sgry_DisposalGroupOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group One</link:label>
    <link:label id="lab_sgry_DisposalGroupOneMember_label_en-US" xlink:label="lab_sgry_DisposalGroupOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group One [Member]</link:label>
    <link:label id="lab_sgry_DisposalGroupOneMember_documentation_en-US" xlink:label="lab_sgry_DisposalGroupOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DisposalGroupOneMember" xlink:href="sgry-20220630.xsd#sgry_DisposalGroupOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DisposalGroupOneMember" xlink:to="lab_sgry_DisposalGroupOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b241601a-8a4a-4a2a-8c75-bf67d663ae76_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_b0e18168-5051-4afe-b98d-f1ec93fd856c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock_c9ecaa96-508a-4b97-8157-8d057d0a6671_terseLabel_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interests&#8212;Redeemable</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock_label_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Policy Text Block]</link:label>
    <link:label id="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock_documentation_en-US" xlink:label="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:href="sgry-20220630.xsd#sgry_RedeemableNoncontrollingInterestPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:to="lab_sgry_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_170dd811-58d1-4971-ae23-931bb5404944_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_e8838c81-c77d-485d-ba51-39c7ed7ff9bb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction and integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_7097403a-d94b-45f6-ae57-0dde49a9291a_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_010e22ed-4cd7-49d6-9d03-3ea806ce8ef7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a98529e4-6e8c-4040-ab69-d4671e9cf80e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount estimated to be reclassified as a reduction to interest expense over next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_39abf04c-4e47-4ac2-81f6-34f03f21707e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_645f90cf-2d9e-4bfa-8146-89efc26c8c2f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ProceedsFromGovernmentAssistance_d099491c-ad7a-421e-bf82-1e9cb7619563_terseLabel_en-US" xlink:label="lab_sgry_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from grants received</link:label>
    <link:label id="lab_sgry_ProceedsFromGovernmentAssistance_label_en-US" xlink:label="lab_sgry_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:label id="lab_sgry_ProceedsFromGovernmentAssistance_documentation_en-US" xlink:label="lab_sgry_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ProceedsFromGovernmentAssistance" xlink:href="sgry-20220630.xsd#sgry_ProceedsFromGovernmentAssistance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ProceedsFromGovernmentAssistance" xlink:to="lab_sgry_ProceedsFromGovernmentAssistance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_3d48f4ca-8a21-4c11-962d-5e19a36c07a3_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Source</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_2b758982-6033-4198-9253-c16737ce9b73_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50ca6e5b-9540-4093-9206-1b621bd9f770_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a6a1b74-07a8-4095-8fef-308d8f0ea294_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b95689d1-d745-4e5c-b21c-7407d1d482f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1f632bf7-364f-4ea2-99a6-bcc0fcb3b131_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6aca8278-71f0-4523-a282-01cc9bae4b6c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3de82ae0-ddc5-4d53-9558-16e0b62bf301_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_63e1d638-ae1c-42ed-a816-26cfb31adf92_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2a5ea319-45fe-47aa-b189-e08242bad1d1_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_141c4c8e-d462-47e4-8ce1-f3af1dda4a05_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_c7db96ed-29d6-4376-b5e4-ffd99d8f40fd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_f761f871-021b-4280-9d37-33e7211d1e62_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_LeaseRightOfUseAsset_d6b59850-bd48-4d31-afa3-3752accdc0db_totalLabel_en-US" xlink:label="lab_sgry_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total leased assets</link:label>
    <link:label id="lab_sgry_LeaseRightOfUseAsset_label_en-US" xlink:label="lab_sgry_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_sgry_LeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_sgry_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_LeaseRightOfUseAsset" xlink:href="sgry-20220630.xsd#sgry_LeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_LeaseRightOfUseAsset" xlink:to="lab_sgry_LeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_54b7dfce-19c5-4f61-a2a9-7b3cd2b24c4c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6af133d5-871d-40f0-a9fe-902b29acc75b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Start-up costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_9ebd04e6-4959-4fc6-956d-8bae3f2ea69b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_7b980108-deae-4e15-a816-8127c0209f51_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SelfPayRevenueMember_dc8ee560-5c76-4922-bde9-5af502cdd334_terseLabel_en-US" xlink:label="lab_sgry_SelfPayRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-pay</link:label>
    <link:label id="lab_sgry_SelfPayRevenueMember_label_en-US" xlink:label="lab_sgry_SelfPayRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Pay Revenue [Member]</link:label>
    <link:label id="lab_sgry_SelfPayRevenueMember_documentation_en-US" xlink:label="lab_sgry_SelfPayRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Pay Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SelfPayRevenueMember" xlink:href="sgry-20220630.xsd#sgry_SelfPayRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SelfPayRevenueMember" xlink:to="lab_sgry_SelfPayRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_OtherPatientServiceRevenueSourcesMember_9ea09e2e-63e1-4ee6-bf58-2b3998ea8b8a_terseLabel_en-US" xlink:label="lab_sgry_OtherPatientServiceRevenueSourcesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_sgry_OtherPatientServiceRevenueSourcesMember_label_en-US" xlink:label="lab_sgry_OtherPatientServiceRevenueSourcesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Patient Service Revenue Sources [Member]</link:label>
    <link:label id="lab_sgry_OtherPatientServiceRevenueSourcesMember_documentation_en-US" xlink:label="lab_sgry_OtherPatientServiceRevenueSourcesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Patient Service Revenue Sources [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherPatientServiceRevenueSourcesMember" xlink:href="sgry-20220630.xsd#sgry_OtherPatientServiceRevenueSourcesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_OtherPatientServiceRevenueSourcesMember" xlink:to="lab_sgry_OtherPatientServiceRevenueSourcesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e3955eca-d779-4539-ac03-cee33be1558f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_MateriallyMoreRestrictiveMember_f4b69bd4-271d-4e01-994f-148cb9db1980_terseLabel_en-US" xlink:label="lab_sgry_MateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materially More Restrictive</link:label>
    <link:label id="lab_sgry_MateriallyMoreRestrictiveMember_label_en-US" xlink:label="lab_sgry_MateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materially More Restrictive [Member]</link:label>
    <link:label id="lab_sgry_MateriallyMoreRestrictiveMember_documentation_en-US" xlink:label="lab_sgry_MateriallyMoreRestrictiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materially More Restrictive [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MateriallyMoreRestrictiveMember" xlink:href="sgry-20220630.xsd#sgry_MateriallyMoreRestrictiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_MateriallyMoreRestrictiveMember" xlink:to="lab_sgry_MateriallyMoreRestrictiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_60f81c86-3530-4132-be70-ce387463d2e4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_033bdf33-7917-42da-9a89-a6bbb8fc4a60_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalFees_1bf1ca7c-812e-4b58-ad5e-69e50f3abdbc_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional and medical fees</link:label>
    <link:label id="lab_us-gaap_ProfessionalFees_label_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees" xlink:to="lab_us-gaap_ProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_b27fc8ac-ed3c-46c8-aac0-c26a4ea43c59_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities:</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwned_539fd391-aac0-487d-86ae-d4ffdbb57d82_terseLabel_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of surgical facilities owned</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwned_label_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Surgical Facilities Owned</link:label>
    <link:label id="lab_sgry_NumberOfSurgicalFacilitiesOwned_documentation_en-US" xlink:label="lab_sgry_NumberOfSurgicalFacilitiesOwned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Surgical Facilities Owned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwned" xlink:href="sgry-20220630.xsd#sgry_NumberOfSurgicalFacilitiesOwned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NumberOfSurgicalFacilitiesOwned" xlink:to="lab_sgry_NumberOfSurgicalFacilitiesOwned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_338f08ef-1977-43e9-b5b0-2973378d2d5a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to Surgery Partners, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_0cdedb7a-709f-44a1-a402-69f5f865b39b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, including post acquisition adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b5ab44db-c4bc-433a-8362-ffb70118c1a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Information by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_182a5bb5-b233-46cc-bda5-1ccdddbc4628_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Adjusted EBITDA:</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Other Significant Reconciling Item, Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:to="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_371fbe0b-704e-4781-bd26-576fb8dfcf0d_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_5c7f1fbf-7a9c-4dae-9565-e16340369023_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_90d25b63-a0f3-426a-a884-11e0aadcd359_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_3b779dff-76ce-4bf3-9101-3d0c99ea6844_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_741451da-cbcf-41dc-800f-6aef864adb64_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SurgicalFacilityServicesMember_7e539399-12d6-4b70-920b-e866e5cbd2a2_terseLabel_en-US" xlink:label="lab_sgry_SurgicalFacilityServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facility Services</link:label>
    <link:label id="lab_sgry_SurgicalFacilityServicesMember_label_en-US" xlink:label="lab_sgry_SurgicalFacilityServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facility Services [Member]</link:label>
    <link:label id="lab_sgry_SurgicalFacilityServicesMember_documentation_en-US" xlink:label="lab_sgry_SurgicalFacilityServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facility Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SurgicalFacilityServicesMember" xlink:to="lab_sgry_SurgicalFacilityServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_ccdba2ed-74ba-461b-bf6d-4ac18b5cde3e_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_8c281b52-fe7e-418e-b1bc-6727bab11e8d_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_98aa8c0d-2a86-4588-bfbd-8dbbac8d9517_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70b9ed3f-ed38-4329-9794-e2a988e3bfad_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal effective tax rate (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_InterestRateCapTwoMember_fd96a7dd-fce1-4a1a-ae41-7f9dd52ebb5d_terseLabel_en-US" xlink:label="lab_sgry_InterestRateCapTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap</link:label>
    <link:label id="lab_sgry_InterestRateCapTwoMember_label_en-US" xlink:label="lab_sgry_InterestRateCapTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Two [Member]</link:label>
    <link:label id="lab_sgry_InterestRateCapTwoMember_documentation_en-US" xlink:label="lab_sgry_InterestRateCapTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapTwoMember" xlink:href="sgry-20220630.xsd#sgry_InterestRateCapTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_InterestRateCapTwoMember" xlink:to="lab_sgry_InterestRateCapTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2025Member_8b1b1eb4-508a-4522-aff9-3c20db1cbdd6_verboseLabel_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.750% senior unsecured notes due 2025</link:label>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2025Member_label_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2025 [Member]</link:label>
    <link:label id="lab_sgry_SeniorUnsecuredNotesDue2025Member_documentation_en-US" xlink:label="lab_sgry_SeniorUnsecuredNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member" xlink:href="sgry-20220630.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SeniorUnsecuredNotesDue2025Member" xlink:to="lab_sgry_SeniorUnsecuredNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c91ecf09-b78d-4b53-a8d8-c81c546e3fd2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt issuance costs and discounts</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_12b4fb64-5dd5-42f5-bf4a-5963231b016a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_AncillaryServicesMember_03898e00-a773-495c-a154-6ad8b0ea07ca_terseLabel_en-US" xlink:label="lab_sgry_AncillaryServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillary Services</link:label>
    <link:label id="lab_sgry_AncillaryServicesMember_label_en-US" xlink:label="lab_sgry_AncillaryServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillary Services [Member]</link:label>
    <link:label id="lab_sgry_AncillaryServicesMember_documentation_en-US" xlink:label="lab_sgry_AncillaryServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillary Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember" xlink:href="sgry-20220630.xsd#sgry_AncillaryServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_AncillaryServicesMember" xlink:to="lab_sgry_AncillaryServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_dbc445cd-63a0-42f6-abba-83fcff2295d9_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1ffd0c39-040f-4cdb-a027-0534955dfa32_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_b06d5f04-a02c-4dfd-9438-563bfb29d0d3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Rate Derivatives [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_4b51a97e-446f-486d-9c26-939528940b2b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_942069c3-97c8-461b-bb5e-b2d3383b2b02_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_28be7861-e8b6-4038-a46b-846078231810_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_6c6c7e4a-b2cb-47b1-b9b7-c6c2dfde5278_terseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries and benefits</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_d4452130-b477-4c63-ac26-291ace285fcc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_18d7e02f-3562-48d2-ab27-fd32a1d3217e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_5ebcd4fa-df63-4433-9887-56b6d4b07b4b_negatedLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax loss on disposals and deconsolidations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_aea2a9e1-0424-4314-8810-8d2321d2d747_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_f1fa8195-3582-4ce8-ae06-140d04260387_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_b49aed70-5385-4a20-8422-0accfc8b2d32_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional, general and workers' compensation insurance reserve</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserve" xlink:to="lab_us-gaap_SelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_f59023be-c4c4-4eec-899b-16ab788062ff_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7061e378-42f7-4270-a00d-627deb3833ef_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NoncashInterestIncomeExpenseNet_a242f5d4-61b4-44fe-bbec-e4b0ac4b43d8_negatedTerseLabel_en-US" xlink:label="lab_sgry_NoncashInterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense, net</link:label>
    <link:label id="lab_sgry_NoncashInterestIncomeExpenseNet_label_en-US" xlink:label="lab_sgry_NoncashInterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Interest Income (Expense), Net</link:label>
    <link:label id="lab_sgry_NoncashInterestIncomeExpenseNet_documentation_en-US" xlink:label="lab_sgry_NoncashInterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NoncashInterestIncomeExpenseNet" xlink:href="sgry-20220630.xsd#sgry_NoncashInterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NoncashInterestIncomeExpenseNet" xlink:to="lab_sgry_NoncashInterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGuaranteeObligationsTable_95e0f543-0035-492b-8701-b2b0a3a39f9a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Guarantor Obligations [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGuaranteeObligationsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Guarantor Obligations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:to="lab_us-gaap_ScheduleOfGuaranteeObligationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a66e0d81-3d4a-44b7-a056-2cb5897e1123_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_37e61f73-dec0-4053-8930-20c4ba2782df_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember_b57ff812-6efc-41f8-9176-4df557681be2_terseLabel_en-US" xlink:label="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Ambulatory Surgery Centers</link:label>
    <link:label id="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember_label_en-US" xlink:label="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Ambulatory Surgery Centers [Member]</link:label>
    <link:label id="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember_documentation_en-US" xlink:label="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facilities, Ambulatory Surgery Centers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:href="sgry-20220630.xsd#sgry_FacilitiesAmbulatorySurgeryCentersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:to="lab_sgry_FacilitiesAmbulatorySurgeryCentersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2d077f0f-4eea-47af-9359-0f03b1212bb9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8400bede-75ed-4d36-ad51-971854eb70b3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6d625b73-705c-4906-bc13-117a46da1be8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_44fb5cbb-4d99-4469-a87c-c980f3b2fc29_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_9c7bfe25-4124-449c-b8ca-27d2019c8095_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives in cash flow hedging relationships</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_f8131b2c-b498-4b86-83a8-763bf4bb4dce_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3a8bae8e-10c0-460c-8d48-0b806d8b1d1f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_c0cc3e3d-4271-4090-bc2b-ebe9cb06e955_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_46202211-2c5e-42ff-846c-4cedac64e2c2_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Assets from Segment to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_7599fc24-2238-4f7a-9d64-a65a3506db68_terseLabel_en-US" xlink:label="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, notional amount, financing component</link:label>
    <link:label id="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_label_en-US" xlink:label="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount, Financing Component</link:label>
    <link:label id="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_documentation_en-US" xlink:label="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount, Financing Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:href="sgry-20220630.xsd#sgry_DerivativeLiabilityNotionalAmountFinancingComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:to="lab_sgry_DerivativeLiabilityNotionalAmountFinancingComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b7236791-1479-49a0-9f0f-e47e1a8598d9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to non-controlling interests&#8212;non-redeemable holders</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_04ece499-2434-496a-a7f8-c985a72c9b94_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Amounts and Fair Values of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_5f6baa96-8847-48cf-afd9-f69e622eabb3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_f60b2576-f290-457f-b789-7cf6afcb653d_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired_723d3df7-a3ba-4181-859c-f5091169edb5_terseLabel_en-US" xlink:label="lab_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of non-controlling interests in surgical facilities acquired</link:label>
    <link:label id="lab_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired_label_en-US" xlink:label="lab_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Non-Controlling Interests In Surgical Facilities Acquired</link:label>
    <link:label id="lab_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired_documentation_en-US" xlink:label="lab_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Non-Controlling Interests In Surgical Facilities Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired" xlink:href="sgry-20220630.xsd#sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired" xlink:to="lab_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CostReportLiabilitiesCurrent_f5eba6b9-3fb6-436f-a459-4c8ff799a4bc_terseLabel_en-US" xlink:label="lab_sgry_CostReportLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost report liabilities</link:label>
    <link:label id="lab_sgry_CostReportLiabilitiesCurrent_label_en-US" xlink:label="lab_sgry_CostReportLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Report Liabilities, Current</link:label>
    <link:label id="lab_sgry_CostReportLiabilitiesCurrent_documentation_en-US" xlink:label="lab_sgry_CostReportLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Report Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CostReportLiabilitiesCurrent" xlink:href="sgry-20220630.xsd#sgry_CostReportLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CostReportLiabilitiesCurrent" xlink:to="lab_sgry_CostReportLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_aa223da5-fee3-4d05-b427-d0be3feb3333_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_A2017TermLoanMaturing2024Member_18e64135-8070-4d71-902e-2dccbe68a247_verboseLabel_en-US" xlink:label="lab_sgry_A2017TermLoanMaturing2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secure term loan</link:label>
    <link:label id="lab_sgry_A2017TermLoanMaturing2024Member_label_en-US" xlink:label="lab_sgry_A2017TermLoanMaturing2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Term Loan, Maturing 2024 [Member]</link:label>
    <link:label id="lab_sgry_A2017TermLoanMaturing2024Member_documentation_en-US" xlink:label="lab_sgry_A2017TermLoanMaturing2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Term Loan, Maturing 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017TermLoanMaturing2024Member" xlink:href="sgry-20220630.xsd#sgry_A2017TermLoanMaturing2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_A2017TermLoanMaturing2024Member" xlink:to="lab_sgry_A2017TermLoanMaturing2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_f6c56304-2637-4ba1-ba37-ac7c19432c2c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_label_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfRealEstateProperties" xlink:to="lab_us-gaap_NumberOfRealEstateProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2d388e49-7b2d-4a0e-adff-844be8f4e925_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ffeb1859-e128-4cb5-9f85-669f17997eda_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_8dc1f823-0e21-4a0c-97b5-cb31fb9b35b8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred dividends</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember_11ac2400-a1a5-4326-9d5a-ed46c2c1775c_terseLabel_en-US" xlink:label="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Receive-fixed Interest Rate Swaps</link:label>
    <link:label id="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember_label_en-US" xlink:label="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Receive-fixed Interest Rate Swaps [Member]</link:label>
    <link:label id="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember_documentation_en-US" xlink:label="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Receive-fixed Interest Rate Swaps Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:href="sgry-20220630.xsd#sgry_ThreeReceiveFixedInterestRateSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:to="lab_sgry_ThreeReceiveFixedInterestRateSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_08630891-7f94-446a-bc16-d8dd5812468c_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_fedcc441-6f2e-43b4-aa10-01b9e92d6ec3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_f18f76c5-111a-4e64-9df1-9ff4efc38851_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_6205df23-25bd-47c7-b13e-b85bfcbfe1b5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-based compensation (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_e487e7ed-e032-4bc0-ae83-31437453c44e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_8d049486-15a4-4118-b3a7-1f5abf8804f0_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_9499c138-c9af-4df7-b3cf-47b1661d7eac_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_681f6d64-b6b3-4a8b-b926-35e4e0c533ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefits related to vesting of restricted stock awards</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_IncreaseDecreaseInFinanceLeaseLiability_fb9cf046-0778-450e-9e0c-6dbdd214d187_terseLabel_en-US" xlink:label="lab_sgry_IncreaseDecreaseInFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in finance lease liabilities</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInFinanceLeaseLiability_label_en-US" xlink:label="lab_sgry_IncreaseDecreaseInFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Finance Lease Liability</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInFinanceLeaseLiability_documentation_en-US" xlink:label="lab_sgry_IncreaseDecreaseInFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInFinanceLeaseLiability" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_IncreaseDecreaseInFinanceLeaseLiability" xlink:to="lab_sgry_IncreaseDecreaseInFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f5ac2a61-d9d5-4c65-84d4-21f9c03d9db5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c836ff58-aa4e-460d-87a3-b2b6d6851960_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4c562952-ce81-4cbd-9565-b09fcf4e8baf_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_9d978686-1579-418b-8714-a98bda8e5916_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_dc54ec34-baa1-4fda-98a5-8f1b5079c73f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_4db3d019-ba4f-4773-a0b9-3413dc45114d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of facilities acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_f31b1da2-0c45-43fb-8c69-a6c5e635041c_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of businesses acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_6cc6d2d9-123c-428c-be4d-0b00d75b8e6b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation on property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_c68bb59c-7c44-43cd-8e68-c8570fd951d0_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_SurgicalFacilitiesExistingMarketsMember_fb6cfb96-666c-4d21-a497-51348aae2e30_terseLabel_en-US" xlink:label="lab_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities, Existing Markets</link:label>
    <link:label id="lab_sgry_SurgicalFacilitiesExistingMarketsMember_label_en-US" xlink:label="lab_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities, Existing Markets [Member]</link:label>
    <link:label id="lab_sgry_SurgicalFacilitiesExistingMarketsMember_documentation_en-US" xlink:label="lab_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Facilities, Existing Markets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilitiesExistingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:to="lab_sgry_SurgicalFacilitiesExistingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_13cc4114-51b0-4f83-9da7-78fcf97e61d2_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_cace9517-f586-4a1c-ace7-5636e292318a_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Rollforward of Noncontrolling Interest - Redeemable</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_61615d43-284f-41d0-8c69-949f87c3a8ca_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from equity offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_909a89e1-399a-4bdc-85d4-e94ebe8977e3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b8a2abba-1862-4374-aa7d-5746466c8305_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding- basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_28707142-f237-4e49-9c3f-196eb1128425_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_4f4c58bf-ece0-4807-9c0d-e8cd672a3026_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CashFlowLesseeAbstract_f5f494bf-0562-4b94-b4b6-9e5e28e12fc8_terseLabel_en-US" xlink:label="lab_sgry_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_sgry_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_sgry_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:label id="lab_sgry_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_sgry_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CashFlowLesseeAbstract" xlink:href="sgry-20220630.xsd#sgry_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CashFlowLesseeAbstract" xlink:to="lab_sgry_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapOneMember_c93c4054-f656-4843-9940-c857c9949444_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapOneMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap One [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapOneMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap One Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapOneMember" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapOneMember" xlink:to="lab_sgry_PayFixedSwapOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_fb4fabce-204a-45da-b802-c01180c7dd20_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_2ee91f62-740f-43ac-9b30-b3ed555282ba_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_48225c3e-92da-4bff-aac0-41e3b30e7f62_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_5844a0c2-4e59-464d-9208-c241fe745ca0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b980cb48-25fe-4fe1-9ee5-b338522cd74c_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests&#8212;redeemable</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6e0ddfee-0515-41e8-a3a2-dd053158c58d_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_899d2e65-9472-4761-ac3d-a639acf5dd1c_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_01d17c98-6923-4d83-80cd-cc5638fbb124_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted shares</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_29215a95-492d-40d5-95f9-fa9051ea313d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_a9a1bc43-ace4-441e-8c34-6c64aaf81ebb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred share conversion (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired_555cebbc-a895-4477-b109-d07d28059539_terseLabel_en-US" xlink:label="lab_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of non-controlling interests in in-development de novo surgical facilities acquired</link:label>
    <link:label id="lab_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired_label_en-US" xlink:label="lab_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Non-Controlling Interests In In-Development De Novo Surgical Facilities Acquired</link:label>
    <link:label id="lab_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired_documentation_en-US" xlink:label="lab_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Non-Controlling Interests In In-Development De Novo Surgical Facilities Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired" xlink:href="sgry-20220630.xsd#sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired" xlink:to="lab_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_47dee86b-c873-4296-8ec8-91460f037368_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_e3f4f3da-4acd-4482-aaab-3230b95e2966_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets_82de57c9-9f40-440b-a2ce-f8679527a6db_terseLabel_en-US" xlink:label="lab_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in finance lease assets</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets_label_en-US" xlink:label="lab_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Finance Lease, Right-Of-Use Assets</link:label>
    <link:label id="lab_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Finance Lease, Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets" xlink:to="lab_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_d8cde262-3fc6-434e-942a-f4409e46c2b7_terseLabel_en-US" xlink:label="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and disposal of shares of non-controlling interests, net</link:label>
    <link:label id="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_label_en-US" xlink:label="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net</link:label>
    <link:label id="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_documentation_en-US" xlink:label="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:href="sgry-20220630.xsd#sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:to="lab_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_41b9d37a-3446-4836-bec1-9bfe648e33fe_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapTwoMember_27588545-796a-4d68-9839-378f8f879564_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapTwoMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Two [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapTwoMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Two Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapTwoMember" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapTwoMember" xlink:to="lab_sgry_PayFixedSwapTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_dc6bef1a-ee39-4358-8296-8e46f797a744_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_989fad30-7d42-4917-b2d2-403e1da8746a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interests&#8212; Non-Redeemable</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_3bdc9b6b-e6ae-4ec8-a285-8c91a8b73f1e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_e35b3295-c97d-4113-ae35-0b241ba4ef57_terseLabel_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, current</link:label>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_label_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net Of Discount, Current</link:label>
    <link:label id="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_documentation_en-US" xlink:label="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net Of Discount, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:href="sgry-20220630.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:to="lab_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_556ed03f-b119-4e83-904f-25d63cdaed27_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_c2af1634-acb6-4e93-a001-2011c45d2723_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_ec22c190-1a7a-4ab2-9701-133119cdde3e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_63211b91-787b-4970-9a39-b8a7d2ed818c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to non-controlling interests&#8212;redeemable</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_89c46d9c-d158-4341-8a6a-7c29b5470a5c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_a124bac4-6a09-49b3-821e-a993bd585a69_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_de537a63-e418-48b7-b63e-a5f06f612ab3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_183bebec-ed46-4048-a3b4-455683d5f1cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b54ac714-643b-4ef2-bf72-34b11d8d2f90_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_c69b82f3-bdb0-40ca-87fa-332472851ee8_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Revenue and Operating Income</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_63af66d8-405b-4836-bae8-8c466b0047bc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized non-controlling interests</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_bbd178bd-8100-4b24-ae75-436844779f9c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsMember_e2d9c078-13b1-4a47-97f0-46c856246bbb_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsMember" xlink:to="lab_us-gaap_EquityMethodInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_abe8af1f-071e-4e0e-8a49-f6c5a0a872b0_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a5ca8da1-41be-41a6-a171-d10cccca0ec2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_c918c843-8714-4d0f-9af1-09387252e548_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of equity offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_8dab1649-c8fa-4f77-b3e9-5160f193560c_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_3c531ac8-9aba-435c-b413-e9a191e19801_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1d6b1964-5035-4010-b44c-813b722c8ce3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_40c11595-4edb-4637-9b9e-d5bdb84b7241_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_f86dfd74-0f96-43e6-b33c-dac3b83ff7cd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_2998a27e-6ccf-430e-a80e-9f50cd95d692_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_HealthcareOrganizationPatientServiceMember_278baa34-cbf2-404e-afa7-be407c1851ea_verboseLabel_en-US" xlink:label="lab_sgry_HealthcareOrganizationPatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent service revenues</link:label>
    <link:label id="lab_sgry_HealthcareOrganizationPatientServiceMember_393026ee-e932-464e-a2d6-099d45840ae6_terseLabel_en-US" xlink:label="lab_sgry_HealthcareOrganizationPatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient service revenues</link:label>
    <link:label id="lab_sgry_HealthcareOrganizationPatientServiceMember_label_en-US" xlink:label="lab_sgry_HealthcareOrganizationPatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Organization, Patient Service [Member]</link:label>
    <link:label id="lab_sgry_HealthcareOrganizationPatientServiceMember_documentation_en-US" xlink:label="lab_sgry_HealthcareOrganizationPatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Organization, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_HealthcareOrganizationPatientServiceMember" xlink:href="sgry-20220630.xsd#sgry_HealthcareOrganizationPatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember" xlink:to="lab_sgry_HealthcareOrganizationPatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_3686f0f4-eacc-48b8-b2e2-206b668d9631_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_eac5a62a-85c3-4e62-86b8-a0834a47b852_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_c1594588-8261-4820-a437-97d8ab18f276_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Rate Swaps and Interest Rate Caps Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_7c33c192-68ec-40b1-8115-bc9944b12c5a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_f8ddcbd7-e095-4c24-bd27-ca5dadecbb6d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapThreeMember_ef50e64c-e087-4c2a-8787-3ad918fe52bd_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapThreeMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Three [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapThreeMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Three Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapThreeMember" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapThreeMember" xlink:to="lab_sgry_PayFixedSwapThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_FinanceLeaseCost_cf8ab282-f22e-4a00-8cde-7c40d7e5ac84_totalLabel_en-US" xlink:label="lab_sgry_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease costs</link:label>
    <link:label id="lab_sgry_FinanceLeaseCost_label_en-US" xlink:label="lab_sgry_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_sgry_FinanceLeaseCost_documentation_en-US" xlink:label="lab_sgry_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost" xlink:href="sgry-20220630.xsd#sgry_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_FinanceLeaseCost" xlink:to="lab_sgry_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_83c28b39-3693-4a7a-8ee9-f79d1dd610ec_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_33fc44f8-15d2-40c6-9e72-c01f86a358d6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Availability on line of credit instrument</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6b4ecdb0-c756-475b-9ce2-2cae06355713_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_9d9c668f-f2b4-48d2-835c-cef193425ba4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest rate of derivative instrument (percent)</link:label>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeVariableInterestRate" xlink:to="lab_us-gaap_DerivativeVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_b8afe36f-52cf-4966-830f-fc208cdc55eb_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_52cdd5ff-2cbb-452b-b11c-eaabd3071bb3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_fb5c7ead-fbf9-4b45-b5e3-da3d2a112aa1_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimatedInsuranceRecoveries_b556d5de-7330-456f-8aa3-2d62eba5ecf3_terseLabel_en-US" xlink:label="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected insurance recoveries</link:label>
    <link:label id="lab_us-gaap_EstimatedInsuranceRecoveries_label_en-US" xlink:label="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Insurance Recoveries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimatedInsuranceRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimatedInsuranceRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimatedInsuranceRecoveries" xlink:to="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_b1190a0d-0e17-44d7-930c-bfd45aaef700_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3fe95b24-dbb0-4a00-83e0-af1c91ed1f51_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_c0cf0619-d7f9-4c07-bf1c-33cdc3d9e1bb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_PayFixedSwapFourMember_1669ce01-b30a-4808-a220-779d2ac5c75f_terseLabel_en-US" xlink:label="lab_sgry_PayFixedSwapFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed swap</link:label>
    <link:label id="lab_sgry_PayFixedSwapFourMember_label_en-US" xlink:label="lab_sgry_PayFixedSwapFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Four [Member]</link:label>
    <link:label id="lab_sgry_PayFixedSwapFourMember_documentation_en-US" xlink:label="lab_sgry_PayFixedSwapFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay-fixed Swap Four Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFourMember" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_PayFixedSwapFourMember" xlink:to="lab_sgry_PayFixedSwapFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_bfeb3ab9-7d41-4438-a72c-c5e9006d6165_terseLabel_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected tax savings period</link:label>
    <link:label id="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_label_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Tax Agreement, Projected Tax Savings, Term</link:label>
    <link:label id="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_documentation_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Tax Agreement, Projected Tax Savings, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:href="sgry-20220630.xsd#sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:to="lab_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_6785f51b-bc1e-4a1d-b025-815e6f82ec70_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_a37c4832-5b9a-426c-9e41-3f6f5a2e7cfc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_5bf8f15b-1f04-4244-9dd9-e8be26e16591_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other litigation costs</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a753fd45-1f5f-4666-88d0-7cfa811d3b8c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b9a1742e-77a7-4052-8d24-86aa7c16ae0d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_04f04fb9-b080-41fb-966d-7e98f0631f53_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_4e0cad91-0349-48f4-aeeb-fda8182690f4_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_5bb4f329-d1fe-4d73-8f3b-1fa967f7f89c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_546faabd-c429-4817-8b20-891419ba5b20_terseLabel_en-US" xlink:label="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare accelerated payments and deferred governmental grants</link:label>
    <link:label id="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_label_en-US" xlink:label="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Accelerated Payments And Deferred Governmental Grants, Current</link:label>
    <link:label id="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_documentation_en-US" xlink:label="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Accelerated Payments And Deferred Governmental Grants, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:href="sgry-20220630.xsd#sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:to="lab_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2bcce059-1a03-4571-bd1e-1de3faa51bfe_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_45d6e566-fa84-4de9-813b-5f79c5e00fbd_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_f58966a8-5dbe-481b-9cc8-60085e62ffba_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_492184ba-5409-4d6b-99bb-a801257f167c_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_b00388ee-28f2-4504-a468-daf2296369f0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_2a4993f2-22ba-453d-b9c4-a726358a7af6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_e3c90c90-1171-4e00-92aa-49f65d13cb73_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_4db05133-2b78-4699-8075-58a98cbe38e5_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash consideration</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_410ad55c-109f-4ee0-8c1d-9a06cc6a8da5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_c6b7748c-dad8-4238-9e38-8d3ad4215148_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_VariableAndShortTermLeaseCost_4af14197-bc47-43ba-b8e4-a316269c5178_terseLabel_en-US" xlink:label="lab_sgry_VariableAndShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable and short-term lease costs</link:label>
    <link:label id="lab_sgry_VariableAndShortTermLeaseCost_label_en-US" xlink:label="lab_sgry_VariableAndShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable And Short-Term Lease, Cost</link:label>
    <link:label id="lab_sgry_VariableAndShortTermLeaseCost_documentation_en-US" xlink:label="lab_sgry_VariableAndShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable And Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableAndShortTermLeaseCost" xlink:href="sgry-20220630.xsd#sgry_VariableAndShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_VariableAndShortTermLeaseCost" xlink:to="lab_sgry_VariableAndShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_75428690-f85c-4b44-8567-5d68381f1ad9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_0ae8ced4-24dc-4f4b-9aaa-77e1920a98c1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of equity investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_040d991f-a8cf-44f6-8bc7-0fd3e863503e_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_InterestRateCapOneMember_9df207e4-cd1d-4504-a138-80182bba2415_terseLabel_en-US" xlink:label="lab_sgry_InterestRateCapOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap</link:label>
    <link:label id="lab_sgry_InterestRateCapOneMember_label_en-US" xlink:label="lab_sgry_InterestRateCapOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap One [Member]</link:label>
    <link:label id="lab_sgry_InterestRateCapOneMember_documentation_en-US" xlink:label="lab_sgry_InterestRateCapOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapOneMember" xlink:href="sgry-20220630.xsd#sgry_InterestRateCapOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_InterestRateCapOneMember" xlink:to="lab_sgry_InterestRateCapOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_8b0c00ec-9012-43c3-a74e-3528d34586de_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_a0391d6b-fbd3-4593-8d16-8d2ee6601ba3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_817fc5fe-801b-4456-97d1-2378ca9923ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of unconsolidated affiliates</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration_68c2a057-2f66-45f3-84c3-3d17e5dbb5b9_terseLabel_en-US" xlink:label="lab_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of surgical facilities contributed as non-cash consideration</link:label>
    <link:label id="lab_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration_label_en-US" xlink:label="lab_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Number Of Surgical Facilities Contributed As Non-Cash Consideration</link:label>
    <link:label id="lab_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration_documentation_en-US" xlink:label="lab_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Number Of Surgical Facilities Contributed As Non-Cash Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration" xlink:href="sgry-20220630.xsd#sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration" xlink:to="lab_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_953c5e49-f436-456d-8e86-23894749a843_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e3ee4089-6159-426b-8756-58c04d9c71af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_60f1fdbc-06b2-425b-ac9a-046ad3086d95_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_27a4cd79-8eb4-4c35-927a-30ad61df8f43_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_42500e4c-c67e-425b-84b9-0c6b5e67c1a7_terseLabel_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative tax agreement, basis spread on variable rate (percent)</link:label>
    <link:label id="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_label_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Tax Agreement, Interest Rate, Basis Spread on Variable Rate</link:label>
    <link:label id="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_documentation_en-US" xlink:label="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Tax Agreement, Interest Rate, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:href="sgry-20220630.xsd#sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:to="lab_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_06336f44-1bac-4a37-b150-7ba12a617c92_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b7dff998-0302-4c39-acf0-2fe00e570dfe_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments_20542203-0720-4eb0-a28d-a578a6e36d6a_terseLabel_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred accelerated payments</link:label>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments_label_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grants, Deferred Accelerated Payments</link:label>
    <link:label id="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments_documentation_en-US" xlink:label="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grants, Deferred Accelerated Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:href="sgry-20220630.xsd#sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:to="lab_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>sgry-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bf0c9919-675a-4090-9889-2da6d013d12b,g:8071f056-30bb-4692-9c60-1fa924dc9a77-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.surgerypartners.com/role/Cover" xlink:type="simple" xlink:href="sgry-20220630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1defb89b-c764-4f15-8cbb-90c42acf345a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_DocumentType_1defb89b-c764-4f15-8cbb-90c42acf345a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_214b1cac-b2be-4f2c-82ac-2c9af4b32acc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_DocumentQuarterlyReport_214b1cac-b2be-4f2c-82ac-2c9af4b32acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9300d2c9-9c02-4d9a-8ea9-20554b722a62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_DocumentPeriodEndDate_9300d2c9-9c02-4d9a-8ea9-20554b722a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8df4b13a-d5ed-41b8-8f5d-2afc616bf903" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_DocumentTransitionReport_8df4b13a-d5ed-41b8-8f5d-2afc616bf903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a7a13513-88e7-4f93-a63c-ce3d7c5725e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityFileNumber_a7a13513-88e7-4f93-a63c-ce3d7c5725e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_60b837bf-ee36-4bcb-a554-0bbd7e6dc988" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityRegistrantName_60b837bf-ee36-4bcb-a554-0bbd7e6dc988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4e3cedf5-8730-4785-a833-cc9671454146" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4e3cedf5-8730-4785-a833-cc9671454146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_21edc505-bdf8-4395-89f4-58b578f5c6ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityTaxIdentificationNumber_21edc505-bdf8-4395-89f4-58b578f5c6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2660eb46-18ee-463a-9beb-14ac05fccdbf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityAddressAddressLine1_2660eb46-18ee-463a-9beb-14ac05fccdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3278c970-140a-4f06-90bd-3cb7af4fd7b5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityAddressCityOrTown_3278c970-140a-4f06-90bd-3cb7af4fd7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4d55529b-5f7d-41a9-8a85-021a3466e782" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityAddressStateOrProvince_4d55529b-5f7d-41a9-8a85-021a3466e782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2241f9b8-52a6-4cec-845b-64c73611fb98" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityAddressPostalZipCode_2241f9b8-52a6-4cec-845b-64c73611fb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_1f7b8095-57c5-4e2c-b2e7-9e26306eb120" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_CityAreaCode_1f7b8095-57c5-4e2c-b2e7-9e26306eb120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_53411643-4579-4d45-bed2-4cdc60eaf0ad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_LocalPhoneNumber_53411643-4579-4d45-bed2-4cdc60eaf0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6b97b19b-6896-472c-9d90-398da10cf7d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_Security12bTitle_6b97b19b-6896-472c-9d90-398da10cf7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_48d69ffe-b357-4dbe-80e1-5c4d6915a478" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_TradingSymbol_48d69ffe-b357-4dbe-80e1-5c4d6915a478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c662e156-74b8-44c3-836c-8c21d6719905" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_SecurityExchangeName_c662e156-74b8-44c3-836c-8c21d6719905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_00214466-c704-41c0-88e8-baf13bafbc84" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityCurrentReportingStatus_00214466-c704-41c0-88e8-baf13bafbc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_42ecd8a9-3556-4c49-afbc-b49e20bcf963" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityInteractiveDataCurrent_42ecd8a9-3556-4c49-afbc-b49e20bcf963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_7eefd14a-d36c-4918-8f5c-888b5fff96cc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityFilerCategory_7eefd14a-d36c-4918-8f5c-888b5fff96cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a061e274-d4d2-479f-93b2-5e200ffbff3d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntitySmallBusiness_a061e274-d4d2-479f-93b2-5e200ffbff3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3469a0a5-ad09-4155-a306-7d1f87d73a83" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityEmergingGrowthCompany_3469a0a5-ad09-4155-a306-7d1f87d73a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f270a0d0-2c74-4b6c-8daa-bf47d9f74001" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityShellCompany_f270a0d0-2c74-4b6c-8daa-bf47d9f74001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_17f9bf37-d191-4305-a804-62154ce8ad65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_17f9bf37-d191-4305-a804-62154ce8ad65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c712b246-2ccb-4415-9f41-c714090f003a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_EntityCentralIndexKey_c712b246-2ccb-4415-9f41-c714090f003a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_5574fd1a-7478-46cd-979e-a50f3f3de323" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_CurrentFiscalYearEndDate_5574fd1a-7478-46cd-979e-a50f3f3de323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e9707d89-7a33-4ae3-833f-ffe5b31811f7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_DocumentFiscalYearFocus_e9707d89-7a33-4ae3-833f-ffe5b31811f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8fc1ca2b-de21-45d5-8235-80a8bd8a96d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8fc1ca2b-de21-45d5-8235-80a8bd8a96d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5071ddc5-6390-4d8f-888e-9afe843de8c0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0be397cb-14f6-46e3-9f51-3b263d305758" xlink:to="loc_dei_AmendmentFlag_5071ddc5-6390-4d8f-888e-9afe843de8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sgry-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_66dca4b9-34fb-4038-894f-b7157be31526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_57c887c1-582d-4ed6-b75d-1946f7b52be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_66dca4b9-34fb-4038-894f-b7157be31526" xlink:to="loc_us-gaap_AssetsAbstract_57c887c1-582d-4ed6-b75d-1946f7b52be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_aa9fcfa5-7dbd-4e21-b25c-ef879bb2ce5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_57c887c1-582d-4ed6-b75d-1946f7b52be9" xlink:to="loc_us-gaap_AssetsCurrentAbstract_aa9fcfa5-7dbd-4e21-b25c-ef879bb2ce5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_83cc64e7-5bb4-417e-b086-6da544c448da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aa9fcfa5-7dbd-4e21-b25c-ef879bb2ce5c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_83cc64e7-5bb4-417e-b086-6da544c448da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0d9def6f-b460-48bc-98a7-5d3ed5e5f346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aa9fcfa5-7dbd-4e21-b25c-ef879bb2ce5c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0d9def6f-b460-48bc-98a7-5d3ed5e5f346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4750e79e-3e0b-43c9-b0e4-3bdb80f9e47f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aa9fcfa5-7dbd-4e21-b25c-ef879bb2ce5c" xlink:to="loc_us-gaap_InventoryNet_4750e79e-3e0b-43c9-b0e4-3bdb80f9e47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_1e9e15f4-8c2b-41d6-8fcc-ddb3c177b7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aa9fcfa5-7dbd-4e21-b25c-ef879bb2ce5c" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_1e9e15f4-8c2b-41d6-8fcc-ddb3c177b7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_691b6267-2fc9-458c-b06f-e0deeac0ee4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aa9fcfa5-7dbd-4e21-b25c-ef879bb2ce5c" xlink:to="loc_us-gaap_OtherAssetsCurrent_691b6267-2fc9-458c-b06f-e0deeac0ee4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d30aae8f-7cb0-4c80-bf2d-09dd59d47010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aa9fcfa5-7dbd-4e21-b25c-ef879bb2ce5c" xlink:to="loc_us-gaap_AssetsCurrent_d30aae8f-7cb0-4c80-bf2d-09dd59d47010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_10fbef42-b68a-4ca2-8fd2-7fc676b8d749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_57c887c1-582d-4ed6-b75d-1946f7b52be9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_10fbef42-b68a-4ca2-8fd2-7fc676b8d749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_38aea833-f618-4ec7-a570-1067e9d1c864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_57c887c1-582d-4ed6-b75d-1946f7b52be9" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_38aea833-f618-4ec7-a570-1067e9d1c864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_540f0ddb-f4c4-4944-962b-717b327bc6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_57c887c1-582d-4ed6-b75d-1946f7b52be9" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_540f0ddb-f4c4-4944-962b-717b327bc6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f65de816-bfb4-499f-8afd-cd34d30d893e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_57c887c1-582d-4ed6-b75d-1946f7b52be9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f65de816-bfb4-499f-8afd-cd34d30d893e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ce3da857-2c12-48fd-8438-c4c45a979709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_57c887c1-582d-4ed6-b75d-1946f7b52be9" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ce3da857-2c12-48fd-8438-c4c45a979709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8c2d57de-2011-4e38-b59d-8364a0ea1555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_57c887c1-582d-4ed6-b75d-1946f7b52be9" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8c2d57de-2011-4e38-b59d-8364a0ea1555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d47f015f-4375-4153-a990-65296416cd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_57c887c1-582d-4ed6-b75d-1946f7b52be9" xlink:to="loc_us-gaap_Assets_d47f015f-4375-4153-a990-65296416cd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4c1eae0-eefb-4549-a6fb-5f1bd286d711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_66dca4b9-34fb-4038-894f-b7157be31526" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4c1eae0-eefb-4549-a6fb-5f1bd286d711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_672f1be1-93bb-4f84-970e-da7c2e6d0547" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4c1eae0-eefb-4549-a6fb-5f1bd286d711" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_672f1be1-93bb-4f84-970e-da7c2e6d0547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2c965416-9074-4987-9158-3f3ecbeccd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_672f1be1-93bb-4f84-970e-da7c2e6d0547" xlink:to="loc_us-gaap_AccountsPayableCurrent_2c965416-9074-4987-9158-3f3ecbeccd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_aaa9656c-a44d-4fcb-b4dd-26c29239408f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_672f1be1-93bb-4f84-970e-da7c2e6d0547" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_aaa9656c-a44d-4fcb-b4dd-26c29239408f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_28170413-6c87-4be1-b205-dd349b54c0de" xlink:href="sgry-20220630.xsd#sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_672f1be1-93bb-4f84-970e-da7c2e6d0547" xlink:to="loc_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent_28170413-6c87-4be1-b205-dd349b54c0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a3329529-d81d-4545-a1cc-712e6ae420a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_672f1be1-93bb-4f84-970e-da7c2e6d0547" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_a3329529-d81d-4545-a1cc-712e6ae420a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_7b3aa043-4a0c-48a5-88ab-71c5c6746d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_672f1be1-93bb-4f84-970e-da7c2e6d0547" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_7b3aa043-4a0c-48a5-88ab-71c5c6746d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2ae58243-5d8c-435a-ad8d-3f632fe97523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_672f1be1-93bb-4f84-970e-da7c2e6d0547" xlink:to="loc_us-gaap_LiabilitiesCurrent_2ae58243-5d8c-435a-ad8d-3f632fe97523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cfb1ebce-107a-40d0-8cf7-b155f7b25a80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4c1eae0-eefb-4549-a6fb-5f1bd286d711" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cfb1ebce-107a-40d0-8cf7-b155f7b25a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dadc0f9a-d098-4cd4-8c22-e51ab31afb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4c1eae0-eefb-4549-a6fb-5f1bd286d711" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dadc0f9a-d098-4cd4-8c22-e51ab31afb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_63787e61-8333-419f-81b2-1b789390ef40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4c1eae0-eefb-4549-a6fb-5f1bd286d711" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_63787e61-8333-419f-81b2-1b789390ef40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b2a74d05-bddd-4535-aea1-1333e088034e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4c1eae0-eefb-4549-a6fb-5f1bd286d711" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b2a74d05-bddd-4535-aea1-1333e088034e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6380155d-4489-48f2-918f-be07f1526997" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4c1eae0-eefb-4549-a6fb-5f1bd286d711" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6380155d-4489-48f2-918f-be07f1526997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_37155379-823f-4f18-8a60-9226a44c75c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6380155d-4489-48f2-918f-be07f1526997" xlink:to="loc_us-gaap_PreferredStockValue_37155379-823f-4f18-8a60-9226a44c75c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_41c28705-4982-4d4e-8b15-85c292f0cbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6380155d-4489-48f2-918f-be07f1526997" xlink:to="loc_us-gaap_CommonStockValueOutstanding_41c28705-4982-4d4e-8b15-85c292f0cbd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_51e66eed-0d04-4918-991b-8a22a0d17aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6380155d-4489-48f2-918f-be07f1526997" xlink:to="loc_us-gaap_AdditionalPaidInCapital_51e66eed-0d04-4918-991b-8a22a0d17aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b6bcfbbf-6a66-440b-9f0f-8316ebce30d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6380155d-4489-48f2-918f-be07f1526997" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b6bcfbbf-6a66-440b-9f0f-8316ebce30d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5d98a193-17f0-4c88-972a-d17153616c46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6380155d-4489-48f2-918f-be07f1526997" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5d98a193-17f0-4c88-972a-d17153616c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4c6dc72f-8c2b-4ed5-9c54-306b438991e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6380155d-4489-48f2-918f-be07f1526997" xlink:to="loc_us-gaap_StockholdersEquity_4c6dc72f-8c2b-4ed5-9c54-306b438991e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3b30a0a1-6dc3-44bb-b586-0a348165716f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6380155d-4489-48f2-918f-be07f1526997" xlink:to="loc_us-gaap_MinorityInterest_3b30a0a1-6dc3-44bb-b586-0a348165716f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_848dfe62-65b1-4851-8d20-93c660eb12a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6380155d-4489-48f2-918f-be07f1526997" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_848dfe62-65b1-4851-8d20-93c660eb12a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d6165d47-7509-4296-8238-25071600f919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4c1eae0-eefb-4549-a6fb-5f1bd286d711" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d6165d47-7509-4296-8238-25071600f919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="sgry-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f035a7c5-efdd-4bfd-bee4-1d0bff45b665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_53908572-694e-44bc-b006-69849d201e26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f035a7c5-efdd-4bfd-bee4-1d0bff45b665" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_53908572-694e-44bc-b006-69849d201e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9bd4c7e9-b4d5-46be-894a-137cc22e07a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f035a7c5-efdd-4bfd-bee4-1d0bff45b665" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9bd4c7e9-b4d5-46be-894a-137cc22e07a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_df2659c7-5921-4efa-b343-4555017def19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f035a7c5-efdd-4bfd-bee4-1d0bff45b665" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_df2659c7-5921-4efa-b343-4555017def19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_42c349fe-bff9-4b33-8d12-817b5480a870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f035a7c5-efdd-4bfd-bee4-1d0bff45b665" xlink:to="loc_us-gaap_PreferredStockSharesIssued_42c349fe-bff9-4b33-8d12-817b5480a870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_aae4910e-84e6-4aa7-8bc1-ccf391b96ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f035a7c5-efdd-4bfd-bee4-1d0bff45b665" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_aae4910e-84e6-4aa7-8bc1-ccf391b96ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9a46d3d5-ea64-431a-9dc8-c092af4766d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f035a7c5-efdd-4bfd-bee4-1d0bff45b665" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9a46d3d5-ea64-431a-9dc8-c092af4766d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d7c46f32-c3a8-4be8-ac05-8415b19894ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f035a7c5-efdd-4bfd-bee4-1d0bff45b665" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d7c46f32-c3a8-4be8-ac05-8415b19894ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_eb023e39-d9de-4747-9689-cb63499761a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f035a7c5-efdd-4bfd-bee4-1d0bff45b665" xlink:to="loc_us-gaap_CommonStockSharesIssued_eb023e39-d9de-4747-9689-cb63499761a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6469e4b0-1f66-42cf-82e6-81ce66ae1815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f035a7c5-efdd-4bfd-bee4-1d0bff45b665" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6469e4b0-1f66-42cf-82e6-81ce66ae1815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="sgry-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_a92ff1da-b375-4f19-a90f-ab70672dee92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_a92ff1da-b375-4f19-a90f-ab70672dee92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_70758e11-e1b7-42c4-8813-a933737193fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_LaborAndRelatedExpense_70758e11-e1b7-42c4-8813-a933737193fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SuppliesExpense_cdd49a48-9211-46df-8205-a2df6e92dd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SuppliesExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_SuppliesExpense_cdd49a48-9211-46df-8205-a2df6e92dd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_9f5a6c91-44b4-4eab-815f-8b9ae8c3aa75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_ProfessionalFees_9f5a6c91-44b4-4eab-815f-8b9ae8c3aa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OperatingAndFinanceLeaseExpense_6e7260a6-5720-40fb-a515-378d4a08f810" xlink:href="sgry-20220630.xsd#sgry_OperatingAndFinanceLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_sgry_OperatingAndFinanceLeaseExpense_6e7260a6-5720-40fb-a515-378d4a08f810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_b7ae09bf-96e5-4b6e-9a0b-67e13cb832cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_b7ae09bf-96e5-4b6e-9a0b-67e13cb832cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_bd0aa598-672b-446b-9139-57f1af293dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_bd0aa598-672b-446b-9139-57f1af293dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_804ab975-7adc-4add-8e61-ec34e4236630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_804ab975-7adc-4add-8e61-ec34e4236630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1c874677-5bba-4161-9218-a8516bfb1d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1c874677-5bba-4161-9218-a8516bfb1d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_0109f276-8df2-406b-8418-38933afd9b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_0109f276-8df2-406b-8418-38933afd9b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GrantRevenue_cbf2b958-42d7-4500-87c3-9105c758f635" xlink:href="sgry-20220630.xsd#sgry_GrantRevenue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_sgry_GrantRevenue_cbf2b958-42d7-4500-87c3-9105c758f635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_e4df1c2e-4daa-472e-afd5-fdf0c4f652d8" xlink:href="sgry-20220630.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_e4df1c2e-4daa-472e-afd5-fdf0c4f652d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_86df73a6-7066-4878-bef5-83f141533efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_86df73a6-7066-4878-bef5-83f141533efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_5f3d3434-0514-4c88-a74f-446a73d6f2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_5f3d3434-0514-4c88-a74f-446a73d6f2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f4117ea2-0dc2-4147-8ed1-bc9137d66230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f4117ea2-0dc2-4147-8ed1-bc9137d66230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonrecurringIncomeExpense_4d126090-806b-487c-80cd-52f8fcf95688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonrecurringIncomeExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_OtherNonrecurringIncomeExpense_4d126090-806b-487c-80cd-52f8fcf95688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d3d154b9-69cb-4117-a942-5f57df1773a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9cf8db1d-a225-48a9-85c0-6c026bde9c9f" xlink:to="loc_us-gaap_OperatingExpenses_d3d154b9-69cb-4117-a942-5f57df1773a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_26a0a45d-9eaf-4904-bdd5-c9f92e996bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_OperatingIncomeLoss_26a0a45d-9eaf-4904-bdd5-c9f92e996bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_8e1e0a89-44f8-4c9c-9a3f-76fa1430c925" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_8e1e0a89-44f8-4c9c-9a3f-76fa1430c925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_395d48d5-5272-4b14-8373-bd8147207155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_395d48d5-5272-4b14-8373-bd8147207155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1395495a-84b8-4b87-9bb3-d1bfe3a03cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1395495a-84b8-4b87-9bb3-d1bfe3a03cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1042391f-ecff-4487-afb4-6c7d08e1a347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_ProfitLoss_1042391f-ecff-4487-afb4-6c7d08e1a347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4103b00-5bd3-4309-b1ea-22dc132cd3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4103b00-5bd3-4309-b1ea-22dc132cd3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_868c8aaa-f537-4743-8281-aad7b45dcd56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_NetIncomeLoss_868c8aaa-f537-4743-8281-aad7b45dcd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_e967e824-5ee5-4809-abbf-676b24c580f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_e967e824-5ee5-4809-abbf-676b24c580f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e730e2a2-f093-4bf5-ac99-2b98612a3437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e730e2a2-f093-4bf5-ac99-2b98612a3437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_20a206b6-5c21-47bd-a19d-235fec95ccf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_20a206b6-5c21-47bd-a19d-235fec95ccf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c56510e5-b595-4b3e-b842-86b83e30dacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_20a206b6-5c21-47bd-a19d-235fec95ccf0" xlink:to="loc_us-gaap_EarningsPerShareBasic_c56510e5-b595-4b3e-b842-86b83e30dacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3930759f-4bbe-4e5b-88eb-85ad144d5597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_20a206b6-5c21-47bd-a19d-235fec95ccf0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3930759f-4bbe-4e5b-88eb-85ad144d5597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_46209a7b-364c-4267-b05c-ec847fb1dc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a1e61fd-af0e-4e61-a560-fc83885a6d35" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_46209a7b-364c-4267-b05c-ec847fb1dc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_889c2608-d07d-4028-8017-c57198886be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_46209a7b-364c-4267-b05c-ec847fb1dc0f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_889c2608-d07d-4028-8017-c57198886be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0afa1cbd-62b8-4a8c-be49-d335759bd2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_46209a7b-364c-4267-b05c-ec847fb1dc0f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0afa1cbd-62b8-4a8c-be49-d335759bd2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="sgry-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3c4ab7f3-5560-4676-afe5-63752c047084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ea28e3c6-fd93-4986-b465-4d643fa96abc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3c4ab7f3-5560-4676-afe5-63752c047084" xlink:to="loc_us-gaap_ProfitLoss_ea28e3c6-fd93-4986-b465-4d643fa96abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e95de568-eda0-4074-9177-a739cedf3873" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3c4ab7f3-5560-4676-afe5-63752c047084" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e95de568-eda0-4074-9177-a739cedf3873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2888fe42-d5f6-4b80-a9b1-e1f3ba36eb20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e95de568-eda0-4074-9177-a739cedf3873" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2888fe42-d5f6-4b80-a9b1-e1f3ba36eb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_711dd0d8-d013-4985-98f5-4f83d92cd380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3c4ab7f3-5560-4676-afe5-63752c047084" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_711dd0d8-d013-4985-98f5-4f83d92cd380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99799afa-f94f-43d5-90ab-87b315591e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3c4ab7f3-5560-4676-afe5-63752c047084" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_99799afa-f94f-43d5-90ab-87b315591e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a6b2735c-be1c-4729-914f-03dbc51c3fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3c4ab7f3-5560-4676-afe5-63752c047084" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a6b2735c-be1c-4729-914f-03dbc51c3fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sgry-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_085b2615-784e-4bf0-aa87-b61e46fad097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c0cd0809-fcb6-407e-af0f-cd3474dd0f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_085b2615-784e-4bf0-aa87-b61e46fad097" xlink:to="loc_us-gaap_StatementTable_c0cd0809-fcb6-407e-af0f-cd3474dd0f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_dab59b8e-fc72-4ddb-9ce0-6f0956ebfa19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c0cd0809-fcb6-407e-af0f-cd3474dd0f83" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_dab59b8e-fc72-4ddb-9ce0-6f0956ebfa19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_dab59b8e-fc72-4ddb-9ce0-6f0956ebfa19" xlink:to="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1d54c5ae-1c78-48c6-a320-16df19563c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:to="loc_us-gaap_CommonStockMember_1d54c5ae-1c78-48c6-a320-16df19563c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_795ff030-5960-4af7-adb6-49177d71786c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_795ff030-5960-4af7-adb6-49177d71786c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4e2a53b7-affd-41ae-8a64-2cde32512a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4e2a53b7-affd-41ae-8a64-2cde32512a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_874e910a-6f63-49b8-83d2-1bb4437d89c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:to="loc_us-gaap_RetainedEarningsMember_874e910a-6f63-49b8-83d2-1bb4437d89c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_3aea65ef-40b0-4e8d-8e31-5fe798780c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbc61564-05ce-4112-bbe2-46820912cfed" xlink:to="loc_us-gaap_NoncontrollingInterestMember_3aea65ef-40b0-4e8d-8e31-5fe798780c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1d7be473-efaf-4e08-85df-54b7a7cb5b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c0cd0809-fcb6-407e-af0f-cd3474dd0f83" xlink:to="loc_us-gaap_StatementLineItems_1d7be473-efaf-4e08-85df-54b7a7cb5b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d7be473-efaf-4e08-85df-54b7a7cb5b1c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5f22d306-af79-42ac-9a59-69859df09572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5f22d306-af79-42ac-9a59-69859df09572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_09cff53c-3f16-42d8-8627-fe5bd38fea1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_09cff53c-3f16-42d8-8627-fe5bd38fea1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_271ab156-aca0-4669-a221-21693084b619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_271ab156-aca0-4669-a221-21693084b619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ad1fe98f-7488-41ef-9e79-206264dd9800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ad1fe98f-7488-41ef-9e79-206264dd9800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0e607e0a-6c4e-40f4-afe9-1fb29fc2b24e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0e607e0a-6c4e-40f4-afe9-1fb29fc2b24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_c483c729-40aa-4c9f-ac0e-1a26b741a198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings_c483c729-40aa-4c9f-ac0e-1a26b741a198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_34b80661-233c-41ac-867e-ad55ac3fcce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_34b80661-233c-41ac-867e-ad55ac3fcce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fed6532a-21c6-4bb8-bf08-912da355948a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fed6532a-21c6-4bb8-bf08-912da355948a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3b60bbd1-e60e-40c3-b14b-721c83e3dba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3b60bbd1-e60e-40c3-b14b-721c83e3dba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2e5ef320-fb45-45d6-a7d2-7a7b4489d79c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2e5ef320-fb45-45d6-a7d2-7a7b4489d79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_00c080d6-5950-4a01-a05a-d3fc5f0f883a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_00c080d6-5950-4a01-a05a-d3fc5f0f883a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_bb1cd298-2ec5-457e-9dfc-f80fe12b3a3a" xlink:href="sgry-20220630.xsd#sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet_bb1cd298-2ec5-457e-9dfc-f80fe12b3a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_a1990b6a-9f61-4c61-8204-c5aa614c3636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_a1990b6a-9f61-4c61-8204-c5aa614c3636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5d28abaf-a9c6-41ff-8007-593e13bbad23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5d28abaf-a9c6-41ff-8007-593e13bbad23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_939ff3f5-c0c7-46f3-bab6-202eb9471a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_025e7f2b-744b-457f-9a9e-9c750c57c95d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_939ff3f5-c0c7-46f3-bab6-202eb9471a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sgry-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f8084244-6b14-45d5-ad46-6507ed6a50bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b4f3c0e0-3d8a-47e1-840e-3a49892773e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f8084244-6b14-45d5-ad46-6507ed6a50bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b4f3c0e0-3d8a-47e1-840e-3a49892773e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_85a83b9f-7d44-4011-a666-991967a7105c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b4f3c0e0-3d8a-47e1-840e-3a49892773e4" xlink:to="loc_us-gaap_ProfitLoss_85a83b9f-7d44-4011-a666-991967a7105c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f1f070f-0d59-42ac-b652-50b0bb5f3a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b4f3c0e0-3d8a-47e1-840e-3a49892773e4" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f1f070f-0d59-42ac-b652-50b0bb5f3a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6208668b-3fb0-4621-a94d-cd5bf81ecef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f1f070f-0d59-42ac-b652-50b0bb5f3a89" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6208668b-3fb0-4621-a94d-cd5bf81ecef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NoncashInterestIncomeExpenseNet_dcc0af27-c48f-4ed6-9713-976031d1103e" xlink:href="sgry-20220630.xsd#sgry_NoncashInterestIncomeExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f1f070f-0d59-42ac-b652-50b0bb5f3a89" xlink:to="loc_sgry_NoncashInterestIncomeExpenseNet_dcc0af27-c48f-4ed6-9713-976031d1103e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_253586d7-753f-43b4-b818-d8aaeeb20b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f1f070f-0d59-42ac-b652-50b0bb5f3a89" xlink:to="loc_us-gaap_ShareBasedCompensation_253586d7-753f-43b4-b818-d8aaeeb20b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_5de230cb-7533-409b-b95b-cc8a94eed342" xlink:href="sgry-20220630.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f1f070f-0d59-42ac-b652-50b0bb5f3a89" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_5de230cb-7533-409b-b95b-cc8a94eed342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_32081270-0538-4d1b-ab9c-edf165bb7937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f1f070f-0d59-42ac-b652-50b0bb5f3a89" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_32081270-0538-4d1b-ab9c-edf165bb7937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_27c12471-5242-40bf-a74c-28aeb04a9b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f1f070f-0d59-42ac-b652-50b0bb5f3a89" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_27c12471-5242-40bf-a74c-28aeb04a9b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_952ab917-95d6-4e31-94bf-32c1dec170e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f1f070f-0d59-42ac-b652-50b0bb5f3a89" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_952ab917-95d6-4e31-94bf-32c1dec170e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_c04f90c0-6e8e-48c3-8e64-fc8d6947cc57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f1f070f-0d59-42ac-b652-50b0bb5f3a89" xlink:to="loc_us-gaap_OperatingLeaseExpense_c04f90c0-6e8e-48c3-8e64-fc8d6947cc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1917f26b-1794-4296-b2b9-249bb3fb17f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f1f070f-0d59-42ac-b652-50b0bb5f3a89" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1917f26b-1794-4296-b2b9-249bb3fb17f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8c18e713-3ae9-4da2-b59c-7824e54abbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1917f26b-1794-4296-b2b9-249bb3fb17f4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8c18e713-3ae9-4da2-b59c-7824e54abbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_2876e52b-2237-4971-88e6-32e7695a29a9" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1917f26b-1794-4296-b2b9-249bb3fb17f4" xlink:to="loc_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants_2876e52b-2237-4971-88e6-32e7695a29a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInSettlementPayments_8e2b96c6-4a84-4c91-9345-ec11f79db4b5" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInSettlementPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1917f26b-1794-4296-b2b9-249bb3fb17f4" xlink:to="loc_sgry_IncreaseDecreaseInSettlementPayments_8e2b96c6-4a84-4c91-9345-ec11f79db4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ba8385a4-0582-4011-97b3-0adca612a1a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1917f26b-1794-4296-b2b9-249bb3fb17f4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ba8385a4-0582-4011-97b3-0adca612a1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fbdd5ef6-d326-4192-a7a8-53271537e40a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b4f3c0e0-3d8a-47e1-840e-3a49892773e4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fbdd5ef6-d326-4192-a7a8-53271537e40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6df70c98-dbe8-4c6a-98f1-99428468a9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f8084244-6b14-45d5-ad46-6507ed6a50bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6df70c98-dbe8-4c6a-98f1-99428468a9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cbf7979a-2c59-470c-afbc-a3580f6ae66b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6df70c98-dbe8-4c6a-98f1-99428468a9c2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cbf7979a-2c59-470c-afbc-a3580f6ae66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9708184c-65b0-4f8d-8ff5-4c99adc15cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6df70c98-dbe8-4c6a-98f1-99428468a9c2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9708184c-65b0-4f8d-8ff5-4c99adc15cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_d877a739-e728-4fe5-bbca-9918a744d3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6df70c98-dbe8-4c6a-98f1-99428468a9c2" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_d877a739-e728-4fe5-bbca-9918a744d3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_43b1c5be-61ef-4f3a-b0cd-5998b068defd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6df70c98-dbe8-4c6a-98f1-99428468a9c2" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_43b1c5be-61ef-4f3a-b0cd-5998b068defd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_23cd3f79-7be0-4b3d-b103-bc56b022f9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6df70c98-dbe8-4c6a-98f1-99428468a9c2" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_23cd3f79-7be0-4b3d-b103-bc56b022f9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e8d3a16e-b155-48cd-b0a3-28004f3811cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6df70c98-dbe8-4c6a-98f1-99428468a9c2" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e8d3a16e-b155-48cd-b0a3-28004f3811cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_78aa08bd-11c0-45cc-bd23-27e96fb0a448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6df70c98-dbe8-4c6a-98f1-99428468a9c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_78aa08bd-11c0-45cc-bd23-27e96fb0a448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f8084244-6b14-45d5-ad46-6507ed6a50bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_e600bfae-3e96-42f1-80d5-a5b0cb6933eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_e600bfae-3e96-42f1-80d5-a5b0cb6933eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_6948ecf5-5f53-49d9-92b3-8edc5454ea8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_6948ecf5-5f53-49d9-92b3-8edc5454ea8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_ecfc5f02-814f-4adf-9d19-986f8cc8f7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_ecfc5f02-814f-4adf-9d19-986f8cc8f7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DebtInstrumentPrepaymentPenaltyAmount_bee87e43-470c-4afc-a17e-9c5abcb8202a" xlink:href="sgry-20220630.xsd#sgry_DebtInstrumentPrepaymentPenaltyAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_sgry_DebtInstrumentPrepaymentPenaltyAmount_bee87e43-470c-4afc-a17e-9c5abcb8202a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3ac90c2c-d7f4-4079-86b1-931d8b0990d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3ac90c2c-d7f4-4079-86b1-931d8b0990d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_3e070804-6417-402c-bf1e-8ca5aba25627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_3e070804-6417-402c-bf1e-8ca5aba25627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_b9aa9a51-4230-400f-a174-916a8c70aa94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock_b9aa9a51-4230-400f-a174-916a8c70aa94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_0cdc6ab1-f84a-4647-aed5-e3dc06a77517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_0cdc6ab1-f84a-4647-aed5-e3dc06a77517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_c9991a53-312e-459d-b15d-2ced3bce68e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_c9991a53-312e-459d-b15d-2ced3bce68e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_58706a14-fc08-47e4-86df-e3eb4ea2e9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_58706a14-fc08-47e4-86df-e3eb4ea2e9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b293e193-17f1-4d48-b384-ef8912a6387c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b293e193-17f1-4d48-b384-ef8912a6387c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6457f52d-74ee-439d-a1df-b8f192a56564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f642274f-431a-480e-820f-a2825cd05ce7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6457f52d-74ee-439d-a1df-b8f192a56564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_61052b13-3ab7-4f10-928d-e858b172fc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f8084244-6b14-45d5-ad46-6507ed6a50bc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_61052b13-3ab7-4f10-928d-e858b172fc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_280b27c2-99a9-4903-b9ca-5a0c1f8f6b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f8084244-6b14-45d5-ad46-6507ed6a50bc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_280b27c2-99a9-4903-b9ca-5a0c1f8f6b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d6c535f3-8a6e-4fe7-bbb3-1933325ebaae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f8084244-6b14-45d5-ad46-6507ed6a50bc" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d6c535f3-8a6e-4fe7-bbb3-1933325ebaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_278381fc-15cf-4cf4-a23f-97e865b275b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9a46c962-bcfe-442b-97ba-43527ebf6921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_278381fc-15cf-4cf4-a23f-97e865b275b0" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_9a46c962-bcfe-442b-97ba-43527ebf6921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b8b094a9-9fb9-4d97-8156-92be3d319a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b8b094a9-9fb9-4d97-8156-92be3d319a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_1cd6c645-4d11-4030-a30f-4da8e77681c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_1cd6c645-4d11-4030-a30f-4da8e77681c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_704a6d10-dc85-49a3-9d0a-b811c26b3d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:to="loc_us-gaap_UseOfEstimates_704a6d10-dc85-49a3-9d0a-b811c26b3d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_30374d02-fe3d-42fe-b1a9-b70c27aa27a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_30374d02-fe3d-42fe-b1a9-b70c27aa27a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_c1fb439e-d589-4fad-8fa0-502058e49dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_c1fb439e-d589-4fad-8fa0-502058e49dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_744b4713-5145-454f-aa63-2c00cf797faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_744b4713-5145-454f-aa63-2c00cf797faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_572a43e3-7af4-4d75-8793-f9f31910d9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_572a43e3-7af4-4d75-8793-f9f31910d9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_19d08019-01f2-404d-b6ae-8c24834883ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_19d08019-01f2-404d-b6ae-8c24834883ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestPolicyTextBlock_359e92c4-d451-425e-b8bb-e3e14d4d48af" xlink:href="sgry-20220630.xsd#sgry_RedeemableNoncontrollingInterestPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:to="loc_sgry_RedeemableNoncontrollingInterestPolicyTextBlock_359e92c4-d451-425e-b8bb-e3e14d4d48af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b52ffc82-2e3e-4f62-b4a2-b8f3236a83eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b52ffc82-2e3e-4f62-b4a2-b8f3236a83eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_d0ef923c-f90a-4627-bbad-8130d8d1d614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_618dae7c-514e-494c-bd07-c18a0b78229c" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_d0ef923c-f90a-4627-bbad-8130d8d1d614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_99b6b937-2678-46f0-945d-61aa3009191d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_cca5bca9-42a8-44b3-a8f5-348f7a47961c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_99b6b937-2678-46f0-945d-61aa3009191d" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_cca5bca9-42a8-44b3-a8f5-348f7a47961c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_15b328d5-94e3-44df-adea-80850f213528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_99b6b937-2678-46f0-945d-61aa3009191d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_15b328d5-94e3-44df-adea-80850f213528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_30cdab7e-3246-4683-8a64-ee4ce588a723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_99b6b937-2678-46f0-945d-61aa3009191d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_30cdab7e-3246-4683-8a64-ee4ce588a723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_eb7355b0-3405-4ce1-9d56-f140d2871920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_99b6b937-2678-46f0-945d-61aa3009191d" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_eb7355b0-3405-4ce1-9d56-f140d2871920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesOrganizationDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_49bd7392-aa00-4c51-b72b-4d03344599b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsTable_7a1a701d-8e62-4681-8165-5bad572daa80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_49bd7392-aa00-4c51-b72b-4d03344599b0" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsTable_7a1a701d-8e62-4681-8165-5bad572daa80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d006c4dc-e46d-48eb-8c6e-ec95a91ab234" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_7a1a701d-8e62-4681-8165-5bad572daa80" xlink:to="loc_srt_ProductOrServiceAxis_d006c4dc-e46d-48eb-8c6e-ec95a91ab234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_71e6cf82-63d3-4e48-8814-149cba3a9b22" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d006c4dc-e46d-48eb-8c6e-ec95a91ab234" xlink:to="loc_srt_ProductsAndServicesDomain_71e6cf82-63d3-4e48-8814-149cba3a9b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember_af5db90f-f4ea-4eaf-9777-0f24f813c318" xlink:href="sgry-20220630.xsd#sgry_FacilitiesAmbulatorySurgeryCentersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_71e6cf82-63d3-4e48-8814-149cba3a9b22" xlink:to="loc_sgry_FacilitiesAmbulatorySurgeryCentersMember_af5db90f-f4ea-4eaf-9777-0f24f813c318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FacilitiesSurgicalHospitalsMember_3788c3a3-d5f1-46c4-a5e6-a005fc77a1fe" xlink:href="sgry-20220630.xsd#sgry_FacilitiesSurgicalHospitalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_71e6cf82-63d3-4e48-8814-149cba3a9b22" xlink:to="loc_sgry_FacilitiesSurgicalHospitalsMember_3788c3a3-d5f1-46c4-a5e6-a005fc77a1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsTable_7a1a701d-8e62-4681-8165-5bad572daa80" xlink:to="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwned_c3c53209-7bf6-47c1-95e5-babc99507098" xlink:href="sgry-20220630.xsd#sgry_NumberOfSurgicalFacilitiesOwned"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwned_c3c53209-7bf6-47c1-95e5-babc99507098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_4f62ca3d-cee6-4e59-b9f1-7532a7e932c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_4f62ca3d-cee6-4e59-b9f1-7532a7e932c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_6348039f-1912-4c24-a166-ee905b294d7f" xlink:href="sgry-20220630.xsd#sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest_6348039f-1912-4c24-a166-ee905b294d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_2fdc6faa-a17e-4850-a071-8bdee378cc6f" xlink:href="sgry-20220630.xsd#sgry_NumberOfSurgicalFacilitiesOwnedConsolidated"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfInvestmentHoldingsLineItems_88f0108c-7de5-457e-b55f-c52db12c7f42" xlink:to="loc_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated_2fdc6faa-a17e-4850-a071-8bdee378cc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75f737dc-40ec-4a1b-b447-8feb6c4b63f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_fba3bba8-5d47-427d-be55-7fc4de2e7562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_75f737dc-40ec-4a1b-b447-8feb6c4b63f3" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_fba3bba8-5d47-427d-be55-7fc4de2e7562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_642649b2-6f5c-44cc-9890-9f9c4ffc85ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_fba3bba8-5d47-427d-be55-7fc4de2e7562" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_642649b2-6f5c-44cc-9890-9f9c4ffc85ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a920e700-e1c8-4e42-a15e-bb86542c1e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_642649b2-6f5c-44cc-9890-9f9c4ffc85ad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a920e700-e1c8-4e42-a15e-bb86542c1e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_48ff841d-716e-405a-99eb-90cc5fa4cac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a920e700-e1c8-4e42-a15e-bb86542c1e9a" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_48ff841d-716e-405a-99eb-90cc5fa4cac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3e85e01c-4bb1-4dd8-a8ef-a336bb57a784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_fba3bba8-5d47-427d-be55-7fc4de2e7562" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3e85e01c-4bb1-4dd8-a8ef-a336bb57a784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0844d5-4ef8-49a0-a4d4-db718e326a34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3e85e01c-4bb1-4dd8-a8ef-a336bb57a784" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0844d5-4ef8-49a0-a4d4-db718e326a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_5746753a-32f1-449a-a1e7-b295c1af819d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e0844d5-4ef8-49a0-a4d4-db718e326a34" xlink:to="loc_us-gaap_SalesRevenueNetMember_5746753a-32f1-449a-a1e7-b295c1af819d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_00378d8b-6a70-4cb9-9aee-e08724db50a7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_fba3bba8-5d47-427d-be55-7fc4de2e7562" xlink:to="loc_srt_ProductOrServiceAxis_00378d8b-6a70-4cb9-9aee-e08724db50a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6f62583f-ab15-466e-bae9-39e6b9f89a04" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_00378d8b-6a70-4cb9-9aee-e08724db50a7" xlink:to="loc_srt_ProductsAndServicesDomain_6f62583f-ab15-466e-bae9-39e6b9f89a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_HealthcareOrganizationPatientServiceMember_309d9f1a-bd87-4a66-b611-25f548cc130f" xlink:href="sgry-20220630.xsd#sgry_HealthcareOrganizationPatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6f62583f-ab15-466e-bae9-39e6b9f89a04" xlink:to="loc_sgry_HealthcareOrganizationPatientServiceMember_309d9f1a-bd87-4a66-b611-25f548cc130f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_f7fab0ed-f4e6-4000-959e-56406e60c247" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_309d9f1a-bd87-4a66-b611-25f548cc130f" xlink:to="loc_sgry_SurgicalFacilityServicesMember_f7fab0ed-f4e6-4000-959e-56406e60c247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_0280a719-2e22-4ec7-9ae4-a74c430cb77c" xlink:href="sgry-20220630.xsd#sgry_AncillaryServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_309d9f1a-bd87-4a66-b611-25f548cc130f" xlink:to="loc_sgry_AncillaryServicesMember_0280a719-2e22-4ec7-9ae4-a74c430cb77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherServicesMember_8e5b8d4d-386b-4427-b9e8-a126b67e59f4" xlink:href="sgry-20220630.xsd#sgry_OtherServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6f62583f-ab15-466e-bae9-39e6b9f89a04" xlink:to="loc_sgry_OtherServicesMember_8e5b8d4d-386b-4427-b9e8-a126b67e59f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ab5da6d9-a6a3-4878-b006-f4f2172683c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_fba3bba8-5d47-427d-be55-7fc4de2e7562" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ab5da6d9-a6a3-4878-b006-f4f2172683c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0fdd96e0-da2d-4edc-a556-e63689bce8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_ab5da6d9-a6a3-4878-b006-f4f2172683c4" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0fdd96e0-da2d-4edc-a556-e63689bce8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fbc9392c-2041-426a-9ac5-99d1af545105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_639f40f9-e67b-4c88-9c79-259dcca71ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fbc9392c-2041-426a-9ac5-99d1af545105" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_639f40f9-e67b-4c88-9c79-259dcca71ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_50d4093e-5294-48e9-a3ad-7f123fc51296" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_639f40f9-e67b-4c88-9c79-259dcca71ffb" xlink:to="loc_srt_ProductOrServiceAxis_50d4093e-5294-48e9-a3ad-7f123fc51296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5e62cd43-7097-4549-a56a-28dcf94a52db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_50d4093e-5294-48e9-a3ad-7f123fc51296" xlink:to="loc_srt_ProductsAndServicesDomain_5e62cd43-7097-4549-a56a-28dcf94a52db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:href="sgry-20220630.xsd#sgry_HealthcareOrganizationPatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5e62cd43-7097-4549-a56a-28dcf94a52db" xlink:to="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PrivateInsuranceMember_18415261-4312-4485-a1db-010ad82c8c5d" xlink:href="sgry-20220630.xsd#sgry_PrivateInsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:to="loc_sgry_PrivateInsuranceMember_18415261-4312-4485-a1db-010ad82c8c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractMember_96a13745-3364-4050-b1e0-c499be1059e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:to="loc_us-gaap_GovernmentContractMember_96a13745-3364-4050-b1e0-c499be1059e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SelfPayRevenueMember_146c4be4-6e58-4fc3-8843-34cf43ee360f" xlink:href="sgry-20220630.xsd#sgry_SelfPayRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:to="loc_sgry_SelfPayRevenueMember_146c4be4-6e58-4fc3-8843-34cf43ee360f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherPatientServiceRevenueSourcesMember_729c1170-9cd2-4e79-9bde-881a5b7ede83" xlink:href="sgry-20220630.xsd#sgry_OtherPatientServiceRevenueSourcesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_HealthcareOrganizationPatientServiceMember_0bb8f667-3680-4712-b34e-51d6472545ca" xlink:to="loc_sgry_OtherPatientServiceRevenueSourcesMember_729c1170-9cd2-4e79-9bde-881a5b7ede83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_OtherServicesMember_12ef86b3-2981-463d-99b0-9ab4dcac5146" xlink:href="sgry-20220630.xsd#sgry_OtherServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5e62cd43-7097-4549-a56a-28dcf94a52db" xlink:to="loc_sgry_OtherServicesMember_12ef86b3-2981-463d-99b0-9ab4dcac5146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ee47c843-9422-4512-9cc4-5523661d5f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_639f40f9-e67b-4c88-9c79-259dcca71ffb" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ee47c843-9422-4512-9cc4-5523661d5f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f890fe47-d118-4ec6-bd8a-ea8fac3d652b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ee47c843-9422-4512-9cc4-5523661d5f34" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f890fe47-d118-4ec6-bd8a-ea8fac3d652b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_497accc2-1354-42cd-9219-1fa40321b5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f890fe47-d118-4ec6-bd8a-ea8fac3d652b" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_497accc2-1354-42cd-9219-1fa40321b5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d077ebdb-2c68-4c12-9e95-d0ad499a0e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_639f40f9-e67b-4c88-9c79-259dcca71ffb" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d077ebdb-2c68-4c12-9e95-d0ad499a0e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9007dd83-966c-4da6-9c58-83d0bcdb36f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d077ebdb-2c68-4c12-9e95-d0ad499a0e13" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9007dd83-966c-4da6-9c58-83d0bcdb36f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_8d33aa33-3f75-4f13-a05b-6c5159681832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9007dd83-966c-4da6-9c58-83d0bcdb36f6" xlink:to="loc_us-gaap_SalesRevenueNetMember_8d33aa33-3f75-4f13-a05b-6c5159681832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c8b0f3bd-8fad-411c-b1a1-a1e86dc2353b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_639f40f9-e67b-4c88-9c79-259dcca71ffb" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c8b0f3bd-8fad-411c-b1a1-a1e86dc2353b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_6338ba49-07b9-4464-a118-1738480fb6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8b0f3bd-8fad-411c-b1a1-a1e86dc2353b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_6338ba49-07b9-4464-a118-1738480fb6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_786429f3-1a02-4bdf-ba31-0018e875a633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8b0f3bd-8fad-411c-b1a1-a1e86dc2353b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_786429f3-1a02-4bdf-ba31-0018e875a633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_43c118e2-a1db-4eee-800d-9bc4fe04df1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9bec9ce4-046a-4699-9588-441750b33d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_43c118e2-a1db-4eee-800d-9bc4fe04df1a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9bec9ce4-046a-4699-9588-441750b33d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_b6e5166b-3951-4e74-9767-4a4c645c50d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_43c118e2-a1db-4eee-800d-9bc4fe04df1a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_b6e5166b-3951-4e74-9767-4a4c645c50d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_f47f3563-f875-44f3-893d-701c60fcae19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_43c118e2-a1db-4eee-800d-9bc4fe04df1a" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_f47f3563-f875-44f3-893d-701c60fcae19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_98f7c550-8c85-4712-ad3d-f8d1c6a5937a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_43c118e2-a1db-4eee-800d-9bc4fe04df1a" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_98f7c550-8c85-4712-ad3d-f8d1c6a5937a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bb0ea725-9a8e-4adf-aa35-592e51c6a529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_782fd9b5-4201-4019-b4f0-0e07d73dfea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bb0ea725-9a8e-4adf-aa35-592e51c6a529" xlink:to="loc_us-gaap_GoodwillRollForward_782fd9b5-4201-4019-b4f0-0e07d73dfea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e5e31e8a-c21e-40c8-9f28-a9a3bf792706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_782fd9b5-4201-4019-b4f0-0e07d73dfea4" xlink:to="loc_us-gaap_Goodwill_e5e31e8a-c21e-40c8-9f28-a9a3bf792706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_0f8c326d-4e48-4967-940e-78d8f092aa63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_782fd9b5-4201-4019-b4f0-0e07d73dfea4" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_0f8c326d-4e48-4967-940e-78d8f092aa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation_31ad2718-4500-444b-8942-958110fa4b89" xlink:href="sgry-20220630.xsd#sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_782fd9b5-4201-4019-b4f0-0e07d73dfea4" xlink:to="loc_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation_31ad2718-4500-444b-8942-958110fa4b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_61d92b38-e781-4ae3-be56-e3e01838e2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_782fd9b5-4201-4019-b4f0-0e07d73dfea4" xlink:to="loc_us-gaap_Goodwill_61d92b38-e781-4ae3-be56-e3e01838e2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b4886be5-a8f8-4829-b73d-1808f02baed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestRollForward_45a06edd-fbb2-4881-92cb-aa2254953b5f" xlink:href="sgry-20220630.xsd#sgry_RedeemableNoncontrollingInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b4886be5-a8f8-4829-b73d-1808f02baed0" xlink:to="loc_sgry_RedeemableNoncontrollingInterestRollForward_45a06edd-fbb2-4881-92cb-aa2254953b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_83559f29-7cc4-4566-b88d-6e3647595414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward_45a06edd-fbb2-4881-92cb-aa2254953b5f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_83559f29-7cc4-4566-b88d-6e3647595414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_82f7b860-2dfc-49a1-9d61-e65d585521b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward_45a06edd-fbb2-4881-92cb-aa2254953b5f" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_82f7b860-2dfc-49a1-9d61-e65d585521b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests_bcea289a-9037-4cf3-a430-2aabc922b196" xlink:href="sgry-20220630.xsd#sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward_45a06edd-fbb2-4881-92cb-aa2254953b5f" xlink:to="loc_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests_bcea289a-9037-4cf3-a430-2aabc922b196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_10ca0af9-ee06-4d38-8964-7104b4d89438" xlink:href="sgry-20220630.xsd#sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward_45a06edd-fbb2-4881-92cb-aa2254953b5f" xlink:to="loc_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_10ca0af9-ee06-4d38-8964-7104b4d89438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b06ffff4-f89b-45e1-863f-89fbe796fe4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_RedeemableNoncontrollingInterestRollForward_45a06edd-fbb2-4881-92cb-aa2254953b5f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b06ffff4-f89b-45e1-863f-89fbe796fe4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71f66bac-f083-490c-a5ad-9021e0cc2ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ProceedsFromGovernmentAssistance_fdb208c6-6eda-4d65-aa0c-1c5183f03159" xlink:href="sgry-20220630.xsd#sgry_ProceedsFromGovernmentAssistance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71f66bac-f083-490c-a5ad-9021e0cc2ff4" xlink:to="loc_sgry_ProceedsFromGovernmentAssistance_fdb208c6-6eda-4d65-aa0c-1c5183f03159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GrantRevenue_cb2da57a-2175-4ab8-a694-c05d9c07dd49" xlink:href="sgry-20220630.xsd#sgry_GrantRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71f66bac-f083-490c-a5ad-9021e0cc2ff4" xlink:to="loc_sgry_GrantRevenue_cb2da57a-2175-4ab8-a694-c05d9c07dd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_UnrecognizedGrantFundsReceived_83d8468a-592f-4b0f-839b-a82c18518b7f" xlink:href="sgry-20220630.xsd#sgry_UnrecognizedGrantFundsReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71f66bac-f083-490c-a5ad-9021e0cc2ff4" xlink:to="loc_sgry_UnrecognizedGrantFundsReceived_83d8468a-592f-4b0f-839b-a82c18518b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments_90a04b28-fef9-4444-bd9f-b8070785247a" xlink:href="sgry-20220630.xsd#sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71f66bac-f083-490c-a5ad-9021e0cc2ff4" xlink:to="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments_90a04b28-fef9-4444-bd9f-b8070785247a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments_5c76706c-f681-48d1-bdab-84f85e19598b" xlink:href="sgry-20220630.xsd#sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71f66bac-f083-490c-a5ad-9021e0cc2ff4" xlink:to="loc_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments_5c76706c-f681-48d1-bdab-84f85e19598b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bcfff912-d4d7-4a2b-a568-d7003e023e03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bcfff912-d4d7-4a2b-a568-d7003e023e03" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_043fa411-2e0a-4631-b518-34e67c264cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_043fa411-2e0a-4631-b518-34e67c264cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c109e500-b087-4de0-8ea5-5cf095a724bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_043fa411-2e0a-4631-b518-34e67c264cf5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c109e500-b087-4de0-8ea5-5cf095a724bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_3d37583f-f28c-4c23-9f60-9679e5b3749d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c109e500-b087-4de0-8ea5-5cf095a724bc" xlink:to="loc_us-gaap_SecuredDebtMember_3d37583f-f28c-4c23-9f60-9679e5b3749d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d195fb87-71a8-4e2e-b315-a3cc01677acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c109e500-b087-4de0-8ea5-5cf095a724bc" xlink:to="loc_us-gaap_SeniorNotesMember_d195fb87-71a8-4e2e-b315-a3cc01677acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_129eaac4-08fd-482e-a8f4-92a19a257c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:to="loc_us-gaap_DebtInstrumentAxis_129eaac4-08fd-482e-a8f4-92a19a257c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b1ec48de-92cf-4a9b-a948-2ab7fb3d6801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_129eaac4-08fd-482e-a8f4-92a19a257c84" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b1ec48de-92cf-4a9b-a948-2ab7fb3d6801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017TermLoanMaturing2024Member_00275203-9ad7-4849-8f8e-1b103e3d958a" xlink:href="sgry-20220630.xsd#sgry_A2017TermLoanMaturing2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ec48de-92cf-4a9b-a948-2ab7fb3d6801" xlink:to="loc_sgry_A2017TermLoanMaturing2024Member_00275203-9ad7-4849-8f8e-1b103e3d958a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member_2ed32e78-7125-40e7-8b35-f6e38d1c95e1" xlink:href="sgry-20220630.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ec48de-92cf-4a9b-a948-2ab7fb3d6801" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2025Member_2ed32e78-7125-40e7-8b35-f6e38d1c95e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2027Member_7a3cc211-7b63-445c-9dc7-e2cea403a04f" xlink:href="sgry-20220630.xsd#sgry_SeniorUnsecuredNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b1ec48de-92cf-4a9b-a948-2ab7fb3d6801" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2027Member_7a3cc211-7b63-445c-9dc7-e2cea403a04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_7008a28a-7d25-46cc-9706-870fab7c0884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_7008a28a-7d25-46cc-9706-870fab7c0884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5eab982f-c569-4f76-af10-01f7395a22ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_7008a28a-7d25-46cc-9706-870fab7c0884" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5eab982f-c569-4f76-af10-01f7395a22ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_26ba1b47-26e3-4bd4-a081-6a224dba991e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5eab982f-c569-4f76-af10-01f7395a22ab" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_26ba1b47-26e3-4bd4-a081-6a224dba991e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a3893808-4008-4946-ac10-8011ecb17cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_26ba1b47-26e3-4bd4-a081-6a224dba991e" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a3893808-4008-4946-ac10-8011ecb17cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c95af4d8-4d8b-499d-bea0-7233e4e307c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_26ba1b47-26e3-4bd4-a081-6a224dba991e" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c95af4d8-4d8b-499d-bea0-7233e4e307c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a3ce63d-3a59-49c8-ade6-142807c5043b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a3ce63d-3a59-49c8-ade6-142807c5043b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1605a9bb-a48f-4955-b8ea-65f0a28359e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4a3ce63d-3a59-49c8-ade6-142807c5043b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1605a9bb-a48f-4955-b8ea-65f0a28359e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ae5051ea-de46-49d7-b335-b112eb34cf99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1605a9bb-a48f-4955-b8ea-65f0a28359e1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ae5051ea-de46-49d7-b335-b112eb34cf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1da354e3-4e05-4d15-8b9c-70e4341d8a81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7055b7f7-ccfb-4e6b-904a-eadcbef05b79" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1da354e3-4e05-4d15-8b9c-70e4341d8a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d71f22b7-241c-439d-9f30-01a6844320ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1da354e3-4e05-4d15-8b9c-70e4341d8a81" xlink:to="loc_us-gaap_LongTermDebt_d71f22b7-241c-439d-9f30-01a6844320ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8d87d7c4-c931-46f5-8fe9-112228d568bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1da354e3-4e05-4d15-8b9c-70e4341d8a81" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8d87d7c4-c931-46f5-8fe9-112228d568bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f70830b8-cb17-4a70-88e9-9f2c4a5148e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9f10526d-5a26-4173-94c0-946f68a4c045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f70830b8-cb17-4a70-88e9-9f2c4a5148e8" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9f10526d-5a26-4173-94c0-946f68a4c045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5caad319-5217-4379-91e4-8febb915aa3f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9f10526d-5a26-4173-94c0-946f68a4c045" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5caad319-5217-4379-91e4-8febb915aa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_53aafd9c-ccaa-4e7b-8edc-79b6711c4df3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5caad319-5217-4379-91e4-8febb915aa3f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_53aafd9c-ccaa-4e7b-8edc-79b6711c4df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_7e9346f4-6903-48d9-b3fc-4ebee6886426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_53aafd9c-ccaa-4e7b-8edc-79b6711c4df3" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_7e9346f4-6903-48d9-b3fc-4ebee6886426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_90f3f8da-d4fd-40c4-9735-d005868dec11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9f10526d-5a26-4173-94c0-946f68a4c045" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_90f3f8da-d4fd-40c4-9735-d005868dec11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableInterestEntityNumberOfFacilities_1dc7a46c-06ef-4eee-b751-9e149bddaf76" xlink:href="sgry-20220630.xsd#sgry_VariableInterestEntityNumberOfFacilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_90f3f8da-d4fd-40c4-9735-d005868dec11" xlink:to="loc_sgry_VariableInterestEntityNumberOfFacilities_1dc7a46c-06ef-4eee-b751-9e149bddaf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_153a54b6-0721-4523-91d2-897776826a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_90f3f8da-d4fd-40c4-9735-d005868dec11" xlink:to="loc_us-gaap_Assets_153a54b6-0721-4523-91d2-897776826a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2297227b-63c8-45c8-a30e-08d310cb045d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_90f3f8da-d4fd-40c4-9735-d005868dec11" xlink:to="loc_us-gaap_Liabilities_2297227b-63c8-45c8-a30e-08d310cb045d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsandDisposals" xlink:type="simple" xlink:href="sgry-20220630.xsd#AcquisitionsandDisposals"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsandDisposals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5886c9ea-2a3e-48f3-938e-3c0453d702c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_35733b62-7030-4405-90c3-a76e9c96bd09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5886c9ea-2a3e-48f3-938e-3c0453d702c6" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_35733b62-7030-4405-90c3-a76e9c96bd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#AcquisitionsandDisposalsAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7bbfacbb-8c3e-4737-b956-b32cab342a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b4ec394c-4d6a-4b80-ad20-036c4750b6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7bbfacbb-8c3e-4737-b956-b32cab342a79" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b4ec394c-4d6a-4b80-ad20-036c4750b6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6413b4e9-ff2b-4ecf-9772-8524b6c0cc05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b4ec394c-4d6a-4b80-ad20-036c4750b6b5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6413b4e9-ff2b-4ecf-9772-8524b6c0cc05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9abd9c73-55a9-4613-a421-7ba051629b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6413b4e9-ff2b-4ecf-9772-8524b6c0cc05" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9abd9c73-55a9-4613-a421-7ba051629b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesMember_6dbc34dc-3146-4fb2-ab68-da8e6c8c696f" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9abd9c73-55a9-4613-a421-7ba051629b02" xlink:to="loc_sgry_SurgicalFacilitiesMember_6dbc34dc-3146-4fb2-ab68-da8e6c8c696f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilitiesExistingMarketsMember_25b22ed8-18e1-4184-b05c-eb3657e7a99f" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilitiesExistingMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_SurgicalFacilitiesMember_6dbc34dc-3146-4fb2-ab68-da8e6c8c696f" xlink:to="loc_sgry_SurgicalFacilitiesExistingMarketsMember_25b22ed8-18e1-4184-b05c-eb3657e7a99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b4ec394c-4d6a-4b80-ad20-036c4750b6b5" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_34d85efd-47be-4b4f-872f-b1036101b234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_34d85efd-47be-4b4f-872f-b1036101b234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f623a2df-7184-4517-b427-7503f8347f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f623a2df-7184-4517-b427-7503f8347f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_88557461-92e8-46ba-ad79-b89ba0e40d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_88557461-92e8-46ba-ad79-b89ba0e40d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_8c003544-eed5-46e0-9dfd-ff20e11c8019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_8c003544-eed5-46e0-9dfd-ff20e11c8019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_19d2e3e6-b295-465c-ae3c-2bf24c445b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_791a2d9b-e528-4ee2-95db-2e030047b13a" xlink:to="loc_us-gaap_Goodwill_19d2e3e6-b295-465c-ae3c-2bf24c445b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#AcquisitionsandDisposalsOtherAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_14d29883-1897-4040-8dd6-7ac5c0686841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8b8e632e-15b2-430e-b716-1947251cdea0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_14d29883-1897-4040-8dd6-7ac5c0686841" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8b8e632e-15b2-430e-b716-1947251cdea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_126a31a3-ba4b-4db3-832a-17f9b3d746ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8b8e632e-15b2-430e-b716-1947251cdea0" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_126a31a3-ba4b-4db3-832a-17f9b3d746ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_46c1d128-4bb6-41af-a687-ce53fd2af133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_126a31a3-ba4b-4db3-832a-17f9b3d746ce" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_46c1d128-4bb6-41af-a687-ce53fd2af133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember_70829703-6916-40c7-9cf5-ad539578cfd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_46c1d128-4bb6-41af-a687-ce53fd2af133" xlink:to="loc_us-gaap_EquityMethodInvestmentsMember_70829703-6916-40c7-9cf5-ad539578cfd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8ecbd48d-96f2-4426-af9e-cd9c1512b785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8b8e632e-15b2-430e-b716-1947251cdea0" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_8ecbd48d-96f2-4426-af9e-cd9c1512b785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired_cfc2c4b7-691a-49e1-b41f-6ad4eebed6c2" xlink:href="sgry-20220630.xsd#sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8ecbd48d-96f2-4426-af9e-cd9c1512b785" xlink:to="loc_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired_cfc2c4b7-691a-49e1-b41f-6ad4eebed6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired_c2cc5379-1a30-4ac8-aa5b-cbeb4c1d214b" xlink:href="sgry-20220630.xsd#sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8ecbd48d-96f2-4426-af9e-cd9c1512b785" xlink:to="loc_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired_c2cc5379-1a30-4ac8-aa5b-cbeb4c1d214b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_f5a98a29-99aa-4375-9b00-69b60374781d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8ecbd48d-96f2-4426-af9e-cd9c1512b785" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_f5a98a29-99aa-4375-9b00-69b60374781d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ce59f1c8-113a-4612-bdcf-040439c97d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6030127d-bebf-4bc0-94c6-80bf634d5726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ce59f1c8-113a-4612-bdcf-040439c97d07" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6030127d-bebf-4bc0-94c6-80bf634d5726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_df55f4bd-2fd2-4e79-8859-5e365c3131b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6030127d-bebf-4bc0-94c6-80bf634d5726" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_df55f4bd-2fd2-4e79-8859-5e365c3131b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_73a7a309-fc44-435c-9ddd-c56c2e6a1417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_df55f4bd-2fd2-4e79-8859-5e365c3131b9" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_73a7a309-fc44-435c-9ddd-c56c2e6a1417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DisposalGroupOneMember_803e889a-7ac1-4453-bb52-59a953e8e2a0" xlink:href="sgry-20220630.xsd#sgry_DisposalGroupOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_73a7a309-fc44-435c-9ddd-c56c2e6a1417" xlink:to="loc_sgry_DisposalGroupOneMember_803e889a-7ac1-4453-bb52-59a953e8e2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DisposalGroupTwoMember_224c638d-4eff-484c-95e9-a665c1beca91" xlink:href="sgry-20220630.xsd#sgry_DisposalGroupTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_73a7a309-fc44-435c-9ddd-c56c2e6a1417" xlink:to="loc_sgry_DisposalGroupTwoMember_224c638d-4eff-484c-95e9-a665c1beca91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_f78254c2-1cd9-4451-b253-39f7e185f618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6030127d-bebf-4bc0-94c6-80bf634d5726" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_f78254c2-1cd9-4451-b253-39f7e185f618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3e5010f1-c2e9-4102-acba-dcc6854c6a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_f78254c2-1cd9-4451-b253-39f7e185f618" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3e5010f1-c2e9-4102-acba-dcc6854c6a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_d5374c23-1e9a-46c8-9a27-4fa1fe30f5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3e5010f1-c2e9-4102-acba-dcc6854c6a70" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_d5374c23-1e9a-46c8-9a27-4fa1fe30f5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f83fd5cd-568d-4148-a525-58e356a9c401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6030127d-bebf-4bc0-94c6-80bf634d5726" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f83fd5cd-568d-4148-a525-58e356a9c401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97943e10-8fbd-4077-bd02-f98e5eff2964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f83fd5cd-568d-4148-a525-58e356a9c401" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97943e10-8fbd-4077-bd02-f98e5eff2964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_fa064c32-5c53-4b3d-b254-e188ef9960df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_97943e10-8fbd-4077-bd02-f98e5eff2964" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_fa064c32-5c53-4b3d-b254-e188ef9960df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_6030127d-bebf-4bc0-94c6-80bf634d5726" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_6082b790-650d-4194-824e-459640ad7979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_6082b790-650d-4194-824e-459640ad7979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_8ed01ea8-442e-4798-b219-f370d4febf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_8ed01ea8-442e-4798-b219-f370d4febf1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration_80608609-245b-49a8-9139-e69eb3286574" xlink:href="sgry-20220630.xsd#sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:to="loc_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration_80608609-245b-49a8-9139-e69eb3286574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_e35c9173-e618-42f6-9187-b3cf09d67179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_e35c9173-e618-42f6-9187-b3cf09d67179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_24bbe046-f77e-4e87-bbf1-47655a2267d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_07fadc7c-1ed9-4e86-90c5-fe724a18d9e7" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_24bbe046-f77e-4e87-bbf1-47655a2267d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebt" xlink:type="simple" xlink:href="sgry-20220630.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0b285837-ad36-48d2-a8a2-110dd82bff35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_e66d1f66-f81e-43b7-bfab-7da5e2789668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0b285837-ad36-48d2-a8a2-110dd82bff35" xlink:to="loc_us-gaap_LongTermDebtTextBlock_e66d1f66-f81e-43b7-bfab-7da5e2789668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="sgry-20220630.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9e839a1b-fb06-4a66-86c6-39098c0c5fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_c274f19d-45aa-4070-a47d-5c3280947f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9e839a1b-fb06-4a66-86c6-39098c0c5fc7" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_c274f19d-45aa-4070-a47d-5c3280947f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#LongTermDebtSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b3aa0ef1-f1a1-480b-82dc-288986e92b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_28a99ac9-ec0a-4b91-8b4c-1fbe5e83b199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b3aa0ef1-f1a1-480b-82dc-288986e92b79" xlink:to="loc_us-gaap_DebtInstrumentTable_28a99ac9-ec0a-4b91-8b4c-1fbe5e83b199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9f018cf6-69d6-4caa-95cb-f27c7445702a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_28a99ac9-ec0a-4b91-8b4c-1fbe5e83b199" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9f018cf6-69d6-4caa-95cb-f27c7445702a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c2706ffe-4635-4535-b049-d36f7e0e4033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9f018cf6-69d6-4caa-95cb-f27c7445702a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c2706ffe-4635-4535-b049-d36f7e0e4033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4d5882e4-a599-4dd7-8c79-57e102489cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2706ffe-4635-4535-b049-d36f7e0e4033" xlink:to="loc_us-gaap_SecuredDebtMember_4d5882e4-a599-4dd7-8c79-57e102489cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1fff0faa-084c-481d-9516-2dd084c366b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2706ffe-4635-4535-b049-d36f7e0e4033" xlink:to="loc_us-gaap_SeniorNotesMember_1fff0faa-084c-481d-9516-2dd084c366b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotesPayableAndSecuredLoansMember_c4e3447f-c2ea-4b22-8b27-c7c264d1e1c0" xlink:href="sgry-20220630.xsd#sgry_NotesPayableAndSecuredLoansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2706ffe-4635-4535-b049-d36f7e0e4033" xlink:to="loc_sgry_NotesPayableAndSecuredLoansMember_c4e3447f-c2ea-4b22-8b27-c7c264d1e1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_129c263a-346b-45c2-a5a2-c659e46e2baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_28a99ac9-ec0a-4b91-8b4c-1fbe5e83b199" xlink:to="loc_us-gaap_DebtInstrumentAxis_129c263a-346b-45c2-a5a2-c659e46e2baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b013c558-0c51-45c8-9e18-b80eef094563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_129c263a-346b-45c2-a5a2-c659e46e2baa" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b013c558-0c51-45c8-9e18-b80eef094563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017TermLoanMaturing2024Member_45ed4213-0b44-4eb3-abf8-f36bb6cdfa85" xlink:href="sgry-20220630.xsd#sgry_A2017TermLoanMaturing2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b013c558-0c51-45c8-9e18-b80eef094563" xlink:to="loc_sgry_A2017TermLoanMaturing2024Member_45ed4213-0b44-4eb3-abf8-f36bb6cdfa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2025Member_5ec7f5b0-442f-4b7e-830a-971f4de131c6" xlink:href="sgry-20220630.xsd#sgry_SeniorUnsecuredNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b013c558-0c51-45c8-9e18-b80eef094563" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2025Member_5ec7f5b0-442f-4b7e-830a-971f4de131c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SeniorUnsecuredNotesDue2027Member_588196b2-1189-4913-bd93-fdeffd1994c9" xlink:href="sgry-20220630.xsd#sgry_SeniorUnsecuredNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b013c558-0c51-45c8-9e18-b80eef094563" xlink:to="loc_sgry_SeniorUnsecuredNotesDue2027Member_588196b2-1189-4913-bd93-fdeffd1994c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_28a99ac9-ec0a-4b91-8b4c-1fbe5e83b199" xlink:to="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a61fe4d9-301a-4cca-879b-e424cb89b2a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a61fe4d9-301a-4cca-879b-e424cb89b2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_ac87cb2e-36d1-4c97-b630-5d767d964578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_FinanceLeaseLiability_ac87cb2e-36d1-4c97-b630-5d767d964578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c34b67f5-25c2-4188-8c99-ce285a651f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c34b67f5-25c2-4188-8c99-ce285a651f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_c27304f0-a4cf-425a-af9d-e488a76cd9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_c27304f0-a4cf-425a-af9d-e488a76cd9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d8059adc-9e2c-4b78-a14e-d5043438af5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d8059adc-9e2c-4b78-a14e-d5043438af5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_172e570e-aa3d-44da-a175-3dd521472932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_172e570e-aa3d-44da-a175-3dd521472932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cdfa63c5-08ef-4240-870b-7ddbed3cc096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cdfa63c5-08ef-4240-870b-7ddbed3cc096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_8c3aad51-5c03-4b77-8db5-2640eb9bac90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_824d2c76-c903-457e-a1cd-5855d3432ef8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_8c3aad51-5c03-4b77-8db5-2640eb9bac90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1" xlink:type="simple" xlink:href="sgry-20220630.xsd#LongTermDebtSummaryDetails_1"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_db5cfc51-3607-466b-a8ed-c37a1dfb4b03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d47d26ce-df63-406f-86ca-6822d9827b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_db5cfc51-3607-466b-a8ed-c37a1dfb4b03" xlink:to="loc_us-gaap_DebtInstrumentTable_d47d26ce-df63-406f-86ca-6822d9827b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c8b248d1-00d0-4e46-9423-b1d990f22934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d47d26ce-df63-406f-86ca-6822d9827b2b" xlink:to="loc_us-gaap_CreditFacilityAxis_c8b248d1-00d0-4e46-9423-b1d990f22934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8e90c8f8-6d2e-46e8-82b7-a3f56fd92cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c8b248d1-00d0-4e46-9423-b1d990f22934" xlink:to="loc_us-gaap_CreditFacilityDomain_8e90c8f8-6d2e-46e8-82b7-a3f56fd92cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7a416432-505a-4227-88b8-b027a79a7858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8e90c8f8-6d2e-46e8-82b7-a3f56fd92cc6" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7a416432-505a-4227-88b8-b027a79a7858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_53a3da95-980e-4450-8f1a-d031235734c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8e90c8f8-6d2e-46e8-82b7-a3f56fd92cc6" xlink:to="loc_us-gaap_LetterOfCreditMember_53a3da95-980e-4450-8f1a-d031235734c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_03fb5122-f691-43d0-ad90-5bbe921a2c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d47d26ce-df63-406f-86ca-6822d9827b2b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_03fb5122-f691-43d0-ad90-5bbe921a2c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d4aa49d7-1fad-41ad-b3b6-c8ef65d54d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03fb5122-f691-43d0-ad90-5bbe921a2c5f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d4aa49d7-1fad-41ad-b3b6-c8ef65d54d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_aba872ae-3bd7-493d-90ab-30030acef78b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d4aa49d7-1fad-41ad-b3b6-c8ef65d54d74" xlink:to="loc_us-gaap_SecuredDebtMember_aba872ae-3bd7-493d-90ab-30030acef78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b26229b0-825c-4edb-8e1d-996456ed2ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d47d26ce-df63-406f-86ca-6822d9827b2b" xlink:to="loc_us-gaap_DebtInstrumentAxis_b26229b0-825c-4edb-8e1d-996456ed2ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d904ee56-e7aa-4303-8165-85465b26aae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b26229b0-825c-4edb-8e1d-996456ed2ba4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d904ee56-e7aa-4303-8165-85465b26aae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_A2017SeniorSecuredCreditFacilityMember_b5f9bd7c-ef16-4c64-8b1b-2c722d251344" xlink:href="sgry-20220630.xsd#sgry_A2017SeniorSecuredCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d904ee56-e7aa-4303-8165-85465b26aae5" xlink:to="loc_sgry_A2017SeniorSecuredCreditFacilityMember_b5f9bd7c-ef16-4c64-8b1b-2c722d251344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e30cb7c3-f03e-49ec-b6f2-6c58056c67e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d47d26ce-df63-406f-86ca-6822d9827b2b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e30cb7c3-f03e-49ec-b6f2-6c58056c67e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_247cd034-84b3-4e81-ad61-03b658cd4aae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e30cb7c3-f03e-49ec-b6f2-6c58056c67e3" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_247cd034-84b3-4e81-ad61-03b658cd4aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_7d6e9507-c7cd-461d-98ba-192d63b4f4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e30cb7c3-f03e-49ec-b6f2-6c58056c67e3" xlink:to="loc_us-gaap_LineOfCredit_7d6e9507-c7cd-461d-98ba-192d63b4f4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/Leases" xlink:type="simple" xlink:href="sgry-20220630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ae7be058-4457-4d26-bd61-6e717840ac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_6c5ae089-8897-44d9-a641-e04015b1f282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ae7be058-4457-4d26-bd61-6e717840ac8a" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_6c5ae089-8897-44d9-a641-e04015b1f282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_476221a3-7c2b-4390-a3e3-d96cd4858858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ae7be058-4457-4d26-bd61-6e717840ac8a" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_476221a3-7c2b-4390-a3e3-d96cd4858858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LeasesTables" xlink:type="simple" xlink:href="sgry-20220630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6b243c3e-eba1-42f0-8849-d2e22ce53494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AssetsAndLiabilitiesLesseeTableTextBlock_f83c7577-992e-416a-9600-84ffc2421a1f" xlink:href="sgry-20220630.xsd#sgry_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6b243c3e-eba1-42f0-8849-d2e22ce53494" xlink:to="loc_sgry_AssetsAndLiabilitiesLesseeTableTextBlock_f83c7577-992e-416a-9600-84ffc2421a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_a229e18a-20a6-4ab2-bb43-6b62d066acd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6b243c3e-eba1-42f0-8849-d2e22ce53494" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_a229e18a-20a6-4ab2-bb43-6b62d066acd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bac0c32f-2e21-4111-8bde-1e8cea2c6004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_2e64ed0f-c2ee-443a-9ac6-923903d495bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bac0c32f-2e21-4111-8bde-1e8cea2c6004" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_2e64ed0f-c2ee-443a-9ac6-923903d495bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_5d5c2906-9b88-49e9-aa19-6e09ffbd16c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bac0c32f-2e21-4111-8bde-1e8cea2c6004" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_5d5c2906-9b88-49e9-aa19-6e09ffbd16c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_9262c546-7aea-4aea-87a9-23812f6f0db8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bac0c32f-2e21-4111-8bde-1e8cea2c6004" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_9262c546-7aea-4aea-87a9-23812f6f0db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_40ce7739-41d4-4fbb-8bd5-367dc1212a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bac0c32f-2e21-4111-8bde-1e8cea2c6004" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_40ce7739-41d4-4fbb-8bd5-367dc1212a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e4d071d4-1d10-485b-9112-093a776065a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bac0c32f-2e21-4111-8bde-1e8cea2c6004" xlink:to="loc_us-gaap_AssetsAbstract_e4d071d4-1d10-485b-9112-093a776065a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ed39d161-8dc2-40a4-8271-e4239f6b92c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e4d071d4-1d10-485b-9112-093a776065a9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ed39d161-8dc2-40a4-8271-e4239f6b92c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_cab2db60-9c0d-45b3-8a4b-c4ce201f5eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e4d071d4-1d10-485b-9112-093a776065a9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_cab2db60-9c0d-45b3-8a4b-c4ce201f5eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_LeaseRightOfUseAsset_db7292fc-e3aa-4ff5-b67e-44b1ccde0949" xlink:href="sgry-20220630.xsd#sgry_LeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e4d071d4-1d10-485b-9112-093a776065a9" xlink:to="loc_sgry_LeaseRightOfUseAsset_db7292fc-e3aa-4ff5-b67e-44b1ccde0949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_bf4e1531-631c-450c-92dd-34964138fe0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bac0c32f-2e21-4111-8bde-1e8cea2c6004" xlink:to="loc_us-gaap_LiabilitiesAbstract_bf4e1531-631c-450c-92dd-34964138fe0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract_4c5fef2b-2025-45ac-bb2b-1975f3042ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bf4e1531-631c-450c-92dd-34964138fe0e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityAbstract_4c5fef2b-2025-45ac-bb2b-1975f3042ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c0e32784-1919-4e4d-8f35-26ee84b209d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_4c5fef2b-2025-45ac-bb2b-1975f3042ba3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c0e32784-1919-4e4d-8f35-26ee84b209d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_74e836fb-4f78-4d16-848b-6d5c02d04a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_4c5fef2b-2025-45ac-bb2b-1975f3042ba3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_74e836fb-4f78-4d16-848b-6d5c02d04a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_cf1656fc-2a20-4377-9a70-029beb135e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_4c5fef2b-2025-45ac-bb2b-1975f3042ba3" xlink:to="loc_us-gaap_OperatingLeaseLiability_cf1656fc-2a20-4377-9a70-029beb135e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract_e3ced13d-ef30-43a0-a712-dc86e3a4f767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bf4e1531-631c-450c-92dd-34964138fe0e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityAbstract_e3ced13d-ef30-43a0-a712-dc86e3a4f767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_3d925fb7-5b53-4612-82a7-4e5ff9838ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_e3ced13d-ef30-43a0-a712-dc86e3a4f767" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_3d925fb7-5b53-4612-82a7-4e5ff9838ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fb3f02a2-499e-46aa-a04e-e441f5df2a04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_e3ced13d-ef30-43a0-a712-dc86e3a4f767" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fb3f02a2-499e-46aa-a04e-e441f5df2a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b2963f9a-f061-4b35-8904-c898eab95274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_e3ced13d-ef30-43a0-a712-dc86e3a4f767" xlink:to="loc_us-gaap_FinanceLeaseLiability_b2963f9a-f061-4b35-8904-c898eab95274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_LeaseLiability_635f3fe8-3e18-40da-82cc-8a4a53ac3adf" xlink:href="sgry-20220630.xsd#sgry_LeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bac0c32f-2e21-4111-8bde-1e8cea2c6004" xlink:to="loc_sgry_LeaseLiability_635f3fe8-3e18-40da-82cc-8a4a53ac3adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5885bbd2-fbce-4a73-9dea-da1013d3b7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInFinanceLeaseLiability_87e0a1d7-2217-4243-a1e0-50dafd97d647" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInFinanceLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5885bbd2-fbce-4a73-9dea-da1013d3b7f1" xlink:to="loc_sgry_IncreaseDecreaseInFinanceLeaseLiability_87e0a1d7-2217-4243-a1e0-50dafd97d647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets_bd200a9d-d58e-4fee-aca6-02a58fc40a9a" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5885bbd2-fbce-4a73-9dea-da1013d3b7f1" xlink:to="loc_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets_bd200a9d-d58e-4fee-aca6-02a58fc40a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4fcec7e9-0e59-4f07-ba31-fb1558c787c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5885bbd2-fbce-4a73-9dea-da1013d3b7f1" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4fcec7e9-0e59-4f07-ba31-fb1558c787c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_85338a13-41ab-4a63-af24-cfe6fd257be8" xlink:href="sgry-20220630.xsd#sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5885bbd2-fbce-4a73-9dea-da1013d3b7f1" xlink:to="loc_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_85338a13-41ab-4a63-af24-cfe6fd257be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#LeasesLeaseExpenseandCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d8b26676-228d-4c09-9f0f-2151b4aa169f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_3900a758-3df2-421e-a60b-125f91a56aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8b26676-228d-4c09-9f0f-2151b4aa169f" xlink:to="loc_us-gaap_OperatingLeaseCost_3900a758-3df2-421e-a60b-125f91a56aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost1Abstract_61d92486-fc09-4384-9a29-0ca8d0e64be8" xlink:href="sgry-20220630.xsd#sgry_FinanceLeaseCost1Abstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8b26676-228d-4c09-9f0f-2151b4aa169f" xlink:to="loc_sgry_FinanceLeaseCost1Abstract_61d92486-fc09-4384-9a29-0ca8d0e64be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e147a221-e92f-4686-9345-a33299eb681b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_FinanceLeaseCost1Abstract_61d92486-fc09-4384-9a29-0ca8d0e64be8" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e147a221-e92f-4686-9345-a33299eb681b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_bf2d93f9-d6f8-4aa5-949a-5a9b3e192ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_FinanceLeaseCost1Abstract_61d92486-fc09-4384-9a29-0ca8d0e64be8" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_bf2d93f9-d6f8-4aa5-949a-5a9b3e192ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_FinanceLeaseCost_bfb7a4b0-7854-4f00-9d03-5aa009e35ada" xlink:href="sgry-20220630.xsd#sgry_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_FinanceLeaseCost1Abstract_61d92486-fc09-4384-9a29-0ca8d0e64be8" xlink:to="loc_sgry_FinanceLeaseCost_bfb7a4b0-7854-4f00-9d03-5aa009e35ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_VariableAndShortTermLeaseCost_a2d6c9ed-94d0-4ee5-8b05-f6c255a66b0a" xlink:href="sgry-20220630.xsd#sgry_VariableAndShortTermLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8b26676-228d-4c09-9f0f-2151b4aa169f" xlink:to="loc_sgry_VariableAndShortTermLeaseCost_a2d6c9ed-94d0-4ee5-8b05-f6c255a66b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_d43631c1-250e-41e4-a3ec-00e6445b3b62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8b26676-228d-4c09-9f0f-2151b4aa169f" xlink:to="loc_us-gaap_LeaseCost_d43631c1-250e-41e4-a3ec-00e6445b3b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CashFlowLesseeAbstract_6e01dc2b-8966-4250-aa3e-7ad8777dcb93" xlink:href="sgry-20220630.xsd#sgry_CashFlowLesseeAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8b26676-228d-4c09-9f0f-2151b4aa169f" xlink:to="loc_sgry_CashFlowLesseeAbstract_6e01dc2b-8966-4250-aa3e-7ad8777dcb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_932e8c78-c74d-48da-8449-21045d3b93e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_CashFlowLesseeAbstract_6e01dc2b-8966-4250-aa3e-7ad8777dcb93" xlink:to="loc_us-gaap_OperatingLeasePayments_932e8c78-c74d-48da-8449-21045d3b93e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_f4586a21-fba7-4fba-a7c9-50ecde287a86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_CashFlowLesseeAbstract_6e01dc2b-8966-4250-aa3e-7ad8777dcb93" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_f4586a21-fba7-4fba-a7c9-50ecde287a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_143a4c99-7809-4d5e-8e9a-856a2041be9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgry_CashFlowLesseeAbstract_6e01dc2b-8966-4250-aa3e-7ad8777dcb93" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_143a4c99-7809-4d5e-8e9a-856a2041be9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8ca9bb26-b40d-47f3-b2e0-89d04c7c6b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8b26676-228d-4c09-9f0f-2151b4aa169f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8ca9bb26-b40d-47f3-b2e0-89d04c7c6b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_a4c5e4fc-0a1c-4f8b-9236-36cc7a897bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d8b26676-228d-4c09-9f0f-2151b4aa169f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_a4c5e4fc-0a1c-4f8b-9236-36cc7a897bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivities" xlink:type="simple" xlink:href="sgry-20220630.xsd#DerivativesandHedgingActivities"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e546980a-9278-4f83-9f5c-243375aa09f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_bcaea90b-eed9-4d81-aedc-77399562cadd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e546980a-9278-4f83-9f5c-243375aa09f1" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_bcaea90b-eed9-4d81-aedc-77399562cadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables" xlink:type="simple" xlink:href="sgry-20220630.xsd#DerivativesandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40bd78ca-55ae-498d-a71d-42d44e388c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_26f860f6-f944-454d-a884-9af5ec8f4801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40bd78ca-55ae-498d-a71d-42d44e388c36" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_26f860f6-f944-454d-a884-9af5ec8f4801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5c10dd63-fa60-4b4d-85ad-4837d92a6e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40bd78ca-55ae-498d-a71d-42d44e388c36" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5c10dd63-fa60-4b4d-85ad-4837d92a6e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_7c43f6b7-2b67-4692-86c0-adda63b504db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_40bd78ca-55ae-498d-a71d-42d44e388c36" xlink:to="loc_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_7c43f6b7-2b67-4692-86c0-adda63b504db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#DerivativesandHedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_896f9963-c63c-49ce-869e-46cb57a962f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_896f9963-c63c-49ce-869e-46cb57a962f0" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_71cfc553-0e80-4bd7-b0dc-16f48eea924d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_71cfc553-0e80-4bd7-b0dc-16f48eea924d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_71cfc553-0e80-4bd7-b0dc-16f48eea924d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ecd6eb7c-3617-4398-a69a-0874eacc7e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:to="loc_us-gaap_InterestRateSwapMember_ecd6eb7c-3617-4398-a69a-0874eacc7e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c5ac2ad4-3c59-4280-907d-61f19271d2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:to="loc_us-gaap_InterestRateCapMember_c5ac2ad4-3c59-4280-907d-61f19271d2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreePayFixedInterestRateSwapsMember_1e8db266-5fb1-49d8-8f5b-9646915388b9" xlink:href="sgry-20220630.xsd#sgry_ThreePayFixedInterestRateSwapsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:to="loc_sgry_ThreePayFixedInterestRateSwapsMember_1e8db266-5fb1-49d8-8f5b-9646915388b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember_de02a757-205f-4484-bd3a-e19ee8ebcd42" xlink:href="sgry-20220630.xsd#sgry_ThreeReceiveFixedInterestRateSwapsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b3ac6986-cfab-4c2f-ac85-6b6d4fa5def2" xlink:to="loc_sgry_ThreeReceiveFixedInterestRateSwapsMember_de02a757-205f-4484-bd3a-e19ee8ebcd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_28a6edf7-80fe-4188-86c2-68ebf1c56367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:to="loc_us-gaap_HedgingDesignationAxis_28a6edf7-80fe-4188-86c2-68ebf1c56367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0449048a-d952-47ea-a65d-3f7f33a61995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_28a6edf7-80fe-4188-86c2-68ebf1c56367" xlink:to="loc_us-gaap_HedgingDesignationDomain_0449048a-d952-47ea-a65d-3f7f33a61995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a6092f33-b957-46b4-8812-04cdb08ce86b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0449048a-d952-47ea-a65d-3f7f33a61995" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_a6092f33-b957-46b4-8812-04cdb08ce86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_dd8676e4-8fa9-43b0-afa2-b20b3783b090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0449048a-d952-47ea-a65d-3f7f33a61995" xlink:to="loc_us-gaap_NondesignatedMember_dd8676e4-8fa9-43b0-afa2-b20b3783b090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f62117c6-82f6-4f9a-b83a-f94cf25ec3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:to="loc_us-gaap_VariableRateAxis_f62117c6-82f6-4f9a-b83a-f94cf25ec3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2e587e5f-1046-4e7d-8e96-35c6573e2be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f62117c6-82f6-4f9a-b83a-f94cf25ec3b5" xlink:to="loc_us-gaap_VariableRateDomain_2e587e5f-1046-4e7d-8e96-35c6573e2be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9ef525c3-f1b0-405c-b7ab-c42630943c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_2e587e5f-1046-4e7d-8e96-35c6573e2be0" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9ef525c3-f1b0-405c-b7ab-c42630943c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_55ac22db-9537-4b9e-b1e4-8ceaa2534663" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:to="loc_srt_RangeAxis_55ac22db-9537-4b9e-b1e4-8ceaa2534663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_94144845-1fb5-44b3-ac8c-df7df87cbe05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_55ac22db-9537-4b9e-b1e4-8ceaa2534663" xlink:to="loc_srt_RangeMember_94144845-1fb5-44b3-ac8c-df7df87cbe05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fb2a5264-4815-4a92-9e08-791083bf694c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_94144845-1fb5-44b3-ac8c-df7df87cbe05" xlink:to="loc_srt_MinimumMember_fb2a5264-4815-4a92-9e08-791083bf694c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_0de1c9a1-7943-4ae1-a1d0-4211cf98fb6c" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a0f45993-1e6d-4f91-849a-438274fc9c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_a0f45993-1e6d-4f91-849a-438274fc9c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_56078ae7-a4d3-474f-b433-62a83fc015c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_56078ae7-a4d3-474f-b433-62a83fc015c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_9cdedf2d-dad3-472a-a6a9-727d82d809db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:to="loc_us-gaap_DerivativeNotionalAmount_9cdedf2d-dad3-472a-a6a9-727d82d809db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_5bd2b5fb-1b7c-45dd-9148-41fafa4aa69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_cd50fc13-e176-421d-a679-eee5a5cd38fc" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_5bd2b5fb-1b7c-45dd-9148-41fafa4aa69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cbb55153-b06b-4547-9d40-1f196d4aba9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3308c8c3-fcaf-4a20-8ce0-b8c6ef2bc0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cbb55153-b06b-4547-9d40-1f196d4aba9f" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3308c8c3-fcaf-4a20-8ce0-b8c6ef2bc0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0d05850-dd44-4e12-9163-b0efae9ad42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3308c8c3-fcaf-4a20-8ce0-b8c6ef2bc0c8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0d05850-dd44-4e12-9163-b0efae9ad42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0d05850-dd44-4e12-9163-b0efae9ad42f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapOneMember_13fd82d7-51b4-45d9-a913-997381db3d5d" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapOneMember_13fd82d7-51b4-45d9-a913-997381db3d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapTwoMember_0913c2ac-f020-49df-a37e-ac2db8777661" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapTwoMember_0913c2ac-f020-49df-a37e-ac2db8777661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapThreeMember_7d7151eb-c953-4f51-85be-06ac16cddf4e" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapThreeMember_7d7151eb-c953-4f51-85be-06ac16cddf4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapOneMember_7af1fd84-2a70-444d-aae7-f7003298723b" xlink:href="sgry-20220630.xsd#sgry_InterestRateCapOneMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_InterestRateCapOneMember_7af1fd84-2a70-444d-aae7-f7003298723b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InterestRateCapTwoMember_731c9023-fc37-463b-852c-a4a7cf62eaf5" xlink:href="sgry-20220630.xsd#sgry_InterestRateCapTwoMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_InterestRateCapTwoMember_731c9023-fc37-463b-852c-a4a7cf62eaf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFourMember_b8d3ceb3-1daf-49bd-9df4-0ab8d9220c9a" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapFourMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapFourMember_b8d3ceb3-1daf-49bd-9df4-0ab8d9220c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapFiveMember_698dfea5-93db-45da-911f-84602c77015f" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapFiveMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapFiveMember_698dfea5-93db-45da-911f-84602c77015f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_PayFixedSwapSixMember_2775b5de-7e4c-4c98-9db3-eca57dca8428" xlink:href="sgry-20220630.xsd#sgry_PayFixedSwapSixMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_PayFixedSwapSixMember_2775b5de-7e4c-4c98-9db3-eca57dca8428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapOneMember_cfe743dd-8d0c-4296-90c9-c2b87cf68448" xlink:href="sgry-20220630.xsd#sgry_ReceiveFixedSwapOneMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_ReceiveFixedSwapOneMember_cfe743dd-8d0c-4296-90c9-c2b87cf68448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapTwoMember_7b7f0ed7-2051-4278-b651-058384837d17" xlink:href="sgry-20220630.xsd#sgry_ReceiveFixedSwapTwoMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_ReceiveFixedSwapTwoMember_7b7f0ed7-2051-4278-b651-058384837d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_ReceiveFixedSwapThreeMember_1b220fcb-775b-4191-9e4b-98df21249224" xlink:href="sgry-20220630.xsd#sgry_ReceiveFixedSwapThreeMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_96188cf9-4dda-43c3-8189-0da1dcb079c7" xlink:to="loc_sgry_ReceiveFixedSwapThreeMember_1b220fcb-775b-4191-9e4b-98df21249224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a47bce7b-e07f-4041-8ef4-622576a611c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_3308c8c3-fcaf-4a20-8ce0-b8c6ef2bc0c8" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a47bce7b-e07f-4041-8ef4-622576a611c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_f560ef4f-d86c-4825-ab6e-b41aff607be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a47bce7b-e07f-4041-8ef4-622576a611c5" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_f560ef4f-d86c-4825-ab6e-b41aff607be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_16f115d5-d1a8-473f-ab99-4c2212e467e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a47bce7b-e07f-4041-8ef4-622576a611c5" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_16f115d5-d1a8-473f-ab99-4c2212e467e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_63edbc4d-7eb5-478d-9ebb-21b834896b76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_a47bce7b-e07f-4041-8ef4-622576a611c5" xlink:to="loc_us-gaap_DerivativeNotionalAmount_63edbc4d-7eb5-478d-9ebb-21b834896b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec741233-3df9-45cb-95be-6c89d91a9fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d5770736-784e-4d6f-9f03-8a515f720896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec741233-3df9-45cb-95be-6c89d91a9fd7" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d5770736-784e-4d6f-9f03-8a515f720896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_31007059-0047-4b60-844a-761bcc237d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d5770736-784e-4d6f-9f03-8a515f720896" xlink:to="loc_us-gaap_HedgingDesignationAxis_31007059-0047-4b60-844a-761bcc237d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_10d9aa60-c958-40f8-8e1e-5dc9a4ad3e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_31007059-0047-4b60-844a-761bcc237d6e" xlink:to="loc_us-gaap_HedgingDesignationDomain_10d9aa60-c958-40f8-8e1e-5dc9a4ad3e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e332a524-d4fb-406f-9e23-f7e5375652c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_10d9aa60-c958-40f8-8e1e-5dc9a4ad3e99" xlink:to="loc_us-gaap_NondesignatedMember_e332a524-d4fb-406f-9e23-f7e5375652c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7677019c-b65c-4de3-8d1c-77c2716aab5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_10d9aa60-c958-40f8-8e1e-5dc9a4ad3e99" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_7677019c-b65c-4de3-8d1c-77c2716aab5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ad0a2ee8-98b4-462c-9f9a-390cb6473ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d5770736-784e-4d6f-9f03-8a515f720896" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ad0a2ee8-98b4-462c-9f9a-390cb6473ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_be29d973-aa1e-4e0b-b20c-6364b1bf2e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ad0a2ee8-98b4-462c-9f9a-390cb6473ba0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_be29d973-aa1e-4e0b-b20c-6364b1bf2e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_5e815fcb-9cfe-4b1b-8ce5-b52c51c001f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_be29d973-aa1e-4e0b-b20c-6364b1bf2e63" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_5e815fcb-9cfe-4b1b-8ce5-b52c51c001f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_5ca923c1-5495-4d17-b81b-39ff181e92fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_be29d973-aa1e-4e0b-b20c-6364b1bf2e63" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_5ca923c1-5495-4d17-b81b-39ff181e92fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e646e6-86b0-4201-9666-5820b64f4463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d5770736-784e-4d6f-9f03-8a515f720896" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e646e6-86b0-4201-9666-5820b64f4463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e26d905d-d4bc-45b4-a824-ad7d975937e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f0e646e6-86b0-4201-9666-5820b64f4463" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e26d905d-d4bc-45b4-a824-ad7d975937e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d47c191f-30d9-43d2-992b-6217940e51a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e26d905d-d4bc-45b4-a824-ad7d975937e1" xlink:to="loc_us-gaap_InterestRateSwapMember_d47c191f-30d9-43d2-992b-6217940e51a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_afa8be96-5afe-4638-809c-c0923d48c85b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e26d905d-d4bc-45b4-a824-ad7d975937e1" xlink:to="loc_us-gaap_InterestRateCapMember_afa8be96-5afe-4638-809c-c0923d48c85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0dc59bcf-633e-4547-b4c0-1a494a38828f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_d5770736-784e-4d6f-9f03-8a515f720896" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0dc59bcf-633e-4547-b4c0-1a494a38828f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_3ee00429-c959-45a7-a5bb-6732f04cbf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0dc59bcf-633e-4547-b4c0-1a494a38828f" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_3ee00429-c959-45a7-a5bb-6732f04cbf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_b061f8eb-d7c2-4925-9685-b0ace3148aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0dc59bcf-633e-4547-b4c0-1a494a38828f" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_b061f8eb-d7c2-4925-9685-b0ace3148aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_914bde5b-5ad7-4195-972c-95fb2e8da55b" xlink:href="sgry-20220630.xsd#sgry_DerivativeLiabilityNotionalAmountFinancingComponent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_0dc59bcf-633e-4547-b4c0-1a494a38828f" xlink:to="loc_sgry_DerivativeLiabilityNotionalAmountFinancingComponent_914bde5b-5ad7-4195-972c-95fb2e8da55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec1f1b35-1316-4020-8e2f-f986d808dab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_9705c163-9d50-4a31-bb6f-f8646967857e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec1f1b35-1316-4020-8e2f-f986d808dab9" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_9705c163-9d50-4a31-bb6f-f8646967857e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7e39db68-bef3-42dc-8b07-29a04cec2a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_9705c163-9d50-4a31-bb6f-f8646967857e" xlink:to="loc_us-gaap_HedgingDesignationAxis_7e39db68-bef3-42dc-8b07-29a04cec2a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c1b0da24-bb20-425b-a3b3-35a063d3ff96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7e39db68-bef3-42dc-8b07-29a04cec2a0f" xlink:to="loc_us-gaap_HedgingDesignationDomain_c1b0da24-bb20-425b-a3b3-35a063d3ff96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_712f06c8-7863-4d40-a2e5-c985e470ce72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c1b0da24-bb20-425b-a3b3-35a063d3ff96" xlink:to="loc_us-gaap_NondesignatedMember_712f06c8-7863-4d40-a2e5-c985e470ce72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_03d6a1e6-8d67-417f-bc0a-bacf8bd5d7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c1b0da24-bb20-425b-a3b3-35a063d3ff96" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_03d6a1e6-8d67-417f-bc0a-bacf8bd5d7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a7ee09f1-df95-401e-b8ce-811e9d656e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_9705c163-9d50-4a31-bb6f-f8646967857e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a7ee09f1-df95-401e-b8ce-811e9d656e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2ffb9406-bbc0-4dc4-bc37-455a0c3eb54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a7ee09f1-df95-401e-b8ce-811e9d656e62" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2ffb9406-bbc0-4dc4-bc37-455a0c3eb54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_2993c255-081c-4ec6-977b-c3f2be6cf450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2ffb9406-bbc0-4dc4-bc37-455a0c3eb54f" xlink:to="loc_us-gaap_OtherIncomeMember_2993c255-081c-4ec6-977b-c3f2be6cf450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_2687fded-a21b-489d-93bb-6c69de52cb20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2ffb9406-bbc0-4dc4-bc37-455a0c3eb54f" xlink:to="loc_us-gaap_InterestExpenseMember_2687fded-a21b-489d-93bb-6c69de52cb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_8b9d3c54-a40e-4bc7-be04-6827c16beb91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_9705c163-9d50-4a31-bb6f-f8646967857e" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_8b9d3c54-a40e-4bc7-be04-6827c16beb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3d102e8f-1f47-4453-baed-3dad22cfaeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_8b9d3c54-a40e-4bc7-be04-6827c16beb91" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3d102e8f-1f47-4453-baed-3dad22cfaeb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_da74095c-5dfb-4044-ab74-6a85b7c39f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_8b9d3c54-a40e-4bc7-be04-6827c16beb91" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_da74095c-5dfb-4044-ab74-6a85b7c39f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_daa9df6e-d24c-4177-9d14-633975689556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_8b9d3c54-a40e-4bc7-be04-6827c16beb91" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax_daa9df6e-d24c-4177-9d14-633975689556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/EarningsPerShare" xlink:type="simple" xlink:href="sgry-20220630.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c562370c-dbde-4a49-a6f6-c32ba48f17ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_9113bf7b-ddf6-41ea-9edc-919cfc1cfb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c562370c-dbde-4a49-a6f6-c32ba48f17ba" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_9113bf7b-ddf6-41ea-9edc-919cfc1cfb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="sgry-20220630.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fbc0f0a2-bea6-4007-8d64-59df20a8f4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_241ae1fd-645e-427f-b42f-f9cbee572d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fbc0f0a2-bea6-4007-8d64-59df20a8f4e6" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_241ae1fd-645e-427f-b42f-f9cbee572d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#EarningsPerShareSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_85edbd42-550c-45fd-9944-82f5599f75cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_be7fb48d-bc45-4649-bd81-7ae14548428d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_85edbd42-550c-45fd-9944-82f5599f75cf" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_be7fb48d-bc45-4649-bd81-7ae14548428d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_961f73cd-134f-419f-a05b-974c5a7ca4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_be7fb48d-bc45-4649-bd81-7ae14548428d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_961f73cd-134f-419f-a05b-974c5a7ca4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_86013e8a-48ca-4f10-950e-bf86c97373da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_961f73cd-134f-419f-a05b-974c5a7ca4fd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_86013e8a-48ca-4f10-950e-bf86c97373da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1a56cc87-d285-4c42-8aad-ee462fb0da27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_86013e8a-48ca-4f10-950e-bf86c97373da" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1a56cc87-d285-4c42-8aad-ee462fb0da27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_195a8385-533f-470f-9b92-b2bdf7f748ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_86013e8a-48ca-4f10-950e-bf86c97373da" xlink:to="loc_us-gaap_RestrictedStockMember_195a8385-533f-470f-9b92-b2bdf7f748ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_be7fb48d-bc45-4649-bd81-7ae14548428d" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_5e8b9030-81be-4969-9c63-42a3f15591e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:to="loc_us-gaap_NetIncomeLossAbstract_5e8b9030-81be-4969-9c63-42a3f15591e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e4018fd1-1ca6-43f4-9376-eb50fcab88b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_5e8b9030-81be-4969-9c63-42a3f15591e7" xlink:to="loc_us-gaap_NetIncomeLoss_e4018fd1-1ca6-43f4-9376-eb50fcab88b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_15039c42-cef0-4e4a-a89e-6b011f0cb8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_5e8b9030-81be-4969-9c63-42a3f15591e7" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_15039c42-cef0-4e4a-a89e-6b011f0cb8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c77bb98b-4785-4fb7-9acf-fed7383f724f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_5e8b9030-81be-4969-9c63-42a3f15591e7" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c77bb98b-4785-4fb7-9acf-fed7383f724f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cbbe7a36-ddf4-465c-af81-8af48720fc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cbbe7a36-ddf4-465c-af81-8af48720fc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_df807833-447c-47a3-9102-870597e179c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cbbe7a36-ddf4-465c-af81-8af48720fc98" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_df807833-447c-47a3-9102-870597e179c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16113bd3-6b68-4489-b90f-96a339f3fd08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_cbbe7a36-ddf4-465c-af81-8af48720fc98" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16113bd3-6b68-4489-b90f-96a339f3fd08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_d91d0167-a57d-41c7-aa23-a332ebd091e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_d91d0167-a57d-41c7-aa23-a332ebd091e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_02a78140-8d63-47ce-9124-ca0e7ee2e260" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_d91d0167-a57d-41c7-aa23-a332ebd091e3" xlink:to="loc_us-gaap_EarningsPerShareBasic_02a78140-8d63-47ce-9124-ca0e7ee2e260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_596f2ab8-0f77-4dd4-8636-e70fd3c5530e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_d91d0167-a57d-41c7-aa23-a332ebd091e3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_596f2ab8-0f77-4dd4-8636-e70fd3c5530e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_55d2e47e-a41f-4e70-b3b6-2663ee1fce68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_e9aaa3de-ed57-47e4-b15b-d45fe601021b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_55d2e47e-a41f-4e70-b3b6-2663ee1fce68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilities" xlink:type="simple" xlink:href="sgry-20220630.xsd#OtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_a1590528-d858-48d8-8fce-b00b2682f23b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_a48fd2d9-f564-438c-bf04-c233f9d23606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_a1590528-d858-48d8-8fce-b00b2682f23b" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_a48fd2d9-f564-438c-bf04-c233f9d23606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="sgry-20220630.xsd#OtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_a2be5418-3734-445b-b172-04bf0cd0f921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_08c64771-e5af-4a52-a0dd-92b1da3b771c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_a2be5418-3734-445b-b172-04bf0cd0f921" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_08c64771-e5af-4a52-a0dd-92b1da3b771c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#OtherCurrentLiabilitiesSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_35d16298-cd3b-46ca-8f2f-d55baf461e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_949a6bd9-4954-4aa8-90eb-29042b2d6d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_35d16298-cd3b-46ca-8f2f-d55baf461e5f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_949a6bd9-4954-4aa8-90eb-29042b2d6d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_6d0a87d0-a1e6-4f9e-b175-75547d774c32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_35d16298-cd3b-46ca-8f2f-d55baf461e5f" xlink:to="loc_us-gaap_InterestPayableCurrent_6d0a87d0-a1e6-4f9e-b175-75547d774c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_PayablesToCustomers_dd1153b8-3460-40de-be7d-fe8550329a4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_PayablesToCustomers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_35d16298-cd3b-46ca-8f2f-d55baf461e5f" xlink:to="loc_srt_PayablesToCustomers_dd1153b8-3460-40de-be7d-fe8550329a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CostReportLiabilitiesCurrent_4671a962-39c2-4259-926d-af16639cb5d7" xlink:href="sgry-20220630.xsd#sgry_CostReportLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_35d16298-cd3b-46ca-8f2f-d55baf461e5f" xlink:to="loc_sgry_CostReportLiabilitiesCurrent_4671a962-39c2-4259-926d-af16639cb5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_TaxReceivableAgreementLiabilityCurrent_49b9e0b3-7fb2-4143-8950-628d7d540f39" xlink:href="sgry-20220630.xsd#sgry_TaxReceivableAgreementLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_35d16298-cd3b-46ca-8f2f-d55baf461e5f" xlink:to="loc_sgry_TaxReceivableAgreementLiabilityCurrent_49b9e0b3-7fb2-4143-8950-628d7d540f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_63edfeef-17b7-49ff-ab6c-538862bd035f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_35d16298-cd3b-46ca-8f2f-d55baf461e5f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_63edfeef-17b7-49ff-ab6c-538862bd035f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_8ea8e14c-8144-4e46-a062-4f40a9871e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_35d16298-cd3b-46ca-8f2f-d55baf461e5f" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_8ea8e14c-8144-4e46-a062-4f40a9871e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="sgry-20220630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c9ccbc9b-fe22-49ee-86c0-e7b7a8f9f64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2f263539-7314-48fb-bcb5-0e590a4f601a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c9ccbc9b-fe22-49ee-86c0-e7b7a8f9f64e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2f263539-7314-48fb-bcb5-0e590a4f601a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_438d0577-4e24-454b-9212-ed3716262d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b7b57b88-06ce-4d6a-a1eb-76e02b48e8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGuaranteeObligationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_438d0577-4e24-454b-9212-ed3716262d10" xlink:to="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b7b57b88-06ce-4d6a-a1eb-76e02b48e8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_a1fa22c1-1d95-49c8-a3a1-80c337cdf8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b7b57b88-06ce-4d6a-a1eb-76e02b48e8c3" xlink:to="loc_us-gaap_VariableRateAxis_a1fa22c1-1d95-49c8-a3a1-80c337cdf8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_30868e33-d40a-40ce-86f4-f118fba46814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_a1fa22c1-1d95-49c8-a3a1-80c337cdf8a9" xlink:to="loc_us-gaap_VariableRateDomain_30868e33-d40a-40ce-86f4-f118fba46814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_a360549d-f0bf-428d-862f-48dbf2f3ee34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalFundsEffectiveSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_30868e33-d40a-40ce-86f4-f118fba46814" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_a360549d-f0bf-428d-862f-48dbf2f3ee34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9458b1fe-eace-4210-9112-c7e87207d3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_30868e33-d40a-40ce-86f4-f118fba46814" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9458b1fe-eace-4210-9112-c7e87207d3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_4d2d44e7-b108-40ce-96a1-6b67e84806b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualRiskOrUncertaintyByNatureAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b7b57b88-06ce-4d6a-a1eb-76e02b48e8c3" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_4d2d44e7-b108-40ce-96a1-6b67e84806b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_3d483e8a-3a4b-4e07-939e-e1204cc514c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualRiskOrUncertaintyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyByNatureAxis_4d2d44e7-b108-40ce-96a1-6b67e84806b6" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_3d483e8a-3a4b-4e07-939e-e1204cc514c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_MateriallyMoreRestrictiveMember_1ad1f459-4915-4ea5-a16e-000fac014367" xlink:href="sgry-20220630.xsd#sgry_MateriallyMoreRestrictiveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_3d483e8a-3a4b-4e07-939e-e1204cc514c3" xlink:to="loc_sgry_MateriallyMoreRestrictiveMember_1ad1f459-4915-4ea5-a16e-000fac014367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_NotMateriallyMoreRestrictiveMember_0ca2ee35-2b2e-4eb2-a486-37e0274656aa" xlink:href="sgry-20220630.xsd#sgry_NotMateriallyMoreRestrictiveMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyNatureDomain_3d483e8a-3a4b-4e07-939e-e1204cc514c3" xlink:to="loc_sgry_NotMateriallyMoreRestrictiveMember_0ca2ee35-2b2e-4eb2-a486-37e0274656aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGuaranteeObligationsTable_b7b57b88-06ce-4d6a-a1eb-76e02b48e8c3" xlink:to="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_161a0857-aa2a-49a1-a6e1-50b382533a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_SelfInsuranceReserve_161a0857-aa2a-49a1-a6e1-50b382533a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimatedInsuranceRecoveries_9966ee64-fc2a-4353-8f13-416fc64eb1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimatedInsuranceRecoveries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_EstimatedInsuranceRecoveries_9966ee64-fc2a-4353-8f13-416fc64eb1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_2bce2b17-ed86-4130-9da7-c68ba270e5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_2bce2b17-ed86-4130-9da7-c68ba270e5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0a73db9a-6f3e-4902-96b4-7c5a62987816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0a73db9a-6f3e-4902-96b4-7c5a62987816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_a50ba708-7c4d-4d4e-9e73-35fc7dc9de56" xlink:href="sgry-20220630.xsd#sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm_a50ba708-7c4d-4d4e-9e73-35fc7dc9de56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_25c553ae-5c4c-4f7d-874d-266845718247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_25c553ae-5c4c-4f7d-874d-266845718247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_a71ea49b-78e4-4ee8-8809-673bd680df3b" xlink:href="sgry-20220630.xsd#sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate_a71ea49b-78e4-4ee8-8809-673bd680df3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_ed3a10c5-cd6e-4d65-87c7-55df770af271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_ed3a10c5-cd6e-4d65-87c7-55df770af271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_7e0b16a1-4fb6-47f8-af08-60078bf16ee4" xlink:href="sgry-20220630.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount_7e0b16a1-4fb6-47f8-af08-60078bf16ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_5ed6e740-2c98-443d-9799-05230c346edc" xlink:href="sgry-20220630.xsd#sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsLineItems_db76b19b-f702-4b12-b247-bd40f32345c6" xlink:to="loc_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent_5ed6e740-2c98-443d-9799-05230c346edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReporting" xlink:type="simple" xlink:href="sgry-20220630.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_012e21c5-72ee-4102-8e6e-bbc40aad359f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_3fd023a7-85d0-42ac-a8f6-35399cddb000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_012e21c5-72ee-4102-8e6e-bbc40aad359f" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_3fd023a7-85d0-42ac-a8f6-35399cddb000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="sgry-20220630.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f0e8dcc0-7ea4-4959-bd72-c64fc0ac1405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_4dd28be3-0007-407c-ba89-d3ad0e1d3866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f0e8dcc0-7ea4-4959-bd72-c64fc0ac1405" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_4dd28be3-0007-407c-ba89-d3ad0e1d3866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_607bff41-bd8a-4026-9c9d-0c51802dbb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f0e8dcc0-7ea4-4959-bd72-c64fc0ac1405" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_607bff41-bd8a-4026-9c9d-0c51802dbb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_19d97e37-c440-4a40-9836-2096e1059e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f0e8dcc0-7ea4-4959-bd72-c64fc0ac1405" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_19d97e37-c440-4a40-9836-2096e1059e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_17448c49-410e-4f07-adb5-7615632120db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_1237c1a7-89a2-4c65-bd45-a16ee740c934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_17448c49-410e-4f07-adb5-7615632120db" xlink:to="loc_us-gaap_NumberOfOperatingSegments_1237c1a7-89a2-4c65-bd45-a16ee740c934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fef48871-f52f-4ec4-aad7-2a6dd918865e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_17448c49-410e-4f07-adb5-7615632120db" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fef48871-f52f-4ec4-aad7-2a6dd918865e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b79df458-8e08-49a5-836b-1adb6a84037e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fef48871-f52f-4ec4-aad7-2a6dd918865e" xlink:to="loc_srt_ConsolidationItemsAxis_b79df458-8e08-49a5-836b-1adb6a84037e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9d0a60cd-b093-4863-8c8b-2c4ff921b6a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b79df458-8e08-49a5-836b-1adb6a84037e" xlink:to="loc_srt_ConsolidationItemsDomain_9d0a60cd-b093-4863-8c8b-2c4ff921b6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9a3f8b13-b5ed-4b9c-ba7f-a4a966670f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9d0a60cd-b093-4863-8c8b-2c4ff921b6a1" xlink:to="loc_us-gaap_OperatingSegmentsMember_9a3f8b13-b5ed-4b9c-ba7f-a4a966670f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7898b6a7-ccf2-42bc-b30d-65334b91f990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9d0a60cd-b093-4863-8c8b-2c4ff921b6a1" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7898b6a7-ccf2-42bc-b30d-65334b91f990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_617816df-59be-468c-acb2-c5d7e02506c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fef48871-f52f-4ec4-aad7-2a6dd918865e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_617816df-59be-468c-acb2-c5d7e02506c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4b374d9e-902d-4e71-a2b6-d236ba655f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_617816df-59be-468c-acb2-c5d7e02506c4" xlink:to="loc_us-gaap_SegmentDomain_4b374d9e-902d-4e71-a2b6-d236ba655f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_f7337b9f-dad0-4ea8-9752-c960d56ca317" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4b374d9e-902d-4e71-a2b6-d236ba655f79" xlink:to="loc_sgry_SurgicalFacilityServicesMember_f7337b9f-dad0-4ea8-9752-c960d56ca317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_d40174c5-7d9b-4d33-b49d-830f43b493d7" xlink:href="sgry-20220630.xsd#sgry_AncillaryServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4b374d9e-902d-4e71-a2b6-d236ba655f79" xlink:to="loc_sgry_AncillaryServicesMember_d40174c5-7d9b-4d33-b49d-830f43b493d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_a4c83073-aabc-4a81-a157-6cb19cbefcdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fef48871-f52f-4ec4-aad7-2a6dd918865e" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_a4c83073-aabc-4a81-a157-6cb19cbefcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7de7f941-5bdd-48c8-a136-1c2abee53923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a4c83073-aabc-4a81-a157-6cb19cbefcdc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7de7f941-5bdd-48c8-a136-1c2abee53923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_455d098c-eefa-4f5d-8b04-f3d6956571bc" xlink:href="sgry-20220630.xsd#sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a4c83073-aabc-4a81-a157-6cb19cbefcdc" xlink:to="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_455d098c-eefa-4f5d-8b04-f3d6956571bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a4c83073-aabc-4a81-a157-6cb19cbefcdc" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2297bda5-7f3a-4703-a721-432aee8c9a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2297bda5-7f3a-4703-a721-432aee8c9a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9be22a77-dc42-4f8e-951a-399254f0cbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9be22a77-dc42-4f8e-951a-399254f0cbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_984cea7f-4e39-40db-b530-5eb338ae442f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_984cea7f-4e39-40db-b530-5eb338ae442f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_f48b48b5-37f3-4cca-839e-c6021a4fe069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_f48b48b5-37f3-4cca-839e-c6021a4fe069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_74e76639-f3e8-482c-93af-7e6f7892641a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_ShareBasedCompensation_74e76639-f3e8-482c-93af-7e6f7892641a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_04828c83-54be-41b2-bb60-4b45d1770bd9" xlink:href="sgry-20220630.xsd#sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts_04828c83-54be-41b2-bb60-4b45d1770bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_5c0e6627-e077-4c56-b83c-51bd33f1b035" xlink:href="sgry-20220630.xsd#sgry_GainLossOnDispositionOfAssetsAndDeconsolidation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation_5c0e6627-e077-4c56-b83c-51bd33f1b035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_1249e5cc-7f56-4da9-91b9-14c85dece32b" xlink:href="sgry-20220630.xsd#sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts_1249e5cc-7f56-4da9-91b9-14c85dece32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1344bc59-f20b-4eeb-b88d-f70646bc1eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1344bc59-f20b-4eeb-b88d-f70646bc1eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_e5719958-5f80-4f29-acb4-a05e716a6f45" xlink:href="sgry-20220630.xsd#sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization_e5719958-5f80-4f29-acb4-a05e716a6f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_06a01de2-323b-4da8-b55a-d33fbef82e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_06a01de2-323b-4da8-b55a-d33fbef82e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_38a82085-be84-432a-9fb5-dcf5a0ac0534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_38a82085-be84-432a-9fb5-dcf5a0ac0534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_c2a4a6df-5923-40d2-a0b2-29f310a3e02f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_LitigationSettlementExpense_c2a4a6df-5923-40d2-a0b2-29f310a3e02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_c67a49d5-66d7-482a-9893-5e36f16fd191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_758a78be-3037-4f2e-b123-06549e5baa55" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_c67a49d5-66d7-482a-9893-5e36f16fd191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_373836de-0142-411b-a0ef-7ca24c00d68e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5bd28f39-1e5a-4988-ac75-f63824af970b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_373836de-0142-411b-a0ef-7ca24c00d68e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5bd28f39-1e5a-4988-ac75-f63824af970b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_2bbdc752-90ad-4ed1-b962-e75815d472fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5bd28f39-1e5a-4988-ac75-f63824af970b" xlink:to="loc_srt_ConsolidationItemsAxis_2bbdc752-90ad-4ed1-b962-e75815d472fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_859e822f-0295-4fe6-b804-02b3c9c2c52b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_2bbdc752-90ad-4ed1-b962-e75815d472fb" xlink:to="loc_srt_ConsolidationItemsDomain_859e822f-0295-4fe6-b804-02b3c9c2c52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_616bcc06-4b03-4d3a-acc1-4bff60ea8392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_859e822f-0295-4fe6-b804-02b3c9c2c52b" xlink:to="loc_us-gaap_OperatingSegmentsMember_616bcc06-4b03-4d3a-acc1-4bff60ea8392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_600a0c70-90a2-4765-87ce-707bb095288a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_859e822f-0295-4fe6-b804-02b3c9c2c52b" xlink:to="loc_us-gaap_CorporateNonSegmentMember_600a0c70-90a2-4765-87ce-707bb095288a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1b7ef44f-9ee5-4929-b1f0-94a8f175c144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5bd28f39-1e5a-4988-ac75-f63824af970b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1b7ef44f-9ee5-4929-b1f0-94a8f175c144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_63919232-2993-425a-ac3f-79d439816585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1b7ef44f-9ee5-4929-b1f0-94a8f175c144" xlink:to="loc_us-gaap_SegmentDomain_63919232-2993-425a-ac3f-79d439816585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityServicesMember_bf123fe4-633f-461e-98f6-ec7cd6feb3bc" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilityServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_63919232-2993-425a-ac3f-79d439816585" xlink:to="loc_sgry_SurgicalFacilityServicesMember_bf123fe4-633f-461e-98f6-ec7cd6feb3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_AncillaryServicesMember_f083f23b-5cd8-43a3-b341-29f10871c9fd" xlink:href="sgry-20220630.xsd#sgry_AncillaryServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_63919232-2993-425a-ac3f-79d439816585" xlink:to="loc_sgry_AncillaryServicesMember_f083f23b-5cd8-43a3-b341-29f10871c9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f23896ed-7960-40da-b258-80c38a153b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5bd28f39-1e5a-4988-ac75-f63824af970b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f23896ed-7960-40da-b258-80c38a153b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8c2a5f28-efed-423d-959e-ba2fe580eac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f23896ed-7960-40da-b258-80c38a153b5f" xlink:to="loc_us-gaap_Assets_8c2a5f28-efed-423d-959e-ba2fe580eac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_95b18d54-4c3e-49a0-a439-10d7d58bab77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f23896ed-7960-40da-b258-80c38a153b5f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_95b18d54-4c3e-49a0-a439-10d7d58bab77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SubsequentEvents" xlink:type="simple" xlink:href="sgry-20220630.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_66d6ddd5-5bdf-4fa9-97f6-1ae94bf6737e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_3e320005-b4bd-485c-a416-339719ab092b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_66d6ddd5-5bdf-4fa9-97f6-1ae94bf6737e" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_3e320005-b4bd-485c-a416-339719ab092b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.surgerypartners.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="sgry-20220630.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.surgerypartners.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_de2b0bbf-5dfc-4a0c-af5c-f215956fade7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_ee9213f9-c3c2-4946-a736-a2f9f3b3ec58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_de2b0bbf-5dfc-4a0c-af5c-f215956fade7" xlink:to="loc_us-gaap_SubsequentEventTable_ee9213f9-c3c2-4946-a736-a2f9f3b3ec58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4772e1ae-39d1-40c3-ae54-83f6ec4b59a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_ee9213f9-c3c2-4946-a736-a2f9f3b3ec58" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4772e1ae-39d1-40c3-ae54-83f6ec4b59a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_43625078-a3f0-4833-a165-74a2bdd50704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4772e1ae-39d1-40c3-ae54-83f6ec4b59a8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_43625078-a3f0-4833-a165-74a2bdd50704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b29868ce-ed87-41a2-9f1b-e6c514ef7233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_43625078-a3f0-4833-a165-74a2bdd50704" xlink:to="loc_us-gaap_SubsequentEventMember_b29868ce-ed87-41a2-9f1b-e6c514ef7233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_b756f30e-b279-42a2-a5c4-defd86495463" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_ee9213f9-c3c2-4946-a736-a2f9f3b3ec58" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_b756f30e-b279-42a2-a5c4-defd86495463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3000049c-7c2d-4812-b0a9-11ca4fc9549d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_b756f30e-b279-42a2-a5c4-defd86495463" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3000049c-7c2d-4812-b0a9-11ca4fc9549d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_SurgicalFacilityMember_24d07d94-af71-44c1-82e2-19b2568b912b" xlink:href="sgry-20220630.xsd#sgry_SurgicalFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3000049c-7c2d-4812-b0a9-11ca4fc9549d" xlink:to="loc_sgry_SurgicalFacilityMember_24d07d94-af71-44c1-82e2-19b2568b912b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgry_InDevelopmentDeNovoSurgicalFacilityMember_dcba96e6-c564-4a62-a341-932a8124f1c8" xlink:href="sgry-20220630.xsd#sgry_InDevelopmentDeNovoSurgicalFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_3000049c-7c2d-4812-b0a9-11ca4fc9549d" xlink:to="loc_sgry_InDevelopmentDeNovoSurgicalFacilityMember_dcba96e6-c564-4a62-a341-932a8124f1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_0c3ad200-c83f-42fb-aa0b-0f1b71152fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_ee9213f9-c3c2-4946-a736-a2f9f3b3ec58" xlink:to="loc_us-gaap_SubsequentEventLineItems_0c3ad200-c83f-42fb-aa0b-0f1b71152fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_fccc5c5f-771d-4397-9b8b-1eca0d1e79ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0c3ad200-c83f-42fb-aa0b-0f1b71152fc9" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_fccc5c5f-771d-4397-9b8b-1eca0d1e79ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_77f7ef46-5880-46c0-a9d5-3a26a11b8716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0c3ad200-c83f-42fb-aa0b-0f1b71152fc9" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_77f7ef46-5880-46c0-a9d5-3a26a11b8716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752557792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Surgery Partners, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3620923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">310 Seven Springs Way, Suite&#160;500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brentwood<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">234-5900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGRY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,935,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001638833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752751648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 227.4<span></span>
</td>
<td class="nump">$ 389.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">412.0<span></span>
</td>
<td class="nump">430.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">64.0<span></span>
</td>
<td class="nump">61.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">37.4<span></span>
</td>
<td class="nump">25.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">47.6<span></span>
</td>
<td class="nump">39.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">788.4<span></span>
</td>
<td class="nump">946.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net of accumulated depreciation of $320.7 and $272.3, respectively</a></td>
<td class="nump">789.1<span></span>
</td>
<td class="nump">629.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Goodwill and other intangible assets, net</a></td>
<td class="nump">4,035.6<span></span>
</td>
<td class="nump">3,955.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in and advances to affiliates</a></td>
<td class="nump">159.7<span></span>
</td>
<td class="nump">88.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use operating lease assets</a></td>
<td class="nump">277.8<span></span>
</td>
<td class="nump">324.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Long-term deferred tax assets</a></td>
<td class="nump">110.4<span></span>
</td>
<td class="nump">114.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">130.6<span></span>
</td>
<td class="nump">59.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,291.6<span></span>
</td>
<td class="nump">6,117.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">126.4<span></span>
</td>
<td class="nump">124.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and benefits</a></td>
<td class="nump">83.8<span></span>
</td>
<td class="nump">77.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent', window );">Medicare accelerated payments and deferred governmental grants</a></td>
<td class="nump">21.4<span></span>
</td>
<td class="nump">64.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">221.8<span></span>
</td>
<td class="nump">210.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current maturities of long-term debt</a></td>
<td class="nump">68.3<span></span>
</td>
<td class="nump">60.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">521.7<span></span>
</td>
<td class="nump">536.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt, less current maturities</a></td>
<td class="nump">3,019.4<span></span>
</td>
<td class="nump">2,878.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Right-of-use operating lease liabilities</a></td>
<td class="nump">271.8<span></span>
</td>
<td class="nump">315.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">96.4<span></span>
</td>
<td class="nump">87.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Non-controlling interests&#8212;redeemable</a></td>
<td class="nump">341.8<span></span>
</td>
<td class="nump">330.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 89,935,287 and 89,332,557, respectively</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,618.8<span></span>
</td>
<td class="nump">1,622.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">44.3<span></span>
</td>
<td class="num">(31.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained deficit</a></td>
<td class="num">(508.9)<span></span>
</td>
<td class="num">(502.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Surgery Partners, Inc. stockholders' equity</a></td>
<td class="nump">1,155.1<span></span>
</td>
<td class="nump">1,089.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests&#8212;non-redeemable</a></td>
<td class="nump">885.4<span></span>
</td>
<td class="nump">880.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">2,040.5<span></span>
</td>
<td class="nump">1,969.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 6,291.6<span></span>
</td>
<td class="nump">$ 6,117.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medicare Accelerated Payments And Deferred Governmental Grants, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752365280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Accumulated depreciation on property and equipment</a></td>
<td class="nump">$ 320.7<span></span>
</td>
<td class="nump">$ 272.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (shares)</a></td>
<td class="nump">20,310,000<span></span>
</td>
<td class="nump">20,310,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (shares)</a></td>
<td class="nump">89,935,287<span></span>
</td>
<td class="nump">89,332,557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (shares)</a></td>
<td class="nump">89,935,287<span></span>
</td>
<td class="nump">89,332,557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306749870000">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 615.4<span></span>
</td>
<td class="nump">$ 543.3<span></span>
</td>
<td class="nump">$ 1,211.6<span></span>
</td>
<td class="nump">$ 1,055.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries and benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">181.9<span></span>
</td>
<td class="nump">155.3<span></span>
</td>
<td class="nump">360.8<span></span>
</td>
<td class="nump">307.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SuppliesExpense', window );">Supplies</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">173.5<span></span>
</td>
<td class="nump">157.5<span></span>
</td>
<td class="nump">345.1<span></span>
</td>
<td class="nump">304.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional and medical fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">66.7<span></span>
</td>
<td class="nump">57.4<span></span>
</td>
<td class="nump">130.3<span></span>
</td>
<td class="nump">112.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_OperatingAndFinanceLeaseExpense', window );">Lease expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20.2<span></span>
</td>
<td class="nump">22.6<span></span>
</td>
<td class="nump">40.2<span></span>
</td>
<td class="nump">45.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38.5<span></span>
</td>
<td class="nump">32.2<span></span>
</td>
<td class="nump">75.8<span></span>
</td>
<td class="nump">63.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">480.8<span></span>
</td>
<td class="nump">425.0<span></span>
</td>
<td class="nump">952.2<span></span>
</td>
<td class="nump">833.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26.1<span></span>
</td>
<td class="nump">24.5<span></span>
</td>
<td class="nump">55.6<span></span>
</td>
<td class="nump">51.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28.0<span></span>
</td>
<td class="nump">25.2<span></span>
</td>
<td class="nump">55.4<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">14.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GrantRevenue', window );">Grant funds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(20.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation', window );">Loss on disposals and deconsolidations, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of unconsolidated affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(5.7)<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(32.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonrecurringIncomeExpense', window );">Other income, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">538.9<span></span>
</td>
<td class="nump">483.8<span></span>
</td>
<td class="nump">1,034.7<span></span>
</td>
<td class="nump">931.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">76.5<span></span>
</td>
<td class="nump">59.5<span></span>
</td>
<td class="nump">176.9<span></span>
</td>
<td class="nump">123.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(56.9)<span></span>
</td>
<td class="num">(53.4)<span></span>
</td>
<td class="num">(113.2)<span></span>
</td>
<td class="num">(106.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19.6<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">63.7<span></span>
</td>
<td class="nump">17.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4.3)<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
<td class="nump">58.1<span></span>
</td>
<td class="nump">19.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(33.7)<span></span>
</td>
<td class="num">(35.7)<span></span>
</td>
<td class="num">(64.3)<span></span>
</td>
<td class="num">(67.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Surgery Partners, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(18.4)<span></span>
</td>
<td class="num">(26.9)<span></span>
</td>
<td class="num">(6.2)<span></span>
</td>
<td class="num">(47.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Less: Amounts attributable to participating securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(10.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (18.4)<span></span>
</td>
<td class="num">$ (26.9)<span></span>
</td>
<td class="num">$ (6.2)<span></span>
</td>
<td class="num">$ (58.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Net loss per share attributable to common stockholders</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.94)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.94)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Weighted average common shares outstanding</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">88,900<span></span>
</td>
<td class="nump">69,267<span></span>
</td>
<td class="nump">88,450<span></span>
</td>
<td class="nump">62,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">88,900<span></span>
</td>
<td class="nump">69,267<span></span>
</td>
<td class="nump">88,450<span></span>
</td>
<td class="nump">62,060<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposition of Assets And Deconsolidation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GainLossOnDispositionOfAssetsAndDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GrantRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grant Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GrantRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_OperatingAndFinanceLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_OperatingAndFinanceLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonrecurringIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) that is infrequent in occurrence or unusual in nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=114868883&amp;loc=SL114871943-224233<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonrecurringIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SuppliesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense associated with supplies that were used during the current accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SuppliesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752740912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 15.3<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="nump">$ 58.1<span></span>
</td>
<td class="nump">$ 19.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Derivative activity</a></td>
<td class="nump">19.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">75.8<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">34.3<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">133.9<span></span>
</td>
<td class="nump">26.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to non-controlling interests</a></td>
<td class="num">(33.7)<span></span>
</td>
<td class="num">(35.7)<span></span>
</td>
<td class="num">(64.3)<span></span>
</td>
<td class="num">(67.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to Surgery Partners, Inc.</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="num">$ (26.7)<span></span>
</td>
<td class="nump">$ 69.6<span></span>
</td>
<td class="num">$ (41.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306748559408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
<th class="th"><div>Retained Deficit</div></th>
<th class="th"><div>Non-Controlling Interests&#8212; Non-Redeemable</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 882.1<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 607.9<span></span>
</td>
<td class="num">$ (61.0)<span></span>
</td>
<td class="num">$ (431.8)<span></span>
</td>
<td class="nump">$ 766.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.0)<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">812,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity-based compensation</a></td>
<td class="num">(2.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings', window );">Preferred dividends</a></td>
<td class="num">(10.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Equity offering (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Equity offering</a></td>
<td class="nump">248.3<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">248.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet', window );">Acquisition and disposal of shares of non-controlling interests, net</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interests&#8212;non-redeemable holders</a></td>
<td class="num">(20.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.8)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,899,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2021</a></td>
<td class="nump">1,105.3<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">843.3<span></span>
</td>
<td class="num">(54.6)<span></span>
</td>
<td class="num">(452.8)<span></span>
</td>
<td class="nump">768.8<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">882.1<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">607.9<span></span>
</td>
<td class="num">(61.0)<span></span>
</td>
<td class="num">(431.8)<span></span>
</td>
<td class="nump">766.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income</a></td>
<td class="nump">6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,479,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">1,527.3<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">1,298.4<span></span>
</td>
<td class="num">(54.4)<span></span>
</td>
<td class="num">(479.7)<span></span>
</td>
<td class="nump">762.2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,899,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Mar. 31, 2021</a></td>
<td class="nump">1,105.3<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="nump">843.3<span></span>
</td>
<td class="num">(54.6)<span></span>
</td>
<td class="num">(452.8)<span></span>
</td>
<td class="nump">768.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="num">(4.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26.9)<span></span>
</td>
<td class="nump">22.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity-based compensation</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Preferred share conversion (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,609,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Preferred share conversion</a></td>
<td class="nump">439.7<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">439.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet', window );">Acquisition and disposal of shares of non-controlling interests, net</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interests&#8212;non-redeemable holders</a></td>
<td class="num">(22.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,479,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">$ 1,527.3<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">1,298.4<span></span>
</td>
<td class="num">(54.4)<span></span>
</td>
<td class="num">(479.7)<span></span>
</td>
<td class="nump">762.2<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2021</a></td>
<td class="nump">89,332,557<span></span>
</td>
<td class="nump">89,333,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 1,969.6<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">1,622.3<span></span>
</td>
<td class="num">(31.5)<span></span>
</td>
<td class="num">(502.7)<span></span>
</td>
<td class="nump">880.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="nump">32.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity-based compensation</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income</a></td>
<td class="nump">56.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet', window );">Acquisition and disposal of shares of non-controlling interests, net</a></td>
<td class="num">(29.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interests&#8212;non-redeemable holders</a></td>
<td class="num">(24.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.6)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,905,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2022</a></td>
<td class="nump">$ 2,012.6<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">1,625.2<span></span>
</td>
<td class="nump">25.3<span></span>
</td>
<td class="num">(490.5)<span></span>
</td>
<td class="nump">851.7<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Dec. 31, 2021</a></td>
<td class="nump">89,332,557<span></span>
</td>
<td class="nump">89,333,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 1,969.6<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">1,622.3<span></span>
</td>
<td class="num">(31.5)<span></span>
</td>
<td class="num">(502.7)<span></span>
</td>
<td class="nump">880.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income</a></td>
<td class="nump">$ 75.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2022</a></td>
<td class="nump">89,935,287<span></span>
</td>
<td class="nump">89,935,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="nump">$ 2,040.5<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">1,618.8<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
<td class="num">(508.9)<span></span>
</td>
<td class="nump">885.4<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,905,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Mar. 31, 2022</a></td>
<td class="nump">2,012.6<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">1,625.2<span></span>
</td>
<td class="nump">25.3<span></span>
</td>
<td class="num">(490.5)<span></span>
</td>
<td class="nump">851.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net (loss) income</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.4)<span></span>
</td>
<td class="nump">22.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity-based compensation</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other comprehensive income</a></td>
<td class="nump">19.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet', window );">Acquisition and disposal of shares of non-controlling interests, net</a></td>
<td class="nump">27.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interests&#8212;non-redeemable holders</a></td>
<td class="num">$ (27.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27.7)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (shares) at Jun. 30, 2022</a></td>
<td class="nump">89,935,287<span></span>
</td>
<td class="nump">89,935,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="nump">$ 2,040.5<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 1,618.8<span></span>
</td>
<td class="nump">$ 44.3<span></span>
</td>
<td class="num">$ (508.9)<span></span>
</td>
<td class="nump">$ 885.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306750030288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 58.1<span></span>
</td>
<td class="nump">$ 19.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">55.4<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NoncashInterestIncomeExpenseNet', window );">Non-cash interest expense, net</a></td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity-based compensation expense</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">9.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation', window );">Loss on disposals and deconsolidations, net</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in earnings of unconsolidated affiliates, net of distributions received</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">17.1<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants', window );">Medicare accelerated payments and deferred governmental grants</a></td>
<td class="num">(40.2)<span></span>
</td>
<td class="num">(28.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_IncreaseDecreaseInSettlementPayments', window );">DOJ settlement payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(32.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other operating assets and liabilities</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">121.9<span></span>
</td>
<td class="nump">52.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(40.6)<span></span>
</td>
<td class="num">(28.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions, net of cash acquired</a></td>
<td class="num">(74.9)<span></span>
</td>
<td class="num">(15.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from disposals of facilities and other assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchases of equity investments</a></td>
<td class="num">(65.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sales of equity investments</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities</a></td>
<td class="num">(11.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(181.4)<span></span>
</td>
<td class="num">(40.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="num">(33.3)<span></span>
</td>
<td class="num">(309.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Borrowings of long-term debt</a></td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">283.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(8.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DebtInstrumentPrepaymentPenaltyAmount', window );">Payment of premium on debt extinguishment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from equity offering</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">260.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of equity offering costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(12.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock', window );">Payment of preferred dividends</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(5.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to non-controlling interest holders</a></td>
<td class="num">(75.2)<span></span>
</td>
<td class="num">(63.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">(Payments) receipts related to ownership transactions with non-controlling interest holders</a></td>
<td class="num">(4.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">(Payments) receipts related to ownership transactions with non-controlling interest holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(10.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(103.0)<span></span>
</td>
<td class="nump">134.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(162.5)<span></span>
</td>
<td class="nump">146.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">389.9<span></span>
</td>
<td class="nump">318.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 227.4<span></span>
</td>
<td class="nump">$ 464.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DebtInstrumentPrepaymentPenaltyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Prepayment Penalty Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DebtInstrumentPrepaymentPenaltyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposition of Assets And Deconsolidation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GainLossOnDispositionOfAssetsAndDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Medicare Accelerated Payments And Deferred Governmental Grants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_IncreaseDecreaseInSettlementPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Settlement Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_IncreaseDecreaseInSettlementPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NoncashInterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Interest Income (Expense), Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NoncashInterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306759852368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Organization and Summary of Accounting Policies</a></td>
<td class="text">Organization and Summary of Accounting Policies<div style="margin-bottom:6pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Organization</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of multi-specialty physician practices, urgent care facilities and anesthesia services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the Company owned or operated a portfolio of 133 surgical facilities, comprised of 115 ASCs and 18 surgical hospitals in 32 states. The Company owns these facilities in partnership with physicians and, in some cases, health care systems in the markets and communities it serves.&#160;The Company owned a majority interest in 85 of the surgical facilities and consolidated 109 of the facilities for financial reporting purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the "2021 Annual Report on Form 10-K").</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide health care services. The Company recognizes revenues in the period in which its obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to receive. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid and private insurance organizations, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of revenues by service type as a percentage of total revenues follows:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Surgical facilities revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Ancillary services revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Patient service revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This revenue is related to charging facility fees in exchange for providing patient care. The fee charged for health care procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other service revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Other service revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period, which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.887%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">543.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.887%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">608.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">519.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">507.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">452.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,055.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable from third-party payors are recorded net of estimated implicit price concessions, which are estimated based on the historical trend of the Company's surgical hospitals&#8217; cash collections and contractual write-offs, and for the Company's surgical facilities in general, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), private insurance organizations, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#8217;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. Collection efforts include direct contact with third-party payors or patients, written correspondence and the use of legal or collection agency assistance, as required. </span></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in health care regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's effective tax rate was 8.8% for the six months ended June&#160;30, 2022 compared to (14.6)% for the six months ended June&#160;30, 2021. For the six months ended June&#160;30, 2022, the effective tax rate differed from the federal corporate tax rate of 21% primarily due to earnings attributable to non-controlling interests, an increase in the Company&#8217;s valuation allowance attributable to interest expense limitations, and discrete tax benefits of (a) $4.6&#160;million related to the vesting of restricted stock awards, (b) $1.8&#160;million attributable to non-recurring earnings&#8217; impact on the Company&#8217;s valuation allowance, and (c) $1.0&#160;million related to entity divestitures. For the six months ended June&#160;30, 2021, the effective tax rate differed from 21% due to tax benefits of $4.1&#160;million related to the vesting of restricted stock awards, as well as a $3.0&#160;million tax benefit related to entity divestitures. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill represents the excess of the fair value of the consideration provided in an acquisition plus the fair value of any non-controlling interests over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions and disposals for the six months ended June 30, 2022 is included in Note 2. "Acquisitions and Disposals."</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to goodwill for the six months ended June&#160;30, 2022 is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,911.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, including post acquisition adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposals and deconsolidations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,993.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A detailed evaluation of potential impairment indicators was performed as of June&#160;30, 2022, which specifically considered the ongoing impact of the COVID-19 pandemic, recent increases in interest rates, inflation risk and market volatility. On the basis of available evidence as of June&#160;30, 2022, no indicators of impairment were identified. Future estimates of fair value could be adversely affected if the actual outcome of one or more of the Company's assumptions changes materially in the future, including a material decline in the Company&#8217;s stock price and the fair value of its long-term debt, lower than expected surgical case volumes, higher market interest rates or increased operating costs. Such changes impacting the calculation of fair value could result in a material impairment charge in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records all derivatives on the balance sheet at fair value and any financing elements treated as debt instruments are recorded at amortized cost. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-Controlling Interests&#8212;Redeemable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to non-controlling interests&#8212;redeemable is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.443%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests&#8212;redeemable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of shares of non-controlling interests, net&#8212;redeemable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to non-controlling interest&#8212;redeemable holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Medicare Accelerated Payments and Deferred Governmental Grants</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has received grant funds distributed under the Coronavirus Aid, Relief and Economic Security Act (the &#8220;CARES Act&#8221;) and other governmental assistance programs, including approximately $1&#160;million during the six months ended June&#160;30, 2022. Grant funds received during the three months ended June 30, 2022 were minimal. During the three and six months ended June 30, 2021, the Company received grant funds of approximately $1&#160;million and $8&#160;million, respectively. The recognition of amounts received is conditioned upon attestation with terms and conditions that funds will be used for COVID-19 related healthcare expenses or lost revenues. Amounts received, but not recognized as a reduction to operating expenses, are reflected as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets. Any unrecognized amounts may be recognized as a reduction in operating expenses in subsequent periods if the underlying conditions for recognition are met. The Company estimates $0.1 million and $1.3 million of grant funds received qualified for recognition as a reduction in operating expenses for the three and six months ended June&#160;30, 2022, respectively. During the three and six months ended June 30, 2021, $4.9 million and $20.0 million, respectively, was recognized as a reduction in operating expenses. As of both June&#160;30, 2022 and December&#160;31, 2021, approximately $4&#160;million of unrecognized grant funds received was reflected within the condensed consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company received accelerated payments under the Medicare Accelerated and Advance Payment Program. The payments received were deferred and included in the condensed consolidated balance sheets. During the three and six months ended June&#160;30, 2022, approximately $25&#160;million and $43&#160;million, respectively, has been repaid in accordance with the terms of the program. These repayments are included as a component of the change in Medicare accelerated payments and deferred government grants in the condensed consolidated statements of cash flows. As of June&#160;30, 2022 and December&#160;31, 2021, the remaining deferred accelerated payments was approximately $17&#160;million and $60&#160;million, respectively, which was included as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets. The Company does not expect to receive additional Medicare accelerated payments.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s accounting policies for relief received under the CARES Act and other governmental assistance programs, including the recognition of grant funds, is unchanged from the policies described in Note 1 to the Company&#8217;s consolidated financial statements included in the 2021 Annual Report on Form 10-K. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on inputs classified into the following hierarchy:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These may include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, depending on the nature of the item being valued.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.788%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,523.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,439.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.750% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.000% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">577.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values in the table above were based on Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values based on Level 3 inputs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">". The Company has the power to direct the activities that most significantly impact a VIE's economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of June&#160;30, 2022, the Company's consolidated VIEs include six surgical facilities and five physician practices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of June&#160;30, 2022 and December&#160;31, 2021 were $69.7 million and $48.1 million, respectively, and the total liabilities of the consolidated VIEs were $44.0 million and $20.1 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306757765984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Disposals<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions and Disposals</a></td>
<td class="text">Acquisitions and Disposals<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company acquired a controlling interest in four surgical facilities, two of which were merged into existing surgical facilities, for aggregate cash consideration of $74.9&#160;million, net of cash acquired, and non-cash consideration of $2.6&#160;million, which consisted of a non-controlling interest in one of the Company's existing surgical facilities. In connection with the acquisitions the Company preliminarily recognized non-controlling interests of $41.5&#160;million and goodwill of $114.4&#160;million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, the Company acquired a controlling interest in a surgical facility in a new market and two surgical facilities in existing markets that were merged into existing facilities for aggregate cash consideration of $15.2&#160;million, net of cash acquired. In connection with the acquisitions the Company preliminarily recognized non-controlling interests of $7.5&#160;million and goodwill of $20.0&#160;million. During the six months ended June&#160;30, 2022, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other Acquisitions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, the Company acquired non-controlling interests in five surgical facilities and four in-development de novo surgical facilities for an aggregate cash purchase price of $65.8&#160;million. The non-controlling interests were accounted for as equity method investments and recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Disposals and Deconsolidations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company sold its interests in a surgical facility, which was previously accounted for as an equity method investment, for net cash proceeds of $11.5&#160;million. The Company recognized a pre-tax loss on the sale of $0.4&#160;million included in loss on disposals and deconsolidations, net in the condensed consolidated statements of operations for the six months ended June&#160;30, 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company contributed its interests in two surgical facilities as non-cash consideration for non-controlling interests in two new separate entities. As a result of these transactions, the Company lost control of the previously controlled surgical facilities but retains a non-controlling interest in each, resulting in the deconsolidation of the previously consolidated entities. The remaining non-controlling interests were accounted for as equity method investments, and initially measured and recorded at fair value as of the dates of the transactions. The fair value measurement utilizes Level 3 inputs, which includes unobservable data, to measure the fair value of the retained non-controlling interests. The fair value determination was based on a combination of multiple valuation methods, which included discounted cash flow and market value approach, which incorporates estimates of future earnings and market valuation multiples for certain guideline companies. The preliminary fair value of the investments of $9.8&#160;million was recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets. Further, based on the preliminary valuation, the transactions resulted in a pretax net loss on deconsolidations of $5.6&#160;million, which is included in loss on disposals and deconsolidations, net, in the accompanying condensed consolidated statement of operations for the six months ended June&#160;30, </span></div>2022. The net loss was determined based on the difference between the fair value of the Company's retained interests in the entities and the carrying values of both the tangible and intangible assets of the entities immediately prior to the transactions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752844112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,523.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.750% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.000% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and other secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs and discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,087.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,938.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,019.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,878.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:4pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes unamortized fair value discount of $2.7 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and $3.0&#160;million as of June&#160;30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">December&#160;31, 2021, respectively. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The increase in finance lease obligations is a result of the modification of certain existing facility real estate leases that were previously classified as operating leases. See Note 4. "Leases" for further discussion.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility</span></div>As of June&#160;30, 2022, the Company's availability on its revolving credit facility (the "Revolver") was $203.0 million (including outstanding letters of credit of $7.0 million). There were no outstanding borrowings under the Revolver as of both June&#160;30, 2022 and December&#160;31, 2021<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752556448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the consolidated balance sheets (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.941%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.634%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification in Consolidated Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_0490c164-1bcc-4f55-85d3-15e9331ed7ed"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_4a2e4f93-28b9-4c5f-bc07-6358d546de18">Property and equipment, net of accumulated depreciation</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">738.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">653.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_00060c4f-1b87-4bb0-b65b-4b1328751e7d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_f34bfa11-29e3-4790-b94f-70125ea4d07f">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_82470289-02c8-4ee9-bb12-c86df2a2d59b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_d09186d5-2c70-43f5-ba46-c5f5d380a2bb">Current maturities of long-term debt</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_2188135b-10a8-4d73-88ea-7b90cf795fbd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_eb2749f0-b898-4460-8f9b-f8a8c6f0701f">Long-term debt, less current maturities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">345.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">811.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">720.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company extended certain existing facility real estate leases, resulting in the reclassification of the leases from operating to finance. The modifications resulted in an increase to finance lease liabilities and assets of $146.5&#160;million and $145.0&#160;million, respectively, including the reclassification of existing operating lease liabilities and assets of $60.8&#160;million and $59.3&#160;million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information (dollars in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the consolidated balance sheets (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.941%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.634%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification in Consolidated Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_0490c164-1bcc-4f55-85d3-15e9331ed7ed"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_4a2e4f93-28b9-4c5f-bc07-6358d546de18">Property and equipment, net of accumulated depreciation</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">738.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">653.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_00060c4f-1b87-4bb0-b65b-4b1328751e7d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_f34bfa11-29e3-4790-b94f-70125ea4d07f">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_82470289-02c8-4ee9-bb12-c86df2a2d59b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_d09186d5-2c70-43f5-ba46-c5f5d380a2bb">Current maturities of long-term debt</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_2188135b-10a8-4d73-88ea-7b90cf795fbd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_eb2749f0-b898-4460-8f9b-f8a8c6f0701f">Long-term debt, less current maturities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">345.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">811.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">720.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2022, the Company extended certain existing facility real estate leases, resulting in the reclassification of the leases from operating to finance. The modifications resulted in an increase to finance lease liabilities and assets of $146.5&#160;million and $145.0&#160;million, respectively, including the reclassification of existing operating lease liabilities and assets of $60.8&#160;million and $59.3&#160;million, respectively. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information (dollars in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306759622976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives and Hedging Activities</a></td>
<td class="text">Derivatives and Hedging Activities<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and interest rate caps as part of its interest rate risk management strategy. During 2022 and 2021, such derivatives have been used to hedge the variable cash flows associated with existing variable-rate debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income ("OCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#8217;s accounting policy election. Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. Over the next 12 months, the Company estimates that an additional $7.2 million will be reclassified as a decrease to interest expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the Company had nine interest rate swaps with a total net hedged notional amount of $1.2&#160;billion and two interest rate caps with a total hedged notional amount of $325.9&#160;million. Of the nine interest rate swaps, three are pay-fixed, receive 1-Month LIBOR (subject to a minimum of 0.75%) interest rate swaps designated in cash flow hedging relationships with a total notional amount of $1.2&#160;billion and a termination date of March 31, 2025. The remaining six interest rate swaps are undesignated and consist of three pay-fixed, receive 1-Month LIBOR (subject to a minimum of 1.00%) interest rate swaps and three pay 1-Month LIBOR (subject to a minimum of 1.00%), receive-fixed interest rate swaps with a termination date of November 30, 2023. The pay-floating, receive-fixed swaps are designed to economically offset the undesignated pay-fixed, receive-floating swaps. The interest rate caps each have a termination date of March&#160;31, 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The pay-fixed, receive floating interest rate swaps did not meet the requirements to be considered derivatives in their entirety as a result of the financing component. Accordingly, the swaps are considered hybrid instruments, consisting of a financing element treated as a debt instrument and an embedded at-market derivative that was designated as a cash flow hedge. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Within the Company&#8217;s condensed consolidated balance sheets, the financing elements treated as debt instruments described above are carried at amortized cost and the embedded at-market derivatives and the undesignated swaps are recorded at fair value. The cash flows related to the portion treated as debt are classified as financing activities in the condensed consolidated statements of cash flows while the portion treated as an at-market derivative are classified as operating activities. Cash settlements related to the undesignated swaps will offset and are classified as operating activities in the condensed consolidated cash flows. Within the Company&#8217;s condensed consolidated balance sheets, the interest rate caps are recorded at fair value. The cash flows related to the interest rate caps are classified as operating activities in the condensed consolidated statements of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The key terms of interest rate swaps and interest rate caps outstanding are presented below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.352%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(165.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(165.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(120.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(120.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(150.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(150.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,525.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,533.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our interest rate swap agreements, excluding the portion treated as debt, are recognized at fair value in the condensed consolidated balance sheets and are valued using pricing models that rely on market observable inputs such as yield curve data, which are classified as Level 2 inputs within the fair value hierarchy. The fair value of the interest rate caps are determined using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the caps. The variable interest rates used in the calculation of projected receipts on the caps are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. The interest rate caps are classified using Level 2 inputs within the fair value hierarchy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the fair values of our derivatives and their location on the condensed consolidated balance sheets (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate caps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.02pt">The balance as of June&#160;30, 2022 and December&#160;31, 2021 is related to the financing component of the pay-fixed, receive floating interest rate swaps.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the pre-tax effect of the interest rate swaps and caps on the Company's accumulated OCI and condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.275%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain) loss recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss reclassified from accumulated OCI into income (effective portion) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $5.3 million and $3.2 million for the three months ended June&#160;30, 2022 and 2021, respectively. Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $10.6 million and $3.2 million for the six months ended June&#160;30, 2022 and 2021, respectively.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306757429584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted earnings per share are calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands): </span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: amounts allocated to participating securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding- basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding- diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes dividends accrued for the Series A Preferred Stock for the six months ended June 30, 2021. The Series A Preferred Stock did  not participate in undistributed losses and was converted to common stock during the second quarter of 2021. There were no participating securities for the three and six months ended June 30, 2022 and the three months ended June 30, 2021.</span></div><div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306759634064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Current Liabilities</a></td>
<td class="text">Other Current Liabilities<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of other current liabilities is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due to patients and payors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost report liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax receivable agreement liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306759798288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Professional, General and Workers' Compensation Liability Risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains professional, general and workers' compensation liability insurance in excess of self-insured retentions through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity. Total professional, general and workers' compensation claim liabilities as of June&#160;30, 2022 and December&#160;31, 2021 were $18.2 million and $19.8 million, respectively. Expected insurance recoveries of $8.7 million as of both June&#160;30, 2022 and December&#160;31, 2021 are included as a component of other current assets and other long-term assets in the condensed consolidated balance sheets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory sanctions including fines, penalties, and exclusion from the Medicare, Medicaid and other federal health care programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Stockholder Litigation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December 4, 2017, a purported Company stockholder filed an action in the Delaware Court of Chancery (the "Delaware Action"). That action is captioned Witmer v. H.I.G. Capital, L.L.C., et al., C.A. No. 2017-0862. The plaintiff in the Delaware Action asserted claims against (i) certain current and former members of the Company&#8217;s Board of Directors (together, the "Directors"); (ii) H.I.G. Capital, LLC and certain of its affiliates (collectively, "H.I.G."); and (iii) Bain Capital Private Equity, L.P. and certain of its affiliates (collectively, "Bain Capital" and, together with the Directors and H.I.G., the "Defendants"). The parties to the Delaware Action negotiated a final stipulation of settlement (the &#8220;Settlement Stipulation&#8221;), which governs the terms of the settlement of the Delaware Action, and which they filed with the Court of Chancery on November 22, 2021. On February 11, 2022, the Court of Chancery approved the settlement of the Delaware Action as memorialized in the Settlement Stipulation. That decision became final and non-appealable on March 14, 2022. The case is now closed. Pursuant to the settlement, the Company received $32.8&#160;million in March 2022, which was included in litigation settlement in the condensed consolidated statements of operations for the six months ended June&#160;30, 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Acquired Facilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with health care laws and regulations, such as billing and reimbursement laws and regulations, the Stark Law, the Anti-Kickback Statute, the FCA, and similar fraud and abuse laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other health care providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Potential Physician Investor Liability</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Tax Receivable Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the "TRA"), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company&#8217;s projected realized tax savings over the next five years and are not dependent on the Company&#8217;s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA, such payments will be deferred and will accrue interest at a rate of the LIBOR plus 500 basis points until paid. If the terms of credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 300 basis points until paid.</span></div>Assuming the Company's tax rate is 24%, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates the total remaining amounts payable under the TRA was approximately $22.0 million as of both June&#160;30, 2022 and December&#160;31, 2021. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company&#8217;s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $20.7 million and $19.7 million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. The current portion of the liability was $20.2 million and $19.7 million as of June&#160;30, 2022 and December&#160;31, 2021, respectively, and is included as a component of other current liabilities in the condensed consolidated balance sheets. The long-term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306759636496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company currently operates in&#160;two&#160;major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities and the operation of ancillary services. The Surgical Facility Services segment consists of the operation of ASCs, surgical hospitals and anesthesia services. The Ancillary Services segment consists of multi-specialty physician practices. The "All other" line item primarily consists of the Company's corporate general and administrative functions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables present financial information for each reportable segment (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">597.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">525.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,176.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,021.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">543.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,055.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction, integration and acquisition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on litigation settlement and other litigation costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes transaction and integration costs of $8.2 million and $9.2 million for the three months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.2 million for the three months ended June&#160;30, 2021. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes transaction and integration costs of $15.3 million and $14.5 million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million for the six months ended June&#160;30, 2021. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes other litigation costs of $1.7 million and $0.8 million for the three months ended June&#160;30, 2022 and 2021, respectively. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes other litigation costs of $3.7 million and $1.8 million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount also includes gain on litigation settlement of $32.8 million for the six months ended June&#160;30, 2022.</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,691.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,552.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">555.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">517.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,291.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,117.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash purchases of property and equipment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306759639920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent EventsIn July 2022, the Company acquired non-controlling interests in two surgical facilities and three in-development de novo surgical facilities for a combined purchase price of $29.3&#160;million. The non-controlling interests will be accounted for as equity method investments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306746570592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the "2021 Annual Report on Form 10-K").</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenues</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide health care services. The Company recognizes revenues in the period in which its obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to receive. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid and private insurance organizations, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Patient service revenues.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This revenue is related to charging facility fees in exchange for providing patient care. The fee charged for health care procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other service revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Other service revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period, which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable from third-party payors are recorded net of estimated implicit price concessions, which are estimated based on the historical trend of the Company's surgical hospitals&#8217; cash collections and contractual write-offs, and for the Company's surgical facilities in general, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), private insurance organizations, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#8217;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.</span></div>The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. Collection efforts include direct contact with third-party payors or patients, written correspondence and the use of legal or collection agency assistance, as required.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in health care regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">GoodwillGoodwill represents the excess of the fair value of the consideration provided in an acquisition plus the fair value of any non-controlling interests over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records all derivatives on the balance sheet at fair value and any financing elements treated as debt instruments are recorded at amortized cost. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</span></div>For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income ("OCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#8217;s accounting policy election. Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_RedeemableNoncontrollingInterestPolicyTextBlock', window );">Non-Controlling Interests&#8212;Redeemable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-Controlling Interests&#8212;Redeemable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on inputs classified into the following hierarchy:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These may include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, depending on the nature of the item being valued.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text">Variable Interest Entities<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span>". The Company has the power to direct the activities that most significantly impact a VIE's economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_RedeemableNoncontrollingInterestPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interest [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_RedeemableNoncontrollingInterestPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306760684400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of Revenues</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of revenues by service type as a percentage of total revenues follows:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Surgical facilities revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Ancillary services revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.887%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">543.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.887%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private insurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">608.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">519.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">507.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">452.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Self-pay</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total patient service revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,195.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other service revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,055.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table>(1)Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Rollforward of Goodwill</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to goodwill for the six months ended June&#160;30, 2022 is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.167%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,911.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, including post acquisition adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disposals and deconsolidations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,993.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Schedule of Rollforward of Noncontrolling Interest - Redeemable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of activity related to non-controlling interests&#8212;redeemable is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.443%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests&#8212;redeemable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of shares of non-controlling interests, net&#8212;redeemable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to non-controlling interest&#8212;redeemable holders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at&#160;end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Amounts and Fair Values of Long-Term Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.191%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.788%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,523.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,439.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.750% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.000% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">577.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306759606576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Summary of Long-term Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of long-term debt follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior secured term loan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,523.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,530.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.750% senior unsecured notes due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.000% senior unsecured notes due 2027</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">545.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and other secured loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs and discounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,087.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,938.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,019.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,878.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes unamortized fair value discount of $2.7 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and $3.0&#160;million as of June&#160;30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span>December&#160;31, 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306759622544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Components of Right-of-use Assets and Liabilities Related to Leases</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the consolidated balance sheets (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.941%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.634%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification in Consolidated Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">324.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_0490c164-1bcc-4f55-85d3-15e9331ed7ed"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_4a2e4f93-28b9-4c5f-bc07-6358d546de18">Property and equipment, net of accumulated depreciation</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">329.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total leased assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">738.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">653.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_00060c4f-1b87-4bb0-b65b-4b1328751e7d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_f34bfa11-29e3-4790-b94f-70125ea4d07f">Other current liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_82470289-02c8-4ee9-bb12-c86df2a2d59b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_d09186d5-2c70-43f5-ba46-c5f5d380a2bb">Current maturities of long-term debt</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_2188135b-10a8-4d73-88ea-7b90cf795fbd"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_eb2749f0-b898-4460-8f9b-f8a8c6f0701f">Long-term debt, less current maturities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">481.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">345.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">811.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">720.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Expense and Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Variable and short-term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents supplemental cash flow information (dollars in millions):</span></div><div style="margin-bottom:12pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.840%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities: </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306748551712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Interest Rate Swaps and Interest Rate Caps Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The key terms of interest rate swaps and interest rate caps outstanding are presented below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.352%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.144%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Status</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">435.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pay-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(165.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(165.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(120.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(120.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Receive-fixed swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(150.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(150.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Active</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">November 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,525.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,533.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the fair values of our derivatives and their location on the condensed consolidated balance sheets (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate caps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.02pt">The balance as of June&#160;30, 2022 and December&#160;31, 2021 is related to the financing component of the pay-fixed, receive floating interest rate swaps.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock', window );">Schedule of Effect of Interest Rate Swaps</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents the pre-tax effect of the interest rate swaps and caps on the Company's accumulated OCI and condensed consolidated statement of operations (in millions):</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.275%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Gain) loss recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) recognized in OCI (effective portion)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss reclassified from accumulated OCI into income (effective portion) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $5.3 million and $3.2 million for the three months ended June&#160;30, 2022 and 2021, respectively. Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $10.6 million and $3.2 million for the six months ended June&#160;30, 2022 and 2021, respectively.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306759603344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands): </span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.114%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Surgery Partners, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: amounts allocated to participating securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding- basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding- diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">Includes dividends accrued for the Series A Preferred Stock for the six months ended June 30, 2021. The Series A Preferred Stock did  not participate in undistributed losses and was converted to common stock during the second quarter of 2021. There were no participating securities for the three and six months ended June 30, 2022 and the three months ended June 30, 2021.</span></div><div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306759688128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Summary of Other Current Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A summary of other current liabilities is as follows (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts due to patients and payors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost report liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax receivable agreement liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306760668688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Schedule of Segment Revenue and Operating Income</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following tables present financial information for each reportable segment (in millions):</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">597.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">525.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,176.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,021.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">543.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,055.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reconciliation of Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction, integration and acquisition costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposals and deconsolidations, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on litigation settlement and other litigation costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on debt extinguishment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes transaction and integration costs of $8.2 million and $9.2 million for the three months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.2 million for the three months ended June&#160;30, 2021. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes transaction and integration costs of $15.3 million and $14.5 million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million for the six months ended June&#160;30, 2021. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt">This amount includes other litigation costs of $1.7 million and $0.8 million for the three months ended June&#160;30, 2022 and 2021, respectively. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This amount includes other litigation costs of $3.7 million and $1.8 million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount also includes gain on litigation settlement of $32.8 million for the six months ended June&#160;30, 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Schedule of Reconciliation of Assets from Segment to Consolidated</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,691.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,552.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">555.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">517.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,291.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,117.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Financial Information by Reportable Segment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.953%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.956%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash purchases of property and equipment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Facility Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ancillary Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306746598288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Organization (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>facility </div>
<div>state</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfSurgicalFacilitiesOwned', window );">Number of surgical facilities owned</a></td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which entity operates | state</a></td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest', window );">Number of surgical facilities owned, majority interest</a></td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated', window );">Number of surgical facilities owned, consolidated</a></td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_FacilitiesAmbulatorySurgeryCentersMember', window );">Facilities, Ambulatory Surgery Centers</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfSurgicalFacilitiesOwned', window );">Number of surgical facilities owned</a></td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_FacilitiesSurgicalHospitalsMember', window );">Facilities, Surgical Hospitals</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfSurgicalFacilitiesOwned', window );">Number of surgical facilities owned</a></td>
<td class="nump">18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NumberOfSurgicalFacilitiesOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Surgical Facilities Owned</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NumberOfSurgicalFacilitiesOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NumberOfSurgicalFacilitiesOwnedConsolidated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Surgical Facilities Owned, Consolidated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NumberOfSurgicalFacilitiesOwnedConsolidated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Surgical Facilities Owned, Majority Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfInvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfInvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_FacilitiesAmbulatorySurgeryCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_FacilitiesAmbulatorySurgeryCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_FacilitiesSurgicalHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_FacilitiesSurgicalHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306749760128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details) - Revenue Source - Revenue<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by service type as a proportion of total revenues (as a percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Patent service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by service type as a proportion of total revenues (as a percent)</a></td>
<td class="nump">98.70%<span></span>
</td>
<td class="nump">98.70%<span></span>
</td>
<td class="nump">98.60%<span></span>
</td>
<td class="nump">98.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Surgical Facility Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by service type as a proportion of total revenues (as a percent)</a></td>
<td class="nump">95.90%<span></span>
</td>
<td class="nump">95.50%<span></span>
</td>
<td class="nump">95.80%<span></span>
</td>
<td class="nump">95.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Ancillary Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by service type as a proportion of total revenues (as a percent)</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember', window );">Other service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by service type as a proportion of total revenues (as a percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_SurgicalFacilityServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_SurgicalFacilityServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_AncillaryServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_AncillaryServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_OtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_OtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306748495664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 615.4<span></span>
</td>
<td class="nump">$ 543.3<span></span>
</td>
<td class="nump">$ 1,211.6<span></span>
</td>
<td class="nump">$ 1,055.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember', window );">Patient service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 607.3<span></span>
</td>
<td class="nump">$ 535.9<span></span>
</td>
<td class="nump">$ 1,195.0<span></span>
</td>
<td class="nump">$ 1,041.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember', window );">Patient service revenues | Customer | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by service type as a proportion of total revenues (as a percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_PrivateInsuranceMember', window );">Private insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 309.5<span></span>
</td>
<td class="nump">$ 273.0<span></span>
</td>
<td class="nump">$ 608.6<span></span>
</td>
<td class="nump">$ 519.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_PrivateInsuranceMember', window );">Private insurance | Customer | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by service type as a proportion of total revenues (as a percent)</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">50.90%<span></span>
</td>
<td class="nump">50.90%<span></span>
</td>
<td class="nump">49.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GovernmentContractMember', window );">Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 258.1<span></span>
</td>
<td class="nump">$ 226.2<span></span>
</td>
<td class="nump">$ 507.0<span></span>
</td>
<td class="nump">$ 452.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GovernmentContractMember', window );">Government | Customer | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by service type as a proportion of total revenues (as a percent)</a></td>
<td class="nump">42.50%<span></span>
</td>
<td class="nump">42.20%<span></span>
</td>
<td class="nump">42.40%<span></span>
</td>
<td class="nump">43.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_SelfPayRevenueMember', window );">Self-pay</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 16.5<span></span>
</td>
<td class="nump">$ 17.8<span></span>
</td>
<td class="nump">$ 33.2<span></span>
</td>
<td class="nump">$ 31.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_SelfPayRevenueMember', window );">Self-pay | Customer | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by service type as a proportion of total revenues (as a percent)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_OtherPatientServiceRevenueSourcesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 23.2<span></span>
</td>
<td class="nump">$ 18.9<span></span>
</td>
<td class="nump">$ 46.2<span></span>
</td>
<td class="nump">$ 38.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_OtherPatientServiceRevenueSourcesMember', window );">Other | Customer | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue by service type as a proportion of total revenues (as a percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sgry_OtherServicesMember', window );">Other service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="nump">$ 16.6<span></span>
</td>
<td class="nump">$ 14.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_HealthcareOrganizationPatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_PrivateInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_PrivateInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GovernmentContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GovernmentContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_SelfPayRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_SelfPayRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_OtherPatientServiceRevenueSourcesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_OtherPatientServiceRevenueSourcesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgry_OtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgry_OtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306749743808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate (percent)</a></td>
<td class="nump">8.80%<span></span>
</td>
<td class="num">(14.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Tax benefits related to vesting of restricted stock awards</a></td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Tax benefits attributable to non-recurring earnings' impact on the valuation allowance</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness', window );">Tax benefits related to the sale of partnership interests</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306748799568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning of period</a></td>
<td class="nump">$ 3,911.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions, including post acquisition adjustments</a></td>
<td class="nump">110.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation', window );">Disposals and deconsolidations</a></td>
<td class="num">(29.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, end of period</a></td>
<td class="nump">$ 3,993.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Written off Related to Sale of Business Unit and Deconsolidation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306760486880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_RedeemableNoncontrollingInterestRollForward', window );"><strong>Non-Controlling Interests - Redeemable [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance at beginning of period</a></td>
<td class="nump">$ 330.2<span></span>
</td>
<td class="nump">$ 306.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to non-controlling interests&#8212;redeemable</a></td>
<td class="nump">21.6<span></span>
</td>
<td class="nump">24.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests', window );">Acquisition of shares of non-controlling interests, net&#8212;redeemable</a></td>
<td class="nump">12.9<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interest&#8212;redeemable holders</a></td>
<td class="num">(22.9)<span></span>
</td>
<td class="num">(20.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance at end of period</a></td>
<td class="nump">$ 341.8<span></span>
</td>
<td class="nump">$ 312.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interest, Increase (Decrease) from Redemptions or Purchase of Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_RedeemableNoncontrollingInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interest [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_RedeemableNoncontrollingInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306747373840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Medicare Accelerated Payments and Deferred Governmental Grants (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_ProceedsFromGovernmentAssistance', window );">Proceeds from grants received</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GrantRevenue', window );">Grant funds</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">$ (4.9)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">$ (20.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_UnrecognizedGrantFundsReceived', window );">Unrecognized grant funds received</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments', window );">Repayments of grants received</a></td>
<td class="nump">25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments', window );">Deferred accelerated payments</a></td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Repayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grants, Deferred Accelerated Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GrantRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grant Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GrantRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_ProceedsFromGovernmentAssistance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Government Assistance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_ProceedsFromGovernmentAssistance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_UnrecognizedGrantFundsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Grant Funds Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_UnrecognizedGrantFundsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306750006496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Senior secure term loan | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,523.3<span></span>
</td>
<td class="nump">$ 1,530.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Senior secure term loan | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 1,439.5<span></span>
</td>
<td class="nump">1,530.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.750% senior unsecured notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.750% senior unsecured notes due 2025 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 370.0<span></span>
</td>
<td class="nump">370.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.750% senior unsecured notes due 2025 | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 339.0<span></span>
</td>
<td class="nump">371.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 10.000% senior unsecured notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 10.000% senior unsecured notes due 2027 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 545.0<span></span>
</td>
<td class="nump">545.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 10.000% senior unsecured notes due 2027 | Fair Value | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 531.4<span></span>
</td>
<td class="nump">$ 577.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_A2017TermLoanMaturing2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_A2017TermLoanMaturing2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752401968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization and Summary of Accounting Policies - Variable Interest Entities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>facility</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>physician_practice</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_VariableInterestEntityNumberOfFacilities', window );">Number of facilities included in VIE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 6,291.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,117.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">69.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">$ 44.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_VariableInterestEntityNumberOfFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Number of Facilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_VariableInterestEntityNumberOfFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306749807472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Disposals - Acquisitions (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>facility</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions, net of cash acquired</a></td>
<td class="nump">$ 74.9<span></span>
</td>
<td class="nump">$ 15.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,993.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,911.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesMember', window );">Surgical Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of facilities acquired | facility</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for acquisitions, net of cash acquired</a></td>
<td class="nump">$ 74.9<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1', window );">Noncash consideration</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Recognized non-controlling interests</a></td>
<td class="nump">41.5<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 114.4<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesExistingMarketsMember', window );">Surgical Facilities, Existing Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of facilities acquired | facility</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesExistingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=sgry_SurgicalFacilitiesExistingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306749851424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Disposals - Other Acquisitions (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>non-controlling_interest</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments | $</a></td>
<td class="nump">$ 65.8<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquityMethodInvestmentsMember', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired', window );">Number of non-controlling interests in surgical facilities acquired</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired', window );">Number of non-controlling interests in in-development de novo surgical facilities acquired</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Non-Controlling Interests In In-Development De Novo Surgical Facilities Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Non-Controlling Interests In Surgical Facilities Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquityMethodInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquityMethodInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306749758960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Disposals - Disposals and Deconsolidations (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>facility</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>business_entity</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from disposals of facilities and other assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=sgry_DisposalGroupOneMember', window );">Disposal Group One | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from disposals of facilities and other assets</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Pre-tax loss on disposals and deconsolidations</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=sgry_DisposalGroupTwoMember', window );">Disposal Group Two | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Pre-tax loss on disposals and deconsolidations</a></td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration', window );">Number of surgical facilities contributed as non-cash consideration | facility</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Fair value of investments</a></td>
<td class="nump">$ 9.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=sgry_DisposalGroupTwoMember', window );">Disposal Group Two | Disposed of by Sale | Series of Individually Immaterial Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | business_entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Number Of Surgical Facilities Contributed As Non-Cash Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column C))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=sgry_DisposalGroupOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=sgry_DisposalGroupOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=sgry_DisposalGroupTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=sgry_DisposalGroupTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306750000448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease obligations</a></td>
<td class="nump">$ 504.3<span></span>
</td>
<td class="nump">$ 364.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt issuance costs and discounts</a></td>
<td class="num">(15.1)<span></span>
</td>
<td class="num">(16.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Total debt</a></td>
<td class="nump">3,087.7<span></span>
</td>
<td class="nump">2,938.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current maturities</a></td>
<td class="nump">68.3<span></span>
</td>
<td class="nump">60.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">3,019.4<span></span>
</td>
<td class="nump">2,878.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Senior secure term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">1,523.3<span></span>
</td>
<td class="nump">1,530.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized fair value discount</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.750% senior unsecured notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 370.0<span></span>
</td>
<td class="nump">370.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 10.000% senior unsecured notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 545.0<span></span>
</td>
<td class="nump">545.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=sgry_NotesPayableAndSecuredLoansMember', window );">Notes payable and other secured loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 160.2<span></span>
</td>
<td class="nump">$ 145.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_A2017TermLoanMaturing2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_A2017TermLoanMaturing2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_SeniorUnsecuredNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=sgry_NotesPayableAndSecuredLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=sgry_NotesPayableAndSecuredLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752633392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details) - Secured Debt - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Availability on line of credit instrument</a></td>
<td class="nump">$ 203,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | The Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amount of line of credit outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Availability on line of credit instrument</a></td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sgry_A2017SeniorSecuredCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sgry_A2017SeniorSecuredCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752146272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Property and equipment, net of accumulated depreciation of $320.7 and $272.3, respectively<span></span>
</td>
<td class="text">Property and equipment, net of accumulated depreciation of $320.7 and $272.3, respectively<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">Other current liabilities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Less: Current maturities<span></span>
</td>
<td class="text">Less: Current maturities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Long-term debt, less current maturities<span></span>
</td>
<td class="text">Long-term debt, less current maturities<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 277.8<span></span>
</td>
<td class="nump">$ 324.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease assets</a></td>
<td class="nump">460.2<span></span>
</td>
<td class="nump">329.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_LeaseRightOfUseAsset', window );">Total leased assets</a></td>
<td class="nump">738.0<span></span>
</td>
<td class="nump">653.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current</a></td>
<td class="nump">35.7<span></span>
</td>
<td class="nump">40.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term</a></td>
<td class="nump">271.8<span></span>
</td>
<td class="nump">315.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">307.5<span></span>
</td>
<td class="nump">355.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityAbstract', window );"><strong>Finance lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current</a></td>
<td class="nump">22.7<span></span>
</td>
<td class="nump">19.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term</a></td>
<td class="nump">481.6<span></span>
</td>
<td class="nump">345.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease obligations</a></td>
<td class="nump">504.3<span></span>
</td>
<td class="nump">364.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_LeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 811.8<span></span>
</td>
<td class="nump">$ 720.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_LeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_LeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752684672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_IncreaseDecreaseInFinanceLeaseLiability', window );">Increase in finance lease liabilities</a></td>
<td class="nump">$ 146.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets', window );">Increase in finance lease assets</a></td>
<td class="nump">145.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Decrease in operating lease liabilities</a></td>
<td class="nump">60.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets', window );">Decrease in operating lease assets</a></td>
<td class="nump">$ 59.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_IncreaseDecreaseInFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Finance Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_IncreaseDecreaseInFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Finance Lease, Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease, Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752335232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Expense and Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 32.7<span></span>
</td>
<td class="nump">$ 37.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_FinanceLeaseCost1Abstract', window );"><strong>Finance lease costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of leased assets</a></td>
<td class="nump">18.9<span></span>
</td>
<td class="nump">13.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">19.7<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_FinanceLeaseCost', window );">Total finance lease costs</a></td>
<td class="nump">38.6<span></span>
</td>
<td class="nump">26.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_VariableAndShortTermLeaseCost', window );">Variable and short-term lease costs</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">9.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">79.8<span></span>
</td>
<td class="nump">73.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">31.7<span></span>
</td>
<td class="nump">36.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash outflows from finance leases</a></td>
<td class="nump">19.6<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash outflows from finance leases</a></td>
<td class="nump">12.1<span></span>
</td>
<td class="nump">10.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease obligations</a></td>
<td class="nump">31.1<span></span>
</td>
<td class="nump">31.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for finance lease obligations</a></td>
<td class="nump">$ 91.9<span></span>
</td>
<td class="nump">$ 6.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_FinanceLeaseCost1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost1 [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_FinanceLeaseCost1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_VariableAndShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable And Short-Term Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_VariableAndShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306748520000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>interest_rate_swap</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Amount estimated to be reclassified as a reduction to interest expense over next 12 months</a></td>
<td class="num">$ (7.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 1,525.9<span></span>
</td>
<td class="nump">$ 1,533.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate swaps | interest_rate_swap</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Derivatives in cash flow hedging relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 1,200.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate swaps | interest_rate_swap</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Cap | Derivatives in cash flow hedging relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 325.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreePayFixedInterestRateSwapsMember', window );">Three Pay-fixed Interest Rate Swaps | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate of derivative instrument (percent)</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreePayFixedInterestRateSwapsMember', window );">Three Pay-fixed Interest Rate Swaps | Derivatives not designated as hedging instruments | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate of derivative instrument (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreeReceiveFixedInterestRateSwapsMember', window );">Three Receive-fixed Interest Rate Swaps | Derivatives not designated as hedging instruments | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate of derivative instrument (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreePayFixedInterestRateSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreePayFixedInterestRateSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreeReceiveFixedInterestRateSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_ThreeReceiveFixedInterestRateSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306749925904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">$ 78.9<span></span>
</td>
<td class="nump">$ 23.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="num">(41.7)<span></span>
</td>
<td class="num">(58.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">1,525.9<span></span>
</td>
<td class="nump">1,533.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapOneMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">435.0<span></span>
</td>
<td class="nump">435.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapTwoMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">330.0<span></span>
</td>
<td class="nump">330.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapThreeMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">435.0<span></span>
</td>
<td class="nump">435.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapOneMember', window );">Interest rate cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">163.0<span></span>
</td>
<td class="nump">166.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapTwoMember', window );">Interest rate cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">162.9<span></span>
</td>
<td class="nump">166.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFourMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">165.0<span></span>
</td>
<td class="nump">165.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFiveMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">120.0<span></span>
</td>
<td class="nump">120.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapSixMember', window );">Pay-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">150.0<span></span>
</td>
<td class="nump">150.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapOneMember', window );">Receive-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="num">(165.0)<span></span>
</td>
<td class="num">(165.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapTwoMember', window );">Receive-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="num">(120.0)<span></span>
</td>
<td class="num">(120.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapThreeMember', window );">Receive-fixed swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="num">$ (150.0)<span></span>
</td>
<td class="num">$ (150.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_InterestRateCapTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_PayFixedSwapSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=sgry_ReceiveFixedSwapThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752659600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives and Hedging Activities - Derivatives Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">$ 78.9<span></span>
</td>
<td class="nump">$ 23.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="nump">41.7<span></span>
</td>
<td class="nump">58.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DerivativeLiabilityNotionalAmountFinancingComponent', window );">Derivative liability, notional amount, financing component</a></td>
<td class="nump">38.8<span></span>
</td>
<td class="nump">45.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Other long-term assets | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Other long-term liabilities | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Derivative liability, notional amount</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives in cash flow hedging relationships | Other long-term assets | Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">13.5<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives in cash flow hedging relationships | Other long-term liabilities | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative asset, notional amount</a></td>
<td class="nump">$ 62.5<span></span>
</td>
<td class="nump">$ 8.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DerivativeLiabilityNotionalAmountFinancingComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Liability, Notional Amount, Financing Component</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DerivativeLiabilityNotionalAmountFinancingComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752332240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax', window );">Amortization of accumulated OCI related</a></td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="nump">$ 10.6<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">(Gain) loss recognized in income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives in cash flow hedging relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) recognized in OCI (effective portion)</a></td>
<td class="nump">12.7<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
<td class="nump">63.1<span></span>
</td>
<td class="num">(4.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives in cash flow hedging relationships | Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">(Gain) loss recognized in income</a></td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="nump">$ 6.0<span></span>
</td>
<td class="nump">$ 12.7<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306752381200">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Summary (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Surgery Partners, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (18.4)<span></span>
</td>
<td class="num">$ (26.9)<span></span>
</td>
<td class="num">$ (6.2)<span></span>
</td>
<td class="num">$ (47.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Less: Amounts attributable to participating securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(10.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (18.4)<span></span>
</td>
<td class="num">$ (26.9)<span></span>
</td>
<td class="num">$ (6.2)<span></span>
</td>
<td class="num">$ (58.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding- basic (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">88,900<span></span>
</td>
<td class="nump">69,267<span></span>
</td>
<td class="nump">88,450<span></span>
</td>
<td class="nump">62,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding- diluted (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">88,900<span></span>
</td>
<td class="nump">69,267<span></span>
</td>
<td class="nump">88,450<span></span>
</td>
<td class="nump">62,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.94)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.94)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,559<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
<td class="nump">1,599<span></span>
</td>
<td class="nump">1,901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">628<span></span>
</td>
<td class="nump">1,484<span></span>
</td>
<td class="nump">644<span></span>
</td>
<td class="nump">1,451<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306852792912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Current Liabilities - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Right-of-use operating lease liabilities</a></td>
<td class="nump">$ 35.7<span></span>
</td>
<td class="nump">$ 40.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest payable</a></td>
<td class="nump">28.8<span></span>
</td>
<td class="nump">29.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_PayablesToCustomers', window );">Amounts due to patients and payors</a></td>
<td class="nump">32.5<span></span>
</td>
<td class="nump">26.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CostReportLiabilitiesCurrent', window );">Cost report liabilities</a></td>
<td class="nump">22.1<span></span>
</td>
<td class="nump">26.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_TaxReceivableAgreementLiabilityCurrent', window );">Tax receivable agreement liability</a></td>
<td class="nump">20.2<span></span>
</td>
<td class="nump">19.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other</a></td>
<td class="nump">82.5<span></span>
</td>
<td class="nump">68.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 221.8<span></span>
</td>
<td class="nump">$ 210.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CostReportLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost Report Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CostReportLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_TaxReceivableAgreementLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Receivable Agreement Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_TaxReceivableAgreementLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_PayablesToCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount payable to customer by broker-dealer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Rule 15c3-1<br> -Number 240<br> -Section 15c3-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_PayablesToCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306755113664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Professional, general and workers' compensation insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EstimatedInsuranceRecoveries', window );">Expected insurance recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlement</a></td>
<td class="nump">$ 32.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 32.8<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm', window );">Projected tax savings period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal effective tax rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Long-term tax receivable agreement liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount', window );">Carrying value of liability, net of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent', window );">Deferred tax liabilities, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember', window );">Federal Funds Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate', window );">Collaborative tax agreement, basis spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">LIBOR | Materially More Restrictive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">LIBOR | Not Materially More Restrictive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsLineItems', window );"><strong>Guarantor Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Tax Agreement, Interest Rate, Basis Spread on Variable Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Tax Agreement, Projected Tax Savings, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax Liabilities, Net Of Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Income Tax Liabilities, Net Of Discount, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EstimatedInsuranceRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts expected to be recovered under the terms of insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EstimatedInsuranceRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualRiskOrUncertaintyByNatureAxis=sgry_MateriallyMoreRestrictiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualRiskOrUncertaintyByNatureAxis=sgry_MateriallyMoreRestrictiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualRiskOrUncertaintyByNatureAxis=sgry_NotMateriallyMoreRestrictiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualRiskOrUncertaintyByNatureAxis=sgry_NotMateriallyMoreRestrictiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306747279488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 615.4<span></span>
</td>
<td class="nump">$ 543.3<span></span>
</td>
<td class="nump">$ 1,211.6<span></span>
</td>
<td class="nump">$ 1,055.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86.1<span></span>
</td>
<td class="nump">75.9<span></span>
</td>
<td class="nump">163.2<span></span>
</td>
<td class="nump">148.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Reconciliation of Adjusted EBITDA:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.6<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">63.7<span></span>
</td>
<td class="nump">17.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33.7)<span></span>
</td>
<td class="num">(35.7)<span></span>
</td>
<td class="num">(64.3)<span></span>
</td>
<td class="num">(67.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
<td class="nump">25.2<span></span>
</td>
<td class="nump">55.4<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.9<span></span>
</td>
<td class="nump">53.4<span></span>
</td>
<td class="nump">113.2<span></span>
</td>
<td class="nump">106.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">9.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts', window );">Transaction, integration and acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">11.4<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">20.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation', window );">Loss on disposals and deconsolidations, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts', window );">Loss (gain) on litigation settlement and other litigation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="num">(29.1)<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86.1<span></span>
</td>
<td class="nump">75.9<span></span>
</td>
<td class="nump">163.2<span></span>
</td>
<td class="nump">148.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">14.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Start-up costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Other litigation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation settlement</a></td>
<td class="num">$ (32.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(32.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Surgical Facility Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">597.9<span></span>
</td>
<td class="nump">525.8<span></span>
</td>
<td class="nump">1,176.7<span></span>
</td>
<td class="nump">1,021.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108.7<span></span>
</td>
<td class="nump">95.6<span></span>
</td>
<td class="nump">209.7<span></span>
</td>
<td class="nump">190.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Reconciliation of Adjusted EBITDA:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108.7<span></span>
</td>
<td class="nump">95.6<span></span>
</td>
<td class="nump">209.7<span></span>
</td>
<td class="nump">190.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Ancillary Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.5<span></span>
</td>
<td class="nump">17.5<span></span>
</td>
<td class="nump">34.9<span></span>
</td>
<td class="nump">34.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Reconciliation of Adjusted EBITDA:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">All other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.8)<span></span>
</td>
<td class="num">(19.6)<span></span>
</td>
<td class="num">(45.8)<span></span>
</td>
<td class="num">(40.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Reconciliation of Adjusted EBITDA:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (21.8)<span></span>
</td>
<td class="num">$ (19.6)<span></span>
</td>
<td class="num">$ (45.8)<span></span>
</td>
<td class="num">$ (40.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Integration Related Costs, And Merger Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Before Interest Taxes Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GainLossOnDispositionOfAssetsAndDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposition of Assets And Deconsolidation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GainLossOnDispositionOfAssetsAndDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) Related to Litigation Settlement And Other Litigation Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgry_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sgry_SurgicalFacilityServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sgry_SurgicalFacilityServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sgry_AncillaryServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sgry_AncillaryServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306760066640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 6,291.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,117.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total cash purchases of property and equipment</a></td>
<td class="nump">40.6<span></span>
</td>
<td class="nump">$ 28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Surgical Facility Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">5,691.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,552.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total cash purchases of property and equipment</a></td>
<td class="nump">36.9<span></span>
</td>
<td class="nump">27.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Ancillary Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">44.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total cash purchases of property and equipment</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">All other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">555.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 517.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total cash purchases of property and equipment</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sgry_SurgicalFacilityServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sgry_SurgicalFacilityServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sgry_AncillaryServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sgry_AncillaryServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140306748451232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65.8<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments | $</a></td>
<td class="nump">$ 29.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Surgical Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of properties acquired | property</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | In-Development De Novo Surgical Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of properties acquired | property</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=sgry_SurgicalFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=sgry_SurgicalFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=sgry_InDevelopmentDeNovoSurgicalFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=sgry_InDevelopmentDeNovoSurgicalFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>sgry-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sgry="http://www.surgerypartners.com/20220630"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sgry-20220630.xsd" xlink:type="simple"/>
    <context id="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i08eaf5cf61dd49bda81b3a7c558d3bc4_I20220726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2022-07-26</instant>
        </period>
    </context>
    <context id="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i05b7208bc5d946119ab875dbf0311579_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i65b4d531cb9b48cd894460f4e16463be_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i874b93f4f80843419c99212b693021ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a8ee0761a1d4c8c9f56f071d5e4f410_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5321f94b5324566bedb956ae6c2fb92_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie15ac736956f49c883e02995bab6b9aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ce39eddcaef4480b057800dbc9fc415_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i44e20b461fac4de38f9910707892a5b3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i727c848f12464ac9868395007955636a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iddbc40dd884d4204a58cb11045457ae7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i70c54c1f4edd4426a5c3c25dbe35d19a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic945102fb54c4d69855b08862add35a9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i70a9d633a0ba4f6b8deb6abf6e42e588_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0bbcf15e953044c9bb4256698275b17c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1a2a308f404d4462a20f521a6049c6e7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia9f9d0d0f7404a6fb2b9f70e9127679b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8cc82a550101490d9ba4c262f7e759a9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iaa9e74d27950455e8f7ebd062dccc167_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7600816d839d42ceb914df213ec157f6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic9b0391f35644b1d9d20974a5c75b7a8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i20255b89339547c0a3a555a0aa07dc59_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic2627c134a054c6c8194c8cf5b5c40e3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i520879363a004c03b48b9aa26d49ec3b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i86d62a7c424e47d19d145f6ebf771221_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i64a8818a24674f2faae8cfbfd2edb750_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id0cb6e6c59764f929e1812a53232bc2f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i75ea718f255443ed9371e7d4a9085825_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie4482a6ba65743ca8c0b52945eadf553_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i293881ff9efc4258a9030c4efeddff54_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i95848062d06c4c1a9b5d0bb79f725a76_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd8e1125342f40899ab99713e4cf2a1d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d8a3b98e81649a1bd4caa715cb0da2e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9eb703a1f5b144eebc1858b52f17e2f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id814edaeefa14859bd8a994f03809e5f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibdb0efe93e7640ae8d172d601a4692d6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibb268f2da5f547d8a14d3c95c0580e06_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i83f9cc0cf2f746de84d60298eb4a0c6f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0d1e6d43a40d46928b3eb06e51ef68eb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7e600af0037644c58476a1a9eda6a026_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1ceadb6d58d648b589f0df8a7a6b998a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2ad66b78a6b64609ac23769c262610e5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i92460d1af80c4ff7b3a654fd318e31a3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iffdcc560f54a4d43ada125b516d24346_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iafdeb370ccbb4184863d2f97c17b9079_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8f3cf04cf3c64d81915962e56cdaae10_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic07b7144afd5431eb46020ecbc41d2b5_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id7a924e0937d48aa9ee3d55bea4ef7c2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i39bd68b89c0941a289562ee539763064_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i350bb6d8c988458096fa290f02419cc7_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic14c278f188a4ea6be8e3287cf313398_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5d50b5caa3534d6f84e75102afd14fdb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7dae7f18f2f34d56b658f35f31fdd441_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaa2a718bde80444eb214d2eaf59e0b6c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4cdb2c56dc4745448c8e6a876c8890db_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id4909f7c61db49b69aa8ecd11570d198_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8635a31bb616432d8bb3e7a8d312f3a5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:FacilitiesAmbulatorySurgeryCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9538a3fb78354d13ae2d5c04403980a5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:FacilitiesSurgicalHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i69a8b63234044edb8f0a6afda70cdd7f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibf657c1e4474414d9ed07e96c58ad59d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i552bb5d715f746d0af0896cb8236e297_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i86904f5d11ef43b59e207be1a0a75042_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibff8350d312b4ee2964eceaea94a35b0_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0c0d2eeb74d34cfc9128ab781a805818_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idab948c415d74a1e874e667af7cefd2c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ife3f7aa0dc10478fa288248a9670fa92_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i34e9e7220c934670b27ad119a843e336_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i840850c9edd84feea92967f120b69408_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3b11393d1e4444258098013cd223901e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia6ce9b604fc54f51a04400f3ffd18e4c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8ccf871acc2e48a18834c00109df962f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iab3bce97216f4963af800c138848af24_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib016f83f44d74921b4f5ce6b9ab4976f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7a2aaf930d1c431f8bcf8bc5136ad3b0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0d812678eaf54267847b2530339322ec_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic47817178a934289aa981ee5da388b9d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic37df66186ae4e5fb918bd1d2efca702_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icf41c461015444fe83e5e4ac21755f08_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i44cb302421034882ae2b0562737c1761_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if244251d5c944d3c8d006f96aa5ebbeb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i60b170b8d71c411192b47b3305a64616_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3c2399a17532427a98c0603b2322f33f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i26fcec9c0227498db8204ef1cbf8fc8f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if0822a8d0912456b81a264a53b470d89_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia0f939d7f48e447e90a63291660e7944_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5cc712172b944863ad8e1ec9d1f576b5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if9a48f2904b44c188eea35ede6799f83_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia80790d713364217852ad6b20c5b9b80_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i63e081ac08c44dc5a177a46e62b24af8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3b40d040385048f4892471ac83e1a711_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6b2cd8126cda47679574168e7959c24f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id61b7b590da346e2947662ec3b207f85_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9bc26bedce494bfea61792a1ff92ace3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idcc3a089528340bbba1aff28988c6812_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0d7024453b0a4f5c8ce5d266c8c9e818_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i27735b9da4154030bf4e696fb6bc2a59_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i97572a73c7164e119219a51fbc609a03_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id1dd63f253344cbf9b6a3ea5aca75cc1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1eba6e7221624a33acd805897dd778ed_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib2da709eec92472d8e6b2eb875df017d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3084cb440f6440539f725074cc141064_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if3379039f97441b69503564797be213b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iee70145afa7b4a67822ee29af8d0ac67_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iad2ccb4850c7418299a1f3d759ad4c1c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:PrivateInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i90f42610982f4a29bc29dac6a196477b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iff79ffa556644f829d223ebc6d3e3e4e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0de9d3bf0e784880a751f9e1dc386914_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i18be6ab1a0c548c2b344fd6ed2142372_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GovernmentContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibc8dfce5bc944bfd937fcf89a20c4c8a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iebe60e2bb5c545f98959f8d0f9d2db95_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iddd55bfbcc5443ce8c95abb22f917ef7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaf891198937c45b68701f2071a3a79c1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:SelfPayRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if3c06ae7e4574d1087fab3bfb50d7437_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib1be2d60556148108356e7e3d0c609e6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5b0201ec336d4d759ab22d8b3f999534_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if99bdea32bbb4844a79014c52607f56e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherPatientServiceRevenueSourcesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic90c5193afd6420fb1c2f4aa57b405e7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i18b50bcfbdfb4bb791ecefea65280045_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibbbf27a71e2f456398a50c2893221fad_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i07a9608cfa094c6684c2b726c01884cb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:HealthcareOrganizationPatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i02fc46716fa94295ba0d78ef52b9bc23_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8831be04004f4e43925db4244ecc0d5c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgry:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6b3dc06c3b0940c6864cf95b82437b22_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia4014a2b0728429f99f1aff4ee095837_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i48593468d901450b9f2b3750f730873f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iab78f5af1da94146958f7005f99d54ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17b9522ee1a5410c9e521102b0938024_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iee1640a7d9ed442fb5430f01e5f729e5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ife931bd0ec79459bb3908847c1c58b78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc9575728f644eaa83de881b7d5e9813_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i240776d65f63482e82bae1bb71ef09b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id97f2fe451ad49ebab6e84dfc7448640_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iada7c3ad8c6043cf83baea26ca96c7f5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6e7433e734c44d0fbaf0eb6487f2a2fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0455e535db8f4f838179eed4ab11e337_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idb5f2b0b8b3a4fb38bed91efd6ed8703_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0c7f757289414463a07207dec757e8d0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idfd8f7a8f4154e65a697ab7d0057cc7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia73c117591c64b64acb148493f0ec6d8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6a3bff3446ca40c28509f17868f1adc1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesExistingMarketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iea5f3abaa0984b2eaa7055cba2542341_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iefa24cf2b7dc4ebc86ae0a7a096deb4d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifdc566837054408da2d934e520986ebb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">sgry:SurgicalFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie3963d4281e5468c8e5368c83dc0b938_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i765634ba75024131a79a3d390bb13989_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">sgry:DisposalGroupOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i97c9ba13353b4c19b6ed54c8402d44cf_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">sgry:DisposalGroupTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib185c098b450421d89d993a6a054fd2c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">sgry:DisposalGroupTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2b6f41648efd461697a23bab27bf16e5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">sgry:DisposalGroupTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if2194c6aaf1a4eec8b2eab9c9b7c3c3a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia1aeee4881fa47c580bb5e99e88641ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017TermLoanMaturing2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17cc9fb2945a48038ba149c83e32f783_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i49d20d5258ec48e59311e50fe392c175_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:SeniorUnsecuredNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea1883c76fa04d069ea8e3cf7e28a781_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sgry:NotesPayableAndSecuredLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i63c44749e22b461ca1d58d166427ced2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sgry:NotesPayableAndSecuredLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a5a30a093dc41659d3f312026cb301c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i86130d880fcf401e909db4519bccc94f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i34519792c7c644368bc1218b81d5eb35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3520bf24329a4e13a3d203c231caa136_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sgry:A2017SeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0d641fec5a614286a665a368239cb7fe_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i624ef5b3954c440ca2df8007f64bb190_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9405d2dfa6a44be3b5a5fddf7e37ce73_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibec9eb2e922848e193c29ccb4d324b59_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if84173ed23fc455c8dc5af7694d68f70_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreePayFixedInterestRateSwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i652bb49f02444b3a89f17f2300107e97_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreePayFixedInterestRateSwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0fccee9038b24758ba351eba3d11e91a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ThreeReceiveFixedInterestRateSwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7e675653b29b4a30a95a33a4eafccfa8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0bac16b3932b4d9f8c149cbe0186184c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea63fb7682374f5fbce4eaf0268880b3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i92b3a62c12c645209db966edaf59e976_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0910d6248ac74aa9bcf915cfa2b93d37_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibf9ff04a00914131a0f5c3d690dd4103_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica6bbd0b30fa447bbaa6e2d70abf379e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie5e9e67aafa642f1b536a59d612f21b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87459cd7cbda4d60b240d0999c63bd43_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i963697d6f96e442d98f5756ec73485b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:InterestRateCapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icfd2fc8ece9341b3adef2ac0e05a7557_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i35884d0598254ccb991a911d3502b131_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ied5ab0dab33041f989a6b88eb2b43ce3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id545da56246a458a9f507b5e10d6b9cb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ee2b1492ec349a2b51e75e9df9f3bb0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i113be4a99c604b2da5b072d5e5d8fa21_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:PayFixedSwapSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i533833368b6c47bf89ba7a880f670cd8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic848ed09b98c48b0a8a7f23e355be28f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib229dcc9506d4c8398a0910a44f53196_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifa055d97ac3b4c02add1ba0a6cc7c820_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5ccb9be430ab41d58f216a21128552cf_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8fd5b2180b57439b962339cd3bf1d9c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">sgry:ReceiveFixedSwapThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ff529d76c974a7a8aea1a917b35b64b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i91cee683d0cb47b8a7410f692915b4ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic454598ff0b04e2b96bfa6db8aed8d32_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iccbe30e44be742e4a2c505011293909f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3112ecc656048f9963864a981edf6e8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic1c2b5dd09894633b50efcebda46b25c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87e28fb347c94eb9abfe022c9393fe3f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id40745034fee45fba37203084540e1fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida372175cdc044c591964aa8bc62bf11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id1657924a29746e68c995f79d41d18f2_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia390bedd4c604d87b921bb743e5001af_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id1d2ff8d35f9424eac0c1076c4c642a4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i99fa76822a7c4953b5d77c75c594a220_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6f2dff4c01ce4f1c8dc3f58ea1d2f195_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iabfd2c1c39ee49308512e86fea44e1e4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5aa994d75ecc45929183b091586f7b83_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3daec31ecd414074ac61cd4c7433ff05_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaf3f8870fede40489dc7020e3bc79d19_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib66f2867150d4f6d9cbba76ffaa3892d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0309fa024ab34d959fd9963466f2ccc3_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i36b6a3ca602748ce951abd5c3ecb073a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i63a22d68b90b48909dc3d1b1b5b8a20e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i020ea1b80b0942b19fcb6613eff5fd71_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i58659716e1cf471dafca42309eeb5309_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idd945ed3ab5f4ffda421c746ebe77bab_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i34857924f21749c1b51e0cd2f31b0597_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2612faa6b1474823bc2ad95518bc8aa3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i590c785262294ff4b5426d751376a0aa_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie7846148240d4ef5af33eeefb926fa03_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibe0c66f9f387475f844569ed2d3b3205_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iba332caf963a4b5a996c1691527ca638_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:FederalFundsEffectiveSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5c7f8902d58045f499cdd85fdd43307b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualRiskOrUncertaintyByNatureAxis">sgry:MateriallyMoreRestrictiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i892c4c41e2e949ed919cd99526bbb6dd_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualRiskOrUncertaintyByNatureAxis">sgry:NotMateriallyMoreRestrictiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i33740e780fe041819c21399ef852290a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i87b86506be1b428c860321716b7a66d8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i403f917fe58449dd84f395f95d5d45f5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i62d2cc75b7bf4e3991b46bd2fe6ab2bf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i410d8e1eee01450cb5b6cfd107a06e90_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3118082a6eee4654817ff68f7ff8cd11_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if9e54a8543c64c13be3bc0583a316c0b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4cc71adeac1b48e983f02714d00ddc72_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i95419c314ef74baa801a963119c98dc5_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icd1554a1349741dba5cff54478d06171_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2293dc828b4c49858d186288dc517883_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4ea00fc2deb741eeaefccb889320e7bf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i23bc251b6a3e49908aa27d058a4353bb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i05385bb60fbf427ead13dc4825931c47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:SurgicalFacilityServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73110b114b4e4de8888b67e05068b98f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i15e47b2c1f284ef6921de8dbbd99e9a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sgry:AncillaryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e234b442be44c11a6adaee5cffc93f3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i981cc515616546ff8ac377ab4fc32af5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib78433cb866f4b209cb42b742ebd6d86_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">sgry:SurgicalFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="i1b0e6fb212964ed98b69386800807bd2_I20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">sgry:InDevelopmentDeNovoSurgicalFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="if47fc0612aa043b48a03337684354a15_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="facility">
        <measure>sgry:facility</measure>
    </unit>
    <unit id="state">
        <measure>sgry:state</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="physician_practice">
        <measure>sgry:physician_practice</measure>
    </unit>
    <unit id="non-controlling_interest">
        <measure>sgry:non-controlling_interest</measure>
    </unit>
    <unit id="business_entity">
        <measure>sgry:business_entity</measure>
    </unit>
    <unit id="interest_rate_swap">
        <measure>sgry:interest_rate_swap</measure>
    </unit>
    <unit id="segment">
        <measure>sgry:segment</measure>
    </unit>
    <unit id="property">
        <measure>sgry:property</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80L2ZyYWc6MjFmM2ViNGIwM2M5NDFkMDg3NDVhYTI0NWE0MTVmOTIvdGFibGU6ODg4NzkxNGZmODJlNDNjNzkwMmY2OTU4MTAwNTFmZTkvdGFibGVyYW5nZTo4ODg3OTE0ZmY4MmU0M2M3OTAyZjY5NTgxMDA1MWZlOV80LTEtMS0xLTQ3NTc1_411be701-095a-43c7-85f1-b8a5aa0109d4">0001638833</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80L2ZyYWc6MjFmM2ViNGIwM2M5NDFkMDg3NDVhYTI0NWE0MTVmOTIvdGFibGU6ODg4NzkxNGZmODJlNDNjNzkwMmY2OTU4MTAwNTFmZTkvdGFibGVyYW5nZTo4ODg3OTE0ZmY4MmU0M2M3OTAyZjY5NTgxMDA1MWZlOV81LTEtMS0xLTQ3NTc1_7d5ff8d3-1a42-4402-a976-ccda2d0ae06a">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80L2ZyYWc6MjFmM2ViNGIwM2M5NDFkMDg3NDVhYTI0NWE0MTVmOTIvdGFibGU6ODg4NzkxNGZmODJlNDNjNzkwMmY2OTU4MTAwNTFmZTkvdGFibGVyYW5nZTo4ODg3OTE0ZmY4MmU0M2M3OTAyZjY5NTgxMDA1MWZlOV85LTEtMS0xLTQ3NTc1_136d182c-844b-45e0-8953-0e42cfc62816">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80L2ZyYWc6MjFmM2ViNGIwM2M5NDFkMDg3NDVhYTI0NWE0MTVmOTIvdGFibGU6ODg4NzkxNGZmODJlNDNjNzkwMmY2OTU4MTAwNTFmZTkvdGFibGVyYW5nZTo4ODg3OTE0ZmY4MmU0M2M3OTAyZjY5NTgxMDA1MWZlOV8xMC0xLTEtMS00NzU3NQ_6d185400-9471-40f3-90c7-3821be85b064">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80L2ZyYWc6MjFmM2ViNGIwM2M5NDFkMDg3NDVhYTI0NWE0MTVmOTIvdGFibGU6ODg4NzkxNGZmODJlNDNjNzkwMmY2OTU4MTAwNTFmZTkvdGFibGVyYW5nZTo4ODg3OTE0ZmY4MmU0M2M3OTAyZjY5NTgxMDA1MWZlOV8xMS0xLTEtMS00NzU3NQ_2f120ab3-2858-4f34-b90d-80d78cc52483">false</dei:AmendmentFlag>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_0490c164-1bcc-4f55-85d3-15e9331ed7ed">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_4a2e4f93-28b9-4c5f-bc07-6358d546de18">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_00060c4f-1b87-4bb0-b65b-4b1328751e7d">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_f34bfa11-29e3-4790-b94f-70125ea4d07f">http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_82470289-02c8-4ee9-bb12-c86df2a2d59b">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_d09186d5-2c70-43f5-ba46-c5f5d380a2bb">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_2188135b-10a8-4d73-88ea-7b90cf795fbd">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_eb2749f0-b898-4460-8f9b-f8a8c6f0701f">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQz_8cd891c1-1fea-4010-8802-8fab377bcaa2">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQw_c2454d9a-be58-4eec-80e7-588a5c78de7b">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yOTg_c5f49270-0ed7-469b-baaa-19a44f4c7f75">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzUw_d6877614-6a76-4990-b6e5-cd41cb51ac70">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQ0_fbfe78ef-662c-45a3-b774-ce63e8a3248d">001-37576</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQx_6309ef20-8593-488c-801e-552353236a9e">Surgery Partners, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6MjA2MjJmZWRlYWViNGIwNzg2N2VhZDM1N2U0NDFjYTYvdGFibGVyYW5nZToyMDYyMmZlZGVhZWI0YjA3ODY3ZWFkMzU3ZTQ0MWNhNl8wLTAtMS0xLTQ3NTc1_8187d0ad-006a-4130-bfaf-5c76b5188a44">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6MjA2MjJmZWRlYWViNGIwNzg2N2VhZDM1N2U0NDFjYTYvdGFibGVyYW5nZToyMDYyMmZlZGVhZWI0YjA3ODY3ZWFkMzU3ZTQ0MWNhNl8wLTItMS0xLTQ3NTc1_596f5b26-741d-4c4e-bd34-6d3de6a24de2">47-3620923</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzM3_8780c5c9-bb0e-4c23-9a32-1e3f8af66ca0">310 Seven Springs Way, Suite&#160;500</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzM4_b51fbd3a-341d-48cc-a953-36abb530f977">Brentwood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQ1_968e4d8f-501c-423a-bb3b-237f5e41e0c9">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQy_48564234-bdfb-4cee-be33-d6dc996b695b">37027</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzU0_987808e0-f065-47e3-b744-fe888bd48c64">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQ2_ae09b67d-f4d1-4b22-b151-65c8411727b7">234-5900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTJiNjQ1OGQ4MzY5NGNiNWI4MzhmOTk3OTg5MTRhOWYvdGFibGVyYW5nZTplMmI2NDU4ZDgzNjk0Y2I1YjgzOGY5OTc5ODkxNGE5Zl8xLTAtMS0xLTQ3NTc1_5fc7b657-51f2-4cd6-98b2-a500112e6652">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTJiNjQ1OGQ4MzY5NGNiNWI4MzhmOTk3OTg5MTRhOWYvdGFibGVyYW5nZTplMmI2NDU4ZDgzNjk0Y2I1YjgzOGY5OTc5ODkxNGE5Zl8xLTItMS0xLTQ3NTc1_4d2c3e9f-7db0-4949-bdf0-2c7790455e17">SGRY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTJiNjQ1OGQ4MzY5NGNiNWI4MzhmOTk3OTg5MTRhOWYvdGFibGVyYW5nZTplMmI2NDU4ZDgzNjk0Y2I1YjgzOGY5OTc5ODkxNGE5Zl8xLTQtMS0xLTQ3NTc1_2c121149-135c-499c-9b85-445c5a7565ef">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQ4_bab9ed02-464f-4973-bb20-0208f5e44ac1">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzM5_64d79b4f-b9d9-415d-b173-4339699a0e60">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTZmMThhODNjNzBjNGM0ZWFkNTk5NzRjNzNmMzRjMGUvdGFibGVyYW5nZTplNmYxOGE4M2M3MGM0YzRlYWQ1OTk3NGM3M2YzNGMwZV8wLTAtMS0xLTQ3NTc1L3RleHRyZWdpb246NzA0MDdhNGJlNDU0NGViMWEyMjYzYTI4N2Q2YzdhMjJfNA_db12ede4-acf4-4180-99ed-c9d564bf3373">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTZmMThhODNjNzBjNGM0ZWFkNTk5NzRjNzNmMzRjMGUvdGFibGVyYW5nZTplNmYxOGE4M2M3MGM0YzRlYWQ1OTk3NGM3M2YzNGMwZV8xLTItMS0xLTQ3NTc1L3RleHRyZWdpb246OWQ1OGY4ODQyYTliNGUwMWE1YjE2YThkNjc1ZTQyNzBfMzA_d2fb74d3-76e0-4a2e-8d11-32298558fe53">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGFibGU6ZTZmMThhODNjNzBjNGM0ZWFkNTk5NzRjNzNmMzRjMGUvdGFibGVyYW5nZTplNmYxOGE4M2M3MGM0YzRlYWQ1OTk3NGM3M2YzNGMwZV8yLTItMS0xLTQ3NTc1L3RleHRyZWdpb246MTRlMzVlNTMyYjExNDQ0YWE1ZWFkYmEzZGI5MTljNGVfMjg_0be9b5ed-9bdd-4d69-8434-e48c0a858165">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMzQ3_af7a22ee-4e16-45f2-a190-651ea39ace87">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i08eaf5cf61dd49bda81b3a7c558d3bc4_I20220726"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xL2ZyYWc6ZjllMWIxMjcxNzc5NDAwY2E5MTY5NzNlMmY4NDY0MTkvdGV4dHJlZ2lvbjpmOWUxYjEyNzE3Nzk0MDBjYTkxNjk3M2UyZjg0NjQxOV8yMjgx_983ca64e-7cf2-4928-a094-20333a0a0a26"
      unitRef="shares">89935287</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNC0yLTEtMS00NzU3NQ_ae9fd8ce-90e2-44d7-8040-4fa0ad4b2d7f"
      unitRef="usd">227400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNC00LTEtMS00NzU3NQ_82d20f5e-385e-4f79-b8b1-33961ea720ca"
      unitRef="usd">389900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNS0yLTEtMS00NzU3NQ_83da3eca-e77d-4058-bcea-61864260d76f"
      unitRef="usd">412000000.0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNS00LTEtMS00NzU3NQ_00f87bac-25a7-4e41-8c67-3e1c9a372081"
      unitRef="usd">430200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNi0yLTEtMS00NzU3NQ_f2c52bc4-7b28-4a69-b016-370c84627cdf"
      unitRef="usd">64000000.0</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNi00LTEtMS00NzU3NQ_4b784208-a21a-432b-8aba-c27634f1e669"
      unitRef="usd">61100000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNy0yLTEtMS00NzU3NQ_03fc0bb4-27e4-4889-ac4b-0c6c8333be6c"
      unitRef="usd">37400000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNy00LTEtMS00NzU3NQ_d6ae9529-b8aa-4026-b61e-d6939131a111"
      unitRef="usd">25600000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfOC0yLTEtMS00NzU3NQ_030f1ce8-ab37-4a69-8809-267d57d03936"
      unitRef="usd">47600000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfOC00LTEtMS00NzU3NQ_7b79ac71-c8bd-497b-8799-4079135d29e2"
      unitRef="usd">39300000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfOS0yLTEtMS00NzU3NQ_d23bb55f-dde4-4537-b493-92f72737e204"
      unitRef="usd">788400000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfOS00LTEtMS00NzU3NQ_dce8d557-6e30-4fd9-8863-4e87f727c890"
      unitRef="usd">946100000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTAtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3MDAzMmIzYWM1ZWI0NDg2OTYzNjA2OTk3MmU4OTgxOV82Mw_de110c94-549e-4916-8404-970cc1974552"
      unitRef="usd">320700000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTAtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3MDAzMmIzYWM1ZWI0NDg2OTYzNjA2OTk3MmU4OTgxOV83MA_df7244ca-09d9-4b50-93f1-e4eaee73b68f"
      unitRef="usd">272300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTAtMi0xLTEtNDc1NzU_0131daf5-d7d0-4936-bd8e-49583c520f45"
      unitRef="usd">789100000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTAtNC0xLTEtNDc1NzU_0c2178f6-01b9-4428-a306-750796f8316f"
      unitRef="usd">629700000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTEtMi0xLTEtNDc1NzU_318ceab7-947d-40d3-a0ac-1c82892090ab"
      unitRef="usd">4035600000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTEtNC0xLTEtNDc1NzU_18241a97-e05f-4ae6-b2e2-7cf4521fba0c"
      unitRef="usd">3955500000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTItMi0xLTEtNDc1NzU_69d6db26-0212-47a6-bc81-b4412a02d161"
      unitRef="usd">159700000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTItNC0xLTEtNDc1NzU_1f67efde-2316-48dc-9c00-2a342099463c"
      unitRef="usd">88700000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTMtMi0xLTEtNDc1NzU_48d8b4dc-c204-4792-98c3-a739f2a2ec4b"
      unitRef="usd">277800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTMtNC0xLTEtNDc1NzU_ea277c3d-9b38-4ffd-ab1a-9ffba860d1da"
      unitRef="usd">324100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTQtMi0xLTEtNDc1NzU_4a3b57e8-c07b-4fd2-8611-231be5561f35"
      unitRef="usd">110400000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTQtNC0xLTEtNDc1NzU_c7136af2-133d-4311-b2c0-c08d4f7f4245"
      unitRef="usd">114400000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTUtMi0xLTEtNDc1NzU_4ba6822a-2933-442e-89df-12d5c7d47d07"
      unitRef="usd">130600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTUtNC0xLTEtNDc1NzU_362cc921-cfdb-4cea-b64d-8b5f25221cab"
      unitRef="usd">59100000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTYtMi0xLTEtNDc1NzU_c613a232-bdd5-431d-8a1b-d006a1f067e8"
      unitRef="usd">6291600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMTYtNC0xLTEtNDc1NzU_34b64aa1-6d16-454e-a855-f9e85a18a420"
      unitRef="usd">6117600000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjAtMi0xLTEtNDc1NzU_26a493c4-6c28-49b6-9b02-369e12eb6bc6"
      unitRef="usd">126400000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjAtNC0xLTEtNDc1NzU_bfa447aa-6970-4ce6-974c-f5ec112d966a"
      unitRef="usd">124900000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjEtMi0xLTEtNDc1NzU_d8d4b542-019a-47ac-9cca-f702e01590b5"
      unitRef="usd">83800000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjEtNC0xLTEtNDc1NzU_8b5adf84-d3d6-468a-b96b-d578a10892f2"
      unitRef="usd">77100000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjItMi0xLTEtNDc1NzU_f68aa1c0-0262-43df-9ab0-3cb91abf549b"
      unitRef="usd">21400000</sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent>
    <sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjItNC0xLTEtNDc1NzU_6b6b8fd4-9e7d-4141-b0d9-11c67c88662c"
      unitRef="usd">64400000</sgry:MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjMtMi0xLTEtNDc1NzU_ff111e1b-b39b-48f0-b8fd-594d7df68423"
      unitRef="usd">221800000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjMtNC0xLTEtNDc1NzU_45ddffb2-b9df-4932-812d-6e59566c1171"
      unitRef="usd">210000000.0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjQtMi0xLTEtNDc1NzU_a7f4d84f-a697-4777-8587-04a9d849a5bc"
      unitRef="usd">68300000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjQtNC0xLTEtNDc1NzU_0087fdaa-e60a-436c-9ae9-fbfa7d1313d6"
      unitRef="usd">60400000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjUtMi0xLTEtNDc1NzU_87a25351-ec34-4570-bc37-cf87f7cc0d23"
      unitRef="usd">521700000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjUtNC0xLTEtNDc1NzU_332127af-1337-45b1-8f12-20b52389b56a"
      unitRef="usd">536800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjYtMi0xLTEtNDc1NzU_f3c5b649-3330-4b1b-87ae-eb7cb9f4785d"
      unitRef="usd">3019400000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjYtNC0xLTEtNDc1NzU_b7b1e88f-527d-4680-9c97-89eb675f2d1a"
      unitRef="usd">2878400000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjctMi0xLTEtNDc1NzU_e0e85778-a5ab-452d-9231-336322008220"
      unitRef="usd">271800000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjctNC0xLTEtNDc1NzU_a7eb6876-4d69-486e-bfcf-3bd8a985da62"
      unitRef="usd">315600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjgtMi0xLTEtNDc1NzU_6f28e8d3-d1cb-41f1-b5bb-b778376b0d79"
      unitRef="usd">96400000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMjgtNC0xLTEtNDc1NzU_2e223b44-9c3c-40bf-8636-7d3bf106b427"
      unitRef="usd">87000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzAtMi0xLTEtNDc1NzU_56417a0a-79d2-4c54-97d0-0c43613f2d87"
      unitRef="usd">341800000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzAtNC0xLTEtNDc1NzU_5f04cf50-0e4f-4c21-9e4b-eb8e19c0c5f3"
      unitRef="usd">330200000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF8yMQ_192fafe0-27af-4009-ae39-4b74daefbb45"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF8yMQ_e38d8e49-4ae3-4082-946d-d93d16ef2fda"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF81NQ_09043aab-c10d-4ad3-ba7d-4dc3d33792e8"
      unitRef="shares">20310000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF81NQ_3539b676-0206-4dcc-b683-2a06362f5c35"
      unitRef="shares">20310000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF85MA_04101c1d-7192-41b3-8226-e0886b73f319"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF85MA_2816bb7a-0bba-4601-8a76-4f08349978fc"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF85MA_7155058c-d479-44e7-9d0b-04844683cf54"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo1ZTI5YWE3ZTU1MTY0M2Q4ODYyYmFjNzYwNTBmODg4OF85MA_9915f4c4-408c-4bd0-a718-90a922defc2f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtMi0xLTEtNDc1NzU_7e0fb213-3255-4289-b88f-b3c5ca68bcba"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzMtNC0xLTEtNDc1NzU_43fb70dc-0265-4a6f-8e86-460bae179c14"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM18xOA_20c24342-9276-423f-8922-e2a7de16cb2b"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM18xOA_c23f3dd3-f2c0-4d8d-9ca9-4b151474ed16"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM181Mg_096f4fc0-e7f4-4a2d-a5b0-c82e0e822292"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM181Mg_f1ba5fab-e6fe-49db-9ee7-d8b15530429f"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM184OA_8150f5b8-dfaf-431b-b09d-b951db5dfbe4"
      unitRef="shares">89935287</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM184OA_ebe3b284-7003-4773-97f5-f8fa2465f7f8"
      unitRef="shares">89935287</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM185NQ_b8d888c8-094f-4990-aa22-d185845035f5"
      unitRef="shares">89332557</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMC0xLTEtNDc1NzUvdGV4dHJlZ2lvbjo3Y2IyM2FjNmNjNmU0YTJmOTFkM2Y2OTRlMjdlMzhlM185NQ_c3b506bf-c184-480e-bb36-73360da90760"
      unitRef="shares">89332557</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtMi0xLTEtNDc1NzU_eb5c7251-b7a8-4903-b162-85c792bf046b"
      unitRef="usd">900000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzQtNC0xLTEtNDc1NzU_cbf507b9-6df6-4180-b0b2-73f62d568e7d"
      unitRef="usd">900000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzUtMi0xLTEtNDc1NzU_7689b7dd-792e-4aca-9218-febbdcaf8083"
      unitRef="usd">1618800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzUtNC0xLTEtNDc1NzU_31d1438d-1802-4ae5-a242-220def5c3a66"
      unitRef="usd">1622300000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzYtMi0xLTEtNDc1NzU_6c5d30f1-5e7e-4295-b3c8-b831bd178940"
      unitRef="usd">44300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzYtNC0xLTEtNDc1NzU_dbb5ac67-c496-441c-b96c-ea6fe03e767f"
      unitRef="usd">-31500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzctMi0xLTEtNDc1NzU_e87b63ef-2b92-4756-ab23-c2ed658cb223"
      unitRef="usd">-508900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzctNC0xLTEtNDc1NzU_fa418730-32a8-4c29-bfc5-2e0426a20c72"
      unitRef="usd">-502700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzgtMi0xLTEtNDc1NzU_6422c03a-ff06-4358-8201-06aafc9652b0"
      unitRef="usd">1155100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzgtNC0xLTEtNDc1NzU_c4c6305d-2ab4-4b3d-b772-56229c6e513b"
      unitRef="usd">1089000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzktMi0xLTEtNDc1NzU_668ad73c-db37-4a00-ada8-8c3086140346"
      unitRef="usd">885400000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfMzktNC0xLTEtNDc1NzU_5c4dcffe-ffd2-4e56-8ba6-07f43a4a1959"
      unitRef="usd">880600000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNDAtMi0xLTEtNDc1NzU_03aa9809-51b1-4e26-9fdc-e0415c4a1620"
      unitRef="usd">2040500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNDAtNC0xLTEtNDc1NzU_5da6c312-e01d-4468-9e42-61f3957e52c6"
      unitRef="usd">1969600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNDEtMi0xLTEtNDc1NzU_dea239c6-21b4-4dc9-83b2-27f068c067da"
      unitRef="usd">6291600000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xMy9mcmFnOjkxZGRhMDVlZTZhMTQxN2I4YjhjMWI2MWQxZWMwYWNmL3RhYmxlOjA1NjZlMmQ1ZTk1NDQxYmFiOThmNTg4MThmYTMwODdjL3RhYmxlcmFuZ2U6MDU2NmUyZDVlOTU0NDFiYWI5OGY1ODgxOGZhMzA4N2NfNDEtNC0xLTEtNDc1NzU_e3724944-ae30-47cd-8bd4-b8913c4e1f35"
      unitRef="usd">6117600000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMy0yLTEtMS00NzU3NQ_36ffc073-befa-4bc0-be79-1400f7d1977f"
      unitRef="usd">615400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMy00LTEtMS00NzU3NQ_a162fb08-8e05-4bde-9556-184ab87ed50c"
      unitRef="usd">543300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMy02LTEtMS00ODg3NQ_c7aa05ab-9535-42e4-a99f-e15cd4612617"
      unitRef="usd">1211600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMy04LTEtMS00ODg4MQ_9acb4a42-b97a-4f71-a6a1-58839997b26d"
      unitRef="usd">1055700000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:LaborAndRelatedExpense
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNS0yLTEtMS00NzU3NQ_c047af7f-7913-4ae6-aa6e-367023b55aa8"
      unitRef="usd">181900000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNS00LTEtMS00NzU3NQ_b3871825-81e9-4669-a7b3-fe8dafbf93b7"
      unitRef="usd">155300000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNS02LTEtMS00ODg4Nw_e246de21-d188-4e43-bb31-3a6c9d4e91d7"
      unitRef="usd">360800000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNS04LTEtMS00ODg5Mw_c3d62f02-08f3-4123-86fb-79a866d97447"
      unitRef="usd">307000000.0</us-gaap:LaborAndRelatedExpense>
    <us-gaap:SuppliesExpense
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNi0yLTEtMS00NzU3NQ_9965df8a-7069-4881-9687-8722380e7e21"
      unitRef="usd">173500000</us-gaap:SuppliesExpense>
    <us-gaap:SuppliesExpense
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNi00LTEtMS00NzU3NQ_9991abcb-977c-4ec6-94cc-bd1c400ac3a7"
      unitRef="usd">157500000</us-gaap:SuppliesExpense>
    <us-gaap:SuppliesExpense
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNi02LTEtMS00ODg4Nw_3ac85c93-5942-4f37-82bb-3924c6dab0fc"
      unitRef="usd">345100000</us-gaap:SuppliesExpense>
    <us-gaap:SuppliesExpense
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNi04LTEtMS00ODg5Mw_b096fd3a-f3e6-45bc-b97a-a1a23ca2ee91"
      unitRef="usd">304800000</us-gaap:SuppliesExpense>
    <us-gaap:ProfessionalFees
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNy0yLTEtMS00NzU3NQ_101730ed-d771-4591-a937-95059230faa9"
      unitRef="usd">66700000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNy00LTEtMS00NzU3NQ_6a579b17-c0ae-4c9b-819a-6a4543161382"
      unitRef="usd">57400000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNy02LTEtMS00ODg5OQ_1ec3e0d3-22e0-46e9-b420-87267d9ba1d0"
      unitRef="usd">130300000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfNy04LTEtMS00ODkwNQ_2ede2de6-3e5d-4eb1-8efc-fb5647f24319"
      unitRef="usd">112900000</us-gaap:ProfessionalFees>
    <sgry:OperatingAndFinanceLeaseExpense
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOC0yLTEtMS00NzU3NQ_0622eff5-3243-4686-bd2b-7dbb935ee8ec"
      unitRef="usd">20200000</sgry:OperatingAndFinanceLeaseExpense>
    <sgry:OperatingAndFinanceLeaseExpense
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOC00LTEtMS00NzU3NQ_1bfbbb02-4b3f-455b-938e-c842868c35b1"
      unitRef="usd">22600000</sgry:OperatingAndFinanceLeaseExpense>
    <sgry:OperatingAndFinanceLeaseExpense
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOC02LTEtMS00ODg5OQ_4d949ec7-9014-4971-a6a8-3ad9c012e7ed"
      unitRef="usd">40200000</sgry:OperatingAndFinanceLeaseExpense>
    <sgry:OperatingAndFinanceLeaseExpense
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOC04LTEtMS00ODkwNQ_5f9bf827-268d-41c9-aae6-12d61f8ae09a"
      unitRef="usd">45400000</sgry:OperatingAndFinanceLeaseExpense>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOS0yLTEtMS00NzU3NQ_f0a1951d-aa6e-4e6e-85e8-755db65a9cbf"
      unitRef="usd">38500000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOS00LTEtMS00NzU3NQ_c3e9903a-6967-4906-b1ad-844590728457"
      unitRef="usd">32200000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOS02LTEtMS00ODg5OQ_2f8d3bfd-99da-4dff-8317-1bb89e015e51"
      unitRef="usd">75800000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfOS04LTEtMS00ODkwNQ_bee0c081-8dbe-4e97-8ce7-1c7e73985dc1"
      unitRef="usd">63800000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTAtMi0xLTEtNDc1NzU_0f76b1ea-848c-434b-b91b-1e24be923bb2"
      unitRef="usd">480800000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTAtNC0xLTEtNDc1NzU_0da63860-1b49-4edf-9856-5f9466cb7df9"
      unitRef="usd">425000000.0</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTAtNi0xLTEtNDg5MTE_e5fc877c-3e9b-4c28-8b3b-0b00ef8f352a"
      unitRef="usd">952200000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTAtOC0xLTEtNDg5MTc_d832a01f-0aa1-498d-87f3-f676fb33dff0"
      unitRef="usd">833900000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTEtMi0xLTEtNDc1NzU_cbd63f0f-96b1-45c9-8906-b1d3f8557d86"
      unitRef="usd">26100000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTEtNC0xLTEtNDc1NzU_e25d2d50-431d-47a6-8c52-a9db1ea204e4"
      unitRef="usd">24500000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTEtNi0xLTEtNDg5MjM_c7639a83-5912-4b85-9ba8-5b85f59ca9ae"
      unitRef="usd">55600000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTEtOC0xLTEtNDg5MzU_e73a19ea-78c4-4226-ab88-b2765a3a6ada"
      unitRef="usd">51300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTItMi0xLTEtNDc1NzU_77059c8c-d8a9-4d53-833f-830f832e370f"
      unitRef="usd">28000000.0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTItNC0xLTEtNDc1NzU_00c73ad5-6396-4554-aff9-4d260f85f08b"
      unitRef="usd">25200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTItNi0xLTEtNDg5MjM_0c320aa2-58d0-49e0-bde9-5ca3807de763"
      unitRef="usd">55400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTItOC0xLTEtNDg5MzU_4ddc79da-4a1e-4943-b9ee-14cb1bcf7380"
      unitRef="usd">50900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTMtMi0xLTEtNDc1NzU_fdd1c9d2-0ca9-4096-8904-96aa4b5b2285"
      unitRef="usd">8200000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTMtNC0xLTEtNDc1NzU_932cbbae-bdb9-4e17-88d9-ee4f49a2da39"
      unitRef="usd">9200000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTMtNi0xLTEtNDg5Mjk_4e226d81-cb1d-434f-96cc-17cdbbd73f34"
      unitRef="usd">15300000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTMtOC0xLTEtNDg5NDE_30e102ba-096f-4e55-af85-c28b6dbfac2d"
      unitRef="usd">14500000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <sgry:GrantRevenue
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTQtMi0xLTEtNDc1NzU_ea8296ab-fff5-4e28-877a-cc85c471b5eb"
      unitRef="usd">100000</sgry:GrantRevenue>
    <sgry:GrantRevenue
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTQtNC0xLTEtNDc1NzU_ce69786e-1f58-4b2a-a007-5472540419a2"
      unitRef="usd">4900000</sgry:GrantRevenue>
    <sgry:GrantRevenue
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTQtNi0xLTEtNDg5Mjk_8ea8632d-7ca9-43df-a56a-9037ef51ccc3"
      unitRef="usd">1300000</sgry:GrantRevenue>
    <sgry:GrantRevenue
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTQtOC0xLTEtNDg5NDE_70695da7-3b29-49d4-a9ce-c5735be9aac0"
      unitRef="usd">20000000.0</sgry:GrantRevenue>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTUtMi0xLTEtNDc1NzU_1a41e639-7a01-4e00-963a-5ad61e463e6b"
      unitRef="usd">-1100000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTUtNC0xLTEtNDc1NzU_b9fa0b91-b3a4-49cc-8b9d-74fa246f364c"
      unitRef="usd">-1000000.0</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTUtNi0xLTEtNDg5NDc_72d6429c-083c-49fa-908d-070b6f39e034"
      unitRef="usd">-1000000.0</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTUtOC0xLTEtNDg5NTM_17adca24-65e0-4817-a8fb-575d743934aa"
      unitRef="usd">-100000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTYtMi0xLTEtNDc1NzU_202e97f3-bcb5-4688-96da-95118aa280c3"
      unitRef="usd">2600000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTYtNC0xLTEtNDc1NzU_9daf215b-003e-40a7-a36c-2317903d8cb3"
      unitRef="usd">3000000.0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTYtNi0xLTEtNDg5NTk_2718bf31-720f-4f36-8a9a-11a19fa96dff"
      unitRef="usd">5700000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTYtOC0xLTEtNDg5NjU_52bc8eb1-01d0-42c8-8fe7-edac71e098a8"
      unitRef="usd">5600000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTctMi0xLTEtNDc1NzU_8f4fac89-4f3e-459e-9a40-eef6542a6ed0"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTctNC0xLTEtNDc1NzU_509bf41d-7f0f-4a20-8029-5ef2fa521d27"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTctNi0xLTEtNDg5NzE_98c0296f-61e3-43fa-bc52-7159bc25f265"
      unitRef="usd">32800000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTctOC0xLTEtNDg5Nzc_dae1927c-40a8-463e-8665-dbbd5adfafbc"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktMi0xLTEtNTY1MjQ_2e0a9a2d-5a48-4328-97f1-574d353f4628"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktNC0xLTEtNTY1MjQ_2ed6f009-4367-4d02-8b5c-d72f8890e078"
      unitRef="usd">-9600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktNi0xLTEtNTY1MjQ_74c2f3fd-7d15-496d-ab71-ba55b140df61"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktOC0xLTEtNTY1MjQ_4effe248-7ddb-4fd6-a041-18bd312221fe"
      unitRef="usd">-9600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTgtMi0xLTEtNDc1NzU_c6ee1b06-7d7f-4d87-9c4c-c7b200f7a5af"
      unitRef="usd">-2600000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTgtNC0xLTEtNDc1NzU_95c2fbe3-fe2b-4aa9-b87f-513ebe29cfe0"
      unitRef="usd">-2800000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTgtNi0xLTEtNDg5ODc_f991091c-b97e-40b1-8b1b-eafbbae8e070"
      unitRef="usd">-5000000.0</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OtherNonrecurringIncomeExpense
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTgtOC0xLTEtNDg5OTM_16673ae4-84a4-4396-9da2-b20564fc04af"
      unitRef="usd">-2800000</us-gaap:OtherNonrecurringIncomeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktMi0xLTEtNDc1NzU_4210b52b-f75a-4398-b6d0-d9290668c4b6"
      unitRef="usd">538900000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMTktNC0xLTEtNDc1NzU_0688724c-0845-4ae0-a52c-8c52dbaca598"
      unitRef="usd">483800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjAtNi0xLTEtNDkwMjY_c6609cb9-ad09-4c5b-b598-6454f03c7f79"
      unitRef="usd">1034700000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjAtOC0xLTEtNDkwMzI_a944bf86-28b6-4730-8603-35597edd799c"
      unitRef="usd">931900000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjAtMi0xLTEtNDc1NzU_717f077d-1921-4659-87c7-c10651cc20a1"
      unitRef="usd">76500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjAtNC0xLTEtNDc1NzU_2bc85921-9697-436d-8925-a07486f890d4"
      unitRef="usd">59500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjEtNi0xLTEtNDkwMzg_560740b9-6062-425a-a1a1-e44cb801a22e"
      unitRef="usd">176900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjEtOC0xLTEtNDkwNDQ_72ed73b8-1346-45ff-a9eb-0c3a7c6e40eb"
      unitRef="usd">123800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjEtMi0xLTEtNDc1NzU_268f04a7-0101-4383-8514-4cd1add57cfd"
      unitRef="usd">-56900000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjEtNC0xLTEtNDc1NzU_12b8cd5a-eef4-4ec1-a4d4-e56afd94a864"
      unitRef="usd">-53400000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjItNi0xLTEtNDkwNTA_9fe969ae-7f9e-4d78-aab8-369c97076e06"
      unitRef="usd">-113200000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjItOC0xLTEtNDkwNDQ_494f77db-9586-4602-9b5c-475fa595ee40"
      unitRef="usd">-106700000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjItMi0xLTEtNDc1NzU_eb518ee5-5cf9-4eda-ba20-c5f9dcfbdffb"
      unitRef="usd">19600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjItNC0xLTEtNDc1NzU_e1a29b0e-8fc0-4b91-a3fc-a3835b70d2c5"
      unitRef="usd">6100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjMtNi0xLTEtNDkwNzA_191fba7e-f82f-463a-99f1-bb5d025bd720"
      unitRef="usd">63700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjMtOC0xLTEtNDkwNzY_a2420d25-e2eb-4d13-a49a-ce42f96dc806"
      unitRef="usd">17100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjMtMi0xLTEtNDc1NzU_53e579cd-bd32-491c-bc77-0ef33d72c61d"
      unitRef="usd">4300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjMtNC0xLTEtNDc1NzU_46767bcb-abb9-4d87-8723-81310177ae7d"
      unitRef="usd">-2700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjQtNi0xLTEtNDkwNzA_de176373-e1f4-4039-add3-5acc8975e127"
      unitRef="usd">5600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjQtOC0xLTEtNDkwNzY_244b2029-fc4a-41eb-92e4-df5c2ff46591"
      unitRef="usd">-2500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjQtMi0xLTEtNDc1NzU_0d70ecf1-6e85-48d4-b069-d9855d4c249f"
      unitRef="usd">15300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjQtNC0xLTEtNDc1NzU_24fc75e7-4937-4736-8abb-60b38f3c7bdc"
      unitRef="usd">8800000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjUtNi0xLTEtNDkwODI_a36ccc60-685c-4eee-bc5a-844558ccab57"
      unitRef="usd">58100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjUtOC0xLTEtNDkwODg_47921fa8-74aa-4c92-8263-746c3f1a270f"
      unitRef="usd">19600000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjUtMi0xLTEtNDc1NzU_32baac21-9e9f-4922-addd-c8783bf1f88e"
      unitRef="usd">33700000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjUtNC0xLTEtNDc1NzU_3c031672-2a57-4918-a6d8-6ea52ff5e188"
      unitRef="usd">35700000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjYtNi0xLTEtNDkwODI_f7fc4768-b3d8-4ac3-bd0b-fa333b89cbec"
      unitRef="usd">64300000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjYtOC0xLTEtNDkwODg_1caa5ecc-6d9e-442e-9e9f-94ac12aa11a9"
      unitRef="usd">67500000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjYtMi0xLTEtNDc1NzU_9ea82799-d83e-48a9-86b0-77b28091e9b7"
      unitRef="usd">-18400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjYtNC0xLTEtNDc1NzU_18f87ff7-b16a-4d20-83c5-74a690327976"
      unitRef="usd">-26900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjctNi0xLTEtNDkwOTQ_646e7645-1df1-4737-b7f4-78963bd30a23"
      unitRef="usd">-6200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjctOC0xLTEtNDkxMDA_e5b493b8-d4aa-4f60-9e30-b2a1b322a926"
      unitRef="usd">-47900000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjctMi0xLTEtNDc1NzU_6964aceb-3eb3-45a7-abb0-f13c05e2c52c"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjctNC0xLTEtNDc1NzU_cbc40d80-a459-4c4e-bfc7-48094f641918"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjgtNi0xLTEtNDkwOTQ_7812fb5b-eccf-428c-b1f1-df98fa6b487d"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjgtOC0xLTEtNDkxMDA_e803d8f5-606f-49c9-b2f1-7f5a133f269c"
      unitRef="usd">10300000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjgtMi0xLTEtNDc1NzU_240af1f4-b4ef-4503-98ae-768bfe22c777"
      unitRef="usd">-18400000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjgtNC0xLTEtNDc1NzU_b69a1566-5e1a-4c84-9453-f3e5a68e7387"
      unitRef="usd">-26900000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjktNi0xLTEtNDkwOTQ_f4936076-303a-4771-957e-78a216628721"
      unitRef="usd">-6200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMjktOC0xLTEtNDkxMDA_a3fae1a0-ab4a-4d38-8746-c93876e37b32"
      unitRef="usd">-58200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzEtMi0xLTEtNDc1NzU_3ba5df49-f9be-4164-844a-3354dde2ed12"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzEtNC0xLTEtNDc1NzU_677d11e6-97ab-4f0b-ac7e-71316d449561"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItNi0xLTEtNDkxMDY_9b215e4b-9d6f-4929-bf09-9af6817aa69a"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItOC0xLTEtNDkxMDY_331546c0-9650-455a-a910-e292d1fc7b31"
      unitRef="usdPerShare">-0.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItMi0xLTEtNDc1NzU_b3757ed0-08fd-40b2-951f-5f73ee2a0304"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItNC0xLTEtNDc1NzU_f904edcd-d3d3-46d3-8485-a04317ab494b"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtNi0xLTEtNDkxMTI_3d1fd00d-04c8-4fa9-adf0-0c1747f8024a"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtOC0xLTEtNDkxMTI_048b778b-e609-4871-8f57-fe0c400a9097"
      unitRef="usdPerShare">-0.94</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzQtMi0xLTEtNDc1NzU_466d934c-31eb-4a7d-b2d2-a37f034cfccc"
      unitRef="shares">88900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzQtNC0xLTEtNDc1NzU_d244d6ff-e1ff-4989-a71f-ab9e6824bf97"
      unitRef="shares">69267000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtNi0xLTEtNDkxMTg_44d9df24-efe3-4000-8ef9-82153e60d058"
      unitRef="shares">88450000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtOC0xLTEtNDkxMTg_df225ac6-d24c-47fa-8226-e45a767d7153"
      unitRef="shares">62060000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtMi0xLTEtNDc1NzU_b5f28d77-5d51-485c-afe8-76e4c5789bb4"
      unitRef="shares">88900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtNC0xLTEtNDc1NzU_e87db349-2d4b-4e41-9b9a-5ae3e02c4c6b"
      unitRef="shares">69267000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtNi0xLTEtNDkxMjQ_d21dc0c1-7abf-4dee-97b9-4bd96e607bae"
      unitRef="shares">88450000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtOC0xLTEtNDkxMjQ_eda99b14-a47d-4f19-bc1f-4fd63729cccd"
      unitRef="shares">62060000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfMy0yLTEtMS00NzU3NQ_0d70ecf1-6e85-48d4-b069-d9855d4c249f"
      unitRef="usd">15300000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfMy00LTEtMS00NzU3NQ_24fc75e7-4937-4736-8abb-60b38f3c7bdc"
      unitRef="usd">8800000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfMy02LTEtMS00OTE1Ng_a36ccc60-685c-4eee-bc5a-844558ccab57"
      unitRef="usd">58100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfMy04LTEtMS00OTE1OA_47921fa8-74aa-4c92-8263-746c3f1a270f"
      unitRef="usd">19600000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNS0yLTEtMS00NzU3NQ_1ace30ce-b144-489a-b79d-8fd6ac4c3b1a"
      unitRef="usd">19000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNS00LTEtMS00NzU3NQ_027e4c75-16db-42af-8021-73ebc076aa40"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNS02LTEtMS00OTE3OQ_963cf77d-934f-49d7-ba32-24af999f7816"
      unitRef="usd">75800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNS04LTEtMS01MTY5NA_d987bd64-4435-4449-b757-824a626c2543"
      unitRef="usd">6600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNi0yLTEtMS00NzU3NQ_3da02112-4d41-4bbf-9151-0907ee93e4ee"
      unitRef="usd">34300000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNi00LTEtMS00NzU3NQ_2f91bf5d-b92f-46dd-bf47-d3ca9560b658"
      unitRef="usd">9000000.0</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNi02LTEtMS01MTY5NA_f3c5382f-6136-4931-bc73-d7aa1b0a40e2"
      unitRef="usd">133900000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNi04LTEtMS01MTY5NA_d9bf69db-e488-4151-a387-58a753a67ef6"
      unitRef="usd">26200000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNy0yLTEtMS00NzU3NQ_88eced1c-d093-41ca-a288-5c53e8e61ac7"
      unitRef="usd">33700000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNy00LTEtMS00NzU3NQ_8a2100b0-ad6a-4230-8976-d885d1125a5e"
      unitRef="usd">35700000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNy02LTEtMS00OTE2OQ_fe868aa3-431c-4793-8238-707f5137bbd7"
      unitRef="usd">64300000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfNy04LTEtMS00OTE3NQ_0d6ef8fc-16c7-4f5e-886d-7e1b9f297cbb"
      unitRef="usd">67500000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfOC0yLTEtMS00NzU3NQ_83434c26-4f49-4ce4-9965-7f849ff8b940"
      unitRef="usd">600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfOC00LTEtMS00NzU3NQ_03ebe1ec-9a36-4619-becf-ae6f98ab20ba"
      unitRef="usd">-26700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfOC02LTEtMS01MTY5NA_ceda42a5-6492-40bb-8da1-f0011b82e122"
      unitRef="usd">69600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xOS9mcmFnOjJmNDQyMGJhMDc0YTRkZTZhNGEwMWYyYWExZTNmZmM2L3RhYmxlOmEwZDYzYTFkZjA3YTQ4OGI4M2ZkOGM5ODYwZWQwZmI3L3RhYmxlcmFuZ2U6YTBkNjNhMWRmMDdhNDg4YjgzZmQ4Yzk4NjBlZDBmYjdfOC04LTEtMS01MTY5NA_97cd92fd-c5b2-44ef-b2b7-7951c360229b"
      unitRef="usd">-41300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i65b4d531cb9b48cd894460f4e16463be_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy0xLTEtMS00NzU3NQ_d37385fc-be74-401c-b4c8-1cc85fa3d2ed"
      unitRef="shares">50462000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65b4d531cb9b48cd894460f4e16463be_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy0zLTEtMS00NzU3NQ_79a3de81-646f-4bad-9a74-c301c89190ba"
      unitRef="usd">500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i874b93f4f80843419c99212b693021ac_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy01LTEtMS00NzU3NQ_7fb587be-9993-4ed0-95af-571b53879870"
      unitRef="usd">607900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5a8ee0761a1d4c8c9f56f071d5e4f410_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy03LTEtMS00NzU3NQ_4ef777dd-6b55-4e77-afe5-dfcef38908d8"
      unitRef="usd">-61000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if5321f94b5324566bedb956ae6c2fb92_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy05LTEtMS00NzU3NQ_e4a40ee0-9927-4592-ae73-cee883ed04de"
      unitRef="usd">-431800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie15ac736956f49c883e02995bab6b9aa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy0xMS0xLTEtNDc1NzU_dafdce8a-c42c-45d2-877e-586fd31d4082"
      unitRef="usd">766500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ce39eddcaef4480b057800dbc9fc415_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMy0xMy0xLTEtNDc1NzU_727d2f5c-4fcf-43f7-b320-671917f54077"
      unitRef="usd">882100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i44e20b461fac4de38f9910707892a5b3_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNC05LTEtMS00NzU3NQ_e0df32dc-6efa-4b4a-b201-dc9b0b61d99f"
      unitRef="usd">-21000000.0</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i727c848f12464ac9868395007955636a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNC0xMS0xLTEtNDc1NzU_6cd7634f-03ee-4ecc-92a0-e30170595fd9"
      unitRef="usd">21100000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNC0xMy0xLTEtNDc1NzU_8a4cc880-001b-4e6a-9edb-42b17cb1d825"
      unitRef="usd">100000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iddbc40dd884d4204a58cb11045457ae7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNS0xLTEtMS00NzU3NQ_fed3f3a6-91b7-464f-ae65-9bcbdee03996"
      unitRef="shares">812000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i70c54c1f4edd4426a5c3c25dbe35d19a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNS01LTEtMS00NzU3NQ_60e6677b-9e27-400b-a67e-d7c46f769615"
      unitRef="usd">-2800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNS0xMy0xLTEtNDc1NzU_d0eea48d-784e-4c5a-9277-2e6d19815b1b"
      unitRef="usd">-2800000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i70c54c1f4edd4426a5c3c25dbe35d19a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNi01LTEtMS00NzU3NQ_a8de31f9-a0cf-43c1-a9f4-72bb706c4bed"
      unitRef="usd">10300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
      contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNi0xMy0xLTEtNDc1NzU_1ad34217-14d1-4a96-915f-aff2b1045088"
      unitRef="usd">10300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="iddbc40dd884d4204a58cb11045457ae7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNy0xLTEtMS00NzU3NQ_b33ab131-8c7a-49f9-a3e8-8a522e1eee02"
      unitRef="shares">8625000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iddbc40dd884d4204a58cb11045457ae7_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNy0zLTEtMS00NzU3NQ_f980fea9-b812-4014-8da4-dd8ee7762545"
      unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i70c54c1f4edd4426a5c3c25dbe35d19a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNy01LTEtMS00NzU3NQ_3f6d8c5e-e886-4b0e-809d-cda8f26a9f5d"
      unitRef="usd">248200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfNy0xMy0xLTEtNDc1NzU_697274d5-7b01-47f8-b16a-69aa7012d244"
      unitRef="usd">248300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ic945102fb54c4d69855b08862add35a9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfOC03LTEtMS00NzU3NQ_cc28db61-ee82-4187-9e9f-bb90a2bd7ada"
      unitRef="usd">6400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfOC0xMy0xLTEtNDc1NzU_c3742412-44d0-4c88-ad97-765c4bcd1e09"
      unitRef="usd">6400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i70c54c1f4edd4426a5c3c25dbe35d19a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfOS01LTEtMS00NzU3NQ_c08cd2d2-ae91-42d4-96bc-acf98c3fde5b"
      unitRef="usd">300000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i727c848f12464ac9868395007955636a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfOS0xMS0xLTEtNDc1NzU_8f5b4879-b3d4-4501-9257-691803f41b5c"
      unitRef="usd">2000000.0</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfOS0xMy0xLTEtNDc1NzU_6c49cc8d-1bc9-4dcd-92cf-11591b922e00"
      unitRef="usd">2300000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i727c848f12464ac9868395007955636a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTAtMTEtMS0xLTQ3NTc1_fd324582-b15e-4114-92e6-b15f517c840a"
      unitRef="usd">20800000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTAtMTMtMS0xLTQ3NTc1_1c24ce57-a79d-4b89-b923-b3f9efbce79f"
      unitRef="usd">20800000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i70a9d633a0ba4f6b8deb6abf6e42e588_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtMS0xLTEtNDc1NzU_89f72166-3517-4d2c-acdd-f0a9c5a33e1f"
      unitRef="shares">59899000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70a9d633a0ba4f6b8deb6abf6e42e588_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtMy0xLTEtNDc1NzU_75a97df0-e442-4ca1-937c-7f7fa690db73"
      unitRef="usd">600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0bbcf15e953044c9bb4256698275b17c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtNS0xLTEtNDc1NzU_658ff105-e3e7-472d-951c-f22df1869433"
      unitRef="usd">843300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a2a308f404d4462a20f521a6049c6e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtNy0xLTEtNDc1NzU_fe5e90a1-8ba8-4ba1-bf75-aa5419c67d8e"
      unitRef="usd">-54600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia9f9d0d0f7404a6fb2b9f70e9127679b_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtOS0xLTEtNDc1NzU_9618cf1e-9866-471f-85b1-833833cc3425"
      unitRef="usd">-452800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8cc82a550101490d9ba4c262f7e759a9_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtMTEtMS0xLTQ3NTc1_5d556cf5-270c-4ed4-91d9-b32380bc8f7b"
      unitRef="usd">768800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa9e74d27950455e8f7ebd062dccc167_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTEtMTMtMS0xLTQ3NTc1_fade6bea-9d79-4753-ab39-ea8dc37ed86a"
      unitRef="usd">1105300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i7600816d839d42ceb914df213ec157f6_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTItOS0xLTEtNDgwOTE_8c8b30c0-cf49-4185-a2e9-441ca0ef7aa8"
      unitRef="usd">-26900000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ic9b0391f35644b1d9d20974a5c75b7a8_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTItMTEtMS0xLTQ4MDk3_f60c5db0-aaee-427e-9dfe-c5f754523c31"
      unitRef="usd">22000000.0</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTItMTMtMS0xLTUxNjk4_ac7730dd-0072-4577-ab61-bba0163d243a"
      unitRef="usd">-4900000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i20255b89339547c0a3a555a0aa07dc59_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTMtMS0xLTEtNDgwNjI_03539aca-d336-48b0-8b68-959728b5a1c5"
      unitRef="shares">-29000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic2627c134a054c6c8194c8cf5b5c40e3_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTMtNS0xLTEtNDgwNzk_ea60e474-81aa-4385-bd9a-48167ef66652"
      unitRef="usd">3700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTMtMTMtMS0xLTUxNjk4_eb7d3995-10b3-4216-80c5-f1d806e131f6"
      unitRef="usd">3700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i20255b89339547c0a3a555a0aa07dc59_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTQtMS0xLTEtNDgwNjI_9aadcd69-4a5d-467b-848b-0a99c8911203"
      unitRef="shares">22609000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i20255b89339547c0a3a555a0aa07dc59_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTQtMy0xLTEtNDgwNjg_d310c367-b563-4554-a2d5-5459af7c3e26"
      unitRef="usd">200000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ic2627c134a054c6c8194c8cf5b5c40e3_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTQtNS0xLTEtNDgwNzk_e530b8d5-614b-4e3b-9c95-8a9280f4f006"
      unitRef="usd">439500000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTQtMTMtMS0xLTUxNjk4_6347635c-e061-460f-95d0-7257c5751165"
      unitRef="usd">439700000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i520879363a004c03b48b9aa26d49ec3b_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTUtNy0xLTEtNDgwODU_d7cdedde-29b8-47b5-b63e-32006f293ca5"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTUtMTMtMS0xLTUxNjk4_b1179653-b065-4fd6-8e15-6e1d0e94b0af"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="ic2627c134a054c6c8194c8cf5b5c40e3_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTYtNS0xLTEtNDgwNzk_baf2f335-73b9-4fec-9bc5-ca45d17c2773"
      unitRef="usd">11900000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="ic9b0391f35644b1d9d20974a5c75b7a8_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTYtMTEtMS0xLTQ4MDk3_b351def2-c57d-4c50-b78e-0edacb8b751d"
      unitRef="usd">-6300000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTYtMTMtMS0xLTUxNjk4_1550697b-a1e2-46d0-a6e4-020821c292be"
      unitRef="usd">5600000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic9b0391f35644b1d9d20974a5c75b7a8_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTctMTEtMS0xLTQ4MDk3_cf2a3c96-0660-4991-8693-47f239c812ac"
      unitRef="usd">22300000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTctMTMtMS0xLTUxNjk4_9fa9d39b-2205-4312-ba6b-a32dc2dd7a26"
      unitRef="usd">22300000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i86d62a7c424e47d19d145f6ebf771221_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtMS0xLTEtNTE2OTg_516058c1-1104-4290-8e5c-db3c31111da4"
      unitRef="shares">82479000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i86d62a7c424e47d19d145f6ebf771221_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtMy0xLTEtNTE2OTg_f08c7980-5c09-4d0a-99f2-615c5509dcb1"
      unitRef="usd">800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64a8818a24674f2faae8cfbfd2edb750_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtNS0xLTEtNTE2OTg_4b0cb101-c320-4446-9af5-f9aa183a491a"
      unitRef="usd">1298400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0cb6e6c59764f929e1812a53232bc2f_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtNy0xLTEtNTE2OTg_b846feb1-506b-4753-a718-dc38435dd3e7"
      unitRef="usd">-54400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i75ea718f255443ed9371e7d4a9085825_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtOS0xLTEtNTE2OTg_e5e66489-a903-4e82-9b20-53bbcea902c6"
      unitRef="usd">-479700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie4482a6ba65743ca8c0b52945eadf553_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtMTEtMS0xLTUxNjk4_88b7d6ff-8547-4c0c-bb7a-470ac04f99b7"
      unitRef="usd">762200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i293881ff9efc4258a9030c4efeddff54_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOjk0YjhlNDEzMTM2ZDRjNWE4Y2I4ZDhmYzNlOWIwMmQwL3RhYmxlcmFuZ2U6OTRiOGU0MTMxMzZkNGM1YThjYjhkOGZjM2U5YjAyZDBfMTgtMTMtMS0xLTUxNjk4_7780ca5b-bda5-4534-8996-f184f194b27e"
      unitRef="usd">1527300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i95848062d06c4c1a9b5d0bb79f725a76_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC0xLTEtMS00NzU3NQ_93da62b1-a8f4-4447-9555-7d3371fcfcff"
      unitRef="shares">89333000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95848062d06c4c1a9b5d0bb79f725a76_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC0zLTEtMS00NzU3NQ_42aecc90-b720-443e-8cef-8adf25c875aa"
      unitRef="usd">900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd8e1125342f40899ab99713e4cf2a1d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC01LTEtMS00NzU3NQ_ff040f17-7f9c-4c19-b24e-045fbb30a90d"
      unitRef="usd">1622300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0d8a3b98e81649a1bd4caa715cb0da2e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC03LTEtMS00NzU3NQ_b2e8516e-30eb-4515-82e3-65628f334b6c"
      unitRef="usd">-31500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9eb703a1f5b144eebc1858b52f17e2f6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC05LTEtMS00NzU3NQ_f5db689f-27d3-4de2-b700-bcbe54c20c7e"
      unitRef="usd">-502700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id814edaeefa14859bd8a994f03809e5f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC0xMS0xLTEtNDc1NzU_a44f848a-0d2c-44db-8996-54d99c19e67c"
      unitRef="usd">880600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMC0xMy0xLTEtNDc1NzU_011bbabb-622c-4951-9242-875ac5d123b2"
      unitRef="usd">1969600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ibdb0efe93e7640ae8d172d601a4692d6_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMS05LTEtMS00NzU3NQ_94e9f07f-8dca-413a-8e7f-9bad9fa9b15c"
      unitRef="usd">12200000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ibb268f2da5f547d8a14d3c95c0580e06_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMS0xMS0xLTEtNDc1NzU_355cadc9-78ac-4799-83f6-966ea407ec28"
      unitRef="usd">20000000.0</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMS0xMy0xLTEtNDc1NzU_354666f3-18ad-4c9c-a26a-a79b49cfb166"
      unitRef="usd">32200000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i83f9cc0cf2f746de84d60298eb4a0c6f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMi0xLTEtMS00NzU3NQ_2731e1c7-1bcf-4b02-be0b-654388a9dd2b"
      unitRef="shares">572000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0d1e6d43a40d46928b3eb06e51ef68eb_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMi01LTEtMS00NzU3NQ_520836d9-522f-4a52-99cd-385654deefc5"
      unitRef="usd">7700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMi0xMy0xLTEtNDc1NzU_b0f4ee21-9254-422c-b5de-95aace630176"
      unitRef="usd">7700000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i7e600af0037644c58476a1a9eda6a026_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMy03LTEtMS00NzU3NQ_ac99b333-3937-4cd0-be3d-ebdbf20f1d6d"
      unitRef="usd">56800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMy0xMy0xLTEtNDc1NzU_467cdd39-3b18-4f4a-9163-5995810b4f26"
      unitRef="usd">56800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i0d1e6d43a40d46928b3eb06e51ef68eb_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNC01LTEtMS00NzU3NQ_2bb91e63-d905-471a-85e6-e988216d35a6"
      unitRef="usd">-4800000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="ibb268f2da5f547d8a14d3c95c0580e06_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNC0xMS0xLTEtNDc1NzU_345cd0c9-b4ff-4f84-9aa2-40690a4eee29"
      unitRef="usd">-24300000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNC0xMy0xLTEtNDc1NzU_11d860c1-cd7c-4faf-836a-e04a0f00b815"
      unitRef="usd">-29100000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ibb268f2da5f547d8a14d3c95c0580e06_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNS0xMS0xLTEtNDc1NzU_3ca9ef05-c796-42b1-874a-4bf5a5e49ef7"
      unitRef="usd">24600000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if6c857275bb247d39e63f2c47e6e906c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNS0xMy0xLTEtNDc1NzU_c47ec79c-2f55-4810-b5fc-a887044f07f6"
      unitRef="usd">24600000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1ceadb6d58d648b589f0df8a7a6b998a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi0xLTEtMS00NzU3NQ_0365b913-32a9-4d99-8786-0b6cfc87298a"
      unitRef="shares">89905000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ceadb6d58d648b589f0df8a7a6b998a_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi0zLTEtMS00NzU3NQ_b34d891d-0102-42e4-b747-96564be9ef0c"
      unitRef="usd">900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2ad66b78a6b64609ac23769c262610e5_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi01LTEtMS00NzU3NQ_27c5f4f7-24cb-4f8b-bcb2-fa9a21356a79"
      unitRef="usd">1625200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92460d1af80c4ff7b3a654fd318e31a3_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi03LTEtMS00NzU3NQ_f852de51-1aa9-4ebb-9f6e-de77fe763de2"
      unitRef="usd">25300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iffdcc560f54a4d43ada125b516d24346_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi05LTEtMS00NzU3NQ_0f54b68b-dea9-467e-8e06-cdc48c72f4c9"
      unitRef="usd">-490500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iafdeb370ccbb4184863d2f97c17b9079_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi0xMS0xLTEtNDc1NzU_a7b2badd-f61f-4cf4-b9bd-c0e26fdc58c0"
      unitRef="usd">851700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f3cf04cf3c64d81915962e56cdaae10_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNi0xMy0xLTEtNDc1NzU_f8c777cc-c4f8-4655-af40-5b9580c8e35d"
      unitRef="usd">2012600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ic07b7144afd5431eb46020ecbc41d2b5_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNy05LTEtMS00ODE2Nw_5db96a8e-12ce-4ec6-b6c7-d65a90508050"
      unitRef="usd">-18400000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="id7a924e0937d48aa9ee3d55bea4ef7c2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNy0xMS0xLTEtNDgxNzM_89b77fc5-e6f6-4a48-af39-90fd90797238"
      unitRef="usd">22700000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfNy0xMy0xLTEtNTE3MDk_1729e945-3f59-4c21-aa11-0c8f3a0dcb23"
      unitRef="usd">4300000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i39bd68b89c0941a289562ee539763064_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfOC0xLTEtMS00ODE0Mw_659be96b-1cfc-4c7a-a408-5bb3c85416a9"
      unitRef="shares">30000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i350bb6d8c988458096fa290f02419cc7_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfOC01LTEtMS00ODE1NQ_287feefb-84e0-4391-a361-96bc0bf90afd"
      unitRef="usd">4400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfOC0xMy0xLTEtNTE3MDk_583157ec-4d53-4d34-8a6f-83d3148a6e19"
      unitRef="usd">4400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ic14c278f188a4ea6be8e3287cf313398_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfOS03LTEtMS00ODE2MQ_62b5c62e-75d2-49f3-9071-a8c6beb43d8f"
      unitRef="usd">19000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfOS0xMy0xLTEtNTE3MDk_8a50ac78-660b-455f-afb3-681933cccec6"
      unitRef="usd">19000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i350bb6d8c988458096fa290f02419cc7_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTAtNS0xLTEtNDgxNTU_3554ed5f-461c-4236-bb51-e207170a8a03"
      unitRef="usd">-10800000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="id7a924e0937d48aa9ee3d55bea4ef7c2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTAtMTEtMS0xLTQ4MTcz_d855029b-583a-451d-935d-c19f4b14d7e6"
      unitRef="usd">38700000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTAtMTMtMS0xLTUxNzA5_5a8b2f0d-7010-4ed9-aedd-0bdf2e1b515a"
      unitRef="usd">27900000</sgry:NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="id7a924e0937d48aa9ee3d55bea4ef7c2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTEtMTEtMS0xLTQ4MTcz_44a0d9a5-0664-4a11-948f-ab5a5c3d9c56"
      unitRef="usd">27700000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTEtMTMtMS0xLTUxNzA5_a8c7b703-cbcc-4752-972f-de2c20345353"
      unitRef="usd">27700000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5d50b5caa3534d6f84e75102afd14fdb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItMS0xLTEtNTE3MDk_1d763c1e-049b-4c0e-8ea7-2204b0dd6fc5"
      unitRef="shares">89935000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5d50b5caa3534d6f84e75102afd14fdb_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItMy0xLTEtNTE3MDk_0ebf4849-27ff-4bcf-9cec-7628082f0995"
      unitRef="usd">900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7dae7f18f2f34d56b658f35f31fdd441_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItNS0xLTEtNTE3MDk_3be9ba50-6b09-43d8-ae9a-736b026e0fd8"
      unitRef="usd">1618800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaa2a718bde80444eb214d2eaf59e0b6c_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItNy0xLTEtNTE3MDk_b02d329e-389f-4638-92b9-490df723a5df"
      unitRef="usd">44300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4cdb2c56dc4745448c8e6a876c8890db_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItOS0xLTEtNTE3MDk_f6fb0a0d-201b-40fc-8deb-7315492c3c79"
      unitRef="usd">-508900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id4909f7c61db49b69aa8ecd11570d198_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItMTEtMS0xLTUxNzA5_7e6755e2-7333-41ce-80ef-c2c0a560fbbf"
      unitRef="usd">885400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yMi9mcmFnOjMyMzBhZWY1MGI1ODQxYTFhNjMxMjQ0ZTEyOGVhYzNjL3RhYmxlOmVmMTAyOWI5NzFkNTRjMTA5NDg1ODdmZWE1ODRhM2Y1L3RhYmxlcmFuZ2U6ZWYxMDI5Yjk3MWQ1NGMxMDk0ODU4N2ZlYTU4NGEzZjVfMTItMTMtMS0xLTUxNzA5_168a854e-4b8f-4c03-afe5-8705de7b9e3e"
      unitRef="usd">2040500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMy0yLTEtMS00NzU3NQ_a36ccc60-685c-4eee-bc5a-844558ccab57"
      unitRef="usd">58100000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMy00LTEtMS00NzU3NQ_47921fa8-74aa-4c92-8263-746c3f1a270f"
      unitRef="usd">19600000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNS0yLTEtMS00NzU3NQ_26e5220c-5171-4670-ac7b-c9af1fd71099"
      unitRef="usd">55400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNS00LTEtMS00NzU3NQ_3e74342b-ba59-4300-9d9b-b82d5458c111"
      unitRef="usd">50900000</us-gaap:DepreciationDepletionAndAmortization>
    <sgry:NoncashInterestIncomeExpenseNet
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNi0yLTEtMS00NzU3NQ_948b03de-6181-42b4-a982-02c310984f96"
      unitRef="usd">-12400000</sgry:NoncashInterestIncomeExpenseNet>
    <sgry:NoncashInterestIncomeExpenseNet
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNi00LTEtMS00NzU3NQ_5ade9f20-0bd9-404f-8cce-b9b99626776f"
      unitRef="usd">-5700000</sgry:NoncashInterestIncomeExpenseNet>
    <us-gaap:ShareBasedCompensation
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNy0yLTEtMS00NzU3NQ_42adf000-a90d-4718-b569-f9d824d4abb1"
      unitRef="usd">8000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfNy00LTEtMS00NzU3NQ_edf5093a-e7f3-4069-9160-cb90f1cda8e0"
      unitRef="usd">9300000</us-gaap:ShareBasedCompensation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOC0yLTEtMS00NzU3NQ_f87055fb-f48b-4e02-8542-1806d27bf216"
      unitRef="usd">-1000000.0</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOC00LTEtMS00NzU3NQ_31548b3e-b334-482c-bb86-7e6ef022a3a4"
      unitRef="usd">-100000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOS0yLTEtMS00OTIyMg_16d21293-46f6-48ee-a9c4-4e101a4605fb"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOS00LTEtMS00OTIyMg_b44dd9fd-c5dc-43c3-aec7-97db74eef147"
      unitRef="usd">-9600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOS0yLTEtMS00NzU3NQ_7489fb44-4cfa-4c53-8593-6bf2372f187d"
      unitRef="usd">4900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfOS00LTEtMS00NzU3NQ_368895b2-afab-4e63-8d13-2f4f62be5ca0"
      unitRef="usd">-3200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTAtMi0xLTEtNDc1NzU_5c5ef3a9-ce04-4179-956f-d151b91616a8"
      unitRef="usd">400000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTAtNC0xLTEtNDc1NzU_1d1f9d3d-0515-48f5-9e93-9389044556bb"
      unitRef="usd">400000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:OperatingLeaseExpense
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTEtMi0xLTEtNDc1NzU_f22d21c9-ecf6-4886-812a-f560de84c278"
      unitRef="usd">17100000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTEtNC0xLTEtNDc1NzU_7785a3a3-ec00-41fd-9f38-bf738e797d8a"
      unitRef="usd">20000000.0</us-gaap:OperatingLeaseExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTMtMi0xLTEtNDc1NzU_039789e4-b875-47dd-9bf9-c01fc541c5df"
      unitRef="usd">-5400000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTMtNC0xLTEtNDc1NzU_c3638435-ba46-4d32-84be-8eb12c90fc36"
      unitRef="usd">3100000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTQtMi0xLTEtNDc1NzU_2fa4eef3-65e7-41f9-8eea-51d27b99fa74"
      unitRef="usd">-40200000</sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants>
    <sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTQtNC0xLTEtNDc1NzU_7d2d339e-22e3-40e6-b34b-c822bbc3bd1d"
      unitRef="usd">-28800000</sgry:IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants>
    <sgry:IncreaseDecreaseInSettlementPayments
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTYtMi0xLTEtNDkyMjg_2d765b2d-f411-4da5-ba4c-ee0e16e20bbd"
      unitRef="usd">0</sgry:IncreaseDecreaseInSettlementPayments>
    <sgry:IncreaseDecreaseInSettlementPayments
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTYtNC0xLTEtNDkyMjg_fc04a61e-1570-48ba-a30f-8677b7d87f1d"
      unitRef="usd">32200000</sgry:IncreaseDecreaseInSettlementPayments>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTUtMi0xLTEtNDc1NzU_ebafd9c6-1f45-49c4-93e6-5bbb5c9d0e59"
      unitRef="usd">-200000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTUtNC0xLTEtNDc1NzU_d3757094-f936-4bc4-b686-1a9dac17e099"
      unitRef="usd">-5000000.0</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTYtMi0xLTEtNDc1NzU_c65c684d-2a7c-4321-8745-f36324936897"
      unitRef="usd">121900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTYtNC0xLTEtNDc1NzU_6158e6c2-9530-4627-a8b2-9d8cf8198804"
      unitRef="usd">52500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTktMi0xLTEtNDc1NzU_507773bd-42ec-424c-a655-1e35f71064a0"
      unitRef="usd">40600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMTktNC0xLTEtNDc1NzU_ed3925b1-2965-4951-857b-22af7df8d757"
      unitRef="usd">28000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjAtMi0xLTEtNDc1NzU_a98334d8-91d6-4fc5-9d53-0fee26465934"
      unitRef="usd">74900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjAtNC0xLTEtNDc1NzU_0163526a-98e1-4276-bae2-a201c92297b7"
      unitRef="usd">15200000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjEtMi0xLTEtNDc1NzU_e0e1a4ba-e7a0-44a8-a33f-587087b8b900"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjEtNC0xLTEtNDc1NzU_8e68f4fb-279f-4e71-ae09-6db944e12ef1"
      unitRef="usd">2500000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjQtMi0xLTEtNTQwNzE_ea101c15-c4de-4cbc-b882-8d3c3d980e79"
      unitRef="usd">65800000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjQtNC0xLTEtNTQwNzE_a9e466e7-a3b6-4fe5-92de-c2b5665c84d8"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjItMi0xLTEtNDc1NzU_3063d692-581d-400f-8f73-544202de0f5d"
      unitRef="usd">11500000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjItNC0xLTEtNDc1NzU_8d266e10-4cc4-48ae-891c-56cd99b4d821"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjMtMi0xLTEtNDc1NzU_44437c65-ae2f-41c8-ab1d-0f6df0fb4bc1"
      unitRef="usd">11600000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjMtNC0xLTEtNDc1NzU_b20a3e3f-c078-4745-8bfd-06b562cfcbaf"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjQtMi0xLTEtNDc1NzU_ad5e33b7-9552-4a1b-b822-3245aa0af781"
      unitRef="usd">-181400000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjQtNC0xLTEtNDc1NzU_7b98ee1c-04c3-4cad-bfe9-9b03eeff382c"
      unitRef="usd">-40700000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjctMi0xLTEtNDc1NzU_81ebcdf7-5144-4c10-94ff-6f158a373c17"
      unitRef="usd">33300000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjctNC0xLTEtNDc1NzU_d766bc58-8948-4792-a041-83b3dba16113"
      unitRef="usd">309400000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjgtMi0xLTEtNDc1NzU_c0bf6231-819d-4e48-ae0a-f703f4b3c629"
      unitRef="usd">12400000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjgtNC0xLTEtNDc1NzU_cf92fc42-0373-4625-8a27-769aa5c94c95"
      unitRef="usd">283100000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjktMi0xLTEtNDc1NzU_43dc86e0-74b5-4480-9c55-66ec11f8e75b"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMjktNC0xLTEtNDc1NzU_69682002-0f83-467b-a7a3-b03d6af83a22"
      unitRef="usd">8700000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <sgry:DebtInstrumentPrepaymentPenaltyAmount
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzItMi0xLTEtNDkyNDQ_5cc8ed32-d636-42df-81de-1fc8c54e8489"
      unitRef="usd">0</sgry:DebtInstrumentPrepaymentPenaltyAmount>
    <sgry:DebtInstrumentPrepaymentPenaltyAmount
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzItNC0xLTEtNDkyMzc_90b155f5-d863-4bcc-8b2c-5b95739999ad"
      unitRef="usd">2400000</sgry:DebtInstrumentPrepaymentPenaltyAmount>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzAtMi0xLTEtNDc1NzU_3fae6217-b28b-4457-9feb-1887b243c6b5"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzAtNC0xLTEtNDc1NzU_f5eca210-6772-4aef-b938-4e0272fbca78"
      unitRef="usd">260900000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzEtMi0xLTEtNDc1NzU_5ab2ee7d-3cbc-4e6e-9262-163e80aac1a5"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzEtNC0xLTEtNDc1NzU_8f117843-1d47-45d8-8204-a9c53d7ec5f9"
      unitRef="usd">12700000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzItMi0xLTEtNDc1NzU_9b9dc6b8-f60f-4db2-a7a7-9451b36a6c4f"
      unitRef="usd">0</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzItNC0xLTEtNDc1NzU_a7dfd65c-f337-4d85-80da-6ebaa9dc9b7f"
      unitRef="usd">5100000</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzMtMi0xLTEtNDc1NzU_f45c08cc-423f-4814-859a-019caf08418e"
      unitRef="usd">75200000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzMtNC0xLTEtNDc1NzU_c4eb1ce9-6eb2-4d83-b761-18a9ccf53f42"
      unitRef="usd">63400000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzQtMi0xLTEtNDc1NzU_0f13a7de-9c9f-4a66-b874-cda05e88c95b"
      unitRef="usd">4000000.0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzQtNC0xLTEtNDc1NzU_7b2ed1d7-d083-470d-b96a-3a9e188cd578"
      unitRef="usd">3400000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzUtMi0xLTEtNDc1NzU_24f36b6a-9d0f-4752-a218-2ca351e7238a"
      unitRef="usd">-2900000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzUtNC0xLTEtNDc1NzU_680a70ec-baa2-43da-aeb8-ae97a34110bf"
      unitRef="usd">-10900000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzYtMi0xLTEtNDc1NzU_47bd124f-21ff-4977-a589-49aea47f97fe"
      unitRef="usd">-103000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzYtNC0xLTEtNDc1NzU_0bfe8efc-d64c-4efd-a0d8-13698fbe5584"
      unitRef="usd">134800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzctMi0xLTEtNDc1NzU_21daeaaa-1ebf-49b6-b0be-c0b0422b177f"
      unitRef="usd">-162500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzctNC0xLTEtNDc1NzU_a0ed6ad4-2f68-4a3a-98f0-f8531c2d7e87"
      unitRef="usd">146600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzgtMi0xLTEtNDc1NzU_55873795-0add-42d2-9985-9b38c7389ec4"
      unitRef="usd">389900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9ce39eddcaef4480b057800dbc9fc415_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzgtNC0xLTEtNDc1NzU_6a642306-6f8e-401f-87c0-2b6d7a79fa62"
      unitRef="usd">318200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzktMi0xLTEtNDc1NzU_0f30a8a2-f5a5-4a4d-bbb6-607146df53c5"
      unitRef="usd">227400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i293881ff9efc4258a9030c4efeddff54_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8yNS9mcmFnOjVjYzhlNjgzMjA2ODQ1NGU5ODFlNjdiMjhhZWE4OGNlL3RhYmxlOjA5ZWJlYWU5NGUwYzQxMDk5NjE5NjkwM2YzNmMzMzcxL3RhYmxlcmFuZ2U6MDllYmVhZTk0ZTBjNDEwOTk2MTk2OTAzZjM2YzMzNzFfMzktNC0xLTEtNDc1NzU_9747e862-5773-47d5-a578-3acee56c1060"
      unitRef="usd">464800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzMzk_4f82f117-b436-4f2d-a0ec-8f0feb2e3a5e">Organization and Summary of Accounting Policies&lt;div style="margin-bottom:6pt;margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Organization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of multi-specialty physician practices, urgent care facilities and anesthesia services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the Company owned or operated a portfolio of 133 surgical facilities, comprised of 115 ASCs and 18 surgical hospitals in 32 states. The Company owns these facilities in partnership with physicians and, in some cases, health care systems in the markets and communities it serves.&#160;The Company owned a majority interest in 85 of the surgical facilities and consolidated 109 of the facilities for financial reporting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#x2019;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the "2021 Annual Report on Form 10-K").&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide health care services. The Company recognizes revenues in the period in which its obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to receive. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid and private insurance organizations, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of revenues by service type as a percentage of total revenues follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Surgical facilities revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Ancillary services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patient service revenues.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;This revenue is related to charging facility fees in exchange for providing patient care. The fee charged for health care procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#x2019;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other service revenues.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Other service revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period, which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;309.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Self-pay&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;607.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;535.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;543.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;608.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;519.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;507.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;452.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Self-pay&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,041.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,211.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,055.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable from third-party payors are recorded net of estimated implicit price concessions, which are estimated based on the historical trend of the Company's surgical hospitals&#x2019; cash collections and contractual write-offs, and for the Company's surgical facilities in general, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), private insurance organizations, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#x2019;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. Collection efforts include direct contact with third-party payors or patients, written correspondence and the use of legal or collection agency assistance, as required. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in health care regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's effective tax rate was 8.8% for the six months ended June&#160;30, 2022 compared to (14.6)% for the six months ended June&#160;30, 2021. For the six months ended June&#160;30, 2022, the effective tax rate differed from the federal corporate tax rate of 21% primarily due to earnings attributable to non-controlling interests, an increase in the Company&#x2019;s valuation allowance attributable to interest expense limitations, and discrete tax benefits of (a) $4.6&#160;million related to the vesting of restricted stock awards, (b) $1.8&#160;million attributable to non-recurring earnings&#x2019; impact on the Company&#x2019;s valuation allowance, and (c) $1.0&#160;million related to entity divestitures. For the six months ended June&#160;30, 2021, the effective tax rate differed from 21% due to tax benefits of $4.1&#160;million related to the vesting of restricted stock awards, as well as a $3.0&#160;million tax benefit related to entity divestitures. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the fair value of the consideration provided in an acquisition plus the fair value of any non-controlling interests over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions and disposals for the six months ended June 30, 2022 is included in Note 2. "Acquisitions and Disposals."&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of activity related to goodwill for the six months ended June&#160;30, 2022 is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.167%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,911.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions, including post acquisition adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Disposals and deconsolidations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,993.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A detailed evaluation of potential impairment indicators was performed as of June&#160;30, 2022, which specifically considered the ongoing impact of the COVID-19 pandemic, recent increases in interest rates, inflation risk and market volatility. On the basis of available evidence as of June&#160;30, 2022, no indicators of impairment were identified. Future estimates of fair value could be adversely affected if the actual outcome of one or more of the Company's assumptions changes materially in the future, including a material decline in the Company&#x2019;s stock price and the fair value of its long-term debt, lower than expected surgical case volumes, higher market interest rates or increased operating costs. Such changes impacting the calculation of fair value could result in a material impairment charge in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company records all derivatives on the balance sheet at fair value and any financing elements treated as debt instruments are recorded at amortized cost. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Non-Controlling Interests&#x2014;Redeemable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#x2019; or physician minority members&#x2019;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of activity related to non-controlling interests&#x2014;redeemable is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at&#160;beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&#x2014;redeemable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition of shares of non-controlling interests, net&#x2014;redeemable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distributions to non-controlling interest&#x2014;redeemable holders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at&#160;end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;312.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Medicare Accelerated Payments and Deferred Governmental Grants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has received grant funds distributed under the Coronavirus Aid, Relief and Economic Security Act (the &#x201c;CARES Act&#x201d;) and other governmental assistance programs, including approximately $1&#160;million during the six months ended June&#160;30, 2022. Grant funds received during the three months ended June 30, 2022 were minimal. During the three and six months ended June 30, 2021, the Company received grant funds of approximately $1&#160;million and $8&#160;million, respectively. The recognition of amounts received is conditioned upon attestation with terms and conditions that funds will be used for COVID-19 related healthcare expenses or lost revenues. Amounts received, but not recognized as a reduction to operating expenses, are reflected as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets. Any unrecognized amounts may be recognized as a reduction in operating expenses in subsequent periods if the underlying conditions for recognition are met. The Company estimates $0.1 million and $1.3 million of grant funds received qualified for recognition as a reduction in operating expenses for the three and six months ended June&#160;30, 2022, respectively. During the three and six months ended June 30, 2021, $4.9 million and $20.0 million, respectively, was recognized as a reduction in operating expenses. As of both June&#160;30, 2022 and December&#160;31, 2021, approximately $4&#160;million of unrecognized grant funds received was reflected within the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company received accelerated payments under the Medicare Accelerated and Advance Payment Program. The payments received were deferred and included in the condensed consolidated balance sheets. During the three and six months ended June&#160;30, 2022, approximately $25&#160;million and $43&#160;million, respectively, has been repaid in accordance with the terms of the program. These repayments are included as a component of the change in Medicare accelerated payments and deferred government grants in the condensed consolidated statements of cash flows. As of June&#160;30, 2022 and December&#160;31, 2021, the remaining deferred accelerated payments was approximately $17&#160;million and $60&#160;million, respectively, which was included as a component of Medicare accelerated payments and deferred governmental grants in the condensed consolidated balance sheets. The Company does not expect to receive additional Medicare accelerated payments.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounting policies for relief received under the CARES Act and other governmental assistance programs, including the recognition of grant funds, is unchanged from the policies described in Note 1 to the Company&#x2019;s consolidated financial statements included in the 2021 Annual Report on Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on inputs classified into the following hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These may include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, depending on the nature of the item being valued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior secured term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,523.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,439.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.750% senior unsecured notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;339.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;371.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.000% senior unsecured notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;577.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values in the table above were based on Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;". The Company has the power to direct the activities that most significantly impact a VIE's economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of June&#160;30, 2022, the Company's consolidated VIEs include six surgical facilities and five physician practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of June&#160;30, 2022 and December&#160;31, 2021 were $69.7 million and $48.1 million, respectively, and the total liabilities of the consolidated VIEs were $44.0 million and $20.1 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <sgry:NumberOfSurgicalFacilitiesOwned
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTAyMQ_83de3048-171b-45d9-9131-f896b560e234"
      unitRef="facility">133</sgry:NumberOfSurgicalFacilitiesOwned>
    <sgry:NumberOfSurgicalFacilitiesOwned
      contextRef="i8635a31bb616432d8bb3e7a8d312f3a5_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTA1OA_7a8c3ced-dfc5-4f67-b638-9c65f93e838c"
      unitRef="facility">115</sgry:NumberOfSurgicalFacilitiesOwned>
    <sgry:NumberOfSurgicalFacilitiesOwned
      contextRef="i9538a3fb78354d13ae2d5c04403980a5_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTA3MA_bd531742-86b8-453f-aba8-6457e7e6a1c5"
      unitRef="facility">18</sgry:NumberOfSurgicalFacilitiesOwned>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTA5NQ_a72b7eb9-2e64-449e-8ceb-bdb579d8c3a8"
      unitRef="state">32</us-gaap:NumberOfStatesInWhichEntityOperates>
    <sgry:NumberOfSurgicalFacilitiesOwnedMajorityInterest
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTI5NA_4568d25f-6432-446c-bb93-ec3981ffc166"
      unitRef="facility">85</sgry:NumberOfSurgicalFacilitiesOwnedMajorityInterest>
    <sgry:NumberOfSurgicalFacilitiesOwnedConsolidated
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTM0MQ_526945af-4ed7-425a-aad4-a287cedaaf9e"
      unitRef="facility">109</sgry:NumberOfSurgicalFacilitiesOwnedConsolidated>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUyNzY_1cab20ce-25b7-4a54-a0ef-a6547bae8335">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#x2019;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the "2021 Annual Report on Form 10-K").&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzNjM_424399cc-c7b7-48a5-9d73-589eb5b36fbb">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzMDQ_26745659-80c3-428c-b704-a8450a3ee309">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUyNzM_e792e529-25e8-42e7-bc90-510a7865ac8b">&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide health care services. The Company recognizes revenues in the period in which its obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to receive. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid and private insurance organizations, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patient service revenues.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;This revenue is related to charging facility fees in exchange for providing patient care. The fee charged for health care procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#x2019;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other service revenues.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Other service revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period, which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUyNzQ_7fb53cb0-e9dc-4b32-b7fd-82780ad5bd93">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of revenues by service type as a percentage of total revenues follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Surgical facilities revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Ancillary services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;309.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;273.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Self-pay&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;607.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;535.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;543.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.815%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Private insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;608.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;519.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;507.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;452.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Self-pay&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,195.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,041.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,211.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,055.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;(1)Other is comprised of anesthesia service agreements, automobile liability, letters of protection and other payor types.</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i69a8b63234044edb8f0a6afda70cdd7f_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfMy0yLTEtMS00NzU3NQ_a6829922-e08d-4753-b6b6-8dec3c8ac8da"
      unitRef="number">0.959</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibf657c1e4474414d9ed07e96c58ad59d_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfMy00LTEtMS00NzU3NQ_c7b81cdb-11d0-4b55-aed1-5b388355bd1a"
      unitRef="number">0.955</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i552bb5d715f746d0af0896cb8236e297_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfMy02LTEtMS00OTI1OQ_f944aecd-784a-4488-9274-669a9879b90d"
      unitRef="number">0.958</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i86904f5d11ef43b59e207be1a0a75042_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfMy04LTEtMS00OTI2NQ_e5d68771-96bc-4603-b448-c274290546ea"
      unitRef="number">0.955</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibff8350d312b4ee2964eceaea94a35b0_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNC0yLTEtMS00NzU3NQ_92b51d85-ccbd-4dc9-8f74-d5808bc3bf53"
      unitRef="number">0.028</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0c0d2eeb74d34cfc9128ab781a805818_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNC00LTEtMS00NzU3NQ_e7a26b10-339e-41a8-b631-421f1b4da671"
      unitRef="number">0.032</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idab948c415d74a1e874e667af7cefd2c_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNC02LTEtMS00OTI1OQ_09142088-aeda-459d-ab6d-a0bbc7daeead"
      unitRef="number">0.028</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ife3f7aa0dc10478fa288248a9670fa92_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNC04LTEtMS00OTI2NQ_e55fb768-6118-4aee-8596-173df1aa2add"
      unitRef="number">0.032</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i34e9e7220c934670b27ad119a843e336_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNS0yLTEtMS00NzU3NQ_e13e23b5-038f-4882-8940-026a88ea6c52"
      unitRef="number">0.987</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i840850c9edd84feea92967f120b69408_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNS00LTEtMS00NzU3NQ_b4704f5a-ef51-4cce-b646-02ef877d7d52"
      unitRef="number">0.987</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3b11393d1e4444258098013cd223901e_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNS02LTEtMS01MTcyNg_d700e7f3-7d97-4c67-a994-bcf613e98607"
      unitRef="number">0.986</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia6ce9b604fc54f51a04400f3ffd18e4c_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNS04LTEtMS01MTcyNg_7be84d4a-d86b-4adf-9be0-71e8554edc14"
      unitRef="number">0.987</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8ccf871acc2e48a18834c00109df962f_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNi0yLTEtMS00NzU3NQ_d410f030-e1d5-4ab5-b6c8-561a293204a4"
      unitRef="number">0.013</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iab3bce97216f4963af800c138848af24_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNi00LTEtMS00NzU3NQ_c250e1fb-0d4a-4e40-8aa1-8527cf189052"
      unitRef="number">0.013</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib016f83f44d74921b4f5ce6b9ab4976f_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNi02LTEtMS00OTI3Mw_a8c7869b-5459-451a-867d-5f73ea02fac9"
      unitRef="number">0.014</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7a2aaf930d1c431f8bcf8bc5136ad3b0_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNi04LTEtMS00OTI3OQ_6b087508-c6c6-44f9-92c5-a1dc21ceb980"
      unitRef="number">0.013</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0d812678eaf54267847b2530339322ec_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNy0yLTEtMS00NzU3NQ_3d0a7fea-32ac-4900-a6b2-f63f3269ac0a"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic47817178a934289aa981ee5da388b9d_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNy00LTEtMS00NzU3NQ_8b5a834a-3387-4a2a-84e1-217730b714fa"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic37df66186ae4e5fb918bd1d2efca702_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNy02LTEtMS01MTcyNg_613ff6ec-2836-4405-ac05-61bf860cecd0"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icf41c461015444fe83e5e4ac21755f08_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmI5MzZhN2Q1MjVlNjQ2MmRiOGJmYmQ3NmQyZjE3ZDg5L3RhYmxlcmFuZ2U6YjkzNmE3ZDUyNWU2NDYyZGI4YmZiZDc2ZDJmMTdkODlfNy04LTEtMS01MTcyNg_d832ffb7-5f69-4eae-a572-df3ee00afe52"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i44cb302421034882ae2b0562737c1761_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNC0yLTEtMS00NzU3NQ_ce388313-dc8e-4dd2-a663-472cadbfb6e7"
      unitRef="usd">309500000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if244251d5c944d3c8d006f96aa5ebbeb_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNC00LTEtMS00NzU3NQ_5faa8153-47ce-45f0-811c-f9267db1101a"
      unitRef="number">0.510</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i60b170b8d71c411192b47b3305a64616_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNC02LTEtMS00NzU3NQ_e668f05d-07eb-4a59-af2d-908c0d8347ee"
      unitRef="usd">273000000.0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3c2399a17532427a98c0603b2322f33f_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNC04LTEtMS00NzU3NQ_632d686d-8a45-4793-9ea1-9781895f3384"
      unitRef="number">0.509</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i26fcec9c0227498db8204ef1cbf8fc8f_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNS0yLTEtMS00NzU3NQ_fb3b8974-a497-447f-bd74-6f868d56a69c"
      unitRef="usd">258100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if0822a8d0912456b81a264a53b470d89_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNS00LTEtMS00NzU3NQ_f432db86-1b84-402f-9c34-0b66d357c574"
      unitRef="number">0.425</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia0f939d7f48e447e90a63291660e7944_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNS02LTEtMS00NzU3NQ_2bd8a477-215d-4e43-b0e9-4e659e27e795"
      unitRef="usd">226200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5cc712172b944863ad8e1ec9d1f576b5_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNS04LTEtMS00NzU3NQ_7f09cb5f-dfc9-4891-9164-35c8d393acd6"
      unitRef="number">0.422</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if9a48f2904b44c188eea35ede6799f83_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNi0yLTEtMS00NzU3NQ_d10d0d9a-3f9e-409e-9948-c874a565d00b"
      unitRef="usd">16500000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia80790d713364217852ad6b20c5b9b80_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNi00LTEtMS00NzU3NQ_e72fb33e-9716-4c55-8422-fda225e7c944"
      unitRef="number">0.027</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i63e081ac08c44dc5a177a46e62b24af8_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNi02LTEtMS00NzU3NQ_55265791-7af1-4fd4-8500-fc3c6fc6b707"
      unitRef="usd">17800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3b40d040385048f4892471ac83e1a711_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNi04LTEtMS00NzU3NQ_5246c99a-eceb-466e-9b8c-fdafa8e5af41"
      unitRef="number">0.033</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6b2cd8126cda47679574168e7959c24f_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNy0yLTEtMS00NzU3NQ_57e1984a-47b4-4588-85c7-338e0341b047"
      unitRef="usd">23200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id61b7b590da346e2947662ec3b207f85_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNy00LTEtMS00NzU3NQ_beb1e67f-8c20-4738-8054-2982511df304"
      unitRef="number">0.038</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9bc26bedce494bfea61792a1ff92ace3_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNy02LTEtMS00NzU3NQ_cf82fd35-c298-4c56-99f4-f16cbb40845d"
      unitRef="usd">18900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idcc3a089528340bbba1aff28988c6812_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfNy04LTEtMS00NzU3NQ_60b9d1cb-800e-46cc-b445-07060a1b16ba"
      unitRef="number">0.036</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0d7024453b0a4f5c8ce5d266c8c9e818_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOC0yLTEtMS00NzU3NQ_656a4745-490e-4b18-9889-7cde13407855"
      unitRef="usd">607300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i27735b9da4154030bf4e696fb6bc2a59_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOC00LTEtMS00NzU3NQ_d276ab2b-2685-4e2d-908e-ba69f9b14630"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i97572a73c7164e119219a51fbc609a03_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOC02LTEtMS00NzU3NQ_51ef9e0e-f737-470b-8cff-44a2085643af"
      unitRef="usd">535900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id1dd63f253344cbf9b6a3ea5aca75cc1_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOC04LTEtMS00NzU3NQ_0512af97-59a4-4121-b6b4-c397a921f964"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1eba6e7221624a33acd805897dd778ed_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOS0yLTEtMS00NzU3NQ_83f9e4a4-9301-4c64-98fa-79d114fbbf57"
      unitRef="usd">8100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib2da709eec92472d8e6b2eb875df017d_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfOS02LTEtMS00NzU3NQ_e2bcf8b2-aa44-4b6e-bcfc-6a72d9b36180"
      unitRef="usd">7400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfMTAtMi0xLTEtNDc1NzU_65398768-1388-4efc-a030-97e030952d0f"
      unitRef="usd">615400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjk0NzFmMmQ1ZjhkMDRkZjI5YjRlNTkwZDEwZjNhOTljL3RhYmxlcmFuZ2U6OTQ3MWYyZDVmOGQwNGRmMjliNGU1OTBkMTBmM2E5OWNfMTAtNi0xLTEtNDc1NzU_a6587222-f1fe-4685-bf00-54962dc17ff4"
      unitRef="usd">543300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3084cb440f6440539f725074cc141064_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNC0yLTEtMS00OTMxMg_d922627b-8524-43e9-96fc-046e4154e170"
      unitRef="usd">608600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if3379039f97441b69503564797be213b_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNC00LTEtMS00OTMzMA_faef13cb-634b-492a-8cbe-91b5921af4b8"
      unitRef="number">0.509</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iee70145afa7b4a67822ee29af8d0ac67_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNC02LTEtMS00OTMwMA_ef14165c-3c1d-471c-955b-af1658810e28"
      unitRef="usd">519100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iad2ccb4850c7418299a1f3d759ad4c1c_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNC04LTEtMS00OTMyNA_98a831f5-fc83-401b-9370-fb7b5e3379d4"
      unitRef="number">0.498</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i90f42610982f4a29bc29dac6a196477b_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNS0yLTEtMS00OTMxMg_d6414a52-0007-4540-b433-21daa54530c3"
      unitRef="usd">507000000.0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iff79ffa556644f829d223ebc6d3e3e4e_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNS00LTEtMS00OTMzMA_0262b503-b230-492d-a1b8-d10000911740"
      unitRef="number">0.424</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0de9d3bf0e784880a751f9e1dc386914_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNS02LTEtMS00OTMwMA_be9585db-9c74-4531-a71c-ccc5e6a4d433"
      unitRef="usd">452600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i18be6ab1a0c548c2b344fd6ed2142372_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNS04LTEtMS00OTMyNA_339c88a8-fdad-46a3-aa20-630fdcef63ff"
      unitRef="number">0.435</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibc8dfce5bc944bfd937fcf89a20c4c8a_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNi0yLTEtMS00OTMxMg_d37cfb07-b2da-43b6-a19e-d28b3f9ff964"
      unitRef="usd">33200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iebe60e2bb5c545f98959f8d0f9d2db95_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNi00LTEtMS00OTMzMA_b177d87c-15b7-4346-a1d7-1598ce34be68"
      unitRef="number">0.028</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iddd55bfbcc5443ce8c95abb22f917ef7_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNi02LTEtMS00OTMwMA_17f2adc5-21e0-4039-9ae6-53819bdb0627"
      unitRef="usd">31000000.0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iaf891198937c45b68701f2071a3a79c1_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNi04LTEtMS00OTMyNA_64702548-c23c-4de0-a93b-3fc3f7114beb"
      unitRef="number">0.030</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if3c06ae7e4574d1087fab3bfb50d7437_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNy0yLTEtMS00OTMxMg_a278e00c-ebdd-4ad5-9f93-9a973b0b8373"
      unitRef="usd">46200000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib1be2d60556148108356e7e3d0c609e6_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNy00LTEtMS00OTMzMA_0f7771f4-7947-48fb-930c-2e6cd482de8f"
      unitRef="number">0.039</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5b0201ec336d4d759ab22d8b3f999534_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNy02LTEtMS00OTMwMA_c064e3d2-b45b-40fd-92a7-886009ddb981"
      unitRef="usd">38900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if99bdea32bbb4844a79014c52607f56e_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfNy04LTEtMS00OTMyNA_c007f970-f08f-4f42-92f2-310230c0e35a"
      unitRef="number">0.037</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic90c5193afd6420fb1c2f4aa57b405e7_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOC0yLTEtMS01MTcyOA_5700e0ed-8038-4644-b1af-03f88500b422"
      unitRef="usd">1195000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i18b50bcfbdfb4bb791ecefea65280045_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOC00LTEtMS00OTMzNg_e3fef7bb-01bd-46b7-9f1b-c24557dc874c"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibbbf27a71e2f456398a50c2893221fad_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOC02LTEtMS01MTcyOA_e8ae32eb-876d-407f-9998-b8c08c360f16"
      unitRef="usd">1041600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i07a9608cfa094c6684c2b726c01884cb_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOC04LTEtMS01MTcyOA_006e5ba2-6353-4a27-915c-56584b688067"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i02fc46716fa94295ba0d78ef52b9bc23_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOS0yLTEtMS00OTMxOA_780afaf8-a5cd-40e6-b645-18844f6135ee"
      unitRef="usd">16600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8831be04004f4e43925db4244ecc0d5c_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfOS02LTEtMS00OTMwNg_dbab727f-f969-422f-bd2b-fef322f91386"
      unitRef="usd">14100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfMTAtMi0xLTEtNTE3Mjg_546174a9-d284-497f-a46d-70e1f7264285"
      unitRef="usd">1211600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOmFlYzBhYTAwNzM3YTQ1ZDc4YmE2MGU5OWIxODVhNzYzL3RhYmxlcmFuZ2U6YWVjMGFhMDA3MzdhNDVkNzhiYTYwZTk5YjE4NWE3NjNfMTAtNi0xLTEtNTE3Mjg_a503e215-4eb3-4e23-b157-d545494168a4"
      unitRef="usd">1055700000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzNjI_30f9bad1-346f-4b35-8291-c64802f9abe4">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable from third-party payors are recorded net of estimated implicit price concessions, which are estimated based on the historical trend of the Company's surgical hospitals&#x2019; cash collections and contractual write-offs, and for the Company's surgical facilities in general, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), private insurance organizations, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#x2019;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.&lt;/span&gt;&lt;/div&gt;The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. Collection efforts include direct contact with third-party payors or patients, written correspondence and the use of legal or collection agency assistance, as required.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTY0OTI2NzUwNTM5MA_d19ed411-7cec-4090-bded-39127e9b8795">&lt;div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in health care regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4Njk0Mg_fdd5419e-d8dd-4d46-b03d-b22fa4b2b15e"
      unitRef="number">0.088</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4Njk4OA_87386d38-48ca-4406-a4c5-df62ee6baaf1"
      unitRef="number">-0.146</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4NzI5MQ_6dc8039c-df0b-4c28-8822-636c63dea46b"
      unitRef="usd">-4600000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4NzM1MA_a5a5cf3c-aff7-481d-a769-d29d081e054c"
      unitRef="usd">-1800000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4NzQ0Nw_9e44de2c-6c98-4c4d-800f-7c3584406351"
      unitRef="usd">-1000000</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4NzU3OA_0813f5f1-8881-4f99-9337-ac74f8948044"
      unitRef="usd">-4100000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4NzY0Ng_256d5790-795e-4af2-b3b2-e4fddec50964"
      unitRef="usd">-3000000</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzMzU_44d777cf-9d91-430c-80eb-8bfa78b48647">GoodwillGoodwill represents the excess of the fair value of the consideration provided in an acquisition plus the fair value of any non-controlling interests over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUyOTU_4abc226e-9a3a-45f2-b2dd-672739518b17">&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of activity related to goodwill for the six months ended June&#160;30, 2022 is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.167%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,911.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisitions, including post acquisition adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Disposals and deconsolidations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,993.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjg2OWRkNmVkYjY1NTRlM2NhMGU2YWZjZGFhODc1ZDMxL3RhYmxlcmFuZ2U6ODY5ZGQ2ZWRiNjU1NGUzY2EwZTZhZmNkYWE4NzVkMzFfMC0yLTEtMS00NzU3NQ_fef9cfa8-f8bb-4e0a-bf07-d04e9741373b"
      unitRef="usd">3911800000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjg2OWRkNmVkYjY1NTRlM2NhMGU2YWZjZGFhODc1ZDMxL3RhYmxlcmFuZ2U6ODY5ZGQ2ZWRiNjU1NGUzY2EwZTZhZmNkYWE4NzVkMzFfMS0yLTEtMS00NzU3NQ_eca397b3-8be1-46d0-a5b2-1711f61f0535"
      unitRef="usd">110700000</us-gaap:GoodwillAcquiredDuringPeriod>
    <sgry:GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjg2OWRkNmVkYjY1NTRlM2NhMGU2YWZjZGFhODc1ZDMxL3RhYmxlcmFuZ2U6ODY5ZGQ2ZWRiNjU1NGUzY2EwZTZhZmNkYWE4NzVkMzFfMi0yLTEtMS00NzU3NQ_9b0c327c-9de3-4247-bab0-b65e1e03d95f"
      unitRef="usd">29400000</sgry:GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation>
    <us-gaap:Goodwill
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjg2OWRkNmVkYjY1NTRlM2NhMGU2YWZjZGFhODc1ZDMxL3RhYmxlcmFuZ2U6ODY5ZGQ2ZWRiNjU1NGUzY2EwZTZhZmNkYWE4NzVkMzFfMy0yLTEtMS00NzU3NQ_c116e3c3-bc99-4f40-980c-6bd96f404e0a"
      unitRef="usd">3993100000</us-gaap:Goodwill>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzNDU_6b6cc28d-c663-4ed8-bbd5-6d627757e047">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company records all derivatives on the balance sheet at fair value and any financing elements treated as debt instruments are recorded at amortized cost. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.&lt;/span&gt;&lt;/div&gt;For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income ("OCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#x2019;s accounting policy election. Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#x2019;s variable-rate debt.</us-gaap:DerivativesPolicyTextBlock>
    <sgry:RedeemableNoncontrollingInterestPolicyTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzMzc_d1e59f0a-9b54-42c1-94bd-bf891cfa82ff">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Non-Controlling Interests&#x2014;Redeemable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#x2019; or physician minority members&#x2019;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</sgry:RedeemableNoncontrollingInterestPolicyTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMjUzMjc_2abd0b40-e664-4c19-bbf6-ae612a28fd10">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of activity related to non-controlling interests&#x2014;redeemable is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at&#160;beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;330.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;306.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&#x2014;redeemable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition of shares of non-controlling interests, net&#x2014;redeemable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Distributions to non-controlling interest&#x2014;redeemable holders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at&#160;end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;312.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfMy0yLTEtMS00NzU3NQ_2f029b17-bf15-4f8b-a6f7-450305529356"
      unitRef="usd">330200000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i9ce39eddcaef4480b057800dbc9fc415_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfMy00LTEtMS00NzU3NQ_b74537e1-4c22-4ae6-9c69-5a1a3cb07cbf"
      unitRef="usd">306800000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNC0yLTEtMS00NzU3NQ_350a6c14-cc40-416c-b8fb-4e8b14307423"
      unitRef="usd">21600000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNC00LTEtMS00NzU3NQ_a648a579-26d8-46a5-931d-4721d149e29c"
      unitRef="usd">24400000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNS0yLTEtMS00NzU3NQ_f3358fc3-cc86-4561-b4cf-cb37fdc606ac"
      unitRef="usd">12900000</sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests>
    <sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNS00LTEtMS00NzU3NQ_73bc72d4-301f-4c16-8584-b9dce6f259de"
      unitRef="usd">1900000</sgry:RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests>
    <sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNi0yLTEtMS00NzU3NQ_4a54efd4-e7c0-419e-8ba7-4f3e1809b31a"
      unitRef="usd">22900000</sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNi00LTEtMS00NzU3NQ_6cebef27-3a7b-44d7-b3f1-8fa12c0929b5"
      unitRef="usd">20300000</sgry:RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNy0yLTEtMS00NzU3NQ_343e9342-7994-4d43-ba42-218a89ce4bff"
      unitRef="usd">341800000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i293881ff9efc4258a9030c4efeddff54_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjE0YzhlYmNmM2E1OTRlOGI4ODMxYTcwNzVhZjZiZGVkL3RhYmxlcmFuZ2U6MTRjOGViY2YzYTU5NGU4Yjg4MzFhNzA3NWFmNmJkZWRfNy00LTEtMS00NzU3NQ_9da11924-bd94-4877-a7fc-0912950780eb"
      unitRef="usd">312800000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <sgry:ProceedsFromGovernmentAssistance
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3MjkyOQ_260fbade-d36c-48ab-a41f-3d9a4e282b2a"
      unitRef="usd">1000000</sgry:ProceedsFromGovernmentAssistance>
    <sgry:ProceedsFromGovernmentAssistance
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5MDY2Mw_01fb032f-404b-4dd0-9fa1-0ed0b6a57f69"
      unitRef="usd">1000000</sgry:ProceedsFromGovernmentAssistance>
    <sgry:ProceedsFromGovernmentAssistance
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5MTgyNQ_04d840b8-78c3-44d6-9070-1e1691dc8080"
      unitRef="usd">8000000</sgry:ProceedsFromGovernmentAssistance>
    <sgry:GrantRevenue
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3Mzk2Mg_6aae4cf3-0997-445d-bf74-d7a12f12f17c"
      unitRef="usd">100000</sgry:GrantRevenue>
    <sgry:GrantRevenue
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3Mzk3MA_041ba430-2434-4ef9-9c83-0e1d3688e35f"
      unitRef="usd">1300000</sgry:GrantRevenue>
    <sgry:GrantRevenue
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5NzUwMQ_7f1bc2d4-acc3-4ad4-8c99-d3beda7c8f86"
      unitRef="usd">4900000</sgry:GrantRevenue>
    <sgry:GrantRevenue
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5NzUyMQ_ba209041-9036-4724-99ca-df33c22e45c2"
      unitRef="usd">20000000</sgry:GrantRevenue>
    <sgry:UnrecognizedGrantFundsReceived
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5Nzc4MQ_627eae93-b3d7-42be-88cb-1759dc928052"
      unitRef="usd">4000000</sgry:UnrecognizedGrantFundsReceived>
    <sgry:UnrecognizedGrantFundsReceived
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg5Nzc4MQ_788b2180-edd4-4afd-9d3a-503482e7f7f6"
      unitRef="usd">4000000</sgry:UnrecognizedGrantFundsReceived>
    <sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3NTQwNg_118a1f74-e2e5-4b7f-a6f3-9f658340b84d"
      unitRef="usd">25000000</sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments>
    <sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3NTQxNA_22b32e39-c933-4be5-a3ff-01a7aa926f88"
      unitRef="usd">43000000</sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments>
    <sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3NjEwOQ_c3f113b1-b9b5-471a-b3c0-12e59104f734"
      unitRef="usd">17000000</sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments>
    <sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg3NjExNw_81421577-e96a-4b08-b692-53d9bcf8bee8"
      unitRef="usd">60000000</sgry:CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTY0OTI2NzUwNTM5MQ_b61d6a50-9de6-4a86-a73d-917ef1a77c59">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on inputs classified into the following hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These may include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt"&gt;Level 3: Unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, depending on the nature of the item being valued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTY0OTI2NzUwNTM5Mw_1d827fb9-7ead-4fbc-9e79-b6e8a92803da">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior secured term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,523.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,439.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.750% senior unsecured notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;339.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;371.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.000% senior unsecured notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;577.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i6b3dc06c3b0940c6864cf95b82437b22_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfMy0yLTEtMS01NDc0MA_d2e39e13-87c9-44a9-8533-44b6a3d9af97"
      unitRef="usd">1523300000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia4014a2b0728429f99f1aff4ee095837_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfMy00LTEtMS01NDc0MA_5cb2a54c-0cc4-4eca-886b-498b88959f19"
      unitRef="usd">1530700000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i48593468d901450b9f2b3750f730873f_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfMy02LTEtMS01NDc0MA_0e3bcfd0-5623-4ffd-8ac5-2dfb787294f5"
      unitRef="usd">1439500000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iab78f5af1da94146958f7005f99d54ed_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfMy04LTEtMS01NDc0MA_9773e165-fd9a-4f23-b102-6f0fd24438b5"
      unitRef="usd">1530700000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i17b9522ee1a5410c9e521102b0938024_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNC0wLTEtMS01NDc0MC90ZXh0cmVnaW9uOjFjNzc4YWM2YjIzZTRhMDA5MGFkMjU4ZTRlNjRlYzc1XzQ_00899d8b-08cd-48fd-822d-639c4066095a"
      unitRef="number">0.06750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iee1640a7d9ed442fb5430f01e5f729e5_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNC0yLTEtMS01NDc0MA_e6567e55-7db5-4d79-a1a5-9fa0a9936fcc"
      unitRef="usd">370000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ife931bd0ec79459bb3908847c1c58b78_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNC00LTEtMS01NDc0MA_64c658a3-fc31-4a84-82e8-e2f1024ff803"
      unitRef="usd">370000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibc9575728f644eaa83de881b7d5e9813_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNC02LTEtMS01NDc0MA_40cd6edc-fc86-47c6-ad9f-3f15a035329a"
      unitRef="usd">339000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i240776d65f63482e82bae1bb71ef09b4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNC04LTEtMS01NDc0MA_baf18240-01da-440d-84f5-ce57d1afd7ac"
      unitRef="usd">371900000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id97f2fe451ad49ebab6e84dfc7448640_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNS0wLTEtMS01NDc0MC90ZXh0cmVnaW9uOmY2Y2E2MzNmNDE2OTRlYTQ5NjFlY2VhODc4MmJlZDY1XzQ_5fb3dcf9-54e6-47ca-82cb-8f72caf48f0f"
      unitRef="number">0.10000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iada7c3ad8c6043cf83baea26ca96c7f5_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNS0yLTEtMS01NDc0MA_9c872d89-00de-4026-b6f8-72635a7fca83"
      unitRef="usd">545000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6e7433e734c44d0fbaf0eb6487f2a2fd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNS00LTEtMS01NDc0MA_36c327e4-15d9-49b6-9939-c72a24324076"
      unitRef="usd">545000000.0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0455e535db8f4f838179eed4ab11e337_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNS02LTEtMS01NDc0MA_6bbb7a7e-e294-4206-aa7f-a94a987933fc"
      unitRef="usd">531400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="idb5f2b0b8b3a4fb38bed91efd6ed8703_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RhYmxlOjc4MzliOWRjMmU5ZDRiZjk5YTNmYjZiMTgwNWNhZmY0L3RhYmxlcmFuZ2U6NzgzOWI5ZGMyZTlkNGJmOTlhM2ZiNmIxODA1Y2FmZjRfNS04LTEtMS01NDc0MA_879b6d86-0368-43ed-b537-352c5443c419"
      unitRef="usd">577000000.0</us-gaap:LongTermDebt>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfMTY0OTI2NzUwNTM5Mg_0a4bcb65-992c-48d8-a7e6-430485b8af47">Variable Interest Entities&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation&lt;/span&gt;". The Company has the power to direct the activities that most significantly impact a VIE's economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <sgry:VariableInterestEntityNumberOfFacilities
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTEwNg_dbfe2277-34e9-47e7-9c39-26044e5f91ac"
      unitRef="facility">6</sgry:VariableInterestEntityNumberOfFacilities>
    <sgry:VariableInterestEntityNumberOfFacilities
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTEzNA_fa71543c-c20f-437b-819c-4c4ef81283a0"
      unitRef="physician_practice">5</sgry:VariableInterestEntityNumberOfFacilities>
    <us-gaap:Assets
      contextRef="i0c7f757289414463a07207dec757e8d0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTMzOQ_bcfd1843-272d-4272-b7ef-10e62ddbcbd3"
      unitRef="usd">69700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idfd8f7a8f4154e65a697ab7d0057cc7e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTM0Nw_38f77019-8f1a-4ef5-a23d-7cc85517fd82"
      unitRef="usd">48100000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i0c7f757289414463a07207dec757e8d0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTQyMg_d7fd5d4d-bcca-490f-820a-b2d0df949a92"
      unitRef="usd">44000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="idfd8f7a8f4154e65a697ab7d0057cc7e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zMS9mcmFnOjJjMjYwN2JhZWUwMTRkMDQ4OWRkMmMxNDEwNmRiZDkyL3RleHRyZWdpb246MmMyNjA3YmFlZTAxNGQwNDg5ZGQyYzE0MTA2ZGJkOTJfOTM0NTg0ODg4MTQzMA_39407bc4-b0d0-46f0-a1d4-228fdc8057ab"
      unitRef="usd">20100000</us-gaap:Liabilities>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMzY3Nw_002ab508-b1c2-4ffd-bc3b-d2d19b9761b2">Acquisitions and Disposals&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2022, the Company acquired a controlling interest in four surgical facilities, two of which were merged into existing surgical facilities, for aggregate cash consideration of $74.9&#160;million, net of cash acquired, and non-cash consideration of $2.6&#160;million, which consisted of a non-controlling interest in one of the Company's existing surgical facilities. In connection with the acquisitions the Company preliminarily recognized non-controlling interests of $41.5&#160;million and goodwill of $114.4&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the six months ended June 30, 2021, the Company acquired a controlling interest in a surgical facility in a new market and two surgical facilities in existing markets that were merged into existing facilities for aggregate cash consideration of $15.2&#160;million, net of cash acquired. In connection with the acquisitions the Company preliminarily recognized non-controlling interests of $7.5&#160;million and goodwill of $20.0&#160;million. During the six months ended June&#160;30, 2022, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the six months ended June 30, 2022, the Company acquired non-controlling interests in five surgical facilities and four in-development de novo surgical facilities for an aggregate cash purchase price of $65.8&#160;million. The non-controlling interests were accounted for as equity method investments and recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disposals and Deconsolidations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2022, the Company sold its interests in a surgical facility, which was previously accounted for as an equity method investment, for net cash proceeds of $11.5&#160;million. The Company recognized a pre-tax loss on the sale of $0.4&#160;million included in loss on disposals and deconsolidations, net in the condensed consolidated statements of operations for the six months ended June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2022, the Company contributed its interests in two surgical facilities as non-cash consideration for non-controlling interests in two new separate entities. As a result of these transactions, the Company lost control of the previously controlled surgical facilities but retains a non-controlling interest in each, resulting in the deconsolidation of the previously consolidated entities. The remaining non-controlling interests were accounted for as equity method investments, and initially measured and recorded at fair value as of the dates of the transactions. The fair value measurement utilizes Level 3 inputs, which includes unobservable data, to measure the fair value of the retained non-controlling interests. The fair value determination was based on a combination of multiple valuation methods, which included discounted cash flow and market value approach, which incorporates estimates of future earnings and market valuation multiples for certain guideline companies. The preliminary fair value of the investments of $9.8&#160;million was recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets. Further, based on the preliminary valuation, the transactions resulted in a pretax net loss on deconsolidations of $5.6&#160;million, which is included in loss on disposals and deconsolidations, net, in the accompanying condensed consolidated statement of operations for the six months ended June&#160;30, &lt;/span&gt;&lt;/div&gt;2022. The net loss was determined based on the difference between the fair value of the Company's retained interests in the entities and the carrying values of both the tangible and intangible assets of the entities immediately prior to the transactions.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ia73c117591c64b64acb148493f0ec6d8_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMTY0OTI2NzQ0NzQ0MQ_7e403ea7-14f9-4918-8752-b3f3a788cf51"
      unitRef="facility">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i6a3bff3446ca40c28509f17868f1adc1_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMTY0OTI2NzQ0NzQ1MA_b37f414a-2a55-4fa2-8881-619356709bec"
      unitRef="facility">2</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ia73c117591c64b64acb148493f0ec6d8_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMjMz_7726217b-a5b2-42d1-ad2d-acbaa342058f"
      unitRef="usd">74900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
      contextRef="ia73c117591c64b64acb148493f0ec6d8_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMjg5_ea96b702-e229-4528-8864-d095468237e9"
      unitRef="usd">2600000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="iea5f3abaa0984b2eaa7055cba2542341_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0Nzc3NQ_edb78ba9-a5ee-4c32-9b53-2acdec0b6160"
      unitRef="usd">41500000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:Goodwill
      contextRef="iea5f3abaa0984b2eaa7055cba2542341_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0Nzc4NA_d4b4f342-f238-4ae7-ae6c-e3f2a5df8c49"
      unitRef="usd">114400000</us-gaap:Goodwill>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iefa24cf2b7dc4ebc86ae0a7a096deb4d_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0NDE5OQ_6538b334-4f88-4204-accc-a522df750375"
      unitRef="usd">15200000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="ifdc566837054408da2d934e520986ebb_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0NzkyMA_2548773c-fc2f-4ddb-b636-2df28876718c"
      unitRef="usd">7500000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:Goodwill
      contextRef="ifdc566837054408da2d934e520986ebb_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0NzkyOA_50a6a99f-ea1d-4856-ad33-e2bdc8b3ecca"
      unitRef="usd">20000000</us-gaap:Goodwill>
    <sgry:NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired
      contextRef="ie3963d4281e5468c8e5368c83dc0b938_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0MjcwMQ_ca096f0f-f5f0-4757-a1e8-315cc3e0f2dd"
      unitRef="non-controlling_interest">5</sgry:NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired>
    <sgry:NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired
      contextRef="ie3963d4281e5468c8e5368c83dc0b938_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0MjcyNg_121e2dc3-e858-4358-bc46-4bfeb95b6953"
      unitRef="non-controlling_interest">4</sgry:NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfOTM0NTg0ODg0Mjc5Mw_1b3275f2-c7fd-45ef-aa28-a8a2e283592c"
      unitRef="usd">65800000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i765634ba75024131a79a3d390bb13989_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMTc2OQ_70619b3e-c7e1-46f8-9251-0950a44ea84a"
      unitRef="usd">11500000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i765634ba75024131a79a3d390bb13989_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMTgwNg_77b532be-6fee-47ec-b0de-c29cee45f225"
      unitRef="usd">-400000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <sgry:DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration
      contextRef="i97c9ba13353b4c19b6ed54c8402d44cf_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMjAzNQ_8df450ac-75fd-4c66-8bdd-fa31eaa0e6cd"
      unitRef="facility">2</sgry:DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ib185c098b450421d89d993a6a054fd2c_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMjExNw_6b78311e-ddaf-4952-b52c-b21a54b25226"
      unitRef="business_entity">2</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="i2b6f41648efd461697a23bab27bf16e5_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMzAxNg_0bec397a-f6be-45f7-b3f7-87df9281a26e"
      unitRef="usd">9800000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i97c9ba13353b4c19b6ed54c8402d44cf_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNC9mcmFnOmU1MTRkNGY2NjQ0OTRiZmY5Y2RhYWIwYjMzMjY5NDZkL3RleHRyZWdpb246ZTUxNGQ0ZjY2NDQ5NGJmZjljZGFhYjBiMzMyNjk0NmRfMzI2Ng_070fc474-503b-4828-bb6e-5cc97fed50e5"
      unitRef="usd">-5600000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:LongTermDebtTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNjgx_2a7fc825-9af1-4729-86af-fa9962b54db5">Long-Term Debt&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of long-term debt follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior secured term loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,523.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.750% senior unsecured notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.000% senior unsecured notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Notes payable and other secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;504.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;364.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,087.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,938.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,019.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,878.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:4pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes unamortized fair value discount of $2.7 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;and $3.0&#160;million as of June&#160;30, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The increase in finance lease obligations is a result of the modification of certain existing facility real estate leases that were previously classified as operating leases. See Note 4. "Leases" for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;As of June&#160;30, 2022, the Company's availability on its revolving credit facility (the "Revolver") was $203.0 million (including outstanding letters of credit of $7.0 million). There were no outstanding borrowings under the Revolver as of both June&#160;30, 2022 and December&#160;31, 2021</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNjg0_06c7f279-e473-4e5a-b342-8088d4da3d20">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of long-term debt follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior secured term loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,523.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,530.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.750% senior unsecured notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.000% senior unsecured notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;545.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Notes payable and other secured loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;504.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;364.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs and discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,087.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,938.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,019.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,878.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes unamortized fair value discount of $2.7 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;and $3.0&#160;million as of June&#160;30, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;December&#160;31, 2021, respectively.</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if2194c6aaf1a4eec8b2eab9c9b7c3c3a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMi0yLTEtMS00NzU3NQ_1179d1ad-0d0e-49de-9979-139019ac5d14"
      unitRef="usd">1523300000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia1aeee4881fa47c580bb5e99e88641ce_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMi00LTEtMS00NzU3NQ_158994a2-102e-4f56-add6-d8fb0d5122bf"
      unitRef="usd">1530700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i17b9522ee1a5410c9e521102b0938024_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMy0wLTEtMS00NzU3NS90ZXh0cmVnaW9uOjg3MDU1M2IxZWI0YzQyYmI5YzA5MDA2OTVmM2FmNTA0XzQ_00899d8b-08cd-48fd-822d-639c4066095a"
      unitRef="number">0.06750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i17b9522ee1a5410c9e521102b0938024_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMy0yLTEtMS00NzU3NQ_8b34ec4f-96c3-48a1-a5a3-bbba33766d4d"
      unitRef="usd">370000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i17cc9fb2945a48038ba149c83e32f783_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMy00LTEtMS00NzU3NQ_6025d9ae-aa43-4020-899f-2d3d5680ae8d"
      unitRef="usd">370000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id97f2fe451ad49ebab6e84dfc7448640_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNC0wLTEtMS00NzU3NS90ZXh0cmVnaW9uOmQxMTczMzMwZmEzZTQ1MGViZGI2YjQ2MzdhMzVhMDMwXzQ_5fb3dcf9-54e6-47ca-82cb-8f72caf48f0f"
      unitRef="number">0.10000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id97f2fe451ad49ebab6e84dfc7448640_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNC0yLTEtMS00NzU3NQ_7ce996a2-a8d3-46c9-a6bc-316e06159285"
      unitRef="usd">545000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i49d20d5258ec48e59311e50fe392c175_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNC00LTEtMS00NzU3NQ_a0e7711b-8730-4de0-ab49-b5ad90c26ee5"
      unitRef="usd">545000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iea1883c76fa04d069ea8e3cf7e28a781_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNS0yLTEtMS00NzU3NQ_4258d282-ad7f-421c-85a0-7088db9ab559"
      unitRef="usd">160200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i63c44749e22b461ca1d58d166427ced2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNS00LTEtMS00NzU3NQ_10adca60-b3ab-43cf-ac03-3440da3d00ff"
      unitRef="usd">145000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNi0yLTEtMS00NzU3NQ_8dfeefe1-f77e-4dbe-a1f4-a8a4279d3af0"
      unitRef="usd">504300000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNi00LTEtMS00NzU3NQ_d1dfc08c-6d3f-41e1-970c-30aa65a87825"
      unitRef="usd">364600000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNy0yLTEtMS00NzU3NQ_d3b1c4b0-ff08-4562-be7f-1fbd234d34c8"
      unitRef="usd">15100000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfNy00LTEtMS00NzU3NQ_96affc0f-45c7-41c0-a638-1277fb43310b"
      unitRef="usd">16500000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfOC0yLTEtMS00NzU3NQ_ad1ffe03-af66-4619-a6bf-12a86cb14d8a"
      unitRef="usd">3087700000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfOC00LTEtMS00NzU3NQ_4a9f53b4-8534-426d-b428-f548eb9c1ac4"
      unitRef="usd">2938800000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfOS0yLTEtMS00NzU3NQ_a7f4d84f-a697-4777-8587-04a9d849a5bc"
      unitRef="usd">68300000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfOS00LTEtMS00NzU3NQ_0087fdaa-e60a-436c-9ae9-fbfa7d1313d6"
      unitRef="usd">60400000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMTAtMi0xLTEtNDc1NzU_7b43634e-e453-4abd-aa53-8bf80841c8e0"
      unitRef="usd">3019400000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RhYmxlOmZhNWUwNjIzZTMzMzQwOGI5YzUzOWI3YjMxOTM1YjU0L3RhYmxlcmFuZ2U6ZmE1ZTA2MjNlMzMzNDA4YjljNTM5YjdiMzE5MzViNTRfMTAtNC0xLTEtNDc1NzU_649b9ab8-ee32-484a-a7dc-6e871517a28e"
      unitRef="usd">2878400000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="if2194c6aaf1a4eec8b2eab9c9b7c3c3a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfMTIy_93dfcdfe-f9fe-4e93-a6fe-f3108a009143"
      unitRef="usd">2700000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ia1aeee4881fa47c580bb5e99e88641ce_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfMTI5_c69a6535-083a-48f5-8431-b16d79dec704"
      unitRef="usd">3000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i1a5a30a093dc41659d3f312026cb301c_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNTEz_cd34665a-5c54-4ff3-aae7-a18e849b0572"
      unitRef="usd">203000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i86130d880fcf401e909db4519bccc94f_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNTYw_eeb083e2-6e0b-4f9a-b29d-902861f8656c"
      unitRef="usd">7000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i34519792c7c644368bc1218b81d5eb35_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNTc2_17c48399-f892-4f54-8fb5-ab08e1018bc9"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i3520bf24329a4e13a3d203c231caa136_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8zNy9mcmFnOmQyNjI4NTQwODIwNTRkZjU4MWVhZTYxOTE3NGNkNTUwL3RleHRyZWdpb246ZDI2Mjg1NDA4MjA1NGRmNTgxZWFlNjE5MTc0Y2Q1NTBfNTc2_2addccbe-dcb9-45cd-a635-1e269ef37b74"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfMTE1MQ_335078b2-f348-4789-af04-1e9c69e408b4">Leases&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the consolidated balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification in Consolidated Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_0490c164-1bcc-4f55-85d3-15e9331ed7ed"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_4a2e4f93-28b9-4c5f-bc07-6358d546de18"&gt;Property and equipment, net of accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;738.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;653.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_00060c4f-1b87-4bb0-b65b-4b1328751e7d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_f34bfa11-29e3-4790-b94f-70125ea4d07f"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;355.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_82470289-02c8-4ee9-bb12-c86df2a2d59b"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_d09186d5-2c70-43f5-ba46-c5f5d380a2bb"&gt;Current maturities of long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_2188135b-10a8-4d73-88ea-7b90cf795fbd"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_eb2749f0-b898-4460-8f9b-f8a8c6f0701f"&gt;Long-term debt, less current maturities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;481.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;345.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;504.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;364.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;811.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;720.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2022, the Company extended certain existing facility real estate leases, resulting in the reclassification of the leases from operating to finance. The modifications resulted in an increase to finance lease liabilities and assets of $146.5&#160;million and $145.0&#160;million, respectively, including the reclassification of existing operating lease liabilities and assets of $60.8&#160;million and $59.3&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Variable and short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information (dollars in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfMTE1MQ_f2a6c562-0502-4281-a465-548c4a044a72">Leases&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the consolidated balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification in Consolidated Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_0490c164-1bcc-4f55-85d3-15e9331ed7ed"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_4a2e4f93-28b9-4c5f-bc07-6358d546de18"&gt;Property and equipment, net of accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;738.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;653.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_00060c4f-1b87-4bb0-b65b-4b1328751e7d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_f34bfa11-29e3-4790-b94f-70125ea4d07f"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;355.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_82470289-02c8-4ee9-bb12-c86df2a2d59b"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_d09186d5-2c70-43f5-ba46-c5f5d380a2bb"&gt;Current maturities of long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_2188135b-10a8-4d73-88ea-7b90cf795fbd"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_eb2749f0-b898-4460-8f9b-f8a8c6f0701f"&gt;Long-term debt, less current maturities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;481.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;345.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;504.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;364.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;811.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;720.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2022, the Company extended certain existing facility real estate leases, resulting in the reclassification of the leases from operating to finance. The modifications resulted in an increase to finance lease liabilities and assets of $146.5&#160;million and $145.0&#160;million, respectively, including the reclassification of existing operating lease liabilities and assets of $60.8&#160;million and $59.3&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Variable and short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information (dollars in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <sgry:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfMTE0OA_f38a8c10-8590-420c-a330-52cc22047b36">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the consolidated balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification in Consolidated Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;324.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_0490c164-1bcc-4f55-85d3-15e9331ed7ed"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC0yLTEtMS00NzU3NQ_4a2e4f93-28b9-4c5f-bc07-6358d546de18"&gt;Property and equipment, net of accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;329.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;738.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;653.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_00060c4f-1b87-4bb0-b65b-4b1328751e7d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS0yLTEtMS00NzU3NQ_f34bfa11-29e3-4790-b94f-70125ea4d07f"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;271.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;307.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;355.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_82470289-02c8-4ee9-bb12-c86df2a2d59b"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtMi0xLTEtNDc1NzU_d09186d5-2c70-43f5-ba46-c5f5d380a2bb"&gt;Current maturities of long-term debt&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_2188135b-10a8-4d73-88ea-7b90cf795fbd"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtMi0xLTEtNDc1NzU_eb2749f0-b898-4460-8f9b-f8a8c6f0701f"&gt;Long-term debt, less current maturities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;481.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;345.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;504.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;364.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;811.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;720.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sgry:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMy00LTEtMS00NzU3NQ_ad822242-d017-49d3-9010-dd2b65d6add6"
      unitRef="usd">277800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMy02LTEtMS00NzU3NQ_467f8508-7e44-407c-9d6b-2d856efa7280"
      unitRef="usd">324100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC00LTEtMS00NzU3NQ_9d64b13b-6af9-4693-8d15-4d71476ce510"
      unitRef="usd">460200000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNC02LTEtMS00NzU3NQ_9d118167-42f5-45fb-be7a-7741ffe2643b"
      unitRef="usd">329600000</us-gaap:FinanceLeaseRightOfUseAsset>
    <sgry:LeaseRightOfUseAsset
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNS00LTEtMS00NzU3NQ_910f1002-84a5-4abd-8e8c-d5a2a9dff2c3"
      unitRef="usd">738000000.0</sgry:LeaseRightOfUseAsset>
    <sgry:LeaseRightOfUseAsset
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfNS02LTEtMS00NzU3NQ_197b8394-4adc-4a20-9ebf-4fd11350bbf9"
      unitRef="usd">653700000</sgry:LeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS00LTEtMS00NzU3NQ_a4c06b6b-5e4e-482c-ac06-a760bad79df5"
      unitRef="usd">35700000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfOS02LTEtMS00NzU3NQ_d5f8993c-ef50-44a3-a58a-e6088d1e93ff"
      unitRef="usd">40100000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTAtNC0xLTEtNDc1NzU_cb06fec6-f27a-45a9-9ac1-554f9dd8310a"
      unitRef="usd">271800000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTAtNi0xLTEtNDc1NzU_027e122a-4434-42fb-a002-869de8efc13d"
      unitRef="usd">315600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTEtNC0xLTEtNDc1NzU_493cc604-0448-4806-bcb6-dd5fd6d5ea67"
      unitRef="usd">307500000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTEtNi0xLTEtNDc1NzU_31d98d20-e559-4a9d-8149-818a151690f5"
      unitRef="usd">355700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtNC0xLTEtNDc1NzU_e9ea9474-edf7-419e-ac2e-1e433e749233"
      unitRef="usd">22700000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTMtNi0xLTEtNDc1NzU_524e841a-2dfb-4b64-b766-f6c559b27ae1"
      unitRef="usd">19000000.0</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtNC0xLTEtNDc1NzU_c4eefb60-ed4c-46e0-8546-e5e8572b9e9c"
      unitRef="usd">481600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTQtNi0xLTEtNDc1NzU_d486c94f-cae7-4170-bfc9-0a8fb1105477"
      unitRef="usd">345600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTUtNC0xLTEtNDc1NzU_a7525f84-ab02-4c65-9a1a-ca51589af4ce"
      unitRef="usd">504300000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTUtNi0xLTEtNDc1NzU_db5cd3c8-7262-48d6-9399-69247e6ca853"
      unitRef="usd">364600000</us-gaap:FinanceLeaseLiability>
    <sgry:LeaseLiability
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTYtNC0xLTEtNDc1NzU_dac3846b-6648-4d4d-a229-295a6cd2f0eb"
      unitRef="usd">811800000</sgry:LeaseLiability>
    <sgry:LeaseLiability
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjQzNjhjOTFiNTBhZTQ0OGM4YWNjZjUxNzcyYjJmMTY2L3RhYmxlcmFuZ2U6NDM2OGM5MWI1MGFlNDQ4YzhhY2NmNTE3NzJiMmYxNjZfMTYtNi0xLTEtNDc1NzU_8382d472-39a5-4955-86da-286539c7739e"
      unitRef="usd">720300000</sgry:LeaseLiability>
    <sgry:IncreaseDecreaseInFinanceLeaseLiability
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfNzUw_55fa5719-5f41-41df-a7f7-ea82482af575"
      unitRef="usd">146500000</sgry:IncreaseDecreaseInFinanceLeaseLiability>
    <sgry:IncreaseDecreaseInFinanceLeaseRightOfUseAssets
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfNzU3_0ec49909-c27b-4822-9138-90d41b2999e2"
      unitRef="usd">145000000</sgry:IncreaseDecreaseInFinanceLeaseRightOfUseAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfODYw_248cef59-48a5-42b3-86e2-7db9fd7303fa"
      unitRef="usd">-60800000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <sgry:IncreaseDecreaseInOperatingLeaseRightOfUseAssets
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfODY3_784aea4e-4f31-4b86-9eb2-b2918ccd4cce"
      unitRef="usd">-59300000</sgry:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RleHRyZWdpb246ZmRmYTRjOGY4ZTc3NDM3ODhkNWJlNGIxMWYxNTM5ZjhfMTE1NQ_e3d3c1ab-d789-45c5-809b-c96b0127c44b">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Variable and short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:1pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental cash flow information (dollars in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.840%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfMi0yLTEtMS00NzU3NQ_d612f97e-9064-4557-b936-1f4da19c5706"
      unitRef="usd">32700000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfMi00LTEtMS00NzU3NQ_f8554af4-42d7-41cc-b003-71b96120b367"
      unitRef="usd">37500000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNC0yLTEtMS00NzU3NQ_961c04f6-8d9d-487e-affc-383be2a58865"
      unitRef="usd">18900000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNC00LTEtMS00NzU3NQ_ea772cac-0684-49cc-9ffe-886473d2b6ad"
      unitRef="usd">13800000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNS0yLTEtMS00NzU3NQ_f0f91b46-db66-4e60-bbe1-8ae6c47c89d5"
      unitRef="usd">19700000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNS00LTEtMS00NzU3NQ_31ab3c76-7d1f-4b0e-976f-e431bac46efa"
      unitRef="usd">12600000</us-gaap:FinanceLeaseInterestExpense>
    <sgry:FinanceLeaseCost
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNi0yLTEtMS00NzU3NQ_514270a3-cc0b-405c-adc9-1a6f45e65910"
      unitRef="usd">38600000</sgry:FinanceLeaseCost>
    <sgry:FinanceLeaseCost
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNi00LTEtMS00NzU3NQ_c5b5ab6b-e87c-4de5-8c81-4936cf6a5d6a"
      unitRef="usd">26400000</sgry:FinanceLeaseCost>
    <sgry:VariableAndShortTermLeaseCost
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNy0yLTEtMS00NzU3NQ_3e6654dd-37d0-49c8-ad6d-b1a262776265"
      unitRef="usd">8500000</sgry:VariableAndShortTermLeaseCost>
    <sgry:VariableAndShortTermLeaseCost
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfNy00LTEtMS00NzU3NQ_d4da9f8f-6148-462f-8f4c-c15c063b55bc"
      unitRef="usd">9800000</sgry:VariableAndShortTermLeaseCost>
    <us-gaap:LeaseCost
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfOC0yLTEtMS00NzU3NQ_e604c493-46f7-4cf7-ba22-ac82cc0ade6d"
      unitRef="usd">79800000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOjg3ZWU3ZTg1YTQwOTQ5MmE5NzUyNGJjNGY3ZjU2NTY2L3RhYmxlcmFuZ2U6ODdlZTdlODVhNDA5NDkyYTk3NTI0YmM0ZjdmNTY1NjZfOC00LTEtMS00NzU3NQ_7f93e33a-ee12-4890-a0f1-85e8c9eb53c5"
      unitRef="usd">73700000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfMy0xLTEtMS00NzU3NQ_836b8759-1974-44e8-8f44-e5fd8f85f960"
      unitRef="usd">31700000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfMy0zLTEtMS00NzU3NQ_b1f86644-7cb4-4216-8445-559b32fb9806"
      unitRef="usd">36700000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfNC0xLTEtMS00NzU3NQ_09807605-d068-4947-a1fe-4c28143f6e40"
      unitRef="usd">19600000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfNC0zLTEtMS00NzU3NQ_0b6d76dd-ae31-45a7-bf4f-9140723869f0"
      unitRef="usd">11900000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfNS0xLTEtMS00NzU3NQ_86ddb2e8-f2e9-42d9-a457-9c914de63436"
      unitRef="usd">12100000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfNS0zLTEtMS00NzU3NQ_b88d41a9-118b-416a-82bb-22b92f7c6456"
      unitRef="usd">10600000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfOC0xLTEtMS00NzU3NQ_f9527a87-a551-45e2-ab25-1e68380fee9d"
      unitRef="usd">31100000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfOC0zLTEtMS00NzU3NQ_ff6f9990-861d-4e20-9362-5fc412c68e6c"
      unitRef="usd">31400000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfOS0xLTEtMS00NzU3NQ_3f92c09a-9f8e-4f4f-9b17-ffc10e4e426e"
      unitRef="usd">91900000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80MC9mcmFnOmZkZmE0YzhmOGU3NzQzNzg4ZDViZTRiMTFmMTUzOWY4L3RhYmxlOmVjMzI4NGYyNzZmMjQyN2FhYzA3MzU2NzViMTYwNGM0L3RhYmxlcmFuZ2U6ZWMzMjg0ZjI3NmYyNDI3YWFjMDczNTY3NWIxNjA0YzRfOS0zLTEtMS00NzU3NQ_7415ffe0-8a33-4731-ac82-6e26c7f45397"
      unitRef="usd">6600000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNDkwOQ_4b98b53c-e928-44b0-8431-b796d2665050">Derivatives and Hedging Activities&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps and interest rate caps as part of its interest rate risk management strategy. During 2022 and 2021, such derivatives have been used to hedge the variable cash flows associated with existing variable-rate debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income ("OCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#x2019;s accounting policy election. Amounts reported in accumulated OCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#x2019;s variable-rate debt. Over the next 12 months, the Company estimates that an additional $7.2 million will be reclassified as a decrease to interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the Company had nine interest rate swaps with a total net hedged notional amount of $1.2&#160;billion and two interest rate caps with a total hedged notional amount of $325.9&#160;million. Of the nine interest rate swaps, three are pay-fixed, receive 1-Month LIBOR (subject to a minimum of 0.75%) interest rate swaps designated in cash flow hedging relationships with a total notional amount of $1.2&#160;billion and a termination date of March 31, 2025. The remaining six interest rate swaps are undesignated and consist of three pay-fixed, receive 1-Month LIBOR (subject to a minimum of 1.00%) interest rate swaps and three pay 1-Month LIBOR (subject to a minimum of 1.00%), receive-fixed interest rate swaps with a termination date of November 30, 2023. The pay-floating, receive-fixed swaps are designed to economically offset the undesignated pay-fixed, receive-floating swaps. The interest rate caps each have a termination date of March&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The pay-fixed, receive floating interest rate swaps did not meet the requirements to be considered derivatives in their entirety as a result of the financing component. Accordingly, the swaps are considered hybrid instruments, consisting of a financing element treated as a debt instrument and an embedded at-market derivative that was designated as a cash flow hedge. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Within the Company&#x2019;s condensed consolidated balance sheets, the financing elements treated as debt instruments described above are carried at amortized cost and the embedded at-market derivatives and the undesignated swaps are recorded at fair value. The cash flows related to the portion treated as debt are classified as financing activities in the condensed consolidated statements of cash flows while the portion treated as an at-market derivative are classified as operating activities. Cash settlements related to the undesignated swaps will offset and are classified as operating activities in the condensed consolidated cash flows. Within the Company&#x2019;s condensed consolidated balance sheets, the interest rate caps are recorded at fair value. The cash flows related to the interest rate caps are classified as operating activities in the condensed consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The key terms of interest rate swaps and interest rate caps outstanding are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;163.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;120.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;120.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(165.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(165.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(120.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(120.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(150.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(150.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,525.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,533.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our interest rate swap agreements, excluding the portion treated as debt, are recognized at fair value in the condensed consolidated balance sheets and are valued using pricing models that rely on market observable inputs such as yield curve data, which are classified as Level 2 inputs within the fair value hierarchy. The fair value of the interest rate caps are determined using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the caps. The variable interest rates used in the calculation of projected receipts on the caps are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities. The interest rate caps are classified using Level 2 inputs within the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the fair values of our derivatives and their location on the condensed consolidated balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.995%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives in cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;The balance as of June&#160;30, 2022 and December&#160;31, 2021 is related to the financing component of the pay-fixed, receive floating interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the pre-tax effect of the interest rate swaps and caps on the Company's accumulated OCI and condensed consolidated statement of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(Gain) loss recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives in cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in OCI (effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss reclassified from accumulated OCI into income (effective portion) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $5.3 million and $3.2 million for the three months ended June&#160;30, 2022 and 2021, respectively. Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $10.6 million and $3.2 million for the six months ended June&#160;30, 2022 and 2021, respectively.&lt;/span&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTEyNg_a9d6f8cc-c8fb-47b1-847a-53134e878daa"
      unitRef="usd">7200000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i0d641fec5a614286a665a368239cb7fe_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTIxMg_bf7f35c0-3976-4102-b8f3-b07cdf16b0f9"
      unitRef="interest_rate_swap">9</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i624ef5b3954c440ca2df8007f64bb190_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTI3OA_8fc9c0bd-9035-44da-ab43-34be73c24fb5"
      unitRef="usd">1200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i9405d2dfa6a44be3b5a5fddf7e37ce73_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTI4NQ_8cf7f7d8-ce66-426c-ac24-26b39d7a8dcc"
      unitRef="interest_rate_swap">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibec9eb2e922848e193c29ccb4d324b59_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTM0Ng_bb7b1d43-c3ba-48b9-9779-23f1a0cf635a"
      unitRef="usd">325900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="i0d641fec5a614286a665a368239cb7fe_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTM1Nw_2ff88dd4-3145-4ee8-b55d-b559cc650a6b"
      unitRef="interest_rate_swap">9</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="if84173ed23fc455c8dc5af7694d68f70_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTQ0Ng_644ba327-8412-4113-a66f-965e768b1017"
      unitRef="number">0.0075</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i624ef5b3954c440ca2df8007f64bb190_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTU0OA_a0914b44-4c0e-485d-bb18-56cb778f6c1c"
      unitRef="usd">1200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="i652bb49f02444b3a89f17f2300107e97_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTcxMQ_ac4d3620-ce9e-43a5-b6da-e7705dd2ec98"
      unitRef="number">0.0100</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="i0fccee9038b24758ba351eba3d11e91a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfMTc4NQ_939a99c3-8a9f-4669-98b7-7dbcbd90bba2"
      unitRef="number">0.0100</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNDkxMQ_b0109d50-de31-4783-bd27-c16383f9df1a">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The key terms of interest rate swaps and interest rate caps outstanding are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.144%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effective Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Status&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;330.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;May 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;435.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;163.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;120.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;120.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pay-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;June 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;150.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(165.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(165.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(120.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(120.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Receive-fixed swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(150.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(150.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Active&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,525.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,533.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i7e675653b29b4a30a95a33a4eafccfa8_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMi00LTEtMS00NzU3NQ_4e9bd4ae-15e9-4c1e-a4ad-71b7f2b3d0c5"
      unitRef="usd">435000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i0bac16b3932b4d9f8c149cbe0186184c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMi04LTEtMS00NzU3NQ_1c1152f0-d2fd-4913-becf-4cecbd51862d"
      unitRef="usd">435000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="iea63fb7682374f5fbce4eaf0268880b3_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMy00LTEtMS00NzU3NQ_e940219b-7080-4642-9ddf-23e28157eaed"
      unitRef="usd">330000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i92b3a62c12c645209db966edaf59e976_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMy04LTEtMS00NzU3NQ_48d208ff-ae09-40a3-b3d7-80528529195f"
      unitRef="usd">330000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i0910d6248ac74aa9bcf915cfa2b93d37_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNC00LTEtMS00NzU3NQ_86078262-b572-49d6-8623-c5aa7802394b"
      unitRef="usd">435000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ibf9ff04a00914131a0f5c3d690dd4103_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNC04LTEtMS00NzU3NQ_6d3487d3-c94a-49aa-90bd-0510e0033324"
      unitRef="usd">435000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ica6bbd0b30fa447bbaa6e2d70abf379e_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNS00LTEtMS00NzU3NQ_c9185407-e3ab-4f94-bab8-6744ae3673c3"
      unitRef="usd">163000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie5e9e67aafa642f1b536a59d612f21b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNS04LTEtMS00NzU3NQ_caf25322-9f8b-46db-b8cc-94ad36f23a17"
      unitRef="usd">166800000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i87459cd7cbda4d60b240d0999c63bd43_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNi00LTEtMS00NzU3NQ_421b189b-6aa1-49cb-955a-7b79526b3db7"
      unitRef="usd">162900000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i963697d6f96e442d98f5756ec73485b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNi04LTEtMS00NzU3NQ_44296949-88ce-452f-bb56-d97f2d1b353e"
      unitRef="usd">166800000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="icfd2fc8ece9341b3adef2ac0e05a7557_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNy00LTEtMS00NzU3NQ_c9dda88b-aa3b-4d21-a71a-6aefdeb9f6cc"
      unitRef="usd">165000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i35884d0598254ccb991a911d3502b131_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfNy04LTEtMS00NzU3NQ_61cf3e05-47e6-4ba3-a63e-4ca79d692c8c"
      unitRef="usd">165000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ied5ab0dab33041f989a6b88eb2b43ce3_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfOC00LTEtMS00NzU3NQ_a54b29d9-5c4d-4af3-b1ab-7f378e8c84c3"
      unitRef="usd">120000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="id545da56246a458a9f507b5e10d6b9cb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfOC04LTEtMS00NzU3NQ_14602742-f834-4c9a-bc91-e437b365f790"
      unitRef="usd">120000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i5ee2b1492ec349a2b51e75e9df9f3bb0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfOS00LTEtMS00NzU3NQ_9339dccf-c789-45ed-8fa0-4a4f3edd483d"
      unitRef="usd">150000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i113be4a99c604b2da5b072d5e5d8fa21_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfOS04LTEtMS00NzU3NQ_fd4028fc-667c-404c-b97c-8d15146d51b1"
      unitRef="usd">150000000.0</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i533833368b6c47bf89ba7a880f670cd8_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTAtNC0xLTEtNDc1NzU_ea70d54d-9b29-4e72-ae9c-dd963edc0a56"
      unitRef="usd">165000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ic848ed09b98c48b0a8a7f23e355be28f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTAtOC0xLTEtNDc1NzU_201bf56a-683c-4446-80ed-ef656c16b356"
      unitRef="usd">165000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ib229dcc9506d4c8398a0910a44f53196_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTEtNC0xLTEtNDc1NzU_17342a67-aacb-4a65-8ec8-65c55258bfd2"
      unitRef="usd">120000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ifa055d97ac3b4c02add1ba0a6cc7c820_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTEtOC0xLTEtNDc1NzU_125f36fb-0fd1-4be8-bc6e-dc903a87242e"
      unitRef="usd">120000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i5ccb9be430ab41d58f216a21128552cf_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTItNC0xLTEtNDc1NzU_bd6a750e-6a4e-482b-a8df-b23c28ed8983"
      unitRef="usd">150000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i8fd5b2180b57439b962339cd3bf1d9c0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTItOC0xLTEtNDc1NzU_e55f64a2-ac55-4f50-b44d-deb6071d1e16"
      unitRef="usd">150000000.0</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTMtNC0xLTEtNDc1NzU_83df8c68-6006-4ffd-a1fc-83b5a567499e"
      unitRef="usd">1525900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmFkYzE0MTU2OGJlZTRiMTBiNGRlNDgyN2JjOWFiYjQ1L3RhYmxlcmFuZ2U6YWRjMTQxNTY4YmVlNGIxMGI0ZGU0ODI3YmM5YWJiNDVfMTMtOC0xLTEtNDc1NzU_feea789b-25a4-45d7-8c41-cb61e05c90bb"
      unitRef="usd">1533600000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNDkxMg_aee92b04-1351-4606-82ae-3eb78e9aa393">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the fair values of our derivatives and their location on the condensed consolidated balance sheets (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.995%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives in cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:3.02pt"&gt;The balance as of June&#160;30, 2022 and December&#160;31, 2021 is related to the financing component of the pay-fixed, receive floating interest rate swaps.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i7ff529d76c974a7a8aea1a917b35b64b_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMy00LTEtMS00NzU3NQ_24954b6b-e505-470c-a39a-e3bb43e0e997"
      unitRef="usd">2900000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i91cee683d0cb47b8a7410f692915b4ab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMy04LTEtMS00NzU3NQ_8a1ead4b-161a-4608-adb4-ce94cd646310"
      unitRef="usd">12500000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ic454598ff0b04e2b96bfa6db8aed8d32_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfNC02LTEtMS00NzU3NQ_001f7ff5-cce9-44be-b658-a5b3621842b7"
      unitRef="usd">2900000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="iccbe30e44be742e4a2c505011293909f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfNC0xMC0xLTEtNDc1NzU_ed19f64a-ddc4-4d56-a012-78fe220a6b9a"
      unitRef="usd">12400000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ic3112ecc656048f9963864a981edf6e8_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfNy00LTEtMS00NzU3NQ_f597e208-ddfd-4c3d-88b5-7fd3c1d01107"
      unitRef="usd">13500000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ic1c2b5dd09894633b50efcebda46b25c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfNy04LTEtMS00NzU3NQ_0c84f7c1-4071-4fe1-856b-fe81868d07c8"
      unitRef="usd">2900000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i87e28fb347c94eb9abfe022c9393fe3f_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfOC00LTEtMS00NzU3NQ_5798531f-a15c-4172-9405-f40b9dd069a9"
      unitRef="usd">62500000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="id40745034fee45fba37203084540e1fc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfOC04LTEtMS00NzU3NQ_9b108102-66c0-493b-9a31-aea47814a66f"
      unitRef="usd">8200000</us-gaap:DerivativeAssetNotionalAmount>
    <sgry:DerivativeLiabilityNotionalAmountFinancingComponent
      contextRef="i0d641fec5a614286a665a368239cb7fe_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfOS02LTEtMS00NzU3NQ_bbf159cd-514e-49e2-a96f-fcd953d3f502"
      unitRef="usd">38800000</sgry:DerivativeLiabilityNotionalAmountFinancingComponent>
    <sgry:DerivativeLiabilityNotionalAmountFinancingComponent
      contextRef="ida372175cdc044c591964aa8bc62bf11_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfOS0xMC0xLTEtNDc1NzU_799b73f4-3413-4686-bc6e-1988f9c00716"
      unitRef="usd">45800000</sgry:DerivativeLiabilityNotionalAmountFinancingComponent>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMTAtNC0xLTEtNDc1NzU_21f6f7ff-b296-4f3c-9188-a3d19ab9ac5c"
      unitRef="usd">78900000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMTAtNi0xLTEtNDc1NzU_e68bd371-023e-4aa9-9f4f-9260480333cd"
      unitRef="usd">41700000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMTAtOC0xLTEtNDc1NzU_4edcd8cc-1fa9-4a7d-83cb-b8f4034ff84e"
      unitRef="usd">23600000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOjdlOWVkOWU4NGE3YjQxMzlhYWMwZWQyOGUwMTM4YjNkL3RhYmxlcmFuZ2U6N2U5ZWQ5ZTg0YTdiNDEzOWFhYzBlZDI4ZTAxMzhiM2RfMTAtMTAtMS0xLTQ3NTc1_b3b12f87-0940-40a5-b2cb-e7bb60825048"
      unitRef="usd">58200000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNDkxMw_b20d5db6-9130-4772-9fd0-3b6257f27233">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following table presents the pre-tax effect of the interest rate swaps and caps on the Company's accumulated OCI and condensed consolidated statement of operations (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(Gain) loss recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives in cash flow hedging relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain (loss) recognized in OCI (effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss reclassified from accumulated OCI into income (effective portion) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $5.3 million and $3.2 million for the three months ended June&#160;30, 2022 and 2021, respectively. Includes amortization of accumulated OCI related to de-designated and terminated interest rate swaps of $10.6 million and $3.2 million for the six months ended June&#160;30, 2022 and 2021, respectively.&lt;/span&gt;</us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="id1657924a29746e68c995f79d41d18f2_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfMy0zLTEtMS00NzU3NQ_b2c5d5a8-8775-442d-a1ee-24b895c659aa"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ia390bedd4c604d87b921bb743e5001af_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfMy01LTEtMS00NzU3NQ_899550cb-55ed-45a3-bfa8-050597fa2de2"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="id1d2ff8d35f9424eac0c1076c4c642a4_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfMy03LTEtMS00OTM2Mw_72711e75-cc21-4960-9d29-9321a454a0a7"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i99fa76822a7c4953b5d77c75c594a220_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfMy05LTEtMS00OTM2Mw_3766d279-af7a-4ad6-9316-fa944649aa5a"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6f2dff4c01ce4f1c8dc3f58ea1d2f195_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNi0zLTEtMS00NzU3NQ_07f4eb39-8c67-4af6-a902-09935a73bcd2"
      unitRef="usd">12700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iabfd2c1c39ee49308512e86fea44e1e4_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNi01LTEtMS00NzU3NQ_9a8430bd-910e-46d4-aa76-159836aedb92"
      unitRef="usd">-5800000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5aa994d75ecc45929183b091586f7b83_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNi03LTEtMS00OTM3MA_be4e0c9c-4921-48a1-a0f8-6809a9a67dad"
      unitRef="usd">63100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3daec31ecd414074ac61cd4c7433ff05_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNi05LTEtMS00OTM3MA_882598ac-cc4e-4e60-9f7b-87839082c7c8"
      unitRef="usd">-4900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="iaf3f8870fede40489dc7020e3bc79d19_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNy0zLTEtMS00NzU3NQ_75d6908e-be98-425d-870c-902b24dae28c"
      unitRef="usd">6300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib66f2867150d4f6d9cbba76ffaa3892d_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNy01LTEtMS00NzU3NQ_85d61e08-8d45-4c55-aa64-5c31c0277849"
      unitRef="usd">6000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i0309fa024ab34d959fd9963466f2ccc3_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNy03LTEtMS00OTM3Ng_578d0e09-21b0-410d-b07c-aa8599f4103c"
      unitRef="usd">12700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i36b6a3ca602748ce951abd5c3ecb073a_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RhYmxlOmVhZmU5OWFkOGE1YTRjNWI5ZjNlN2Y3NTZlMTE1OTU0L3RhYmxlcmFuZ2U6ZWFmZTk5YWQ4YTVhNGM1YjlmM2U3Zjc1NmUxMTU5NTRfNy05LTEtMS00OTM3Ng_884f7361-5d43-4176-893a-c67b54cc5041"
      unitRef="usd">11500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNDgyMQ_d3765c41-aa85-48e2-90ef-acf779270cfe"
      unitRef="usd">5300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNTQ5NzU1ODE4ODA2_51f24acb-08fd-417a-8d53-a99c60125b23"
      unitRef="usd">3200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNTQ5NzU1ODE5MDY3_1bb5571a-16ba-44b5-8d2e-5ea3acfe66e2"
      unitRef="usd">10600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80My9mcmFnOmFjNzVlNGZiZjVmNjQyMjc5MmE5MzU3ZTcyZWUxN2E0L3RleHRyZWdpb246YWM3NWU0ZmJmNWY2NDIyNzkyYTkzNTdlNzJlZTE3YTRfNTQ5NzU1ODE5MDcx_8a61ff05-789a-49f2-a43a-7ad3f889413a"
      unitRef="usd">3200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RleHRyZWdpb246YTkzMDQwYzc4ZDQwNDhkMDhkMzVjNzYzZDQ1YWVhYjlfMTI5MQ_5e0b8b13-43d0-4be0-920b-59b95526d628">Earnings Per Share&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings per share are calculated based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Surgery Partners, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: amounts allocated to participating securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding- basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding- diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes dividends accrued for the Series A Preferred Stock for the six months ended June 30, 2021. The Series A Preferred Stock did  not participate in undistributed losses and was converted to common stock during the second quarter of 2021. There were no participating securities for the three and six months ended June 30, 2022 and the three months ended June 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RleHRyZWdpb246YTkzMDQwYzc4ZDQwNDhkMDhkMzVjNzYzZDQ1YWVhYjlfMTI4OA_1ee13820-bed2-4c5c-8c1b-466d39ac1700">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.114%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss attributable to Surgery Partners, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(47.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: amounts allocated to participating securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(58.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding- basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding- diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;Includes dividends accrued for the Series A Preferred Stock for the six months ended June 30, 2021. The Series A Preferred Stock did  not participate in undistributed losses and was converted to common stock during the second quarter of 2021. There were no participating securities for the three and six months ended June 30, 2022 and the three months ended June 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMy0xLTEtMS00NzU3NQ_9ea82799-d83e-48a9-86b0-77b28091e9b7"
      unitRef="usd">-18400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMy0zLTEtMS00NzU3NQ_18f87ff7-b16a-4d20-83c5-74a690327976"
      unitRef="usd">-26900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMy01LTEtMS00OTQ2Ng_646e7645-1df1-4737-b7f4-78963bd30a23"
      unitRef="usd">-6200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMy03LTEtMS00OTQ2OA_e5b493b8-d4aa-4f60-9e30-b2a1b322a926"
      unitRef="usd">-47900000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNC0xLTEtMS00NzU3NQ_19b03f33-9a3e-4662-9493-851c86b6275e"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNC0zLTEtMS00NzU3NQ_f6027f64-02ec-4b94-b1d5-fd928043110b"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNC01LTEtMS00OTQ3MA_c7e153c9-ac2f-485e-8f3f-4c1dcc2ad668"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNC03LTEtMS00OTQ3MA_03c73afc-80a4-446c-855f-22efc10bb635"
      unitRef="usd">10300000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNS0xLTEtMS00NzU3NQ_dc46afe8-59d0-4d8b-abc3-1b3e1e09921a"
      unitRef="usd">-18400000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNS0zLTEtMS00NzU3NQ_ed44b16c-961e-426d-88dc-a5b1bf81dc11"
      unitRef="usd">-26900000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNS01LTEtMS01MTczNw_5d2382ea-9d00-44c0-a364-a202665ff488"
      unitRef="usd">-6200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfNS03LTEtMS01MTczNw_0c929359-1124-44c1-8292-b8c65ed06446"
      unitRef="usd">-58200000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOC0xLTEtMS00NzU3NQ_7006dcc6-d746-4afb-836f-825cc0074099"
      unitRef="shares">88900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOC0zLTEtMS00NzU3NQ_5210479c-ebc8-460e-ab3d-8e73badf45cc"
      unitRef="shares">69267000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOC01LTEtMS00OTQ3OQ_91bfc1f2-63bc-4f0a-9857-1325b7978fd1"
      unitRef="shares">88450000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOC03LTEtMS00OTQ3OQ_2be5af9a-09bc-4bd9-86c2-67bd21a09e56"
      unitRef="shares">62060000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOS0xLTEtMS00NzU3NQ_6fa8e59d-067d-4f1a-8a3e-44ccb24bae22"
      unitRef="shares">88900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOS0zLTEtMS00NzU3NQ_9188b746-7511-4a6e-83f4-d2ad76d21a40"
      unitRef="shares">69267000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOS01LTEtMS00OTQ5Mw_3d53d51f-b98c-4857-b5d8-4a02d9344f76"
      unitRef="shares">88450000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfOS03LTEtMS00OTQ5Mw_b68bb13b-2f72-4575-a8cd-8f774d4d26b1"
      unitRef="shares">62060000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTItMS0xLTEtNDc1NzU_4acb88b2-0234-46ed-80b0-23278799b001"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTItMy0xLTEtNDc1NzU_d1bfbe4b-efb7-466e-b40e-5bf6f8bef257"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTItNS0xLTEtNDk1NDI_77981cef-2e63-417d-bfdc-741b1f25724f"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTItNy0xLTEtNDk1NDI_6ae84e80-d9b7-49b6-b459-f31d3f8ea4e2"
      unitRef="usdPerShare">-0.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTMtMS0xLTEtNDc1NzU_20c37dcb-16cf-4cd3-81d4-b787c48fd9b3"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTMtMy0xLTEtNDc1NzU_f6027967-7a44-4bca-b236-23ca39f1e501"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTMtNS0xLTEtNDk1NTc_3f034659-b327-4d87-ae7a-dac3fbff533b"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTMtNy0xLTEtNDk1NjM_effbfac6-e310-4c59-9acb-dfb22a6c610d"
      unitRef="usdPerShare">-0.94</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i63a22d68b90b48909dc3d1b1b5b8a20e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTYtMS0xLTEtNDc1NzU_a4812940-92dd-45cc-be97-b46d11c37270"
      unitRef="shares">1559000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i020ea1b80b0942b19fcb6613eff5fd71_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTYtMy0xLTEtNDc1NzU_41cbfd37-75a7-4f1b-be59-0783641e3982"
      unitRef="shares">2016000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i58659716e1cf471dafca42309eeb5309_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTYtNS0xLTEtNDk1Njk_9a7e049b-67dc-4b1d-8a41-a6dd6c0e1972"
      unitRef="shares">1599000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idd945ed3ab5f4ffda421c746ebe77bab_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTYtNy0xLTEtNDk1Njk_24a575cd-b66b-4c42-a962-6512c1d7d58c"
      unitRef="shares">1901000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i34857924f21749c1b51e0cd2f31b0597_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTctMS0xLTEtNDc1NzU_3822b379-dd36-42b6-ac48-5eba85a25666"
      unitRef="shares">628000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2612faa6b1474823bc2ad95518bc8aa3_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTctMy0xLTEtNDc1NzU_4ee5c161-4561-4664-ad69-0156ef32d432"
      unitRef="shares">1484000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i590c785262294ff4b5426d751376a0aa_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTctNS0xLTEtNDk1NzU_eeaa7c9a-bc6d-4299-a659-c5b7934b7a01"
      unitRef="shares">644000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie7846148240d4ef5af33eeefb926fa03_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RhYmxlOjJhNGI2NGMxZWVkYzRjM2ZhNWQ1OGE1YzI5MGVhZDkxL3RhYmxlcmFuZ2U6MmE0YjY0YzFlZWRjNGMzZmE1ZDU4YTVjMjkwZWFkOTFfMTctNy0xLTEtNDk1NzU_c8be3cda-83b7-4885-9e00-8d5c4bdb8951"
      unitRef="shares">1451000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RleHRyZWdpb246YTkzMDQwYzc4ZDQwNDhkMDhkMzVjNzYzZDQ1YWVhYjlfMTA2Mg_3165975f-4fa5-4fa5-87a3-82469e937080"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RleHRyZWdpb246YTkzMDQwYzc4ZDQwNDhkMDhkMzVjNzYzZDQ1YWVhYjlfMTA2Mg_323deb2e-de00-473a-85da-b05aac93f76f"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80Ni9mcmFnOmE5MzA0MGM3OGQ0MDQ4ZDA4ZDM1Yzc2M2Q0NWFlYWI5L3RleHRyZWdpb246YTkzMDQwYzc4ZDQwNDhkMDhkMzVjNzYzZDQ1YWVhYjlfMTA2Mg_4e7875d6-c7dd-4c87-bb6f-2500d40f65dc"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RleHRyZWdpb246ZDE0ZmRlZmViN2EyNGYwMmE0ODE5MmNhZmE1NmY3OGNfMTEw_605b159e-1380-4297-9557-5c0685b817fa">Other Current Liabilities&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of other current liabilities is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts due to patients and payors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost report liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax receivable agreement liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;221.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RleHRyZWdpb246ZDE0ZmRlZmViN2EyNGYwMmE0ODE5MmNhZmE1NmY3OGNfMTA1_57261f1b-27b5-48c4-971e-e52a74fd9fb3">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A summary of other current liabilities is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right-of-use operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts due to patients and payors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost report liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax receivable agreement liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;221.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfMi0yLTEtMS00NzU3NQ_fda4c622-400d-447a-b809-fc33a8a9f284"
      unitRef="usd">35700000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfMi00LTEtMS00NzU3NQ_b33076df-5eab-406d-acda-933313934591"
      unitRef="usd">40100000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfMy0yLTEtMS00NzU3NQ_7a9350cb-81ba-45c0-9111-d2701c081d71"
      unitRef="usd">28800000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfMy00LTEtMS00NzU3NQ_b7360234-d2c5-4918-83a9-7f2101fc359e"
      unitRef="usd">29200000</us-gaap:InterestPayableCurrent>
    <srt:PayablesToCustomers
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNC0yLTEtMS00NzU3NQ_80edbd2d-f181-41ea-a5be-d14dd541a30b"
      unitRef="usd">32500000</srt:PayablesToCustomers>
    <srt:PayablesToCustomers
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNC00LTEtMS00NzU3NQ_86b9ff02-d676-4dd1-a5b6-35f619a89659"
      unitRef="usd">26000000.0</srt:PayablesToCustomers>
    <sgry:CostReportLiabilitiesCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNS0yLTEtMS00NzU3NQ_03cedbb5-aee0-4a3c-bee4-f7c2a73b544f"
      unitRef="usd">22100000</sgry:CostReportLiabilitiesCurrent>
    <sgry:CostReportLiabilitiesCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNS00LTEtMS00NzU3NQ_22b805d5-b148-46e5-aae8-cca7426ab304"
      unitRef="usd">26400000</sgry:CostReportLiabilitiesCurrent>
    <sgry:TaxReceivableAgreementLiabilityCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNi0yLTEtMS00NzU3NQ_7fe71624-0511-48cb-bc6f-5fcf48986cfc"
      unitRef="usd">20200000</sgry:TaxReceivableAgreementLiabilityCurrent>
    <sgry:TaxReceivableAgreementLiabilityCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNi00LTEtMS00NzU3NQ_03d97f29-e361-4caa-be26-e33af3165e6e"
      unitRef="usd">19700000</sgry:TaxReceivableAgreementLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNy0yLTEtMS00NzU3NQ_b52d7e9e-ebb5-4f5e-9194-9d4c8e6e4162"
      unitRef="usd">82500000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfNy00LTEtMS00NzU3NQ_e68a3c59-07e2-45dd-80c7-e7938cfb468c"
      unitRef="usd">68600000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfOC0yLTEtMS00NzU3NQ_3d0f07a9-e353-46f8-b657-cc363beaa5cf"
      unitRef="usd">221800000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF80OS9mcmFnOmQxNGZkZWZlYjdhMjRmMDJhNDgxOTJjYWZhNTZmNzhjL3RhYmxlOmM1OTliNTQwMjNkMjRkZDhiMmMwZmE0YWEzMGI4YTFkL3RhYmxlcmFuZ2U6YzU5OWI1NDAyM2QyNGRkOGIyYzBmYTRhYTMwYjhhMWRfOC00LTEtMS00NzU3NQ_40ff9162-8cd7-4bd4-b41c-987342dc07c3"
      unitRef="usd">210000000.0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODU4Mg_72f8b5c8-7a93-4dcb-be00-8457a1f483dc">Commitments and Contingencies&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Professional, General and Workers' Compensation Liability Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains professional, general and workers' compensation liability insurance in excess of self-insured retentions through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity. Total professional, general and workers' compensation claim liabilities as of June&#160;30, 2022 and December&#160;31, 2021 were $18.2 million and $19.8 million, respectively. Expected insurance recoveries of $8.7 million as of both June&#160;30, 2022 and December&#160;31, 2021 are included as a component of other current assets and other long-term assets in the condensed consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Laws and Regulations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory sanctions including fines, penalties, and exclusion from the Medicare, Medicaid and other federal health care programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stockholder Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December 4, 2017, a purported Company stockholder filed an action in the Delaware Court of Chancery (the "Delaware Action"). That action is captioned Witmer v. H.I.G. Capital, L.L.C., et al., C.A. No. 2017-0862. The plaintiff in the Delaware Action asserted claims against (i) certain current and former members of the Company&#x2019;s Board of Directors (together, the "Directors"); (ii) H.I.G. Capital, LLC and certain of its affiliates (collectively, "H.I.G."); and (iii) Bain Capital Private Equity, L.P. and certain of its affiliates (collectively, "Bain Capital" and, together with the Directors and H.I.G., the "Defendants"). The parties to the Delaware Action negotiated a final stipulation of settlement (the &#x201c;Settlement Stipulation&#x201d;), which governs the terms of the settlement of the Delaware Action, and which they filed with the Court of Chancery on November 22, 2021. On February 11, 2022, the Court of Chancery approved the settlement of the Delaware Action as memorialized in the Settlement Stipulation. That decision became final and non-appealable on March 14, 2022. The case is now closed. Pursuant to the settlement, the Company received $32.8&#160;million in March 2022, which was included in litigation settlement in the condensed consolidated statements of operations for the six months ended June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquired Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with health care laws and regulations, such as billing and reimbursement laws and regulations, the Stark Law, the Anti-Kickback Statute, the FCA, and similar fraud and abuse laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other health care providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Potential Physician Investor Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Tax Receivable Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the "TRA"), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company&#x2019;s projected realized tax savings over the next five years and are not dependent on the Company&#x2019;s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA, such payments will be deferred and will accrue interest at a rate of the LIBOR plus 500 basis points until paid. If the terms of credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 300 basis points until paid.&lt;/span&gt;&lt;/div&gt;Assuming the Company's tax rate is 24%, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates the total remaining amounts payable under the TRA was approximately $22.0 million as of both June&#160;30, 2022 and December&#160;31, 2021. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company&#x2019;s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $20.7 million and $19.7 million as of June&#160;30, 2022 and December&#160;31, 2021, respectively. The current portion of the liability was $20.2 million and $19.7 million as of June&#160;30, 2022 and December&#160;31, 2021, respectively, and is included as a component of other current liabilities in the condensed consolidated balance sheets. The long-term portion is included as a component of other long-term liabilities in the condensed consolidated balance sheets.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SelfInsuranceReserve
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfMTAwNg_891820dd-9b95-471b-b295-62d204ca4ffe"
      unitRef="usd">18200000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfMTAxMw_72f42ab9-be74-4332-85ad-7eb866065e1e"
      unitRef="usd">19800000</us-gaap:SelfInsuranceReserve>
    <us-gaap:EstimatedInsuranceRecoveries
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfMTA2NA_54303898-0d81-422e-86f4-93f981d79402"
      unitRef="usd">8700000</us-gaap:EstimatedInsuranceRecoveries>
    <us-gaap:EstimatedInsuranceRecoveries
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfMTA2NA_835229b9-8e96-4baf-8708-9d0e5caf063e"
      unitRef="usd">8700000</us-gaap:EstimatedInsuranceRecoveries>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ibe0c66f9f387475f844569ed2d3b3205_D20220301-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfMzQ1Nw_68d83e3f-da08-44cd-842a-2ecd0df55fe9"
      unitRef="usd">32800000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iba332caf963a4b5a996c1691527ca638_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzA2Mg_3e3aae33-132e-49f2-b2f8-22b8666a7f62"
      unitRef="number">0.03</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <sgry:CollaborativeTaxAgreementProjectedTaxSavingsTerm
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzE4Mg_13ca625a-d293-493e-8149-b1c4ce9f7909">P5Y</sgry:CollaborativeTaxAgreementProjectedTaxSavingsTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5c7f8902d58045f499cdd85fdd43307b_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzU0MQ_11d08f7a-08bb-4255-8ee4-23fc916f7f5d"
      unitRef="number">0.0500</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i892c4c41e2e949ed919cd99526bbb6dd_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzg2Nw_83a5e03f-7458-43ad-834f-da268b628a5b"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzkzMA_129d53c9-e1cc-4c26-80a3-e8a90dc6aa2b"
      unitRef="number">0.24</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <sgry:CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate
      contextRef="iba332caf963a4b5a996c1691527ca638_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfNzk5Mg_83101175-e4f6-40fc-bf45-938151ca7d60"
      unitRef="number">0.03</sgry:CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODEzNg_9d19ab05-d386-4b9c-8ef3-3a3bb5d0f29f"
      unitRef="usd">22000000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODEzNg_ee3c9965-8dcc-4620-acfc-21e95d9573e8"
      unitRef="usd">22000000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODQzNA_0f99eddc-c5e5-4016-b598-d460f3d20395"
      unitRef="usd">20700000</sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount>
    <sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODQ0MQ_ae96f083-1747-483f-94e7-d7f37799b943"
      unitRef="usd">19700000</sgry:DeferredIncomeTaxLiabilitiesNetOfDiscount>
    <sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODI0NjMzNzIxNzk4Mg_c15b821f-47b1-43ae-b4ea-f7bdfc6eb967"
      unitRef="usd">20200000</sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent>
    <sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81Mi9mcmFnOjA0YmRkZmZlY2M5ODRjN2Q4YWViNjRlMzdjMTAxZmZmL3RleHRyZWdpb246MDRiZGRmZmVjYzk4NGM3ZDhhZWI2NGUzN2MxMDFmZmZfODI0NjMzNzIxNzk4OQ_f7760710-09a5-41f3-8713-554ccae8db21"
      unitRef="usd">19700000</sgry:DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfMTE0Nw_54936d36-aaa3-4810-a8af-032fe7ba5d29">Segment Reporting&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company currently operates in&#160;two&#160;major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities and the operation of ancillary services. The Surgical Facility Services segment consists of the operation of ASCs, surgical hospitals and anesthesia services. The Ancillary Services segment consists of multi-specialty physician practices. The "All other" line item primarily consists of the Company's corporate general and administrative functions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following tables present financial information for each reportable segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;597.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;525.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,176.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,021.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;543.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,211.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,055.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(45.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(40.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reconciliation of Adjusted EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction, integration and acquisition costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on disposals and deconsolidations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss (gain) on litigation settlement and other litigation costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;This amount includes transaction and integration costs of $8.2 million and $9.2 million for the three months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.2 million for the three months ended June&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;This amount includes transaction and integration costs of $15.3 million and $14.5 million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million for the six months ended June&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;This amount includes other litigation costs of $1.7 million and $0.8 million for the three months ended June&#160;30, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;This amount includes other litigation costs of $3.7 million and $1.8 million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount also includes gain on litigation settlement of $32.8 million for the six months ended June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,691.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,552.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;555.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;517.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,291.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,117.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash purchases of property and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cash purchases of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNjE_3dcf1a2a-6c2b-4bcc-ac96-ebe41669f6b9"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfMTEzMg_65f89926-51c3-4cb5-a0d4-a4c22672df28">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following tables present financial information for each reportable segment (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;597.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;525.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,176.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,021.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;543.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,211.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,055.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(45.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(40.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Reconciliation of Adjusted EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(64.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(67.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Equity-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transaction, integration and acquisition costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on disposals and deconsolidations, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss (gain) on litigation settlement and other litigation costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss on debt extinguishment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;This amount includes transaction and integration costs of $8.2 million and $9.2 million for the three months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $2.2 million for the three months ended June&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;This amount includes transaction and integration costs of $15.3 million and $14.5 million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $6.3 million for the six months ended June&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:5.34pt"&gt;This amount includes other litigation costs of $1.7 million and $0.8 million for the three months ended June&#160;30, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;This amount includes other litigation costs of $3.7 million and $1.8 million for the six months ended June&#160;30, 2022 and 2021, respectively. This amount also includes gain on litigation settlement of $32.8 million for the six months ended June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i33740e780fe041819c21399ef852290a_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMy0yLTEtMS00NzU3NQ_13411bc8-d801-4846-a097-f91ea2b659ba"
      unitRef="usd">597900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i87b86506be1b428c860321716b7a66d8_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMy00LTEtMS00NzU3NQ_fad32a0c-1f4c-4569-8e34-3354045a2d31"
      unitRef="usd">525800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i403f917fe58449dd84f395f95d5d45f5_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMy02LTEtMS00OTYxMg_99c0f40f-1d12-4973-a9fa-4f1eae019595"
      unitRef="usd">1176700000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i62d2cc75b7bf4e3991b46bd2fe6ab2bf_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMy04LTEtMS00OTYxMg_4466eac5-5b97-4f95-95cf-d4d4c2a677ca"
      unitRef="usd">1021600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i410d8e1eee01450cb5b6cfd107a06e90_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNC0yLTEtMS00NzU3NQ_a0cbbe21-9d74-48a7-b679-c760843df3d2"
      unitRef="usd">17500000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3118082a6eee4654817ff68f7ff8cd11_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNC00LTEtMS00NzU3NQ_240abf8a-fdab-42c8-80f4-9610003bf716"
      unitRef="usd">17500000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if9e54a8543c64c13be3bc0583a316c0b_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNC02LTEtMS00OTYxMg_489c6e70-9dfb-4aba-ac22-41ae9f057855"
      unitRef="usd">34900000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4cc71adeac1b48e983f02714d00ddc72_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNC04LTEtMS00OTYxMg_eb025101-8f57-4a5c-a07e-ebba60f6784d"
      unitRef="usd">34100000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNS0yLTEtMS00NzU3NQ_1bf6d495-5d54-4664-8602-7b9089230d49"
      unitRef="usd">615400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNS00LTEtMS00NzU3NQ_75a7dcc1-6879-448b-8168-d9ecbe7a7637"
      unitRef="usd">543300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNS02LTEtMS01MTM0NA_ca83e3ca-2dbe-40aa-abef-d712527ec2fd"
      unitRef="usd">1211600000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfNS04LTEtMS01MTM0NA_3e5454cd-8685-42b3-b9e9-d1804fc3ab2e"
      unitRef="usd">1055700000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i33740e780fe041819c21399ef852290a_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOC0yLTEtMS00NzU3NQ_6051e6de-22fc-45c9-8a81-66adf0c8ac54"
      unitRef="usd">108700000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i87b86506be1b428c860321716b7a66d8_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOC00LTEtMS00NzU3NQ_96bde9d0-d4c2-4dfa-bb2b-678ee2608898"
      unitRef="usd">95600000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i403f917fe58449dd84f395f95d5d45f5_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOC02LTEtMS00OTYyMg_a7a66fa2-63a7-46af-b1c5-e2432545198e"
      unitRef="usd">209700000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i62d2cc75b7bf4e3991b46bd2fe6ab2bf_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOC04LTEtMS00OTYyMg_b6ef6082-f225-4228-9695-c06ac00a1781"
      unitRef="usd">190600000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i410d8e1eee01450cb5b6cfd107a06e90_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOS0yLTEtMS00NzU3NQ_64f4313a-0898-4288-8788-c1ca12ddbc00"
      unitRef="usd">-800000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i3118082a6eee4654817ff68f7ff8cd11_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOS00LTEtMS00NzU3NQ_73720d3a-f22b-46c9-99ef-68f73a2ac6cd"
      unitRef="usd">-100000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="if9e54a8543c64c13be3bc0583a316c0b_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOS02LTEtMS00OTYyMg_3648533c-ff11-488b-8dc6-7f06ab844857"
      unitRef="usd">-700000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i4cc71adeac1b48e983f02714d00ddc72_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfOS04LTEtMS00OTYyMg_48b858ef-2748-4ee7-9957-ecc0acb2c17a"
      unitRef="usd">-1000000.0</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i95419c314ef74baa801a963119c98dc5_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTAtMi0xLTEtNDc1NzU_52d22716-b1c8-4ffc-a468-a442d88d3f8b"
      unitRef="usd">-21800000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="icd1554a1349741dba5cff54478d06171_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTAtNC0xLTEtNDc1NzU_928f91b0-8d3b-4070-b710-39a35ab292f8"
      unitRef="usd">-19600000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i2293dc828b4c49858d186288dc517883_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTAtNi0xLTEtNDk2MjI_3957e87c-9888-4843-9adb-1c00f49bc0f4"
      unitRef="usd">-45800000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i4ea00fc2deb741eeaefccb889320e7bf_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTAtOC0xLTEtNDk2MjI_b14f591d-f629-471c-b560-3d5bcdb60d3f"
      unitRef="usd">-40800000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTEtMi0xLTEtNDc1NzU_ea6135f7-b656-4642-aa14-a2b593439129"
      unitRef="usd">86100000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTEtNC0xLTEtNDc1NzU_6b43ede6-ad5f-4ab5-b58c-c751f136ac9d"
      unitRef="usd">75900000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTEtNi0xLTEtNTE3NDc_3635bc1f-13f5-40b9-a349-9a0e6963e20e"
      unitRef="usd">163200000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTEtOC0xLTEtNTE3NDc_4983e579-a652-4571-931c-26f03b24479c"
      unitRef="usd">148800000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTQtMi0xLTEtNDc1NzU_b05bdb24-4aa9-49d0-bc74-9644888f6654"
      unitRef="usd">19600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTQtNC0xLTEtNDc1NzU_8ac1615e-f4f9-468b-9f83-6407833b1fa8"
      unitRef="usd">6100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTQtNi0xLTEtNDk2Mjg_a33f476a-4f74-4b4d-aeae-9da541f76103"
      unitRef="usd">63700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTQtOC0xLTEtNDk2Mjg_bcd41dae-acb6-4b16-9e0b-ad990791cddc"
      unitRef="usd">17100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTYtMi0xLTEtNDc1NzU_0d507d66-6117-4ad5-b16d-473b853e32b5"
      unitRef="usd">33700000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTYtNC0xLTEtNDc1NzU_7dceef9f-acf3-40ca-b5ce-0cb2e0919b04"
      unitRef="usd">35700000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTYtNi0xLTEtNDk2MzQ_83ec9c69-17a5-4ceb-9c69-cab3007c2b16"
      unitRef="usd">64300000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTYtOC0xLTEtNDk2MzQ_7fdf70b1-b607-49ec-8e59-14269f7309c6"
      unitRef="usd">67500000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTctMi0xLTEtNDc1NzU_f75e3299-6fa3-44d3-9e27-cbf16b34d2cd"
      unitRef="usd">28000000.0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTctNC0xLTEtNDc1NzU_befa1e3f-ffae-4cf8-b3d6-5e0d75ea2782"
      unitRef="usd">25200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTctNi0xLTEtNDk2MzQ_5e327f7a-7261-43e7-aabd-53b876c55cad"
      unitRef="usd">55400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTctOC0xLTEtNDk2MzQ_92491e4b-56e5-4dad-a204-36ce998fd03c"
      unitRef="usd">50900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTgtMi0xLTEtNDc1NzU_70e055bb-a479-4d2f-86d0-f1dd212e77cc"
      unitRef="usd">-56900000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTgtNC0xLTEtNDc1NzU_9d9acc4a-666d-42d0-9494-5c626119ab79"
      unitRef="usd">-53400000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTgtNi0xLTEtNDk2MzQ_4440a585-8817-4ee8-a931-bfdde4bd52cb"
      unitRef="usd">-113200000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTgtOC0xLTEtNDk2MzQ_f1760f64-e4d0-4d3a-a90f-75b452aa3ea0"
      unitRef="usd">-106700000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:ShareBasedCompensation
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTktMi0xLTEtNDc1NzU_2f6aed2c-1cef-44e7-a802-b9a16f109a8d"
      unitRef="usd">4300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTktNC0xLTEtNDc1NzU_05aece36-9245-476b-b0c8-2158e74c09d3"
      unitRef="usd">4100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTktNi0xLTEtNDk2MzQ_e318632e-4019-42dc-b46c-76ae8f2841f6"
      unitRef="usd">8000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMTktOC0xLTEtNDk2MzQ_bc4167d4-7ca9-4a9e-b810-c628b5e5a651"
      unitRef="usd">9300000</us-gaap:ShareBasedCompensation>
    <sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjAtMi0xLTEtNDc1NzU_a78384f4-84b0-42a3-a956-3e278aea7a53"
      unitRef="usd">8200000</sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts>
    <sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjAtNC0xLTEtNDc1NzU_240ee087-e33e-44f9-8bf4-4c695dfa0e25"
      unitRef="usd">11400000</sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts>
    <sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjAtNi0xLTEtNDk2NDA_7245500b-0392-4ea5-a73b-155adccbae84"
      unitRef="usd">15300000</sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts>
    <sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjAtOC0xLTEtNDk2NDA_29c9df19-de08-4c1e-bb02-d88273f578a6"
      unitRef="usd">20800000</sgry:BusinessCombinationIntegrationRelatedCostsAndMergerCosts>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjEtMi0xLTEtNDc1NzU_a0201bba-38ff-4418-9410-77d87d5ef1c4"
      unitRef="usd">-1100000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjEtNC0xLTEtNDc1NzU_3af69366-56f3-431d-9f5d-9bd1bfe1b525"
      unitRef="usd">-1000000.0</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjEtNi0xLTEtNDk2NDY_46295914-9d6a-4861-88bf-ffd519bc95f4"
      unitRef="usd">-1000000.0</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossOnDispositionOfAssetsAndDeconsolidation
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjEtOC0xLTEtNDk2NDY_2ead19e0-0d0c-4430-ab01-6b2571d63220"
      unitRef="usd">-100000</sgry:GainLossOnDispositionOfAssetsAndDeconsolidation>
    <sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItMi0xLTEtNTUxMTc_de177f8a-6ddc-4ff6-84dd-fe3cdfc3bb0b"
      unitRef="usd">-1700000</sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts>
    <sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItNC0xLTEtNTUxMTc_b13a772d-d302-4833-9c15-ab7ea2fadd00"
      unitRef="usd">-800000</sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts>
    <sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItNi0xLTEtNTUxMTc_8e9ba0a9-0b3a-4fee-8075-52144bbe6871"
      unitRef="usd">29100000</sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts>
    <sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItOC0xLTEtNTUxMTc_2990205a-7149-4e1c-9753-9513d5006a45"
      unitRef="usd">-1800000</sgry:GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItMi0xLTEtNDk2NTY_8bb6eee8-e830-46d1-9af5-92690aee93d7"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItNC0xLTEtNDk2NTY_6cde9d05-6437-4c2f-b1f1-21fc1730e0b6"
      unitRef="usd">-9600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItNi0xLTEtNDk2NTY_4ef6ed58-63ab-4f98-8ce0-4b7220a9c475"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjItOC0xLTEtNDk2NTY_a7e0cde3-bf89-47e8-bfbf-d7d7b14dc078"
      unitRef="usd">-9600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjMtMi0xLTEtNDc1NzU_1d0f1159-6f30-42e6-9598-bb7bc41c022b"
      unitRef="usd">86100000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjMtNC0xLTEtNDc1NzU_d51512b1-c471-49f0-94bf-30a24ae8a181"
      unitRef="usd">75900000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjQtNi0xLTEtNTE3NDc_20c9bca2-6c33-4519-8327-e1fb12ee64d5"
      unitRef="usd">163200000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjE3M2Y2MGQzNzkxOTRlZTA4ODg5ZWM1ODlmNWY1NTZmL3RhYmxlcmFuZ2U6MTczZjYwZDM3OTE5NGVlMDg4ODllYzU4OWY1ZjU1NmZfMjQtOC0xLTEtNTE3NDc_d7ca1bd6-6850-4180-a698-cdecd91b740b"
      unitRef="usd">148800000</sgry:EarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNjg5_8c2cd4dd-2d29-44e9-82f6-cb96a8d678a9"
      unitRef="usd">8200000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNjk2_c42b1966-6682-4f85-a273-8827d8c397f3"
      unitRef="usd">9200000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfODM0_b8158109-cedb-4377-b64a-5e1e40199c0e"
      unitRef="usd">2200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE1MzY4_8a0d6667-1e17-4f7e-8495-19794755d607"
      unitRef="usd">15300000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE1Mzcy_d16984fe-ff69-4788-9947-3b55a19a538c"
      unitRef="usd">14500000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE1Mzk0_92076463-e89a-49ed-b762-1cc9af425444"
      unitRef="usd">6300000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:LitigationSettlementExpense
      contextRef="i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfOTIz_fd8791bf-2d75-4a77-8e62-f86958305370"
      unitRef="usd">1700000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i6e8cd90502ca4fa2b3c0a0c1f92fd6ce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfOTMw_564143ce-5529-46c0-83fa-dc9c690b4f51"
      unitRef="usd">800000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE2MTM3_b68f5cab-5fa2-4dbb-acee-c00650a9ef76"
      unitRef="usd">3700000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE2MTQx_c9d97fc2-f7cc-44b0-a61a-1534ef9eb2e6"
      unitRef="usd">1800000</us-gaap:LitigationSettlementExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfNTQ5NzU1ODE2MTQ5_55f50bbc-92a7-4ed7-9159-ff4b0579a2d1"
      unitRef="usd">32800000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfMTE0Ng_1c8f1f95-b792-4d40-8f0b-2de417f64302">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,691.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,552.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;555.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;517.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,291.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,117.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="i23bc251b6a3e49908aa27d058a4353bb_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfMi0yLTEtMS00NzU3NQ_0b1cc874-42c5-42df-b349-34d918e9582b"
      unitRef="usd">5691300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i05385bb60fbf427ead13dc4825931c47_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfMi00LTEtMS00NzU3NQ_501ef99b-da8a-4b2f-af6e-dda85bcc11c3"
      unitRef="usd">5552800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i73110b114b4e4de8888b67e05068b98f_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfMy0yLTEtMS00NzU3NQ_aaef5505-4126-4b95-99b6-477b3a7ff800"
      unitRef="usd">44500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i15e47b2c1f284ef6921de8dbbd99e9a8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfMy00LTEtMS00NzU3NQ_b8222728-f585-4aee-bbd6-bcb36eeee77c"
      unitRef="usd">47500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0e234b442be44c11a6adaee5cffc93f3_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfNC0yLTEtMS00NzU3NQ_975a3429-0f70-4c2f-9e01-936f208f9c1c"
      unitRef="usd">555800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i981cc515616546ff8ac377ab4fc32af5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfNC00LTEtMS00NzU3NQ_87d3b96e-2b18-4681-8d76-f6acaa2d8ac2"
      unitRef="usd">517300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfNS0yLTEtMS00NzU3NQ_248a4965-a0de-4d0b-81d2-acc8307b6025"
      unitRef="usd">6291600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i05b7208bc5d946119ab875dbf0311579_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOjY2MjY0YzhiOWI5YjRiMTk5ZDg5YTE0MTU5NTk3ZDZkL3RhYmxlcmFuZ2U6NjYyNjRjOGI5YjliNGIxOTlkODlhMTQxNTk1OTdkNmRfNS00LTEtMS00NzU3NQ_886ab263-0fe0-4174-a3f3-99c08b3c461d"
      unitRef="usd">6117600000</us-gaap:Assets>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RleHRyZWdpb246OWE2ODUyMzMxZjQ3NDhhYTk5MTc2NzhkNzY5Y2MzYzVfMTEyOQ_fd62d89b-b386-4b71-9b1c-3ab0e644c9dd">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash purchases of property and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Surgical Facility Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ancillary Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cash purchases of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i403f917fe58449dd84f395f95d5d45f5_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfMy0yLTEtMS00NzU3NQ_258bb3d7-11c6-4895-9c83-1c4ea43767cc"
      unitRef="usd">36900000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i62d2cc75b7bf4e3991b46bd2fe6ab2bf_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfMy00LTEtMS00NzU3NQ_1b71a43e-515e-4287-b382-7285742c740a"
      unitRef="usd">27200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if9e54a8543c64c13be3bc0583a316c0b_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNC0yLTEtMS00NzU3NQ_77565932-f5ea-4962-9979-6732903b0fa4"
      unitRef="usd">500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4cc71adeac1b48e983f02714d00ddc72_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNC00LTEtMS00NzU3NQ_3ba21654-c535-4594-99c2-d16694a8bddb"
      unitRef="usd">200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2293dc828b4c49858d186288dc517883_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNS0yLTEtMS00NzU3NQ_ea31a26a-63b3-4c2a-8405-179c71033dda"
      unitRef="usd">3200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4ea00fc2deb741eeaefccb889320e7bf_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNS00LTEtMS00NzU3NQ_1b88ad9c-15ef-4d27-81b6-cf6628578629"
      unitRef="usd">600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNi0yLTEtMS00NzU3NQ_60fed64b-54b7-4a81-b82f-626e03f1b7fa"
      unitRef="usd">40600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i530c0dbad7c8480caea66f77225aeb50_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81NS9mcmFnOjlhNjg1MjMzMWY0NzQ4YWE5OTE3Njc4ZDc2OWNjM2M1L3RhYmxlOmEzMWFmNjE0ODMwZDQwZTU5Zjc0MmE3ZjIyODM1NDk4L3RhYmxlcmFuZ2U6YTMxYWY2MTQ4MzBkNDBlNTlmNzQyYTdmMjI4MzU0OThfNi00LTEtMS00NzU3NQ_939e5b50-ab9d-4bcc-bfac-d7481676d61a"
      unitRef="usd">28000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81OC9mcmFnOjQyMzk3MTFiYWFkNjQ4OGE4OTQ0ZGZlYzVmYjc4MGU4L3RleHRyZWdpb246NDIzOTcxMWJhYWQ2NDg4YTg5NDRkZmVjNWZiNzgwZThfMjg0_da274322-c3c4-4372-ba5b-2752c8d6ab83">Subsequent EventsIn July 2022, the Company acquired non-controlling interests in two surgical facilities and three in-development de novo surgical facilities for a combined purchase price of $29.3&#160;million. The non-controlling interests will be accounted for as equity method investments.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="ib78433cb866f4b209cb42b742ebd6d86_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81OC9mcmFnOjQyMzk3MTFiYWFkNjQ4OGE4OTQ0ZGZlYzVmYjc4MGU4L3RleHRyZWdpb246NDIzOTcxMWJhYWQ2NDg4YTg5NDRkZmVjNWZiNzgwZThfMTY0OTI2NzQ0MjU3MQ_7b66ab63-82e6-4488-8675-84efeee63d0f"
      unitRef="property">2</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i1b0e6fb212964ed98b69386800807bd2_I20220731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81OC9mcmFnOjQyMzk3MTFiYWFkNjQ4OGE4OTQ0ZGZlYzVmYjc4MGU4L3RleHRyZWdpb246NDIzOTcxMWJhYWQ2NDg4YTg5NDRkZmVjNWZiNzgwZThfMTY0OTI2NzQ0MjU3OQ_ffca4545-b35f-4510-8ece-f72ada488637"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="if47fc0612aa043b48a03337684354a15_D20220701-20220731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF81OC9mcmFnOjQyMzk3MTFiYWFkNjQ4OGE4OTQ0ZGZlYzVmYjc4MGU4L3RleHRyZWdpb246NDIzOTcxMWJhYWQ2NDg4YTg5NDRkZmVjNWZiNzgwZThfMTY0OTI2NzQ0MjU1Mg_46dbcb07-5ac8-4aea-9b9d-5661ee8d20e5"
      unitRef="usd">29300000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtMi0xLTEtNDc1NzU_b5f28d77-5d51-485c-afe8-76e4c5789bb4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtMi0xLTEtNDc1NzU_b5f28d77-5d51-485c-afe8-76e4c5789bb4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtNi0xLTEtNDkxMTI_3d1fd00d-04c8-4fa9-adf0-0c1747f8024a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtNi0xLTEtNDkxMTI_3d1fd00d-04c8-4fa9-adf0-0c1747f8024a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtOC0xLTEtNDkxMTI_048b778b-e609-4871-8f57-fe0c400a9097"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtOC0xLTEtNDkxMTI_048b778b-e609-4871-8f57-fe0c400a9097"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItMi0xLTEtNDc1NzU_b3757ed0-08fd-40b2-951f-5f73ee2a0304"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItMi0xLTEtNDc1NzU_b3757ed0-08fd-40b2-951f-5f73ee2a0304"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtOC0xLTEtNDkxMjQ_eda99b14-a47d-4f19-bc1f-4fd63729cccd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtOC0xLTEtNDkxMjQ_eda99b14-a47d-4f19-bc1f-4fd63729cccd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtNC0xLTEtNDc1NzU_e87db349-2d4b-4e41-9b9a-5ae3e02c4c6b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtNC0xLTEtNDc1NzU_e87db349-2d4b-4e41-9b9a-5ae3e02c4c6b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtNi0xLTEtNDkxMjQ_d21dc0c1-7abf-4dee-97b9-4bd96e607bae"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtNi0xLTEtNDkxMjQ_d21dc0c1-7abf-4dee-97b9-4bd96e607bae"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItNC0xLTEtNDc1NzU_f904edcd-d3d3-46d3-8485-a04317ab494b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItNC0xLTEtNDc1NzU_f904edcd-d3d3-46d3-8485-a04317ab494b"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtMi0xLTEtNDc1NzU_b5f28d77-5d51-485c-afe8-76e4c5789bb4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtNi0xLTEtNDkxMTI_3d1fd00d-04c8-4fa9-adf0-0c1747f8024a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzMtOC0xLTEtNDkxMTI_048b778b-e609-4871-8f57-fe0c400a9097"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItMi0xLTEtNDc1NzU_b3757ed0-08fd-40b2-951f-5f73ee2a0304"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtOC0xLTEtNDkxMjQ_eda99b14-a47d-4f19-bc1f-4fd63729cccd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzUtNC0xLTEtNDc1NzU_e87db349-2d4b-4e41-9b9a-5ae3e02c4c6b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzYtNi0xLTEtNDkxMjQ_d21dc0c1-7abf-4dee-97b9-4bd96e607bae"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RhYmxlOjhhMmYyMDBlOTJhMTQxZGNhYTAyZjcwZGJhOTIzNjhiL3RhYmxlcmFuZ2U6OGEyZjIwMGU5MmExNDFkY2FhMDJmNzBkYmE5MjM2OGJfMzItNC0xLTEtNDc1NzU_f904edcd-d3d3-46d3-8485-a04317ab494b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjdjNWJhYmNiMmM2YjQ4ZGJiNjJmYzFjMDZiZGNkODMwL3NlYzo3YzViYWJjYjJjNmI0OGRiYjYyZmMxYzA2YmRjZDgzMF8xNi9mcmFnOmY1MmYwNzM2NzFkMTQyNDA5MDVmMmRmMjFmMGRjOTJiL3RleHRyZWdpb246ZjUyZjA3MzY3MWQxNDI0MDkwNWYyZGYyMWYwZGM5MmJfMzky_f7a5ab58-bc1f-4f26-acfc-cd0b4abe33ff"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>63
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MA_S("G#>.8MU5U'5E<D$QP4A\71^/COVW;&M:)).T];J1.>\U3GWZKS,,G$
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M;I*.4QJ.(8-5#^&64C(.P_CYG32QT1[T2JQF3/Q&I^=]'?&IG_B7JU5NS@"
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MW'(&LHT!/%\+H1]OS!>U]@OJXG]02P,$%     @ E(4"5<WDH5A2 P  $PL
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MP9'(#",XM1*A ^#^DG/U.-'GHO(<'/P%4$L#!!0    ( )2% E6*RYSRZ@@
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M*R*(E ; \TT&L:\O= /-8=;%_P!02P,$%     @ E(4"50DRULC4 P  I0T
M !@   !X;"]W;W)K<VAE971S+W-H965T-2YX;6RM5UUOHS@4_2L6.UJU4@L$
M OG8)%(;&$U635*5SNS#:A^<Q$G0@)VQG:3]]WL-E"'@1IW=Y"%@<\ZQ[_'%
M7 ^.C'\76T(D>DD3*H;&5LI=W[+$<DM2+$RV(Q2>K!E/L80FWUABQPE>9:0T
ML1S;]JT4Q]08#;*^1SX:L+U,8DH>.1+[-,7\]9XD[#@T6L9;QU.\V4K588T&
M.[PA$9%?=X\<6E:ILHI30D7,*.)D/33N6OVPI_ 9X%M,CJ)RCU0D"\:^J\9D
M-31L-2&2D*54"A@N!S(F2:*$8!H_"DVC'%(1J_=OZI^SV"&6!19DS)*_XI7<
M#HVN@59DC?>)?&+'+Z2(QU-Z2Y:([!\="ZQMH.5>2)869)A!&M/\BE\*'RH$
MT-$3G(+@U GM=PAN07 _.D*[(+0_.H)7$++0K3SVS+@ 2SP:<'9$7*%!3=UD
M[F=L\"NF*D\BR>%I##PY&L]G03B+P@#!731_F 1WS]"(GN$R#6?/$9I_AD?3
MQZ?P"^ FWT(TF4$[1%</\RBZ1K?H:Q2@JT_7Z!.**9K&20()( :6A-FI,:QE
M,9/[?";..S-QT911N14HI"NRTO"#\WS_#-\"5TIKG#=K[IVS@G_NJ8E<^P8Y
MMN-HYC/^.+VE"^?_C1[^Y]%/S'#+/'$S/?<=O4AB26!_D(BMT9BEL"EMU6YQ
M(&A"ERPEZ.^[A9 <7OQ_=&N?J[?UZFHS[(L=7I*A <*"\ ,Q1K__UO+M/W3&
M7U(LN*18>"&QDR5JETO4/J<^FL%7)<[60K< .=?/N.KC<1BU/-,=6(>JL4U0
MU^S:U5_KE!$T&5[7K(%"S=@]TR]!)]%Z9;3>V82<RRWA:'F2B7GT-XB2+$TE
M?NGKK/ NF8N7% LN*19>2.QD=?QR=?RSN1@0'A^PJ@'R4B"6K[J5R$6\D\2H
MI60.Z50@MNG4DK")Z7AFMY:$39#_7@YVRB@[9Z,<:[)/%V:G,;3;;KQ[G887
M-2N"IDS+=<T:*FRB'+_BV$F@W3+0[ME 'X@0?:0+%V$I>;S82[Q(")(,449O
ME_ AY@P* ;H!F"207U);$70;<[V%B#HU9W0HKXX*-"B_X7*H0W5,3V]/K[2G
M]\MY@*X2)L1UPY]HSS>$OZ)'S"4E7-RH[Z>I,Z?7V#7M2L+FUC0QM[#:=6N:
M*+]G>KWJKV:31K?=JIB9VV15ZLZ40%RJX!>P*>^IS$N+LK<\4]QEI72M_[[5
M'[<T_0&<0?(CPT_Y_  SQ7P34X$2LH:A;+,#+P[/#P5Y0[)=5O4NF(0:.KO=
MPCF*< 6 YVO&Y%M##5">S$;_ E!+ P04    " "4A0)55*8Q W ,  !=>
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M7F2/OR;U%_(KWB);%=M_K<?:UAY9B_NBS-9U87D%ZW2S^S_^HZZ(@P*.VU&
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M'9XV0B.7*P@[?;FB-GIRN8*PHY8K*#-JN8*P,RQ7N(V@Y?;>:S5D3Q!=S[J
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M_/PZR\HO;ZI?9]W_HO#9_P%02P,$%     @ E(4"59B'3AK\!P  QR,  !@
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6R]FFMOX[82AO\*X5,<[ *U+5'R
M+2<QD-MB6VPNJ+?M9UFB;9Y*HDO2R6Y_?8>4+%HF13M%T'Q82S))OS,<SL/A
MZO*5\3_$AA")OA5Y*:YZ&RFW%\.A2#>D2,2 ;4D)WZP8+Q()MWP]%%M.DDQW
M*O(A#H+QL$AHV9M?ZF?/?'[)=C*G)7GF2.R*(N'?;TC.7J]Z86__X!>ZWDCU
M8#B_W"9KLB#RU^TSA[MA,TI&"U(*RDK$R>JJ=QU>W,:1ZJ!;_$;)JSBX1LJ4
M)6-_J)N?LJM>H!21G*12#9' QPNY)7FN1@(=?]:#]IK?5!T/K_>C?]+&@S'+
M1)!;EO].,[FYZDU[*".K9)?+7]CK9U(;-%+CI2P7^E_T6K<->BC="<F*NC,H
M*&A9?2;?:D<<=(!QW!UPW0$?=X@[.D1U!^VY8:5,FW67R&1^R=DKXJHUC*8N
MM&]T;["&EFH:%Y+#MQ3ZR?GMT^/=_>/B_@[!U>+IRT]WUU_A9O$5/A[N'[\N
MT-,G='N]^(P^?7GZ?8'ZZ-?%'?KPPT?T Z(E>J!Y#K,A+H<2Q*@AAVG]PS?5
M#^..'QZC!U;*C4#W94:R=O\A&-%8@O>6W&#O@#_OR@&*@A\1#C!VZ+D]OWOH
MD1,UCHWT>%&78Q.Q02M8)0*M."L0+#R>2%JNJ\BEDA)QX7);-6SL'E:MZ@NQ
M35)RU8-E*PA_(;WY?_\3CH/_N6Q^I\%:'H@;#\2^T>>/D(1HF;*"N,RL^HYU
M7Y5K7N:CZ0 <_W(HWVX4S@;CIE%+UJB1-?).S'7V?UA6D(FD0))!*DI9F=*<
MH++1JYZKNU3-X9:S%PHABI;?SY_$T7M.XCL-UO+6N/'6V#N)=P0&36E2Y=PR
M0TG!N*1_Z0<NRZOA)H?S.AK$1_/J:!0,9NYYG31*)_YP8V5?3Q@M)0%'2$2^
M >P$^5'-I4OJQ%(18DNJW6@TF+B53ANE4Z_2^S]W5'[O*_ID".)-J:P<7"MV
MB:V&'!WHF!XIG5I*9X,H./P+W;IGC>Z95_<7)@0"E1D56R:27.B R-0"$BRG
MF;9!=+I[9EEPO-QGE@7!H$-S&!C !>>I)DL5$FKU[JC8J 3@I%9@R0R.9-9-
MVI[NR$KA 8C#$RMM13B'B-CGH.0;<7,UM'X^/E@\M4:[43\:X Z1V(C$9X2N
M(C])> FN!->NT*XT(0 &)*L5S2%ED"H65 L(&<GI<J<C1.5< INWS&D=MH4'
MUJH\U:IMGF%VZ 6BR2$Y@<7I6X[U0*WD,;'X5;<Z#"8<=(@T6 UC_\YBDY1K
M(M0D'/!(""*K!0FN7X+_%9L:_R<I3)R@E?OUJ@7_"TGECG<0+/3"_:T(>Z_1
MVBXSR ^]C)Q?IRG;*>!7D9<L<_>DCAS)W@H]NQ&LK*XT93@;^D'[0#*:)IS
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M4"G]!>J.CAHC=E \'&.KRG"T"^-QU_%_;  ?^P%_VR46)1(MR9J6ZKA=)WM
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M23%9*I^;%2SF]'H98F?P5\%GY]!R)#?@^^#]3<M:X^Z@X)!LJWU)_&N4ZB4
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M73E-Y60T4SDB,1.I4%62]>0F9X><P:*1+9UF/W>I>64VUMS=[1DHZF/#'C=
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M=:<->#\UQE<+8E#_.<75?P%02P,$%     @ E(4"58!GN^49!0  P0P  !D
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M_0A,VZC:A=-U: Y+[:C5A&E)O1V-!]#W0FNW6_@$^W^+Z5]02P,$%     @
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MP?B%6/])8+B2PUNT;8?E%6V.NEHF6^IMH?GJM8/:6#V9:)YC[0< ^IA10U<
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M3B5QC^GVTMMVK*K=17.F+*ZMKID+G@E-$S ^5\HN.Z1@]<_#\=]02P,$%
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M'J8UM50T/H'V*ZW=-O '#$TZ^P-02P,$%     @ E(4"5<*9Q'D*%0  #D$
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M/$"_XR6F\ <6B/\+A!?_#U!+ P04    " "4A0)5:<XO;P@&   !$0  &0
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MC*-U3I-L4\IFDT=&WT4*S#TN@''+.%N 2<F),X_#:8?NJW9,M<0B82_8_=P
M;/&%8;3!1WLLONWY0CR@G[#6N\-PH;X*R5K7!1+=S$2*ZJ<\%5(X8G>%9)"T
M!NPE-4G1]#>C$09=2K*V%%K;%_F%<2O"WWK_WANZV .&#?JM'BFHFNYF]-'-
MP3S=$K9B_+C^[53]^VV7AD'0"NCCGO9^#J7;*<T=)3?J<A0+X^;[$6-P?5 Q
MB O^J(W/D+T1WBL&M3"T#[,M7W#U^)-E:95W&%J[(T:GF2;O6R84%D0I,1OM
MV6'*;.@PRJFB41#7G?T$N3/B 5&@'H2!F0[L!*4-D -)Z'UWPJ)>C+TD\&1Y
MJQ_ *"H#+$KZK9!U(L^7*.HB!W! 1!B#G)ZCQUC8Q8^1CW#80Z;$/GI%L$_#
M,Q81<6)/H;"/\F//B6=XU UZ*&8=VR0F%J]'>WA$0'O(G^]X<\*Z88+3)RSI
M$+1CLN[_.K<;$/%+;Z+B<$!.''@?U)R;H)$!^9-(WTDBW(,0D[IS8W)>F7\4
MJ[CF 7)NI^N=2WKBPKF]YYT;-D.L ,$FA9I!)T3ESS@8 XUK.FC*$Q>'S2@D
M"=0+D@1!'*CS257GD^/K/*8*IMB*FXR&;[7.5I@RN\K^0:%'E'U_O1+N$>V3
M/G>=9K-27Y7F%EF4%RR"'2P2EDI(>0JPT^T$O^;2\X0[=@LIY!-T=APV"^IA
M9C8'Z,L^7EJ^+H45=$C;)M(KE<N,2MM"6X<@JX^,9W_C]:HXM<,P0.??"HNK
MN+2^F&60UJ\ B"<:M#IG=1S;Z#V&08R!/A#%;A7%[H]&\8-6B,P9G"7#WBD'
M&!+'SO%8SP#O[%C#=T7XH,(?C+#2ZKP.1I1@[*L7_2B,7IL*T>'@'E->:HZ?
MP$PH10KI_ $C=$;NCX.6#T/012)\P!<-AE_GM,,9,5D6I]M_0QU1?D8=K#4U
M8I%6.^>XA7I[I369 O=49!A15<8_Y%N!R]/K *ZG,N9:9F"(DRCL#)N@%6]1
M$]-KVS<=2@YL0RJ+!PC:JPC:.YJ@-]R81P)<%/XB?]YP8=AG+I>%EW[3:G9^
M#R;'[)VX7?P\J.\(?E*!2==(> T)>E#DGK%3PO108=J^>4A"Z AAA@CW,?4[
M6VMF;CB[59]VSXY!"4VG1;HTE$JD5FJN_%F01'3D^EY,A8EZG9AN'INY;JN7
M!"]1@)>S5&M)2CLT+D,XF#2T(>[1\51K45 Q#OWMH!4$S\KI^7M XO=5;1P6
M]X,>'<>[&-6N/4MS,#/_^*8;'OJM>*%6L]7[?E0\:S?+BW\.O.=X$<0DD3#%
MK6@_'E>F>' 7 Z<7_I$[T0Z?S+X[!XXY0@OP^U2C/>6 %%3_]1C^"U!+ P04
M    " "4A0)5&59RFSP#  #U!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6R%5=N.TS 0_951**@KE5R;MI2VTEY @';1BEW@ ?'@)M/6PK&+[6R!
MKV?LI*&@;GEQ?)ES?&;&,YGME/YF-H@6?E1"FGFPL78[C2)3;+!B)E1;E'2R
M4KIBEI9Z'9FM1E9Z4"6B-(Y'4<6X#!8SOW>K%S-56\$EWFHP=54Q_?,"A=K-
M@R38;WS@ZXUU&]%BMF5KO$/[<7NK:15U+"6O4!JN)&A<S8/S9'HQ=/;>X!/'
MG3F8@_-DJ=0WMWA;SH/8"4*!A74,C#X/>(E"."*2\;WE#+HK'?!POF=_[7TG
M7Y;,X*42GWEI-_-@$D")*U8+^T'MWF#K3^[X"B6,'V'7V*;C (K:6%6U8%)0
M<=E\V8\V#@> 2?P((&T!J=?=7.157C'+%C.M=J"=-;&YB7?5HTD<ERXI=U;3
M*2><75PKN7Y^C[J"*UQ:Z-^SI4!S-HLLD3N3J&B)+AJB]!&B$=PH:3<&7LD2
MR[_Q$8GJE*5[91?I2<)WM0PABP>0QFEZ@B_K/,T\7_8(G_?OBIM"*%-KA"_G
M2V,UO8JOQYQMN(;'N5RE3,V6%3@/J!0,Z@<,%L^>)*/XY0FEPT[I\!3[XJXI
M$% K\.FQ^_0<$WJ2ZKC0\WT)NAM$=T/I K12@NK40)]+>FY"4.68LRE0,M G
MXPH+K):H(4L&<(>2*ZIP+"B@)7@6H9B$?G(&/4@&>9J%63/+XG ,HW"<QT\)
MX'&UW".ELFB@K-$E.X=L'(=Q.R8TQ/_%C"$?YF3=C._]T9;]=(\9F"Q!V0W^
M$>HT&J!LA2DD'O&:2R8+!(%4X:"6@J^9ZQH&\GA(+F2C83B":S1F2A)8I;3E
MOXC)QXP;4WMTH8PU_KZ2WIFJ):WZ21Y2-/K)*,S/X%Y9)AI4-H@G8XI).GB1
M3<))2WY9:XW24HG;6G/+R8_1A 20UF&+_B=C/<>4O*#C'G%-QA.:N?B_E86H
M2\(?ZETQKN&!"8K:7J)[!+V4A+3I]OI[&06EVS#.IGL"KAZ]T;&G'AVTH@KU
MVC=< _ZFIBMUNUU//V]:V1_SYH=PP_2:4P8$K@A*SR</0#=-MEE8M?6-;:DL
MM4D_W=!_";4SH/.5HG?0+MP%W9]N\1M02P,$%     @ E(4"5;1'WHC"!
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MQCO0]Z76;F_X!.W_Q.0?4$L#!!0    ( )2% E7F_]D&Q@4  !40   9
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M&%B3@$/NA!FX,(H-6FB&_D)Q3+$'R]"JL%8;W%+@Z<*.4VE5@PNGM%Q *\<
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ME)V [Q=2FO7 'BB:\V#X%U!+ P04    " "4A0)5K(VH+"T$  #!&0  &0
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M)2"_KR@5^Q<U07UK,_L74$L#!!0    ( )2% E4=-A-2H@8  )LV   9
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M/V":JG[+](9+ P)S@HP&4SIANJF4S<"JRA>;M;)4NGRWH(\+U,Z UG.E[,/
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MDV,D=-WTZHE5A6\T2V6Q;?GA!K\3H-T!W%\I9?<3=T'SY4E_ 5!+ P04
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ME=EY*[O18F//!X]"XVG#7J[QB K2!.#SE1#Z<&,2%(?>T7]02P,$%     @
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M'N*IT".[H,Q)!$P2SI" Q<BZ="^"@9F?3G@DL)&E8V0RF7'^9 :3^<AR3$!
M(52&@/7?&JZ!4@/28?S*F59Q2R,L'[_0/Z:YZUQF6,(UI]_(7*U&UL!"<UC@
MA*H[OOD$>3Y=PPLYE>DOVN1S'0N%B50\RL4Z@HBP[!\_YSZ4!)YW0.#E F]?
MT#X@:.>"]IZ@?4C0R06=OPVIFPO2U.TL]]2X,5;8'PJ^0<+,UC1SD+J?JK5?
MA)EU<J^$ODJT3OE?Q1(S\AMG56-S=)\M&,07Z#(,><(484LTY92$!"1ZCQZQ
M('A& 4V8 @%2H4#/4>;BZ1@4)E2^0R>(,'1+*-58.;25CM3<SP[SJ*ZRJ+P#
M47U.6 NUG3/D.9Z''N['Z/3D707F^AC, H>$$K6MX(R/X<2KK=1F8/8S%F:=
MAU!!#.J)8P@UT4V);G6"MJYD44ZO**>7<ML'N >*LT7?;_1,-%$0R1]5]<BP
MG6JL:587,L8AC"S=C22(-5C^VS=NS_E0594F8>,F84%#L)W:M(O:M.OH_I<D
MFH$P&RM?B6;+$!;29 YSLU\>)T%5:6JIQY8F@W53F'F&K/W>T%Z7_7X]H[L[
M(V@HH!T3.X6)G5H3+Z4$5=E1,EVOG)EW[K;VTKNNQ1^[-IN$!14)N&Z_E,".
M8=W"L&ZM88<ZPAF:"I)V^BM@L# -352UQJM:_+'+KTG8N$E8T!!LIT:]HD:]
M_].U>TW6IDG8N$E8T!!LIS;]HC;]?VPXF:Y?WJ_GK?Y>NZF%'VMJD[#@=?B=
M0<NM;C:#PJQ!K5DW>AGG3[8JQS+Q>?F6G3V_:OG'^M4D+!B\:L^>\\HON_0F
M;KZS;K%8$B81A866.:V^;C,B^W;)!HK'Z<OYC"O]JI\>KO3G'@@S05]?<*Y>
M!N9]O_B ]/\ 4$L#!!0    ( )2% E6;K9V@!00  (,3   9    >&PO=V]R
M:W-H965T<R]S:&5E=#,U+GAM;+58T6[;-A3]%4(KAA9()5&6[3BS#<11V[58
MAB!!MX=A#XQ$VT0DTB6I.!GZ\2,E699DF:@]S@^V2/&>>\\A>7G-Z9;Q)['&
M6(*7+*5BYJREW%QYGHC7.$/"91M,U9LEXQF2JLE7GMAPC)+"*$N]P/='7H8(
M=>;3HN^.SZ<LERFA^(X#D6<9XJ\+G++MS('.KN.>K-92=WCSZ0:M\ .67S=W
M7+6\&B4A&::", HX7LZ<:W@5P:$V*$;\0?!6-)Z!IO+(V)-N?$YFCJ\CPBF.
MI89 ZN<9W^ TU4@JCF\5J%/[U(;-YQWZQX*\(O.(!+YAZ9\DD>N9<^F !"]1
MGLI[MOT55X2* &.6BN(;;,NQHY$#XEQ(EE7&*H*,T/(7O51"- P&\(A!4!D$
M'8,@.&(PJ P&/VH05@9AH4Q)I= A0A+-IYQM =>C%9I^*,0LK!5]0O6\/TBN
MWA)E)^?7\;><"*+G0 !$$Q 1L6$"I0*\!ZV7;R,L$4G%._ &$ IN29KJ_JDG
M51@:S(LKEXO297#$Y0C<,BK7 GR@"4[:]IX*O^80[#@L B/@EYRZ8.!?@, /
M O#U(0)OW[P#2Q23E,C7G@!O?AP/[O!Z8"(S3(1C!0--,"VZ@WK*!@7NX CN
M(A>J1XCF]("_?E-]X+/$F?B[;TI*R+ ?4B>7*[%!,9XY*GL(S)^Q,__Y)SCR
M?^F3SR989 FL)6582QF:T.=WZ%7E,"F 2J J!>U7^P6@*N>R)8B16)=O>'>M
MEL*6#D:% YUDG^?CT)WXC0^<>L]-]0XMX- -VH,B8]QGJC*L51D:5?G$6+)5
MV[N/[O @^,%D,G"['(T.3ETA?3XA="]KGRV6HYKER,CR(><K$J,4?"P3!<&]
MN<P(<NK&L0D660)KB3>NQ1O;ST%CFU+:!(LL@;6DO*REO#2NP]_S[!%SG6N6
M]4*L,P[X;CK'%B7RL+$SPLY&-/H^529+8"V9)K5,D_\[54].3M6EQ=B<JHUQ
MGZD*]/?UFV]>/HP6Q&,E!4DP1UJ4WJ+,/R 3N*,.8;.S4]>++;2V-(W2%AJE
MN<<Q6U'RC]I&E-'W2B')F:I:Z4H5L!(KE[*_?(4'2H70'7:E.APU[@Z*S!&>
MJT"P5R X^R2O3%MU" S=;@*IADV:R\;OLC1&<2[+?3T,C35BWTE^ 3Z\$"'U
M5-\B_H2/3+35JM@J6F0+K:WIOC"&H?T#'EJJ6BL];:)%MM#:>NY+:FBNJ?_+
M*5]!-X_YH+M+K1;<MM!*K;S&[42&^:JXY1'JP,JI+/_DU[WU3=)U<7_2Z5_
MJYOR/F@/4UY/J3V^(E2 %"\5I.^.%0%>WOB4#<DVQ1W((Y.29<7C&B-U7.H!
MZOV2,;EK: ?UO=O\7U!+ P04    " "4A0)5&6?)LQ0#  #O"0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970S-BYX;6RM5FUOVC 0_BM65DV=M)(0(+ .(A7:
M:9W&AEIU^S!-DTD.8M6Q4]N!5MJ/WSF!-#! Z\27)+[</?<\Y[?K+Z6ZUPF
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M7IZ.E3>2[?4!TXI)R3)]N<-HC7EAH)YOF$KAZJ8XLZK/*!?_ U!+ P04
M" "4A0)5%%,(ANT"  "Q"P  &0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6RUEFU/VS 0Q[^*E4T32(,\]8&R-A*T0C"Q"5'87DQ[X:;7UB*).]M)0=J'
MW]E)0\/2:*"L+UH_W=_W.Y_=&VZX>) K $4>XRB1(VNEU/K4MF6X@IC*8[Z&
M!&<67,1485<L;;D60.?&*(YLSW%Z=DQ98@5#,W8C@B%/5<02N!%$IG%,Q=,Y
M1'PSLEQK.W#+EBNE!^Q@N*9+F(*Z7]\([-FERIS%D$C&$R)@,;+.W-.QZV@#
ML^(;@XW<:1.-,N/\07>NYB/+T1Y!!*'2$A1_,AA#%&DE].-7(6J5>VK#W?96
M_<+ (\R,2ACSZ#N;J]7(.K'('!8TC=0MWUQ" =35>B&/I/DFFWQMS[-(F$K%
MX\(8/8A9DO_2QR(0.P9N9X^!5QAX_VK@%P:^ <T],U@3JF@P%'Q#A%Z-:KIA
M8F.LD88E^ABG2N L0SL57/-D>70'(B83F"ER1+Y2(:@.+3F8@*(LDH<X.H4P
M%3#?+KJ?3LC!^\.AK= %+62'Q7;G^7;>GNT^I\DQ\9V/Q',\K\9\W&P^@1#-
M76/N5LUM!"_IO9+>,WJ=/7JWD/$H8\F2C)&.*7)!0Q8Q]51'UBBEK]NI7-,0
M1A;>)PDB ROX\,[M.9_J.%L2JU#[);5OU/V]4<1#O$JD$BE>2$5^7.,"<J4@
MEC_KP/TVP5L2JX!W2O!.XW&?99C/=&9.F. ;HN<)7Y P/WQ6AJ0N"KGTP$CK
MQS$+/,=WS&=H9[N(C4Z\$;%;(G;?EM'D-[E; <GG0=01-BJ_]IQ;$JL$H5<&
MH==J@O?:!&])K +>+\'[S0D>\Q1Y,:5?I#;^@4M%DSDF1ET <M7N3FZ_S.G^
M7]G_O*+BZDGIZDFCJ]>@% CM8IZH=6XU*KSV7%H2J\ .2MA!JPDY:!.\);$*
MN.L\UQ?._WMS"^W=M.O7/KG-3KP6TMZIIW0Q^X6*)3I*(EB@O'/<QYLB\OHP
M[RB^-B76C"LLV$QSA34U"+T YQ><JVU'5VUEE1[\ 5!+ P04    " "4A0)5
M;NT*+7,$   6$P  &0   'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6S-6-MN
MXS80_15"#8I=P)%$R9+LU#:0=;IHBVP;)$W[L.@#;=,VL93H):DX^?N2E*R+
M)3/9P@OTQ=9EYO#,\'"&XF3/^!>QQ5B"YY1F8NILI=Q=>9Y8;G&*A,MV.%-O
MUHRG2*I;OO'$CF.T,DXI]0+?C[T4D<R93<RS.SZ;L%Q2DN$[#D2>IHB_?,"4
M[:<.= X/[LEF*_4#;S;9H0U^P/)Q=\?5G5>AK$B*,T%8!CA>3YUK>#6'8^U@
M+/XB>"\:UT"'LF#LB[[Y=35U?,T(4[R4&@*IOR<\QY1J),7C:PGJ5&-JQ^;U
M ?VC"5X%LT "SQG]FZSD=NJ,'+#":Y13><_VO^ RH$CC+1D5YA?L2UO? <M<
M2):6SHI!2K+B'SV7B7B+0U Z!&]U"$N'T 1:,#-AW2")9A/.]H!K:X6F+TQN
MC+>*AF1Z&A\D5V^)\I.S6ZQR(, EF+-TQS*<20'8&ICIO&3KRUR :R&P>HJR
M%;@E:$$HD42YW&.*)%X!R4 )\NX&2T2H>*_@'A]NP+N+]^ "D Q\(I2J.1,3
M3RK*>F!O6=+[4- +3M#[+<]<$/H#$/A!T.,^M[O?X*5RA\8=MMT]E:@J6T&5
MK<#@A?9L?;Y>",F5 O_IBZB &/9#Z&5Y)79HB:>.6G<"\R?LS'[\ <;^3WWQ
MG0FL%6U811O:T&<?28:R)2ZF=U!KXE'@0A0#\""5!M2JEEHTA3U!%-PQ0<PJ
M_?SSL]1K?D$5#!']";.SN..J9G'Y8@2(O^9DI\<;@ R;0=%RF:=Y(<455EE0
M!,S0ZMU%&/AN8APO@B1PPX&J/&*'3>F@+WWY_G]P:4W7L)JNH97<'XJ:&B[;
M'";LL%I?!F"><VZ8GF7"7N$AMYBKVF5&!+0N&7WY/@M4*UU1E:[H6]3]W9)E
M9W&+A;@ZC*@*N\SYR5R= ZF5JKA*5?P?4_4[RY9GS9:=R"W+-I<2\U0MKX4:
MDJJ8*WG8D_<=@%NY3*I<)M864G33J[[8DW,VCC.!M6(<53&.WEB)J%8,0";F
MOI +G-C@Z!WGTRQ($G<T\9Z:L72MPF#HPLJJ17)<D1R_2=2O42Q0DL;@P]AW
M@R.*7:LP&+MQ/T7HU[LSWTKR3R;5$C(45Q:.)4K4&#X)C[-8&C4YQE'H)B<X
M-G:0T*KHX]ENE.E>F9=P9]+YN=#:P=<;0FC=@<W*>ML;9]#51-1(=\F_:S7T
M3VD;UELW:-^I5 6MEUG8&3-(8&?9]9B%,#HIZGJ? NU=O1 U.RV;7L[#+AD_
M<:-CSCUF4712Y/5F 496D;>KQ:L2M[;J;Y;XF=#:H=?-']I[HTWB<5=(05?B
M<:<ZP?&)":G;*+1VL%<$GG07U0@VE%L2ZYJ%P],"K]L?M/>_MEC8@I*-^0[H
M%_:H0R+RAVYXS+5K%L;#DUSK+@CM;;#185Y=@N-.'Q[!GK+1-4O4MT]XQ-1K
M'%KH$Z-/B&]()A25M?)3WTI*+[PXA"EN)-N9<XP%DY*EYG*+T0IS;:#>KQF3
MAQM]-%(=A<W^!5!+ P04    " "4A0)5$S"M6W0"  !*!@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970T,2YX;6R=E5UOVC 4AO^*E553*VTD! @="Y&@;%JG
M,:&B;A?3+DQRDEAU[,QV2/?OYP](Z09HZ@VQG?.^?LYQ?(A;+AYD":#08T69
MG'JE4O7$]V5:0H5EC]? ])N<BPHK/16%+VL!.+.BBOIA$$1^A0GSDMBNK402
M\T91PF ED&RJ"HO?<Z"\G7I];[]P1XI2F04_B6M<P!K4?;T2>N9W+AFI@$G"
M&1*03[U9?S(?FW@;\(U *P_&R&2RX?S!3&ZSJ1<8(*"0*N. ]6,+-T"I,=(8
MOW:>7K>E$1Z.]^X?;>XZEPV6<,/I=Y*I<NI=>RB#'#=4W?'V$^SR&1F_E%-I
M?U'K8H<##Z6-5+S:B35!19A[XL=='0X$87A"$.X$H>5V&UG*!58XB05OD3#1
MVLT,;*I6K>$(,X>R5D*_)5JGDB^@4Y+H+?J*A<"F0NAR 0H3*J_0!2(,+0FE
MNGXR]I7>SZC\=.<]=][A">\(+3E3I40?6 ;9<[VO.3O8< \[#\\:?FY8#PV"
M-R@,PA#=KQ?H\N+JC.^@*\+ ^@[.%^'';".5T-_)SV.Y.HOA<0MS=R:RQBE,
M/7TY)(@M>,GK5_TH>'\&<-@!#L^Y)[<L%8;1G$=.&&8I(&H7*,$;0HDB</2
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M.%,'I23#NT)]XOM?2"UHK/$27DCS'^UK6]]!R4XJ7M;.P*"DK/K%SW4@6@Z
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M=08P-R(_D\QO%%]FQWHSKA1/LLN($F!*#X#?YYRK[8UV4)X,C_\#4$L#!!0
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M!,WU98I@@I@RD,\WE(JG&Q6@/A5>_ M02P,$%     @ E(4"507F6EJ2!0
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M=P0#4TH ^C<,N*]>U #U#=_J/U!+ P04    " "4A0)5K^:LGB(#   ."0
M&0   'AL+W=O<FMS:&5E=',O<VAE970T."YX;6RMEEUOFS 4AO^*Q:JIE58^
M X$N06H33>NT:E6S;A?3+APX2:P:S&R3I/]^-B2,%,IVL5XT&,Y[_)SW8)O)
MCO$GL0&0:)_17$R-C93%E66)9 ,9%B8K(%=/5HQG6*HA7UNBX(#32I11R[7M
MP,HPR8UX4MV[Y_&$E9*2'.XY$F668?Y\ Y3MIH9C'&\\D/5&ZAM6/"GP&A8@
M'XM[KD96DR4E&>2"L!QQ6$V-:^=J%NGX*N ;@9UH72-=R9*Q)SVX3:>&K8&
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M:YXI+4W2(E.TMI:/1P^W=TO^_S+<_R7#SS_0_:T/ULKH\<(^.8RGP+?EI89
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MVV"SA$!O0[V-0&]#O8U ;T.]C4!O0[V-0&]#O8U ;T.]C4!O1[V=0&]'O9U
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M+NIC/FM_A4\_ 5!+ 0(4 Q0    ( )2% E4'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ E(4"58";
MC47N    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ E(4"59E<G",0!@  G"<  !,              ( !S $
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "4A0)56H+2;]L%  #<
M'@  &               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ E(4"52*0/%HR!P  31T  !@              ("!'@X
M 'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( )2% E7-Y*%8
M4@,  !,+   8              " @885  !X;"]W;W)K<VAE971S+W-H965T
M,RYX;6Q02P$"% ,4    " "4A0)5BLN<\NH(  #8*@  &
M@($.&0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ E(4"
M50DRULC4 P  I0T  !@              ("!+B(  'AL+W=O<FMS:&5E=',O
M<VAE970U+GAM;%!+ 0(4 Q0    ( )2% E54IC$#< P  %UX   8
M      " @3@F  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4
M" "4A0)5F(=.&OP'  #'(P  &               @('>,@  >&PO=V]R:W-H
M965T<R]S:&5E=#<N>&UL4$L! A0#%     @ E(4"5;RG""W,'P  EF0  !@
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M970Q,BYX;6Q02P$"% ,4    " "4A0)5@&>[Y1D%  #!#   &0
M    @(&J=0  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    (
M )2% E68DJD[S@(  #D&   9              " @?IZ  !X;"]W;W)K<VAE
M971S+W-H965T,30N>&UL4$L! A0#%     @ E(4"56DDLM*T#0  #20  !D
M             ("!_WT  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"
M% ,4    " "4A0)5%JZ>OA@&  "%$   &0              @('JBP  >&PO
M=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( )2% E4KR*P$AP(
M + %   9              " @3F2  !X;"]W;W)K<VAE971S+W-H965T,3<N
M>&UL4$L! A0#%     @ E(4"5<*9Q'D*%0  #D$  !D              ("!
M]Y0  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " "4A0)5
M:<XO;P@&   !$0  &0              @($XJ@  >&PO=V]R:W-H965T<R]S
M:&5E=#$Y+GAM;%!+ 0(4 Q0    ( )2% E495G*;/ ,  /4&   9
M      " @7>P  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%
M  @ E(4"5;1'WHC"!   R@P  !D              ("!ZK,  'AL+W=O<FMS
M:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " "4A0)5LYA&!M4%   [$@
M&0              @('CN   >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+
M 0(4 Q0    ( )2% E5EW)))>P0  'D*   9              " @>^^  !X
M;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ E(4"561PRO79
M @  ,P8  !D              ("!H<,  'AL+W=O<FMS:&5E=',O<VAE970R
M-"YX;6Q02P$"% ,4    " "4A0)5YO_9!L8%   5$   &0
M@(&QQ@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( )2%
M E6[ D_0\0(  !L*   9              " @:[,  !X;"]W;W)K<VAE971S
M+W-H965T,C8N>&UL4$L! A0#%     @ E(4"5:R-J"PM!   P1D  !D
M         ("!UL\  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4
M    " "4A0)5'3834J(&  ";-@  &0              @($ZU   >&PO=V]R
M:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( )2% E5&:L%(1P,  +H(
M   9              " @1/;  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL
M4$L! A0#%     @ E(4"52U.?IVW @  A08  !D              ("!D=X
M 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " "4A0)5D^A"
M.#T#   T"0  &0              @(%_X0  >&PO=V]R:W-H965T<R]S:&5E
M=#,Q+GAM;%!+ 0(4 Q0    ( )2% E78B$A7M0,    /   9
M  " @?/D  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @
ME(4"57ROB.*D!   O1L  !D              ("!W^@  'AL+W=O<FMS:&5E
M=',O<VAE970S,RYX;6Q02P$"% ,4    " "4A0)5(!G:\T0#  !,#@  &0
M            @(&Z[0  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4
M Q0    ( )2% E6;K9V@!00  (,3   9              " @37Q  !X;"]W
M;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ E(4"51EGR;,4 P
M[PD  !D              ("!<?4  'AL+W=O<FMS:&5E=',O<VAE970S-BYX
M;6Q02P$"% ,4    " "4A0)5^!ZBZE$$  !%$P  &0              @(&\
M^   >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( )2% E4F
M:+.EB00  *\4   9              " @43]  !X;"]W;W)K<VAE971S+W-H
M965T,S@N>&UL4$L! A0#%     @ E(4"5113"(;M @  L0L  !D
M     ("!! (! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )2% E5'IK&8(04  $0F   9              "
M@1 6 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ E(4"
M540;P*TH!   )Q8  !D              ("!:!L! 'AL+W=O<FMS:&5E=',O
M<VAE970T-2YX;6Q02P$"% ,4    " "4A0)5#OWJ=&P$   A%@  &0
M        @('''P$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0
M   ( )2% E4%YEI:D@4  .T;   9              " @6HD 0!X;"]W;W)K
M<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ E(4"5:_FK)XB P  #@D
M !D              ("!,RH! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q0
M2P$"% ,4    " "4A0)5KD!D,08&   I+0  &0              @(&,+0$
M>&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( )2% E7<60])
M@@@  /8]   9              " @<DS 0!X;"]W;W)K<VAE971S+W-H965T
M-3 N>&UL4$L! A0#%     @ E(4"53-?=(H@!   T14  !D
M ("!@CP! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " "4
MA0)5)Y NP(P#  !R$@  &0              @('90 $ >&PO=V]R:W-H965T
M<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( )2% E5\"\];+P,  "03   -
M          "  9Q$ 0!X;"]S='EL97,N>&UL4$L! A0#%     @ E(4"59>*
MNQS     $P(   L              ( !]D<! %]R96QS+RYR96QS4$L! A0#
M%     @ E(4"53?]N%$E!   SR(   \              ( !WT@! 'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( )2% E6*,79?SP$  #,?   :
M      "  3%- 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( )2% E4RX8'AQP$  !(?   3              "  3A/ 0!;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     \ #P 6Q   #!1 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>248</ContextCount>
  <ElementCount>278</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>73</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization and Summary of Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies</Role>
      <ShortName>Organization and Summary of Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2113102 - Disclosure - Acquisitions and Disposals</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/AcquisitionsandDisposals</Role>
      <ShortName>Acquisitions and Disposals</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2117103 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2121104 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2126105 - Disclosure - Derivatives and Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivities</Role>
      <ShortName>Derivatives and Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2132106 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2135107 - Disclosure - Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OtherCurrentLiabilities</Role>
      <ShortName>Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2138108 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2140109 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2144110 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Organization and Summary of Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Summary of Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Organization and Summary of Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables</Role>
      <ShortName>Organization and Summary of Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2318302 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/LongTermDebt</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2322303 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/Leases</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2327304 - Disclosure - Derivatives and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables</Role>
      <ShortName>Derivatives and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/DerivativesandHedgingActivities</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2333305 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/EarningsPerShare</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2336306 - Disclosure - Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2341307 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/SegmentReporting</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Organization and Summary of Accounting Policies - Organization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Organization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Organization and Summary of Accounting Policies - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2410407 - Disclosure - Organization and Summary of Accounting Policies - Medicare Accelerated Payments and Deferred Governmental Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Medicare Accelerated Payments and Deferred Governmental Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2411408 - Disclosure - Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2412409 - Disclosure - Organization and Summary of Accounting Policies - Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails</Role>
      <ShortName>Organization and Summary of Accounting Policies - Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2414410 - Disclosure - Acquisitions and Disposals - Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails</Role>
      <ShortName>Acquisitions and Disposals - Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2415411 - Disclosure - Acquisitions and Disposals - Other Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails</Role>
      <ShortName>Acquisitions and Disposals - Other Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2416412 - Disclosure - Acquisitions and Disposals - Disposals and Deconsolidations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails</Role>
      <ShortName>Acquisitions and Disposals - Disposals and Deconsolidations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2419413 - Disclosure - Long-Term Debt - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LongTermDebtSummaryDetails</Role>
      <ShortName>Long-Term Debt - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2420414 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2423415 - Disclosure - Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails</Role>
      <ShortName>Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2424416 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2425417 - Disclosure - Leases - Lease Expense and Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails</Role>
      <ShortName>Leases - Lease Expense and Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2428418 - Disclosure - Derivatives and Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails</Role>
      <ShortName>Derivatives and Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2429419 - Disclosure - Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails</Role>
      <ShortName>Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2430420 - Disclosure - Derivatives and Hedging Activities - Derivatives Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails</Role>
      <ShortName>Derivatives and Hedging Activities - Derivatives Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2431421 - Disclosure - Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails</Role>
      <ShortName>Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2434422 - Disclosure - Earnings Per Share - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails</Role>
      <ShortName>Earnings Per Share - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2437423 - Disclosure - Other Current Liabilities - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails</Role>
      <ShortName>Other Current Liabilities - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2439424 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/CommitmentsandContingencies</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2442425 - Disclosure - Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails</Role>
      <ShortName>Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails</Role>
      <ShortName>Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="sgry-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2445427 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.surgerypartners.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.surgerypartners.com/role/SubsequentEvents</ParentRole>
      <Position>52</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="sgry-20220630.htm">sgry-20220630.htm</File>
    <File>a2022q2exhibit311.htm</File>
    <File>a2022q2exhibit312.htm</File>
    <File>a2022q2exhibit321.htm</File>
    <File>sgry-20220630.xsd</File>
    <File>sgry-20220630_cal.xml</File>
    <File>sgry-20220630_def.xml</File>
    <File>sgry-20220630_lab.xml</File>
    <File>sgry-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/srt/2022</BaseTaxonomy>
    <BaseTaxonomy items="769">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>68
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sgry-20220630.htm": {
   "axisCustom": 0,
   "axisStandard": 26,
   "contextCount": 248,
   "dts": {
    "calculationLink": {
     "local": [
      "sgry-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sgry-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sgry-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sgry-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgry-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sgry-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 472,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 8,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 13
   },
   "keyCustom": 42,
   "keyStandard": 236,
   "memberCustom": 35,
   "memberStandard": 36,
   "nsprefix": "sgry",
   "nsuri": "http://www.surgerypartners.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.surgerypartners.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117103 - Disclosure - Long-Term Debt",
     "role": "http://www.surgerypartners.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121104 - Disclosure - Leases",
     "role": "http://www.surgerypartners.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126105 - Disclosure - Derivatives and Hedging Activities",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivities",
     "shortName": "Derivatives and Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132106 - Disclosure - Earnings Per Share",
     "role": "http://www.surgerypartners.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135107 - Disclosure - Other Current Liabilities",
     "role": "http://www.surgerypartners.com/role/OtherCurrentLiabilities",
     "shortName": "Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138108 - Disclosure - Commitments and Contingencies",
     "role": "http://www.surgerypartners.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140109 - Disclosure - Segment Reporting",
     "role": "http://www.surgerypartners.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144110 - Disclosure - Subsequent Events",
     "role": "http://www.surgerypartners.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Organization and Summary of Accounting Policies (Policies)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies",
     "shortName": "Organization and Summary of Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Organization and Summary of Accounting Policies (Tables)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables",
     "shortName": "Organization and Summary of Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318302 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://www.surgerypartners.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sgry:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322303 - Disclosure - Leases (Tables)",
     "role": "http://www.surgerypartners.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sgry:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327304 - Disclosure - Derivatives and Hedging Activities (Tables)",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables",
     "shortName": "Derivatives and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333305 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.surgerypartners.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336306 - Disclosure - Other Current Liabilities (Tables)",
     "role": "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables",
     "shortName": "Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341307 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.surgerypartners.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sgry:NumberOfSurgicalFacilitiesOwned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Organization and Summary of Accounting Policies - Organization (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails",
     "shortName": "Organization and Summary of Accounting Policies - Organization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sgry:NumberOfSurgicalFacilitiesOwned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d812678eaf54267847b2530339322ec_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
     "shortName": "Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d812678eaf54267847b2530339322ec_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails",
     "shortName": "Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d7024453b0a4f5c8ce5d266c8c9e818_D20220401-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Organization and Summary of Accounting Policies - Income Taxes (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails",
     "shortName": "Organization and Summary of Accounting Policies - Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i05b7208bc5d946119ab875dbf0311579_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails",
     "shortName": "Organization and Summary of Accounting Policies - Rollforward of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i05b7208bc5d946119ab875dbf0311579_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails",
     "shortName": "Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i9ce39eddcaef4480b057800dbc9fc415_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sgry:ProceedsFromGovernmentAssistance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410407 - Disclosure - Organization and Summary of Accounting Policies - Medicare Accelerated Payments and Deferred Governmental Grants (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails",
     "shortName": "Organization and Summary of Accounting Policies - Medicare Accelerated Payments and Deferred Governmental Grants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "sgry:ProceedsFromGovernmentAssistance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i6b3dc06c3b0940c6864cf95b82437b22_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411408 - Disclosure - Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails",
     "shortName": "Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i6b3dc06c3b0940c6864cf95b82437b22_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sgry:VariableInterestEntityNumberOfFacilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412409 - Disclosure - Organization and Summary of Accounting Policies - Variable Interest Entities (Details)",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails",
     "shortName": "Organization and Summary of Accounting Policies - Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sgry:VariableInterestEntityNumberOfFacilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414410 - Disclosure - Acquisitions and Disposals - Acquisitions (Details)",
     "role": "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails",
     "shortName": "Acquisitions and Disposals - Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ia73c117591c64b64acb148493f0ec6d8_D20220101-20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415411 - Disclosure - Acquisitions and Disposals - Other Acquisitions (Details)",
     "role": "http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails",
     "shortName": "Acquisitions and Disposals - Other Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ie3963d4281e5468c8e5368c83dc0b938_D20220101-20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "sgry:NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "non-controlling_interest",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfProductiveAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416412 - Disclosure - Acquisitions and Disposals - Disposals and Deconsolidations (Details)",
     "role": "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails",
     "shortName": "Acquisitions and Disposals - Disposals and Deconsolidations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i765634ba75024131a79a3d390bb13989_D20220101-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419413 - Disclosure - Long-Term Debt - Summary (Details)",
     "role": "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
     "shortName": "Long-Term Debt - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i1a5a30a093dc41659d3f312026cb301c_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420414 - Disclosure - Long-Term Debt - Narrative (Details)",
     "role": "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i1a5a30a093dc41659d3f312026cb301c_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423415 - Disclosure - Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details)",
     "role": "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails",
     "shortName": "Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sgry:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "sgry:IncreaseDecreaseInFinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424416 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.surgerypartners.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "sgry:IncreaseDecreaseInFinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425417 - Disclosure - Leases - Lease Expense and Cash Flow Information (Details)",
     "role": "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails",
     "shortName": "Leases - Lease Expense and Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428418 - Disclosure - Derivatives and Hedging Activities - Narrative (Details)",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
     "shortName": "Derivatives and Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429419 - Disclosure - Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details)",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails",
     "shortName": "Derivatives and Hedging Activities - Interest Rate Swaps and Interest Rate Caps Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i7e675653b29b4a30a95a33a4eafccfa8_I20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430420 - Disclosure - Derivatives and Hedging Activities - Derivatives Assets and Liabilities (Details)",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
     "shortName": "Derivatives and Hedging Activities - Derivatives Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d641fec5a614286a665a368239cb7fe_I20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "sgry:DerivativeLiabilityNotionalAmountFinancingComponent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431421 - Disclosure - Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details)",
     "role": "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails",
     "shortName": "Derivatives and Hedging Activities - Pre-tax Effect of Derivatives on AOCI and Statement of Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434422 - Disclosure - Earnings Per Share - Summary (Details)",
     "role": "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails",
     "shortName": "Earnings Per Share - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i63a22d68b90b48909dc3d1b1b5b8a20e_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sgry:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437423 - Disclosure - Other Current Liabilities - Summary (Details)",
     "role": "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails",
     "shortName": "Other Current Liabilities - Summary (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SelfInsuranceReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439424 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i05b7208bc5d946119ab875dbf0311579_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:SelfInsuranceReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i9369fe6e049741b2b6c4bf1643f136b1_D20220401-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442425 - Disclosure - Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)",
     "role": "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails",
     "shortName": "Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i0d9ba7ce0b9e46c1820451f4e69f70a0_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details)",
     "role": "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
     "shortName": "Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i23bc251b6a3e49908aa27d058a4353bb_I20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445427 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.surgerypartners.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "if47fc0612aa043b48a03337684354a15_D20220701-20220731",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i65b4d531cb9b48cd894460f4e16463be_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "i4a91eb65e6f347b7872477d3c18e5539_D20210101-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "sgry:NoncashInterestIncomeExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization and Summary of Accounting Policies",
     "role": "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies",
     "shortName": "Organization and Summary of Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113102 - Disclosure - Acquisitions and Disposals",
     "role": "http://www.surgerypartners.com/role/AcquisitionsandDisposals",
     "shortName": "Acquisitions and Disposals",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220630.htm",
      "contextRef": "ifaaf855edb3d40c59f9381447ecbe447_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 73,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "sgry_A2017SeniorSecuredCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Senior Secured Credit Facility [Member]",
        "label": "2017 Senior Secured Credit Facility [Member]",
        "terseLabel": "The Revolver"
       }
      }
     },
     "localname": "A2017SeniorSecuredCreditFacilityMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_A2017TermLoanMaturing2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Term Loan, Maturing 2024 [Member]",
        "label": "2017 Term Loan, Maturing 2024 [Member]",
        "verboseLabel": "Senior secure term loan"
       }
      }
     },
     "localname": "A2017TermLoanMaturing2024Member",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_AncillaryServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ancillary Services [Member]",
        "label": "Ancillary Services [Member]",
        "terseLabel": "Ancillary Services"
       }
      }
     },
     "localname": "AncillaryServicesMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Schedule of Components of Right-of-use Assets and Liabilities Related to Leases"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sgry_BusinessCombinationIntegrationRelatedCostsAndMergerCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Integration Related Costs, And Merger Costs",
        "label": "Business Combination, Integration Related Costs, And Merger Costs",
        "terseLabel": "Transaction, integration and acquisition costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCostsAndMergerCosts",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee",
        "label": "Cash Flow, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sgry_CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Tax Agreement, Interest Rate, Basis Spread on Variable Rate",
        "label": "Collaborative Tax Agreement, Interest Rate, Basis Spread on Variable Rate",
        "terseLabel": "Collaborative tax agreement, basis spread on variable rate (percent)"
       }
      }
     },
     "localname": "CollaborativeTaxAgreementInterestRateBasisSpreadonVariableRate",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sgry_CollaborativeTaxAgreementProjectedTaxSavingsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Tax Agreement, Projected Tax Savings, Term",
        "label": "Collaborative Tax Agreement, Projected Tax Savings, Term",
        "terseLabel": "Projected tax savings period"
       }
      }
     },
     "localname": "CollaborativeTaxAgreementProjectedTaxSavingsTerm",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Repayments",
        "label": "Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grant Received, Repayments",
        "terseLabel": "Repayments of grants received"
       }
      }
     },
     "localname": "CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grants, Deferred Accelerated Payments",
        "label": "Coronavirus Aid, Relief, and Economic Security Act CARES Act, Government Grants, Deferred Accelerated Payments",
        "terseLabel": "Deferred accelerated payments"
       }
      }
     },
     "localname": "CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_CostReportLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Report Liabilities, Current",
        "label": "Cost Report Liabilities, Current",
        "terseLabel": "Cost report liabilities"
       }
      }
     },
     "localname": "CostReportLiabilitiesCurrent",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_DebtInstrumentPrepaymentPenaltyAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Prepayment Penalty Amount",
        "label": "Debt Instrument, Prepayment Penalty Amount",
        "negatedTerseLabel": "Payment of premium on debt extinguishment"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPenaltyAmount",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_DeferredIncomeTaxLiabilitiesNetOfDiscount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax Liabilities, Net Of Discount",
        "label": "Deferred Income Tax Liabilities, Net Of Discount",
        "terseLabel": "Carrying value of liability, net of discount"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNetOfDiscount",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax Liabilities, Net Of Discount, Current",
        "label": "Deferred Income Tax Liabilities, Net Of Discount, Current",
        "terseLabel": "Deferred tax liabilities, current"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_DerivativeLiabilityNotionalAmountFinancingComponent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Liability, Notional Amount, Financing Component",
        "label": "Derivative Liability, Notional Amount, Financing Component",
        "terseLabel": "Derivative liability, notional amount, financing component"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmountFinancingComponent",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Number Of Surgical Facilities Contributed As Non-Cash Consideration",
        "label": "Disposal Group, Number Of Surgical Facilities Contributed As Non-Cash Consideration",
        "terseLabel": "Number of surgical facilities contributed as non-cash consideration"
       }
      }
     },
     "localname": "DisposalGroupNumberOfSurgicalFacilitiesContributedAsNonCashConsideration",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sgry_DisposalGroupOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group One [Member]",
        "label": "Disposal Group One [Member]",
        "terseLabel": "Disposal Group One"
       }
      }
     },
     "localname": "DisposalGroupOneMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_DisposalGroupTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group Two",
        "label": "Disposal Group Two [Member]",
        "terseLabel": "Disposal Group Two"
       }
      }
     },
     "localname": "DisposalGroupTwoMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_EarningsBeforeInterestTaxesDepreciationAndAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Before Interest Taxes Depreciation And Amortization",
        "label": "Earnings Before Interest Taxes Depreciation And Amortization",
        "terseLabel": "Adjusted EBITDA"
       }
      }
     },
     "localname": "EarningsBeforeInterestTaxesDepreciationAndAmortization",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_FacilitiesAmbulatorySurgeryCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facilities, Ambulatory Surgery Centers [Member]",
        "label": "Facilities, Ambulatory Surgery Centers [Member]",
        "terseLabel": "Facilities, Ambulatory Surgery Centers"
       }
      }
     },
     "localname": "FacilitiesAmbulatorySurgeryCentersMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_FacilitiesSurgicalHospitalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facilities, Surgical Hospitals [Member]",
        "label": "Facilities, Surgical Hospitals [Member]",
        "terseLabel": "Facilities, Surgical Hospitals"
       }
      }
     },
     "localname": "FacilitiesSurgicalHospitalsMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total finance lease costs"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_FinanceLeaseCost1Abstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost1 [Abstract]",
        "label": "Finance Lease, Cost1 [Abstract]",
        "terseLabel": "Finance lease costs:"
       }
      }
     },
     "localname": "FinanceLeaseCost1Abstract",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sgry_GainLossOnDispositionOfAssetsAndDeconsolidation": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Disposition of Assets And Deconsolidation",
        "label": "Gain (Loss) On Disposition Of Assets And Deconsolidation",
        "negatedLabel": "Loss on disposals and deconsolidations, net",
        "negatedTerseLabel": "Loss on disposals and deconsolidations, net"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssetsAndDeconsolidation",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) Related to Litigation Settlement And Other Litigation Costs",
        "label": "Gain (Loss) Related to Litigation Settlement And Other Litigation Costs",
        "negatedTerseLabel": "Loss (gain) on litigation settlement and other litigation costs"
       }
      }
     },
     "localname": "GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Written off Related to Sale of Business Unit and Deconsolidation",
        "label": "Goodwill, Written off Related to Sale of Business Unit and Deconsolidation",
        "negatedTerseLabel": "Disposals and deconsolidations"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_GrantRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Revenue",
        "label": "Grant Revenue",
        "negatedTerseLabel": "Grant funds"
       }
      }
     },
     "localname": "GrantRevenue",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_HealthcareOrganizationPatientServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Organization, Patient Service [Member]",
        "label": "Healthcare Organization, Patient Service [Member]",
        "terseLabel": "Patient service revenues",
        "verboseLabel": "Patent service revenues"
       }
      }
     },
     "localname": "HealthcareOrganizationPatientServiceMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_InDevelopmentDeNovoSurgicalFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In-Development De Novo Surgical Facility",
        "label": "In-Development De Novo Surgical Facility [Member]",
        "terseLabel": "In-Development De Novo Surgical Facility"
       }
      }
     },
     "localname": "InDevelopmentDeNovoSurgicalFacilityMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_IncreaseDecreaseInFinanceLeaseLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Finance Lease Liability",
        "label": "Increase (Decrease) in Finance Lease Liability",
        "terseLabel": "Increase in finance lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinanceLeaseLiability",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_IncreaseDecreaseInFinanceLeaseRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Finance Lease, Right-Of-Use Assets",
        "label": "Increase (Decrease) in Finance Lease, Right-Of-Use Assets",
        "terseLabel": "Increase in finance lease assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinanceLeaseRightOfUseAssets",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Medicare Accelerated Payments And Deferred Governmental Grants",
        "label": "Increase (Decrease) In Medicare Accelerated Payments And Deferred Governmental Grants",
        "terseLabel": "Medicare accelerated payments and deferred governmental grants"
       }
      }
     },
     "localname": "IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_IncreaseDecreaseInOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Operating Lease, Right-Of-Use Assets",
        "label": "Increase (Decrease) in Operating Lease, Right-Of-Use Assets",
        "negatedTerseLabel": "Decrease in operating lease assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_IncreaseDecreaseInSettlementPayments": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Settlement Payments",
        "label": "Increase (Decrease) in Settlement Payments",
        "negatedTerseLabel": "DOJ settlement payments"
       }
      }
     },
     "localname": "IncreaseDecreaseInSettlementPayments",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_InterestRateCapOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cap One",
        "label": "Interest Rate Cap One [Member]",
        "terseLabel": "Interest rate cap"
       }
      }
     },
     "localname": "InterestRateCapOneMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_InterestRateCapTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cap Two",
        "label": "Interest Rate Cap Two [Member]",
        "terseLabel": "Interest rate cap"
       }
      }
     },
     "localname": "InterestRateCapTwoMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_LeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Right-of-Use Asset",
        "label": "Lease, Right-Of-Use Asset",
        "totalLabel": "Total leased assets"
       }
      }
     },
     "localname": "LeaseRightOfUseAsset",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_MateriallyMoreRestrictiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Materially More Restrictive [Member]",
        "label": "Materially More Restrictive [Member]",
        "terseLabel": "Materially More Restrictive"
       }
      }
     },
     "localname": "MateriallyMoreRestrictiveMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Accelerated Payments And Deferred Governmental Grants, Current",
        "label": "Medicare Accelerated Payments And Deferred Governmental Grants, Current",
        "terseLabel": "Medicare accelerated payments and deferred governmental grants"
       }
      }
     },
     "localname": "MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net",
        "label": "Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net",
        "terseLabel": "Acquisition and disposal of shares of non-controlling interests, net"
       }
      }
     },
     "localname": "NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_NoncashInterestIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Interest Income (Expense), Net",
        "label": "Noncash Interest Income (Expense), Net",
        "negatedTerseLabel": "Non-cash interest expense, net"
       }
      }
     },
     "localname": "NoncashInterestIncomeExpenseNet",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_NotMateriallyMoreRestrictiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Not Materially More Restrictive [Member]",
        "label": "Not Materially More Restrictive [Member]",
        "terseLabel": "Not Materially More Restrictive"
       }
      }
     },
     "localname": "NotMateriallyMoreRestrictiveMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_NotesPayableAndSecuredLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Payable and Secured Loans [Member]",
        "label": "Notes Payable and Secured Loans [Member]",
        "terseLabel": "Notes payable and other secured loans"
       }
      }
     },
     "localname": "NotesPayableAndSecuredLoansMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Non-Controlling Interests In In-Development De Novo Surgical Facilities Acquired",
        "label": "Number Of Non-Controlling Interests In In-Development De Novo Surgical Facilities Acquired",
        "terseLabel": "Number of non-controlling interests in in-development de novo surgical facilities acquired"
       }
      }
     },
     "localname": "NumberOfNonControllingInterestsInInDevelopmentDeNovoSurgicalFacilitiesAcquired",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sgry_NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Non-Controlling Interests In Surgical Facilities Acquired",
        "label": "Number Of Non-Controlling Interests In Surgical Facilities Acquired",
        "terseLabel": "Number of non-controlling interests in surgical facilities acquired"
       }
      }
     },
     "localname": "NumberOfNonControllingInterestsInSurgicalFacilitiesAcquired",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sgry_NumberOfSurgicalFacilitiesOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Surgical Facilities Owned",
        "label": "Number of Surgical Facilities Owned",
        "terseLabel": "Number of surgical facilities owned"
       }
      }
     },
     "localname": "NumberOfSurgicalFacilitiesOwned",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sgry_NumberOfSurgicalFacilitiesOwnedConsolidated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Surgical Facilities Owned, Consolidated",
        "label": "Number Of Surgical Facilities Owned, Consolidated",
        "terseLabel": "Number of surgical facilities owned, consolidated"
       }
      }
     },
     "localname": "NumberOfSurgicalFacilitiesOwnedConsolidated",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sgry_NumberOfSurgicalFacilitiesOwnedMajorityInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Surgical Facilities Owned, Majority Interest",
        "label": "Number Of Surgical Facilities Owned, Majority Interest",
        "terseLabel": "Number of surgical facilities owned, majority interest"
       }
      }
     },
     "localname": "NumberOfSurgicalFacilitiesOwnedMajorityInterest",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sgry_OperatingAndFinanceLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Expense",
        "label": "Operating And Finance Lease, Expense",
        "terseLabel": "Lease expense"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseExpense",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_OtherPatientServiceRevenueSourcesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Patient Service Revenue Sources [Member]",
        "label": "Other Patient Service Revenue Sources [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherPatientServiceRevenueSourcesMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_OtherServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Services [Member]",
        "label": "Other Services [Member]",
        "verboseLabel": "Other service revenues"
       }
      }
     },
     "localname": "OtherServicesMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Five Member",
        "label": "Pay-fixed Swap Five [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapFiveMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Four Member",
        "label": "Pay-fixed Swap Four [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapFourMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap One Member",
        "label": "Pay-fixed Swap One [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapOneMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapSixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Six Member",
        "label": "Pay-fixed Swap Six [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapSixMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Three Member",
        "label": "Pay-fixed Swap Three [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapThreeMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PayFixedSwapTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pay-fixed Swap Two Member",
        "label": "Pay-fixed Swap Two [Member]",
        "terseLabel": "Pay-fixed swap"
       }
      }
     },
     "localname": "PayFixedSwapTwoMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_PrivateInsuranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Insurance [Member]",
        "label": "Private Insurance [Member]",
        "terseLabel": "Private insurance"
       }
      }
     },
     "localname": "PrivateInsuranceMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_ProceedsFromGovernmentAssistance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Government Assistance",
        "label": "Proceeds From Government Assistance",
        "terseLabel": "Proceeds from grants received"
       }
      }
     },
     "localname": "ProceedsFromGovernmentAssistance",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_ReceiveFixedSwapOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receive-fixed Swap One Member",
        "label": "Receive-fixed Swap One [Member]",
        "terseLabel": "Receive-fixed swap"
       }
      }
     },
     "localname": "ReceiveFixedSwapOneMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_ReceiveFixedSwapThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receive-fixed Swap Three Member",
        "label": "Receive-fixed Swap Three [Member]",
        "terseLabel": "Receive-fixed swap"
       }
      }
     },
     "localname": "ReceiveFixedSwapThreeMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_ReceiveFixedSwapTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receive-fixed Swap Two Member",
        "label": "Receive-fixed Swap Two [Member]",
        "terseLabel": "Receive-fixed swap"
       }
      }
     },
     "localname": "ReceiveFixedSwapTwoMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Redeemable Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to non-controlling interest\u2014redeemable holders"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest, Increase (Decrease) from Redemptions or Purchase of Interests",
        "label": "Redeemable Noncontrolling Interest, Increase (Decrease) From Redemptions Or Purchase Of Interests",
        "terseLabel": "Acquisition of shares of non-controlling interests, net\u2014redeemable"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_RedeemableNoncontrollingInterestPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Policy Text Block]",
        "label": "Redeemable Noncontrolling Interest [Policy Text Block]",
        "terseLabel": "Non-Controlling Interests\u2014Redeemable"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestPolicyTextBlock",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sgry_RedeemableNoncontrollingInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Roll Forward]",
        "label": "Redeemable Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Non-Controlling Interests - Redeemable [Roll Forward]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestRollForward",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sgry_SelfPayRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Self-Pay Revenue [Member]",
        "label": "Self-Pay Revenue [Member]",
        "terseLabel": "Self-pay"
       }
      }
     },
     "localname": "SelfPayRevenueMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_SeniorUnsecuredNotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes Due 2025",
        "label": "Senior Unsecured Notes Due 2025 [Member]",
        "verboseLabel": "6.750% senior unsecured notes due 2025"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDue2025Member",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_SeniorUnsecuredNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, Due 2027",
        "label": "Senior Unsecured Notes, Due 2027 [Member]",
        "terseLabel": "10.000% senior unsecured notes due 2027"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDue2027Member",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_SurgicalFacilitiesExistingMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Facilities, Existing Markets",
        "label": "Surgical Facilities, Existing Markets [Member]",
        "terseLabel": "Surgical Facilities, Existing Markets"
       }
      }
     },
     "localname": "SurgicalFacilitiesExistingMarketsMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_SurgicalFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Facilities",
        "label": "Surgical Facilities [Member]",
        "terseLabel": "Surgical Facilities"
       }
      }
     },
     "localname": "SurgicalFacilitiesMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_SurgicalFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Facility",
        "label": "Surgical Facility [Member]",
        "terseLabel": "Surgical Facility"
       }
      }
     },
     "localname": "SurgicalFacilityMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_SurgicalFacilityServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Facility Services [Member]",
        "label": "Surgical Facility Services [Member]",
        "terseLabel": "Surgical Facility Services"
       }
      }
     },
     "localname": "SurgicalFacilityServicesMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_TaxReceivableAgreementLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Receivable Agreement Liability, Current",
        "label": "Tax Receivable Agreement Liability, Current",
        "terseLabel": "Tax receivable agreement liability"
       }
      }
     },
     "localname": "TaxReceivableAgreementLiabilityCurrent",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_ThreePayFixedInterestRateSwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Pay-fixed Interest Rate Swaps Member",
        "label": "Three Pay-fixed Interest Rate Swaps [Member]",
        "terseLabel": "Three Pay-fixed Interest Rate Swaps"
       }
      }
     },
     "localname": "ThreePayFixedInterestRateSwapsMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_ThreeReceiveFixedInterestRateSwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Receive-fixed Interest Rate Swaps Member",
        "label": "Three Receive-fixed Interest Rate Swaps [Member]",
        "terseLabel": "Three Receive-fixed Interest Rate Swaps"
       }
      }
     },
     "localname": "ThreeReceiveFixedInterestRateSwapsMember",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sgry_UnrecognizedGrantFundsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Grant Funds Received",
        "label": "Unrecognized Grant Funds Received",
        "terseLabel": "Unrecognized grant funds received"
       }
      }
     },
     "localname": "UnrecognizedGrantFundsReceived",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesMedicareAcceleratedPaymentsandDeferredGovernmentalGrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_VariableAndShortTermLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable And Short-Term Lease, Cost",
        "label": "Variable And Short-Term Lease, Cost",
        "terseLabel": "Variable and short-term lease costs"
       }
      }
     },
     "localname": "VariableAndShortTermLeaseCost",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgry_VariableInterestEntityNumberOfFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity, Number of Facilities",
        "label": "Variable Interest Entity, Number Of Facilities",
        "terseLabel": "Number of facilities included in VIE"
       }
      }
     },
     "localname": "VariableInterestEntityNumberOfFacilities",
     "nsuri": "http://www.surgerypartners.com/20220630",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r111",
      "r246",
      "r251",
      "r259",
      "r373",
      "r374",
      "r381",
      "r382",
      "r472",
      "r551",
      "r561",
      "r571",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r111",
      "r246",
      "r251",
      "r259",
      "r373",
      "r374",
      "r381",
      "r382",
      "r472",
      "r551",
      "r561",
      "r571",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r111",
      "r164",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r184",
      "r188",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r256",
      "r258",
      "r259",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r111",
      "r164",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r184",
      "r188",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r256",
      "r258",
      "r259",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r242",
      "r264",
      "r295",
      "r330",
      "r332",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r491",
      "r525",
      "r527",
      "r553",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_PayablesToCustomers": {
     "auth_ref": [
      "r583"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount payable to customer by broker-dealer.",
        "label": "Broker-Dealer, Payable to Customer",
        "terseLabel": "Amounts due to patients and payors"
       }
      }
     },
     "localname": "PayablesToCustomers",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r191",
      "r240",
      "r241",
      "r311",
      "r312",
      "r492",
      "r524",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r191",
      "r240",
      "r241",
      "r311",
      "r312",
      "r492",
      "r524",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r231",
      "r239",
      "r240",
      "r241",
      "r242",
      "r264",
      "r295",
      "r320",
      "r330",
      "r332",
      "r334",
      "r335",
      "r336",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r491",
      "r525",
      "r527",
      "r553",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r231",
      "r239",
      "r240",
      "r241",
      "r242",
      "r264",
      "r295",
      "r320",
      "r330",
      "r332",
      "r334",
      "r335",
      "r336",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r491",
      "r525",
      "r527",
      "r553",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": {
     "auth_ref": [
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r552",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of property.",
        "label": "Name of Property [Axis]",
        "terseLabel": "Name of Property [Axis]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": {
     "auth_ref": [
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r552",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the property, for example, but not limited to, ABC Shopping Center.",
        "label": "Name of Property [Domain]",
        "terseLabel": "Name of Property [Domain]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r39",
      "r475"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r196",
      "r197"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r31",
      "r54",
      "r55",
      "r56",
      "r513",
      "r532",
      "r533"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r53",
      "r56",
      "r64",
      "r65",
      "r66",
      "r113",
      "r114",
      "r115",
      "r379",
      "r471",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r29",
      "r475"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r337",
      "r338",
      "r339",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings": {
     "auth_ref": [
      "r296",
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance.",
        "label": "Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings",
        "negatedTerseLabel": "Preferred dividends"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r23",
      "r105",
      "r172",
      "r179",
      "r186",
      "r205",
      "r246",
      "r247",
      "r248",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r257",
      "r259",
      "r260",
      "r373",
      "r381",
      "r440",
      "r473",
      "r475",
      "r494",
      "r510"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets",
        "verboseLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails",
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS",
        "verboseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r18",
      "r38",
      "r105",
      "r205",
      "r246",
      "r247",
      "r248",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r257",
      "r259",
      "r260",
      "r373",
      "r381",
      "r440",
      "r473",
      "r475"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r400",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Organization and Summary of Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r329",
      "r331",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails",
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r329",
      "r331",
      "r362",
      "r363",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails",
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails",
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "terseLabel": "Recognized non-controlling interests"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r361"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Start-up costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions and Disposals"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposals"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Transaction and integration costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r15",
      "r20",
      "r97"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r92",
      "r97",
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r92",
      "r441"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months",
        "negatedTerseLabel": "Amount estimated to be reclassified as a reduction to interest expense over next 12 months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r235",
      "r236",
      "r237",
      "r243",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r113",
      "r114",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r28",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)",
        "terseLabel": "Common stock, shares outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "terseLabel": "Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 89,935,287 and 89,332,557, respectively"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r59",
      "r61",
      "r62",
      "r71",
      "r504",
      "r521"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to Surgery Partners, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r59",
      "r61",
      "r70",
      "r371",
      "r372",
      "r392",
      "r503",
      "r520"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Less: Comprehensive income attributable to non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r59",
      "r61",
      "r69",
      "r370",
      "r392",
      "r502",
      "r519"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r153",
      "r154",
      "r194",
      "r437",
      "r438",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r153",
      "r154",
      "r194",
      "r437",
      "r438",
      "r534",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r153",
      "r154",
      "r194",
      "r437",
      "r438",
      "r534",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r153",
      "r154",
      "r194",
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Revenue by service type as a proportion of total revenues (as a percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r153",
      "r154",
      "r194",
      "r437",
      "r438",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r380",
      "r384",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r188",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "verboseLabel": "All other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r151",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r104",
      "r111",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r282",
      "r283",
      "r284",
      "r285",
      "r453",
      "r495",
      "r497",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r26",
      "r279",
      "r497",
      "r509"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r45",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r46",
      "r104",
      "r111",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r282",
      "r283",
      "r284",
      "r285",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r46",
      "r104",
      "r111",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r282",
      "r283",
      "r284",
      "r285",
      "r297",
      "r298",
      "r299",
      "r300",
      "r449",
      "r450",
      "r453",
      "r454",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r268",
      "r280",
      "r282",
      "r283",
      "r451"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less: unamortized debt issuance costs and discounts"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r268",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "terseLabel": "Unamortized fair value discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Long-term deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r95",
      "r106",
      "r350",
      "r355",
      "r356",
      "r357"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r95",
      "r167"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r394",
      "r395",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Derivative asset, notional amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r51",
      "r401",
      "r403",
      "r409",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r421",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivatives and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r394",
      "r395",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "negatedTerseLabel": "Derivative liability, notional amount",
        "terseLabel": "Derivative liability, notional amount"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r395",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.",
        "label": "Derivative, Variable Interest Rate",
        "terseLabel": "Variable interest rate of derivative instrument (percent)"
       }
      }
     },
     "localname": "DerivativeVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r110",
      "r393",
      "r396",
      "r398",
      "r399",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives in cash flow hedging relationships"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r223",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by Sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r95",
      "r223",
      "r226"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "negatedLabel": "Pre-tax loss on disposals and deconsolidations"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r329",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r72",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r126",
      "r129",
      "r134",
      "r137",
      "r138",
      "r142",
      "r143",
      "r423",
      "r424",
      "r505",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r72",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r129",
      "r134",
      "r137",
      "r138",
      "r142",
      "r143",
      "r423",
      "r424",
      "r505",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Net loss per share attributable to common stockholders",
        "verboseLabel": "Loss per share:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r108",
      "r346",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal effective tax rate (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r340",
      "r346"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "negatedTerseLabel": "Tax benefits related to vesting of restricted stock awards"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued payroll and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r64",
      "r65",
      "r66",
      "r113",
      "r114",
      "r115",
      "r117",
      "r123",
      "r125",
      "r145",
      "r206",
      "r296",
      "r301",
      "r337",
      "r338",
      "r339",
      "r352",
      "r353",
      "r422",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r471",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsMember": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in the stock of an investee which is adjusted for the investor's share of the earnings or losses of the investee after the date of acquisition.",
        "label": "Equity Method Investments [Member]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r270",
      "r282",
      "r283",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimatedInsuranceRecoveries": {
     "auth_ref": [
      "r22"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts expected to be recovered under the terms of insurance contracts.",
        "label": "Estimated Insurance Recoveries",
        "terseLabel": "Expected insurance recoveries"
       }
      }
     },
     "localname": "EstimatedInsuranceRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r426",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r426",
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r270",
      "r282",
      "r283",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r427",
      "r479",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r270",
      "r282",
      "r283",
      "r426",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r270",
      "r282",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r270",
      "r282",
      "r283",
      "r321",
      "r322",
      "r327",
      "r328",
      "r427",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r270",
      "r282",
      "r283",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r479",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r431",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FederalFundsEffectiveSwapRateMember": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.",
        "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]",
        "terseLabel": "Federal Funds Rate"
       }
      }
     },
     "localname": "FederalFundsEffectiveSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r458",
      "r463",
      "r469"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": 2.0,
       "parentTag": "sgry_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r461",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash outflows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r456",
      "r468"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails": {
       "order": 1.0,
       "parentTag": "sgry_LeaseLiability",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance lease obligations",
        "totalLabel": "Finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability [Abstract]",
        "terseLabel": "Finance lease liabilities:"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r456"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r456"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r460",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash outflows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r455"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails": {
       "order": 2.0,
       "parentTag": "sgry_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r458",
      "r463",
      "r469"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": 1.0,
       "parentTag": "sgry_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of leased assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r238"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 8.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation settlement",
        "verboseLabel": "Litigation settlement"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r95",
      "r286",
      "r287"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 10.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r21",
      "r209",
      "r210",
      "r217",
      "r221",
      "r475",
      "r493"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, end of period",
        "periodStartLabel": "Goodwill, beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r211",
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions, including post acquisition adjustments"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r220",
      "r221",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesRollforwardofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GovernmentContractMember": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Formal agreement with government or its agency.",
        "label": "Government Contract [Member]",
        "terseLabel": "Government"
       }
      }
     },
     "localname": "GovernmentContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GuaranteeObligationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Guarantor Obligations [Line Items]",
        "terseLabel": "Guarantor Obligations [Line Items]"
       }
      }
     },
     "localname": "GuaranteeObligationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r398",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r107",
      "r358"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Income before income taxes",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r67",
      "r95",
      "r169",
      "r204",
      "r500",
      "r517"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity in earnings of unconsolidated affiliates"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedTerseLabel": "Equity in earnings of unconsolidated affiliates, net of distributions received"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r329",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r2",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r12",
      "r13",
      "r14",
      "r229",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r227",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r109",
      "r124",
      "r125",
      "r170",
      "r345",
      "r354",
      "r360",
      "r523"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax (expense) benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r63",
      "r341",
      "r342",
      "r347",
      "r348",
      "r349",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r346"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "negatedTerseLabel": "Tax benefits attributable to non-recurring earnings' impact on the valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r346"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Amount",
        "negatedTerseLabel": "Tax benefits related to the sale of partnership interests"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r94",
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "negatedTerseLabel": "Decrease in operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other operating assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "terseLabel": "Goodwill and other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "negatedTerseLabel": "Interest expense, net",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Interest payable"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest Rate Cap"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r16",
      "r35",
      "r475"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "auth_ref": [
      "r535",
      "r538",
      "r540"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.",
        "label": "Investment Owned, at Fair Value",
        "terseLabel": "Fair value of investments"
       }
      }
     },
     "localname": "InvestmentOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in and advances to affiliates"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LaborAndRelatedExpense": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.",
        "label": "Labor and Related Expense",
        "terseLabel": "Salaries and benefits"
       }
      }
     },
     "localname": "LaborAndRelatedExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r467",
      "r469"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Expense and Cash Flow Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r41",
      "r105",
      "r180",
      "r205",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r255",
      "r257",
      "r259",
      "r260",
      "r374",
      "r381",
      "r382",
      "r440",
      "r473",
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r34",
      "r105",
      "r205",
      "r440",
      "r475",
      "r499",
      "r516"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r44",
      "r105",
      "r205",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r255",
      "r257",
      "r259",
      "r260",
      "r374",
      "r381",
      "r382",
      "r440",
      "r473",
      "r474",
      "r475"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r26",
      "r497",
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Amount of line of credit outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Availability on line of credit instrument"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Other litigation costs"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r26",
      "r269",
      "r281",
      "r282",
      "r283",
      "r497",
      "r512"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt, less current maturities",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "terseLabel": "Less: Current maturities",
        "verboseLabel": "Current maturities of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r46",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r50",
      "r105",
      "r205",
      "r246",
      "r251",
      "r252",
      "r253",
      "r259",
      "r260",
      "r440",
      "r498",
      "r515"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interests\u2014non-redeemable"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to non-controlling interests\u2014non-redeemable holders"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r92",
      "r93",
      "r96"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r14",
      "r58",
      "r60",
      "r66",
      "r68",
      "r96",
      "r105",
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r124",
      "r125",
      "r131",
      "r172",
      "r178",
      "r182",
      "r185",
      "r188",
      "r205",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r255",
      "r257",
      "r259",
      "r260",
      "r424",
      "r440",
      "r501",
      "r518"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss attributable to Surgery Partners, Inc.",
        "totalLabel": "Net loss attributable to Surgery Partners, Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r58",
      "r60",
      "r66",
      "r124",
      "r125",
      "r377",
      "r391"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net income attributable to non-controlling interests",
        "negatedTerseLabel": "Less: Net income attributable to non-controlling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Net income attributable to non-controlling interests\u2014redeemable"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r121",
      "r126",
      "r127",
      "r133",
      "r138",
      "r172",
      "r178",
      "r182",
      "r185",
      "r188"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net loss attributable to common stockholders",
        "totalLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r291",
      "r377",
      "r378"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net (loss) income"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1": {
     "auth_ref": [
      "r98",
      "r99",
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.",
        "label": "Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)",
        "terseLabel": "Noncash consideration"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r301",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-Controlling Interests\u2014 Non-Redeemable"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated as hedging instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of facilities acquired",
        "verboseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails",
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "auth_ref": [
      "r395",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.",
        "label": "Number of Interest Rate Derivatives Held",
        "terseLabel": "Number of interest rate swaps"
       }
      }
     },
     "localname": "NumberOfInterestRateDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfRealEstateProperties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of real estate properties owned as of the balance sheet date.",
        "label": "Number of Real Estate Properties",
        "terseLabel": "Number of properties acquired"
       }
      }
     },
     "localname": "NumberOfRealEstateProperties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which entity operates"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Cost of revenues"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r172",
      "r178",
      "r182",
      "r185",
      "r188"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r464",
      "r469"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r459"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r456"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails": {
       "order": 2.0,
       "parentTag": "sgry_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]",
        "terseLabel": "Operating lease liabilities:"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r456"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current",
        "verboseLabel": "Right-of-use operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails",
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r456"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Right-of-use operating lease liabilities",
        "verboseLabel": "Long-term"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r462",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash outflows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r455"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails": {
       "order": 1.0,
       "parentTag": "sgry_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets",
        "verboseLabel": "Right-of-use operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/LeasesComponentsofRightofusAssetsandLiabilitiesRelatedtoLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r37",
      "r475"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r52",
      "r54"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Derivative activity",
        "verboseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r52",
      "r54",
      "r402",
      "r406",
      "r419"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Gain (loss) recognized in OCI (effective portion)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r54",
      "r57",
      "r407"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "terseLabel": "(Gain) loss recognized in income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax": {
     "auth_ref": [
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification from accumulated other comprehensive income (AOCI) for gain (loss) from discontinuance of cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax",
        "terseLabel": "Amortization of accumulated OCI related"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Cost and Expense, Operating",
        "terseLabel": "Other operating expenses"
       }
      }
     },
     "localname": "OtherCostAndExpenseOperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Summary of Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r42",
      "r475"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/OtherCurrentLiabilitiesSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonrecurringIncomeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 9.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature.",
        "label": "Other Nonrecurring (Income) Expense",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonrecurringIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r80",
      "r83"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other investing activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedTerseLabel": "Distributions to non-controlling interest holders"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock",
        "negatedTerseLabel": "Payment of preferred dividends"
       }
      }
     },
     "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedTerseLabel": "Payments of equity offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Payments for acquisitions, net of cash acquired",
        "terseLabel": "Payments for acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Purchases of equity investments",
        "terseLabel": "Payments to acquire equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment",
        "terseLabel": "Total cash purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "(Payments) receipts related to ownership transactions with non-controlling interest holders"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r27",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r27",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r27",
      "r475"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r17",
      "r36",
      "r207",
      "r208"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from equity offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Borrowings of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "(Payments) receipts related to ownership transactions with non-controlling interest holders"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r86",
      "r90"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Proceeds from Sale of Equity Method Investments",
        "terseLabel": "Proceeds from sales of equity investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Proceeds from Sale of Productive Assets",
        "terseLabel": "Proceeds from disposals of facilities and other assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Revenue Source"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r536",
      "r537"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees",
        "terseLabel": "Professional and medical fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r14",
      "r58",
      "r60",
      "r66",
      "r91",
      "r105",
      "r116",
      "r124",
      "r125",
      "r172",
      "r178",
      "r182",
      "r185",
      "r188",
      "r205",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r255",
      "r257",
      "r259",
      "r260",
      "r370",
      "r376",
      "r378",
      "r391",
      "r392",
      "r424",
      "r440",
      "r507"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r224",
      "r458",
      "r463"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "terseLabel": "Accumulated depreciation on property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r225",
      "r463"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net of accumulated depreciation of $320.7 and $272.3, respectively"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r198",
      "r200",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesDerivativesAssetsandLiabilitiesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesInterestRateSwapsandInterestRateCapsOutstandingDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesPretaxEffectofDerivativesonAOCIandStatementofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r179",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Assets from Segment to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r178",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Segment Revenue and Operating Income"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r289",
      "r290",
      "r292",
      "r293"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Non-controlling interests\u2014redeemable"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofNonControllingInterestsRedeemableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "terseLabel": "Schedule of Rollforward of Noncontrolling Interest - Redeemable"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedTerseLabel": "Principal payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted shares"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r30",
      "r301",
      "r475",
      "r514",
      "r531",
      "r533"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r113",
      "r114",
      "r115",
      "r117",
      "r123",
      "r125",
      "r206",
      "r337",
      "r338",
      "r339",
      "r352",
      "r353",
      "r422",
      "r528",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r163",
      "r164",
      "r177",
      "r183",
      "r184",
      "r191",
      "r192",
      "r194",
      "r310",
      "r311",
      "r492"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Revenues",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r466",
      "r469"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for finance lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r466",
      "r469"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LeasesLeaseExpenseandCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r153",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbySourcesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r362",
      "r363",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsAcquisitionsDetails",
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsOtherAcquisitionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Amounts and Fair Values of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Summary of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r393",
      "r396",
      "r397",
      "r398",
      "r399",
      "r405",
      "r409",
      "r415",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Interest Rate Swaps and Interest Rate Caps Outstanding"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r129",
      "r130",
      "r134",
      "r138",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesScheduleofRevenuesbyServiceTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Rollforward of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGuaranteeObligationsTable": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the type or nature of guarantees, for example performance, indemnification, payment and other guarantees, and related information such as term, origin and purpose, triggering event, maximum exposure, and carrying value. Represents the guarantor's disclosures which include the information about each guarantee, or each group of similar guarantees, even if the likelihood of the guarantor's need to make any payments under the guarantee is remote. This excludes disclosures for product warranties.",
        "label": "Schedule of Guarantor Obligations [Table]",
        "terseLabel": "Schedule of Guarantor Obligations [Table]"
       }
      }
     },
     "localname": "ScheduleOfGuaranteeObligationsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.",
        "label": "Schedule of Interest Rate Derivatives [Table Text Block]",
        "terseLabel": "Schedule of Effect of Interest Rate Swaps"
       }
      }
     },
     "localname": "ScheduleOfInterestRateDerivativesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r172",
      "r175",
      "r181",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r172",
      "r175",
      "r181",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Financial Information by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r373",
      "r374",
      "r381",
      "r382",
      "r383",
      "r385",
      "r387",
      "r388",
      "r389",
      "r488",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r150",
      "r153",
      "r154",
      "r155",
      "r437",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedule of Revenues"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtNarrativeDetails",
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r159",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r194",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r221",
      "r233",
      "r234",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r159",
      "r161",
      "r162",
      "r172",
      "r176",
      "r182",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r193",
      "r194",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Other Significant Reconciling Item, Consolidated [Abstract]",
        "terseLabel": "Reconciliation of Adjusted EBITDA:"
       }
      }
     },
     "localname": "SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self Insurance Reserve",
        "terseLabel": "Professional, general and workers' compensation insurance reserve"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/LongTermDebtSummaryDetails",
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesCarryingAmountandFairValueofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "terseLabel": "Series of Individually Immaterial Business Acquisitions"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/AcquisitionsandDisposalsDisposalsandDeconsolidationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Equity-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r159",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r194",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r221",
      "r228",
      "r233",
      "r234",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SegmentReportingAssetsandCashPurchasesofPropertyandEquipmentbyOperatingSegmentDetails",
      "http://www.surgerypartners.com/role/SegmentReportingRevenuesandOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r49",
      "r64",
      "r65",
      "r66",
      "r113",
      "r114",
      "r115",
      "r117",
      "r123",
      "r125",
      "r145",
      "r206",
      "r296",
      "r301",
      "r337",
      "r338",
      "r339",
      "r352",
      "r353",
      "r422",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r471",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r145",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r48",
      "r272",
      "r296",
      "r297",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Preferred share conversion (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r27",
      "r28",
      "r296",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Equity offering (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r27",
      "r28",
      "r296",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Equity-based compensation (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r49",
      "r296",
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Preferred share conversion"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r27",
      "r28",
      "r296",
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "verboseLabel": "Equity offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r27",
      "r28",
      "r301",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Equity-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r28",
      "r32",
      "r33",
      "r105",
      "r199",
      "r205",
      "r440",
      "r475"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Surgery Partners, Inc. stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r65",
      "r105",
      "r113",
      "r114",
      "r115",
      "r117",
      "r123",
      "r205",
      "r206",
      "r301",
      "r337",
      "r338",
      "r339",
      "r352",
      "r353",
      "r368",
      "r369",
      "r390",
      "r422",
      "r440",
      "r442",
      "r443",
      "r447",
      "r471",
      "r529",
      "r530"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r448",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r448",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r448",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r448",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r476",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfInvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Summary of Investment Holdings [Line Items]",
        "terseLabel": "Summary of Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "SummaryOfInvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfInvestmentHoldingsTable": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The summary of investment holding table is used for any listing of investment in a summary form. Table lists the 50 largest investments and any other investment the value of which exceeded 1 percent of net asset value of the registrant as of the close of the period.",
        "label": "Summary of Investment Holdings [Table]",
        "terseLabel": "Summary of Investment Holdings [Table]"
       }
      }
     },
     "localname": "SummaryOfInvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesOrganizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SuppliesExpense": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense associated with supplies that were used during the current accounting period.",
        "label": "Supplies Expense",
        "terseLabel": "Supplies"
       }
      }
     },
     "localname": "SuppliesExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r25",
      "r496",
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.",
        "label": "Taxes Payable",
        "terseLabel": "Long-term tax receivable agreement liability"
       }
      }
     },
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r132",
      "r135",
      "r136"
     ],
     "calculation": {
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "negatedLabel": "Less: Amounts attributable to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.",
        "label": "Unusual Risk or Uncertainty, Nature [Axis]",
        "terseLabel": "Unusual Risk or Uncertainty, Nature [Axis]"
       }
      }
     },
     "localname": "UnusualRiskOrUncertaintyByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualRiskOrUncertaintyNatureDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.",
        "label": "Unusual Risk or Uncertainty, Nature [Domain]",
        "terseLabel": "Unusual Risk or Uncertainty, Nature [Domain]"
       }
      }
     },
     "localname": "UnusualRiskOrUncertaintyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r149",
      "r156",
      "r157",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r373",
      "r374",
      "r381",
      "r382",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/OrganizationandSummaryofAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CommitmentsandContingenciesDetails",
      "http://www.surgerypartners.com/role/DerivativesandHedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r128",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (shares)",
        "verboseLabel": "Weighted average shares outstanding- diluted (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r126",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (shares)",
        "verboseLabel": "Weighted average shares outstanding- basic (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.surgerypartners.com/role/EarningsPerShareSummaryDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.surgerypartners.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "65",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2793-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2814-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=123583895&loc=d3e30768-111565"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.14)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 5))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r555": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r556": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r557": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r558": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r559": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r560": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r561": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r562": {
   "Footnote": "5",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r563": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r564": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r565": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r566": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r567": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r568": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r569": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r570": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r571": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r572": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r573": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r574": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r575": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r576": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r577": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r578": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r579": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r580": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r581": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r582": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "c",
   "Publisher": "SEC",
   "Section": "5",
   "Subparagraph": "Schedule III",
   "Subsection": "04"
  },
  "r583": {
   "Name": "Rule 15c3-1",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15c3-1"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>69
<FILENAME>0001638833-22-000122-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001638833-22-000122-xbrl.zip
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M?<HC7ORO_,8O4\(W,J?_ 5!+ P04    " "4A0)5RR4@+ P(  !8(P  %0
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M5?/]$7M-]Z$]E^WF&9QS=GK6;.WDC=;+T^/66WA6G1V];YP=GQU>-J[<&-H
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MX$[>:EX"#)?=*OV&DZH7(LK>>\YMM XDF5$7E-/<6$M(U%B&N *YI:=>X[&
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M&25TGC/'4GK>4B:=9L%J8V, #7#@V6D,M 2YK67P[=4.$(\^HX$AR3BB+(;
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M:0GR'0S1J+&,@4,,HX&VL4@UCYI[[H'+\1+YU4J>EH"G">*)<Y);:2,+X.G
M3 GK20S"6&)CB9(EE3PM0::%8>15P"$$A!E'SG(K7/0828-$T&C%^--&%^2H
M;?HK+4@+(4X48X44,0)$B0G.%#B]*%2$G\IY7*8Y))4@+9(Q11TX,XHSZ@1S
MJ>0$M0YQ10W%PJ$R9;LJ05HD56+ D[#QP3C@2"IH12,B$C./D/=.DA6C2K^%
M("V$(VG.L'84LQ EL\8HA(T6X/"TT\J[,JP"O@^6F[W^>0_0#(U>=PKG*A(5
M(",<' RF3$N&O37<Q<@9D\HC@4LQV74YT5P(6R!$4^\4498YIA57'BM!5%)+
M+%4I5OHN)YJ+<=G!(!0=\<&";H9@0G3.*J4I04&6(KNQG&@NQ&\6$_XX3DN9
M M,:*6.(]$#E#:.<VA*4M:A25(^S727B5'%K!8HV,B*#\1BL.%.$:XH=D\N_
M#6 E&8]4"@=H-;(8,\L"\T'!/RMD0!RE56NJ!!ON_LZQVN.4'>6!24L<CD1!
M""8TP2 8WEJO==!&K8:Q^ U$8GY6 @5"P4(P8@-C#F,CC#<AI$C.:1J7N+CV
MTM##QZD:I;"#P(L++#@3,2KCJ)3&LN@H,9$OKZHN(RYS+' J%:,4(BDA(K,$
M:6=!=U*U&NN%5[,"IW(Y<=D/IKT]2#9TH^LWG!MU1NVT:'\KG/>#RPNXML+
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M&9BW#O3!^*_$CN%VP"%3MYW43OJ]3\/3V>%UX,FA:)L/,>\6*_N+R1MI3)3
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M!OW+<B@V]$+LE+26E?"7=LX^=?L7(;P-XV).?WR/[ J/W8?'9DN;>.69Y8P
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M9_N'+S^F$2/[AV^[[0^^V_YZVFUC]64_Q?3($489 4UR)$]H@GIRDB$0(WW
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M+@/)[5"@I#3@<C-B)K'EP39;Z)9D_W^5O8<U@&:UO04*-!> YG0,[X+04HD
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M8C!,D:@"MP9KH:DH</HPX'1WAJ5&$:7DVB 0)$,\:HJ, [XJF',^PIO4Y_S
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M$PJ1>HH9%TRP)NGVTZK9_I_C7FPQO+*2[76WGC,8_- _SEZ1*DWYTRWH+H+
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M.,C?@B;9IC2E=3#(J]__7"X=M;:Q7YV*[*=6/EJ<%>=??]B-19*_3Y!8-
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M_/U\[;A;]9HS;/VVMKGW8KCV>_6(TUL=](='><V#.QT-P* ?P/!.CNE4*4[
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MWB/@G/!@8L J&NF%MD&8,"[UQ2\H]54 XS8! \\ AE=.$Q\<(B1@Q)T0R,9
MD'!,:R:$"Z0&C/ECN 4P"F"L!#!$WL0401&1%)<!VX0UP(73E,E(S67U10M@
MW"9@T E@[.Z_)KMO/R7#N8T^(*6Y19QKC0Q5'$G@B48KXPP.%6"L*MUV 8P"
M&'.)H SF201"8N+,"1,I5BX2BZT2F--+BHD6P+A-P.!3@$&!8401I%:*(".=
M1UQB,$D -I 'U* &"RYC81B/UOUZ50_/@JR1-W+PE$*$2]AK"9@^SEGT'(]
MN"2//MIH#;=,.%P<//>%INT7<PX>0YT@00ODO0N(!V^0!M:,@M"Y-"QS2;"U
M#7IS]K6:@H/W#J8%+U:.%[F0.XW1*1X8]\D;0K5U2A.KL=!$%__./>+%K'\G
M*DNE(Q@Q9B+B(*.<SI,@3DDBC@<K%5G;8$TI4%KPXO'A1;#.<)VK&@?%+8E:
M\2BELDGYF +UQ;USCW@QZ][!AG"*M<Y>8(NX, %9)W/-"^>\"C9&&PJ_*'AQ
MBWB1(DO*6AP\D BEDZ5:TWS872J<K"G>G?O$BWGOCDA.28TD(1IQP >DA9&(
M*!82L9;"9"W\X@;.G5\XM0AKMI=GOSIQ<W1!J-U].\EO5A"X<=-L.8QE/)JH
M@&QYPSC@JJ/*!D*,U9Q%QF3Q^=P;QN[-^7PB89$R)Q!F.B$.JR'2AF.$J;1:
M1RN]H&L;1J^KU5:XO94"MO>.P 5J[GBSCF,M &=B")HGL!\,!2:7",5.PBPN
M[J+[A)I9=Y'C*N^L6A23((@#Z4).<@E0$Y-6*JA0H*9 35.AACE"F&$AQQYR
M3H7&1F/"?*"4&4QB\33=(]1,/$UD9]^?M#]_"@KCJ!)#*A@%4",5LL9PY'R2
M0'B,EEA54",+U!2H:1K4 .F.QDE8++V !9/87*T,)Y92(#IR7YQ4]P@U? 9J
ME(N:!VY1T-(A;D-"QD6,%(E:"!Z#)[RPFB<9G[3X>.ANE?U\)1ZKXOB_NJ7H
M/1@9Q'I/(]>6:,VXQX"A)B0C:3EI=G^8VIES2@5.<,(,HTB" $QU BQ%KY&0
MQ%+#0$PV5X9=GZ\,^S0=_P4O5L_!''/ PA0E,G$CF4T:8T^8UH >B?+B6;I'
MO)@[:$8%CB0YA#,1XY%CI*TE2 NJ?"+:X.Q9*GA1\.+V ITQ (5FB?.@N*'$
M@>'FHW3&.FZ43,4]=(]X,1V(Q':^?[+:*RV-0X(+@SA8V$A+%9!(BD6+:;+>
M9+S@!2\*7MP.7BA+<_59A@/QG)&DG<__!&'2!C8^&%%\//>#%].!2&SW[2?I
ML%8":^2EEXCS9)"A7B!+@J?$1V<T+OSBE@*13%/<.;\*1&I8X-%9OOA6Z!_G
MK,%Y'"YV'3YZN,5!$RJ5CC8)GE]PY:A@F#'#*(W^$O?/5 GV K@K!]SY5$,L
M8*M2M(A1ZQ$W&",K'45)LL2H--9CF^NVXW6\6J_ZC13G(4)UP:C&8)3G2A-%
ME+:&<:J-M4:3&$6P3&MW:6ZC@E&WBU&S3B?MA-6, T8QK1 '/H\TCR ;HA3#
M3A&>"D85C'ID&,542%(2+6WD421GB':!!!J3MPK32]Q<!:-N%Z-FXZ D82G)
MZ!'5+!NN&&Q6#S\D<4E+[*,/N&!4P:C'A5&)$\\E8)#@G*>H61216P\+LQ#I
M-"C\(M=:P:C;Q:C9 *J@&4W)*222-(A'&Y$5BJ*06(P8VQ2KS;N"4:MQR_U1
M%83:N+AT]WQMN$L+0U^]_-<,TMQY^:_JAHLJZ2TN"'91*O_U5FLRLG<KU7$1
MY\YI!JM6];*N6ILKPQY48_UYDLS\I)5B7=YU4L"W*H);U[VM2@"/>YBKOM;E
M:>&"<;W:4'UWNJ9R58,V' ]RZ=RZ\G.L"C,/%^10_V8'^5==]#<_:E+R-]=0
MZZ?3,9W4X'W6<L>CUO&P+HA;%RG.U9N[W4GYW*HYQ\-QS348]OY159X9[CWH
M]P^?M6Q51AKT[V3\1E6T-Y?1_;_'G:-<MO=9Z["JE=R%)A\==3NYWG+O>##,
M]QB.;$I5 =OZ.U5!V[,Q"7UH0:\_@G^#P^DVYAZD.!S"U_,(Y/&>C)\[J2M8
MUX/\__R/AC7HSV$U7+'?@P;WXA"^ )=V^Y\[PU&N?MROX@/M:#0>MJ.#DV$'
M>@%?K^M?9T&X3C>7G X=Z/ (FI)KU!W#9Z=?'DY*&D\$7)4^GJF(O-[Z=_\[
MS*-!58-ZF%]5(S,GS&?GZE]/B^.T!W:JL/=<PK7IFM[UF%7#5$W%<?N^=8:=
MT6FKSVHHG_8(ACFCOL^M.8(6'%H_E= MBRUT[.=>'Q#%MT;0JF&K0O):#&<#
M<W&1TH=;N/ BG*KFRFEI]9!+%_ZJ8OMIE?3UUIM??,W9(=QKK,X].P(\F%+H
MLZK:H#N3\MGG)]!\L?>JFG;KJ-^!3N2R[S V9P7?SU5R'^02XH-Q(??IFQ[8
MK)Y3C9TN#)^.!Y5:S1P8SW-U>.XN1P.@@0,0T&2@8!8=CR:7G>'?LU\.Y.?8
MRZJ4RX:?%IX? J5L!7LR+I$]A=ZGXAD/::[A/36@CW'"3M=!#S%7&(>O#!>7
ME3^;;\#FAL-S\#,WYP#.XR@/WKAR>BYHWC^K96Y#'H=Q ?<*,H:^KN%>536_
MJ,K\I*F3FP*.P257N_%IZ\]]_?,@UL7JGU6WFGP=5 "826<,:+#.C_J#"HOC
M#YAO, =A.K1>G!5M7[:7$SP8A'KAKE8(N'$_Y#&K&<)ZZV%.N"6YW>(X_/7;
MY747MG%Q)>?[9)FMQ0-TNH+#_8&)Y4E6S3$;0(5AOF9"]BV>7E:M\P#8\%Z8
MZ!@L&OT>V&2]RK:J9N\4;QP=P%HP#<G63U0TT[^,_M7'F=.!FA[&T4$?U'ZJ
M.1DZ%Q#2T_6D,SHC<_WOO<PD.[EP&BC3LYK_G=UK#F"J566>DU2-JV\_W?9.
M_91!;NQ@?/%X2?+V*,^#3,RR73FJZ:,=#N.H1IUAG(*)3)OKI71RLW//F;HO
MJ/?Q8)"9XZ)N9'8,*^WA<7?402?1#L;JOX!<YI& N=8%AED#&%P&L^8@TTT[
M[)Q1XWD!#\]/C\$@X\H8CZ8)!"SY,"H3_ ^S594/IJ9=AG0+#3PU;"HSIA[]
M>@*>ISKGP>U4]HO&9(Y6U ,PL^[^,6,;7V L7UXY^WRE[>298\SA)'+2RY"<
M-9($%R/F&D?FEC"N[QN +UWQZ[K8>6J.2UG'6JO!O+PHDT]E0HTMQFI%KF5]
M40GN"V^3^H,9P^(<_BS"B]]"+JD]J( #QJ.;V=WO5ZWI37XIFG&AQ@62>3 U
MOB5;ITS?0G%GS:]7,OI7C57KFERO9/1E);[IRMLJUK5F3WQ<;Z.M>5Q5T^I[
M4S);]/4,/QYRW=>K%@"_EU+JCZJ\[NW7)7ZD [=47>)2=?W7X[EYF$VT4B+[
M&D-WE3B")SDP94ZM:$X]@:0:I>9Z:>3#;.0JSTJI=26:HJ>+ U+>##K?\NY6
MIS<\'N2ML]L(HEMFZ!8&P#5MU/[73<K4-3M"Z<+0ON-AF(GKX]P[AFEVK;*<
MJ-A&ZK"05#'EB9+DDC-<2,R&];VK%XF7@_[AB_'NV3^=T<&+XR$,1QR\KC8Z
M8!@WA\,(_P_[]L=IM)]\R,%^7[[B]L^7ASN';\G'+P?P_7=?/WYY+3Y\>==M
M[W_]_A&N^?BE?;"[W_TR&^RWN_^6[?P#;=KZ^W#WU=OO[5?O#G>^=#OM5^_)
M[OY?7W?V_X+>;HO=?]J+2HSYF$L_$X:"UQ'Q$"BR4C+$%?4VN.1D5&L;#)NF
M5&PL959OJ1 'S4E421#><!Z8UP%CF8RT5D3GHBOYN.Y1:V>/.HEDK28BJZD'
MK14)(TV(1\E0J8(C!.="[H*L+$+WH4?:%B)3B,S%1$9B1Q1V.BCB.2'$4,>5
M8PP+*[DD\I*#GH7(W ,DTMFZ&5+JA$5 6,6<]E489!,-R&#M<=",JQC7-H";
M-@43"Y&YI;SPGC)C+%&"@6FBK 'Y2\P<990FQE))%'B/6LMGM%8R&J26 6G+
M!; 9PY")EB"C--%&@+PT!R*#UTTSE/;>B<R*7,</Q#OU*D?']7)P6$E_=HO\
MA\KDHS<>[#K%C0Y.@Z$7$_$NZ>3U9;F8"_^Y<R2=KQN6''/:*(XLSQ4VN$K(
M!?A3)BUU$-)*XX'_"+U.FI$4K6CR+3ERL*;4ZH -H5Q(IXFE$O@PR^6>@C;%
MD7./6COKR$D<")#3$A&G.>*8)F0\XP@[*0,3R@L%_(?3FWM?'TDFPP(8JUWZ
M+4Z&F: 2UQ$6C6BP!4YNB)0X*L,O2ZM>EOY[ )%9UP=U <PGI1 E(N1LZPPY
M''/J!BE,I H$*6#II[(IA9F+)M_.TB^\5X0211UHKI;,!AT)$/M DE#2B>+Z
MN$>MG75]J(2-=R*AD#SHJC8$ >QRQ(37@1EF?9#5TM\0I;WWI?]I!>;LQ6Y"
M1_;DOI-:/2+,G&<_R5BN$S68.\X]T3I&RT0,42ICDF;%\=$T'%U0FXK@@(.Q
MB"43P82"'\9PC;Q68/5*$3!V:QM$E@"61Z/(BPM$::P,#HHP)CF0("VH#=)1
M[(4S3N/B][A'I9WU>T1%DV,,5%41B;@7 FE.*4K!4BJBRD%(8+*LK$;G0^<^
M!2]6'/'!(M;$>JP]Y\$+2Y2R7$9)'>4VZ>+V:!Z&S+H]A*!2*#";E$T$\10X
MT@)CE#SS,GGI5*XI3M2Z;@:(%$6^I8 /QX$!<LQ ^L#FP9*F/!>6U2P2JP@I
M7H][5-I9KX>@7'H#;#WZ'*8E)5  IWU>^)/54=C$R=H&NWGEID>R\-_U4<&I
M_"GC6Z#\_>>R<IC<SXC4>:]N)?.66-?B"FWX\Z@_K!)"/:]2NW:^Q3_SB3+$
MULF"M"XYFU*^P]K&;^3WF9Q%Q?-]"V3.45^5D_+!<B65$8H3J?.VA_&4E_"5
MQJT+\P6FA(K$Z%PL6#F.N- :R)Q7N99+Q(P3ASF0.<J:X@TOBGP[9"Y(XI03
M!@?+P!ZC!A1:TNB9HU@E+8H7YQZ5=M:+XZ(C4:J$M*<8-)>!TF+!$36:"D)"
M8IAG,G=C ^R1[& 5O%CMPF^<I]+%X",WW*5H)5&&6I(2_/21%2].\S!DUHOC
MDZ8I,($\H$;V!$MD3.(H$>D=6/::B["V0?3-3P"4A;\ABKQXX?>>6:R-H)IQ
M[)RSQ*9$M=':2R#WQ8MSCTH[=VP'.Q.(=[#<XXBX]!XYS@7""DMLB2/2V;SP
MRV;H[+TO_"NMO\W7&QZZLO_+S+_WO:]UY:1B#QQEY^D2#@I34%/FL.5)>.VC
M"%1*>&&B)KKX21J&O+OS^5JDD):K?%;29.1U1"-8(0U2/D0""Z?20JQM2*Q6
MYD%?)@G?0]D2>RH8L)!I4:68@/7;<B(X9M@E'J61R4DPIZRX[(#0TRS'>'<:
M/^MD"51)ZZA#5&I0^UCG-(C(66F2<81G^=Q&.<9;T?A[IV(%;>[20:.$HE8Q
MKXCD,2=6(<8*DIR7V%A<'#0-Q)^Y,!L2DXE -I)B"G&%P>KS*2'.+<5:2,YL
M6ML03*PL1T-A' \7 Q;[=D@(DB4J&,LY(V'5DI9%*ZRW2GA_681.81RWJ_&S
MWATL"+7)*"2,Y8@32A!P0XX\,\H"A"<C>6$<C0WAN=4.+\[VO;@R7=G[ND5J
M12(8 %%12B3EEN7C@AH+;50(2ND8BC.G:4 [G[-%YR-+'##6,! 3]Q)>Z621
M,H$0GIQ+0JUM/.Z,+4VYQU/'$T>#5=C$Z'/X- TZ2D>CTTJ$A(D*Q51K'I[,
MY<"DSB?M*+*6 W%S,B)XPR-I0:#&,4DT7MM0Z[S@R:V6?:#X86S1W>:6W!4I
M_[BZ'CO*)8"/<ZG-2=]O9C$W;<"73K2\PO%Y+$N48=*D*"/F1G'BJ).>NT0D
M9XDPZ4J]B:8M43O[FZ.=#OZ1EZGVEB>P3'V2@AFMI$:$:8UXA.7)8H:141%^
M&4$#3FL;DHB;KU(KUZ2F^!OO^1X%V@NTK_H(3]0^&"PP]98G2QWSV&)/DJ$I
M2!^+]=% :&_/0+N50BN:LSB0E*,"M4 N88P$-Y(&3U1*.9DW7]WIS@+MY\R7
M/ZJZ\Z=G#6&(LY)U>L?5-LFB=Z:.>XY55W#0[?GCCJ?EZ?_W^4.BXZ''9Y=8
M!Z-\/+KXDKE"G6-TVOB7&_RQ<?Z\Y!4N6QFH$7P9JM'<%35SHG/JY\'@[.SL
M9["]!]%^139!6Y_;[G=[,ES[XUR7#CN]R;T5A8?/CMB%'4SI.AU4E_GRH7_U
M] =D[==[:\]A_L5!?9KU7[8I36D=#/*R\3\=Y86SSCOJI>,Z."=I\L1CZ8(/
MFN%/"FS=K!2M?FKEA0!F#IB[]N)I=F@'GT$L9Y R7UAVU1/OTA*RU;S;>__N
MU?:[#ZTWF^_VV]OO]IZU7K=?K-^?NERMU>W=_>V]UOYNZ\4N+%?MO>VM_&IO
M][^OMS;WX8^7K]N;[1>O-__;VMN'-W:VV_M[#>A3=</GG1$\S%^AE[^][UF@
M$Z,89L][5S]G8+=F%X+[)(,FL&@2;BG5E$;J DQGRK"TKF9(<$T,FZ-L_4I-
MK%.1)(ZYH,+2&)))S)&DL9%X[1?3.#/H\3MY*90+RR57[W1 QWK0+5TM+0L;
MGCQSC#F<A%,\A.2LD22X"':YQI'--1QKS0)16"<'#3?,IJ E-10ZXYW/A<K^
M5:U;9TM*M6:#,+OV:!B?3U[\&3K#HZX]>=[I51*H+OKS?$<7G,:ONE5_? :P
MZ[@&V;'#;_SD\<?KU4<S'*3^3+)URO2%'^-U<LW/-+_XH;^Z\E>-5>N:B%MH
MJ^!TY6T5ZS!+GOBXWD9;\[BJ*]WU$@?X$LSU\KTV,EOB_0RG'G*5][W.C]8.
M?.M@V-H&' VM_QSW8HOA9\O$@ZQRH,WL.%_)$&KV(&?7[E4V+&Y4G?R1#ARY
MKXFXI%P>Q'AN'H)Q?J7"5#>:BH]QZ*X2DO\D!Z;,J17-J2<0=/GF@@.VSV\U
M[O(*]UC9W"R-?)R-?%J5'-X,.M_L*+8ZO>'QP/9\+)7);V-7]5'NBS*LN7><
MXR3AAV F*2JPXMX33K#DXY 74D)>+ML7/7P)S_OKX,/^YO?VSQWV8?\M^;CE
M^8?#;;KSZKW8_>?UC]VMOP_:/S_\G-T7_?#/WU]V7KT\V-G:9#L_PT%[Z^^O
M[9\'G0_['[Y_W/\J/GS9YNU_MEG[2U7C^#3*>W=_Y\?.YT_!4"JI<D@+RA%G
MT2 CDT>8RYB/8$>B<#ZRKV^>+F4U26]+HNI;JLS)F#(8=-@HSHF31F F)%=&
MN4@)<Y<H\U-,<71W6HNGM/;GSN:G9&,BS#LD&7>(&VJ1]BXB0YPPE-C$G2Z5
MR0N1*43F2D0F1H4)%S99Y;B5*N]V1FILT@%;+]4XP(N4 *_F0"*=@L3O (D
MB)Q(X1'S)""NB$=&"(=LRIO8FN!(,R02<_,#:X7(-$23%Y?:"M2#5:(%]HH3
M38VQ)+&@A+&!>^(O4>9"9&Y3:_F4UIZT-S\9;34C2:#D-4,<$X<,4QBEG&<[
M9DH:<HEQTY0R.?=.9%;D.GX@WJE7?6A,[S!>;=>A'*^][MDEG#B5!!M-$[<T
M9ZXV 8B/)08L0'69[5?XSYTCZ=Z\(T=RPJV@"":50EQPC!QG#%$2K!5<,.Q9
M-@G5S?.B-/B [=/2Y,6.G*1,2E8(*3E/P'\"I2PZ+P.++/)8'#GWJ+6SCAQ,
M)74",Y3C:K,C)R!+G$:!Y"EE"%$<5W76&W(J_M[Y3P&,5:==CB8PEW!4FFN-
MK1(DF4B"9UH:PHOKHWD@,NOZ<-$(+0*83F#QPM+/"++9_^&]%U%:'H ' (@(
MVI24]T63;V?I)]J!O!VQV NN/74,&$"0,5#"*5.TN#[N46MG71__/WMO_M1&
MDJV!_BL*[ILWW1$DDVM5IGN""-K8OLQK1-O&W1?_0N0*PD)BM!C#7_].9E5I
MEUDL0."Z,=<-2%65E7G.=Y8\^1W&E)52R]A=U"&>:8:TIAC!H@1G?<A8"*"U
M;$NLA](^N>G_N0IS/OIV0!?ZZJGYH5\09B[@%;/2!>N%L8IS$YQB>;!!*M!#
MRZW4=>)CW7"T-9_X8+D-!N<HDL0ASDP&(93RR%%I6(!0.!'"LA4TYZSW?=9$
MD1<Z/QY\'^RI,0*<'Q&45$+%#=R@''5&B3KO\81*.YOW,"3/G<PM(L+DH+0\
M*JW+X5<EK6<<UE)N;--ZVZ?&BP<Q_,XY(4PP$"%SSJR75@EM#*5!D=R'NN)C
M#3%D-NU!\D"ULP)1XC'BF"FDM,^08)(HXPS.: Z&GZR,"+XV_$^MR(L+/L!A
M)P3L/3B"7)A,YI@$BG.BF<[5J(%#G?5X"J6=S7ID/,=4<(DL919Q!YJK%3.(
M!<M"3@A8?A.;<ZZ)SCZYX7_LHX(3+"WE+5#\_JLL)4R>9D:*!@[5M*QT &)+
MBEN,80'G6#Q1AM@664#J8G3?%Z14OY!9RITZ\[UZ9RXPBS/M<\]%SAW!,@_:
M,/#N!'8Y9WF=Q5DWNW UE\71-)<>8XN\<0YQ[01203'PZ%3.##:2Y7$/*_OQ
M+$Z]A;4FBKS0F3/$>.HR+$1&N 1=9B(#S68.QZY\/JNS.$^HM'/5*R'/<Q(X
MRA7/$9<A5N^"#E.?6<<E=5Z&Z,S]\"FD%[*#5>/%:@V_,!B@P%O&,L=3A;^A
MU*6TOU*"U<4K:X@ALUD<<-TXP#M%!F)WQ'%P2%&=(RDSC)5S1DD"&"+7!41J
M17Z@LE6EC/.:46,,EYSK7&'"K: 9S@/X '46YPF5=C:+8S$LBHKG=+ ,B =.
M06D#18Q@"@X ]DSH:/CS]=#9)S?\JRQ=(?QY]&^Z6,( ]=3[6C]+L^-Y=\DJ
M; 5)',<9IS@88N-Y'RURP['PCY0G"=W>N8[4R]\&K\ 2(-=-/.KQ(;4O=0=8
M/AB3N9#]0WMUL',L<HP]]@Y)S"3B&>?($!T09D%*@;'AE&YLDTVBQ+/HCEQ#
MQ-,4$0ML;# N&&Y,KB# \L'K3%"),;^ICN;G[(?^>#H_E8-IGAQ[%GS(C4&8
MF%A&;'*D C'(4BY$[JS,N:W[H:]SH<W/@C8+RF^-"337.?'@AXB,*:D%ME0J
M1BD)VCU._J9V2%8&3G3&(?%2>T:]03+/ )P@:$1**8F,M%A:EN% LNB08$Y6
MQB]7.R3/%R(6.B0XURH#<0D:*VZS3')+34XSBXF,!)0WH$3MD#RLSO,9G<<X
M\\)HBC(F&.*:@D-"A$4B$Y*;3$J<Y;5#LK8%0 _ZPHNYPHOZGI7DB>J$^RV/
M?=-@>9:3+&C%J0)]Q2Z7/@AJ(OL+JTMFU@UH9QA? &ASB77002(M;'2N?(9,
MQ@6*5I&'C##A/0!M]J)/?:_+/7YV0)&2$>,QW(<'[CE35#C#*>?>6NS$3:Q[
M-: \ :!,;<4W3XYC>\><0HP65*80IS0@XZA!P0>63L8P&:,U_N,,FB\04%:Y
MQ4?Q\]CB>\@MO5LZ_:OH4_\BB9I7.#\OQ48%#=Z2$-X9YCBV(A882\)Y[JWQ
M\)]Z__,Y&;#]PYW!?@M_BT:L>?B&[9^=' N>D9QK%0__<\05V#+-,X=R[$G(
M:<:I%#'?2,G*\XTK4+1U24@^\3UJY*^1?]6%PK$H#=Q;EUO));;:ZRP+>4ZI
MT-X(7&\T/3?D;\X@OQ:8>4H$XMXP^(<R9(C(D1-<<,5))C5/.TU"_'A58HW\
MBX*??Z6>]]MI<J/VM3K#M,%2G7V<.%IZKGLGK4XU<U'=R[_$J<K@UZFSIX2-
MPZ%6Q_G.X!4J_K9JX,EO AY: <_D"Q8:BZ5DCN18!H.Y2%5V,J.*0DQMC26Z
M@"2XQKN=" *1JR9W.,.>22Y"9C*C&<4ZXT%Z'KMNI=.C\Y/Y ,=@;_/>TVLB
MMAA/\[]X+FY\MR+GW^K#I)Q?]%H D8UN:.B.[\,'_98>;0?HDY[WD0&^O]G0
M0Q"7KFF!BK5;&O[;&EQM-MI^,/"]?KS^HM<=^,(:Z [<,3WD0E]U>XW!U87O
M;\W/9V/Z@&X!#,TA@'C+KB!\F#4;UK>^1C7I_PE@8*\.X>Z_M[OVR_.$_;;_
MWP]7G_]V%X;R##Z_:I[ML",P Y\/=[XUW[V_;.Z>B,_OWE\=7;_! -L4QOSE
MX/ _8?_LTW7S;.^8X:# +!/$>!80-TP@215!-@,S38/2,+.SBN.(E5)YF&-%
M.#-<X1P',/"!"95S ACFP9A>P+0/>D._\1W@R>:!9P)_S\"8M\+5H^^))8S9
ML38V6^XWQB(S+:@_]E)38$KD$YSLGW[+WN@M&P%\JL;@M-5SZ$+W!E>%_O8;
MNA?W!FTTJ:[1\8.H[X 6X#T-X ^M\PO0I]8 (""BAHT[_/T^*#C QN5IRYZF
MZ\??CV?T 2 Z\"3?.&V!V]:+5K8QZ/E.@J+X]]> 3;IS]<]^HS^$"8V?GW;[
M%ZT!>(7_[_](2O+?&E;W3Z,!;1>XTT_ 8TN?< A77/9: X^Z(40 @\]"!*/%
M-P_:1DQKP?RV.HT3W_$]W=Z,HX:9:?5/8<3!>W 5X:<A8,AFHZ C@,>>MB[Z
MC4MP04?3!8\".+3P37AQN,, 7K)E^UN-OT\C@-I3W3DI'C2>E9YOG9MAKY\
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MP#$75&CJ75"!&1(D5AF>K7\(5ED*WI@R/G JJ8SR[B@W3A/B,?WABH?U\UG
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M3'DSCZ>3HW8^LI*.1A_1,54/3'#;CK^^.46E-,DIZMLC;BGG8U5NJKJ<N+0
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MUZ<AO B?"80 O9XHVZW$H#B;2'\;B\L+Y#)[<S>JK,%I+Z%UQ6,YAJ+N95F
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MQ(3I_;/6U]OJZ]F;RX/WQQ9,-&&&(*,, 'Y.-(HI)D0 _Q7!/.2,;VR3?,6
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M!&=%EDD&MH3SF/.C3C'N!04KDWECBBV/VCE91YF]_G*UOW,,YE_F$%NA8&E
MW#F#3,:RV"* 2IEG.9$6(L ']4U6)46U;W*7Q3_8.1989UJI@+PFD=E91)XS
MQB!2,\X"E'EK==HU6W;,IG)-&G?-;7>ZDU6E#0NZ?>++/?9S'2N=BT,<%\,>
M?-;WQ3F1AFZWNW9D0<N*HRAZ$SOXFV.+K(NBUKB)G[X_AI3-R=,BX :UOK;<
M,!8Q36)IK#=J^T%1@A1%<*OQ+$YSW+'@^2 =CYG< OJ)/<UE^R[+3>;WMEYF
MKCJNKIIU[YC*F.-4$A]3(E9ZP>)_8O-!H]@=MF)2&6B5<@<;^7K>1O;W.A]+
MAW=<$5KGY&^)G/MG]G+__;&-KG?  041,.*Y@*B.>(D8$=8RCP-U;EEEZ)VK
MA]=4BO8ZN_&H6_<B1A*[OMG]VJT%ZT<$ZZIY<DPH\=19L,%2Q*.O\(^Q/$/<
M!&^4,)D2;-D.(."P&Z\(+"V@UM?%X6T*4#NS,>J,M;VK&W>?.I [!:EOX-_!
MU;X?G';=7N<KB&'ZO/;W;B%<8O_RF!A&<Q$HLGD ?T_X@+2F$FFIJ:>2"47!
MV<_$EKS)WXMEW\M-8G+CRG-J\4A;%#8PMFGU&N=I^>#;H_5+Z!?#TUZTQO!-
MG5RO;B=*,0CAY%=;1:BAW==8Z-V/[IL. <1:#\9'D>]>*OX\CNG>T;$;%?%4
M]>Z3)]M^1B?O>Q4V,#,@E$G")CR[!6G$:B/J$@3UHN>_MKK#?OMJ7MSA[9=)
M?+'!'I,\!>SVNM9[=^?L2YZ)C'&C<X$I)XSH7&GFF,+&$*:DNCO@E@-YV^N>
M?P30/ CP%S=,)9'/J6;]\8LV+#UX?YSCC"B(F@%>/8E%J!(I*@C""@+M2.XN
MN8ZI_IN2*=/'-2?R=CH*'!KH;^F08R0;2*(.<_X$HA/C=_AICKZV!)UWO>[P
MHMD=Q#K.JMSOX*+,?[_3K<X?\ H'G>KKM6 M%JR3>%0QSXU@U'B4A;B#" Y5
MK',&.:,*])6#1:=B8QO?M(,T=:2JDB W923<C)$H4M&E65UB22?.J8,4=JLU
M+IS,6V+QS[BY]3UKE/RJEAFFY-.L4;IK49_*K3*:,":8X18@*O-.<"LYIHYS
M&^X8&$YK>!DESD=^K\>OL-./0228NM>3FV!U2+BP9&;GNOG^6+K P6A8!.XZ
M>.HVRY TSH&<,N*UQCZS;DG-W\+T0G]9&59R1.Z5VS+EGLUQ.HX_*W.&2&&Q
MD@9>@U/BI')*,9UI+'APU-ZP8UD7DOZX(+WYUKP\SDPN&2$>.:<#XBH6$PL*
M]H/&]IV&"DJS)8(4=\K[_D+W8GZ@XES8BOP).AZ5&;8'8TJ&00]PLKBP/XUD
M[<@@44I758TUX397<A?MR +!!?B 9PW 7>C?4.SEM3W=+,=5?%;D_J<-VN(1
MC&W9^#6C"];SY_#D>+>5Q;J;Y6%H>$KDQH!OZ'ZB?Y^.@0<3W%+E,>9J)V/T
MR^2<%^.=N*:\;TH$#0<PG==PX30U517(E%Y!'U2[:\#4?4V,,O HO1G#Z_).
MZ9$3#R@'42S.]Q+D<T-S/K)PE=N\*8P:<6>EP+_: 8Z/.(^K>0'#B9<6?RWF
M=';T+CHRU2(DG OM[F6:U;+:HYS+2.*51&5T>;=WT>VEB87A)GJO-,5A.(BO
M[74O2D!_]E;E8,KQ%<Z.];TX&XV3(0!L= @:11YB)%#C'?FK!7,YF>>XHS]/
M318XR;CTP?&,Q).'E!EM:&X"R6[?%7.<53NX[,3S.?6.^@UGM':^@8..C;<,
MYAR%#+QT<,CS>&0C1S)W05%)XNFFC6UU4UXM*<,3)\(:;X>]N"&X.=;*P8SD
MCL1_<PZ'2@ N0HP4KL9H-<80HWAC)L*XJZ3_H#-;1ZZ/I1A[-"I&CH/E.4<"
M,X.XI!(96#$DK%5Y@)7#'B)7<=OB[U;_OC'LYEU48A31WB^@O<W1X3(4+0-&
MP2&BA%=(V^^O4FE"ZZO_[;+E!J<5I>W$564PC,>71#ZM-H1:2R^9B))C^93O
ME3'Q]K]-[U_+J?R67;:R4)K@6\72A,Q,ZL2_I[UJ-!?ZQ"/3\_H+T@$&^TJW
M+_55?^-?TQF%5J>Z>1[/6<].V=(W#.$^;YC?XI!UD;&(@EN(VJO$PA>_!4/2
MZS*4QFDO0O#_W'SD/=_8/DQ>).A/S -$B_7O?^G;4D:RZ;3.PTB>O-7A]X^?
M/KQ[\^&H\>?.A\/FFP\?-QM[S=?+LU5K,NKFP>&;CXW#@\;K@^;NF^;'-[OQ
MIX\'?^SM[AS"+V_WFCO-UWL[?S0^'L(?]M\T#S^NP3LMW=]:_):_?.KHH6L!
M8O^Z"!W6=!/O'A2/-Y^03SG48E>V\K6B+UF%6LG-F_#F7"L$B,ZBVV?\X-+[
MSI+P;GQN:A3H366'$F%C1<=8D>J,F)E+:F2X%\S\:<D279& +>($&W% 5K=L
MG9][%UW:=BQGC@W3RL+ J>!W@8V=$^9;<G7DSYNK@ST\5\<DT?W:4'-<5=[M
M>_! ]WCS\/WEP>[>91,\W<]GG_C^WW^=?CX\^@:PR)KPG.;AI\LY[W9WC^Z?
MG9#F[@[?/]LAS7<?SIN')]\^__VVW3Q[(_8/+3ZB[TGS\/?0/#OY=DQC!R])
M!5(Z$,1SJI#,=(!U52JC1G!GQ"S7A?*:>W!]A=>42XRE=9J9G EII<!:S!)S
MQ,E&<;8;<;KO0<9Q\P.G!X@YQ[FE(?8,XCQ@31*OCL44) 8"S >G _]H3[T;
MQKWG)&#1B_B)I0P?X]B]C^8*>9XSQ+W0R,3C9!)+Z3@LIJ-XCO2:,?@VA>@X
MQYQD0DN2T1PNXT8HY\*LE+V,_;:=1G]XGOBLP8K,L/V';KO=O>PW?@&;5<:4
M_5]?W=(=53. 3Y:XIT4'A%&,U@._.;:9:.N+OG]5_?!;#%;;^NI5JY->(5WT
MV_0#Q<5<JXGTO.+C<< 26XM&IZ%LQEL^N?QX*WTTTP"C^"RG6SE62S_&6^2>
MGTE^ORN_-UB"MY1@SVFPV:UN>T,;Y65MB%;SU07MB0HQ?IPN/C=&,4FNJ[K\
ME**(]F*VJ\M/-!<56VV#D=%\D*GY*.5I)K.DTBP\IHB5P%>VL6FDK%JCFI]U
M>>3/TL/\8]%ENNHQG0QBNPO#>)"6"V*+WF)4"Q*=<>40W9+S=B^&K44>[!<R
M&^77S=WJYFXW'$F@1'&;051"( SR5D;F"Z.L,KEEENG;;HO&4&2OTP=O.>X*
MO"[S&SNI\=0SV?^Y7^Q2=(([_WS:_/O3)5QW_?EP_WK_&JY]MR>.KC_%+F_L
MZ&P?KMLG1V>?YCK!?3Y_0SX?[D#,TVS'*V/<<W36/HL=C8[.7&O_&F(>> \8
M1]AOC3IHX^;UI\B=0DBN'-$.88<]XLIYI!0$0X0I3)2VPA&^L4TV!65;;(UZ
MP=6P5,/2=\C,B/;><RE)T#RW0F)CA%?*1V(L8F_-%%W#TB/!$IZ%)2&5XIHB
M@BG 4D@'YUV&G P&.T$H-2'!$L,+^@\\<8O*N[B](?W?LW-[EQ^E346D,^I(
M<J,$I=['DDB"K?("M ]3@Q63F/(;F^\LUL?JJ.P'/? ?8T6!*[E+](D?*2"B
MM0;>K(%7^')* S\J_/G_3K$]_ZNC_U;#@[,3MK_[B>S3O6^?_][#1]?OKX[.
MXSAVQ/[N#CTX_ MF[NUY\W '_]_U^V.,07V=-"BFPQ&7P2%)J4,94Y;C+,-*
MZ(WM;"L7\\07_X!@*L54PTX5576ZL>3*#7TLY!<_$*3,:-O2R)?>36,7>@;/
MV7[>3V'O:C]K$WD7!9WUW*5AW%L>D,HL QW3!&FA&3+&:,;R+'/<;6RS?#FY
MS*T-Y&(C]:!^>ZVIM]54:U4P5'&AN<1,&DVXLI)Y1D,N;]U=O=;4U6GJK#.;
M@=%R2GND-0=-Q10C&4FAJ&-.9!)K+]=04W^6#.[=7%FG\D"#YX)HQY4WVF1>
M<A=LSCG$EC?WD:Q=V8?5O^;K&US9\_??]@\MW&7_$NX+8WE/]M_]!?.R%^>+
M[E^[4[C7Z3[,471E13#,V:!0;#F%>&XUN++6(!ER:G4 WQ;'2#1M%=_9E\T?
M+N%^*PMYVRS7<[:0]]/8VD(^I(;.^K*Y]4IEFB(M'5C(S"JD,V,1(YG'&1&*
MRGB*@8L?MY#KEX.N-;745*X<Q4Y0(2&ND5ZH>*Y6X."9HI;DHO9E'U]39WU9
MC7V>$P+V+V<8<><QTH8K9(1V"EN:>;^&FOK8:=DGT+-F\BLN])6NBK^[B7:T
M\CMB44+_%O4]=2A^7_CRFDC);)X%C;G#F?):>F9#[JG4N;QU!X@:OE8%7Q_G
M' T.QL51"8Z&RP/BE%@DA<8HC\6^1FDC1&P6D>&E%/)UTNSY:VK&+.<Y! .4
M&IX1JXD#L2!9QBEXHH[6CL;C:^K<#C#6SNH,(\.T01QP%&F+&6*<XUB4'X]H
M@J:NPM%XQDFS)]"SMZU.HC-H^TADVS4PH!F^RSHV6CUD8:>,!G#"1GF(CXFD
MF L2N,]4R+&^=1:C7+T_XN)5;?:N:JRZ"U;-%]%)%T "/4$ASST$1<8C#6L3
M:7_!HBC'=, 0%&'^$DOH:A6M5%28G&)IK' *O H"WJ3,A3,!,T)$KF[K5=0J
MN@(5G74G'''!8FE1YA@X_@245>78(H:UCN?W<AD9/EG&ES*EU'F+!U&PV'GJ
M%:B5/N_"F"();SI/V.KWA\G-L-U^26!>\8_568P[3_(O3^!I3 ='G\8+O%NN
MXY\]?]X:GN]T7/IJN>"OXWHW?1T_W0GPYLN#'#/$<H-1"%@B+C**C,\#(L$X
MRKACW,K4*X_,X=VO=8[C)>CQBMR16H\?58]G'1>5Z0">"_@LPN;@N%B,=,8D
M(C3/@^&,$6QBQG(!Y_V3Z/&*,B#IV?E6+M;;>SGL#G0[>2Q/G?VXU1'=YX-T
M3^"P3/+N )B]UA>1*"N%80?C+-=>HD>$R7P][/4 $/?U8-A+7$KU@:!5P>#!
M?(6(=B0$CQG2(<L0V+-4(0+N#-4RLX9P)S7$;YM8YBL[$'1KE7I&&9B?&"96
MY _5,+%&,#'K+7&M0N0M1E+$-N$T<\AP*E$07'JC+-&6;VS33<7D4J[HM8.)
MGR8+5.I*XWRD+'6JY\4X3N7BU@AW%X2;KV#1>0!?AP=P?Q3$@WF> ];)'&&
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M%+,\2($ERCWG*-;!(^4R@ZB3(O-!YU1&^@G*%W#'OPRFHO5WJ*>[</V  _@
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M2>VDY\HE;9Q55FN<I,(^W*)(UA^E=66G')XVVL7M<_+NK@U;;_%)UC!:ZYZ
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M+=$!F ;(7AR0_7(#)+/,8!=#X%YB'K1RAA+G%&=18$QLJI",3)",S$.R;%#
M7_<):0UTW02ZR'0%5EB<!/8.Y>UIQ(5ER"5 ,BRP,"I9&B)=>8/G1'?\VB#6
M\HCU,T:L&ZE>@::D Q/)<,JC]=@3K*0'!./4\KEQ%@^E>C4X=1.<8A.<VM[=
MHEO'^XHJ0J+*A0$I0=Q(C$R@!AE&B>6"6VQ5QBG2J%<-6#T-]<J89)74E%KE
MN1',B:"45\(+ \8CQ6/UBC3JU=.!+3$%6TQ)&:@RR"9E$;=! F(1";QG.)<<
M[$)AETB]FE]U3]RHZMX321C0M/%,VWA67OI'JYAWW8Q%31M-&W>6P&7>.I^O
MYV7%J?@E;Y/].K5/E@.=?ZFCIO.!@J->/POBS&J^%%!YC=,XS]BXF#?"I38N
M;F!;R$1#2MQCXB-/Q.O@61(ZVNPA(4;<_R94;4),&Q9KW=!8%3>S*EKES'X3
M5HE'QPS27BJP*I)$UF"*L#%,6,6<#[2JZ+VHU Y/Z 1R UC+,[0;;3:Y%*@G
MGID8N6%8"T*CEBE:SB.)_ $WFQKH6AQT3>\W&:LYPRX@0W!$7 :.K%42$6$T
MDS8&9P"ZYN6)O+Y#I &M!K0>1,L2UAK#@Q+1>RX,-40SAPT1@%O*:7;_^TT-
M5"T.JBYN.;&MM7T7><3>>,1-WG+2EB"+DT928V.-E2K8L/)&LKOO.36 U0#6
MPVA9+-CH&8D^<)*K65DO"?SM%6<L)2P><,^I@:[%09>8@BZM*>A3UB-8ET#+
MBGFW'%8DI)5F!FOJJSJ_?$Y^U$?1LA[:9?]8M8'^&(?5CSD^AB+U>X<S>1+*
M[K W#CZ?YTI\Z66$GL!J<U9'*YX<Y6P7S1F")C;D)H:%32QIK7"*(7+,M0E>
M88HC<UZ90,RCGB%HEN;K+\VS9P64"!*6X(A<-!IQ*@*LRM@C@ZFC'-0SJCU8
M%:NL"61KP.I)@)63,E$M%1$X\"2#\<Y9)5.REFE#PS4\MPU8+0=8S9P. + B
M$6ND Q>(>R&0M9(C 3:DQU0IS7-Q\E7<@%4#5D\"K###)EE,N76,!R-,"L9(
MQC.&>>\?P&7;@-6"P.J2O[9UL"^4#CAB@RAQ&'&" W)8>4 L+8Q)\ 7SB]D5
M;]"J0:L'02LFG;3,6PEK+=<^&D&L"[#Z1@^LS>PUW+4-6BT'6HDIM-*:)\4D
M02)P!FBE)-*&6>2E<H)[+S G@%9D52P16LW)CSV=!CE_'F?8K1CF4I[6R8$"
MGI-ESW@2SQ*E_O?*I:?&:5;Q^2/6#7J=T?#J1^;E>ZW)Y?K_?'-E'MFK'EL8
M0A!\K?2\1$RY2R_\;)\=SSBR!Q&Y?K3?D$W0V=>V<VQ/!RO_O)P;M^Q.&E?9
MQ3M-LBM'F-(B<G_/1+#GW-\5G0&G>G6>W]? K;%?NXK_SRY+5XIV/X/P/TKE
MA;/..^JEXSHX)VGR8/](EPN(,+RO5MY4Z;=S\N*W&;^K7%GV:CZ[G#^879&@
M^&%/%E2,]_'3SON-G;WBS[6=W=;&SL=7Q6;K[>KCR<OU>MW:WMWX6.QN%V^W
M6^L;K8\;Z_FOC]M_;*ZO[<*'=YNMM=;;S;4_BH^[\,761FOWXQ*,J6KP=3F$
ME_EKC/*73UT["N4PANG-E(<M5# %\/7J+T KL2GJ))WCBCH= Y>@<W.-K4G1
M7_7<3].O/T)I@F4JC"!6&<]4!S6M,PKP"GN8MP%_U"0$O)G>/+Q0_B!$=#&E
M7Q>^C'U8#JJ/\U*Y0W/_=9,#K$S"U,J(N5&<..JDYRX1R5DBH+F2^]NEF-9*
MW_7ZZ^5@PEU='Z](>=0=':+0J_ ^=^*IZ[!WJ)=P<+KU83\P)87GI#*1$=>1
M(H-C0M8GI0Q5V*>8@S%G]R(F2?DKKKH)S\BH?3!88.HM3Y8ZYK'%GB1#4Y ^
MWI^SN.&9._+,[@?1^O&);*]O\.WU-;HO2 +P]@YAG4*V8"S203!DC?$2$RH<
M92MOV)RSS6?< W2N:D8,J_3BA[TJE78\2Z4]I^Y+9HI<KF5P5$=%=$Y7BV7$
MQEN5?&GX?+GX7&RM[[%]XIP0BEA$I+.(<R> SVE$(EH&2!FES"F2")Y3)_#6
M,"D8]C@X&Y37H$)Y&ZV4 ,J4"AN=N$YNB(9]EH!]_,F^MI+DT$JDM 'V,8DB
MRYE%RH8<Y&$XJ+G7A,E!>7);D#RS&&;<,W.^.;,GJIG[J?G+Y<I-C1!"YUH<
MB];VIXLAS3>LY&I1W'/YK@W;[X)./_@S]C^V;7]I"G6URHET9"E8PUOOM]CV
M^P]X:QW>L[X&_[?(W@]/M^@'W/K\KK/W>5/,2 =( =Q_#/?!_1^.6^OM;UOY
M_X^_0.+V?L!W9._S7^V]KYVTM;LI0/$4$3OM"$.<!8RXBQ@9BAT2QADAJ R2
MZNE"7=Q'SR0CEC'0' 4QEGFP/3SU0FJFZ'2AK@G)"Z!Y41%]UE=YT8J>:Y[^
M]*6W+D.U7/7 ?K<#X/J,':',CM50Q GYCH!\@TR^(O\'4/=CC2J'=X9)U:^Z
M]1B0_1[[]B 6L!XX>!+4INIA4*!&P\$0WE#GE(?V?3NW7?;"^7MSF.M@"&)1
M](ZJ_!6O8)'\#II8+A%6-Y/O/;;]ONT.X>JXR!_0,-<.&XR@S4'THWXY+.'>
M>%*"$I>?:$.W"GO^DDE9L^Z<<:X6N^=ES*JJ@4"001[NSTDT&E3UU+)*>]Q#
MU4I:',9ANQ?J5J>_S?2IWY"?F]-@F4=\?L%V.N.R*I,&AFV;,_?7VFL>\VP;
M>?F E\#*<9&(1S8[^LNCNM[A!:J!UMSK5]-44[?L7[P7&JDV"JK,(\#[)7!N
MJ%L<P>0.AOW27:+.ZHR8/4B9Q&G$K3A\K1O6Z\E;JG*)CX#"?'MMG\1(F*88
MN1AHCN[Q2'OB$)<R,&,]@>7RUN4/EQKNUJJD'5U?=LHS8S$+;3>SI1V"O%1R
M'KN]RB3L53AV+0"HBRH.BE]"+B#8KZ1D4L#P%0"2CT?#BY!:52D>_#81S#*C
M:6\$0PN#7U\7U]Q ,%/*U=QJ*SF%UU.I>,C5*B&WJTGWM]7CR"K'5U]>LE)W
M36?OL[/7Z]!=:[<]T<)V3;F_92CW]ZRJ:S5ER9I:=PU3+0OAGE&MNY_Z^*HQ
MMR::_>M;'<-\WH7-FDXV)>*N8SO7DA2'=7TX.ZQ]/951.>P5'T?]@]@_+?ZT
M_6$W]L'<W>SZU3O%<3]NI/KUZ/$D(]6O-[0;9;._>S#0%9E%@.'.]RJ79E_Q
MECZ[.NS\Z[_;K?>;M/5^Z^3+Y[^^[?W8^;I%O[1;GS^0*@S]QZ;8>O]7^\OZ
MMY/IL/.MPPT,?<(PALZ7SSM?H8T?7PXWR)?U3SD,_>O6UV_'7W(X^^Z[G)#^
M9#K_6K2:*F-0T"SFI$8&:>DP4LI1C0V)QJF5-T2O\N7(2/_RSL<TJ/.PX60-
MZBP>=::3'A"=M$I)(4>D13Q0C#3S BENI<$, $E)L$ODG1(2-:C3H,[#H,X"
M@OL:U%D\ZI#S(W8?:.M@7W(9E>0"D9 (XHH!_JC$<R"69"XP;'. JER6XCL-
MZ#2@<[\AH0WH+!YTV$70V5[;C\)QPYQ&@5M0=5).O1@91HY:XABEUE!0=;A:
M%E7GH7V_B\^]>#U1^R,.!J\G\1:3.*KZ+,"5D5#WE&A1BSMD6F2K9$[TQ4U2
M+=*;3>[<-6+ID/0QCZU]NACW-HD[RUBZ-N&RW=Z?%WGLXQF+55%IEP/I4WD2
M _H1^[T&BF\ Q:VW,[XN8AQFB3%D;/9U24F1 6Q&6A"OI9-4"1"8__F'IH3^
M]OQR>#<"?U]G#AN!7PZ!GW8SI9PG)TF.,(T><6<X<B0(E(*A&G-&"':-P#]_
M@5_XX<M&X)=#X"]Z>'*>>Z\B$<P;9#U-B&L1D4X,_O(D>$]MD%(W O]$!?Z!
MG2.+EOA&LF\BV6Q*LC'SBMGDD<:6(\XE_"5$0I3&Y&$9=Y*)ZM#U;&Z*%U'"
M8ID"?R9GR_+!O7:O$V)_IN;TS\AP[>#*Y^FQOO[PGPUB/U"\T-IW6W:JLWZ]
MMQ6;?KS I0U2WQBI/\YX68+G,F?^0L+DL]Q!.V2=9X@X%DG$QE!B%Q51=),8
M[&7>@VO@[J7!W0,%*C5PMVBXF_8QQ<"Y(Z".&DDBXE0&I'7PR I'7-)@=Q*R
MJ%"F!NX:N%N><2]AA%0#=XN&NXF'C6SM^A^MXWT1*-,T6@3*'6AWW&-DF>3(
MPK1)*5+B6B\HAJI!NP;MEF?<2QB:U:#=HM&.3:$=]H8:)@PBA&:OHR=(4T.1
MTU["8H8ES[GNA'X2<#=V24XZ,N;N.N?.XQZF9#"BT!ME]^$2'_EL>OGPO7Q6
M;O3Y)]'7S[-*W>XL^D_4DZ:-)6SC6658F*\P?1YG@"PF&2!G\SZB.H?:E5S_
M++>QK]0C:_HL>%N$36N0DVE9JV>E5:7EW$Y53L3!]OG<S(E3N2JE,VN4RY\J
ME]NSX:BP',C@O41!<8FX30YI)A-HF,)[C!7'QJR\T?J5P7>NI]K$JBRSD-]U
M,Z 1\J41\NGM 9'G31F/HO,:<8DCLHX%I*-BSH;$0=97WDCSBLH[ER%MA'R9
MA?RN+O!&R)=&R"^%G6Y_V#?$)4!KBB1S'O&$+3):*$08%4X9I5,@U4K.1;.2
M/VLAOZOGMQ'RI1%R-B7DU$5AD[$(FRSD+N1,21YD7KE B<4F"@DK.7V%Y3()
M^4-[T![K/.^UW V31.U/\B OO<M!WNLF>WCB^/M0[I)QU8@9&&X0>&$(/!M9
M*I/549B L%0!U"QBD:Y.\G+O'>7.1DH7Y3!9OCPNC9@_O,.D$?,'$/-IEXDA
M6KOL$E6"$,2MC$BSQ%&@H%;+K&MQO"B722/FRRSF#^4R:<3\ <3\HM-$;!WO
MLR#@'TG(&>WS65V%G @:!![38!CG*>> 7(S3I!'S91;SAW*:-&+^ &+.IL3<
M2>T<80[1I"CB0@ED07E#&B:8!QXH6&6+<ILL4,SG!\N9QPJ6:]IX0FV\@*"U
M''Y\7K:PB5M[*6V\@+BUW^>%I-UY7VO91GG]8QSS1KC4RN??GM28E/]=K-^8
M7GE@8V[9X3.=$C<ZY<]SZNYN9GVR<@:WUCUI_?BTSZUW6CN*,&4<<1E!G\0.
M(\JHTLH8AS$HE7@UUS5;AFPP"]),&A1ZWBAT1[=V@T+WC$*GEU$H$)=<Y [%
MY%3.)QN1XS@BX9),VL5$A<HHQ.YR]+]!H0:%'A:%[NAU;U#H?E&H=:8+?2.M
M]<U]I8PF/B9$HV2($Q602\&CK,>2#$&4IXQ">':SK$&A)1+5!H46N2G0H- ]
MH]#I9122-FH>-4;!9%W(. FZD# H,1)8TM'R2#,*F;MD?6O"(F\L>NO/,>+Q
MSANF3Q?[YXWPV6'_@WGCQM+1H/^-T']KQA]'L6<J>(>(]#G;>F!(D\"14UIY
MKA,L"NS._KCE"^)H<.AYX]"#^>,:'+HE#DUYY*J"+T8JI"SGB#MOD:-,(LJ\
M92:1*.I]@3MYY!H<:G#HF7KD&ARZ'0Y=\LGM^GV6,.,2S%_'J,HYT!6R45D4
MK&?)I208<W?VR34XU.#0,_7)-3AT2QRZZ)7[NK4?$Z"-]1)%1C#898!(QH*9
M%I*CU$HO"0YW]LK=>]3MHZ6H;-IX0FV\@*C;"A;+[_%B3>H+Y]N+;F]8E%W?
M&848X(]BV(ZY&-/1:&@KB.^ENF#36>!N80?YIK)? %FCAZ<'A>T.RS!^41/8
M^U+:> &!O55V[*)WE$5AIB#9V9B;)#:E9);2(+4SV'%ML F>!>*($TY;BN.-
MDRBL78"4\[J(&R<U4KWK]P[?GJ/4=IK6!M<.81*&S2FMQ6F*>S,>?,LUH89C
M9&@(*&>E0RX:A1R7@1#/%%5XY0UY)<2LZZS)8/6,A!^#@%OB<CBUX=01D[R3
MDC 8NTA!D1NG5FB$?_F$?\IMSHEW*3"%E+ J)U9Q(/Q@*V*EF>0D,J/IRAOZ
M"A/9"/]S%GZAI3"*R$A\XHH$F[SEE&$3HQ/PZ\8)%QKA7SKAO^2K_OIMWUB5
M RT<DBKDO'8D(&TY05:&(#V.Q"A:K?RF6?F?M?"'8+B(@5DG$D\I@.03K[B,
M+BKEK+MQ&H9&^)=/^$\O"S_E5BCA P(=SR'N.4762(JD(-23H(+0/@N_P;.1
M.R\GI^4CB.Y.' S[I<^AF[6PWLIA<=U]MR>.7"QG#S*4)TH4-YXX02+V@29&
M' :%YK$<%@TXW0"<_(Q/@FE*'5,&A< D F-4(NNY1B(ZJX6E0LHJXZY>HKPQ
M37JHA4LWE80F:Z4C7'%-F?/4!B,$T<YK:UGCD7@&HC_MD8A1>"()XB+_D+G"
M;) &82)D3(P&SBJCA.O9G>M&^)^1\ N#O=*"2DH-&"7<B5QB70G"E+38VL?R
M2#3R?2/YON1T /F.T5KEC47.RP!+NS'(YG@YG^ME,.Z4S8&ZDC?2_:RE.RK-
M)8%%G>/ 8Q(V,1;!3'2&RF0Q:UP.ST#T3R^+OM<N,A\LTBR?%-5:(!,Q1CH(
MSUUPV@A2+>WBSBZ'14>F_7.8JVU/3B/"C\FK#VW_H.RB^I%<W';R3I3]"J\)
M6Q43N2V[(7:'KU']W:*%5/U,2&D5^TE^O9?SH-=Y^V7*B%7&,Q4VZZBE00%$
M+8% 85!8[_NC&+(L5H%,'^%E<,-:\6<_IMCOPZ4ZHF-RPZ \*0[A[>U! 0W
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M(YO+I5 TLKD0V9S6)+1T)B5,49!*(I!'DF53(B:2A#G21@H#FH1<Q4LDFR_
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M'7/&G<#[CR_.?>5SKGR?4-]3A"691U(OBPF660_#D$<9U@D<@#ZL9B-(071
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M$SP5RN;#R;-*8):1%S1-4QJ[,9Q=P,HL#%@,:E<6QAG\&PM)J34!;1XC3YN
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M,CO$71SB5F7DSD^//Y!8 4Q)Y^CGCV>'!X_+DG] XK'/V-)G[$ D[(HSUA\
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M9P%)O#!QN5*)+Z,]0+'8H]Z[#;(16Y;>=,O"$KQM>?AQ%H2:AT,A52+=@
M1X0)+R,IS6"C:"9HY+O*34-,G0TM_VXM_ZZ\)(4]DE_<@%"S,U-9J&00D]#G
M*6%9$I-8*#B<4] A79X(%@7V2-Y^EGZ^FI3V2'XV@T'-PSQ2+IS*/DFS."&
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M>35P;A4OC<(&\B3#:YM;$=0:X>9*U8J%QG6'3E\W.4B\$C#YEWN'.!&J@[9
M&KVK@#=!:RQ04AX8J5[[:+1,U@-I$BBD$%\OBRYJ:L85T:S3T<\?SPX/G!M>
MU2M/X_&VZ$O?Q&&'-M_L:WW V"BZMQUSS[TCIL\^8@_V:G+$43#^9FK$S@%J
MB066.LD-3B*T%7WRZ\'!;RT+STBQXE> T#"&5'5!?#>BV-X'(QDX)\V-Q_7E
MG3UG"UG^3V66^I)+DQRE)1S\ \^C:]ZM[7C-AGC1-&OK;?%<O^..=@K6/2W*
MTCB ! ?1&IG ++ 10]'DHW]$C7W@C!@%E &L6FN>[+O[FC$ZC;],/PV&AE:
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MJ&^O'6BC"L.CKRO3&@U>^/E*"2T; N[LWSWF.EH&.*<VYX[>"7_+G%_T 90
MD%NZR4@C08Z;IRAI'KE1[4!@$W$U4LG*IJ\;YBR!U(?";$NAPXN;$5^CYUF#
MK_:A7]Y6.3RB#P-"OA?Z3E ;$5)S/EH(F/$E!U513"U9:T85H"^<3";@QOB
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M *LA+D(>M@"W)8][T<.:'RUYW(,>.QHIN](V7U['V]JJ>O6\;06>A?6(W:[
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M=YD.IKMB?6QUQ<)S9,W \*>.FQR6N%EO ,1'YQ 0Q>"AAEY/"!1ZD[3>M60
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M. QU(N"H%>3"%5[V$>/;?J^6VJ ;#D7O*N>:=X>UC1%3P;3Z,9N#.,G;(.R
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M6SYTN/DBD=IV@\BG!+>)[P&S6.D=>WP[F5YC.EX0T-6F&<G0D_PL^@MH83R
M@V_3J,E$?A924JI$V9 );E.1G_O$ LV$MBE-,,YH28X<VI7%RF9ESF>/'"+G
M5 Y@(Y.$G_+-[)4UO!EJG)FC&=?=B%F:9TI>@7__1^1,-2,&QODJ4T1#!'5(
M@!Q\_LC=2.1QHJ\D8^**R'OZ9A %,/0 OX.NR.24%^<2SR7-H!0.13>36IJ@
M/X!F)(G Z5C>A%@<G[NPE"(,$-.B(Y=>4.(R\ZV9;->"M,Y,5B>^ON.N#5W>
M<5@*^$B:%E_3),^7W&U;_WBW/%>NUWNW)<2"G1M9Q.M7(1]K35W3_HFH 79(
MA"2"P0,G_O>%':!VH,SM,TK,_XOY/T$WW=K!SV-,UQ8IUT$T^#>P)UY+CL5\
M?9@OJ&D;_@F="GG@SQ-:&DKL2T-/DO!KG[*>\<Q%(HA)QC)OSWVH232$.!V?
MXE^S"=%);HLNS X$E B!:?\/1@AM.KAO6-H8U#^(T)B%D2]%SO&@2<J8AO4?
M08_/\#L<"O7S".,7^8KXA$ 4:)+8,8TPGE2P<%9R4&<)A(,SK6&^.FQ7MF?A
M/@.+1%EA^*$W^[46/+&)G/4DFY"=/Q+MQ?=#)S+#B)RZ@< K*-<^++GG/(I$
M?/XL)H?+)];HY?(DK4[85+0PX.$3YZ!YGCQXZ(M(HH3"IC>&O1A3YP6L!? +
M$'L"?R6@* 180<2::A:M)"$]))_$/X11D;%0:EY^O$O$C!&(S'=*.)5)]2\F
MG4E%)37MTR@$\(8(F?+\;,24!(80"I3$(8/F%0H(@<Q2!UF8#.@E00@I/RT<
M$C&RZ/3)@TUKFDE]1:P!A-D0;' _RB.8 /)X,3P2<KHND( G:&])>!,!AP"?
MV8]R=R.TDP'2/<6[B?>?=#BP2X5Q\R&^L_T,AA)LB_!O!-T@9))4L*B1Y)TD
M_.P 0+1&-F[P/CY&E \1L1FD1-1&W'K 7^)O4F 6-X.QX?,1!XH(X!9OS(\1
M;@-9-$?%(:?X44KZ5)'CB)\3'J87\D/@_F]77VYN8_T+C(C[WPQ99ODXUI9/
M!!8#SR,'NR: +"%-L0TO,KS%SI*07>P/B;:F@2-6"MCEMJ=9$2E"RP;#R><D
MXYCQ+=J8VW((0VC$XW^%4N9,/HFA,P28QB +AZ%K7[([%2[, +B,3+VX06&U
MP=SIJ1QS26$.<P"^:,^08",800%;;O%&"K,G062H08$*"/=#XXF'C#*<!CC[
M60T'K14 BI6S]OK&<FMO_@!4.6NO!=;>N8BP$B3]CL=.:R;0=0NJ8#\SO)1X
M1H*_4[MUPQGWJJSMSMP$Q@FFC4=Y"<?#K73C V-V@IA901SAD:#ID &#]DF\
M:K.@/#6YC\1'*7-D<SAI/L-1BC8T;SBT3>XGRD&\3_=#^;X6ZYM<Y6&EA#*S
MA)HDA-).9@]]MQ%B;!A-=FJT3_A[^K71MN2_TFG3D2\]AE[&IL^9.$0;_6:+
MSI-L3(Z3]_@W/,]!(4P5([E,TB6O">"@!>M2L"8X5[E%4Y,E5^()U&&ZC*6Q
M+N>DME\AJ<W8011*AR:P%%CM!L[QVM=DZ6X). R8\0C-%C YT=;E9(-GM\!D
M?\6%D6RAH8,CPU-^O#!@(_BQL/Z*0+CA9X4XG\1WM)_&NRE80XQX"\$<$3*,
ML,=8 .>2 ;QS[)_<F8HSVMP'M=7&66QX*ERMDKA:_6)<K16,FE9BU"@PK@,%
MXUJB!.<\[J_#M.54_?>SVWOMZDH[U6[N_[R\U:ZNO][<_G5V?W5SO;95WCT"
M'ZP!5OFKW#HL!_;(']4W_@#:^KNXDL*SU&%NN.7A3&C6=Z%G_AQY#IJ/:4SI
MZQ)FX8" +;Z+FQ " (T]%!DS$>R#:P^.W#U=>W?NC<>V1.]$JQ$U!M".P]8+
M(SK5\J?W+D$+]I B:.7.Y 3G.K<2[Q)W OY$E@MY-.P8W#5V5XF[)<^?H!HD
MXYWF@(^1\0=3,3-T9ARH+VI%'KLA7URZ_/H>V4L#@SN!8*Y)K-F:N-@(T0F&
MM(+_U[*7(:;#[+$,?XOL," [$?'ZF7!9R_?P4+X6MIN KD4^BR\/LV=+^1'>
M#%ILS-#RQ;_AT!I(<.A_@UU+CG:?[CGIPB.Y*2%KD^)A"=9X/'$\\OTF[FG1
MOH[SC6&S$R>KR(* IB?P(Y"8X1"9^%>4\2%G!Y8=]B3"^T^PGY-W@NMG,)$?
MR?T]F&;N^CV??D)^V2<[X"^<6LR"KP(^Y]Q*KET]7[H6@TR  'K U]U%P6H[
MAFWTK&K[*%Z1XDTS(IX?IGHK<69-KT;<]&"8>L+1U23O0.(-C*Z.AF)9:#>+
M HG2C&R.\0G:F>M&R8D?!>"KYP.%ZZ?_N0&3-X^ R1M5X_$?KL\?[" D-7?'
MT#,'2DGBC<QYX'X$=):1AF6Q2%21XXV&A/T])[#Z*3"N)2'2)Y$/[(Y["3P.
M1LP7:R#O@@.TN[*.F3)E3[2S_,N2,#, DPR\2%Q=B2TD"D>>+PLF9,853?#!
M;ZVD8F]<B05&63!>X46%'5S[XC'?.I5-X[4G?9%M?N)[#SX;;R"9G2.0S&;5
M)/."#QD9"3\F0-9L&-0L8NKQ;$C7GIMWCBC+A?TCX,)6U;CP+ZQ@<\>&'+12
M)I;L*+DOU-AD LN"3KOU^=!H' $?MJO&A^+D?966&3I*#LS5?[/SPEF4",/.
MS&+)E<A"?_-F3:O;H'*W0<WZ-FZ##*/]:M=!\>]@AN8IK!KZ:SX&T1B89X&:
MVO==T<QH^?/('MCAIWV/[]4OD/)HE%.WHU+[3:=J^\VEX):RALY<UE7A^AY,
MY96>WFNW7Z7P2G&?ZQ9>Z77U?KW<8$L67MESB91R6;;77FHL'%.!F'*SO^"!
MZ=N3&5-PO5(PJQ=MJ5Z=F)5)!UWO)Q&W:>C&SMAV&4K%EBV7,BNP3\MEP_%)
MRX6A+_-70XZJ:1CZ*(3U/,=EQMJE<3#J]R1YYC()K;R1X9/98K<8#RK"05LG
M3(2#BD<8$TJ/9/QIQAV=#0;-!H'2GYB."']F^[CC=$^H->N-I#7F#YC+@].;
M9X=/XZC21KV.0>8OC*QCD\&&DL%CDL'&4AE,XW"5#%9"!AMJ'SPJ&6SD[H-9
M 3!ZV@_]3C_7$U$PFNUZ;8F\B"N_?KVCA.:S43?TJ^N[:LC-'N9_10X![;^_
MW'[3[MFSYWKC*>CA$--"/<S 0* %DVL7GDG)DMJIS!R4SZWXN>7!F%QQX\&9
M'V<T4@8 ,V545,BTH>WP)/$7KY.IZY ]B#1,!"JQ4.5CG$C21CK&N#\][XAV
M'.QX=_ZG8L=\=KPS1WS,4F8\7B8X/_M6#298M)?OD1/.)8@!_OW-=G\BX$+"
M%X>(OJ@=^RY[<?FU&AQ=/6:^P%16.Y^7CUC'?3O[HC@BGR.^L0%WWA0S?+^]
M5,R0SPS?!9)/P69WM#S1J@8_[,L PM!BRA;1,.!"9N&DT;Y__UNO870_!8C-
MAFG=SC0G./Z?";C>LN3OFB;BH$12EI;ER),L=I"\Q8;&C?=ZD<E2""Q:]?"=
MW$"'RL3T&-N)Z4E1"E6*][%$Z"Q$J-EGBO?=U1_79_<_;B_O2L:]5!I=YWO&
MF4J)2_Q79/LR"7;Q?48*,",^Q!09'YL:(98-0K&22\S*9LUB-P/,#WEP!=B,
M37B#(^8,,8$0&R(>DS_ @%8>848MM9=F:)1-I:6HX;F@HUG WEZ]&G%(S7I+
M;]=%"$9^'%(>IKMXV6CHW7;QZX7?+FZXVRW?<GY4B=%Z$5;2.42+]N['[1^7
MM_^C(<+#]>7M74U8&U?7Y[F.VQ5B:S8-G\GOL=4NT67)==^;R?QE^G$%DWFE
MV>S'"%ZTN7\(/FC:!7NT+>U>A\,0Z+YP^D+/[84.>QM5841J00WX)(CF7[;)
MZ9AI6W&IM'."*7MQQU_5N9SDQ27@/,Y2S' YA;PJ-ZO40\BW4/9CD%RPD'_4
MSJ('&(10L0T)YJ52*#8];C6*CUL?!IXUA?^-PK'S^?\!4$L#!!0    ( )2%
M E43M!8@+A$  .NX   1    <V=R>2TR,#(R,#8S,"YX<V3M75MSXC@6?I]?
MH>5E9ZN6C@W.A52GIVA".JE-0A;HZ=FG*6'+Q-O&HF4["?/K]TB^8#"6+\#$
M.S U-1-LG9N^HZ.CJS_^\C:ST0MAKD6=JX;Z06D@XNC4L)SI5>/K^*9YT?CE
MTT\_??Q;L_G;Y^$]NJ:Z/R..AWJ,8(\8Z-7RGM$W@[C?D<GH#'VC[+OU@IO-
M3X*H1^<+9DV?/=126JWUM^QR8BIZIZ-VFF?GI[BI*1VEV;FXZ#1;!CXS%+5M
MJ*W)/Z>7%\JY:BJG9\VV,IDTM;-.J]G1SY2F:N).2S/T#CX_%TS?W$M7?R8S
MC, PQ[U\<Z\:SYXWOSPY>7U]_?#:_D#9]*2E*.K);P_W(U&T$9:U+>?[2NFW
M";.C\NT3_GJ"71(5=Z=LL5+<]=F4L,4<,\^!&OV@T]D)MUHY:RL1$6=I2818
MCNMA1X^%&!YK>HLY<3?3P.L3_IK+49J*VFRI#80]CUD3WR,WE,VNB8E]V[MJ
M^,X/']N6:1$#,+8)1W&E0.*UA\$2[Q'/B#O'.BENY:>?$.(86+,Y91YR4AQ,
M[$Z$YB[S!%D#!7C=4QU[P@EY21>*"B-3Y4^([;G\5Y/_^O#F&HV3XE)]MSG%
M>%Y*<I(FD!X^*:-!POG43J=S\L:]:;,&&_U"E&_R/YMJJ]E62XC-<K#BLN%7
M,Z+;A0[+EE1.AXAN2QTV-IHL7\BC%+_=@FH(1B[1/TSIRXE!K")^N%Z<_['!
M\[#C4$_0\R?AL_G<<DP:/(!'O/XNHTH<$C.*2:G M\%3Q?\N,=,9M7/<^F3.
MZ)PPSR)N,F@*!L^,F%<-'CJ;4=#XW<:3#Z!)5"0E8-43^.L3("'V_=*2B):#
M >P! )L$=5-GP^>,E#4<2%P(W +H_WO[=6R7M1](=-_^:YAO$+.L^4!B.58%
MZSGU&-XCR[AJ]"AD? W$GWT=WN7V[D)R0!,QC=@N]?FD0$X%_Z+F,D=L(D'U
M\62][!H7WR7&P/DD_EYW\) X+"(A7/.,PG2K5;J1+'P8U:&L9@>/U_W'4?\:
M_A@-[N^NN^/^]>?N??>QUQ_=]OOC4=EJSV<HP405F+0 B!'4*(E B7BB)%,4
M<D4!VR-HB3I^P@S,>R:>!0KO',%5[G(X>2BH B?Z>47*/PX=WM$8_OO0?QR/
M!C>#I_ZP.[Z#M[N -H.S'-:VHFC%8%VR1X,;M!1P!'19[;W!P].P?PME[G[M
MWSW"S_[]8+1S=+/$R*'6%.6T"M0KTE @#OW,!1X;<P*4T7C0^]?MX/ZZ/QSU
M__WU;OR?7<.^08(<\5-%.:N">%+0WU$@Z@AUHOUU1[<W]X-ONV_8,6,YL&>*
M<EZI*0-_) 0<$)P#-L6.]8?0 CO&R)_-,%M0LZOKU'<\RYD^4=O28?!4$LX2
MC"5PME1%58/AB^7J-@5Q!'XDF2/@CD+VB)IH*0!%$HYX;JCVO>-:"%\Q[-X6
M7TBCP[\.J=,MCL083^P] AVRE\'<5MKM'< <2#J"O F%9,EKXF'+WA_BFV3)
MX-<43=L>_C6*GT/)1W?8!!%?1#5\FU!S2%Z(XQ-WLA@1]F+I@MN^/:2@>+G3
MG&IBEFQ+IXE4X24B9=!D@4)UD*C<HS.51I/Z3"?NNSC2JFBY$YUI8FYN7TX4
MJ'+T'RF(=PX@3\;X;?_^LD&4W#_.-3')MZ5_!&*1D'MT!BE"0VK;)F6OF!G4
M_$*I\6K9]K[=0BI4[B 7FI@:W-)!$@KP0I$*1U\I&/T?J=.CC@=\@-_TSO$(
M5('G#HE!R(P/"_Z\CJBP*G*_ZFAB G*''1,HUDQHAF+5N/_%VAU=3HKS S$L
M'3,";XA-&-].^807?"+1!<)K8A+&B/&%+Z$[_"FVOS ,+_?M?]OJ)75&5='$
MI.F6SACIB!)*HDA+P2+2$R4518&F1\>4.D /,[: W]T9?P%E;[#%?L6V#R'I
MGCK3,>';1B?>OAVQK!YRQU.A@]W>\2*=4*"4(.)J(:$7I^.:-;EJB.MV=#4I
MQ+]B9O&N(NI ^O"6;Z#:MVOER96[$N]3MW>E2(>X]T21%@?I-%W]AV^Y@IOH
M9RQW3EU<V@<RV4@7?]2VFIX!2K(*^I2(V1$6-_F\6FLMPUG>'C5(*XJ#M_[R
MV-B6=3_PG@G;'[29[.7XGD+O70I?(>>(<A8,\1\BG]?A+?1*!MX#X$4DR;$_
M@^ZV%/;+OX-AP*K0@_2#9+)<$M@54GD7>JZFY[]7D^$#K?)*J^(;&$C7O=6+
M=CJ#61^+'-ZR=K(:PXR\6H23,)('L(ZFYC0+/KD6#A8./3JMUNSOZLY  E9'
MF'8&TR-F#-1YJ3@7+F4EA:FE0+:?"U/,\S"!(M@MW]T$1-(>'OKX] IF0'AP
MU5NM3T^22GOS%M_(MKFJ#[(7%Y;WZ&Q.'3[#3\TAOU2"FK[;=5TB%B;N+3RQ
M;#%_-B0V7Q#P:$!7,4CM1*8\FK5A;)N!,C\\&8D6>T&X\"8UF[Z+ OEB?)/0
M (4J((_&KG*PX6_;'FHS$SF:&HQ6,]$\]DG$%?_MO\V)XQ)PWAYVGV]L^GKG
MF)3-MMA/6I:[',9334VM4,8PBC]0*$6T0"X'<4$H(>D@0;XFS'H1/LYCXRTQ
MIGSQ3H<'(CZ5!#6/FSQ5.5/3>VD2' 5R(4^T9'H$*ZJ)2OE-,9[RQ.>\G<XQ
M\X$[Q*0HI[:W[ '+<I?'U M-32V^%T#UT+O-'!"BA>,AI'VC5SSGA9+/>O!H
MX'O\YB9^H]M>'*&B#G)WZ6AJ:H&]D+O$2^E<-!+ZB,*KS[E.**'4T;?2N"9>
M;QKN[,67"LJ4^@YT'ZW48G AWTD6RAAA'?TDA=D3@RIYZYLFT6%LG"A,G>Z@
M=\>WX43GHZDYF/.M>M67&?>KB]RO5*V56H0NY%>@51/40H%>?"R?)(.Q M<M
MV#(4GR2'0DO]#M+M^I@Y4)7N$V&C9\Q(24])D4N'"^V6FMXB';% P ,))@=<
M_97& QE,I , ^"<]<DM#<8@)_WIU;K6>F<-,'@LUK95::]Z T6$OF(E-2#V?
M\7NW$DE$V3VM&5SD\>Q4W;#+7FR*"EDETYHC)M7N+9#RD@>YL_:&(SE9^!QB
MK,NHW*U"7C&>\LAWKK72AWPS@3OL -BCLYGE10>'^'DQZ!^(4^$N&!DG>2"\
M4-.G/A+<@AG\)+\C/GKEX7T!AO+6U=%:J<E?*5H'V:Y&9,JK8TCX->-0%251
M2I%+6Y"FJ.G#+B$+%/,XX-JOE#MD,)$F#9K:3B=U*20.,5E8K\WHW@P(%^$L
M"C\]S>]-F"R"0KR*0JIJH6XG(J7!4.-+T?EP-Y>WA/#H& N/+HJ8+-!2?DQ_
M#)O.-)YBYBOX3S[3G_D:/S6?@FO<%_"F_\.WYIQHLH@K=J=NLQL=Y'[4UEJI
ML<8F/TK,>8L]#;$Z?#8R4DB\CE7BWK7TN(-V+G_BDA\^&-!_X:E*6;]8)Y?W
MR9J:/O"V9($"'@=<^Q4;9P87>?,ZU5KI7GD=B[]ZF_AXLOJ]F>#WRC=I^!=I
MPN]."<SXQS!^7UX6\DBAOTK==7)-=,9W7-TP.H,:#CYLQ==$QG0SP2VU#0"U
M@? $2F/=NVJ8V.8?XN"?X[EJ[$^@8]DVYWO5\)C//_S!/_5U"<'1HL98?)K#
M\(,%G>C=!-O\DTKP@DPLKX%<\!K/\H2\+XSZ\ZM&4-#RR*R!@N][!$]FU %_
M8HL[>,.9+S\$E*KB\3,C9$AT8KV0&^N-&*D5^P<RF_ /@BRK++ @J+'B]&5J
MH)"M\=?/+@TZPY93P%K(>@1^$8YW3MP_B:U[8AOMP/SJDJ"[RW24\HRV<  0
M8>S/ ]:V8XQ?J1SQ[/)U0/C&<GBE"1!ZU/74;FA$ECD2@IW;$SSA80,B1+XM
MXCJ:,'_/],350K7ULA%TJ_S;(C=8#Z<_Y5Z67;X.7I8,>#S(B2@H-TA*4@>;
MQ#SU$PB!I^&=I*%;A9=+RNTK3%X'6\?X+<"#*]*= A*SQ*S_(IRLSVQS1<GS
M30T^G.C]R8WQT>=0#,QT(QN\.L1XP/^E#.R((GUF/93F4Z)"2EAN 7_(V8M$
M(>)8E'UU7*)#*FX\4H^XUSYI*:W3G'"43U@'O^Y1K@,-]L2"E\:^F>RT/V/7
M<D<P>, &=:)KAOB+3)RW9;O'J@$F.E>D0LS.2W0D!'7 ^@L4NZ=NXF@9M+RI
M$#HBGA<4[SJ&",S+=SS'R<YKMV-:V^PCG:Y+KC'LRJXQ+#$BJ"ZBKH/%2.?X
M<N/$:O8C@?$.G^;@=YEEUE()#G7M/#_[KN40EY_]G,#8@3/G87 : !(V'-$@
M .4'PF>3Y&VN.L.Z^@E7+Y@[3L";EU3)B>KJ#5U'YYJQZ*L".5ER9O$Z]"AK
M:=RBU AM42=+Q&@^SL<S76Z]6%V=K$<9=?"+Q7RW:QD0$2QB0BSHZ]2A,TL?
M\:04#.CJ7J\[[(_@_\M>);I]-XB[&_HB28/<J]2Z5O;F:[63EXIUDW?6F?'M
MUK?$-CXO-I.'\\#0Q64/IO8MM[;9V7+8&,646^K.+4B(<J)I <(Z1*-@"KB[
M<EKI'CI\$FQY'Y,W[[--]>^9KE&<P1[-]2(IVT\P5)U0>/\)A&Y+4<^#R8!1
M,!70$TVC6)=9E+H.3IL#12^^-[$ZG*L\WAO:M)+]-\OE*SH/F'V']E=VPCJ#
MO [@1M,S$%)&SY!Q\^NQXA603#ASJ.HZ&LE;U!W"SYO@DRC94T$E6+SWLE%Z
M)B*YQK7%$J><36W3"T@YXSF\&^LE9YTFJW0=FFV4_0F> R?'DJS2=;"DZMQ8
MWB3"UGSK.BJ)SL]])B9E\8<)PN^+S1G1+8$8&-F=\3U[?X0 9M1357;U;>3B
MS#18XH)\D)?3R#-*UZ%IY/4UZW&9[T7B-+.Y&"0.6+0S,S%$K+SAJ9JPVGJ)
M6+8H-E.WL6@=_".ZN2P8 .9M;\DJ_=Y)ROJVFTP/31>L:YZYDCE0GY7(,Q*E
MZ^!BT2K@P ER"#']-##C:8BU:_-S5Q,+\ZEMX(A&LAG?W+MSTL,_,7/'"HR.
M*_'<4_LM/ES^ZD"60*>.]0?D4SR'NO$=PPW7S+.-SB.KGG_M>45KR[GPR,(A
MF>]]WGV3K-H&349U0@R7)Q9+,R!"6!QE/7M/2CYA74U>&9?E[D+)*EV'?B(O
M>Q2?,UODSV^7YE.3:>X1L4WHQ\-]CGD[R#:5K0.*8B=JE(Y4V?Z?2UL'*Y/Y
MULAZ*YZ<)0K7S8[<*:",PG6PX\ZYAJ9@TWEP5/&1OM!R^P]*,*B#O2MQ/'MA
M1&2"_%01,;HNSPQA_,;722R#,'FRO3L![YY;;IIAEF_B2!6N:1ZYOJ<TMP5+
M".K@U0\0ZIF%;7OQ0!D9$C[^Y[<;YEB52U8'V]8..N5"E5V^#M8D!I&S"3_\
M2=EB%)QU[1&N>>&]%GGT=; VV?'EIM@9A>M@AWP1+G^'6V'ZV@Z6BFX8SEL9
M*L^HKDM!?(P$G79BBAX,"K\YD;/!3$Y7V]FWS/,G3XS^E^B0RL##$7[A*UI\
M4T+Y@RR9C/:4"T5$A5K !+ "<_Q T6A2YXDXV/86P9?F)6Y?B+JVT&_\%/LB
M2F^7G5+NII5\!N^^ 2GSC-EYU<-IYW7JRW+GN_-'=#N95B\IYMU'0U\H-5Y!
MB6_,\CSB#$PS/!,RIB-LDX$9'2#YZEA>F=69;?G6-FC$=S& ULE\)^SL,FLD
MEZZ^65)T97R<TD$4 !'8#B)\8 U8%G\V3M)C5.!5UUQI?4:HV-I_'E4=HJG8
M2RQV8%+LP'C:YPOO$/*U EN0961UL"T]:ED>/LT]ME*,N+:Q:V4PFG^M1&;Q
M.N (<:/B!%$1RCI8>$L@BW[F.PX';(J=<)_<ZC48<DO+<*B#Q2*[!*^+-H('
M.2>/)CE!M0#AGVJ?N(3,U9_)#'_ZZ7]02P,$%     @ E(4"5:>YNFLG'P
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MQ$TJT;8^$UH]N0W^3<B3>+2!9TUF103R.P*%/(8C:.Z8U$8);WPORQA@N/D
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M09.ZI^"9U+VA0(61,1$^BJAL(4/3NB?Z-CQ/X<BY/\+L*)^6]\7$G%.7\-W
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M5IH<B)AC5#;ZW+[&X%9$]YRG]63HT8,\MHP^U[^O?P3R1?_ZI_\#4$L#!!0
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M@6S*1.Y1C YB80X\%SE(K;URH<=3],=FT &ZN4L@U^DF]&(\6N:$S\KBZ]F
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MOEM#ZB%TI\&9CK1QES>F+ZN\6G(NR1"RYJ!3E4BT%ER.9-@9Q3#Z&$A21[+
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MZ^JAK5>UU[-[)_!V[=X9P?P886[DY89#;_GM^D>D#_Z/?_G_ 5!+ P04
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MT0=M++6_/5/G!/39-?F"=>Q]TR9.W2A^ UK$M[H/M76RP6N0S5.GX&?</MD
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MAU9X[#ZK(TW B?ZM8TGNM_C]MEA5*SK_E%=_W)6_:77*)<T7RZ</IBZ3; /
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MS 3$4< 4HPH)Q!WHT8=.$Z7+=8':JKY@$OLZN[0[NW;*NCERM!D8AS/7EMR
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M0-6E56O_*5^KWC_0J<>\V!'UL&@/3,@7\@ V1@P=4M0?Q&%3 [H4F$**@ 5
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ME,20RMB\XOH/%-!$>S8]0@$N"I[H9?_.4<I\K?@-6+2J UKKWO<(Y=P<!%%
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MI88T*SC$*J<<IPS3PJMM[CAJ3XWM.@.:.1W@=_-1K\V.D1?=C3NGMY0#\V_
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M#D8?T87+-6&\\4[QS<=EM5G7<< ?YIMAW/_Y?ROY;EZ)U=-R\WFM'N9/#W:
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MCL^]I$[-5]GI?0-VFH-6==#J[K$=XPR_PZ[6$* .3!=N>(9TDW8&UF/#:PB
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MYTN%9IE($H'R&!*JC)<><00I0BGD(L\QYB@V7J)KN>59*5/CJUI1T*AXT_X
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M44)W[LXCE]%=,/"XE.[2!5>TH[6-;NN82-T1LZD!$)'0$4$YE)D-8(@H,YX
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MWH&M&=:Q; T!QA)0F5(_KJ+:_C;F>):(]EPM-S=^A#48^$7G#3_XH[(%6&-
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MHY33I?TZ1)0CIUPN: 08'3F)4'-P65#(+Y,QK,[F#0_-01\NESCL2YR.@#P
M$#JPK8\E<4>9/ Z=E06KZP @X4W-:CD0M2VS8:SX]A5=C] TK.U]ZJ<9QZNE
M&<R&:HK]=J683[@<IS#YEJM6';*_7>)IVV4_P-Y3]LXN3.I01\MCJ9>!L62R
MFZB 9Q9+43J:!^<B]=H[^] V/;MUZ-'2,Z<MF7NOL'H[M9\9,_17ISS9?8[-
M&XZ?E*&A[W4:X[15SZ;V8.C ]?WVZHJLT-E\I8"\NE)XB_/54*^1CUDEB[X^
MM=&@3)U![E4 +FU*0I!K=8I6FCM0-O1MT,FQVEP]W8%N/3;NV<7R$P61_XEY
ME(LPVB<+VM<1+U@"1%F+U;76C-N,I;F[^3!%0U_^/"G(CE)'I^!ZM5A<$"=*
M)*E\02"1D,,<I:2XC MPW$:MZ@0AV[HP\GYJAKZO&0!4!ZBA4T!=OVL/ 97G
MC$RN0@,J! LN)@XI%>EY]"9AZ[3/(R0-?=4R +0.54@'^+I6QW'_ 1^4R9+.
M=@Q&@9(\@,_)06)>A**L,=DUQM@.9 U]OW)BG+563%]8NWW.VZ1,D0*2#*X^
M:780$M.TB[B.W%>',IX.8P?Y7">\7'DZ;!VEB!XQM3GF,3(A47JH,T9 667!
M&^<A14/'O[>&-R_>NH>4H>\WGAI+!RB@1QQ=/].-,AY59,!++=(1J8 3=+H[
MGM"8@-SQ$]:@'N9A-9^N.1RB#E7%]SB+\_T'^O/WEV\^O#_[]>SMRW?//KRB
MGS:[<KCGXT]^W; +6XVN&M9%=I<HO82D"AP-)R"&0MZYJN_B@C8,2G+2.1W(
MDVJ]B>\AY?@BO"\XO<!?:6L^KQ? ])'_&"\_/;]8+&FY^>6M<<T<T__G6F<8
MO"B%YYH]J?TA"_<0/"L0HF7&BHSH6\>)!Y Y;/*_!7)NU]N=5E<=')V7KYLW
M,YFN^IKZ5%R.G 0GA*Z=/GQ] \# )"9,S.B3/]ES\YO$#)NK/P6TVLB] P#1
MA\SFSZ9YTW9MP\[(,JL=<@[(HZU'O0+G>.UK*Z65EGM96C=/O)N28:U2(S7?
MK.\X7N8=(.?]Q>?/DS$NMN2GG)4/RH$7M0FVR=4[I. UB%P,6<V<1?/"WV])
M&-;,G 8KQTBY Y"\G<\*G:VK9T._(BY&OI!A39[7"W)%1C=$"A\T,1%]0)=D
M"+:U)WB3AF$O]4X#DZ/D/'2SS$N1W*C#V&+>H!6&!0/:"@:*E4@'-=<@K<LJ
M,%?<S<E[]S3#?&2A82_FV@*CN6 [,":;1UV+5>W.FH5+#D?1!F0^%O &24C1
M(/C (AB+7*;HI$BMD]@/T3/L3=QIC$PS^?> I2WAE9_%%4.+4<PL!.T=45[?
MQR@3P7/I:8\4'HKP,C<?&'8O,</>LYT(14TDWT'U_&\X)4XFM0XPGX^GXRJ;
MY?C+I75U3(7HK08;<@(5<@97@TQ,4J$2TM#9U!A(CY T[-7::>#44@L=V*7K
M%:;T]03OG R:G%7&6M Q!E"<V*%PP$%PFIM82)*Z=>^B7>@:]K;M-/!JKH\.
M,/;+Q6(\I6CA^>P\DE=86:@OF#[.5U]NLA(KZSQBG/DBK &7BR /D4RR4\29
M=%[*4+*/S;.(NU,W[%W<:?!V(MT,'>*M>NAO\O&C%(N(7CM0(EM0FC%P-DDZ
M[)E.5KMB;MX&W1//7?_4W1*%[/M PW$RVU_9?JWL*7ZL\/K02.=A/*W]-LZF
M+\:+SYM;ZK.RF;]69RVDV70QFXSSVHJBRH4G@:!R("MJZ2M"L8:2"TNJ&"UN
MEKK=!XO]%MX-.=])COGDDC\67$U.L*MF+O5R;_TJ\G=<?IKE:U.'1\[D8F4P
M8%FM5W#60<2BP<G"ZY0^B:5U2F GPG8#W'>6J&ZODN'-V&6,L=E/F^/WP^PU
M[:AUH_+WN%Q.5O>*(UUDEDHJ8)JK=>^68%6I@6RP,ILB<NNG4CL1MAO<OK.$
M=WN5] 6W164.R8*__+/*[F*\^+2N^ZIM\T=%<6XQ"& YD>O'E:6@-G.(R7-I
MLS&B?6KA,:)V@]EWDCX_C2KZ@=@JE?MF-J78]F(^7[6PJ.9[FS11F0O#//F8
M-:H@,YWHJY1!B^)**EX;U_K5P<,4[0:N[S&?WD8)'605;LEHE&7FND[ -3X1
M [1/('@E0!=MR>&TY @T1]%-(G8#SO>:0C](U!VDSB\9N/(:1\($%I3.X#'0
M">V9JHWI-9 <O$#O32RMW:<[R!BV.."DI6H'RKH#N&S[*WUC'\EPSK:LO<'E
MR"%'%FKG)U7J&!>?P =9P)H2N)(L>=&^QOAQNH8M*C@%H)IKHX/#Z]OHM58+
MCZ<7Q,IF\\RFBU^PS.:;+K(?PI^X>$%?+);C-))>9^5H]VAAR0.,%&DX:27M
M*$?>H&"U'_Q)TPQ[D3ML8<)I\/@TNNO"$&Y8V.RZ7W"*9;P<<>)#>1W J5@?
M#M:QVS%*R#P6E(')5%K77MY#RK 5"Z>#UW$R[R?PJX6"X^7*">!,">EY 4RE
MID2(@5"B(@_49D;V.TC5^A;Y:O5A2Q%.@9,#)=N!5:'S^LJ&[M3GLBC.9&0,
M=,P2Z#CW$#D&$"(G+D7*$ELWQ=^;R&&K$4Z!L-/JJ1\;]0V?(V=<<B$$*%K:
M^IA9@A..Q!:RC13#I*Q;OR;_AH!AJPQ.CJ.]Y-N!L?K;--<:KPK]JT[ZJPTQ
M6?WC>A?P-LS)N1M_7D4C[VMV;=5,]9>P()</O;'HA *-M5#5T9X(JR$0UD2A
MDG:LM,Z='TOSP+4-I\#@DZJQBSOK;ZWWES">K$WWM2?WFRZ_&P:M9"B"@,*\
MK,_X-83D/8CHG>&"? C9VCW;D\2!"R=.?\2V55('QG.[T;9=C-[50I TGFPZ
MFFXE*%@0S$0#.M7&?S:2++G/(*0NF+Q.J;F)W(VR@2LG3H&X$ZBD@WS:3:[6
MNR5IHSDC<QVUKV]$)$)T2H ST<DZ;BFD?&)<[6&X3H6B4VC\$5#M+_X.,?1B
M/*G.PDAZR:SV%%C'6'>;CN <TA\Z9*Y4UKKYY-Y[2!GVP?$ .#I$!1T@Z1]8
M.WIC?O8%Y^$COKDXCS@_*[<Z'&W8>S%>I,EL<3''5V3HKZYLE1',!QM!&I5
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M&7CA,J#3+G(K2A*MZ[>>EL-A4^<G*V+H&";?^R8:"<>BL$F ]\&#\K5:TZ<
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MMGX?$?<!D3NB08U&I*PD6.9MG=9!3&C:1<+E5+P*M:3__Z!L_5XZW2E;OX^
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MCB(A"6?# 8W.VFDM>&R=?CF"W $[83P5;)]*F4-'ZX\Q0T*88UB04[;^;ZV
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M''&DF6H^96TWRH8MW7W* *25>GH"W35?>G&;OXU[PPW3P<<(0;E"S&D-T6$
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M[ZUO@AZ@ITM+L@\2[F_:=:3POR.#\O[BO,XC/^)!Y@.?=BH#\Q#1IS4T48;
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MX;O;@=T!^(#U@,T7GW];7EXN_UDOG<(W^MG5CYE0-F4FZ2BH*&L#7$Z1@N'
MR /4+E7?$!NCZ3 *>U)61X)B/\ :3T*=X6]FLT&OV;I7 X46IMI^%P-P+[*1
M41456[\\W%V_I[N<]M@YB+N]YY#49,#C,B V_[)IKL,#Q#3*:MA\^N95.Z"-
MR'0=4J(I6";;!;&>;8.66Z<H7G;-.][]1,'I%_^K%>+=(J'5;8=3 G1 YCPX
MYVU-Z*QSWA4'9(IQ'7D1KOT#P./T3'SY<KSD[S\!-&)Z#^9BO9=MQ__%Y_W=
M*$L1) \2;!*18@+/($B4D+TAR^>T:_\(^31%$_?E:@VB)HQ_%K;EA$;G=_]]
M>SLS8G/S/;B8*)1,Y'-@K#UG16&D)&J/+H%")-12^>8O)DVLS2;*7X^Q>['(
MNS+4.:XV(-YKK%V<3%9;"][7UU5N GC#:*^JE"04H9J77\G\H!6[,BR'"/GG
M6Y0Q^-N%A2'^U#+0O6T$(6H3CT""#[6Q>Q00HY)@HA&9&1-2;GUQ^P@I7=F4
M8_#3DM7/PIB\7'[]MES09U?+\F'^^<O5LERO-@<H_'2 /N!%K3>Y6F[^W2F9
MWDT6;F^^FK)B'+L70V))B@($88(TY[4!2T;@Z!(&D4AY]6GW=E^[Z^JO>?RN
M_'VUF>MZ,WWK7=G\K7FX>+_<# Q_5;FYFM-1?#-?7<T$&H69K?MHUB0A27H[
M) ->D'<GL_(ZIL9L:$)X5^;U$"P]U4OC/&+LP/S^'&'<M!#9%A<?L&^==1*>
MT4:C<_7:C +;P#T%.\R7$C,WS4?RM**]*P-_"H(G$68'('ZP"\[AN_;"B*25
M 1MJ)^/ZB[/!@Y".BV(*R_$L;8K& ?!X+:?'4<%G$F2O\'V[7*2#-ZY80FNE
M)[9G!:K$6'FO01J;$Q=<!-\ZB:X9\=,^5X\-XM'%V0&.MU<4.QZBRLQ6PGGF
M#)33$3SG IB7P5K#C ZMYS3\3,&TG6$:(NH$QG;1B>-GOV3/MYYAEIX\"N)'
MKJV_6%#@A.6UQ:'TQ40O]OO7-O8<]PB:-J Y1=9/NH.GL+T#Y?)$=#9+(8H<
M#0.?6!W8&"6XH"(DE5 P7C1BZW?:)\B9-IQHB)]6+)\ZS?/!#>1HA1<E <J:
MSEB*AFCJD'$5>4J9 ATUK&OVT1 8S2%O ($V?.NAU]WM#>>M*2X*N98<C.2)
ML,L2>)$S2.6-XM(59.V3ZNZ1,6TCL8;>R:DL[L"X/')Q<K,=E73!(F(5;!V?
M%!+$2'_DWNHBF1(QM$[J_05)$]^ZGBKR81=71_&_7SCM.C8FAE)81PK9<U\;
M&V1P1=;F4HA.1<%\/N]5Z;1@:BK\@VY$#Y)$O[BZO5N8685.FA+),%L'BOQ[
M<,I%,%DG)C)30;7N*?=+HJ;UAR= UY'RZ#!4OVTIGPHWVI#;)X(@)U+6_))@
M&3#A(T8N-?)\'F!-ZUM/ *>#>-^!R_W@_>=M-"(39BXS(+&#-A,8!$O12$[.
M4$A!Y\2T-GY/$C3QXU]C1ZH=[SLP=T^]!LUD]D*7:$%'+6MUA0 G@B4CKDOQ
M3KJ0S_E8-ZT+U5#L![S('22#7O%TQUB7* LC'0O*^]KW)P0(3"&@4KSH7$1H
MGHCT"Y*F54YG1M61DN@56+,HO)'%!RC,<%"1X@KGF8+DO,,0O1;-.^ </_5H
M-(?IS" ZB.L3.DNW%ZRWI!M)+F)!![).+U0L!U*G*=6+]:!E2#+D89GQ1\A_
MM/[Q#2X:3^55,S&/F;/<I-WTPU]JGU5\EA;3>\BI-4TQ9@$E)K()P4KP&0/D
MP!EI$!EM:3XJJ5UYS.M%NJQ?^QTW__]Z\;#Z<A99X-F"$-S6>0<2 D<&FA!>
MLK?9*#M(!PQ<L*OLW4-$_)-R&(.[4[]:/KVGO6>YU8S8QECP&;)VQ+N"""$%
M ^1&:5>2HI^%!L#97[>KW-F1\',2KSMP3^_O[K&;)E42)HL>&&I/&V,68I"<
M^,FU=LDZVSR)>S!Q726Y'H.T<<4Q_5#$1T[2DUE(JYG34KK 9>UL&(F3AE1R
M$>2O%S0E"VTCNB/UUM,K=Y5OVE!S->1W:TR-Z3^O?WWUYS=<K##4*6:K+W]<
M+/_Y>E&6EU_72YWL6 ]?HKW'?>3VQG'%LXO"&&O(C7(95&(>?&$4TW'-HPJ!
M&]^\%W33BKV?ST@MB9U)3R;=:@HH<Q'D&G*RZ89%X$(7SX,V 5OOZ3X577GC
MATCYZ:>L@QD\M>]]U_NKQ//;^FN>O5#.0*G\4-(I\$&0A4[!989&#357CR[1
ME4=]# 8:<K #Y_F)0.#%9H#<6C8SY,H&"BL!O2B@#&W02Z4A2"F\QV@<'[/T
MY@G2IE$J+5$P/"_Y:)%TAK3=3,RMQ9_%(K*7Q4,VQ9'7%C1XY0/HX*/$VE$N
MCXFN/7*F45%G0M0IK._-;A'QT085&5BG:P498Q17,$G$!W+64>J0A]T*[7]Y
MFFA\! B<SK>I7Y'^(US.:T.7%XO\\0NIOSH'\G8G0623/&8"[7J*%FIPD6DH
M)@FM@S&1#4/ D\MT=3ESM-/2CI,=F)-;PK.2-96(@]!U_!!'59O%)6#U2-32
MG6C:-WH\!!CGNF4Y):(YCIU3ZX;=/<&F4]BMHD3&<^T<Z+PQ%(MI5J>Z(]B0
MG;4VI^CE(*7P\/>[*KP]6ALTX%T':N#G2/Q]^%%+SU<S+P76&V1(5A%77'T_
M5\H35YC26=(>]N/8QM<=.THFC$Y:"/C)>X^CN-T!9AYRA[=[>;>X?9XH2CL3
M1'V/J$E_]"L$FSR06DP9A;/!M6X?/HRR">.3$3 U@C0ZP]C[R_DBS;^%BYL#
MPY4,*GE/_G?UY+-&<$A!E].T1:9XQ%$;F=PC:,)P9V1$G<;[#H"T=P/T+EZ%
M^0+SZ\6K/].7L/B,?RPO'WM@=8F"^%C[,JM:Q6Z+A"B0$4\S4\DF$U7K)J,G
MD-M5Q? IOO2Y1/9,T/EPKA*=08VJ4%P1:AE(<;'V$#0@34JDR[V-I?F YV.)
M[2K%=&QDGBZNSIOH_HZ7\^_K],[:(_;?,7^F8_@BT7]8%RH=\X#^JT^V?# _
MB/Q&#^2W:]Z.E*G-NN^M_OM\E2Z61/NM)4>MC'<L$%YJC6AQDO"J$P@EI:T7
MCKYY8NL)Y)X^-^W@I6\[5<<4,'@6 3%7UZ0.6\*<H#9)\]J(%'+K*M13Z)UZ
M.-9Y,'E_4MN9)/R\U>CQ$R^&??B,*G7$&1FG@%BQF"WYBZ!UJ).\R!L(EI-+
M(+)2*)U+LO7]Q(2*]6/Z@OGZ M^5!XFX/6+"%&=8,5"\4J"T(K:X]5-9T9A<
M48ZUMC=#:7N^"O,0K-V;TCV&Y#J(?7ZQK]>+IUJA_A'FE_\1+J[OV :=.,O9
M2"C!,%"Q=FO1=2:ZDS9[$0SJUMGIC;<P]<3#+O$]*@ZZ.@:[V]L/M-T[)G5O
M'(M-2A83+8AH+) ?)NJ47 ;D^00CHV:J>:[/@21.^]H_/8S;R_%YN[(M:E</
M7>*,[NU9JEU/0;7SIGA/"C$9F0C5"0EIZ\8)*6H;O!&E==>O"1W=#Y@NPFHU
M+_.T%OF[:[(;+U*Z_GJ]'F'T[NH+7M:Y1Y?XI793KR22J#=STF8L(T\^<+!>
MR3H;@ ),7O-Y!.>I>%>B:3UFYR2"GZ]+? @J[]W#GDW&'3@(#S'YPWSUCQ=_
MSE<S2Q0GK24P=-79R18BRPFX(7<?,7BASG'EM:-G6CB>$18#+K6.DE%7>'NY
M7*S/ZB?ZE[\OZXS[690A&>\,I%+K Y,H$)+3=1A@5B7HC*5ULN!3]/2G_HZ3
M^J-P.E$$'<#IKC?\\9_AV]_P:\3+&:9L,-H$TM1>"]([",8'8,XJ#*G6-;<>
MZ_ P);U Z%1)WRLC/YGMG8'GY<TFD@Y)A*Q IEKX+NA\>68S&%ZX%Q2PB=A:
M"3U(2"_W-2-"YSBF3UWH\HFD7M,K_YC_65_G?SX)J^V&.+I<4P% E\C) <T.
M7*G3#PP%XUQ3M!^'C7@8LEHO=R*-H#(.E[N #3F12(QZ<E,9F0A66P*#+J"4
M4Q"S#(#<(SJ,*2LQ'#H#5IRV3F)$^+3F=@<V:QO\_HZK^>?%1D;5'Q0N&,S%
M@F.EUH4X5^_[!!C:0>%)&]F\L_'#E$QKM::+T1K(I4MT;<\A4\HSY0)DKP4H
MBX$\.YU!%END#(9[WSI9]3%:IG6I6\CYE] Y@ND=@&>W <PO5ML]W4:N6VT;
M#/."B(?H=7V7B J<J_.@5,J1N83.M'Y?&D!6;Y Z1O[W@ORVPN@ 7V^7BWRS
MJYWUSLY8@T1X";7J.C(()0B(@D5I'?W9MWY]>(",:8W>*/@YE=D=X&5745T]
MOK62+H8,N4T&G"@&5&W4'!VY>L6K5(3&)&-K([9/P[21VG3NT4FRZ Q+V],E
M4#N+%#-PIF@':',M53(@=3+:2A016ZN>^U1,:[E.D^H3$#F"Q1V Y WIS.5B
M'6C&L/C'NT)48*[[>?/ZMW<?MEK48]%")PF%DP)53">(-M3II8*B=SI:R;3&
MS2#"^H'2,=+?[YC07!137A]=7LT^U *@]1G3]:I4Y A>2_+:HD>(M0]$[6$?
MA);*F$'S(.FK=[!#?[K%S4\+3GL[='Z3=3RW>X#(#MF*UZLL#;Q$7>?CRGIO
MEH!"U%R<371T!KDZ0T RI?HX05C[XCZ"<Q,+_&_SQ?SK]=<MX26*H(51H!PG
MPH,7X)$Y@CYGY)L70S:X@<A_6G1BH1\CLF4+_G7@;.PKQA?YOZY75^M$YH$J
M\MWB3N[AF_D"7U_AU]4L9<U*XA*0VUK<SS-%C=8#(NJ@4Y:NC)VDUFHOT_8"
MFB[:Z@(;'9R17?N*>D."_T8^Y9OE:O5I^1O>,@CS?\ZOOLP7G_Z)%]_Q;\O%
MU9?5++"BM/<2.)I<PQ@.KK9=5-()JTKR2;:^*#B2U+Y2XJ;!V?+\0I]^X,'-
M/=UU-5Z/E@7\.U[DF3;,NH 6@LJD2F@S$)648$1PLB3&=6J=#36 K+Y>"KN
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MSB(6.=8FT,;P@Y%P\_F.:]^:(.$X/G:%A%I?L]V#S99KCA&2)Z]0%<W!Z8C
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M,G$R97AH:6)I=#,Q,2YH=&U02P$"% ,4    " "4A0)5RR4@+ P(  !8(P
M%0              @ $F"   83(P,C)Q,F5X:&EB:70S,3(N:'1M4$L! A0#
M%     @ E(4"5539-%\,!0  ^A<  !4              ( !91   &$R,#(R
M<3)E>&AI8FET,S(Q+FAT;5!+ 0(4 Q0    ( )2% E5//)\X7?<! (RI&  1
M              "  :05  !S9W)Y+3(P,C(P-C,P+FAT;5!+ 0(4 Q0    (
M )2% E43M!8@+A$  .NX   1              "  3 - @!S9W)Y+3(P,C(P
M-C,P+GAS9%!+ 0(4 Q0    ( )2% E6GN;IK)Q\  .XH 0 5
M  "  8T> @!S9W)Y+3(P,C(P-C,P7V-A;"YX;6Q02P$"% ,4    " "4A0)5
MQ%,[X8Y+   F- , %0              @ 'G/0( <V=R>2TR,#(R,#8S,%]D
M968N>&UL4$L! A0#%     @ E(4"55B?L7SJW    00) !4
M ( !J(D" '-G<GDM,C R,C V,S!?;&%B+GAM;%!+ 0(4 Q0    ( )2% E5?
ML__ZFH4  %WV!0 5              "  <5F P!S9W)Y+3(P,C(P-C,P7W!R
;92YX;6Q02P4&      D "0!3 @  DNP#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
